{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"name":"signatureSearch.ipynb","provenance":[],"collapsed_sections":[],"authorship_tag":"ABX9TyNbdUAMhPwcotgY1J0so9hj"},"kernelspec":{"name":"ir","display_name":"R"},"language_info":{"name":"R"}},"cells":[{"cell_type":"code","metadata":{"id":"-6-ZYicdCe2W"},"source":["if (!requireNamespace(\"BiocManager\", quietly = TRUE))\n","    install.packages(\"BiocManager\")\n","BiocManager::install(\"yduan004/signatureSearch\")"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"turASPSaCiP4","executionInfo":{"status":"ok","timestamp":1636344680734,"user_tz":-480,"elapsed":300,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":["library(signatureSearch)\n"],"execution_count":58,"outputs":[]},{"cell_type":"code","metadata":{"id":"4V4TmMz8wba1","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1636344693584,"user_tz":-480,"elapsed":9363,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"b6e5238d-2432-4235-a8bc-376f59f76d76"},"source":["library(ExperimentHub); library(rhdf5)\n","eh <- ExperimentHub()\n","cmap <- eh[[\"EH3223\"]]; cmap_expr <- eh[[\"EH3224\"]]\n","lincs <- eh[[\"EH3226\"]]; lincs_expr <- eh[[\"EH3227\"]]\n"],"execution_count":59,"outputs":[{"output_type":"stream","name":"stderr","text":["snapshotDate(): 2021-10-19\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":187},"id":"CAjjSqqHyqRn","executionInfo":{"status":"ok","timestamp":1636344693586,"user_tz":-480,"elapsed":9,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"327bad43-86d7-48a2-c370-c768562a95a6"},"source":["h5ls(lincs)"],"execution_count":60,"outputs":[{"output_type":"display_data","data":{"text/plain":["  group name     otype       dclass dim          \n","0 /     assay    H5I_DATASET FLOAT  12328 x 45956\n","1 /     colnames H5I_DATASET STRING 45956 x 1    \n","2 /     rownames H5I_DATASET STRING 12328 x 1    "],"text/latex":"A data.frame: 3 × 5\n\\begin{tabular}{r|lllll}\n  & group & name & otype & dclass & dim\\\\\n  & <chr> & <chr> & <chr> & <chr> & <chr>\\\\\n\\hline\n\t0 & / & assay    & H5I\\_DATASET & FLOAT  & 12328 x 45956\\\\\n\t1 & / & colnames & H5I\\_DATASET & STRING & 45956 x 1    \\\\\n\t2 & / & rownames & H5I\\_DATASET & STRING & 12328 x 1    \\\\\n\\end{tabular}\n","text/markdown":"\nA data.frame: 3 × 5\n\n| <!--/--> | group &lt;chr&gt; | name &lt;chr&gt; | otype &lt;chr&gt; | dclass &lt;chr&gt; | dim &lt;chr&gt; |\n|---|---|---|---|---|---|\n| 0 | / | assay    | H5I_DATASET | FLOAT  | 12328 x 45956 |\n| 1 | / | colnames | H5I_DATASET | STRING | 45956 x 1     |\n| 2 | / | rownames | H5I_DATASET | STRING | 12328 x 1     |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A data.frame: 3 × 5</caption>\n","<thead>\n","\t<tr><th></th><th scope=col>group</th><th scope=col>name</th><th scope=col>otype</th><th scope=col>dclass</th><th scope=col>dim</th></tr>\n","\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><th scope=row>0</th><td>/</td><td>assay   </td><td>H5I_DATASET</td><td>FLOAT </td><td>12328 x 45956</td></tr>\n","\t<tr><th scope=row>1</th><td>/</td><td>colnames</td><td>H5I_DATASET</td><td>STRING</td><td>45956 x 1    </td></tr>\n","\t<tr><th scope=row>2</th><td>/</td><td>rownames</td><td>H5I_DATASET</td><td>STRING</td><td>12328 x 1    </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"Py_Z2vIswlui"},"source":["1. `lincs` contains moderated z-scores from differential expression (DE) analysis of 12,328 genes from 8,140 compound treatments of 30 cell lines corresponding to a total of 45,956 signatures; \n","2. `lincs_expr` contains gene expression intensity values from 5,925 compound treatments of 30 cell lines corresponding to a total of 38,824 signatures; \n","3. cmap contains log2 fold changes of 12,437 genes from 1,281 compound treatments of 5 cell lines corresponding to a total of 3,478 signatures;\n","4. cmap_expr contains mean expression values from 1,309 drug treatments of 4 cell lines corresponding to a total of 3,587 signatures. \n","\n","To minimize redundancy in the `lincs` and `lincs_expr` databases, they were assembled from GESs corresponding to a compound dosage and treatment time of 10μ\n","M and 24h, respectively. If necessary one can create here easily database instances for all LINCS measurements. However, this will make the search results overwhelmingly complex which we wanted to avoid here\n","\n","# Signature Searches (GESS)\n","Based on the data types represented in the query and database, they can be classified into set- and correlation-based methods (see Figure 1). The first 4 methods described below are set-based, whereas the last one is a correlation-based method. We refer to a search method as set-based if at least one of the two data components (query and/or database) is composed of an identifier set (e.g. gene labels) that may be ranked or unranked. In contrast to this, correlation-based methods require quantitative values, usually of the same type such as normalized intensities, for both the query and the database entries. An advantage of the set-based methods is that their queries can be the highest and lowest ranking gene sets derived from a genome-wide profiling technology that may differ from the one used to generate the reference database. However, the precision of correlation methods often outperforms set-based methods. On the other hand, due to the nature of the expected input, correlation-based methods are usually only an option when both the query and database entries are based on the same or at least comparable technologies. In other words, set-based methods are more technology agnostic than correlation-based methods, but may not provide the best precision performance.\n","\n","## 1. Test Query and database\n","- use small toy to reduce the time taken\n","- a total of 100 GESs from human SKB (muscle) cells. Of the 100 GESs in this toy database, 95 were random sampled and 5 were cherry-picked.\n","- the latter 5 are GESs from HDAC inhibitor treatments including the known drugs: vorinostat, rhamnetin, trichostatin A, pyroxamide, and HC toxin\n","- to further reduce the size of the toy database, the number of its genes was reduced from 12328 genes to 5000 by random sampling.\n","- the query signature is vorinostat GES\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":543},"id":"EDveOOu-yngN","executionInfo":{"status":"ok","timestamp":1636337745176,"user_tz":-480,"elapsed":973,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"f0224681-d2c2-4798-d9a4-d122061bdb23"},"source":["db_path <- system.file('extdata', 'sample_db.h5', package = 'signatureSearch')\n","\n","library(SummarizedExperiment); library(HDF5Array)\n","sample_db <- SummarizedExperiment(HDF5Array(db_path, name=\"assay\"))\n","rownames(sample_db) <- HDF5Array(db_path, name=\"rownames\")\n","colnames(sample_db) <- HDF5Array(db_path, name=\"colnames\")\n","# get \"vorinostat__SKB__trt_cp\" signature drawn from toy database\n","query_mat <- as.matrix(assay(sample_db[,\"vorinostat__SKB__trt_cp\"]))\n","query = as.numeric(query_mat); names(query) = rownames(query_mat)\n","upset <- head(names(query[order(-query)]), 150)\n","head(upset)"],"execution_count":5,"outputs":[{"output_type":"stream","name":"stderr","text":["Loading required package: DelayedArray\n","\n","Loading required package: Matrix\n","\n","\n","Attaching package: ‘Matrix’\n","\n","\n","The following object is masked from ‘package:S4Vectors’:\n","\n","    expand\n","\n","\n","\n","Attaching package: ‘DelayedArray’\n","\n","\n","The following objects are masked from ‘package:base’:\n","\n","    aperm, apply, rowsum, scale, sweep\n","\n","\n","\n","Attaching package: ‘HDF5Array’\n","\n","\n","The following object is masked from ‘package:rhdf5’:\n","\n","    h5ls\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["[1] \"230\"  \"5357\" \"2015\" \"2542\" \"1759\" \"6195\""],"text/latex":"\\begin{enumerate*}\n\\item '230'\n\\item '5357'\n\\item '2015'\n\\item '2542'\n\\item '1759'\n\\item '6195'\n\\end{enumerate*}\n","text/markdown":"1. '230'\n2. '5357'\n3. '2015'\n4. '2542'\n5. '1759'\n6. '6195'\n\n\n","text/html":["<style>\n",".list-inline {list-style: none; margin:0; padding: 0}\n",".list-inline>li {display: inline-block}\n",".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n","</style>\n","<ol class=list-inline><li>'230'</li><li>'5357'</li><li>'2015'</li><li>'2542'</li><li>'1759'</li><li>'6195'</li></ol>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":32},"id":"9zndau6-zXbz","executionInfo":{"status":"ok","timestamp":1636337745180,"user_tz":-480,"elapsed":42,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"c9404f1b-38bf-4312-ea5f-1c2297616921"},"source":["downset <- tail(names(query[order(-query)]), 150)\n","head(downset)"],"execution_count":6,"outputs":[{"output_type":"display_data","data":{"text/plain":["[1] \"22864\" \"9338\"  \"54793\" \"10384\" \"27000\" \"10161\""],"text/latex":"\\begin{enumerate*}\n\\item '22864'\n\\item '9338'\n\\item '54793'\n\\item '10384'\n\\item '27000'\n\\item '10161'\n\\end{enumerate*}\n","text/markdown":"1. '22864'\n2. '9338'\n3. '54793'\n4. '10384'\n5. '27000'\n6. '10161'\n\n\n","text/html":["<style>\n",".list-inline {list-style: none; margin:0; padding: 0}\n",".list-inline>li {display: inline-block}\n",".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n","</style>\n","<ol class=list-inline><li>'22864'</li><li>'9338'</li><li>'54793'</li><li>'10384'</li><li>'27000'</li><li>'10161'</li></ol>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"v7zXBzd60zPF"},"source":["# 2. CMAP Search Method\n","- Uses query the 2 label sets of the most up- and down-regulated genes from a genome-wide expression experiment, while the reference database is composed of rank transformed expression profiles (e.g. ranks of LFC or z-scores)."]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"s3VhuKNj1a3s","executionInfo":{"status":"ok","timestamp":1636337745181,"user_tz":-480,"elapsed":27,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"67a24bf3-e1e5-4681-fdf7-40d6d8a9a992"},"source":["qsig_cmap <- qSig(query = list(upset=upset, downset=downset), \n","                  gess_method=\"CMAP\", refdb=db_path)"],"execution_count":7,"outputs":[{"output_type":"stream","name":"stderr","text":["150 / 150 genes in up set share identifiers with reference database\n","\n","150 / 150 genes in down set share identifiers with reference database\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":411},"id":"uP217uzK1y_W","executionInfo":{"status":"ok","timestamp":1636337749125,"user_tz":-480,"elapsed":3960,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"fb709564-c86c-4d96-c8bd-5529a15bc278"},"source":["cmap <- gess_cmap(qSig=qsig_cmap, chunk_size = 5000, workers=1)\n","cmap"],"execution_count":8,"outputs":[{"output_type":"display_data","data":{"text/plain":["#\n","# gessResult object \n","#\n","@result \n","\u001b[90m# A tibble: 100 × 10\u001b[39m\n","   pert       PCID    cell  type  trend raw_score scaled_score N_upset N_downset\n","   \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m      \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m   \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m     \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m        \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m   \u001b[3m\u001b[90m<int>\u001b[39m\u001b[23m     \u001b[3m\u001b[90m<int>\u001b[39m\u001b[23m\n","\u001b[90m 1\u001b[39m vorinostat 5311    SKB   trt_… up        1.94         1         150       150\n","\u001b[90m 2\u001b[39m rescinnam… 5280954 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m295\u001b[39m       -\u001b[31m1\u001b[39m         150       150\n","\u001b[90m 3\u001b[39m zuclopent… 5311507 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m287\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m972\u001b[39m     150       150\n","\u001b[90m 4\u001b[39m evoxine    673465  SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m244\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m828\u001b[39m     150       150\n","\u001b[90m 5\u001b[39m scoulerine 439654  SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m242\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m821\u001b[39m     150       150\n","\u001b[90m 6\u001b[39m gangliosi… 4673190 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m239\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m809\u001b[39m     150       150\n","\u001b[90m 7\u001b[39m warfarin   546784… SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m234\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m794\u001b[39m     150       150\n","\u001b[90m 8\u001b[39m trichosta… 444732  SKB   trt_… up        1.50         0.775     150       150\n","\u001b[90m 9\u001b[39m endecaphy… 6710740 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m224\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m760\u001b[39m     150       150\n","\u001b[90m10\u001b[39m HC-toxin   3571    SKB   trt_… up        1.44         0.745     150       150\n","\u001b[90m# … with 90 more rows, and 1 more variable: t_gn_sym <chr>\u001b[39m\n","@query \t up gene set (150): \t 230 5357 2015 2542 1759 6195 80347 5050 5883 6251 ... \n","      \t down gene set (150): \t 22864 9338 54793 10384 27000 10161 23363 114034 2997 23108 ... \n","\n","@gess_method \t CMAP \n","\n","@refdb \t /usr/local/lib/R/site-library/signatureSearch/extdata/sample_db.h5 "]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"BVb6daJJ13ME","executionInfo":{"status":"ok","timestamp":1636337749131,"user_tz":-480,"elapsed":26,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"6da845b3-a2ef-433d-eff6-1d79480ed9d5"},"source":["result(cmap)"],"execution_count":9,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                            PCID     cell type   trend raw_score \n","1   vorinostat                      5311     SKB  trt_cp up     1.9406000\n","2   rescinnamine                    5280954  SKB  trt_cp down  -0.2951667\n","3   zuclopenthixol                  5311507  SKB  trt_cp down  -0.2870333\n","4   evoxine                         673465   SKB  trt_cp down  -0.2444333\n","5   scoulerine                      439654   SKB  trt_cp down  -0.2422667\n","6   ganglioside                     4673190  SKB  trt_cp down  -0.2388667\n","7   warfarin                        54678486 SKB  trt_cp down  -0.2342333\n","8   trichostatin-a                  444732   SKB  trt_cp up     1.5049333\n","9   endecaphyllin-x                 6710740  SKB  trt_cp down  -0.2243000\n","10  HC-toxin                        3571     SKB  trt_cp up     1.4448000\n","11  pyroxamide                      4996     SKB  trt_cp up     0.8067333\n","12  APHA-compound-8                 10379137 SKB  trt_cp up     0.4280333\n","13  MD-040                          73707398 SKB  trt_cp up     0.3973000\n","14  scopolamine-n-oxide             3000667  SKB  trt_cp up     0.3574667\n","15  calcifediol                     46705323 SKB  trt_cp up     0.3518333\n","16  I-070759                        24086306 SKB  trt_cp up     0.3499000\n","17  benzonatate                     7699     SKB  trt_cp up     0.3229000\n","18  fasudil                         3547     SKB  trt_cp up     0.2674333\n","19  ryuvidine                       481747   SKB  trt_cp up     0.2605333\n","20  hydroquinidine                  45479756 SKB  trt_cp up     0.2582000\n","21  calcitriol                      21158442 SKB  trt_cp up     0.2542667\n","22  crotamiton                      688020   SKB  trt_cp up     0.2395333\n","23  GSK-0660                        46233311 SKB  trt_cp up     0.2334333\n","24  fenobam                         162834   SKB  trt_cp up     0.2245333\n","25  GDC-0879                        11717001 SKB  trt_cp up     0.2145000\n","26  ST-4066738                      1043828  SKB  trt_cp up     0.1936333\n","27  vicriviroc                      73707391 SKB  trt_cp up     0.1167000\n","28  rhamnetin                       5281691  SKB  trt_cp up     0.0000000\n","29  huperzine-a                     1253     SKB  trt_cp up     0.0000000\n","30  XE-991                          656732   SKB  trt_cp up     0.0000000\n","⋮   ⋮                               ⋮        ⋮    ⋮      ⋮     ⋮         \n","71  formoterol                      23581795 SKB  trt_cp up    0         \n","72  propylpyrazole                  35027762 SKB  trt_cp up    0         \n","73  midostaurin                     9829523  SKB  trt_cp up    0         \n","74  NSC-693868                      438981   SKB  trt_cp up    0         \n","75  CGP-13501                       3519541  SKB  trt_cp up    0         \n","76  SPB02303                        2744062  SKB  trt_cp up    0         \n","77  aprepitant                      151165   SKB  trt_cp up    0         \n","78  carbetocin                      73707428 SKB  trt_cp up    0         \n","79  decafluorobutane                9638     SKB  trt_cp up    0         \n","80  ketorolac                       3826     SKB  trt_cp up    0         \n","81  4,5,6,7-tetrabromobenzotriazole 1694     SKB  trt_cp up    0         \n","82  TUL-XIX029                      67243342 SKB  trt_cp up    0         \n","83  SKF-77434                       11957703 SKB  trt_cp up    0         \n","84  oxalomalic-acid                 439620   SKB  trt_cp up    0         \n","85  BAY-11-7082                     5353431  SKB  trt_cp up    0         \n","86  ST-013960                       2300880  SKB  trt_cp up    0         \n","87  dibenzepin                      9419     SKB  trt_cp up    0         \n","88  NNC-63-0532                     3906780  SKB  trt_cp up    0         \n","89  pantoprazole                    4679     SKB  trt_cp up    0         \n","90  trazodone                       5533     SKB  trt_cp up    0         \n","91  quinpirol-(-)                   NotFound SKB  trt_cp up    0         \n","92  vinorelbine                     73707409 SKB  trt_cp up    0         \n","93  afatinib                        22225683 SKB  trt_cp up    0         \n","94  ST-001903                       674282   SKB  trt_cp up    0         \n","95  L-erythro-MAPP                  6610217  SKB  trt_cp up    0         \n","96  loreclezole                     50988829 SKB  trt_cp up    0         \n","97  D-609                           45479729 SKB  trt_cp up    0         \n","98  RAN-05                          44229302 SKB  trt_cp up    0         \n","99  terguride                       11957722 SKB  trt_cp up    0         \n","100 K784-3131                       4381125  SKB  trt_cp up    0         \n","    scaled_score N_upset N_downset\n","1    1.00000000  150     150      \n","2   -1.00000000  150     150      \n","3   -0.97244495  150     150      \n","4   -0.82811971  150     150      \n","5   -0.82077922  150     150      \n","6   -0.80926030  150     150      \n","7   -0.79356296  150     150      \n","8    0.77549899  150     150      \n","9   -0.75990966  150     150      \n","10   0.74451201  150     150      \n","11   0.41571335  150     150      \n","12   0.22056752  150     150      \n","13   0.20473050  150     150      \n","14   0.18420420  150     150      \n","15   0.18130132  150     150      \n","16   0.18030506  150     150      \n","17   0.16639184  150     150      \n","18   0.13780961  150     150      \n","19   0.13425401  150     150      \n","20   0.13305163  150     150      \n","21   0.13102477  150     150      \n","22   0.12343262  150     150      \n","23   0.12028926  150     150      \n","24   0.11570305  150     150      \n","25   0.11053282  150     150      \n","26   0.09978014  150     150      \n","27   0.06013604  150     150      \n","28   0.00000000  150     150      \n","29   0.00000000  150     150      \n","30   0.00000000  150     150      \n","⋮   ⋮            ⋮       ⋮        \n","71  0            150     150      \n","72  0            150     150      \n","73  0            150     150      \n","74  0            150     150      \n","75  0            150     150      \n","76  0            150     150      \n","77  0            150     150      \n","78  0            150     150      \n","79  0            150     150      \n","80  0            150     150      \n","81  0            150     150      \n","82  0            150     150      \n","83  0            150     150      \n","84  0            150     150      \n","85  0            150     150      \n","86  0            150     150      \n","87  0            150     150      \n","88  0            150     150      \n","89  0            150     150      \n","90  0            150     150      \n","91  0            150     150      \n","92  0            150     150      \n","93  0            150     150      \n","94  0            150     150      \n","95  0            150     150      \n","96  0            150     150      \n","97  0            150     150      \n","98  0            150     150      \n","99  0            150     150      \n","100 0            150     150      \n","    t_gn_sym                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","2   ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","3   ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","4   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","5   ADRA1D                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","6   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","7   ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","8   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","9   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","10  HDAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","11  HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","12  HDAC8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","13  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","14  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","15  VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","16  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","17  SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","18  CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","19  CDK2; CDK4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","20  KMT2A; PSIP1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","21  CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","22  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","23  PPARD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","24  GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","25  BRAF; RAF1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","26  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","27  CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","28  ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","29  ACHE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","30  KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","⋮   ⋮                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","71  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","72  ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","73  AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\n","74  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","75  GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","76  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","77  CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","78  OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","79  GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","80  LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","81  AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","82  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","83  DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","84  ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","85  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","86  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","87  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","88  OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","89  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","90  ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","91  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","92  TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","93  EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","94  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","95  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","96  GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","97  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","98  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","99  ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","100 NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     "],"text/latex":"A tibble: 100 × 10\n\\begin{tabular}{llllllllll}\n pert & PCID & cell & type & trend & raw\\_score & scaled\\_score & N\\_upset & N\\_downset & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <int> & <int> & <chr>\\\\\n\\hline\n\t vorinostat          & 5311     & SKB & trt\\_cp & up   &  1.9406000 &  1.00000000 & 150 & 150 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9      \\\\\n\t rescinnamine        & 5280954  & SKB & trt\\_cp & down & -0.2951667 & -1.00000000 & 150 & 150 & ACE                                                                                \\\\\n\t zuclopenthixol      & 5311507  & SKB & trt\\_cp & down & -0.2870333 & -0.97244495 & 150 & 150 & ADRA1A; DRD1; HRH1                                                                 \\\\\n\t evoxine             & 673465   & SKB & trt\\_cp & down & -0.2444333 & -0.82811971 & 150 & 150 & NA                                                                                 \\\\\n\t scoulerine          & 439654   & SKB & trt\\_cp & down & -0.2422667 & -0.82077922 & 150 & 150 & ADRA1D                                                                             \\\\\n\t ganglioside         & 4673190  & SKB & trt\\_cp & down & -0.2388667 & -0.80926030 & 150 & 150 & NA                                                                                 \\\\\n\t warfarin            & 54678486 & SKB & trt\\_cp & down & -0.2342333 & -0.79356296 & 150 & 150 & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1\\\\\n\t trichostatin-a      & 444732   & SKB & trt\\_cp & up   &  1.5049333 &  0.77549899 & 150 & 150 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9              \\\\\n\t endecaphyllin-x     & 6710740  & SKB & trt\\_cp & down & -0.2243000 & -0.75990966 & 150 & 150 & NA                                                                                 \\\\\n\t HC-toxin            & 3571     & SKB & trt\\_cp & up   &  1.4448000 &  0.74451201 & 150 & 150 & HDAC1                                                                              \\\\\n\t pyroxamide          & 4996     & SKB & trt\\_cp & up   &  0.8067333 &  0.41571335 & 150 & 150 & HDAC1; HDAC3; HDAC6                                                                \\\\\n\t APHA-compound-8     & 10379137 & SKB & trt\\_cp & up   &  0.4280333 &  0.22056752 & 150 & 150 & HDAC8                                                                              \\\\\n\t MD-040              & 73707398 & SKB & trt\\_cp & up   &  0.3973000 &  0.20473050 & 150 & 150 & NA                                                                                 \\\\\n\t scopolamine-n-oxide & 3000667  & SKB & trt\\_cp & up   &  0.3574667 &  0.18420420 & 150 & 150 & NA                                                                                 \\\\\n\t calcifediol         & 46705323 & SKB & trt\\_cp & up   &  0.3518333 &  0.18130132 & 150 & 150 & VDR                                                                                \\\\\n\t I-070759            & 24086306 & SKB & trt\\_cp & up   &  0.3499000 &  0.18030506 & 150 & 150 & NA                                                                                 \\\\\n\t benzonatate         & 7699     & SKB & trt\\_cp & up   &  0.3229000 &  0.16639184 & 150 & 150 & SCN5A                                                                              \\\\\n\t fasudil             & 3547     & SKB & trt\\_cp & up   &  0.2674333 &  0.13780961 & 150 & 150 & CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                           \\\\\n\t ryuvidine           & 481747   & SKB & trt\\_cp & up   &  0.2605333 &  0.13425401 & 150 & 150 & CDK2; CDK4                                                                         \\\\\n\t hydroquinidine      & 45479756 & SKB & trt\\_cp & up   &  0.2582000 &  0.13305163 & 150 & 150 & KMT2A; PSIP1                                                                       \\\\\n\t calcitriol          & 21158442 & SKB & trt\\_cp & up   &  0.2542667 &  0.13102477 & 150 & 150 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                     \\\\\n\t crotamiton          & 688020   & SKB & trt\\_cp & up   &  0.2395333 &  0.12343262 & 150 & 150 & NA                                                                                 \\\\\n\t GSK-0660            & 46233311 & SKB & trt\\_cp & up   &  0.2334333 &  0.12028926 & 150 & 150 & PPARD                                                                              \\\\\n\t fenobam             & 162834   & SKB & trt\\_cp & up   &  0.2245333 &  0.11570305 & 150 & 150 & GRM5                                                                               \\\\\n\t GDC-0879            & 11717001 & SKB & trt\\_cp & up   &  0.2145000 &  0.11053282 & 150 & 150 & BRAF; RAF1                                                                         \\\\\n\t ST-4066738          & 1043828  & SKB & trt\\_cp & up   &  0.1936333 &  0.09978014 & 150 & 150 & NA                                                                                 \\\\\n\t vicriviroc          & 73707391 & SKB & trt\\_cp & up   &  0.1167000 &  0.06013604 & 150 & 150 & CCR5                                                                               \\\\\n\t rhamnetin           & 5281691  & SKB & trt\\_cp & up   &  0.0000000 &  0.00000000 & 150 & 150 & ALOX5; MAPK8                                                                       \\\\\n\t huperzine-a         & 1253     & SKB & trt\\_cp & up   &  0.0000000 &  0.00000000 & 150 & 150 & ACHE                                                                               \\\\\n\t XE-991              & 656732   & SKB & trt\\_cp & up   &  0.0000000 &  0.00000000 & 150 & 150 & KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                  \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t formoterol                      & 23581795 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t propylpyrazole                  & 35027762 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t midostaurin                     & 9829523  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\\\\\n\t NSC-693868                      & 438981   & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t CGP-13501                       & 3519541  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t SPB02303                        & 2744062  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t aprepitant                      & 151165   & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \\\\\n\t carbetocin                      & 73707428 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t decafluorobutane                & 9638     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t ketorolac                       & 3826     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \\\\\n\t 4,5,6,7-tetrabromobenzotriazole & 1694     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t TUL-XIX029                      & 67243342 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t SKF-77434                       & 11957703 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t oxalomalic-acid                 & 439620   & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t BAY-11-7082                     & 5353431  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t ST-013960                       & 2300880  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t dibenzepin                      & 9419     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t NNC-63-0532                     & 3906780  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t pantoprazole                    & 4679     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t trazodone                       & 5533     & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \\\\\n\t quinpirol-(-)                   & NotFound & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t vinorelbine                     & 73707409 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t afatinib                        & 22225683 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t ST-001903                       & 674282   & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t L-erythro-MAPP                  & 6610217  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t loreclezole                     & 50988829 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t D-609                           & 45479729 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t RAN-05                          & 44229302 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t terguride                       & 11957722 & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t K784-3131                       & 4381125  & SKB & trt\\_cp & up & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 10\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | raw_score &lt;dbl&gt; | scaled_score &lt;dbl&gt; | N_upset &lt;int&gt; | N_downset &lt;int&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| vorinostat          | 5311     | SKB | trt_cp | up   |  1.9406000 |  1.00000000 | 150 | 150 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9       |\n| rescinnamine        | 5280954  | SKB | trt_cp | down | -0.2951667 | -1.00000000 | 150 | 150 | ACE                                                                                 |\n| zuclopenthixol      | 5311507  | SKB | trt_cp | down | -0.2870333 | -0.97244495 | 150 | 150 | ADRA1A; DRD1; HRH1                                                                  |\n| evoxine             | 673465   | SKB | trt_cp | down | -0.2444333 | -0.82811971 | 150 | 150 | NA                                                                                  |\n| scoulerine          | 439654   | SKB | trt_cp | down | -0.2422667 | -0.82077922 | 150 | 150 | ADRA1D                                                                              |\n| ganglioside         | 4673190  | SKB | trt_cp | down | -0.2388667 | -0.80926030 | 150 | 150 | NA                                                                                  |\n| warfarin            | 54678486 | SKB | trt_cp | down | -0.2342333 | -0.79356296 | 150 | 150 | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1 |\n| trichostatin-a      | 444732   | SKB | trt_cp | up   |  1.5049333 |  0.77549899 | 150 | 150 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9               |\n| endecaphyllin-x     | 6710740  | SKB | trt_cp | down | -0.2243000 | -0.75990966 | 150 | 150 | NA                                                                                  |\n| HC-toxin            | 3571     | SKB | trt_cp | up   |  1.4448000 |  0.74451201 | 150 | 150 | HDAC1                                                                               |\n| pyroxamide          | 4996     | SKB | trt_cp | up   |  0.8067333 |  0.41571335 | 150 | 150 | HDAC1; HDAC3; HDAC6                                                                 |\n| APHA-compound-8     | 10379137 | SKB | trt_cp | up   |  0.4280333 |  0.22056752 | 150 | 150 | HDAC8                                                                               |\n| MD-040              | 73707398 | SKB | trt_cp | up   |  0.3973000 |  0.20473050 | 150 | 150 | NA                                                                                  |\n| scopolamine-n-oxide | 3000667  | SKB | trt_cp | up   |  0.3574667 |  0.18420420 | 150 | 150 | NA                                                                                  |\n| calcifediol         | 46705323 | SKB | trt_cp | up   |  0.3518333 |  0.18130132 | 150 | 150 | VDR                                                                                 |\n| I-070759            | 24086306 | SKB | trt_cp | up   |  0.3499000 |  0.18030506 | 150 | 150 | NA                                                                                  |\n| benzonatate         | 7699     | SKB | trt_cp | up   |  0.3229000 |  0.16639184 | 150 | 150 | SCN5A                                                                               |\n| fasudil             | 3547     | SKB | trt_cp | up   |  0.2674333 |  0.13780961 | 150 | 150 | CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                            |\n| ryuvidine           | 481747   | SKB | trt_cp | up   |  0.2605333 |  0.13425401 | 150 | 150 | CDK2; CDK4                                                                          |\n| hydroquinidine      | 45479756 | SKB | trt_cp | up   |  0.2582000 |  0.13305163 | 150 | 150 | KMT2A; PSIP1                                                                        |\n| calcitriol          | 21158442 | SKB | trt_cp | up   |  0.2542667 |  0.13102477 | 150 | 150 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                      |\n| crotamiton          | 688020   | SKB | trt_cp | up   |  0.2395333 |  0.12343262 | 150 | 150 | NA                                                                                  |\n| GSK-0660            | 46233311 | SKB | trt_cp | up   |  0.2334333 |  0.12028926 | 150 | 150 | PPARD                                                                               |\n| fenobam             | 162834   | SKB | trt_cp | up   |  0.2245333 |  0.11570305 | 150 | 150 | GRM5                                                                                |\n| GDC-0879            | 11717001 | SKB | trt_cp | up   |  0.2145000 |  0.11053282 | 150 | 150 | BRAF; RAF1                                                                          |\n| ST-4066738          | 1043828  | SKB | trt_cp | up   |  0.1936333 |  0.09978014 | 150 | 150 | NA                                                                                  |\n| vicriviroc          | 73707391 | SKB | trt_cp | up   |  0.1167000 |  0.06013604 | 150 | 150 | CCR5                                                                                |\n| rhamnetin           | 5281691  | SKB | trt_cp | up   |  0.0000000 |  0.00000000 | 150 | 150 | ALOX5; MAPK8                                                                        |\n| huperzine-a         | 1253     | SKB | trt_cp | up   |  0.0000000 |  0.00000000 | 150 | 150 | ACHE                                                                                |\n| XE-991              | 656732   | SKB | trt_cp | up   |  0.0000000 |  0.00000000 | 150 | 150 | KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                   |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| formoterol                      | 23581795 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| propylpyrazole                  | 35027762 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| midostaurin                     | 9829523  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2 |\n| NSC-693868                      | 438981   | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| CGP-13501                       | 3519541  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| SPB02303                        | 2744062  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| aprepitant                      | 151165   | SKB | trt_cp | up | 0 | 0 | 150 | 150 | CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n| carbetocin                      | 73707428 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| decafluorobutane                | 9638     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| ketorolac                       | 3826     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |\n| 4,5,6,7-tetrabromobenzotriazole | 1694     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| TUL-XIX029                      | 67243342 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| SKF-77434                       | 11957703 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| oxalomalic-acid                 | 439620   | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| BAY-11-7082                     | 5353431  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| ST-013960                       | 2300880  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| dibenzepin                      | 9419     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| NNC-63-0532                     | 3906780  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| pantoprazole                    | 4679     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| trazodone                       | 5533     | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |\n| quinpirol-(-)                   | NotFound | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| vinorelbine                     | 73707409 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| afatinib                        | 22225683 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| ST-001903                       | 674282   | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| L-erythro-MAPP                  | 6610217  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| loreclezole                     | 50988829 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| D-609                           | 45479729 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| RAN-05                          | 44229302 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| terguride                       | 11957722 | SKB | trt_cp | up | 0 | 0 | 150 | 150 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| K784-3131                       | 4381125  | SKB | trt_cp | up | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>raw_score</th><th scope=col>scaled_score</th><th scope=col>N_upset</th><th scope=col>N_downset</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat         </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.9406000</td><td> 1.00000000</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9      </td></tr>\n","\t<tr><td>rescinnamine       </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2951667</td><td>-1.00000000</td><td>150</td><td>150</td><td>ACE                                                                                </td></tr>\n","\t<tr><td>zuclopenthixol     </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2870333</td><td>-0.97244495</td><td>150</td><td>150</td><td>ADRA1A; DRD1; HRH1                                                                 </td></tr>\n","\t<tr><td>evoxine            </td><td>673465  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2444333</td><td>-0.82811971</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>scoulerine         </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2422667</td><td>-0.82077922</td><td>150</td><td>150</td><td>ADRA1D                                                                             </td></tr>\n","\t<tr><td>ganglioside        </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2388667</td><td>-0.80926030</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>warfarin           </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2342333</td><td>-0.79356296</td><td>150</td><td>150</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1</td></tr>\n","\t<tr><td>trichostatin-a     </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.5049333</td><td> 0.77549899</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9              </td></tr>\n","\t<tr><td>endecaphyllin-x    </td><td>6710740 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2243000</td><td>-0.75990966</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>HC-toxin           </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.4448000</td><td> 0.74451201</td><td>150</td><td>150</td><td>HDAC1                                                                              </td></tr>\n","\t<tr><td>pyroxamide         </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8067333</td><td> 0.41571335</td><td>150</td><td>150</td><td>HDAC1; HDAC3; HDAC6                                                                </td></tr>\n","\t<tr><td>APHA-compound-8    </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4280333</td><td> 0.22056752</td><td>150</td><td>150</td><td>HDAC8                                                                              </td></tr>\n","\t<tr><td>MD-040             </td><td>73707398</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3973000</td><td> 0.20473050</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>scopolamine-n-oxide</td><td>3000667 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3574667</td><td> 0.18420420</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>calcifediol        </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3518333</td><td> 0.18130132</td><td>150</td><td>150</td><td>VDR                                                                                </td></tr>\n","\t<tr><td>I-070759           </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3499000</td><td> 0.18030506</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>benzonatate        </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3229000</td><td> 0.16639184</td><td>150</td><td>150</td><td>SCN5A                                                                              </td></tr>\n","\t<tr><td>fasudil            </td><td>3547    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2674333</td><td> 0.13780961</td><td>150</td><td>150</td><td>CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                           </td></tr>\n","\t<tr><td>ryuvidine          </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2605333</td><td> 0.13425401</td><td>150</td><td>150</td><td>CDK2; CDK4                                                                         </td></tr>\n","\t<tr><td>hydroquinidine     </td><td>45479756</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2582000</td><td> 0.13305163</td><td>150</td><td>150</td><td>KMT2A; PSIP1                                                                       </td></tr>\n","\t<tr><td>calcitriol         </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2542667</td><td> 0.13102477</td><td>150</td><td>150</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                     </td></tr>\n","\t<tr><td>crotamiton         </td><td>688020  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2395333</td><td> 0.12343262</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>GSK-0660           </td><td>46233311</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2334333</td><td> 0.12028926</td><td>150</td><td>150</td><td>PPARD                                                                              </td></tr>\n","\t<tr><td>fenobam            </td><td>162834  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2245333</td><td> 0.11570305</td><td>150</td><td>150</td><td>GRM5                                                                               </td></tr>\n","\t<tr><td>GDC-0879           </td><td>11717001</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2145000</td><td> 0.11053282</td><td>150</td><td>150</td><td>BRAF; RAF1                                                                         </td></tr>\n","\t<tr><td>ST-4066738         </td><td>1043828 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1936333</td><td> 0.09978014</td><td>150</td><td>150</td><td>NA                                                                                 </td></tr>\n","\t<tr><td>vicriviroc         </td><td>73707391</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1167000</td><td> 0.06013604</td><td>150</td><td>150</td><td>CCR5                                                                               </td></tr>\n","\t<tr><td>rhamnetin          </td><td>5281691 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0000000</td><td> 0.00000000</td><td>150</td><td>150</td><td>ALOX5; MAPK8                                                                       </td></tr>\n","\t<tr><td>huperzine-a        </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0000000</td><td> 0.00000000</td><td>150</td><td>150</td><td>ACHE                                                                               </td></tr>\n","\t<tr><td>XE-991             </td><td>656732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0000000</td><td> 0.00000000</td><td>150</td><td>150</td><td>KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                  </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>formoterol                     </td><td>23581795</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>propylpyrazole                 </td><td>35027762</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>midostaurin                    </td><td>9829523 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2</td></tr>\n","\t<tr><td>NSC-693868                     </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>CGP-13501                      </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>SPB02303                       </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>aprepitant                     </td><td>151165  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>carbetocin                     </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>decafluorobutane               </td><td>9638    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>ketorolac                      </td><td>3826    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                </td></tr>\n","\t<tr><td>4,5,6,7-tetrabromobenzotriazole</td><td>1694    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>TUL-XIX029                     </td><td>67243342</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>SKF-77434                      </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>oxalomalic-acid                </td><td>439620  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>BAY-11-7082                    </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>ST-013960                      </td><td>2300880 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>dibenzepin                     </td><td>9419    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>NNC-63-0532                    </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>pantoprazole                   </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>trazodone                      </td><td>5533    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>quinpirol-(-)                  </td><td>NotFound</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>vinorelbine                    </td><td>73707409</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>afatinib                       </td><td>22225683</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>ST-001903                      </td><td>674282  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>L-erythro-MAPP                 </td><td>6610217 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>loreclezole                    </td><td>50988829</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>D-609                          </td><td>45479729</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>RAN-05                         </td><td>44229302</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>terguride                      </td><td>11957722</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>K784-3131                      </td><td>4381125 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"n441aZIA2B2w"},"source":["This table contains the search results for each perturbagen (here drugs) in the reference database ranked by their signature similarity to the query. \n","- For the CMAP method, the similarity metrics are `raw_score` and `scaled_score`. \n","- The raw score represents the bi-directional enrichment score (Kolmogorov-Smirnov statistic) for a given up/down query signature. \n","- Under the `scaled_score` column, the `raw_score` has been scaled to values from 1 to -1 by dividing positive scores and negative scores with the maximum positive score and the absolute value of the minimum negative score, respectively. \n","\n","The remaining columns in the search result table contain the following information. \n","- `pert`: name of perturbagen (e.g. drug) in the reference database; \n","- `cell`: acronym of cell type; \n","- `type`: perturbation type, e.g. compound treatment is `trt_cp`; \n","- `trend`: up or down when reference signature is positively or negatively connected with the query signature, respectively; \n","- `N_upset` or `N_downset`: number of genes in the query up or down sets, respectively; \n","- `t_gn_sym`: gene symbols of the corresponding drug targets.\n","\n","# 3. LINCS Search Method\n","While related to CMAP, there are several important differences among the two approaches. \n","- First, LINCS weights the query genes based on the corresponding differential expression scores of the GEPs in the reference database (e.g. LFC or z-scores). Thus, the reference database used by LINCS needs to store the actual score values rather than their ranks. \n","- Another relevant difference is that the LINCS algorithm uses a bi-directional weighted Kolmogorov-Smirnov enrichment statistic (ES) as similarity metric. "]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"OEk_WxYP2h4F","executionInfo":{"status":"ok","timestamp":1636337749132,"user_tz":-480,"elapsed":23,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"4a477ce5-ffd3-4b42-a8eb-1fd54d384553"},"source":["qsig_lincs <- qSig(query = list(upset=upset, downset=downset),\n","              gess_method='LINCS', refdb=db_path)"],"execution_count":10,"outputs":[{"output_type":"stream","name":"stderr","text":["150 / 150 genes in up set share identifiers with reference database\n","\n","150 / 150 genes in down set share identifiers with reference database\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"TcKrnHlk2wY3","executionInfo":{"status":"ok","timestamp":1636337754727,"user_tz":-480,"elapsed":5610,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"0b518532-6a7d-472f-ff16-82f0474a2a73"},"source":["lincs <- gess_lincs(qsig_lincs, sortby='NCS', tau=FALSE, workers=1)\n","result(lincs)"],"execution_count":11,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                PCID     cell type   trend WTCS       WTCS_Pval   \n","1   vorinostat          5311     SKB  trt_cp up     1.0000000 0.000000e+00\n","2   trichostatin-a      444732   SKB  trt_cp up     0.8632721 5.962030e-06\n","3   HC-toxin            3571     SKB  trt_cp up     0.8566409 6.223141e-06\n","4   pyroxamide          4996     SKB  trt_cp up     0.6253459 1.631943e-05\n","5   zuclopenthixol      5311507  SKB  trt_cp down  -0.3214791 8.285917e-05\n","6   rescinnamine        5280954  SKB  trt_cp down  -0.3188884 9.604526e-05\n","7   APHA-compound-8     10379137 SKB  trt_cp up     0.4449388 2.415275e-05\n","8   epothilone          448013   SKB  trt_cp down  -0.3075832 2.402220e-04\n","9   scopolamine-n-oxide 3000667  SKB  trt_cp up     0.4156802 2.541479e-05\n","10  I-070759            24086306 SKB  trt_cp up     0.4075031 2.576293e-05\n","11  warfarin            54678486 SKB  trt_cp down  -0.2817883 2.448393e-03\n","12  benzonatate         7699     SKB  trt_cp up     0.3993739 2.615460e-05\n","13  MD-040              73707398 SKB  trt_cp up     0.3977545 2.619812e-05\n","14  ganglioside         4673190  SKB  trt_cp down  -0.2742264 4.681304e-03\n","15  calcifediol         46705323 SKB  trt_cp up     0.3943566 2.637219e-05\n","16  rimcazole           5072     SKB  trt_cp up     0.3693924 2.746015e-05\n","17  progesterone        5994     SKB  trt_cp down  -0.2560705 1.725925e-02\n","18  afatinib            22225683 SKB  trt_cp up     0.3645535 2.763423e-05\n","19  huperzine-a         1253     SKB  trt_cp up     0.3629478 2.776478e-05\n","20  calcitriol          21158442 SKB  trt_cp up     0.3602968 2.789534e-05\n","21  fasudil             3547     SKB  trt_cp up     0.3583908 2.798238e-05\n","22  BAY-11-7082         5353431  SKB  trt_cp down  -0.2478859 2.867713e-02\n","23  endecaphyllin-x     6710740  SKB  trt_cp down  -0.2471567 3.045638e-02\n","24  TUL-XIX029          67243342 SKB  trt_cp up     0.3510614 2.887450e-05\n","25  scoulerine          439654   SKB  trt_cp down  -0.2391343 4.793888e-02\n","26  sinensetin          145659   SKB  trt_cp up     0.3373698 3.622913e-05\n","27  raltitrexed         104758   SKB  trt_cp up     0.3334212 4.203884e-05\n","28  JWH-015             4273754  SKB  trt_cp up     0.3322586 4.377958e-05\n","29  GSK-0660            46233311 SKB  trt_cp up     0.3267081 5.600827e-05\n","30  ryuvidine           481747   SKB  trt_cp up     0.3264634 5.940271e-05\n","⋮   ⋮                   ⋮        ⋮    ⋮      ⋮     ⋮          ⋮           \n","71  ST-4029655          691928   SKB  trt_cp down  0          0.3144514   \n","72  tyrphostin-AG-556   2059     SKB  trt_cp down  0          0.3144514   \n","73  alvespimycin        73707383 SKB  trt_cp down  0          0.3144514   \n","74  AS-703026           44187362 SKB  trt_cp down  0          0.3144514   \n","75  procarbazine        9703     SKB  trt_cp down  0          0.3144514   \n","76  TUL-XX023           54596143 SKB  trt_cp down  0          0.3144514   \n","77  CGP-12177           2687     SKB  trt_cp down  0          0.3144514   \n","78  formoterol          23581795 SKB  trt_cp down  0          0.3144514   \n","79  midostaurin         9829523  SKB  trt_cp down  0          0.3144514   \n","80  NSC-693868          438981   SKB  trt_cp down  0          0.3144514   \n","81  CGP-13501           3519541  SKB  trt_cp down  0          0.3144514   \n","82  SPB02303            2744062  SKB  trt_cp down  0          0.3144514   \n","83  aprepitant          151165   SKB  trt_cp down  0          0.3144514   \n","84  evoxine             673465   SKB  trt_cp down  0          0.3144514   \n","85  carbetocin          73707428 SKB  trt_cp down  0          0.3144514   \n","86  ketorolac           3826     SKB  trt_cp down  0          0.3144514   \n","87  SKF-77434           11957703 SKB  trt_cp down  0          0.3144514   \n","88  oxalomalic-acid     439620   SKB  trt_cp down  0          0.3144514   \n","89  dibenzepin          9419     SKB  trt_cp down  0          0.3144514   \n","90  NNC-63-0532         3906780  SKB  trt_cp down  0          0.3144514   \n","91  pantoprazole        4679     SKB  trt_cp down  0          0.3144514   \n","92  trazodone           5533     SKB  trt_cp down  0          0.3144514   \n","93  quinpirol-(-)       NotFound SKB  trt_cp down  0          0.3144514   \n","94  vinorelbine         73707409 SKB  trt_cp down  0          0.3144514   \n","95  ST-001903           674282   SKB  trt_cp down  0          0.3144514   \n","96  L-erythro-MAPP      6610217  SKB  trt_cp down  0          0.3144514   \n","97  loreclezole         50988829 SKB  trt_cp down  0          0.3144514   \n","98  RAN-05              44229302 SKB  trt_cp down  0          0.3144514   \n","99  terguride           11957722 SKB  trt_cp down  0          0.3144514   \n","100 K784-3131           4381125  SKB  trt_cp down  0          0.3144514   \n","    WTCS_FDR     NCS        NCSct      N_upset N_downset\n","1   0.0000000000  2.5663193  2.5663193 150     150      \n","2   0.0001804657  2.2154320  2.2154320 150     150      \n","3   0.0001804657  2.1984140  2.1984140 150     150      \n","4   0.0001804657  1.6048373  1.6048373 150     150      \n","5   0.0003186891 -1.1881347 -1.1881347 150     150      \n","6   0.0003557232 -1.1785601 -1.1785601 150     150      \n","7   0.0001804657  1.1418551  1.1418551 150     150      \n","8   0.0008007398 -1.1367780 -1.1367780 150     150      \n","9   0.0001804657  1.0667682  1.0667682 150     150      \n","10  0.0001804657  1.0457832  1.0457832 150     150      \n","11  0.0069954076 -1.0414442 -1.0414442 150     150      \n","12  0.0001804657  1.0249210  1.0249210 150     150      \n","13  0.0001804657  1.0207651  1.0207651 150     150      \n","14  0.0126521718 -1.0134963 -1.0134963 150     150      \n","15  0.0001804657  1.0120451  1.0120451 150     150      \n","16  0.0001804657  0.9479788  0.9479788 150     150      \n","17  0.0442544901 -0.9463954 -0.9463954 150     150      \n","18  0.0001804657  0.9355606  0.9355606 150     150      \n","19  0.0001804657  0.9314399  0.9314399 150     150      \n","20  0.0001804657  0.9246366  0.9246366 150     150      \n","21  0.0001804657  0.9197452  0.9197452 150     150      \n","22  0.0682788735 -0.9161463 -0.9161463 150     150      \n","23  0.0708287895 -0.9134511 -0.9134511 150     150      \n","24  0.0001804657  0.9009355  0.9009355 150     150      \n","25  0.1065308453 -0.8838018 -0.8838018 150     150      \n","26  0.0002131125  0.8657986  0.8657986 150     150      \n","27  0.0002304188  0.8556654  0.8556654 150     150      \n","28  0.0002304188  0.8526817  0.8526817 150     150      \n","29  0.0002800414  0.8384372  0.8384372 150     150      \n","30  0.0002828701  0.8378093  0.8378093 150     150      \n","⋮   ⋮            ⋮          ⋮          ⋮       ⋮        \n","71  0.3144514    0          0          150     150      \n","72  0.3144514    0          0          150     150      \n","73  0.3144514    0          0          150     150      \n","74  0.3144514    0          0          150     150      \n","75  0.3144514    0          0          150     150      \n","76  0.3144514    0          0          150     150      \n","77  0.3144514    0          0          150     150      \n","78  0.3144514    0          0          150     150      \n","79  0.3144514    0          0          150     150      \n","80  0.3144514    0          0          150     150      \n","81  0.3144514    0          0          150     150      \n","82  0.3144514    0          0          150     150      \n","83  0.3144514    0          0          150     150      \n","84  0.3144514    0          0          150     150      \n","85  0.3144514    0          0          150     150      \n","86  0.3144514    0          0          150     150      \n","87  0.3144514    0          0          150     150      \n","88  0.3144514    0          0          150     150      \n","89  0.3144514    0          0          150     150      \n","90  0.3144514    0          0          150     150      \n","91  0.3144514    0          0          150     150      \n","92  0.3144514    0          0          150     150      \n","93  0.3144514    0          0          150     150      \n","94  0.3144514    0          0          150     150      \n","95  0.3144514    0          0          150     150      \n","96  0.3144514    0          0          150     150      \n","97  0.3144514    0          0          150     150      \n","98  0.3144514    0          0          150     150      \n","99  0.3144514    0          0          150     150      \n","100 0.3144514    0          0          150     150      \n","    t_gn_sym                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","2   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","3   HDAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","4   HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","5   ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","6   ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","7   HDAC8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","8   TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","9   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","10  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","11  ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","12  SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","13  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","14  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","15  VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","16  SIGMAR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","17  AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5                                                                                                                                                                                                                                                                                                                                                         \n","18  EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","19  ACHE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","20  CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","21  CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","22  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","23  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","24  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","25  ADRA1D                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","26  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","27  FPGS; TYMS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","28  CNR2; GPR55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","29  PPARD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","30  CDK2; CDK4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","⋮   ⋮                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","71  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","72  EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","73  HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","74  MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","75  MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","76  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","77  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","78  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","79  AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\n","80  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","81  GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","82  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","83  CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","84  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","85  OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","86  LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","87  DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","88  ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","89  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","90  OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","91  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","92  ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","93  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","94  TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","95  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","96  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","97  GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","98  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","99  ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","100 NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     "],"text/latex":"A tibble: 100 × 13\n\\begin{tabular}{lllllllllllll}\n pert & PCID & cell & type & trend & WTCS & WTCS\\_Pval & WTCS\\_FDR & NCS & NCSct & N\\_upset & N\\_downset & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <int> & <int> & <chr>\\\\\n\\hline\n\t vorinostat          & 5311     & SKB & trt\\_cp & up   &  1.0000000 & 0.000000e+00 & 0.0000000000 &  2.5663193 &  2.5663193 & 150 & 150 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                 \\\\\n\t trichostatin-a      & 444732   & SKB & trt\\_cp & up   &  0.8632721 & 5.962030e-06 & 0.0001804657 &  2.2154320 &  2.2154320 & 150 & 150 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                         \\\\\n\t HC-toxin            & 3571     & SKB & trt\\_cp & up   &  0.8566409 & 6.223141e-06 & 0.0001804657 &  2.1984140 &  2.1984140 & 150 & 150 & HDAC1                                                                                                                                                                                                                                                                                         \\\\\n\t pyroxamide          & 4996     & SKB & trt\\_cp & up   &  0.6253459 & 1.631943e-05 & 0.0001804657 &  1.6048373 &  1.6048373 & 150 & 150 & HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                           \\\\\n\t zuclopenthixol      & 5311507  & SKB & trt\\_cp & down & -0.3214791 & 8.285917e-05 & 0.0003186891 & -1.1881347 & -1.1881347 & 150 & 150 & ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                            \\\\\n\t rescinnamine        & 5280954  & SKB & trt\\_cp & down & -0.3188884 & 9.604526e-05 & 0.0003557232 & -1.1785601 & -1.1785601 & 150 & 150 & ACE                                                                                                                                                                                                                                                                                           \\\\\n\t APHA-compound-8     & 10379137 & SKB & trt\\_cp & up   &  0.4449388 & 2.415275e-05 & 0.0001804657 &  1.1418551 &  1.1418551 & 150 & 150 & HDAC8                                                                                                                                                                                                                                                                                         \\\\\n\t epothilone          & 448013   & SKB & trt\\_cp & down & -0.3075832 & 2.402220e-04 & 0.0008007398 & -1.1367780 & -1.1367780 & 150 & 150 & TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                             \\\\\n\t scopolamine-n-oxide & 3000667  & SKB & trt\\_cp & up   &  0.4156802 & 2.541479e-05 & 0.0001804657 &  1.0667682 &  1.0667682 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t I-070759            & 24086306 & SKB & trt\\_cp & up   &  0.4075031 & 2.576293e-05 & 0.0001804657 &  1.0457832 &  1.0457832 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t warfarin            & 54678486 & SKB & trt\\_cp & down & -0.2817883 & 2.448393e-03 & 0.0069954076 & -1.0414442 & -1.0414442 & 150 & 150 & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                           \\\\\n\t benzonatate         & 7699     & SKB & trt\\_cp & up   &  0.3993739 & 2.615460e-05 & 0.0001804657 &  1.0249210 &  1.0249210 & 150 & 150 & SCN5A                                                                                                                                                                                                                                                                                         \\\\\n\t MD-040              & 73707398 & SKB & trt\\_cp & up   &  0.3977545 & 2.619812e-05 & 0.0001804657 &  1.0207651 &  1.0207651 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t ganglioside         & 4673190  & SKB & trt\\_cp & down & -0.2742264 & 4.681304e-03 & 0.0126521718 & -1.0134963 & -1.0134963 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t calcifediol         & 46705323 & SKB & trt\\_cp & up   &  0.3943566 & 2.637219e-05 & 0.0001804657 &  1.0120451 &  1.0120451 & 150 & 150 & VDR                                                                                                                                                                                                                                                                                           \\\\\n\t rimcazole           & 5072     & SKB & trt\\_cp & up   &  0.3693924 & 2.746015e-05 & 0.0001804657 &  0.9479788 &  0.9479788 & 150 & 150 & SIGMAR1                                                                                                                                                                                                                                                                                       \\\\\n\t progesterone        & 5994     & SKB & trt\\_cp & down & -0.2560705 & 1.725925e-02 & 0.0442544901 & -0.9463954 & -0.9463954 & 150 & 150 & AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5\\\\\n\t afatinib            & 22225683 & SKB & trt\\_cp & up   &  0.3645535 & 2.763423e-05 & 0.0001804657 &  0.9355606 &  0.9355606 & 150 & 150 & EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                  \\\\\n\t huperzine-a         & 1253     & SKB & trt\\_cp & up   &  0.3629478 & 2.776478e-05 & 0.0001804657 &  0.9314399 &  0.9314399 & 150 & 150 & ACHE                                                                                                                                                                                                                                                                                          \\\\\n\t calcitriol          & 21158442 & SKB & trt\\_cp & up   &  0.3602968 & 2.789534e-05 & 0.0001804657 &  0.9246366 &  0.9246366 & 150 & 150 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                \\\\\n\t fasudil             & 3547     & SKB & trt\\_cp & up   &  0.3583908 & 2.798238e-05 & 0.0001804657 &  0.9197452 &  0.9197452 & 150 & 150 & CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                      \\\\\n\t BAY-11-7082         & 5353431  & SKB & trt\\_cp & down & -0.2478859 & 2.867713e-02 & 0.0682788735 & -0.9161463 & -0.9161463 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t endecaphyllin-x     & 6710740  & SKB & trt\\_cp & down & -0.2471567 & 3.045638e-02 & 0.0708287895 & -0.9134511 & -0.9134511 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t TUL-XIX029          & 67243342 & SKB & trt\\_cp & up   &  0.3510614 & 2.887450e-05 & 0.0001804657 &  0.9009355 &  0.9009355 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t scoulerine          & 439654   & SKB & trt\\_cp & down & -0.2391343 & 4.793888e-02 & 0.1065308453 & -0.8838018 & -0.8838018 & 150 & 150 & ADRA1D                                                                                                                                                                                                                                                                                        \\\\\n\t sinensetin          & 145659   & SKB & trt\\_cp & up   &  0.3373698 & 3.622913e-05 & 0.0002131125 &  0.8657986 &  0.8657986 & 150 & 150 & NA                                                                                                                                                                                                                                                                                            \\\\\n\t raltitrexed         & 104758   & SKB & trt\\_cp & up   &  0.3334212 & 4.203884e-05 & 0.0002304188 &  0.8556654 &  0.8556654 & 150 & 150 & FPGS; TYMS                                                                                                                                                                                                                                                                                    \\\\\n\t JWH-015             & 4273754  & SKB & trt\\_cp & up   &  0.3322586 & 4.377958e-05 & 0.0002304188 &  0.8526817 &  0.8526817 & 150 & 150 & CNR2; GPR55                                                                                                                                                                                                                                                                                   \\\\\n\t GSK-0660            & 46233311 & SKB & trt\\_cp & up   &  0.3267081 & 5.600827e-05 & 0.0002800414 &  0.8384372 &  0.8384372 & 150 & 150 & PPARD                                                                                                                                                                                                                                                                                         \\\\\n\t ryuvidine           & 481747   & SKB & trt\\_cp & up   &  0.3264634 & 5.940271e-05 & 0.0002828701 &  0.8378093 &  0.8378093 & 150 & 150 & CDK2; CDK4                                                                                                                                                                                                                                                                                    \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t ST-4029655        & 691928   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t tyrphostin-AG-556 & 2059     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t alvespimycin      & 73707383 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \\\\\n\t AS-703026         & 44187362 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t procarbazine      & 9703     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t TUL-XX023         & 54596143 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t CGP-12177         & 2687     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t formoterol        & 23581795 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t midostaurin       & 9829523  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\\\\\n\t NSC-693868        & 438981   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t CGP-13501         & 3519541  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t SPB02303          & 2744062  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t aprepitant        & 151165   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \\\\\n\t evoxine           & 673465   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t carbetocin        & 73707428 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t ketorolac         & 3826     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \\\\\n\t SKF-77434         & 11957703 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t oxalomalic-acid   & 439620   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t dibenzepin        & 9419     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t NNC-63-0532       & 3906780  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t pantoprazole      & 4679     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t trazodone         & 5533     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \\\\\n\t quinpirol-(-)     & NotFound & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t vinorelbine       & 73707409 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t ST-001903         & 674282   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t L-erythro-MAPP    & 6610217  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t loreclezole       & 50988829 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t RAN-05            & 44229302 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t terguride         & 11957722 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t K784-3131         & 4381125  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 13\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | WTCS &lt;dbl&gt; | WTCS_Pval &lt;dbl&gt; | WTCS_FDR &lt;dbl&gt; | NCS &lt;dbl&gt; | NCSct &lt;dbl&gt; | N_upset &lt;int&gt; | N_downset &lt;int&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| vorinostat          | 5311     | SKB | trt_cp | up   |  1.0000000 | 0.000000e+00 | 0.0000000000 |  2.5663193 |  2.5663193 | 150 | 150 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                  |\n| trichostatin-a      | 444732   | SKB | trt_cp | up   |  0.8632721 | 5.962030e-06 | 0.0001804657 |  2.2154320 |  2.2154320 | 150 | 150 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                          |\n| HC-toxin            | 3571     | SKB | trt_cp | up   |  0.8566409 | 6.223141e-06 | 0.0001804657 |  2.1984140 |  2.1984140 | 150 | 150 | HDAC1                                                                                                                                                                                                                                                                                          |\n| pyroxamide          | 4996     | SKB | trt_cp | up   |  0.6253459 | 1.631943e-05 | 0.0001804657 |  1.6048373 |  1.6048373 | 150 | 150 | HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                            |\n| zuclopenthixol      | 5311507  | SKB | trt_cp | down | -0.3214791 | 8.285917e-05 | 0.0003186891 | -1.1881347 | -1.1881347 | 150 | 150 | ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                             |\n| rescinnamine        | 5280954  | SKB | trt_cp | down | -0.3188884 | 9.604526e-05 | 0.0003557232 | -1.1785601 | -1.1785601 | 150 | 150 | ACE                                                                                                                                                                                                                                                                                            |\n| APHA-compound-8     | 10379137 | SKB | trt_cp | up   |  0.4449388 | 2.415275e-05 | 0.0001804657 |  1.1418551 |  1.1418551 | 150 | 150 | HDAC8                                                                                                                                                                                                                                                                                          |\n| epothilone          | 448013   | SKB | trt_cp | down | -0.3075832 | 2.402220e-04 | 0.0008007398 | -1.1367780 | -1.1367780 | 150 | 150 | TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                              |\n| scopolamine-n-oxide | 3000667  | SKB | trt_cp | up   |  0.4156802 | 2.541479e-05 | 0.0001804657 |  1.0667682 |  1.0667682 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| I-070759            | 24086306 | SKB | trt_cp | up   |  0.4075031 | 2.576293e-05 | 0.0001804657 |  1.0457832 |  1.0457832 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| warfarin            | 54678486 | SKB | trt_cp | down | -0.2817883 | 2.448393e-03 | 0.0069954076 | -1.0414442 | -1.0414442 | 150 | 150 | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                            |\n| benzonatate         | 7699     | SKB | trt_cp | up   |  0.3993739 | 2.615460e-05 | 0.0001804657 |  1.0249210 |  1.0249210 | 150 | 150 | SCN5A                                                                                                                                                                                                                                                                                          |\n| MD-040              | 73707398 | SKB | trt_cp | up   |  0.3977545 | 2.619812e-05 | 0.0001804657 |  1.0207651 |  1.0207651 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| ganglioside         | 4673190  | SKB | trt_cp | down | -0.2742264 | 4.681304e-03 | 0.0126521718 | -1.0134963 | -1.0134963 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| calcifediol         | 46705323 | SKB | trt_cp | up   |  0.3943566 | 2.637219e-05 | 0.0001804657 |  1.0120451 |  1.0120451 | 150 | 150 | VDR                                                                                                                                                                                                                                                                                            |\n| rimcazole           | 5072     | SKB | trt_cp | up   |  0.3693924 | 2.746015e-05 | 0.0001804657 |  0.9479788 |  0.9479788 | 150 | 150 | SIGMAR1                                                                                                                                                                                                                                                                                        |\n| progesterone        | 5994     | SKB | trt_cp | down | -0.2560705 | 1.725925e-02 | 0.0442544901 | -0.9463954 | -0.9463954 | 150 | 150 | AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5 |\n| afatinib            | 22225683 | SKB | trt_cp | up   |  0.3645535 | 2.763423e-05 | 0.0001804657 |  0.9355606 |  0.9355606 | 150 | 150 | EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                   |\n| huperzine-a         | 1253     | SKB | trt_cp | up   |  0.3629478 | 2.776478e-05 | 0.0001804657 |  0.9314399 |  0.9314399 | 150 | 150 | ACHE                                                                                                                                                                                                                                                                                           |\n| calcitriol          | 21158442 | SKB | trt_cp | up   |  0.3602968 | 2.789534e-05 | 0.0001804657 |  0.9246366 |  0.9246366 | 150 | 150 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                 |\n| fasudil             | 3547     | SKB | trt_cp | up   |  0.3583908 | 2.798238e-05 | 0.0001804657 |  0.9197452 |  0.9197452 | 150 | 150 | CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                       |\n| BAY-11-7082         | 5353431  | SKB | trt_cp | down | -0.2478859 | 2.867713e-02 | 0.0682788735 | -0.9161463 | -0.9161463 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| endecaphyllin-x     | 6710740  | SKB | trt_cp | down | -0.2471567 | 3.045638e-02 | 0.0708287895 | -0.9134511 | -0.9134511 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| TUL-XIX029          | 67243342 | SKB | trt_cp | up   |  0.3510614 | 2.887450e-05 | 0.0001804657 |  0.9009355 |  0.9009355 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| scoulerine          | 439654   | SKB | trt_cp | down | -0.2391343 | 4.793888e-02 | 0.1065308453 | -0.8838018 | -0.8838018 | 150 | 150 | ADRA1D                                                                                                                                                                                                                                                                                         |\n| sinensetin          | 145659   | SKB | trt_cp | up   |  0.3373698 | 3.622913e-05 | 0.0002131125 |  0.8657986 |  0.8657986 | 150 | 150 | NA                                                                                                                                                                                                                                                                                             |\n| raltitrexed         | 104758   | SKB | trt_cp | up   |  0.3334212 | 4.203884e-05 | 0.0002304188 |  0.8556654 |  0.8556654 | 150 | 150 | FPGS; TYMS                                                                                                                                                                                                                                                                                     |\n| JWH-015             | 4273754  | SKB | trt_cp | up   |  0.3322586 | 4.377958e-05 | 0.0002304188 |  0.8526817 |  0.8526817 | 150 | 150 | CNR2; GPR55                                                                                                                                                                                                                                                                                    |\n| GSK-0660            | 46233311 | SKB | trt_cp | up   |  0.3267081 | 5.600827e-05 | 0.0002800414 |  0.8384372 |  0.8384372 | 150 | 150 | PPARD                                                                                                                                                                                                                                                                                          |\n| ryuvidine           | 481747   | SKB | trt_cp | up   |  0.3264634 | 5.940271e-05 | 0.0002828701 |  0.8378093 |  0.8378093 | 150 | 150 | CDK2; CDK4                                                                                                                                                                                                                                                                                     |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| ST-4029655        | 691928   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| tyrphostin-AG-556 | 2059     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| alvespimycin      | 73707383 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |\n| AS-703026         | 44187362 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| procarbazine      | 9703     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| TUL-XX023         | 54596143 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| CGP-12177         | 2687     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| formoterol        | 23581795 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| midostaurin       | 9829523  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2 |\n| NSC-693868        | 438981   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| CGP-13501         | 3519541  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| SPB02303          | 2744062  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| aprepitant        | 151165   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n| evoxine           | 673465   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| carbetocin        | 73707428 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| ketorolac         | 3826     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |\n| SKF-77434         | 11957703 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| oxalomalic-acid   | 439620   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| dibenzepin        | 9419     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| NNC-63-0532       | 3906780  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| pantoprazole      | 4679     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| trazodone         | 5533     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |\n| quinpirol-(-)     | NotFound | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| vinorelbine       | 73707409 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| ST-001903         | 674282   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| L-erythro-MAPP    | 6610217  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| loreclezole       | 50988829 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| RAN-05            | 44229302 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| terguride         | 11957722 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| K784-3131         | 4381125  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 13</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>WTCS</th><th scope=col>WTCS_Pval</th><th scope=col>WTCS_FDR</th><th scope=col>NCS</th><th scope=col>NCSct</th><th scope=col>N_upset</th><th scope=col>N_downset</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat         </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.0000000</td><td>0.000000e+00</td><td>0.0000000000</td><td> 2.5663193</td><td> 2.5663193</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>trichostatin-a     </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8632721</td><td>5.962030e-06</td><td>0.0001804657</td><td> 2.2154320</td><td> 2.2154320</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>HC-toxin           </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8566409</td><td>6.223141e-06</td><td>0.0001804657</td><td> 2.1984140</td><td> 2.1984140</td><td>150</td><td>150</td><td>HDAC1                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>pyroxamide         </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.6253459</td><td>1.631943e-05</td><td>0.0001804657</td><td> 1.6048373</td><td> 1.6048373</td><td>150</td><td>150</td><td>HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>zuclopenthixol     </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3214791</td><td>8.285917e-05</td><td>0.0003186891</td><td>-1.1881347</td><td>-1.1881347</td><td>150</td><td>150</td><td>ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>rescinnamine       </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3188884</td><td>9.604526e-05</td><td>0.0003557232</td><td>-1.1785601</td><td>-1.1785601</td><td>150</td><td>150</td><td>ACE                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>APHA-compound-8    </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4449388</td><td>2.415275e-05</td><td>0.0001804657</td><td> 1.1418551</td><td> 1.1418551</td><td>150</td><td>150</td><td>HDAC8                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>epothilone         </td><td>448013  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3075832</td><td>2.402220e-04</td><td>0.0008007398</td><td>-1.1367780</td><td>-1.1367780</td><td>150</td><td>150</td><td>TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>scopolamine-n-oxide</td><td>3000667 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4156802</td><td>2.541479e-05</td><td>0.0001804657</td><td> 1.0667682</td><td> 1.0667682</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>I-070759           </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4075031</td><td>2.576293e-05</td><td>0.0001804657</td><td> 1.0457832</td><td> 1.0457832</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>warfarin           </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2817883</td><td>2.448393e-03</td><td>0.0069954076</td><td>-1.0414442</td><td>-1.0414442</td><td>150</td><td>150</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>benzonatate        </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3993739</td><td>2.615460e-05</td><td>0.0001804657</td><td> 1.0249210</td><td> 1.0249210</td><td>150</td><td>150</td><td>SCN5A                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>MD-040             </td><td>73707398</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3977545</td><td>2.619812e-05</td><td>0.0001804657</td><td> 1.0207651</td><td> 1.0207651</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>ganglioside        </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2742264</td><td>4.681304e-03</td><td>0.0126521718</td><td>-1.0134963</td><td>-1.0134963</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>calcifediol        </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3943566</td><td>2.637219e-05</td><td>0.0001804657</td><td> 1.0120451</td><td> 1.0120451</td><td>150</td><td>150</td><td>VDR                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>rimcazole          </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3693924</td><td>2.746015e-05</td><td>0.0001804657</td><td> 0.9479788</td><td> 0.9479788</td><td>150</td><td>150</td><td>SIGMAR1                                                                                                                                                                                                                                                                                       </td></tr>\n","\t<tr><td>progesterone       </td><td>5994    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2560705</td><td>1.725925e-02</td><td>0.0442544901</td><td>-0.9463954</td><td>-0.9463954</td><td>150</td><td>150</td><td>AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5</td></tr>\n","\t<tr><td>afatinib           </td><td>22225683</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3645535</td><td>2.763423e-05</td><td>0.0001804657</td><td> 0.9355606</td><td> 0.9355606</td><td>150</td><td>150</td><td>EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>huperzine-a        </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3629478</td><td>2.776478e-05</td><td>0.0001804657</td><td> 0.9314399</td><td> 0.9314399</td><td>150</td><td>150</td><td>ACHE                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>calcitriol         </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3602968</td><td>2.789534e-05</td><td>0.0001804657</td><td> 0.9246366</td><td> 0.9246366</td><td>150</td><td>150</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                </td></tr>\n","\t<tr><td>fasudil            </td><td>3547    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3583908</td><td>2.798238e-05</td><td>0.0001804657</td><td> 0.9197452</td><td> 0.9197452</td><td>150</td><td>150</td><td>CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                      </td></tr>\n","\t<tr><td>BAY-11-7082        </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2478859</td><td>2.867713e-02</td><td>0.0682788735</td><td>-0.9161463</td><td>-0.9161463</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>endecaphyllin-x    </td><td>6710740 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2471567</td><td>3.045638e-02</td><td>0.0708287895</td><td>-0.9134511</td><td>-0.9134511</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>TUL-XIX029         </td><td>67243342</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3510614</td><td>2.887450e-05</td><td>0.0001804657</td><td> 0.9009355</td><td> 0.9009355</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>scoulerine         </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2391343</td><td>4.793888e-02</td><td>0.1065308453</td><td>-0.8838018</td><td>-0.8838018</td><td>150</td><td>150</td><td>ADRA1D                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>sinensetin         </td><td>145659  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3373698</td><td>3.622913e-05</td><td>0.0002131125</td><td> 0.8657986</td><td> 0.8657986</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>raltitrexed        </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3334212</td><td>4.203884e-05</td><td>0.0002304188</td><td> 0.8556654</td><td> 0.8556654</td><td>150</td><td>150</td><td>FPGS; TYMS                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>JWH-015            </td><td>4273754 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3322586</td><td>4.377958e-05</td><td>0.0002304188</td><td> 0.8526817</td><td> 0.8526817</td><td>150</td><td>150</td><td>CNR2; GPR55                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>GSK-0660           </td><td>46233311</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3267081</td><td>5.600827e-05</td><td>0.0002800414</td><td> 0.8384372</td><td> 0.8384372</td><td>150</td><td>150</td><td>PPARD                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>ryuvidine          </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3264634</td><td>5.940271e-05</td><td>0.0002828701</td><td> 0.8378093</td><td> 0.8378093</td><td>150</td><td>150</td><td>CDK2; CDK4                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>ST-4029655       </td><td>691928  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>tyrphostin-AG-556</td><td>2059    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>alvespimycin     </td><td>73707383</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               </td></tr>\n","\t<tr><td>AS-703026        </td><td>44187362</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>procarbazine     </td><td>9703    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>TUL-XX023        </td><td>54596143</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>CGP-12177        </td><td>2687    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>formoterol       </td><td>23581795</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>midostaurin      </td><td>9829523 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2</td></tr>\n","\t<tr><td>NSC-693868       </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>CGP-13501        </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>SPB02303         </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>aprepitant       </td><td>151165  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>evoxine          </td><td>673465  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>carbetocin       </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>ketorolac        </td><td>3826    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                </td></tr>\n","\t<tr><td>SKF-77434        </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>oxalomalic-acid  </td><td>439620  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>dibenzepin       </td><td>9419    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>NNC-63-0532      </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>pantoprazole     </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>trazodone        </td><td>5533    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>quinpirol-(-)    </td><td>NotFound</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>vinorelbine      </td><td>73707409</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>ST-001903        </td><td>674282  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>L-erythro-MAPP   </td><td>6610217 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>loreclezole      </td><td>50988829</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>RAN-05           </td><td>44229302</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>terguride        </td><td>11957722</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>K784-3131        </td><td>4381125 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":148},"id":"W6wUQ6Er21yL","executionInfo":{"status":"ok","timestamp":1636337754732,"user_tz":-480,"elapsed":17,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"01778e6b-7da1-4dfb-d822-add6fbdf12c9"},"source":["upset"],"execution_count":12,"outputs":[{"output_type":"display_data","data":{"text/plain":["  [1] \"230\"       \"5357\"      \"2015\"      \"2542\"      \"1759\"      \"6195\"     \n","  [7] \"80347\"     \"5050\"      \"5883\"      \"6251\"      \"5827\"      \"54499\"    \n"," [13] \"54504\"     \"22823\"     \"28969\"     \"10681\"     \"10362\"     \"5547\"     \n"," [19] \"9217\"      \"29922\"     \"10202\"     \"644\"       \"2517\"      \"2052\"     \n"," [25] \"8349\"      \"57446\"     \"2760\"      \"10467\"     \"11258\"     \"11124\"    \n"," [31] \"3988\"      \"1362\"      \"9054\"      \"8870\"      \"2946\"      \"51070\"    \n"," [37] \"51399\"     \"79095\"     \"84193\"     \"10327\"     \"142\"       \"5052\"     \n"," [43] \"49856\"     \"883\"       \"27095\"     \"11230\"     \"4504\"      \"26610\"    \n"," [49] \"51125\"     \"11007\"     \"2960\"      \"535\"       \"25976\"     \"10382\"    \n"," [55] \"4552\"      \"1528\"      \"2805\"      \"4713\"      \"7923\"      \"5423\"     \n"," [61] \"4291\"      \"4331\"      \"2184\"      \"8424\"      \"64172\"     \"55246\"    \n"," [67] \"55968\"     \"5909\"      \"29911\"     \"7001\"      \"6385\"      \"79090\"    \n"," [73] \"5104\"      \"10668\"     \"83443\"     \"59286\"     \"7430\"      \"11264\"    \n"," [79] \"8508\"      \"9341\"      \"60673\"     \"1191\"      \"55653\"     \"7265\"     \n"," [85] \"7283\"      \"26232\"     \"475\"       \"22824\"     \"2483\"      \"10063\"    \n"," [91] \"10016\"     \"10479\"     \"79632\"     \"2495\"      \"11031\"     \"8677\"     \n"," [97] \"6923\"      \"51550\"     \"51011\"     \"999\"       \"55540\"     \"10953\"    \n","[103] \"23205\"     \"51367\"     \"27236\"     \"10131\"     \"291\"       \"5007\"     \n","[109] \"25813\"     \"53340\"     \"10471\"     \"2232\"      \"10577\"     \"25874\"    \n","[115] \"6307\"      \"23647\"     \"2896\"      \"23242\"     \"4200\"      \"9896\"     \n","[121] \"2944\"      \"3399\"      \"64976\"     \"6691\"      \"344\"       \"23386\"    \n","[127] \"516\"       \"55616\"     \"8260\"      \"5538\"      \"7936\"      \"92815\"    \n","[133] \"5372\"      \"204\"       \"8492\"      \"100507436\" \"987\"       \"5383\"     \n","[139] \"80755\"     \"2948\"      \"27241\"     \"8892\"      \"79665\"     \"10591\"    \n","[145] \"28978\"     \"866\"       \"155066\"    \"51706\"     \"11041\"     \"55093\"    "],"text/latex":"\\begin{enumerate*}\n\\item '230'\n\\item '5357'\n\\item '2015'\n\\item '2542'\n\\item '1759'\n\\item '6195'\n\\item '80347'\n\\item '5050'\n\\item '5883'\n\\item '6251'\n\\item '5827'\n\\item '54499'\n\\item '54504'\n\\item '22823'\n\\item '28969'\n\\item '10681'\n\\item '10362'\n\\item '5547'\n\\item '9217'\n\\item '29922'\n\\item '10202'\n\\item '644'\n\\item '2517'\n\\item '2052'\n\\item '8349'\n\\item '57446'\n\\item '2760'\n\\item '10467'\n\\item '11258'\n\\item '11124'\n\\item '3988'\n\\item '1362'\n\\item '9054'\n\\item '8870'\n\\item '2946'\n\\item '51070'\n\\item '51399'\n\\item '79095'\n\\item '84193'\n\\item '10327'\n\\item '142'\n\\item '5052'\n\\item '49856'\n\\item '883'\n\\item '27095'\n\\item '11230'\n\\item '4504'\n\\item '26610'\n\\item '51125'\n\\item '11007'\n\\item '2960'\n\\item '535'\n\\item '25976'\n\\item '10382'\n\\item '4552'\n\\item '1528'\n\\item '2805'\n\\item '4713'\n\\item '7923'\n\\item '5423'\n\\item '4291'\n\\item '4331'\n\\item '2184'\n\\item '8424'\n\\item '64172'\n\\item '55246'\n\\item '55968'\n\\item '5909'\n\\item '29911'\n\\item '7001'\n\\item '6385'\n\\item '79090'\n\\item '5104'\n\\item '10668'\n\\item '83443'\n\\item '59286'\n\\item '7430'\n\\item '11264'\n\\item '8508'\n\\item '9341'\n\\item '60673'\n\\item '1191'\n\\item '55653'\n\\item '7265'\n\\item '7283'\n\\item '26232'\n\\item '475'\n\\item '22824'\n\\item '2483'\n\\item '10063'\n\\item '10016'\n\\item '10479'\n\\item '79632'\n\\item '2495'\n\\item '11031'\n\\item '8677'\n\\item '6923'\n\\item '51550'\n\\item '51011'\n\\item '999'\n\\item '55540'\n\\item '10953'\n\\item '23205'\n\\item '51367'\n\\item '27236'\n\\item '10131'\n\\item '291'\n\\item '5007'\n\\item '25813'\n\\item '53340'\n\\item '10471'\n\\item '2232'\n\\item '10577'\n\\item '25874'\n\\item '6307'\n\\item '23647'\n\\item '2896'\n\\item '23242'\n\\item '4200'\n\\item '9896'\n\\item '2944'\n\\item '3399'\n\\item '64976'\n\\item '6691'\n\\item '344'\n\\item '23386'\n\\item '516'\n\\item '55616'\n\\item '8260'\n\\item '5538'\n\\item '7936'\n\\item '92815'\n\\item '5372'\n\\item '204'\n\\item '8492'\n\\item '100507436'\n\\item '987'\n\\item '5383'\n\\item '80755'\n\\item '2948'\n\\item '27241'\n\\item '8892'\n\\item '79665'\n\\item '10591'\n\\item '28978'\n\\item '866'\n\\item '155066'\n\\item '51706'\n\\item '11041'\n\\item '55093'\n\\end{enumerate*}\n","text/markdown":"1. '230'\n2. '5357'\n3. '2015'\n4. '2542'\n5. '1759'\n6. '6195'\n7. '80347'\n8. '5050'\n9. '5883'\n10. '6251'\n11. '5827'\n12. '54499'\n13. '54504'\n14. '22823'\n15. '28969'\n16. '10681'\n17. '10362'\n18. '5547'\n19. '9217'\n20. '29922'\n21. '10202'\n22. '644'\n23. '2517'\n24. '2052'\n25. '8349'\n26. '57446'\n27. '2760'\n28. '10467'\n29. '11258'\n30. '11124'\n31. '3988'\n32. '1362'\n33. '9054'\n34. '8870'\n35. '2946'\n36. '51070'\n37. '51399'\n38. '79095'\n39. '84193'\n40. '10327'\n41. '142'\n42. '5052'\n43. '49856'\n44. '883'\n45. '27095'\n46. '11230'\n47. '4504'\n48. '26610'\n49. '51125'\n50. '11007'\n51. '2960'\n52. '535'\n53. '25976'\n54. '10382'\n55. '4552'\n56. '1528'\n57. '2805'\n58. '4713'\n59. '7923'\n60. '5423'\n61. '4291'\n62. '4331'\n63. '2184'\n64. '8424'\n65. '64172'\n66. '55246'\n67. '55968'\n68. '5909'\n69. '29911'\n70. '7001'\n71. '6385'\n72. '79090'\n73. '5104'\n74. '10668'\n75. '83443'\n76. '59286'\n77. '7430'\n78. '11264'\n79. '8508'\n80. '9341'\n81. '60673'\n82. '1191'\n83. '55653'\n84. '7265'\n85. '7283'\n86. '26232'\n87. '475'\n88. '22824'\n89. '2483'\n90. '10063'\n91. '10016'\n92. '10479'\n93. '79632'\n94. '2495'\n95. '11031'\n96. '8677'\n97. '6923'\n98. '51550'\n99. '51011'\n100. '999'\n101. '55540'\n102. '10953'\n103. '23205'\n104. '51367'\n105. '27236'\n106. '10131'\n107. '291'\n108. '5007'\n109. '25813'\n110. '53340'\n111. '10471'\n112. '2232'\n113. '10577'\n114. '25874'\n115. '6307'\n116. '23647'\n117. '2896'\n118. '23242'\n119. '4200'\n120. '9896'\n121. '2944'\n122. '3399'\n123. '64976'\n124. '6691'\n125. '344'\n126. '23386'\n127. '516'\n128. '55616'\n129. '8260'\n130. '5538'\n131. '7936'\n132. '92815'\n133. '5372'\n134. '204'\n135. '8492'\n136. '100507436'\n137. '987'\n138. '5383'\n139. '80755'\n140. '2948'\n141. '27241'\n142. '8892'\n143. '79665'\n144. '10591'\n145. '28978'\n146. '866'\n147. '155066'\n148. '51706'\n149. '11041'\n150. '55093'\n\n\n","text/html":["<style>\n",".list-inline {list-style: none; margin:0; padding: 0}\n",".list-inline>li {display: inline-block}\n",".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n","</style>\n","<ol class=list-inline><li>'230'</li><li>'5357'</li><li>'2015'</li><li>'2542'</li><li>'1759'</li><li>'6195'</li><li>'80347'</li><li>'5050'</li><li>'5883'</li><li>'6251'</li><li>'5827'</li><li>'54499'</li><li>'54504'</li><li>'22823'</li><li>'28969'</li><li>'10681'</li><li>'10362'</li><li>'5547'</li><li>'9217'</li><li>'29922'</li><li>'10202'</li><li>'644'</li><li>'2517'</li><li>'2052'</li><li>'8349'</li><li>'57446'</li><li>'2760'</li><li>'10467'</li><li>'11258'</li><li>'11124'</li><li>'3988'</li><li>'1362'</li><li>'9054'</li><li>'8870'</li><li>'2946'</li><li>'51070'</li><li>'51399'</li><li>'79095'</li><li>'84193'</li><li>'10327'</li><li>'142'</li><li>'5052'</li><li>'49856'</li><li>'883'</li><li>'27095'</li><li>'11230'</li><li>'4504'</li><li>'26610'</li><li>'51125'</li><li>'11007'</li><li>'2960'</li><li>'535'</li><li>'25976'</li><li>'10382'</li><li>'4552'</li><li>'1528'</li><li>'2805'</li><li>'4713'</li><li>'7923'</li><li>'5423'</li><li>'4291'</li><li>'4331'</li><li>'2184'</li><li>'8424'</li><li>'64172'</li><li>'55246'</li><li>'55968'</li><li>'5909'</li><li>'29911'</li><li>'7001'</li><li>'6385'</li><li>'79090'</li><li>'5104'</li><li>'10668'</li><li>'83443'</li><li>'59286'</li><li>'7430'</li><li>'11264'</li><li>'8508'</li><li>'9341'</li><li>'60673'</li><li>'1191'</li><li>'55653'</li><li>'7265'</li><li>'7283'</li><li>'26232'</li><li>'475'</li><li>'22824'</li><li>'2483'</li><li>'10063'</li><li>'10016'</li><li>'10479'</li><li>'79632'</li><li>'2495'</li><li>'11031'</li><li>'8677'</li><li>'6923'</li><li>'51550'</li><li>'51011'</li><li>'999'</li><li>'55540'</li><li>'10953'</li><li>'23205'</li><li>'51367'</li><li>'27236'</li><li>'10131'</li><li>'291'</li><li>'5007'</li><li>'25813'</li><li>'53340'</li><li>'10471'</li><li>'2232'</li><li>'10577'</li><li>'25874'</li><li>'6307'</li><li>'23647'</li><li>'2896'</li><li>'23242'</li><li>'4200'</li><li>'9896'</li><li>'2944'</li><li>'3399'</li><li>'64976'</li><li>'6691'</li><li>'344'</li><li>'23386'</li><li>'516'</li><li>'55616'</li><li>'8260'</li><li>'5538'</li><li>'7936'</li><li>'92815'</li><li>'5372'</li><li>'204'</li><li>'8492'</li><li>'100507436'</li><li>'987'</li><li>'5383'</li><li>'80755'</li><li>'2948'</li><li>'27241'</li><li>'8892'</li><li>'79665'</li><li>'10591'</li><li>'28978'</li><li>'866'</li><li>'155066'</li><li>'51706'</li><li>'11041'</li><li>'55093'</li></ol>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"DR9cHhBB22S4"},"source":["The search results are stored in a `gessResult` object as under the CMAP example above. The similarity scores stored in the LINCS result table are summarized here. `WTCS`: Weighted Connectivity Score; `WTCS_Pval`: nominal p-value of WTCS; `WTCS_FDR`: false discovery rate of WTCS_Pval; `NCS`: normalized connectivity score; `NCSct`: NCS summarized across cell types; `Tau`: enrichment score standardized for a given database. The latter is only included in the result table if `tau=TRUE` in a gess_lincs function call. The example given is run with `tau=FALSE`, because the tau values are only meaningful when the complete LINCS database is used which is not the case for the toy database.\n","\n","The following provides a more detailed description of the similarity scores computed by the LINCS method. Additional details are available in the Supplementary Material Section of the Subramanian et al. (2017) paper.\n","\n","- `WTCS`: The Weighted Connectivity Score is a bi-directional ES for an up/down query set. If the ES values of an up set and a down set are of different signs, then WTCS is (ESup-ESdown)/2, otherwise, it is 0. WTCS values range from -1 to 1. They are positive or negative for signatures that are positively or inversely related, respectively, and close to zero for signatures that are unrelated.\n","\n","- `WTCS_Pval` and `WTCS_FDR`: The nominal p-value of the WTCS and the corresponding false discovery rate (FDR) are computed by comparing the WTCS against a null distribution of WTCS values obtained from a large number of random queries (e.g. 1000).\n","\n","- `NCS`: to make connectivity scores comparable across cell types and perturbation types, the scores are normalized. Given a vector of $WTCS$ values $w$ resulting from a query, the values are normalized within each cell line $c$ and perturbagen type $t$ to obtain the $NCS$ by dividing the $WTCS$ value by the signed mean of the $WTCS$ values within the subset of signatures in the reference databses corresponding to $c$ and $t$.\n","\n","- `NCSct`: The NCS is summarized across cell types as follows. Given a vector of $NCS$ values for perturbagen $p$, relative to query $q$, across all cell lines $c$ which $p$ was profled, a cell-summarized connectivity scores is obtained using a maximum quantile statistic. It compares the 67 and 33 quantiles of $NCSp, c$ and retains whichever is of higher absolute magnitude.\n","\n","- `Tau`: the standardized score Tau compares an observed $NCS$ to a large set of $NCS$ values that have been pre-computed for a specific reference databse. The query results are scored with Tau as a standardized measure ranging from 100 to -100. A Tau of 90 indicates that only 10% of reference perturbations exhibit stronger connectivity to the query. This way one can make more meaningful comparisons across query results\n","\n","# 4. gCMAP Search method\n","\n","It uses as query a rank transformed GEP and the reference database is composed of the labels of up and down regulated DEG sets. This is the opposite situation of the CMAP method, where the query is composed of the labels of up and down regulated DEGs and the database contains rank transformed GESs.\n","\n","In case of the gCMAP GESS method, the GEP-Q is a matrix with a single column representing gene ranks from a biological state of interest, here vorinostat treatment in SKB cells. The corresponding gene labels are stored in the row name slot of the matrix. Instead of ranks one can provide scores (e.g. z-scores) as in the example given below. In such a case the scores will be internally transformed to ranks. The reference database consists of gene label sets that were extracted from the toy databases by applying a higher and lower filter, here set to 1 and -1, respectively.\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"GosSgEN04yGZ","executionInfo":{"status":"ok","timestamp":1636337757397,"user_tz":-480,"elapsed":2679,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"cf15b140-959b-4887-ed2d-21517ba6ad22"},"source":["qsig_cmap <- qSig(query = query_mat, gess_method = 'gCMAP', refdb = db_path)\n","gcmap <- gess_gcmap(qsig_cmap, higher=1, lower=-1, workers=1)\n","result(gcmap)"],"execution_count":13,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                PCID     cell type   trend effect     nSet nFound\n","1   vorinostat          5311     SKB  trt_cp up     1.0000000 1098 1098  \n","2   warfarin            54678486 SKB  trt_cp down  -1.0000000  114  114  \n","3   D-609               45479729 SKB  trt_cp down  -0.7149940  125  125  \n","4   TC-2559             9823180  SKB  trt_cp down  -0.6852566  377  377  \n","5   rescinnamine        5280954  SKB  trt_cp down  -0.6094416  726  726  \n","6   amiodarone          2157     SKB  trt_cp down  -0.5835090  706  706  \n","7   trichostatin-a      444732   SKB  trt_cp up     0.5761681 1430 1430  \n","8   zuclopenthixol      5311507  SKB  trt_cp down  -0.5541334  483  483  \n","9   progesterone        5994     SKB  trt_cp down  -0.5532561  242  242  \n","10  evoxine             673465   SKB  trt_cp down  -0.5327731  461  461  \n","11  mexiletine          4178     SKB  trt_cp down  -0.5306072  598  598  \n","12  dibenzepin          9419     SKB  trt_cp down  -0.5292258  864  864  \n","13  pantoprazole        4679     SKB  trt_cp down  -0.5212137  615  615  \n","14  ganglioside         4673190  SKB  trt_cp down  -0.5043967  602  602  \n","15  HC-toxin            3571     SKB  trt_cp up     0.4837859 1804 1804  \n","16  epothilone          448013   SKB  trt_cp down  -0.4670728  326  326  \n","17  scoulerine          439654   SKB  trt_cp down  -0.4556758  385  385  \n","18  BAY-11-7082         5353431  SKB  trt_cp down  -0.4442813  488  488  \n","19  ST-013960           2300880  SKB  trt_cp down  -0.4409645  405  405  \n","20  clofibric-acid      2797     SKB  trt_cp down  -0.3953659 1943 1943  \n","21  ketorolac           3826     SKB  trt_cp down  -0.3859742  632  632  \n","22  vinorelbine         73707409 SKB  trt_cp down  -0.3747249  327  327  \n","23  TUL-XX023           54596143 SKB  trt_cp down  -0.3716049  885  885  \n","24  pyroxamide          4996     SKB  trt_cp up     0.3497165  641  641  \n","25  L-erythro-MAPP      6610217  SKB  trt_cp down  -0.3304712  856  856  \n","26  quinpirol-(-)       NotFound SKB  trt_cp down  -0.3291852 1644 1644  \n","27  endecaphyllin-x     6710740  SKB  trt_cp down  -0.3079230  523  523  \n","28  hemado              4043357  SKB  trt_cp down  -0.2073644  827  827  \n","29  calcitriol          21158442 SKB  trt_cp up     0.1965277  364  364  \n","30  benzonatate         7699     SKB  trt_cp up     0.1879607  931  931  \n","⋮   ⋮                   ⋮        ⋮    ⋮      ⋮     ⋮          ⋮    ⋮     \n","71  rhamnetin           5281691  SKB  trt_cp up    0          1032 1032  \n","72  fillalbin           933171   SKB  trt_cp up    0           343  343  \n","73  SEW-2871            4077460  SKB  trt_cp up    0           567  567  \n","74  bendroflumethiazide 2315     SKB  trt_cp up    0           915  915  \n","75  MW-A1-2             3125011  SKB  trt_cp up    0          1329 1329  \n","76  GW-4064             9893571  SKB  trt_cp up    0           506  506  \n","77  SB-525334           9967941  SKB  trt_cp up    0           407  407  \n","78  sphingosine         5280335  SKB  trt_cp up    0           777  777  \n","79  mead-acid           5312531  SKB  trt_cp up    0           823  823  \n","80  erythrosine         12961638 SKB  trt_cp up    0           424  424  \n","81  ST-4029655          691928   SKB  trt_cp up    0           432  432  \n","82  tyrphostin-AG-556   2059     SKB  trt_cp up    0           732  732  \n","83  alvespimycin        73707383 SKB  trt_cp up    0          1123 1123  \n","84  AS-703026           44187362 SKB  trt_cp up    0           264  264  \n","85  procarbazine        9703     SKB  trt_cp up    0           387  387  \n","86  CGP-12177           2687     SKB  trt_cp up    0           473  473  \n","87  propylpyrazole      35027762 SKB  trt_cp up    0           328  328  \n","88  midostaurin         9829523  SKB  trt_cp up    0          1955 1955  \n","89  NSC-693868          438981   SKB  trt_cp up    0          1201 1201  \n","90  CGP-13501           3519541  SKB  trt_cp up    0           596  596  \n","91  SPB02303            2744062  SKB  trt_cp up    0           963  963  \n","92  aprepitant          151165   SKB  trt_cp up    0           340  340  \n","93  carbetocin          73707428 SKB  trt_cp up    0          2468 2468  \n","94  SKF-77434           11957703 SKB  trt_cp up    0          2429 2429  \n","95  vicriviroc          73707391 SKB  trt_cp up    0           373  373  \n","96  NNC-63-0532         3906780  SKB  trt_cp up    0           577  577  \n","97  trazodone           5533     SKB  trt_cp up    0           379  379  \n","98  loreclezole         50988829 SKB  trt_cp up    0           324  324  \n","99  RAN-05              44229302 SKB  trt_cp up    0           116  116  \n","100 terguride           11957722 SKB  trt_cp up    0           985  985  \n","    signed\n","1   TRUE  \n","2   TRUE  \n","3   TRUE  \n","4   TRUE  \n","5   TRUE  \n","6   TRUE  \n","7   TRUE  \n","8   TRUE  \n","9   TRUE  \n","10  TRUE  \n","11  TRUE  \n","12  TRUE  \n","13  TRUE  \n","14  TRUE  \n","15  TRUE  \n","16  TRUE  \n","17  TRUE  \n","18  TRUE  \n","19  TRUE  \n","20  TRUE  \n","21  TRUE  \n","22  TRUE  \n","23  TRUE  \n","24  TRUE  \n","25  TRUE  \n","26  TRUE  \n","27  TRUE  \n","28  TRUE  \n","29  TRUE  \n","30  TRUE  \n","⋮   ⋮     \n","71  TRUE  \n","72  TRUE  \n","73  TRUE  \n","74  TRUE  \n","75  TRUE  \n","76  TRUE  \n","77  TRUE  \n","78  TRUE  \n","79  TRUE  \n","80  TRUE  \n","81  TRUE  \n","82  TRUE  \n","83  TRUE  \n","84  TRUE  \n","85  TRUE  \n","86  TRUE  \n","87  TRUE  \n","88  TRUE  \n","89  TRUE  \n","90  TRUE  \n","91  TRUE  \n","92  TRUE  \n","93  TRUE  \n","94  TRUE  \n","95  TRUE  \n","96  TRUE  \n","97  TRUE  \n","98  TRUE  \n","99  TRUE  \n","100 TRUE  \n","    t_gn_sym                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","2   ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","3   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","4   CHRNA4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","5   ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","6   ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; CYP2C9; DIO3; KCNA7; KCNH2; PPARG; SCN5A; THRA; THRB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","7   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","8   ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","9   AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5                                                                                                                                                                                                                                                                                                                                                         \n","10  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","11  AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n","12  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","13  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","14  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","15  HDAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","16  TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","17  ADRA1D                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","18  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","19  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","20  PPARA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","21  LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","22  TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","23  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","24  HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","25  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","26  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","27  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","28  ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n","29  CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","30  SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","⋮   ⋮                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","71  ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","72  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","73  S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","74  CA1; CA4; KCNMA1; SLC12A1; SLC12A3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","75  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","76  NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","77  TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","78  ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n","79  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","80  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","81  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","82  EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","83  HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","84  MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","85  MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","86  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","87  ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","88  AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\n","89  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","90  GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","91  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","92  CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","93  OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","94  DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","95  CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","96  OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","97  ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","98  GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","99  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","100 ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           "],"text/latex":"A tibble: 100 × 10\n\\begin{tabular}{llllllllll}\n pert & PCID & cell & type & trend & effect & nSet & nFound & signed & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <lgl> & <chr>\\\\\n\\hline\n\t vorinostat      & 5311     & SKB & trt\\_cp & up   &  1.0000000 & 1098 & 1098 & TRUE & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                 \\\\\n\t warfarin        & 54678486 & SKB & trt\\_cp & down & -1.0000000 &  114 &  114 & TRUE & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                           \\\\\n\t D-609           & 45479729 & SKB & trt\\_cp & down & -0.7149940 &  125 &  125 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t TC-2559         & 9823180  & SKB & trt\\_cp & down & -0.6852566 &  377 &  377 & TRUE & CHRNA4                                                                                                                                                                                                                                                                                        \\\\\n\t rescinnamine    & 5280954  & SKB & trt\\_cp & down & -0.6094416 &  726 &  726 & TRUE & ACE                                                                                                                                                                                                                                                                                           \\\\\n\t amiodarone      & 2157     & SKB & trt\\_cp & down & -0.5835090 &  706 &  706 & TRUE & ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; CYP2C9; DIO3; KCNA7; KCNH2; PPARG; SCN5A; THRA; THRB                                                                                                                                                                                                 \\\\\n\t trichostatin-a  & 444732   & SKB & trt\\_cp & up   &  0.5761681 & 1430 & 1430 & TRUE & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                         \\\\\n\t zuclopenthixol  & 5311507  & SKB & trt\\_cp & down & -0.5541334 &  483 &  483 & TRUE & ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                            \\\\\n\t progesterone    & 5994     & SKB & trt\\_cp & down & -0.5532561 &  242 &  242 & TRUE & AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5\\\\\n\t evoxine         & 673465   & SKB & trt\\_cp & down & -0.5327731 &  461 &  461 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t mexiletine      & 4178     & SKB & trt\\_cp & down & -0.5306072 &  598 &  598 & TRUE & AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                               \\\\\n\t dibenzepin      & 9419     & SKB & trt\\_cp & down & -0.5292258 &  864 &  864 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t pantoprazole    & 4679     & SKB & trt\\_cp & down & -0.5212137 &  615 &  615 & TRUE & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                         \\\\\n\t ganglioside     & 4673190  & SKB & trt\\_cp & down & -0.5043967 &  602 &  602 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t HC-toxin        & 3571     & SKB & trt\\_cp & up   &  0.4837859 & 1804 & 1804 & TRUE & HDAC1                                                                                                                                                                                                                                                                                         \\\\\n\t epothilone      & 448013   & SKB & trt\\_cp & down & -0.4670728 &  326 &  326 & TRUE & TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                             \\\\\n\t scoulerine      & 439654   & SKB & trt\\_cp & down & -0.4556758 &  385 &  385 & TRUE & ADRA1D                                                                                                                                                                                                                                                                                        \\\\\n\t BAY-11-7082     & 5353431  & SKB & trt\\_cp & down & -0.4442813 &  488 &  488 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t ST-013960       & 2300880  & SKB & trt\\_cp & down & -0.4409645 &  405 &  405 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t clofibric-acid  & 2797     & SKB & trt\\_cp & down & -0.3953659 & 1943 & 1943 & TRUE & PPARA                                                                                                                                                                                                                                                                                         \\\\\n\t ketorolac       & 3826     & SKB & trt\\_cp & down & -0.3859742 &  632 &  632 & TRUE & LTF; TF                                                                                                                                                                                                                                                                                       \\\\\n\t vinorelbine     & 73707409 & SKB & trt\\_cp & down & -0.3747249 &  327 &  327 & TRUE & TUBB                                                                                                                                                                                                                                                                                          \\\\\n\t TUL-XX023       & 54596143 & SKB & trt\\_cp & down & -0.3716049 &  885 &  885 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t pyroxamide      & 4996     & SKB & trt\\_cp & up   &  0.3497165 &  641 &  641 & TRUE & HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                           \\\\\n\t L-erythro-MAPP  & 6610217  & SKB & trt\\_cp & down & -0.3304712 &  856 &  856 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t quinpirol-(-)   & NotFound & SKB & trt\\_cp & down & -0.3291852 & 1644 & 1644 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t endecaphyllin-x & 6710740  & SKB & trt\\_cp & down & -0.3079230 &  523 &  523 & TRUE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t hemado          & 4043357  & SKB & trt\\_cp & down & -0.2073644 &  827 &  827 & TRUE & ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                              \\\\\n\t calcitriol      & 21158442 & SKB & trt\\_cp & up   &  0.1965277 &  364 &  364 & TRUE & CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                \\\\\n\t benzonatate     & 7699     & SKB & trt\\_cp & up   &  0.1879607 &  931 &  931 & TRUE & SCN5A                                                                                                                                                                                                                                                                                         \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t rhamnetin           & 5281691  & SKB & trt\\_cp & up & 0 & 1032 & 1032 & TRUE & ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t fillalbin           & 933171   & SKB & trt\\_cp & up & 0 &  343 &  343 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t SEW-2871            & 4077460  & SKB & trt\\_cp & up & 0 &  567 &  567 & TRUE & S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t bendroflumethiazide & 2315     & SKB & trt\\_cp & up & 0 &  915 &  915 & TRUE & CA1; CA4; KCNMA1; SLC12A1; SLC12A3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t MW-A1-2             & 3125011  & SKB & trt\\_cp & up & 0 & 1329 & 1329 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t GW-4064             & 9893571  & SKB & trt\\_cp & up & 0 &  506 &  506 & TRUE & NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t SB-525334           & 9967941  & SKB & trt\\_cp & up & 0 &  407 &  407 & TRUE & TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t sphingosine         & 5280335  & SKB & trt\\_cp & up & 0 &  777 &  777 & TRUE & ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        \\\\\n\t mead-acid           & 5312531  & SKB & trt\\_cp & up & 0 &  823 &  823 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t erythrosine         & 12961638 & SKB & trt\\_cp & up & 0 &  424 &  424 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t ST-4029655          & 691928   & SKB & trt\\_cp & up & 0 &  432 &  432 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t tyrphostin-AG-556   & 2059     & SKB & trt\\_cp & up & 0 &  732 &  732 & TRUE & EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t alvespimycin        & 73707383 & SKB & trt\\_cp & up & 0 & 1123 & 1123 & TRUE & HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \\\\\n\t AS-703026           & 44187362 & SKB & trt\\_cp & up & 0 &  264 &  264 & TRUE & MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t procarbazine        & 9703     & SKB & trt\\_cp & up & 0 &  387 &  387 & TRUE & MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t CGP-12177           & 2687     & SKB & trt\\_cp & up & 0 &  473 &  473 & TRUE & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t propylpyrazole      & 35027762 & SKB & trt\\_cp & up & 0 &  328 &  328 & TRUE & ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t midostaurin         & 9829523  & SKB & trt\\_cp & up & 0 & 1955 & 1955 & TRUE & AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\\\\\n\t NSC-693868          & 438981   & SKB & trt\\_cp & up & 0 & 1201 & 1201 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t CGP-13501           & 3519541  & SKB & trt\\_cp & up & 0 &  596 &  596 & TRUE & GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t SPB02303            & 2744062  & SKB & trt\\_cp & up & 0 &  963 &  963 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t aprepitant          & 151165   & SKB & trt\\_cp & up & 0 &  340 &  340 & TRUE & CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \\\\\n\t carbetocin          & 73707428 & SKB & trt\\_cp & up & 0 & 2468 & 2468 & TRUE & OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t SKF-77434           & 11957703 & SKB & trt\\_cp & up & 0 & 2429 & 2429 & TRUE & DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t vicriviroc          & 73707391 & SKB & trt\\_cp & up & 0 &  373 &  373 & TRUE & CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t NNC-63-0532         & 3906780  & SKB & trt\\_cp & up & 0 &  577 &  577 & TRUE & OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t trazodone           & 5533     & SKB & trt\\_cp & up & 0 &  379 &  379 & TRUE & ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \\\\\n\t loreclezole         & 50988829 & SKB & trt\\_cp & up & 0 &  324 &  324 & TRUE & GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t RAN-05              & 44229302 & SKB & trt\\_cp & up & 0 &  116 &  116 & TRUE & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t terguride           & 11957722 & SKB & trt\\_cp & up & 0 &  985 &  985 & TRUE & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 10\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | effect &lt;dbl&gt; | nSet &lt;dbl&gt; | nFound &lt;dbl&gt; | signed &lt;lgl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| vorinostat      | 5311     | SKB | trt_cp | up   |  1.0000000 | 1098 | 1098 | TRUE | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                  |\n| warfarin        | 54678486 | SKB | trt_cp | down | -1.0000000 |  114 |  114 | TRUE | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                            |\n| D-609           | 45479729 | SKB | trt_cp | down | -0.7149940 |  125 |  125 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| TC-2559         | 9823180  | SKB | trt_cp | down | -0.6852566 |  377 |  377 | TRUE | CHRNA4                                                                                                                                                                                                                                                                                         |\n| rescinnamine    | 5280954  | SKB | trt_cp | down | -0.6094416 |  726 |  726 | TRUE | ACE                                                                                                                                                                                                                                                                                            |\n| amiodarone      | 2157     | SKB | trt_cp | down | -0.5835090 |  706 |  706 | TRUE | ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; CYP2C9; DIO3; KCNA7; KCNH2; PPARG; SCN5A; THRA; THRB                                                                                                                                                                                                  |\n| trichostatin-a  | 444732   | SKB | trt_cp | up   |  0.5761681 | 1430 | 1430 | TRUE | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                          |\n| zuclopenthixol  | 5311507  | SKB | trt_cp | down | -0.5541334 |  483 |  483 | TRUE | ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                             |\n| progesterone    | 5994     | SKB | trt_cp | down | -0.5532561 |  242 |  242 | TRUE | AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5 |\n| evoxine         | 673465   | SKB | trt_cp | down | -0.5327731 |  461 |  461 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| mexiletine      | 4178     | SKB | trt_cp | down | -0.5306072 |  598 |  598 | TRUE | AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                |\n| dibenzepin      | 9419     | SKB | trt_cp | down | -0.5292258 |  864 |  864 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| pantoprazole    | 4679     | SKB | trt_cp | down | -0.5212137 |  615 |  615 | TRUE | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                          |\n| ganglioside     | 4673190  | SKB | trt_cp | down | -0.5043967 |  602 |  602 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| HC-toxin        | 3571     | SKB | trt_cp | up   |  0.4837859 | 1804 | 1804 | TRUE | HDAC1                                                                                                                                                                                                                                                                                          |\n| epothilone      | 448013   | SKB | trt_cp | down | -0.4670728 |  326 |  326 | TRUE | TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                              |\n| scoulerine      | 439654   | SKB | trt_cp | down | -0.4556758 |  385 |  385 | TRUE | ADRA1D                                                                                                                                                                                                                                                                                         |\n| BAY-11-7082     | 5353431  | SKB | trt_cp | down | -0.4442813 |  488 |  488 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| ST-013960       | 2300880  | SKB | trt_cp | down | -0.4409645 |  405 |  405 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| clofibric-acid  | 2797     | SKB | trt_cp | down | -0.3953659 | 1943 | 1943 | TRUE | PPARA                                                                                                                                                                                                                                                                                          |\n| ketorolac       | 3826     | SKB | trt_cp | down | -0.3859742 |  632 |  632 | TRUE | LTF; TF                                                                                                                                                                                                                                                                                        |\n| vinorelbine     | 73707409 | SKB | trt_cp | down | -0.3747249 |  327 |  327 | TRUE | TUBB                                                                                                                                                                                                                                                                                           |\n| TUL-XX023       | 54596143 | SKB | trt_cp | down | -0.3716049 |  885 |  885 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| pyroxamide      | 4996     | SKB | trt_cp | up   |  0.3497165 |  641 |  641 | TRUE | HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                            |\n| L-erythro-MAPP  | 6610217  | SKB | trt_cp | down | -0.3304712 |  856 |  856 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| quinpirol-(-)   | NotFound | SKB | trt_cp | down | -0.3291852 | 1644 | 1644 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| endecaphyllin-x | 6710740  | SKB | trt_cp | down | -0.3079230 |  523 |  523 | TRUE | NA                                                                                                                                                                                                                                                                                             |\n| hemado          | 4043357  | SKB | trt_cp | down | -0.2073644 |  827 |  827 | TRUE | ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                               |\n| calcitriol      | 21158442 | SKB | trt_cp | up   |  0.1965277 |  364 |  364 | TRUE | CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                 |\n| benzonatate     | 7699     | SKB | trt_cp | up   |  0.1879607 |  931 |  931 | TRUE | SCN5A                                                                                                                                                                                                                                                                                          |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| rhamnetin           | 5281691  | SKB | trt_cp | up | 0 | 1032 | 1032 | TRUE | ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| fillalbin           | 933171   | SKB | trt_cp | up | 0 |  343 |  343 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| SEW-2871            | 4077460  | SKB | trt_cp | up | 0 |  567 |  567 | TRUE | S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| bendroflumethiazide | 2315     | SKB | trt_cp | up | 0 |  915 |  915 | TRUE | CA1; CA4; KCNMA1; SLC12A1; SLC12A3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| MW-A1-2             | 3125011  | SKB | trt_cp | up | 0 | 1329 | 1329 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| GW-4064             | 9893571  | SKB | trt_cp | up | 0 |  506 |  506 | TRUE | NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| SB-525334           | 9967941  | SKB | trt_cp | up | 0 |  407 |  407 | TRUE | TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| sphingosine         | 5280335  | SKB | trt_cp | up | 0 |  777 |  777 | TRUE | ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                         |\n| mead-acid           | 5312531  | SKB | trt_cp | up | 0 |  823 |  823 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| erythrosine         | 12961638 | SKB | trt_cp | up | 0 |  424 |  424 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| ST-4029655          | 691928   | SKB | trt_cp | up | 0 |  432 |  432 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| tyrphostin-AG-556   | 2059     | SKB | trt_cp | up | 0 |  732 |  732 | TRUE | EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| alvespimycin        | 73707383 | SKB | trt_cp | up | 0 | 1123 | 1123 | TRUE | HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |\n| AS-703026           | 44187362 | SKB | trt_cp | up | 0 |  264 |  264 | TRUE | MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| procarbazine        | 9703     | SKB | trt_cp | up | 0 |  387 |  387 | TRUE | MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| CGP-12177           | 2687     | SKB | trt_cp | up | 0 |  473 |  473 | TRUE | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| propylpyrazole      | 35027762 | SKB | trt_cp | up | 0 |  328 |  328 | TRUE | ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| midostaurin         | 9829523  | SKB | trt_cp | up | 0 | 1955 | 1955 | TRUE | AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2 |\n| NSC-693868          | 438981   | SKB | trt_cp | up | 0 | 1201 | 1201 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| CGP-13501           | 3519541  | SKB | trt_cp | up | 0 |  596 |  596 | TRUE | GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| SPB02303            | 2744062  | SKB | trt_cp | up | 0 |  963 |  963 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| aprepitant          | 151165   | SKB | trt_cp | up | 0 |  340 |  340 | TRUE | CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |\n| carbetocin          | 73707428 | SKB | trt_cp | up | 0 | 2468 | 2468 | TRUE | OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| SKF-77434           | 11957703 | SKB | trt_cp | up | 0 | 2429 | 2429 | TRUE | DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| vicriviroc          | 73707391 | SKB | trt_cp | up | 0 |  373 |  373 | TRUE | CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| NNC-63-0532         | 3906780  | SKB | trt_cp | up | 0 |  577 |  577 | TRUE | OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| trazodone           | 5533     | SKB | trt_cp | up | 0 |  379 |  379 | TRUE | ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |\n| loreclezole         | 50988829 | SKB | trt_cp | up | 0 |  324 |  324 | TRUE | GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| RAN-05              | 44229302 | SKB | trt_cp | up | 0 |  116 |  116 | TRUE | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| terguride           | 11957722 | SKB | trt_cp | up | 0 |  985 |  985 | TRUE | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>effect</th><th scope=col>nSet</th><th scope=col>nFound</th><th scope=col>signed</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;lgl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat     </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.0000000</td><td>1098</td><td>1098</td><td>TRUE</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>warfarin       </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-1.0000000</td><td> 114</td><td> 114</td><td>TRUE</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>D-609          </td><td>45479729</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.7149940</td><td> 125</td><td> 125</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>TC-2559        </td><td>9823180 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.6852566</td><td> 377</td><td> 377</td><td>TRUE</td><td>CHRNA4                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>rescinnamine   </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.6094416</td><td> 726</td><td> 726</td><td>TRUE</td><td>ACE                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>amiodarone     </td><td>2157    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5835090</td><td> 706</td><td> 706</td><td>TRUE</td><td>ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; CYP2C9; DIO3; KCNA7; KCNH2; PPARG; SCN5A; THRA; THRB                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>trichostatin-a </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.5761681</td><td>1430</td><td>1430</td><td>TRUE</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>zuclopenthixol </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5541334</td><td> 483</td><td> 483</td><td>TRUE</td><td>ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>progesterone   </td><td>5994    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5532561</td><td> 242</td><td> 242</td><td>TRUE</td><td>AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5</td></tr>\n","\t<tr><td>evoxine        </td><td>673465  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5327731</td><td> 461</td><td> 461</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>mexiletine     </td><td>4178    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5306072</td><td> 598</td><td> 598</td><td>TRUE</td><td>AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                               </td></tr>\n","\t<tr><td>dibenzepin     </td><td>9419    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5292258</td><td> 864</td><td> 864</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>pantoprazole   </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5212137</td><td> 615</td><td> 615</td><td>TRUE</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>ganglioside    </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.5043967</td><td> 602</td><td> 602</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>HC-toxin       </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4837859</td><td>1804</td><td>1804</td><td>TRUE</td><td>HDAC1                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>epothilone     </td><td>448013  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.4670728</td><td> 326</td><td> 326</td><td>TRUE</td><td>TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>scoulerine     </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.4556758</td><td> 385</td><td> 385</td><td>TRUE</td><td>ADRA1D                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>BAY-11-7082    </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.4442813</td><td> 488</td><td> 488</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>ST-013960      </td><td>2300880 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.4409645</td><td> 405</td><td> 405</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>clofibric-acid </td><td>2797    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3953659</td><td>1943</td><td>1943</td><td>TRUE</td><td>PPARA                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>ketorolac      </td><td>3826    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3859742</td><td> 632</td><td> 632</td><td>TRUE</td><td>LTF; TF                                                                                                                                                                                                                                                                                       </td></tr>\n","\t<tr><td>vinorelbine    </td><td>73707409</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3747249</td><td> 327</td><td> 327</td><td>TRUE</td><td>TUBB                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>TUL-XX023      </td><td>54596143</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3716049</td><td> 885</td><td> 885</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>pyroxamide     </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3497165</td><td> 641</td><td> 641</td><td>TRUE</td><td>HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>L-erythro-MAPP </td><td>6610217 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3304712</td><td> 856</td><td> 856</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>quinpirol-(-)  </td><td>NotFound</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3291852</td><td>1644</td><td>1644</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>endecaphyllin-x</td><td>6710740 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3079230</td><td> 523</td><td> 523</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>hemado         </td><td>4043357 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2073644</td><td> 827</td><td> 827</td><td>TRUE</td><td>ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                              </td></tr>\n","\t<tr><td>calcitriol     </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1965277</td><td> 364</td><td> 364</td><td>TRUE</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                </td></tr>\n","\t<tr><td>benzonatate    </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1879607</td><td> 931</td><td> 931</td><td>TRUE</td><td>SCN5A                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>rhamnetin          </td><td>5281691 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>1032</td><td>1032</td><td>TRUE</td><td>ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>fillalbin          </td><td>933171  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 343</td><td> 343</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>SEW-2871           </td><td>4077460 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 567</td><td> 567</td><td>TRUE</td><td>S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>bendroflumethiazide</td><td>2315    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 915</td><td> 915</td><td>TRUE</td><td>CA1; CA4; KCNMA1; SLC12A1; SLC12A3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>MW-A1-2            </td><td>3125011 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>1329</td><td>1329</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>GW-4064            </td><td>9893571 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 506</td><td> 506</td><td>TRUE</td><td>NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>SB-525334          </td><td>9967941 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 407</td><td> 407</td><td>TRUE</td><td>TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>sphingosine        </td><td>5280335 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 777</td><td> 777</td><td>TRUE</td><td>ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>mead-acid          </td><td>5312531 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 823</td><td> 823</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>erythrosine        </td><td>12961638</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 424</td><td> 424</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>ST-4029655         </td><td>691928  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 432</td><td> 432</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>tyrphostin-AG-556  </td><td>2059    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 732</td><td> 732</td><td>TRUE</td><td>EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>alvespimycin       </td><td>73707383</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>1123</td><td>1123</td><td>TRUE</td><td>HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               </td></tr>\n","\t<tr><td>AS-703026          </td><td>44187362</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 264</td><td> 264</td><td>TRUE</td><td>MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>procarbazine       </td><td>9703    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 387</td><td> 387</td><td>TRUE</td><td>MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>CGP-12177          </td><td>2687    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 473</td><td> 473</td><td>TRUE</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>propylpyrazole     </td><td>35027762</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 328</td><td> 328</td><td>TRUE</td><td>ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>midostaurin        </td><td>9829523 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>1955</td><td>1955</td><td>TRUE</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2</td></tr>\n","\t<tr><td>NSC-693868         </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>1201</td><td>1201</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>CGP-13501          </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 596</td><td> 596</td><td>TRUE</td><td>GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>SPB02303           </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 963</td><td> 963</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>aprepitant         </td><td>151165  </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 340</td><td> 340</td><td>TRUE</td><td>CYP2C9; TACR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>carbetocin         </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>2468</td><td>2468</td><td>TRUE</td><td>OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>SKF-77434          </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td>2429</td><td>2429</td><td>TRUE</td><td>DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>vicriviroc         </td><td>73707391</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 373</td><td> 373</td><td>TRUE</td><td>CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>NNC-63-0532        </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 577</td><td> 577</td><td>TRUE</td><td>OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>trazodone          </td><td>5533    </td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 379</td><td> 379</td><td>TRUE</td><td>ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>loreclezole        </td><td>50988829</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 324</td><td> 324</td><td>TRUE</td><td>GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>RAN-05             </td><td>44229302</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 116</td><td> 116</td><td>TRUE</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>terguride          </td><td>11957722</td><td>SKB</td><td>trt_cp</td><td>up</td><td>0</td><td> 985</td><td> 985</td><td>TRUE</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"0nvJBHeh5Gg1"},"source":["- `effect`: scaled bi-directional enrichment score corresponding to the scaled_score under the CMAP result; \n","- `nSet`: number of genes in the reference gene sets after applying the higher and lower cutoff; \n","- `nFound`: number of genes in the reference gene sets that are present in the query signature; \n","- `signed`: whether the gene sets in the reference database have signs, e.g. representing up and down regulated genes when computing scores.\n","\n","# 5. Fisher Search method\n","both the `query` and `refdb` used under the `qSig` call are genome-wide GEPs, here z-scores"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"NnsK5dge5g8T","executionInfo":{"status":"ok","timestamp":1636337759968,"user_tz":-480,"elapsed":2577,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"aa7c5a72-2ec3-4d23-94e0-c5e8b606fdea"},"source":["qsig_fisher <- qSig(query = query_mat, gess_method = 'Fisher', refdb = db_path)\n","fisher <- gess_fisher(qSig = qsig_fisher, higher = 1, lower=-1, workers=1)\n","result(fisher)"],"execution_count":14,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                            PCID     cell type   trend pval         \n","1   vorinostat                      5311     SKB  trt_cp over   0.000000e+00\n","2   trichostatin-a                  444732   SKB  trt_cp over  2.810211e-177\n","3   HC-toxin                        3571     SKB  trt_cp over  1.731209e-132\n","4   SPB02303                        2744062  SKB  trt_cp under  3.176477e-25\n","5   MDL-28170                       72430    SKB  trt_cp under  2.665271e-24\n","6   clofibric-acid                  2797     SKB  trt_cp under  2.095362e-19\n","7   pyroxamide                      4996     SKB  trt_cp over   2.265657e-16\n","8   TUL-XX023                       54596143 SKB  trt_cp under  3.030960e-13\n","9   formoterol                      23581795 SKB  trt_cp under  1.682152e-12\n","10  I-070759                        24086306 SKB  trt_cp over   2.177973e-12\n","11  dibenzepin                      9419     SKB  trt_cp under  6.363321e-11\n","12  afatinib                        22225683 SKB  trt_cp over   1.607759e-09\n","13  sinensetin                      145659   SKB  trt_cp over   1.050770e-08\n","14  MD-040                          73707398 SKB  trt_cp over   5.024331e-08\n","15  carbetocin                      73707428 SKB  trt_cp under  6.585557e-08\n","16  oxalomalic-acid                 439620   SKB  trt_cp under  9.414345e-08\n","17  NSC-693868                      438981   SKB  trt_cp over   2.957989e-07\n","18  AS-703026                       44187362 SKB  trt_cp over   5.808297e-06\n","19  ganglioside                     4673190  SKB  trt_cp over   7.739741e-06\n","20  ryuvidine                       481747   SKB  trt_cp over   1.097115e-05\n","21  IRL-2500                        4574540  SKB  trt_cp under  1.962927e-05\n","22  calmidazolium                   2531     SKB  trt_cp under  2.568386e-05\n","23  sphingosine                     5280335  SKB  trt_cp over   4.840188e-05\n","24  olvanil                         5808649  SKB  trt_cp over   5.857482e-05\n","25  GSK-0660                        46233311 SKB  trt_cp over   6.988858e-05\n","26  rotenonic-acid                  6708539  SKB  trt_cp over   1.590751e-04\n","27  SKF-77434                       11957703 SKB  trt_cp under  1.688158e-04\n","28  vicriviroc                      73707391 SKB  trt_cp over   1.550929e-04\n","29  D-609                           45479729 SKB  trt_cp over   1.638897e-04\n","30  alvespimycin                    73707383 SKB  trt_cp over   1.925443e-04\n","⋮   ⋮                               ⋮        ⋮    ⋮      ⋮     ⋮            \n","71  hydroquinidine                  45479756 SKB  trt_cp over  0.07999223   \n","72  K784-3187                       3689415  SKB  trt_cp under 0.08881854   \n","73  BAY-11-7082                     5353431  SKB  trt_cp over  0.09493517   \n","74  CGP-12177                       2687     SKB  trt_cp over  0.10228141   \n","75  erythrosine                     12961638 SKB  trt_cp over  0.12508457   \n","76  rimcazole                       5072     SKB  trt_cp over  0.13289028   \n","77  decafluorobutane                9638     SKB  trt_cp over  0.13161700   \n","78  K784-3131                       4381125  SKB  trt_cp under 0.13527276   \n","79  hemado                          4043357  SKB  trt_cp over  0.16774426   \n","80  ST-013960                       2300880  SKB  trt_cp over  0.16858756   \n","81  catechin                        73160    SKB  trt_cp over  0.18817485   \n","82  huperzine-a                     1253     SKB  trt_cp over  0.19289063   \n","83  procarbazine                    9703     SKB  trt_cp over  0.20139900   \n","84  LY-456236                       9926999  SKB  trt_cp under 0.21167947   \n","85  GDC-0879                        11717001 SKB  trt_cp over  0.25636129   \n","86  MW-A1-2                         3125011  SKB  trt_cp under 0.26220458   \n","87  progesterone                    5994     SKB  trt_cp over  0.26629222   \n","88  calcifediol                     46705323 SKB  trt_cp over  0.26972134   \n","89  XE-991                          656732   SKB  trt_cp under 0.27696663   \n","90  mexiletine                      4178     SKB  trt_cp under 0.34358960   \n","91  chlorprothixene                 667467   SKB  trt_cp over  0.35044762   \n","92  pantoprazole                    4679     SKB  trt_cp over  0.34955749   \n","93  SB-525334                       9967941  SKB  trt_cp over  0.41678858   \n","94  4,5,6,7-tetrabromobenzotriazole 1694     SKB  trt_cp over  0.41924367   \n","95  ST-4029655                      691928   SKB  trt_cp under 0.42956520   \n","96  scoulerine                      439654   SKB  trt_cp over  0.65402478   \n","97  raltitrexed                     104758   SKB  trt_cp over  0.81207537   \n","98  mead-acid                       5312531  SKB  trt_cp under 0.81800437   \n","99  CGP-13501                       3519541  SKB  trt_cp over  0.83301754   \n","100 NNC-63-0532                     3906780  SKB  trt_cp under 0.91484858   \n","    padj          effect LOR         nSet nFound signed\n","1    0.000000e+00  37.54        Inf  1098 1098   FALSE \n","2   1.405105e-175  28.39  2.0619092  1430  705   FALSE \n","3   5.770697e-131  24.49  1.7399256  1804  746   FALSE \n","4    7.941192e-24 -10.38 -1.0542530   963   99   FALSE \n","5    5.330541e-23 -10.17 -0.7672200  1823  260   FALSE \n","6    3.492270e-18  -9.01 -0.6599277  1943  300   FALSE \n","7    3.236653e-15   8.21  0.7699898   641  225   FALSE \n","8    3.788699e-12  -7.29 -0.7313458   885  116   FALSE \n","9    1.869058e-11  -7.06 -0.4956190  2238  389   FALSE \n","10   2.177973e-11   7.02  0.5368936  1222  359   FALSE \n","11   5.784837e-10  -6.53 -0.6523648   864  120   FALSE \n","12   1.339799e-08   6.03  0.4437014  1421  393   FALSE \n","13   8.082843e-08   5.72  0.5177090   748  226   FALSE \n","14   3.588808e-07   5.45  0.4037113  1399  380   FALSE \n","15   4.390371e-07  -5.40 -0.3712683  2468  463   FALSE \n","16   5.883965e-07  -5.34 -0.3684008  2428  455   FALSE \n","17   1.739994e-06   5.13  0.3964953  1201  329   FALSE \n","18   3.226832e-05   4.53  0.6304943   264   89   FALSE \n","19   4.073548e-05   4.47  0.4431369   602  176   FALSE \n","20   5.485573e-05   4.40  0.3603487  1032  280   FALSE \n","21   9.347271e-05  -4.27 -0.3134800  1740  323   FALSE \n","22   1.167448e-04  -4.21 -0.2898439  2370  459   FALSE \n","23   2.104430e-04   4.06  0.3695371   777  215   FALSE \n","24   2.440618e-04   4.02  0.3711402   731  203   FALSE \n","25   2.795543e-04   3.98  0.3620924   773  213   FALSE \n","26   5.821236e-04   3.78  0.3911275   549  156   FALSE \n","27   5.821236e-04  -3.76 -0.2601087  2429  478   FALSE \n","28   5.821236e-04   3.78  0.4603358   373  112   FALSE \n","29   5.821236e-04   3.77  0.7495359   125   46   FALSE \n","30   6.418143e-04   3.73  0.2979887  1123  293   FALSE \n","⋮   ⋮             ⋮      ⋮           ⋮    ⋮      ⋮     \n","71  0.1126651      1.75   0.21844082  375  96    FALSE \n","72  0.1233591     -1.70  -0.12340403 1832 378    FALSE \n","73  0.1300482      1.67   0.18867655  488 122    FALSE \n","74  0.1382181      1.63   0.18487172  473 118    FALSE \n","75  0.1667794      1.53   0.18589938  424 106    FALSE \n","76  0.1725848      1.50   0.11361328 1460 341    FALSE \n","77  0.1725848      1.51   0.13975524  778 187    FALSE \n","78  0.1734266     -1.49  -0.11545244 1491 307    FALSE \n","79  0.2107345      1.38   0.12713535  827 197    FALSE \n","80  0.2107345      1.38   0.16696058  405 100    FALSE \n","81  0.2323146      1.32   0.13660206  598 144    FALSE \n","82  0.2352325      1.30   0.12354466  735 175    FALSE \n","83  0.2426494      1.28   0.15783535  387  95    FALSE \n","84  0.2519994     -1.25  -0.10575738 1175 242    FALSE \n","85  0.3016015      1.14   0.12920104  504 121    FALSE \n","86  0.3048891     -1.12  -0.08987972 1329 277    FALSE \n","87  0.3060830      1.11   0.16676576  242  60    FALSE \n","88  0.3065015      1.10   0.10490438  744 175    FALSE \n","89  0.3111985     -1.09  -0.10217639  857 176    FALSE \n","90  0.3809213     -0.95  -0.10571072  598 122    FALSE \n","91  0.3809213      0.93   0.07614629 1149 264    FALSE \n","92  0.3809213      0.94   0.09489858  615 144    FALSE \n","93  0.4460039      0.81   0.10098799  407  96    FALSE \n","94  0.4460039      0.81   0.06978764 1012 232    FALSE \n","95  0.4521739     -0.79  -0.10405658  432  88    FALSE \n","96  0.6812758      0.45   0.05597612  385  88    FALSE \n","97  0.8346983      0.24   0.02025125 1233 274    FALSE \n","98  0.8346983     -0.23  -0.02327863  823 178    FALSE \n","99  0.8414319      0.21   0.02342998  596 133    FALSE \n","100 0.9148486     -0.11  -0.01962301  577 125    FALSE \n","    t_gn_sym                                                                                                                                                                                                                                                                                      \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                 \n","2   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                         \n","3   HDAC1                                                                                                                                                                                                                                                                                         \n","4   NA                                                                                                                                                                                                                                                                                            \n","5   CAPN1; CTSB; CTSL                                                                                                                                                                                                                                                                             \n","6   PPARA                                                                                                                                                                                                                                                                                         \n","7   HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                           \n","8   NA                                                                                                                                                                                                                                                                                            \n","9   ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                           \n","10  NA                                                                                                                                                                                                                                                                                            \n","11  NA                                                                                                                                                                                                                                                                                            \n","12  EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                                                                                                                  \n","13  NA                                                                                                                                                                                                                                                                                            \n","14  NA                                                                                                                                                                                                                                                                                            \n","15  OXTR                                                                                                                                                                                                                                                                                          \n","16  ACO1; IDH1                                                                                                                                                                                                                                                                                    \n","17  NA                                                                                                                                                                                                                                                                                            \n","18  MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                \n","19  NA                                                                                                                                                                                                                                                                                            \n","20  CDK2; CDK4                                                                                                                                                                                                                                                                                    \n","21  EDNRB; HBA2; HBB                                                                                                                                                                                                                                                                              \n","22  ATP2B1; PDE1A                                                                                                                                                                                                                                                                                 \n","23  ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                               \n","24  CNR1; GPR119; TRPV1                                                                                                                                                                                                                                                                           \n","25  PPARD                                                                                                                                                                                                                                                                                         \n","26  NA                                                                                                                                                                                                                                                                                            \n","27  DRD1                                                                                                                                                                                                                                                                                          \n","28  CCR5                                                                                                                                                                                                                                                                                          \n","29  NA                                                                                                                                                                                                                                                                                            \n","30  HSP90AA1                                                                                                                                                                                                                                                                                      \n","⋮   ⋮                                                                                                                                                                                                                                                                                             \n","71  KMT2A; PSIP1                                                                                                                                                                                                                                                                                  \n","72  NA                                                                                                                                                                                                                                                                                            \n","73  NA                                                                                                                                                                                                                                                                                            \n","74  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                           \n","75  NA                                                                                                                                                                                                                                                                                            \n","76  SIGMAR1                                                                                                                                                                                                                                                                                       \n","77  GRM5                                                                                                                                                                                                                                                                                          \n","78  NA                                                                                                                                                                                                                                                                                            \n","79  ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                              \n","80  NA                                                                                                                                                                                                                                                                                            \n","81  BACE1; CA1; CA12; CA14; CA4; CA6; CA9; FASN; SCN5A                                                                                                                                                                                                                                            \n","82  ACHE                                                                                                                                                                                                                                                                                          \n","83  MAOA; MAOB                                                                                                                                                                                                                                                                                    \n","84  GRM1                                                                                                                                                                                                                                                                                          \n","85  BRAF; RAF1                                                                                                                                                                                                                                                                                    \n","86  NA                                                                                                                                                                                                                                                                                            \n","87  AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5\n","88  VDR                                                                                                                                                                                                                                                                                           \n","89  KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                             \n","90  AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                               \n","91  CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                  \n","92  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                         \n","93  TGFBR1                                                                                                                                                                                                                                                                                        \n","94  AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                         \n","95  NA                                                                                                                                                                                                                                                                                            \n","96  ADRA1D                                                                                                                                                                                                                                                                                        \n","97  FPGS; TYMS                                                                                                                                                                                                                                                                                    \n","98  NA                                                                                                                                                                                                                                                                                            \n","99  GABBR1                                                                                                                                                                                                                                                                                        \n","100 OPRL1                                                                                                                                                                                                                                                                                         "],"text/latex":"A tibble: 100 × 13\n\\begin{tabular}{lllllllllllll}\n pert & PCID & cell & type & trend & pval & padj & effect & LOR & nSet & nFound & signed & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <lgl> & <chr>\\\\\n\\hline\n\t vorinostat      & 5311     & SKB & trt\\_cp & over  &  0.000000e+00 &  0.000000e+00 &  37.54 &        Inf & 1098 & 1098 & FALSE & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                  \\\\\n\t trichostatin-a  & 444732   & SKB & trt\\_cp & over  & 2.810211e-177 & 1.405105e-175 &  28.39 &  2.0619092 & 1430 &  705 & FALSE & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                          \\\\\n\t HC-toxin        & 3571     & SKB & trt\\_cp & over  & 1.731209e-132 & 5.770697e-131 &  24.49 &  1.7399256 & 1804 &  746 & FALSE & HDAC1                                                                                                                                                                                          \\\\\n\t SPB02303        & 2744062  & SKB & trt\\_cp & under &  3.176477e-25 &  7.941192e-24 & -10.38 & -1.0542530 &  963 &   99 & FALSE & NA                                                                                                                                                                                             \\\\\n\t MDL-28170       & 72430    & SKB & trt\\_cp & under &  2.665271e-24 &  5.330541e-23 & -10.17 & -0.7672200 & 1823 &  260 & FALSE & CAPN1; CTSB; CTSL                                                                                                                                                                              \\\\\n\t clofibric-acid  & 2797     & SKB & trt\\_cp & under &  2.095362e-19 &  3.492270e-18 &  -9.01 & -0.6599277 & 1943 &  300 & FALSE & PPARA                                                                                                                                                                                          \\\\\n\t pyroxamide      & 4996     & SKB & trt\\_cp & over  &  2.265657e-16 &  3.236653e-15 &   8.21 &  0.7699898 &  641 &  225 & FALSE & HDAC1; HDAC3; HDAC6                                                                                                                                                                            \\\\\n\t TUL-XX023       & 54596143 & SKB & trt\\_cp & under &  3.030960e-13 &  3.788699e-12 &  -7.29 & -0.7313458 &  885 &  116 & FALSE & NA                                                                                                                                                                                             \\\\\n\t formoterol      & 23581795 & SKB & trt\\_cp & under &  1.682152e-12 &  1.869058e-11 &  -7.06 & -0.4956190 & 2238 &  389 & FALSE & ADRB1; ADRB2; ADRB3                                                                                                                                                                            \\\\\n\t I-070759        & 24086306 & SKB & trt\\_cp & over  &  2.177973e-12 &  2.177973e-11 &   7.02 &  0.5368936 & 1222 &  359 & FALSE & NA                                                                                                                                                                                             \\\\\n\t dibenzepin      & 9419     & SKB & trt\\_cp & under &  6.363321e-11 &  5.784837e-10 &  -6.53 & -0.6523648 &  864 &  120 & FALSE & NA                                                                                                                                                                                             \\\\\n\t afatinib        & 22225683 & SKB & trt\\_cp & over  &  1.607759e-09 &  1.339799e-08 &   6.03 &  0.4437014 & 1421 &  393 & FALSE & EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                   \\\\\n\t sinensetin      & 145659   & SKB & trt\\_cp & over  &  1.050770e-08 &  8.082843e-08 &   5.72 &  0.5177090 &  748 &  226 & FALSE & NA                                                                                                                                                                                             \\\\\n\t MD-040          & 73707398 & SKB & trt\\_cp & over  &  5.024331e-08 &  3.588808e-07 &   5.45 &  0.4037113 & 1399 &  380 & FALSE & NA                                                                                                                                                                                             \\\\\n\t carbetocin      & 73707428 & SKB & trt\\_cp & under &  6.585557e-08 &  4.390371e-07 &  -5.40 & -0.3712683 & 2468 &  463 & FALSE & OXTR                                                                                                                                                                                           \\\\\n\t oxalomalic-acid & 439620   & SKB & trt\\_cp & under &  9.414345e-08 &  5.883965e-07 &  -5.34 & -0.3684008 & 2428 &  455 & FALSE & ACO1; IDH1                                                                                                                                                                                     \\\\\n\t NSC-693868      & 438981   & SKB & trt\\_cp & over  &  2.957989e-07 &  1.739994e-06 &   5.13 &  0.3964953 & 1201 &  329 & FALSE & NA                                                                                                                                                                                             \\\\\n\t AS-703026       & 44187362 & SKB & trt\\_cp & over  &  5.808297e-06 &  3.226832e-05 &   4.53 &  0.6304943 &  264 &   89 & FALSE & MAP2K1; MAP2K2                                                                                                                                                                                 \\\\\n\t ganglioside     & 4673190  & SKB & trt\\_cp & over  &  7.739741e-06 &  4.073548e-05 &   4.47 &  0.4431369 &  602 &  176 & FALSE & NA                                                                                                                                                                                             \\\\\n\t ryuvidine       & 481747   & SKB & trt\\_cp & over  &  1.097115e-05 &  5.485573e-05 &   4.40 &  0.3603487 & 1032 &  280 & FALSE & CDK2; CDK4                                                                                                                                                                                     \\\\\n\t IRL-2500        & 4574540  & SKB & trt\\_cp & under &  1.962927e-05 &  9.347271e-05 &  -4.27 & -0.3134800 & 1740 &  323 & FALSE & EDNRB; HBA2; HBB                                                                                                                                                                               \\\\\n\t calmidazolium   & 2531     & SKB & trt\\_cp & under &  2.568386e-05 &  1.167448e-04 &  -4.21 & -0.2898439 & 2370 &  459 & FALSE & ATP2B1; PDE1A                                                                                                                                                                                  \\\\\n\t sphingosine     & 5280335  & SKB & trt\\_cp & over  &  4.840188e-05 &  2.104430e-04 &   4.06 &  0.3695371 &  777 &  215 & FALSE & ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3\\\\\n\t olvanil         & 5808649  & SKB & trt\\_cp & over  &  5.857482e-05 &  2.440618e-04 &   4.02 &  0.3711402 &  731 &  203 & FALSE & CNR1; GPR119; TRPV1                                                                                                                                                                            \\\\\n\t GSK-0660        & 46233311 & SKB & trt\\_cp & over  &  6.988858e-05 &  2.795543e-04 &   3.98 &  0.3620924 &  773 &  213 & FALSE & PPARD                                                                                                                                                                                          \\\\\n\t rotenonic-acid  & 6708539  & SKB & trt\\_cp & over  &  1.590751e-04 &  5.821236e-04 &   3.78 &  0.3911275 &  549 &  156 & FALSE & NA                                                                                                                                                                                             \\\\\n\t SKF-77434       & 11957703 & SKB & trt\\_cp & under &  1.688158e-04 &  5.821236e-04 &  -3.76 & -0.2601087 & 2429 &  478 & FALSE & DRD1                                                                                                                                                                                           \\\\\n\t vicriviroc      & 73707391 & SKB & trt\\_cp & over  &  1.550929e-04 &  5.821236e-04 &   3.78 &  0.4603358 &  373 &  112 & FALSE & CCR5                                                                                                                                                                                           \\\\\n\t D-609           & 45479729 & SKB & trt\\_cp & over  &  1.638897e-04 &  5.821236e-04 &   3.77 &  0.7495359 &  125 &   46 & FALSE & NA                                                                                                                                                                                             \\\\\n\t alvespimycin    & 73707383 & SKB & trt\\_cp & over  &  1.925443e-04 &  6.418143e-04 &   3.73 &  0.2979887 & 1123 &  293 & FALSE & HSP90AA1                                                                                                                                                                                       \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t hydroquinidine                  & 45479756 & SKB & trt\\_cp & over  & 0.07999223 & 0.1126651 &  1.75 &  0.21844082 &  375 &  96 & FALSE & KMT2A; PSIP1                                                                                                                                                                                                                                                                                  \\\\\n\t K784-3187                       & 3689415  & SKB & trt\\_cp & under & 0.08881854 & 0.1233591 & -1.70 & -0.12340403 & 1832 & 378 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t BAY-11-7082                     & 5353431  & SKB & trt\\_cp & over  & 0.09493517 & 0.1300482 &  1.67 &  0.18867655 &  488 & 122 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t CGP-12177                       & 2687     & SKB & trt\\_cp & over  & 0.10228141 & 0.1382181 &  1.63 &  0.18487172 &  473 & 118 & FALSE & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                           \\\\\n\t erythrosine                     & 12961638 & SKB & trt\\_cp & over  & 0.12508457 & 0.1667794 &  1.53 &  0.18589938 &  424 & 106 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t rimcazole                       & 5072     & SKB & trt\\_cp & over  & 0.13289028 & 0.1725848 &  1.50 &  0.11361328 & 1460 & 341 & FALSE & SIGMAR1                                                                                                                                                                                                                                                                                       \\\\\n\t decafluorobutane                & 9638     & SKB & trt\\_cp & over  & 0.13161700 & 0.1725848 &  1.51 &  0.13975524 &  778 & 187 & FALSE & GRM5                                                                                                                                                                                                                                                                                          \\\\\n\t K784-3131                       & 4381125  & SKB & trt\\_cp & under & 0.13527276 & 0.1734266 & -1.49 & -0.11545244 & 1491 & 307 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t hemado                          & 4043357  & SKB & trt\\_cp & over  & 0.16774426 & 0.2107345 &  1.38 &  0.12713535 &  827 & 197 & FALSE & ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                              \\\\\n\t ST-013960                       & 2300880  & SKB & trt\\_cp & over  & 0.16858756 & 0.2107345 &  1.38 &  0.16696058 &  405 & 100 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t catechin                        & 73160    & SKB & trt\\_cp & over  & 0.18817485 & 0.2323146 &  1.32 &  0.13660206 &  598 & 144 & FALSE & BACE1; CA1; CA12; CA14; CA4; CA6; CA9; FASN; SCN5A                                                                                                                                                                                                                                            \\\\\n\t huperzine-a                     & 1253     & SKB & trt\\_cp & over  & 0.19289063 & 0.2352325 &  1.30 &  0.12354466 &  735 & 175 & FALSE & ACHE                                                                                                                                                                                                                                                                                          \\\\\n\t procarbazine                    & 9703     & SKB & trt\\_cp & over  & 0.20139900 & 0.2426494 &  1.28 &  0.15783535 &  387 &  95 & FALSE & MAOA; MAOB                                                                                                                                                                                                                                                                                    \\\\\n\t LY-456236                       & 9926999  & SKB & trt\\_cp & under & 0.21167947 & 0.2519994 & -1.25 & -0.10575738 & 1175 & 242 & FALSE & GRM1                                                                                                                                                                                                                                                                                          \\\\\n\t GDC-0879                        & 11717001 & SKB & trt\\_cp & over  & 0.25636129 & 0.3016015 &  1.14 &  0.12920104 &  504 & 121 & FALSE & BRAF; RAF1                                                                                                                                                                                                                                                                                    \\\\\n\t MW-A1-2                         & 3125011  & SKB & trt\\_cp & under & 0.26220458 & 0.3048891 & -1.12 & -0.08987972 & 1329 & 277 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t progesterone                    & 5994     & SKB & trt\\_cp & over  & 0.26629222 & 0.3060830 &  1.11 &  0.16676576 &  242 &  60 & FALSE & AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5\\\\\n\t calcifediol                     & 46705323 & SKB & trt\\_cp & over  & 0.26972134 & 0.3065015 &  1.10 &  0.10490438 &  744 & 175 & FALSE & VDR                                                                                                                                                                                                                                                                                           \\\\\n\t XE-991                          & 656732   & SKB & trt\\_cp & under & 0.27696663 & 0.3111985 & -1.09 & -0.10217639 &  857 & 176 & FALSE & KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                             \\\\\n\t mexiletine                      & 4178     & SKB & trt\\_cp & under & 0.34358960 & 0.3809213 & -0.95 & -0.10571072 &  598 & 122 & FALSE & AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                               \\\\\n\t chlorprothixene                 & 667467   & SKB & trt\\_cp & over  & 0.35044762 & 0.3809213 &  0.93 &  0.07614629 & 1149 & 264 & FALSE & CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                  \\\\\n\t pantoprazole                    & 4679     & SKB & trt\\_cp & over  & 0.34955749 & 0.3809213 &  0.94 &  0.09489858 &  615 & 144 & FALSE & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                         \\\\\n\t SB-525334                       & 9967941  & SKB & trt\\_cp & over  & 0.41678858 & 0.4460039 &  0.81 &  0.10098799 &  407 &  96 & FALSE & TGFBR1                                                                                                                                                                                                                                                                                        \\\\\n\t 4,5,6,7-tetrabromobenzotriazole & 1694     & SKB & trt\\_cp & over  & 0.41924367 & 0.4460039 &  0.81 &  0.06978764 & 1012 & 232 & FALSE & AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                         \\\\\n\t ST-4029655                      & 691928   & SKB & trt\\_cp & under & 0.42956520 & 0.4521739 & -0.79 & -0.10405658 &  432 &  88 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t scoulerine                      & 439654   & SKB & trt\\_cp & over  & 0.65402478 & 0.6812758 &  0.45 &  0.05597612 &  385 &  88 & FALSE & ADRA1D                                                                                                                                                                                                                                                                                        \\\\\n\t raltitrexed                     & 104758   & SKB & trt\\_cp & over  & 0.81207537 & 0.8346983 &  0.24 &  0.02025125 & 1233 & 274 & FALSE & FPGS; TYMS                                                                                                                                                                                                                                                                                    \\\\\n\t mead-acid                       & 5312531  & SKB & trt\\_cp & under & 0.81800437 & 0.8346983 & -0.23 & -0.02327863 &  823 & 178 & FALSE & NA                                                                                                                                                                                                                                                                                            \\\\\n\t CGP-13501                       & 3519541  & SKB & trt\\_cp & over  & 0.83301754 & 0.8414319 &  0.21 &  0.02342998 &  596 & 133 & FALSE & GABBR1                                                                                                                                                                                                                                                                                        \\\\\n\t NNC-63-0532                     & 3906780  & SKB & trt\\_cp & under & 0.91484858 & 0.9148486 & -0.11 & -0.01962301 &  577 & 125 & FALSE & OPRL1                                                                                                                                                                                                                                                                                         \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 13\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | pval &lt;dbl&gt; | padj &lt;dbl&gt; | effect &lt;dbl&gt; | LOR &lt;dbl&gt; | nSet &lt;dbl&gt; | nFound &lt;dbl&gt; | signed &lt;lgl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| vorinostat      | 5311     | SKB | trt_cp | over  |  0.000000e+00 |  0.000000e+00 |  37.54 |        Inf | 1098 | 1098 | FALSE | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                   |\n| trichostatin-a  | 444732   | SKB | trt_cp | over  | 2.810211e-177 | 1.405105e-175 |  28.39 |  2.0619092 | 1430 |  705 | FALSE | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                           |\n| HC-toxin        | 3571     | SKB | trt_cp | over  | 1.731209e-132 | 5.770697e-131 |  24.49 |  1.7399256 | 1804 |  746 | FALSE | HDAC1                                                                                                                                                                                           |\n| SPB02303        | 2744062  | SKB | trt_cp | under |  3.176477e-25 |  7.941192e-24 | -10.38 | -1.0542530 |  963 |   99 | FALSE | NA                                                                                                                                                                                              |\n| MDL-28170       | 72430    | SKB | trt_cp | under |  2.665271e-24 |  5.330541e-23 | -10.17 | -0.7672200 | 1823 |  260 | FALSE | CAPN1; CTSB; CTSL                                                                                                                                                                               |\n| clofibric-acid  | 2797     | SKB | trt_cp | under |  2.095362e-19 |  3.492270e-18 |  -9.01 | -0.6599277 | 1943 |  300 | FALSE | PPARA                                                                                                                                                                                           |\n| pyroxamide      | 4996     | SKB | trt_cp | over  |  2.265657e-16 |  3.236653e-15 |   8.21 |  0.7699898 |  641 |  225 | FALSE | HDAC1; HDAC3; HDAC6                                                                                                                                                                             |\n| TUL-XX023       | 54596143 | SKB | trt_cp | under |  3.030960e-13 |  3.788699e-12 |  -7.29 | -0.7313458 |  885 |  116 | FALSE | NA                                                                                                                                                                                              |\n| formoterol      | 23581795 | SKB | trt_cp | under |  1.682152e-12 |  1.869058e-11 |  -7.06 | -0.4956190 | 2238 |  389 | FALSE | ADRB1; ADRB2; ADRB3                                                                                                                                                                             |\n| I-070759        | 24086306 | SKB | trt_cp | over  |  2.177973e-12 |  2.177973e-11 |   7.02 |  0.5368936 | 1222 |  359 | FALSE | NA                                                                                                                                                                                              |\n| dibenzepin      | 9419     | SKB | trt_cp | under |  6.363321e-11 |  5.784837e-10 |  -6.53 | -0.6523648 |  864 |  120 | FALSE | NA                                                                                                                                                                                              |\n| afatinib        | 22225683 | SKB | trt_cp | over  |  1.607759e-09 |  1.339799e-08 |   6.03 |  0.4437014 | 1421 |  393 | FALSE | EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                    |\n| sinensetin      | 145659   | SKB | trt_cp | over  |  1.050770e-08 |  8.082843e-08 |   5.72 |  0.5177090 |  748 |  226 | FALSE | NA                                                                                                                                                                                              |\n| MD-040          | 73707398 | SKB | trt_cp | over  |  5.024331e-08 |  3.588808e-07 |   5.45 |  0.4037113 | 1399 |  380 | FALSE | NA                                                                                                                                                                                              |\n| carbetocin      | 73707428 | SKB | trt_cp | under |  6.585557e-08 |  4.390371e-07 |  -5.40 | -0.3712683 | 2468 |  463 | FALSE | OXTR                                                                                                                                                                                            |\n| oxalomalic-acid | 439620   | SKB | trt_cp | under |  9.414345e-08 |  5.883965e-07 |  -5.34 | -0.3684008 | 2428 |  455 | FALSE | ACO1; IDH1                                                                                                                                                                                      |\n| NSC-693868      | 438981   | SKB | trt_cp | over  |  2.957989e-07 |  1.739994e-06 |   5.13 |  0.3964953 | 1201 |  329 | FALSE | NA                                                                                                                                                                                              |\n| AS-703026       | 44187362 | SKB | trt_cp | over  |  5.808297e-06 |  3.226832e-05 |   4.53 |  0.6304943 |  264 |   89 | FALSE | MAP2K1; MAP2K2                                                                                                                                                                                  |\n| ganglioside     | 4673190  | SKB | trt_cp | over  |  7.739741e-06 |  4.073548e-05 |   4.47 |  0.4431369 |  602 |  176 | FALSE | NA                                                                                                                                                                                              |\n| ryuvidine       | 481747   | SKB | trt_cp | over  |  1.097115e-05 |  5.485573e-05 |   4.40 |  0.3603487 | 1032 |  280 | FALSE | CDK2; CDK4                                                                                                                                                                                      |\n| IRL-2500        | 4574540  | SKB | trt_cp | under |  1.962927e-05 |  9.347271e-05 |  -4.27 | -0.3134800 | 1740 |  323 | FALSE | EDNRB; HBA2; HBB                                                                                                                                                                                |\n| calmidazolium   | 2531     | SKB | trt_cp | under |  2.568386e-05 |  1.167448e-04 |  -4.21 | -0.2898439 | 2370 |  459 | FALSE | ATP2B1; PDE1A                                                                                                                                                                                   |\n| sphingosine     | 5280335  | SKB | trt_cp | over  |  4.840188e-05 |  2.104430e-04 |   4.06 |  0.3695371 |  777 |  215 | FALSE | ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3 |\n| olvanil         | 5808649  | SKB | trt_cp | over  |  5.857482e-05 |  2.440618e-04 |   4.02 |  0.3711402 |  731 |  203 | FALSE | CNR1; GPR119; TRPV1                                                                                                                                                                             |\n| GSK-0660        | 46233311 | SKB | trt_cp | over  |  6.988858e-05 |  2.795543e-04 |   3.98 |  0.3620924 |  773 |  213 | FALSE | PPARD                                                                                                                                                                                           |\n| rotenonic-acid  | 6708539  | SKB | trt_cp | over  |  1.590751e-04 |  5.821236e-04 |   3.78 |  0.3911275 |  549 |  156 | FALSE | NA                                                                                                                                                                                              |\n| SKF-77434       | 11957703 | SKB | trt_cp | under |  1.688158e-04 |  5.821236e-04 |  -3.76 | -0.2601087 | 2429 |  478 | FALSE | DRD1                                                                                                                                                                                            |\n| vicriviroc      | 73707391 | SKB | trt_cp | over  |  1.550929e-04 |  5.821236e-04 |   3.78 |  0.4603358 |  373 |  112 | FALSE | CCR5                                                                                                                                                                                            |\n| D-609           | 45479729 | SKB | trt_cp | over  |  1.638897e-04 |  5.821236e-04 |   3.77 |  0.7495359 |  125 |   46 | FALSE | NA                                                                                                                                                                                              |\n| alvespimycin    | 73707383 | SKB | trt_cp | over  |  1.925443e-04 |  6.418143e-04 |   3.73 |  0.2979887 | 1123 |  293 | FALSE | HSP90AA1                                                                                                                                                                                        |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| hydroquinidine                  | 45479756 | SKB | trt_cp | over  | 0.07999223 | 0.1126651 |  1.75 |  0.21844082 |  375 |  96 | FALSE | KMT2A; PSIP1                                                                                                                                                                                                                                                                                   |\n| K784-3187                       | 3689415  | SKB | trt_cp | under | 0.08881854 | 0.1233591 | -1.70 | -0.12340403 | 1832 | 378 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| BAY-11-7082                     | 5353431  | SKB | trt_cp | over  | 0.09493517 | 0.1300482 |  1.67 |  0.18867655 |  488 | 122 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| CGP-12177                       | 2687     | SKB | trt_cp | over  | 0.10228141 | 0.1382181 |  1.63 |  0.18487172 |  473 | 118 | FALSE | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                            |\n| erythrosine                     | 12961638 | SKB | trt_cp | over  | 0.12508457 | 0.1667794 |  1.53 |  0.18589938 |  424 | 106 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| rimcazole                       | 5072     | SKB | trt_cp | over  | 0.13289028 | 0.1725848 |  1.50 |  0.11361328 | 1460 | 341 | FALSE | SIGMAR1                                                                                                                                                                                                                                                                                        |\n| decafluorobutane                | 9638     | SKB | trt_cp | over  | 0.13161700 | 0.1725848 |  1.51 |  0.13975524 |  778 | 187 | FALSE | GRM5                                                                                                                                                                                                                                                                                           |\n| K784-3131                       | 4381125  | SKB | trt_cp | under | 0.13527276 | 0.1734266 | -1.49 | -0.11545244 | 1491 | 307 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| hemado                          | 4043357  | SKB | trt_cp | over  | 0.16774426 | 0.2107345 |  1.38 |  0.12713535 |  827 | 197 | FALSE | ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                               |\n| ST-013960                       | 2300880  | SKB | trt_cp | over  | 0.16858756 | 0.2107345 |  1.38 |  0.16696058 |  405 | 100 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| catechin                        | 73160    | SKB | trt_cp | over  | 0.18817485 | 0.2323146 |  1.32 |  0.13660206 |  598 | 144 | FALSE | BACE1; CA1; CA12; CA14; CA4; CA6; CA9; FASN; SCN5A                                                                                                                                                                                                                                             |\n| huperzine-a                     | 1253     | SKB | trt_cp | over  | 0.19289063 | 0.2352325 |  1.30 |  0.12354466 |  735 | 175 | FALSE | ACHE                                                                                                                                                                                                                                                                                           |\n| procarbazine                    | 9703     | SKB | trt_cp | over  | 0.20139900 | 0.2426494 |  1.28 |  0.15783535 |  387 |  95 | FALSE | MAOA; MAOB                                                                                                                                                                                                                                                                                     |\n| LY-456236                       | 9926999  | SKB | trt_cp | under | 0.21167947 | 0.2519994 | -1.25 | -0.10575738 | 1175 | 242 | FALSE | GRM1                                                                                                                                                                                                                                                                                           |\n| GDC-0879                        | 11717001 | SKB | trt_cp | over  | 0.25636129 | 0.3016015 |  1.14 |  0.12920104 |  504 | 121 | FALSE | BRAF; RAF1                                                                                                                                                                                                                                                                                     |\n| MW-A1-2                         | 3125011  | SKB | trt_cp | under | 0.26220458 | 0.3048891 | -1.12 | -0.08987972 | 1329 | 277 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| progesterone                    | 5994     | SKB | trt_cp | over  | 0.26629222 | 0.3060830 |  1.11 |  0.16676576 |  242 |  60 | FALSE | AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5 |\n| calcifediol                     | 46705323 | SKB | trt_cp | over  | 0.26972134 | 0.3065015 |  1.10 |  0.10490438 |  744 | 175 | FALSE | VDR                                                                                                                                                                                                                                                                                            |\n| XE-991                          | 656732   | SKB | trt_cp | under | 0.27696663 | 0.3111985 | -1.09 | -0.10217639 |  857 | 176 | FALSE | KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                              |\n| mexiletine                      | 4178     | SKB | trt_cp | under | 0.34358960 | 0.3809213 | -0.95 | -0.10571072 |  598 | 122 | FALSE | AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                |\n| chlorprothixene                 | 667467   | SKB | trt_cp | over  | 0.35044762 | 0.3809213 |  0.93 |  0.07614629 | 1149 | 264 | FALSE | CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                   |\n| pantoprazole                    | 4679     | SKB | trt_cp | over  | 0.34955749 | 0.3809213 |  0.94 |  0.09489858 |  615 | 144 | FALSE | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                          |\n| SB-525334                       | 9967941  | SKB | trt_cp | over  | 0.41678858 | 0.4460039 |  0.81 |  0.10098799 |  407 |  96 | FALSE | TGFBR1                                                                                                                                                                                                                                                                                         |\n| 4,5,6,7-tetrabromobenzotriazole | 1694     | SKB | trt_cp | over  | 0.41924367 | 0.4460039 |  0.81 |  0.06978764 | 1012 | 232 | FALSE | AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                          |\n| ST-4029655                      | 691928   | SKB | trt_cp | under | 0.42956520 | 0.4521739 | -0.79 | -0.10405658 |  432 |  88 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| scoulerine                      | 439654   | SKB | trt_cp | over  | 0.65402478 | 0.6812758 |  0.45 |  0.05597612 |  385 |  88 | FALSE | ADRA1D                                                                                                                                                                                                                                                                                         |\n| raltitrexed                     | 104758   | SKB | trt_cp | over  | 0.81207537 | 0.8346983 |  0.24 |  0.02025125 | 1233 | 274 | FALSE | FPGS; TYMS                                                                                                                                                                                                                                                                                     |\n| mead-acid                       | 5312531  | SKB | trt_cp | under | 0.81800437 | 0.8346983 | -0.23 | -0.02327863 |  823 | 178 | FALSE | NA                                                                                                                                                                                                                                                                                             |\n| CGP-13501                       | 3519541  | SKB | trt_cp | over  | 0.83301754 | 0.8414319 |  0.21 |  0.02342998 |  596 | 133 | FALSE | GABBR1                                                                                                                                                                                                                                                                                         |\n| NNC-63-0532                     | 3906780  | SKB | trt_cp | under | 0.91484858 | 0.9148486 | -0.11 | -0.01962301 |  577 | 125 | FALSE | OPRL1                                                                                                                                                                                                                                                                                          |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 13</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>pval</th><th scope=col>padj</th><th scope=col>effect</th><th scope=col>LOR</th><th scope=col>nSet</th><th scope=col>nFound</th><th scope=col>signed</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;lgl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat     </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 0.000000e+00</td><td> 0.000000e+00</td><td> 37.54</td><td>       Inf</td><td>1098</td><td>1098</td><td>FALSE</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                  </td></tr>\n","\t<tr><td>trichostatin-a </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>over </td><td>2.810211e-177</td><td>1.405105e-175</td><td> 28.39</td><td> 2.0619092</td><td>1430</td><td> 705</td><td>FALSE</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                          </td></tr>\n","\t<tr><td>HC-toxin       </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>1.731209e-132</td><td>5.770697e-131</td><td> 24.49</td><td> 1.7399256</td><td>1804</td><td> 746</td><td>FALSE</td><td>HDAC1                                                                                                                                                                                          </td></tr>\n","\t<tr><td>SPB02303       </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 3.176477e-25</td><td> 7.941192e-24</td><td>-10.38</td><td>-1.0542530</td><td> 963</td><td>  99</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>MDL-28170      </td><td>72430   </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 2.665271e-24</td><td> 5.330541e-23</td><td>-10.17</td><td>-0.7672200</td><td>1823</td><td> 260</td><td>FALSE</td><td>CAPN1; CTSB; CTSL                                                                                                                                                                              </td></tr>\n","\t<tr><td>clofibric-acid </td><td>2797    </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 2.095362e-19</td><td> 3.492270e-18</td><td> -9.01</td><td>-0.6599277</td><td>1943</td><td> 300</td><td>FALSE</td><td>PPARA                                                                                                                                                                                          </td></tr>\n","\t<tr><td>pyroxamide     </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 2.265657e-16</td><td> 3.236653e-15</td><td>  8.21</td><td> 0.7699898</td><td> 641</td><td> 225</td><td>FALSE</td><td>HDAC1; HDAC3; HDAC6                                                                                                                                                                            </td></tr>\n","\t<tr><td>TUL-XX023      </td><td>54596143</td><td>SKB</td><td>trt_cp</td><td>under</td><td> 3.030960e-13</td><td> 3.788699e-12</td><td> -7.29</td><td>-0.7313458</td><td> 885</td><td> 116</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>formoterol     </td><td>23581795</td><td>SKB</td><td>trt_cp</td><td>under</td><td> 1.682152e-12</td><td> 1.869058e-11</td><td> -7.06</td><td>-0.4956190</td><td>2238</td><td> 389</td><td>FALSE</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                            </td></tr>\n","\t<tr><td>I-070759       </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 2.177973e-12</td><td> 2.177973e-11</td><td>  7.02</td><td> 0.5368936</td><td>1222</td><td> 359</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>dibenzepin     </td><td>9419    </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 6.363321e-11</td><td> 5.784837e-10</td><td> -6.53</td><td>-0.6523648</td><td> 864</td><td> 120</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>afatinib       </td><td>22225683</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.607759e-09</td><td> 1.339799e-08</td><td>  6.03</td><td> 0.4437014</td><td>1421</td><td> 393</td><td>FALSE</td><td>EGF; EGFR; ERBB2; ERBB4; GAK                                                                                                                                                                   </td></tr>\n","\t<tr><td>sinensetin     </td><td>145659  </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.050770e-08</td><td> 8.082843e-08</td><td>  5.72</td><td> 0.5177090</td><td> 748</td><td> 226</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>MD-040         </td><td>73707398</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 5.024331e-08</td><td> 3.588808e-07</td><td>  5.45</td><td> 0.4037113</td><td>1399</td><td> 380</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>carbetocin     </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>under</td><td> 6.585557e-08</td><td> 4.390371e-07</td><td> -5.40</td><td>-0.3712683</td><td>2468</td><td> 463</td><td>FALSE</td><td>OXTR                                                                                                                                                                                           </td></tr>\n","\t<tr><td>oxalomalic-acid</td><td>439620  </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 9.414345e-08</td><td> 5.883965e-07</td><td> -5.34</td><td>-0.3684008</td><td>2428</td><td> 455</td><td>FALSE</td><td>ACO1; IDH1                                                                                                                                                                                     </td></tr>\n","\t<tr><td>NSC-693868     </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 2.957989e-07</td><td> 1.739994e-06</td><td>  5.13</td><td> 0.3964953</td><td>1201</td><td> 329</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>AS-703026      </td><td>44187362</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 5.808297e-06</td><td> 3.226832e-05</td><td>  4.53</td><td> 0.6304943</td><td> 264</td><td>  89</td><td>FALSE</td><td>MAP2K1; MAP2K2                                                                                                                                                                                 </td></tr>\n","\t<tr><td>ganglioside    </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 7.739741e-06</td><td> 4.073548e-05</td><td>  4.47</td><td> 0.4431369</td><td> 602</td><td> 176</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>ryuvidine      </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.097115e-05</td><td> 5.485573e-05</td><td>  4.40</td><td> 0.3603487</td><td>1032</td><td> 280</td><td>FALSE</td><td>CDK2; CDK4                                                                                                                                                                                     </td></tr>\n","\t<tr><td>IRL-2500       </td><td>4574540 </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 1.962927e-05</td><td> 9.347271e-05</td><td> -4.27</td><td>-0.3134800</td><td>1740</td><td> 323</td><td>FALSE</td><td>EDNRB; HBA2; HBB                                                                                                                                                                               </td></tr>\n","\t<tr><td>calmidazolium  </td><td>2531    </td><td>SKB</td><td>trt_cp</td><td>under</td><td> 2.568386e-05</td><td> 1.167448e-04</td><td> -4.21</td><td>-0.2898439</td><td>2370</td><td> 459</td><td>FALSE</td><td>ATP2B1; PDE1A                                                                                                                                                                                  </td></tr>\n","\t<tr><td>sphingosine    </td><td>5280335 </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 4.840188e-05</td><td> 2.104430e-04</td><td>  4.06</td><td> 0.3695371</td><td> 777</td><td> 215</td><td>FALSE</td><td>ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3</td></tr>\n","\t<tr><td>olvanil        </td><td>5808649 </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 5.857482e-05</td><td> 2.440618e-04</td><td>  4.02</td><td> 0.3711402</td><td> 731</td><td> 203</td><td>FALSE</td><td>CNR1; GPR119; TRPV1                                                                                                                                                                            </td></tr>\n","\t<tr><td>GSK-0660       </td><td>46233311</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 6.988858e-05</td><td> 2.795543e-04</td><td>  3.98</td><td> 0.3620924</td><td> 773</td><td> 213</td><td>FALSE</td><td>PPARD                                                                                                                                                                                          </td></tr>\n","\t<tr><td>rotenonic-acid </td><td>6708539 </td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.590751e-04</td><td> 5.821236e-04</td><td>  3.78</td><td> 0.3911275</td><td> 549</td><td> 156</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>SKF-77434      </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>under</td><td> 1.688158e-04</td><td> 5.821236e-04</td><td> -3.76</td><td>-0.2601087</td><td>2429</td><td> 478</td><td>FALSE</td><td>DRD1                                                                                                                                                                                           </td></tr>\n","\t<tr><td>vicriviroc     </td><td>73707391</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.550929e-04</td><td> 5.821236e-04</td><td>  3.78</td><td> 0.4603358</td><td> 373</td><td> 112</td><td>FALSE</td><td>CCR5                                                                                                                                                                                           </td></tr>\n","\t<tr><td>D-609          </td><td>45479729</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.638897e-04</td><td> 5.821236e-04</td><td>  3.77</td><td> 0.7495359</td><td> 125</td><td>  46</td><td>FALSE</td><td>NA                                                                                                                                                                                             </td></tr>\n","\t<tr><td>alvespimycin   </td><td>73707383</td><td>SKB</td><td>trt_cp</td><td>over </td><td> 1.925443e-04</td><td> 6.418143e-04</td><td>  3.73</td><td> 0.2979887</td><td>1123</td><td> 293</td><td>FALSE</td><td>HSP90AA1                                                                                                                                                                                       </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>hydroquinidine                 </td><td>45479756</td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.07999223</td><td>0.1126651</td><td> 1.75</td><td> 0.21844082</td><td> 375</td><td> 96</td><td>FALSE</td><td>KMT2A; PSIP1                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>K784-3187                      </td><td>3689415 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.08881854</td><td>0.1233591</td><td>-1.70</td><td>-0.12340403</td><td>1832</td><td>378</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>BAY-11-7082                    </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.09493517</td><td>0.1300482</td><td> 1.67</td><td> 0.18867655</td><td> 488</td><td>122</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>CGP-12177                      </td><td>2687    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.10228141</td><td>0.1382181</td><td> 1.63</td><td> 0.18487172</td><td> 473</td><td>118</td><td>FALSE</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>erythrosine                    </td><td>12961638</td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.12508457</td><td>0.1667794</td><td> 1.53</td><td> 0.18589938</td><td> 424</td><td>106</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>rimcazole                      </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.13289028</td><td>0.1725848</td><td> 1.50</td><td> 0.11361328</td><td>1460</td><td>341</td><td>FALSE</td><td>SIGMAR1                                                                                                                                                                                                                                                                                       </td></tr>\n","\t<tr><td>decafluorobutane               </td><td>9638    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.13161700</td><td>0.1725848</td><td> 1.51</td><td> 0.13975524</td><td> 778</td><td>187</td><td>FALSE</td><td>GRM5                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>K784-3131                      </td><td>4381125 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.13527276</td><td>0.1734266</td><td>-1.49</td><td>-0.11545244</td><td>1491</td><td>307</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>hemado                         </td><td>4043357 </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.16774426</td><td>0.2107345</td><td> 1.38</td><td> 0.12713535</td><td> 827</td><td>197</td><td>FALSE</td><td>ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                              </td></tr>\n","\t<tr><td>ST-013960                      </td><td>2300880 </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.16858756</td><td>0.2107345</td><td> 1.38</td><td> 0.16696058</td><td> 405</td><td>100</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>catechin                       </td><td>73160   </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.18817485</td><td>0.2323146</td><td> 1.32</td><td> 0.13660206</td><td> 598</td><td>144</td><td>FALSE</td><td>BACE1; CA1; CA12; CA14; CA4; CA6; CA9; FASN; SCN5A                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>huperzine-a                    </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.19289063</td><td>0.2352325</td><td> 1.30</td><td> 0.12354466</td><td> 735</td><td>175</td><td>FALSE</td><td>ACHE                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>procarbazine                   </td><td>9703    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.20139900</td><td>0.2426494</td><td> 1.28</td><td> 0.15783535</td><td> 387</td><td> 95</td><td>FALSE</td><td>MAOA; MAOB                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>LY-456236                      </td><td>9926999 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.21167947</td><td>0.2519994</td><td>-1.25</td><td>-0.10575738</td><td>1175</td><td>242</td><td>FALSE</td><td>GRM1                                                                                                                                                                                                                                                                                          </td></tr>\n","\t<tr><td>GDC-0879                       </td><td>11717001</td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.25636129</td><td>0.3016015</td><td> 1.14</td><td> 0.12920104</td><td> 504</td><td>121</td><td>FALSE</td><td>BRAF; RAF1                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>MW-A1-2                        </td><td>3125011 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.26220458</td><td>0.3048891</td><td>-1.12</td><td>-0.08987972</td><td>1329</td><td>277</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>progesterone                   </td><td>5994    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.26629222</td><td>0.3060830</td><td> 1.11</td><td> 0.16676576</td><td> 242</td><td> 60</td><td>FALSE</td><td>AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5</td></tr>\n","\t<tr><td>calcifediol                    </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.26972134</td><td>0.3065015</td><td> 1.10</td><td> 0.10490438</td><td> 744</td><td>175</td><td>FALSE</td><td>VDR                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>XE-991                         </td><td>656732  </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.27696663</td><td>0.3111985</td><td>-1.09</td><td>-0.10217639</td><td> 857</td><td>176</td><td>FALSE</td><td>KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>mexiletine                     </td><td>4178    </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.34358960</td><td>0.3809213</td><td>-0.95</td><td>-0.10571072</td><td> 598</td><td>122</td><td>FALSE</td><td>AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                               </td></tr>\n","\t<tr><td>chlorprothixene                </td><td>667467  </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.35044762</td><td>0.3809213</td><td> 0.93</td><td> 0.07614629</td><td>1149</td><td>264</td><td>FALSE</td><td>CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>pantoprazole                   </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.34955749</td><td>0.3809213</td><td> 0.94</td><td> 0.09489858</td><td> 615</td><td>144</td><td>FALSE</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>SB-525334                      </td><td>9967941 </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.41678858</td><td>0.4460039</td><td> 0.81</td><td> 0.10098799</td><td> 407</td><td> 96</td><td>FALSE</td><td>TGFBR1                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>4,5,6,7-tetrabromobenzotriazole</td><td>1694    </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.41924367</td><td>0.4460039</td><td> 0.81</td><td> 0.06978764</td><td>1012</td><td>232</td><td>FALSE</td><td>AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                         </td></tr>\n","\t<tr><td>ST-4029655                     </td><td>691928  </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.42956520</td><td>0.4521739</td><td>-0.79</td><td>-0.10405658</td><td> 432</td><td> 88</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>scoulerine                     </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.65402478</td><td>0.6812758</td><td> 0.45</td><td> 0.05597612</td><td> 385</td><td> 88</td><td>FALSE</td><td>ADRA1D                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>raltitrexed                    </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.81207537</td><td>0.8346983</td><td> 0.24</td><td> 0.02025125</td><td>1233</td><td>274</td><td>FALSE</td><td>FPGS; TYMS                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>mead-acid                      </td><td>5312531 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.81800437</td><td>0.8346983</td><td>-0.23</td><td>-0.02327863</td><td> 823</td><td>178</td><td>FALSE</td><td>NA                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>CGP-13501                      </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>over </td><td>0.83301754</td><td>0.8414319</td><td> 0.21</td><td> 0.02342998</td><td> 596</td><td>133</td><td>FALSE</td><td>GABBR1                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>NNC-63-0532                    </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>under</td><td>0.91484858</td><td>0.9148486</td><td>-0.11</td><td>-0.01962301</td><td> 577</td><td>125</td><td>FALSE</td><td>OPRL1                                                                                                                                                                                                                                                                                         </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"xFicL_q_5vCD"},"source":["The columns in the result table specific to the Fisher method include the following information. pval: p-value of the Fisher’s exact test; padj: p-value adjusted for multiple hypothesis testing using R’s p.adjust function with the Benjamini & Hochberg (BH) method; effect: z-score based on the standard normal distribution; LOR: log odds ratio.\n","\n","If the query contains the labels of up and down regulated genes then the two sets can be provided as a list. Internally, they will be combined into a single unsigned set, while the reference database is processed the same way as in the previous example.\n","\n","# 6. Correlation-based Search Method\n","Correlation-based similarity metrics, such as Spearman or Pearson coefficients, can also be used as GESS methods. As non-set-based methods, they require quantitative gene expression values for both the query and the database entries, that usually need to be of the same type to obtain meaningful results, such as normalized intensities or read counts from microarrays or RNA-Seq experiments, respectively. For correlation searches to work, it is important that both the query and reference database contain the same type of gene identifiers. The expected data structure of the query is a matrix with a single numeric column and the gene labels (e.g. Entrez Gene IDs) in the row name slot. For convenience, the correlation-based searches can either be performed with the full set of genes represented in the database or a subset of them. The latter can be useful to focus the computation for the correlation values on certain genes of interest such as a DEG set or the genes in a pathway of interest. For comparing the performance of different GESS methods, it can also be advantageous to subset the genes used for a correlation-based search to same set used in a set-based search, such as the up/down DEGs used in a LINCS GESS. This way the search results of correlation- and set-based methods can be more comparable because both are provided with equivalent information content.\n","\n","## 6.1 CORall\n","- Spearman method using all genes present in the reference database. \n","- The GESs used for both the `query` and `refdb` are z-scores.\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"9J-pLEXK64l0","executionInfo":{"status":"ok","timestamp":1636337762700,"user_tz":-480,"elapsed":2736,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"fa11e255-14a9-4ed6-c1c4-fb38a65d889f"},"source":["qsig_sp <- qSig(query = query_mat, gess_method = 'Cor', refdb = db_path)\n","sp <- gess_cor(qSig = qsig_sp, method = 'spearman', workers=1)\n","result(sp)"],"execution_count":15,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                            PCID      cell type   trend cor_score    \n","1   vorinostat                      5311      SKB  trt_cp up     1.00000000  \n","2   trichostatin-a                  444732    SKB  trt_cp up     0.70150154  \n","3   HC-toxin                        3571      SKB  trt_cp up     0.63433953  \n","4   pyroxamide                      4996      SKB  trt_cp up     0.32514830  \n","5   APHA-compound-8                 10379137  SKB  trt_cp up     0.15157088  \n","6   benzonatate                     7699      SKB  trt_cp up     0.15087456  \n","7   rescinnamine                    5280954   SKB  trt_cp down  -0.13642291  \n","8   evoxine                         673465    SKB  trt_cp down  -0.13372155  \n","9   scopolamine-n-oxide             3000667   SKB  trt_cp up     0.12542234  \n","10  warfarin                        54678486  SKB  trt_cp down  -0.12306803  \n","11  calmidazolium                   2531      SKB  trt_cp up     0.12136303  \n","12  rimcazole                       5072      SKB  trt_cp up     0.11922318  \n","13  zuclopenthixol                  5311507   SKB  trt_cp down  -0.11447437  \n","14  calcifediol                     46705323  SKB  trt_cp up     0.11140561  \n","15  ganglioside                     4673190   SKB  trt_cp down  -0.11081388  \n","16  JWH-015                         4273754   SKB  trt_cp up     0.11019898  \n","17  calcitriol                      21158442  SKB  trt_cp up     0.10969843  \n","18  K784-3187                       3689415   SKB  trt_cp up     0.10945741  \n","19  raltitrexed                     104758    SKB  trt_cp up     0.09923218  \n","20  4,5,6,7-tetrabromobenzotriazole 1694      SKB  trt_cp up     0.09832481  \n","21  ryuvidine                       481747    SKB  trt_cp up     0.09657136  \n","22  TC-2559                         9823180   SKB  trt_cp down  -0.09374568  \n","23  crotamiton                      688020    SKB  trt_cp up     0.09229574  \n","24  scoulerine                      439654    SKB  trt_cp down  -0.09140793  \n","25  epothilone                      448013    SKB  trt_cp down  -0.08834142  \n","26  huperzine-a                     1253      SKB  trt_cp up     0.08503269  \n","27  pantoprazole                    4679      SKB  trt_cp down  -0.08195207  \n","28  BAY-11-7082                     5353431   SKB  trt_cp down  -0.07978165  \n","29  decafluorobutane                9638      SKB  trt_cp up     0.07887714  \n","30  I-070759                        24086306  SKB  trt_cp up     0.07739415  \n","⋮   ⋮                               ⋮         ⋮    ⋮      ⋮     ⋮            \n","71  CGP-13501                       3519541   SKB  trt_cp down  -0.0300698389\n","72  mexiletine                      4178      SKB  trt_cp down  -0.0296749123\n","73  sphingosine                     5280335   SKB  trt_cp down  -0.0270497541\n","74  ketorolac                       3826      SKB  trt_cp down  -0.0269385313\n","75  clozapine                       135398737 SKB  trt_cp up     0.0266862095\n","76  TUL-XX023                       54596143  SKB  trt_cp down  -0.0266823902\n","77  rhamnetin                       5281691   SKB  trt_cp up     0.0266214485\n","78  procarbazine                    9703      SKB  trt_cp down  -0.0265587790\n","79  oxalomalic-acid                 439620    SKB  trt_cp up     0.0263763103\n","80  loreclezole                     50988829  SKB  trt_cp down  -0.0249034297\n","81  NNC-63-0532                     3906780   SKB  trt_cp up     0.0248612092\n","82  CGP-12177                       2687      SKB  trt_cp down  -0.0208771503\n","83  midostaurin                     9829523   SKB  trt_cp down  -0.0181909702\n","84  XE-991                          656732    SKB  trt_cp up     0.0177518328\n","85  mead-acid                       5312531   SKB  trt_cp up     0.0174795924\n","86  carbetocin                      73707428  SKB  trt_cp up     0.0173693232\n","87  ST-013960                       2300880   SKB  trt_cp down  -0.0171066799\n","88  terguride                       11957722  SKB  trt_cp down  -0.0160341410\n","89  erythrosine                     12961638  SKB  trt_cp down  -0.0152043372\n","90  fillalbin                       933171    SKB  trt_cp down  -0.0145711204\n","91  SKF-77434                       11957703  SKB  trt_cp up     0.0136911431\n","92  vicriviroc                      73707391  SKB  trt_cp down  -0.0100475152\n","93  quinpirol-(-)                   NotFound  SKB  trt_cp down  -0.0093453540\n","94  SPB02303                        2744062   SKB  trt_cp down  -0.0088429327\n","95  GW-4064                         9893571   SKB  trt_cp up     0.0049879284\n","96  rotenonic-acid                  6708539   SKB  trt_cp up     0.0038054234\n","97  alvespimycin                    73707383  SKB  trt_cp up     0.0030549580\n","98  SEW-2871                        4077460   SKB  trt_cp up     0.0023144793\n","99  tyrphostin-AG-556               2059      SKB  trt_cp up     0.0012281187\n","100 AS-703026                       44187362  SKB  trt_cp down  -0.0009044138\n","    t_gn_sym                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","2   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","3   HDAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","4   HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","5   HDAC8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","6   SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","7   ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","8   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","9   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","10  ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","11  ATP2B1; PDE1A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","12  SIGMAR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","13  ADRA1A; DRD1; HRH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","14  VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","15  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","16  CNR2; GPR55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","17  CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","18  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","19  FPGS; TYMS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","20  AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","21  CDK2; CDK4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","22  CHRNA4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","23  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","24  ADRA1D                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","25  TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","26  ACHE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","27  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","28  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","29  GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","30  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","⋮   ⋮                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","71  GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","72  AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n","73  ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n","74  LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","75  ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CALY; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; FOS; HRH1; HRH4; HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR3A; HTR5A; HTR6; HTR7; TH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","76  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","77  ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","78  MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","79  ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","80  GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","81  OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","82  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","83  AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\n","84  KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","85  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","86  OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","87  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","88  ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","89  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","90  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","91  DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","92  CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","93  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","94  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","95  NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","96  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","97  HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","98  S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","99  EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","100 MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         "],"text/latex":"A tibble: 100 × 7\n\\begin{tabular}{lllllll}\n pert & PCID & cell & type & trend & cor\\_score & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr>\\\\\n\\hline\n\t vorinostat                      & 5311     & SKB & trt\\_cp & up   &  1.00000000 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                        \\\\\n\t trichostatin-a                  & 444732   & SKB & trt\\_cp & up   &  0.70150154 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                \\\\\n\t HC-toxin                        & 3571     & SKB & trt\\_cp & up   &  0.63433953 & HDAC1                                                                                                                \\\\\n\t pyroxamide                      & 4996     & SKB & trt\\_cp & up   &  0.32514830 & HDAC1; HDAC3; HDAC6                                                                                                  \\\\\n\t APHA-compound-8                 & 10379137 & SKB & trt\\_cp & up   &  0.15157088 & HDAC8                                                                                                                \\\\\n\t benzonatate                     & 7699     & SKB & trt\\_cp & up   &  0.15087456 & SCN5A                                                                                                                \\\\\n\t rescinnamine                    & 5280954  & SKB & trt\\_cp & down & -0.13642291 & ACE                                                                                                                  \\\\\n\t evoxine                         & 673465   & SKB & trt\\_cp & down & -0.13372155 & NA                                                                                                                   \\\\\n\t scopolamine-n-oxide             & 3000667  & SKB & trt\\_cp & up   &  0.12542234 & NA                                                                                                                   \\\\\n\t warfarin                        & 54678486 & SKB & trt\\_cp & down & -0.12306803 & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                  \\\\\n\t calmidazolium                   & 2531     & SKB & trt\\_cp & up   &  0.12136303 & ATP2B1; PDE1A                                                                                                        \\\\\n\t rimcazole                       & 5072     & SKB & trt\\_cp & up   &  0.11922318 & SIGMAR1                                                                                                              \\\\\n\t zuclopenthixol                  & 5311507  & SKB & trt\\_cp & down & -0.11447437 & ADRA1A; DRD1; HRH1                                                                                                   \\\\\n\t calcifediol                     & 46705323 & SKB & trt\\_cp & up   &  0.11140561 & VDR                                                                                                                  \\\\\n\t ganglioside                     & 4673190  & SKB & trt\\_cp & down & -0.11081388 & NA                                                                                                                   \\\\\n\t JWH-015                         & 4273754  & SKB & trt\\_cp & up   &  0.11019898 & CNR2; GPR55                                                                                                          \\\\\n\t calcitriol                      & 21158442 & SKB & trt\\_cp & up   &  0.10969843 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                       \\\\\n\t K784-3187                       & 3689415  & SKB & trt\\_cp & up   &  0.10945741 & NA                                                                                                                   \\\\\n\t raltitrexed                     & 104758   & SKB & trt\\_cp & up   &  0.09923218 & FPGS; TYMS                                                                                                           \\\\\n\t 4,5,6,7-tetrabromobenzotriazole & 1694     & SKB & trt\\_cp & up   &  0.09832481 & AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1\\\\\n\t ryuvidine                       & 481747   & SKB & trt\\_cp & up   &  0.09657136 & CDK2; CDK4                                                                                                           \\\\\n\t TC-2559                         & 9823180  & SKB & trt\\_cp & down & -0.09374568 & CHRNA4                                                                                                               \\\\\n\t crotamiton                      & 688020   & SKB & trt\\_cp & up   &  0.09229574 & NA                                                                                                                   \\\\\n\t scoulerine                      & 439654   & SKB & trt\\_cp & down & -0.09140793 & ADRA1D                                                                                                               \\\\\n\t epothilone                      & 448013   & SKB & trt\\_cp & down & -0.08834142 & TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                    \\\\\n\t huperzine-a                     & 1253     & SKB & trt\\_cp & up   &  0.08503269 & ACHE                                                                                                                 \\\\\n\t pantoprazole                    & 4679     & SKB & trt\\_cp & down & -0.08195207 & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                \\\\\n\t BAY-11-7082                     & 5353431  & SKB & trt\\_cp & down & -0.07978165 & NA                                                                                                                   \\\\\n\t decafluorobutane                & 9638     & SKB & trt\\_cp & up   &  0.07887714 & GRM5                                                                                                                 \\\\\n\t I-070759                        & 24086306 & SKB & trt\\_cp & up   &  0.07739415 & NA                                                                                                                   \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t CGP-13501         & 3519541   & SKB & trt\\_cp & down & -0.0300698389 & GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t mexiletine        & 4178      & SKB & trt\\_cp & down & -0.0296749123 & AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \\\\\n\t sphingosine       & 5280335   & SKB & trt\\_cp & down & -0.0270497541 & ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        \\\\\n\t ketorolac         & 3826      & SKB & trt\\_cp & down & -0.0269385313 & LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \\\\\n\t clozapine         & 135398737 & SKB & trt\\_cp & up   &  0.0266862095 & ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CALY; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; FOS; HRH1; HRH4; HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR3A; HTR5A; HTR6; HTR7; TH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t TUL-XX023         & 54596143  & SKB & trt\\_cp & down & -0.0266823902 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t rhamnetin         & 5281691   & SKB & trt\\_cp & up   &  0.0266214485 & ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t procarbazine      & 9703      & SKB & trt\\_cp & down & -0.0265587790 & MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t oxalomalic-acid   & 439620    & SKB & trt\\_cp & up   &  0.0263763103 & ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t loreclezole       & 50988829  & SKB & trt\\_cp & down & -0.0249034297 & GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\t NNC-63-0532       & 3906780   & SKB & trt\\_cp & up   &  0.0248612092 & OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t CGP-12177         & 2687      & SKB & trt\\_cp & down & -0.0208771503 & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t midostaurin       & 9829523   & SKB & trt\\_cp & down & -0.0181909702 & AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\\\\\n\t XE-991            & 656732    & SKB & trt\\_cp & up   &  0.0177518328 & KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \\\\\n\t mead-acid         & 5312531   & SKB & trt\\_cp & up   &  0.0174795924 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t carbetocin        & 73707428  & SKB & trt\\_cp & up   &  0.0173693232 & OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t ST-013960         & 2300880   & SKB & trt\\_cp & down & -0.0171066799 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t terguride         & 11957722  & SKB & trt\\_cp & down & -0.0160341410 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t erythrosine       & 12961638  & SKB & trt\\_cp & down & -0.0152043372 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t fillalbin         & 933171    & SKB & trt\\_cp & down & -0.0145711204 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t SKF-77434         & 11957703  & SKB & trt\\_cp & up   &  0.0136911431 & DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t vicriviroc        & 73707391  & SKB & trt\\_cp & down & -0.0100475152 & CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t quinpirol-(-)     & NotFound  & SKB & trt\\_cp & down & -0.0093453540 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t SPB02303          & 2744062   & SKB & trt\\_cp & down & -0.0088429327 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t GW-4064           & 9893571   & SKB & trt\\_cp & up   &  0.0049879284 & NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t rotenonic-acid    & 6708539   & SKB & trt\\_cp & up   &  0.0038054234 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t alvespimycin      & 73707383  & SKB & trt\\_cp & up   &  0.0030549580 & HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \\\\\n\t SEW-2871          & 4077460   & SKB & trt\\_cp & up   &  0.0023144793 & S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t tyrphostin-AG-556 & 2059      & SKB & trt\\_cp & up   &  0.0012281187 & EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t AS-703026         & 44187362  & SKB & trt\\_cp & down & -0.0009044138 & MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 7\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | cor_score &lt;dbl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|\n| vorinostat                      | 5311     | SKB | trt_cp | up   |  1.00000000 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                         |\n| trichostatin-a                  | 444732   | SKB | trt_cp | up   |  0.70150154 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                 |\n| HC-toxin                        | 3571     | SKB | trt_cp | up   |  0.63433953 | HDAC1                                                                                                                 |\n| pyroxamide                      | 4996     | SKB | trt_cp | up   |  0.32514830 | HDAC1; HDAC3; HDAC6                                                                                                   |\n| APHA-compound-8                 | 10379137 | SKB | trt_cp | up   |  0.15157088 | HDAC8                                                                                                                 |\n| benzonatate                     | 7699     | SKB | trt_cp | up   |  0.15087456 | SCN5A                                                                                                                 |\n| rescinnamine                    | 5280954  | SKB | trt_cp | down | -0.13642291 | ACE                                                                                                                   |\n| evoxine                         | 673465   | SKB | trt_cp | down | -0.13372155 | NA                                                                                                                    |\n| scopolamine-n-oxide             | 3000667  | SKB | trt_cp | up   |  0.12542234 | NA                                                                                                                    |\n| warfarin                        | 54678486 | SKB | trt_cp | down | -0.12306803 | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                   |\n| calmidazolium                   | 2531     | SKB | trt_cp | up   |  0.12136303 | ATP2B1; PDE1A                                                                                                         |\n| rimcazole                       | 5072     | SKB | trt_cp | up   |  0.11922318 | SIGMAR1                                                                                                               |\n| zuclopenthixol                  | 5311507  | SKB | trt_cp | down | -0.11447437 | ADRA1A; DRD1; HRH1                                                                                                    |\n| calcifediol                     | 46705323 | SKB | trt_cp | up   |  0.11140561 | VDR                                                                                                                   |\n| ganglioside                     | 4673190  | SKB | trt_cp | down | -0.11081388 | NA                                                                                                                    |\n| JWH-015                         | 4273754  | SKB | trt_cp | up   |  0.11019898 | CNR2; GPR55                                                                                                           |\n| calcitriol                      | 21158442 | SKB | trt_cp | up   |  0.10969843 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                        |\n| K784-3187                       | 3689415  | SKB | trt_cp | up   |  0.10945741 | NA                                                                                                                    |\n| raltitrexed                     | 104758   | SKB | trt_cp | up   |  0.09923218 | FPGS; TYMS                                                                                                            |\n| 4,5,6,7-tetrabromobenzotriazole | 1694     | SKB | trt_cp | up   |  0.09832481 | AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1 |\n| ryuvidine                       | 481747   | SKB | trt_cp | up   |  0.09657136 | CDK2; CDK4                                                                                                            |\n| TC-2559                         | 9823180  | SKB | trt_cp | down | -0.09374568 | CHRNA4                                                                                                                |\n| crotamiton                      | 688020   | SKB | trt_cp | up   |  0.09229574 | NA                                                                                                                    |\n| scoulerine                      | 439654   | SKB | trt_cp | down | -0.09140793 | ADRA1D                                                                                                                |\n| epothilone                      | 448013   | SKB | trt_cp | down | -0.08834142 | TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                     |\n| huperzine-a                     | 1253     | SKB | trt_cp | up   |  0.08503269 | ACHE                                                                                                                  |\n| pantoprazole                    | 4679     | SKB | trt_cp | down | -0.08195207 | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                 |\n| BAY-11-7082                     | 5353431  | SKB | trt_cp | down | -0.07978165 | NA                                                                                                                    |\n| decafluorobutane                | 9638     | SKB | trt_cp | up   |  0.07887714 | GRM5                                                                                                                  |\n| I-070759                        | 24086306 | SKB | trt_cp | up   |  0.07739415 | NA                                                                                                                    |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| CGP-13501         | 3519541   | SKB | trt_cp | down | -0.0300698389 | GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| mexiletine        | 4178      | SKB | trt_cp | down | -0.0296749123 | AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |\n| sphingosine       | 5280335   | SKB | trt_cp | down | -0.0270497541 | ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                         |\n| ketorolac         | 3826      | SKB | trt_cp | down | -0.0269385313 | LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |\n| clozapine         | 135398737 | SKB | trt_cp | up   |  0.0266862095 | ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CALY; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; FOS; HRH1; HRH4; HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR3A; HTR5A; HTR6; HTR7; TH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| TUL-XX023         | 54596143  | SKB | trt_cp | down | -0.0266823902 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| rhamnetin         | 5281691   | SKB | trt_cp | up   |  0.0266214485 | ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| procarbazine      | 9703      | SKB | trt_cp | down | -0.0265587790 | MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| oxalomalic-acid   | 439620    | SKB | trt_cp | up   |  0.0263763103 | ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| loreclezole       | 50988829  | SKB | trt_cp | down | -0.0249034297 | GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n| NNC-63-0532       | 3906780   | SKB | trt_cp | up   |  0.0248612092 | OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| CGP-12177         | 2687      | SKB | trt_cp | down | -0.0208771503 | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| midostaurin       | 9829523   | SKB | trt_cp | down | -0.0181909702 | AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2 |\n| XE-991            | 656732    | SKB | trt_cp | up   |  0.0177518328 | KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |\n| mead-acid         | 5312531   | SKB | trt_cp | up   |  0.0174795924 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| carbetocin        | 73707428  | SKB | trt_cp | up   |  0.0173693232 | OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| ST-013960         | 2300880   | SKB | trt_cp | down | -0.0171066799 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| terguride         | 11957722  | SKB | trt_cp | down | -0.0160341410 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| erythrosine       | 12961638  | SKB | trt_cp | down | -0.0152043372 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| fillalbin         | 933171    | SKB | trt_cp | down | -0.0145711204 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| SKF-77434         | 11957703  | SKB | trt_cp | up   |  0.0136911431 | DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| vicriviroc        | 73707391  | SKB | trt_cp | down | -0.0100475152 | CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| quinpirol-(-)     | NotFound  | SKB | trt_cp | down | -0.0093453540 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| SPB02303          | 2744062   | SKB | trt_cp | down | -0.0088429327 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| GW-4064           | 9893571   | SKB | trt_cp | up   |  0.0049879284 | NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| rotenonic-acid    | 6708539   | SKB | trt_cp | up   |  0.0038054234 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| alvespimycin      | 73707383  | SKB | trt_cp | up   |  0.0030549580 | HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |\n| SEW-2871          | 4077460   | SKB | trt_cp | up   |  0.0023144793 | S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| tyrphostin-AG-556 | 2059      | SKB | trt_cp | up   |  0.0012281187 | EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| AS-703026         | 44187362  | SKB | trt_cp | down | -0.0009044138 | MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 7</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>cor_score</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat                     </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.00000000</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                        </td></tr>\n","\t<tr><td>trichostatin-a                 </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.70150154</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                </td></tr>\n","\t<tr><td>HC-toxin                       </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.63433953</td><td>HDAC1                                                                                                                </td></tr>\n","\t<tr><td>pyroxamide                     </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.32514830</td><td>HDAC1; HDAC3; HDAC6                                                                                                  </td></tr>\n","\t<tr><td>APHA-compound-8                </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.15157088</td><td>HDAC8                                                                                                                </td></tr>\n","\t<tr><td>benzonatate                    </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.15087456</td><td>SCN5A                                                                                                                </td></tr>\n","\t<tr><td>rescinnamine                   </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.13642291</td><td>ACE                                                                                                                  </td></tr>\n","\t<tr><td>evoxine                        </td><td>673465  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.13372155</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>scopolamine-n-oxide            </td><td>3000667 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.12542234</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>warfarin                       </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.12306803</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1                                  </td></tr>\n","\t<tr><td>calmidazolium                  </td><td>2531    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.12136303</td><td>ATP2B1; PDE1A                                                                                                        </td></tr>\n","\t<tr><td>rimcazole                      </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.11922318</td><td>SIGMAR1                                                                                                              </td></tr>\n","\t<tr><td>zuclopenthixol                 </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.11447437</td><td>ADRA1A; DRD1; HRH1                                                                                                   </td></tr>\n","\t<tr><td>calcifediol                    </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.11140561</td><td>VDR                                                                                                                  </td></tr>\n","\t<tr><td>ganglioside                    </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.11081388</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>JWH-015                        </td><td>4273754 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.11019898</td><td>CNR2; GPR55                                                                                                          </td></tr>\n","\t<tr><td>calcitriol                     </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.10969843</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                       </td></tr>\n","\t<tr><td>K784-3187                      </td><td>3689415 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.10945741</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>raltitrexed                    </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.09923218</td><td>FPGS; TYMS                                                                                                           </td></tr>\n","\t<tr><td>4,5,6,7-tetrabromobenzotriazole</td><td>1694    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.09832481</td><td>AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; GSK3B; LCK; MAP2K1; MAPK11; MAPK12; MAPK14; MAPK8; PRKCA; ROCK1; RPS6KB1; SGK1</td></tr>\n","\t<tr><td>ryuvidine                      </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.09657136</td><td>CDK2; CDK4                                                                                                           </td></tr>\n","\t<tr><td>TC-2559                        </td><td>9823180 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.09374568</td><td>CHRNA4                                                                                                               </td></tr>\n","\t<tr><td>crotamiton                     </td><td>688020  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.09229574</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>scoulerine                     </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.09140793</td><td>ADRA1D                                                                                                               </td></tr>\n","\t<tr><td>epothilone                     </td><td>448013  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.08834142</td><td>TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; TUBA8; TUBB; TUBB1; TUBB3; TUBB4A; TUBB4B                                    </td></tr>\n","\t<tr><td>huperzine-a                    </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.08503269</td><td>ACHE                                                                                                                 </td></tr>\n","\t<tr><td>pantoprazole                   </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.08195207</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4                                                                                </td></tr>\n","\t<tr><td>BAY-11-7082                    </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.07978165</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>decafluorobutane               </td><td>9638    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.07887714</td><td>GRM5                                                                                                                 </td></tr>\n","\t<tr><td>I-070759                       </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.07739415</td><td>NA                                                                                                                   </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>CGP-13501        </td><td>3519541  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0300698389</td><td>GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>mexiletine       </td><td>4178     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0296749123</td><td>AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>sphingosine      </td><td>5280335  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0270497541</td><td>ACER1; ACER2; ASAH1; ASAH2; ASAH2C; CERS1; CERS2; CERS3; CERS4; CERS5; CERS6; GALC; GBA; GLTP; LPIN1; LPIN2; LPIN3; PPAP2A; PPAP2B; PPAP2C; PSAP; PVR; SGPP1; SGPP2; SMPD1; SPHK1; SPHK2; TRPM3                                                                                                                                                                                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>ketorolac        </td><td>3826     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0269385313</td><td>LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                </td></tr>\n","\t<tr><td>clozapine        </td><td>135398737</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0266862095</td><td>ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CALY; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; FOS; HRH1; HRH4; HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR3A; HTR5A; HTR6; HTR7; TH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>TUL-XX023        </td><td>54596143 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0266823902</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>rhamnetin        </td><td>5281691  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0266214485</td><td>ALOX5; MAPK8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>procarbazine     </td><td>9703     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0265587790</td><td>MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>oxalomalic-acid  </td><td>439620   </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0263763103</td><td>ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>loreclezole      </td><td>50988829 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0249034297</td><td>GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","\t<tr><td>NNC-63-0532      </td><td>3906780  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0248612092</td><td>OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>CGP-12177        </td><td>2687     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0208771503</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>midostaurin      </td><td>9829523  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0181909702</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2</td></tr>\n","\t<tr><td>XE-991           </td><td>656732   </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0177518328</td><td>KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      </td></tr>\n","\t<tr><td>mead-acid        </td><td>5312531  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0174795924</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>carbetocin       </td><td>73707428 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0173693232</td><td>OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>ST-013960        </td><td>2300880  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0171066799</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>terguride        </td><td>11957722 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0160341410</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>erythrosine      </td><td>12961638 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0152043372</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>fillalbin        </td><td>933171   </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0145711204</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>SKF-77434        </td><td>11957703 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0136911431</td><td>DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>vicriviroc       </td><td>73707391 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0100475152</td><td>CCR5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>quinpirol-(-)    </td><td>NotFound </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0093453540</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>SPB02303         </td><td>2744062  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0088429327</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>GW-4064          </td><td>9893571  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0049879284</td><td>NR1H4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>rotenonic-acid   </td><td>6708539  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0038054234</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>alvespimycin     </td><td>73707383 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0030549580</td><td>HSP90AA1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               </td></tr>\n","\t<tr><td>SEW-2871         </td><td>4077460  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0023144793</td><td>S1PR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>tyrphostin-AG-556</td><td>2059     </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.0012281187</td><td>EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>AS-703026        </td><td>44187362 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.0009044138</td><td>MAP2K1; MAP2K2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"VMntksUq7BVc"},"source":["## 6.2 CORsub\n","- on a subset of genes"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"kMIjWOjo9NPd","executionInfo":{"status":"ok","timestamp":1636337765372,"user_tz":-480,"elapsed":2684,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"e1470670-8532-41ae-ac13-889f85493970"},"source":["# Subset z-scores of 150 up and down gene sets from \n","# \"vorinostat__SKB__trt_cp\" signature.\n","query_mat_sub <- as.matrix(query_mat[c(upset, downset),])\n","qsig_spsub <- qSig(query = query_mat_sub, gess_method = \"Cor\", refdb = db_path)\n","spsub <- gess_cor(qSig=qsig_spsub, method=\"spearman\", workers=1)\n","result(spsub)"],"execution_count":16,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                PCID     cell type   trend cor_score   \n","1   vorinostat          5311     SKB  trt_cp up     1.0000000  \n","2   trichostatin-a      444732   SKB  trt_cp up     0.8845716  \n","3   HC-toxin            3571     SKB  trt_cp up     0.8558387  \n","4   pyroxamide          4996     SKB  trt_cp up     0.6463897  \n","5   APHA-compound-8     10379137 SKB  trt_cp up     0.4415442  \n","6   benzonatate         7699     SKB  trt_cp up     0.3328002  \n","7   MD-040              73707398 SKB  trt_cp up     0.3073281  \n","8   K784-3187           3689415  SKB  trt_cp up     0.2973048  \n","9   scopolamine-n-oxide 3000667  SKB  trt_cp up     0.2965809  \n","10  fasudil             3547     SKB  trt_cp up     0.2881912  \n","11  I-070759            24086306 SKB  trt_cp up     0.2751415  \n","12  huperzine-a         1253     SKB  trt_cp up     0.2724758  \n","13  rescinnamine        5280954  SKB  trt_cp down  -0.2671947  \n","14  K784-3131           4381125  SKB  trt_cp up     0.2609171  \n","15  TUL-XIX029          67243342 SKB  trt_cp up     0.2435542  \n","16  calcifediol         46705323 SKB  trt_cp up     0.2395863  \n","17  decafluorobutane    9638     SKB  trt_cp up     0.2262501  \n","18  calmidazolium       2531     SKB  trt_cp up     0.2189600  \n","19  raltitrexed         104758   SKB  trt_cp up     0.2133740  \n","20  ST-4066738          1043828  SKB  trt_cp up     0.1980910  \n","21  loreclezole         50988829 SKB  trt_cp down  -0.1932792  \n","22  fenobam             162834   SKB  trt_cp up     0.1929876  \n","23  rimcazole           5072     SKB  trt_cp up     0.1926962  \n","24  ryuvidine           481747   SKB  trt_cp up     0.1920004  \n","25  calcitriol          21158442 SKB  trt_cp up     0.1918789  \n","26  hydroquinidine      45479756 SKB  trt_cp up     0.1857809  \n","27  ketorolac           3826     SKB  trt_cp down  -0.1794213  \n","28  treprostinil        73707411 SKB  trt_cp up     0.1793196  \n","29  IRL-2500            4574540  SKB  trt_cp up     0.1726840  \n","30  NSC-693868          438981   SKB  trt_cp up     0.1725065  \n","⋮   ⋮                   ⋮        ⋮    ⋮      ⋮     ⋮           \n","71  chlorprothixene     667467   SKB  trt_cp up     0.066704002\n","72  erythrosine         12961638 SKB  trt_cp up     0.066022809\n","73  hemado              4043357  SKB  trt_cp up     0.061488101\n","74  MW-A1-2             3125011  SKB  trt_cp up     0.060711861\n","75  mexiletine          4178     SKB  trt_cp down  -0.060225466\n","76  rotenonic-acid      6708539  SKB  trt_cp up     0.059947020\n","77  ST-013960           2300880  SKB  trt_cp down  -0.056128573\n","78  ST-4029655          691928   SKB  trt_cp down  -0.055377826\n","79  SPB02303            2744062  SKB  trt_cp up     0.053469149\n","80  mead-acid           5312531  SKB  trt_cp up     0.050065755\n","81  oxalomalic-acid     439620   SKB  trt_cp up     0.042835840\n","82  SKF-77434           11957703 SKB  trt_cp up     0.042077215\n","83  MDL-28170           72430    SKB  trt_cp up     0.039495798\n","84  vinorelbine         73707409 SKB  trt_cp up     0.039433738\n","85  NNC-63-0532         3906780  SKB  trt_cp up     0.036651929\n","86  D-609               45479729 SKB  trt_cp up     0.036073642\n","87  carbetocin          73707428 SKB  trt_cp up     0.029291879\n","88  CGP-13501           3519541  SKB  trt_cp up     0.028350059\n","89  tyrphostin-AG-556   2059     SKB  trt_cp up     0.027953994\n","90  RAN-05              44229302 SKB  trt_cp down  -0.024348972\n","91  CGP-12177           2687     SKB  trt_cp down  -0.020334341\n","92  fillalbin           933171   SKB  trt_cp up     0.019178701\n","93  procarbazine        9703     SKB  trt_cp up     0.017789273\n","94  midostaurin         9829523  SKB  trt_cp up     0.015677890\n","95  trazodone           5533     SKB  trt_cp up     0.014784022\n","96  terguride           11957722 SKB  trt_cp down  -0.009828096\n","97  SB-525334           9967941  SKB  trt_cp up     0.006790663\n","98  clofibric-acid      2797     SKB  trt_cp down  -0.005522567\n","99  TUL-XX023           54596143 SKB  trt_cp up     0.002520499\n","100 propylpyrazole      35027762 SKB  trt_cp up     0.001564450\n","    t_gn_sym                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","2   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","3   HDAC1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","4   HDAC1; HDAC3; HDAC6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","5   HDAC8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","6   SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","7   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","8   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","9   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","10  CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               \n","11  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","12  ACHE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","13  ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","14  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","15  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","16  VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","17  GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","18  ATP2B1; PDE1A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          \n","19  FPGS; TYMS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","20  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","21  GABRB2; GABRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","22  GRM5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","23  SIGMAR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","24  CDK2; CDK4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","25  CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \n","26  KMT2A; PSIP1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","27  LTF; TF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                \n","28  CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; PTGER2; PTGER3; PTGER4; PTGIR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","29  EDNRB; HBA2; HBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n","30  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","⋮   ⋮                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","71  CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","72  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","73  ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n","74  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","75  AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \n","76  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","77  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","78  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","79  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","80  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","81  ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","82  DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","83  CAPN1; CTSB; CTSL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \n","84  TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","85  OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","86  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","87  OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","88  GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","89  EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \n","90  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","91  ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \n","92  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","93  MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \n","94  AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\n","95  ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n","96  ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n","97  TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n","98  PPARA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n","99  NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \n","100 ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "],"text/latex":"A tibble: 100 × 7\n\\begin{tabular}{lllllll}\n pert & PCID & cell & type & trend & cor\\_score & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <chr>\\\\\n\\hline\n\t vorinostat          & 5311     & SKB & trt\\_cp & up   &  1.0000000 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9\\\\\n\t trichostatin-a      & 444732   & SKB & trt\\_cp & up   &  0.8845716 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9        \\\\\n\t HC-toxin            & 3571     & SKB & trt\\_cp & up   &  0.8558387 & HDAC1                                                                        \\\\\n\t pyroxamide          & 4996     & SKB & trt\\_cp & up   &  0.6463897 & HDAC1; HDAC3; HDAC6                                                          \\\\\n\t APHA-compound-8     & 10379137 & SKB & trt\\_cp & up   &  0.4415442 & HDAC8                                                                        \\\\\n\t benzonatate         & 7699     & SKB & trt\\_cp & up   &  0.3328002 & SCN5A                                                                        \\\\\n\t MD-040              & 73707398 & SKB & trt\\_cp & up   &  0.3073281 & NA                                                                           \\\\\n\t K784-3187           & 3689415  & SKB & trt\\_cp & up   &  0.2973048 & NA                                                                           \\\\\n\t scopolamine-n-oxide & 3000667  & SKB & trt\\_cp & up   &  0.2965809 & NA                                                                           \\\\\n\t fasudil             & 3547     & SKB & trt\\_cp & up   &  0.2881912 & CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                     \\\\\n\t I-070759            & 24086306 & SKB & trt\\_cp & up   &  0.2751415 & NA                                                                           \\\\\n\t huperzine-a         & 1253     & SKB & trt\\_cp & up   &  0.2724758 & ACHE                                                                         \\\\\n\t rescinnamine        & 5280954  & SKB & trt\\_cp & down & -0.2671947 & ACE                                                                          \\\\\n\t K784-3131           & 4381125  & SKB & trt\\_cp & up   &  0.2609171 & NA                                                                           \\\\\n\t TUL-XIX029          & 67243342 & SKB & trt\\_cp & up   &  0.2435542 & NA                                                                           \\\\\n\t calcifediol         & 46705323 & SKB & trt\\_cp & up   &  0.2395863 & VDR                                                                          \\\\\n\t decafluorobutane    & 9638     & SKB & trt\\_cp & up   &  0.2262501 & GRM5                                                                         \\\\\n\t calmidazolium       & 2531     & SKB & trt\\_cp & up   &  0.2189600 & ATP2B1; PDE1A                                                                \\\\\n\t raltitrexed         & 104758   & SKB & trt\\_cp & up   &  0.2133740 & FPGS; TYMS                                                                   \\\\\n\t ST-4066738          & 1043828  & SKB & trt\\_cp & up   &  0.1980910 & NA                                                                           \\\\\n\t loreclezole         & 50988829 & SKB & trt\\_cp & down & -0.1932792 & GABRB2; GABRB3                                                               \\\\\n\t fenobam             & 162834   & SKB & trt\\_cp & up   &  0.1929876 & GRM5                                                                         \\\\\n\t rimcazole           & 5072     & SKB & trt\\_cp & up   &  0.1926962 & SIGMAR1                                                                      \\\\\n\t ryuvidine           & 481747   & SKB & trt\\_cp & up   &  0.1920004 & CDK2; CDK4                                                                   \\\\\n\t calcitriol          & 21158442 & SKB & trt\\_cp & up   &  0.1918789 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                               \\\\\n\t hydroquinidine      & 45479756 & SKB & trt\\_cp & up   &  0.1857809 & KMT2A; PSIP1                                                                 \\\\\n\t ketorolac           & 3826     & SKB & trt\\_cp & down & -0.1794213 & LTF; TF                                                                      \\\\\n\t treprostinil        & 73707411 & SKB & trt\\_cp & up   &  0.1793196 & CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; PTGER2; PTGER3; PTGER4; PTGIR          \\\\\n\t IRL-2500            & 4574540  & SKB & trt\\_cp & up   &  0.1726840 & EDNRB; HBA2; HBB                                                             \\\\\n\t NSC-693868          & 438981   & SKB & trt\\_cp & up   &  0.1725065 & NA                                                                           \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t chlorprothixene   & 667467   & SKB & trt\\_cp & up   &  0.066704002 & CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t erythrosine       & 12961638 & SKB & trt\\_cp & up   &  0.066022809 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t hemado            & 4043357  & SKB & trt\\_cp & up   &  0.061488101 & ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \\\\\n\t MW-A1-2           & 3125011  & SKB & trt\\_cp & up   &  0.060711861 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t mexiletine        & 4178     & SKB & trt\\_cp & down & -0.060225466 & AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \\\\\n\t rotenonic-acid    & 6708539  & SKB & trt\\_cp & up   &  0.059947020 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t ST-013960         & 2300880  & SKB & trt\\_cp & down & -0.056128573 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t ST-4029655        & 691928   & SKB & trt\\_cp & down & -0.055377826 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t SPB02303          & 2744062  & SKB & trt\\_cp & up   &  0.053469149 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t mead-acid         & 5312531  & SKB & trt\\_cp & up   &  0.050065755 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t oxalomalic-acid   & 439620   & SKB & trt\\_cp & up   &  0.042835840 & ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t SKF-77434         & 11957703 & SKB & trt\\_cp & up   &  0.042077215 & DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t MDL-28170         & 72430    & SKB & trt\\_cp & up   &  0.039495798 & CAPN1; CTSB; CTSL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      \\\\\n\t vinorelbine       & 73707409 & SKB & trt\\_cp & up   &  0.039433738 & TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t NNC-63-0532       & 3906780  & SKB & trt\\_cp & up   &  0.036651929 & OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t D-609             & 45479729 & SKB & trt\\_cp & up   &  0.036073642 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t carbetocin        & 73707428 & SKB & trt\\_cp & up   &  0.029291879 & OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t CGP-13501         & 3519541  & SKB & trt\\_cp & up   &  0.028350059 & GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t tyrphostin-AG-556 & 2059     & SKB & trt\\_cp & up   &  0.027953994 & EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\t RAN-05            & 44229302 & SKB & trt\\_cp & down & -0.024348972 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t CGP-12177         & 2687     & SKB & trt\\_cp & down & -0.020334341 & ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \\\\\n\t fillalbin         & 933171   & SKB & trt\\_cp & up   &  0.019178701 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t procarbazine      & 9703     & SKB & trt\\_cp & up   &  0.017789273 & MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             \\\\\n\t midostaurin       & 9829523  & SKB & trt\\_cp & up   &  0.015677890 & AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2\\\\\n\t trazodone         & 5533     & SKB & trt\\_cp & up   &  0.014784022 & ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            \\\\\n\t terguride         & 11957722 & SKB & trt\\_cp & down & -0.009828096 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \\\\\n\t SB-525334         & 9967941  & SKB & trt\\_cp & up   &  0.006790663 & TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \\\\\n\t clofibric-acid    & 2797     & SKB & trt\\_cp & down & -0.005522567 & PPARA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \\\\\n\t TUL-XX023         & 54596143 & SKB & trt\\_cp & up   &  0.002520499 & NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     \\\\\n\t propylpyrazole    & 35027762 & SKB & trt\\_cp & up   &  0.001564450 & ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 100 × 7\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | cor_score &lt;dbl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|\n| vorinostat          | 5311     | SKB | trt_cp | up   |  1.0000000 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9 |\n| trichostatin-a      | 444732   | SKB | trt_cp | up   |  0.8845716 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9         |\n| HC-toxin            | 3571     | SKB | trt_cp | up   |  0.8558387 | HDAC1                                                                         |\n| pyroxamide          | 4996     | SKB | trt_cp | up   |  0.6463897 | HDAC1; HDAC3; HDAC6                                                           |\n| APHA-compound-8     | 10379137 | SKB | trt_cp | up   |  0.4415442 | HDAC8                                                                         |\n| benzonatate         | 7699     | SKB | trt_cp | up   |  0.3328002 | SCN5A                                                                         |\n| MD-040              | 73707398 | SKB | trt_cp | up   |  0.3073281 | NA                                                                            |\n| K784-3187           | 3689415  | SKB | trt_cp | up   |  0.2973048 | NA                                                                            |\n| scopolamine-n-oxide | 3000667  | SKB | trt_cp | up   |  0.2965809 | NA                                                                            |\n| fasudil             | 3547     | SKB | trt_cp | up   |  0.2881912 | CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                      |\n| I-070759            | 24086306 | SKB | trt_cp | up   |  0.2751415 | NA                                                                            |\n| huperzine-a         | 1253     | SKB | trt_cp | up   |  0.2724758 | ACHE                                                                          |\n| rescinnamine        | 5280954  | SKB | trt_cp | down | -0.2671947 | ACE                                                                           |\n| K784-3131           | 4381125  | SKB | trt_cp | up   |  0.2609171 | NA                                                                            |\n| TUL-XIX029          | 67243342 | SKB | trt_cp | up   |  0.2435542 | NA                                                                            |\n| calcifediol         | 46705323 | SKB | trt_cp | up   |  0.2395863 | VDR                                                                           |\n| decafluorobutane    | 9638     | SKB | trt_cp | up   |  0.2262501 | GRM5                                                                          |\n| calmidazolium       | 2531     | SKB | trt_cp | up   |  0.2189600 | ATP2B1; PDE1A                                                                 |\n| raltitrexed         | 104758   | SKB | trt_cp | up   |  0.2133740 | FPGS; TYMS                                                                    |\n| ST-4066738          | 1043828  | SKB | trt_cp | up   |  0.1980910 | NA                                                                            |\n| loreclezole         | 50988829 | SKB | trt_cp | down | -0.1932792 | GABRB2; GABRB3                                                                |\n| fenobam             | 162834   | SKB | trt_cp | up   |  0.1929876 | GRM5                                                                          |\n| rimcazole           | 5072     | SKB | trt_cp | up   |  0.1926962 | SIGMAR1                                                                       |\n| ryuvidine           | 481747   | SKB | trt_cp | up   |  0.1920004 | CDK2; CDK4                                                                    |\n| calcitriol          | 21158442 | SKB | trt_cp | up   |  0.1918789 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                                |\n| hydroquinidine      | 45479756 | SKB | trt_cp | up   |  0.1857809 | KMT2A; PSIP1                                                                  |\n| ketorolac           | 3826     | SKB | trt_cp | down | -0.1794213 | LTF; TF                                                                       |\n| treprostinil        | 73707411 | SKB | trt_cp | up   |  0.1793196 | CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; PTGER2; PTGER3; PTGER4; PTGIR           |\n| IRL-2500            | 4574540  | SKB | trt_cp | up   |  0.1726840 | EDNRB; HBA2; HBB                                                              |\n| NSC-693868          | 438981   | SKB | trt_cp | up   |  0.1725065 | NA                                                                            |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| chlorprothixene   | 667467   | SKB | trt_cp | up   |  0.066704002 | CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| erythrosine       | 12961638 | SKB | trt_cp | up   |  0.066022809 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| hemado            | 4043357  | SKB | trt_cp | up   |  0.061488101 | ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |\n| MW-A1-2           | 3125011  | SKB | trt_cp | up   |  0.060711861 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| mexiletine        | 4178     | SKB | trt_cp | down | -0.060225466 | AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |\n| rotenonic-acid    | 6708539  | SKB | trt_cp | up   |  0.059947020 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| ST-013960         | 2300880  | SKB | trt_cp | down | -0.056128573 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| ST-4029655        | 691928   | SKB | trt_cp | down | -0.055377826 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| SPB02303          | 2744062  | SKB | trt_cp | up   |  0.053469149 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| mead-acid         | 5312531  | SKB | trt_cp | up   |  0.050065755 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| oxalomalic-acid   | 439620   | SKB | trt_cp | up   |  0.042835840 | ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| SKF-77434         | 11957703 | SKB | trt_cp | up   |  0.042077215 | DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| MDL-28170         | 72430    | SKB | trt_cp | up   |  0.039495798 | CAPN1; CTSB; CTSL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |\n| vinorelbine       | 73707409 | SKB | trt_cp | up   |  0.039433738 | TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| NNC-63-0532       | 3906780  | SKB | trt_cp | up   |  0.036651929 | OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| D-609             | 45479729 | SKB | trt_cp | up   |  0.036073642 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| carbetocin        | 73707428 | SKB | trt_cp | up   |  0.029291879 | OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| CGP-13501         | 3519541  | SKB | trt_cp | up   |  0.028350059 | GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| tyrphostin-AG-556 | 2059     | SKB | trt_cp | up   |  0.027953994 | EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n| RAN-05            | 44229302 | SKB | trt_cp | down | -0.024348972 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| CGP-12177         | 2687     | SKB | trt_cp | down | -0.020334341 | ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |\n| fillalbin         | 933171   | SKB | trt_cp | up   |  0.019178701 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| procarbazine      | 9703     | SKB | trt_cp | up   |  0.017789273 | MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |\n| midostaurin       | 9829523  | SKB | trt_cp | up   |  0.015677890 | AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2 |\n| trazodone         | 5533     | SKB | trt_cp | up   |  0.014784022 | ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |\n| terguride         | 11957722 | SKB | trt_cp | down | -0.009828096 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |\n| SB-525334         | 9967941  | SKB | trt_cp | up   |  0.006790663 | TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |\n| clofibric-acid    | 2797     | SKB | trt_cp | down | -0.005522567 | PPARA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |\n| TUL-XX023         | 54596143 | SKB | trt_cp | up   |  0.002520499 | NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |\n| propylpyrazole    | 35027762 | SKB | trt_cp | up   |  0.001564450 | ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 100 × 7</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>cor_score</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat         </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.0000000</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9</td></tr>\n","\t<tr><td>trichostatin-a     </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8845716</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9        </td></tr>\n","\t<tr><td>HC-toxin           </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8558387</td><td>HDAC1                                                                        </td></tr>\n","\t<tr><td>pyroxamide         </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.6463897</td><td>HDAC1; HDAC3; HDAC6                                                          </td></tr>\n","\t<tr><td>APHA-compound-8    </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4415442</td><td>HDAC8                                                                        </td></tr>\n","\t<tr><td>benzonatate        </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3328002</td><td>SCN5A                                                                        </td></tr>\n","\t<tr><td>MD-040             </td><td>73707398</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3073281</td><td>NA                                                                           </td></tr>\n","\t<tr><td>K784-3187          </td><td>3689415 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2973048</td><td>NA                                                                           </td></tr>\n","\t<tr><td>scopolamine-n-oxide</td><td>3000667 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2965809</td><td>NA                                                                           </td></tr>\n","\t<tr><td>fasudil            </td><td>3547    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2881912</td><td>CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; PRKX; ROCK1; ROCK2                     </td></tr>\n","\t<tr><td>I-070759           </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2751415</td><td>NA                                                                           </td></tr>\n","\t<tr><td>huperzine-a        </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2724758</td><td>ACHE                                                                         </td></tr>\n","\t<tr><td>rescinnamine       </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2671947</td><td>ACE                                                                          </td></tr>\n","\t<tr><td>K784-3131          </td><td>4381125 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2609171</td><td>NA                                                                           </td></tr>\n","\t<tr><td>TUL-XIX029         </td><td>67243342</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2435542</td><td>NA                                                                           </td></tr>\n","\t<tr><td>calcifediol        </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2395863</td><td>VDR                                                                          </td></tr>\n","\t<tr><td>decafluorobutane   </td><td>9638    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2262501</td><td>GRM5                                                                         </td></tr>\n","\t<tr><td>calmidazolium      </td><td>2531    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2189600</td><td>ATP2B1; PDE1A                                                                </td></tr>\n","\t<tr><td>raltitrexed        </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2133740</td><td>FPGS; TYMS                                                                   </td></tr>\n","\t<tr><td>ST-4066738         </td><td>1043828 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1980910</td><td>NA                                                                           </td></tr>\n","\t<tr><td>loreclezole        </td><td>50988829</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.1932792</td><td>GABRB2; GABRB3                                                               </td></tr>\n","\t<tr><td>fenobam            </td><td>162834  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1929876</td><td>GRM5                                                                         </td></tr>\n","\t<tr><td>rimcazole          </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1926962</td><td>SIGMAR1                                                                      </td></tr>\n","\t<tr><td>ryuvidine          </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1920004</td><td>CDK2; CDK4                                                                   </td></tr>\n","\t<tr><td>calcitriol         </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1918789</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; HOXA10; VDR                               </td></tr>\n","\t<tr><td>hydroquinidine     </td><td>45479756</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1857809</td><td>KMT2A; PSIP1                                                                 </td></tr>\n","\t<tr><td>ketorolac          </td><td>3826    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.1794213</td><td>LTF; TF                                                                      </td></tr>\n","\t<tr><td>treprostinil       </td><td>73707411</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1793196</td><td>CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; PTGER2; PTGER3; PTGER4; PTGIR          </td></tr>\n","\t<tr><td>IRL-2500           </td><td>4574540 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1726840</td><td>EDNRB; HBA2; HBB                                                             </td></tr>\n","\t<tr><td>NSC-693868         </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.1725065</td><td>NA                                                                           </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>chlorprothixene  </td><td>667467  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.066704002</td><td>CHRM1; CHRM4; CHRM5; DRD1; DRD3; HRH1; HTR2B                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>erythrosine      </td><td>12961638</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.066022809</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>hemado           </td><td>4043357 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.061488101</td><td>ADORA1; ADORA2A; ADORA2B; ADORA3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       </td></tr>\n","\t<tr><td>MW-A1-2          </td><td>3125011 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.060711861</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>mexiletine       </td><td>4178    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.060225466</td><td>AHR; CYP2B6; CYP2E1; KCNK2; KCNK3; SCN4A; SCN5A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        </td></tr>\n","\t<tr><td>rotenonic-acid   </td><td>6708539 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.059947020</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>ST-013960        </td><td>2300880 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.056128573</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>ST-4029655       </td><td>691928  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.055377826</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>SPB02303         </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.053469149</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>mead-acid        </td><td>5312531 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.050065755</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>oxalomalic-acid  </td><td>439620  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.042835840</td><td>ACO1; IDH1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>SKF-77434        </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.042077215</td><td>DRD1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>MDL-28170        </td><td>72430   </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.039495798</td><td>CAPN1; CTSB; CTSL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      </td></tr>\n","\t<tr><td>vinorelbine      </td><td>73707409</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.039433738</td><td>TUBB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>NNC-63-0532      </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.036651929</td><td>OPRL1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>D-609            </td><td>45479729</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.036073642</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>carbetocin       </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.029291879</td><td>OXTR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>CGP-13501        </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.028350059</td><td>GABBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>tyrphostin-AG-556</td><td>2059    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.027953994</td><td>EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","\t<tr><td>RAN-05           </td><td>44229302</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.024348972</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>CGP-12177        </td><td>2687    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.020334341</td><td>ADRB1; ADRB2; ADRB3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    </td></tr>\n","\t<tr><td>fillalbin        </td><td>933171  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.019178701</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>procarbazine     </td><td>9703    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.017789273</td><td>MAOA; MAOB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             </td></tr>\n","\t<tr><td>midostaurin      </td><td>9829523 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.015677890</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; CAMK2A; CAMK2D; CAMKK1; CAMKK2; CCNB1; CLK4; CUX1; EIF2AK4; FER; FGFR1OP; FGFR1OP2; FGR; FLT1; FLT3; FLT4; GRK1; GRK7; GSK3A; HCK; IKBKE; KDR; KIT; LIMK1; LRRK2; MAP3K10; MAP3K11; MAP3K19; MAP3K2; MAP3K3; MAP3K7; MAP3K9; MAP4K2; MAP4K4; MAP4K5; MARK1; MARK2; MARK3; MARK4; MELK; MINK1; MST4; MYLK; NTRK1; NTRK2; NTRK3; NUAK1; NUAK2; PDGFRA; PDGFRB; PHKG1; PKN1; PKN2; PLK4; PRKCA; PRKCB; PRKCE; PRKCG; PRKCH; PRKG1; PRKG2; PRPF4B; RET; ROS1; RPS6KA1; RPS6KA2; RPS6KA3; RPS6KA4; RPS6KA5; RPS6KA6; RPS6KB1; SIK2; SLK; SRPK1; SRPK3; STK10; STK3; STK4; TBK1; TNK1; TNK2; TSSK1B; TYK2; VEGFA; YES1; ZMYM2</td></tr>\n","\t<tr><td>trazodone        </td><td>5533    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.014784022</td><td>ADRA1A; HRH1; HTR2B; SLC6A4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </td></tr>\n","\t<tr><td>terguride        </td><td>11957722</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.009828096</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; HTR1B; HTR1D; HTR2B; PRL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </td></tr>\n","\t<tr><td>SB-525334        </td><td>9967941 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.006790663</td><td>TGFBR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 </td></tr>\n","\t<tr><td>clofibric-acid   </td><td>2797    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.005522567</td><td>PPARA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  </td></tr>\n","\t<tr><td>TUL-XX023        </td><td>54596143</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.002520499</td><td>NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     </td></tr>\n","\t<tr><td>propylpyrazole   </td><td>35027762</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.001564450</td><td>ESR1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"Lmm-03Wr9Op0"},"source":["# Summary of search results\n","Although the toy database is artificially small, one can use the above search results for a preliminary performance assessment of the different GESS methods in ranking drugs based on known modes of action (MOA). Four of the five cherry-picked HDAC inhibitors (vorinostat, trichostatin-a, HC-toxin, pyroxamide) were ranked among the top 10 ranking drugs in the search results of the LINCS, Fisher and Spearman correlation methods. If generalizable, this result implies a promising performance of these search methods for grouping drugs by their MOA categories. In addition, the LINCS and Spearman methods were able to rank another HDAC inhibitor, APHA-compound-8, at the top of their search results, indicating a better sensitivity of these two methods compared to the other methods.\n","\n","# GESS Result Visualization\n","The `gess_res_vis` function allows to summarize the ranking scores of selected perturbagens for GESS results across cell types along with cell type classifications, such as normal and tumor cells. In the following plot (Figure 3) the perturbagens are drugs (along x-axis) and the ranking scores are LINCS’ NCS values (y-axis). For each drug the NCS values are plotted for each cell type as differently colored dots, while their shape indicates the cell type class. Note, the code for generating the plot is not evaluated here since the toy database used by this vignette contains only treatments for one cell type (here SKB cells). This would result in a not very informative plot. To illustrate the full potential of the `gess_res_vis` function, the following code section applies to a search where the vorinostat signature was used to query with the `gess_lincs` method the full LINCS database. Subsequently, the search result is processed by the `gess_res_vis` function to generate the plot shown in Figure 3."]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":568},"id":"0iAUMJK39sTY","executionInfo":{"status":"ok","timestamp":1636338199168,"user_tz":-480,"elapsed":433807,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"9b3c7b0b-7fa3-441f-a60b-31fc143a7ba1"},"source":["vor_qsig_full <- qSig(query = list(upset=upset, downset=downset), \n","                   gess_method=\"LINCS\", refdb=\"lincs\")\n","vori_res_full <- gess_lincs(qSig=vor_qsig_full, sortby=\"NCS\", tau=TRUE)\n","vori_tb <- result(vori_res_full)\n","drugs_top10 <- unique(result(lincs)$pert)[1:10]\n","drugs_hdac <- c(\"panobinostat\",\"mocetinostat\",\"ISOX\",\"scriptaid\",\"entinostat\",\n","      \"belinostat\",\"HDAC3-selective\",\"tubastatin-a\",\"tacedinaline\",\"depudecin\")\n","drugs = c(drugs_top10, drugs_hdac)\n","gess_res_vis(vori_tb, drugs = drugs, col = \"NCS\")"],"execution_count":17,"outputs":[{"output_type":"stream","name":"stderr","text":["see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","150 / 150 genes in up set share identifiers with reference database\n","\n","150 / 150 genes in down set share identifiers with reference database\n","\n"]},{"output_type":"display_data","data":{"image/png":"iVBORw0KGgoAAAANSUhEUgAAA0gAAANICAIAAAByhViMAAAACXBIWXMAABJ0AAASdAHeZh94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\nIxDsAAAAAGwEgh0AAACAjfg/aZWAX1x1KxgAAAAASUVORK5CYII=","text/plain":["plot without title"]},"metadata":{"image/png":{"width":420,"height":420}}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":502},"id":"AUlLZDmz9zmX","executionInfo":{"status":"ok","timestamp":1636338202753,"user_tz":-480,"elapsed":3596,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"007074ee-2b23-41dd-f512-b5f3f8119950"},"source":["cellNtestPlot(refdb='lincs')"],"execution_count":18,"outputs":[{"output_type":"stream","name":"stderr","text":["see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n"]},{"output_type":"display_data","data":{"image/png":"iVBORw0KGgoAAAANSUhEUgAAA0gAAANICAIAAAByhViMAAAACXBIWXMAABJ0AAASdAHeZh94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\nJpDYAQAAAJiJ/w/8KDbA7y3uRgAAAABJRU5ErkJggg==","text/plain":["plot without title"]},"metadata":{"image/png":{"width":420,"height":420}}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"4Rvyce4s-RLb","executionInfo":{"status":"ok","timestamp":1636338202754,"user_tz":-480,"elapsed":20,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"67786c8a-1dd7-4081-befd-8a4a9bd5f397"},"source":["data('cell_info')\n","cell_info"],"execution_count":19,"outputs":[{"output_type":"display_data","data":{"text/plain":["   cell_id  cell_type primary_site                      \n","1  A375     tumor     skin                              \n","2  A549     tumor     lung                              \n","3  BT20     tumor     breast                            \n","4  HA1E     normal    kidney                            \n","5  HCC515   normal    lung                              \n","6  HEK293T  normal    kidney                            \n","7  HEPG2    tumor     liver                             \n","8  HL60     tumor     haematopoietic and lymphoid tissue\n","9  HS578T   tumor     breast                            \n","10 HT29     tumor     large intestine                   \n","11 HUH7     tumor     liver                             \n","12 JURKAT   tumor     haematopoietic and lymphoid tissue\n","13 MCF10A   normal    breast                            \n","14 MCF7     tumor     breast                            \n","15 MDAMB231 tumor     breast                            \n","16 NKDBA    normal    kidney                            \n","17 NOMO1    tumor     haematopoietic and lymphoid tissue\n","18 PC3      tumor     prostate                          \n","19 SKBR3    tumor     breast                            \n","20 THP1     tumor     haematopoietic and lymphoid tissue\n","21 U266     tumor     blood                             \n","22 U937     tumor     haematopoietic and lymphoid tissue\n","23 VCAP     tumor     prostate                          \n","24 NEU      normal    nervous system                    \n","25 NPC      normal    central nervous system            \n","26 FIBRNPC  normal    skin                              \n","27 ASC      normal    adipose                           \n","28 CD34     normal    bone                              \n","29 PHH      normal    liver                             \n","30 SKB      normal    muscle                            \n","   subtype                                              donor_sex\n","1  malignant melanoma                                   F        \n","2  non small cell lung cancer| carcinoma                M        \n","3  carcinoma                                            F        \n","4  normal kidney                                        unknown  \n","5  carcinoma                                            unknown  \n","6  embryonal kidney                                     unknown  \n","7  hepatocellular carcinoma                             M        \n","8  acute myelogenous leukemia (AML)| M3 (promyelocytic) F        \n","9  carcinoma                                            F        \n","10 colorectal adenocarcinoma                            F        \n","11 hepatocellular carcinoma                             M        \n","12 acute lymphoblastic leukemia (ALL)| T-cell           M        \n","13 epithelial                                           F        \n","14 adenocarcinoma                                       F        \n","15 adenocarcinoma                                       F        \n","16 kidney epithelial                                    M        \n","17 acute myeloid leukemia (AML)                         F        \n","18 adenocarcinoma                                       M        \n","19 adenocarcinoma                                       F        \n","20 acute myelogenous leukemia| M5 (monocytic)           M        \n","21 myeloman, haematopoietic,lymphoid                    unknown  \n","22 lymphoma| B-cell| non-hodgkin's| histiocytic         M        \n","23 carcinoma                                            M        \n","24 unknown                                              unknown  \n","25 normal stem fibroblast-derived iPScs                 unknown  \n","26 unknown                                              unknown  \n","27 normal primary adipocyte stem cells                  unknown  \n","28 bone marrow                                          unknown  \n","29 normal primary liver                                 unknown  \n","30 myoblast                                             unknown  "],"text/latex":"A tibble: 30 × 5\n\\begin{tabular}{lllll}\n cell\\_id & cell\\_type & primary\\_site & subtype & donor\\_sex\\\\\n <chr> & <chr> & <chr> & <chr> & <chr>\\\\\n\\hline\n\t A375     & tumor  & skin                               & malignant melanoma                                   & F      \\\\\n\t A549     & tumor  & lung                               & non small cell lung cancer\\textbar{} carcinoma                & M      \\\\\n\t BT20     & tumor  & breast                             & carcinoma                                            & F      \\\\\n\t HA1E     & normal & kidney                             & normal kidney                                        & unknown\\\\\n\t HCC515   & normal & lung                               & carcinoma                                            & unknown\\\\\n\t HEK293T  & normal & kidney                             & embryonal kidney                                     & unknown\\\\\n\t HEPG2    & tumor  & liver                              & hepatocellular carcinoma                             & M      \\\\\n\t HL60     & tumor  & haematopoietic and lymphoid tissue & acute myelogenous leukemia (AML)\\textbar{} M3 (promyelocytic) & F      \\\\\n\t HS578T   & tumor  & breast                             & carcinoma                                            & F      \\\\\n\t HT29     & tumor  & large intestine                    & colorectal adenocarcinoma                            & F      \\\\\n\t HUH7     & tumor  & liver                              & hepatocellular carcinoma                             & M      \\\\\n\t JURKAT   & tumor  & haematopoietic and lymphoid tissue & acute lymphoblastic leukemia (ALL)\\textbar{} T-cell           & M      \\\\\n\t MCF10A   & normal & breast                             & epithelial                                           & F      \\\\\n\t MCF7     & tumor  & breast                             & adenocarcinoma                                       & F      \\\\\n\t MDAMB231 & tumor  & breast                             & adenocarcinoma                                       & F      \\\\\n\t NKDBA    & normal & kidney                             & kidney epithelial                                    & M      \\\\\n\t NOMO1    & tumor  & haematopoietic and lymphoid tissue & acute myeloid leukemia (AML)                         & F      \\\\\n\t PC3      & tumor  & prostate                           & adenocarcinoma                                       & M      \\\\\n\t SKBR3    & tumor  & breast                             & adenocarcinoma                                       & F      \\\\\n\t THP1     & tumor  & haematopoietic and lymphoid tissue & acute myelogenous leukemia\\textbar{} M5 (monocytic)           & M      \\\\\n\t U266     & tumor  & blood                              & myeloman, haematopoietic,lymphoid                    & unknown\\\\\n\t U937     & tumor  & haematopoietic and lymphoid tissue & lymphoma\\textbar{} B-cell\\textbar{} non-hodgkin's\\textbar{} histiocytic         & M      \\\\\n\t VCAP     & tumor  & prostate                           & carcinoma                                            & M      \\\\\n\t NEU      & normal & nervous system                     & unknown                                              & unknown\\\\\n\t NPC      & normal & central nervous system             & normal stem fibroblast-derived iPScs                 & unknown\\\\\n\t FIBRNPC  & normal & skin                               & unknown                                              & unknown\\\\\n\t ASC      & normal & adipose                            & normal primary adipocyte stem cells                  & unknown\\\\\n\t CD34     & normal & bone                               & bone marrow                                          & unknown\\\\\n\t PHH      & normal & liver                              & normal primary liver                                 & unknown\\\\\n\t SKB      & normal & muscle                             & myoblast                                             & unknown\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 30 × 5\n\n| cell_id &lt;chr&gt; | cell_type &lt;chr&gt; | primary_site &lt;chr&gt; | subtype &lt;chr&gt; | donor_sex &lt;chr&gt; |\n|---|---|---|---|---|\n| A375     | tumor  | skin                               | malignant melanoma                                   | F       |\n| A549     | tumor  | lung                               | non small cell lung cancer| carcinoma                | M       |\n| BT20     | tumor  | breast                             | carcinoma                                            | F       |\n| HA1E     | normal | kidney                             | normal kidney                                        | unknown |\n| HCC515   | normal | lung                               | carcinoma                                            | unknown |\n| HEK293T  | normal | kidney                             | embryonal kidney                                     | unknown |\n| HEPG2    | tumor  | liver                              | hepatocellular carcinoma                             | M       |\n| HL60     | tumor  | haematopoietic and lymphoid tissue | acute myelogenous leukemia (AML)| M3 (promyelocytic) | F       |\n| HS578T   | tumor  | breast                             | carcinoma                                            | F       |\n| HT29     | tumor  | large intestine                    | colorectal adenocarcinoma                            | F       |\n| HUH7     | tumor  | liver                              | hepatocellular carcinoma                             | M       |\n| JURKAT   | tumor  | haematopoietic and lymphoid tissue | acute lymphoblastic leukemia (ALL)| T-cell           | M       |\n| MCF10A   | normal | breast                             | epithelial                                           | F       |\n| MCF7     | tumor  | breast                             | adenocarcinoma                                       | F       |\n| MDAMB231 | tumor  | breast                             | adenocarcinoma                                       | F       |\n| NKDBA    | normal | kidney                             | kidney epithelial                                    | M       |\n| NOMO1    | tumor  | haematopoietic and lymphoid tissue | acute myeloid leukemia (AML)                         | F       |\n| PC3      | tumor  | prostate                           | adenocarcinoma                                       | M       |\n| SKBR3    | tumor  | breast                             | adenocarcinoma                                       | F       |\n| THP1     | tumor  | haematopoietic and lymphoid tissue | acute myelogenous leukemia| M5 (monocytic)           | M       |\n| U266     | tumor  | blood                              | myeloman, haematopoietic,lymphoid                    | unknown |\n| U937     | tumor  | haematopoietic and lymphoid tissue | lymphoma| B-cell| non-hodgkin's| histiocytic         | M       |\n| VCAP     | tumor  | prostate                           | carcinoma                                            | M       |\n| NEU      | normal | nervous system                     | unknown                                              | unknown |\n| NPC      | normal | central nervous system             | normal stem fibroblast-derived iPScs                 | unknown |\n| FIBRNPC  | normal | skin                               | unknown                                              | unknown |\n| ASC      | normal | adipose                            | normal primary adipocyte stem cells                  | unknown |\n| CD34     | normal | bone                               | bone marrow                                          | unknown |\n| PHH      | normal | liver                              | normal primary liver                                 | unknown |\n| SKB      | normal | muscle                             | myoblast                                             | unknown |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 30 × 5</caption>\n","<thead>\n","\t<tr><th scope=col>cell_id</th><th scope=col>cell_type</th><th scope=col>primary_site</th><th scope=col>subtype</th><th scope=col>donor_sex</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>A375    </td><td>tumor </td><td>skin                              </td><td>malignant melanoma                                  </td><td>F      </td></tr>\n","\t<tr><td>A549    </td><td>tumor </td><td>lung                              </td><td>non small cell lung cancer| carcinoma               </td><td>M      </td></tr>\n","\t<tr><td>BT20    </td><td>tumor </td><td>breast                            </td><td>carcinoma                                           </td><td>F      </td></tr>\n","\t<tr><td>HA1E    </td><td>normal</td><td>kidney                            </td><td>normal kidney                                       </td><td>unknown</td></tr>\n","\t<tr><td>HCC515  </td><td>normal</td><td>lung                              </td><td>carcinoma                                           </td><td>unknown</td></tr>\n","\t<tr><td>HEK293T </td><td>normal</td><td>kidney                            </td><td>embryonal kidney                                    </td><td>unknown</td></tr>\n","\t<tr><td>HEPG2   </td><td>tumor </td><td>liver                             </td><td>hepatocellular carcinoma                            </td><td>M      </td></tr>\n","\t<tr><td>HL60    </td><td>tumor </td><td>haematopoietic and lymphoid tissue</td><td>acute myelogenous leukemia (AML)| M3 (promyelocytic)</td><td>F      </td></tr>\n","\t<tr><td>HS578T  </td><td>tumor </td><td>breast                            </td><td>carcinoma                                           </td><td>F      </td></tr>\n","\t<tr><td>HT29    </td><td>tumor </td><td>large intestine                   </td><td>colorectal adenocarcinoma                           </td><td>F      </td></tr>\n","\t<tr><td>HUH7    </td><td>tumor </td><td>liver                             </td><td>hepatocellular carcinoma                            </td><td>M      </td></tr>\n","\t<tr><td>JURKAT  </td><td>tumor </td><td>haematopoietic and lymphoid tissue</td><td>acute lymphoblastic leukemia (ALL)| T-cell          </td><td>M      </td></tr>\n","\t<tr><td>MCF10A  </td><td>normal</td><td>breast                            </td><td>epithelial                                          </td><td>F      </td></tr>\n","\t<tr><td>MCF7    </td><td>tumor </td><td>breast                            </td><td>adenocarcinoma                                      </td><td>F      </td></tr>\n","\t<tr><td>MDAMB231</td><td>tumor </td><td>breast                            </td><td>adenocarcinoma                                      </td><td>F      </td></tr>\n","\t<tr><td>NKDBA   </td><td>normal</td><td>kidney                            </td><td>kidney epithelial                                   </td><td>M      </td></tr>\n","\t<tr><td>NOMO1   </td><td>tumor </td><td>haematopoietic and lymphoid tissue</td><td>acute myeloid leukemia (AML)                        </td><td>F      </td></tr>\n","\t<tr><td>PC3     </td><td>tumor </td><td>prostate                          </td><td>adenocarcinoma                                      </td><td>M      </td></tr>\n","\t<tr><td>SKBR3   </td><td>tumor </td><td>breast                            </td><td>adenocarcinoma                                      </td><td>F      </td></tr>\n","\t<tr><td>THP1    </td><td>tumor </td><td>haematopoietic and lymphoid tissue</td><td>acute myelogenous leukemia| M5 (monocytic)          </td><td>M      </td></tr>\n","\t<tr><td>U266    </td><td>tumor </td><td>blood                             </td><td>myeloman, haematopoietic,lymphoid                   </td><td>unknown</td></tr>\n","\t<tr><td>U937    </td><td>tumor </td><td>haematopoietic and lymphoid tissue</td><td>lymphoma| B-cell| non-hodgkin's| histiocytic        </td><td>M      </td></tr>\n","\t<tr><td>VCAP    </td><td>tumor </td><td>prostate                          </td><td>carcinoma                                           </td><td>M      </td></tr>\n","\t<tr><td>NEU     </td><td>normal</td><td>nervous system                    </td><td>unknown                                             </td><td>unknown</td></tr>\n","\t<tr><td>NPC     </td><td>normal</td><td>central nervous system            </td><td>normal stem fibroblast-derived iPScs                </td><td>unknown</td></tr>\n","\t<tr><td>FIBRNPC </td><td>normal</td><td>skin                              </td><td>unknown                                             </td><td>unknown</td></tr>\n","\t<tr><td>ASC     </td><td>normal</td><td>adipose                           </td><td>normal primary adipocyte stem cells                 </td><td>unknown</td></tr>\n","\t<tr><td>CD34    </td><td>normal</td><td>bone                              </td><td>bone marrow                                         </td><td>unknown</td></tr>\n","\t<tr><td>PHH     </td><td>normal</td><td>liver                             </td><td>normal primary liver                                </td><td>unknown</td></tr>\n","\t<tr><td>SKB     </td><td>normal</td><td>muscle                            </td><td>myoblast                                            </td><td>unknown</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"J_5Ugd49-TQa"},"source":["# Batch processing of GESSs\n","The above 5 GESS methods support searching reference database parallelly by defining the workers parameter, the default is 1. It means that when submitting one query, the parallelization happens on the GES database level where one splits up a single query process into searching several chunks of the database in parallel. Multiple GES queries can also be processed sequentially or in parallel mode. Parallel evaluations can substantially reduce processing times. The parallelization techniques covered in this vignette, are based on utilities of the BiocParallel and batchtools packages. For demonstration purposes the following example uses a small batch query containing several GESs. First, this batch query is processed sequentially without any parallelization using a simple lapply loop. Next, the same query is processed in parallel mode using multiple CPU cores of a single machine. The third option demonstrates how this query can be processed in parallel mode on multiple machines of a computer cluster with a workload management (queueing) system (e.g. Slurm or Torque).\n","\n","## 1. Sequential Processsing\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Hy2zPPJ4-giK","executionInfo":{"status":"ok","timestamp":1636338235486,"user_tz":-480,"elapsed":32748,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"83dc0123-7db5-4e4c-ebb8-4f9902f9e619"},"source":["library(readr)\n","batch_queries <- list(q1=list(upset=c(\"23645\", \"5290\"), downset=c(\"54957\", \"2767\")),\n","                      q2=list(upset=c(\"27101\",\"65083\"), downset=c(\"5813\", \"84\")))\n","refdb <- system.file(\"extdata\", \"sample_db.h5\", package=\"signatureSearch\")\n","gess_list <- lapply(seq_along(batch_queries), function(i){\n","    qsig_lincs <- qSig(query = batch_queries[[i]], \n","                   gess_method=\"LINCS\", refdb=refdb)\n","    lincs <- gess_lincs(qsig_lincs, sortby=\"NCS\", tau=TRUE)\n","    if(!dir.exists(\"batch_res\")){\n","        dir.create(\"batch_res\")\n","    }\n","    write_tsv(result(lincs), paste0(\"batch_res/lincs_res_\", i, \".tsv\"))\n","    return(result(lincs))\n","})"],"execution_count":20,"outputs":[{"output_type":"stream","name":"stderr","text":["2 / 2 genes in up set share identifiers with reference database\n","\n","2 / 2 genes in down set share identifiers with reference database\n","\n","Warning message in .lincsScores(esout = ESout, upset = upset, downset = downset, :\n","“QueryDB and tauRefDB differ by 99.8% of their entries. Accurate tau computation requires close to 0% divergence. \n","”\n","2 / 2 genes in up set share identifiers with reference database\n","\n","1 / 2 genes in down set share identifiers with reference database\n","\n","Warning message in .lincsScores(esout = ESout, upset = upset, downset = downset, :\n","“QueryDB and tauRefDB differ by 99.8% of their entries. Accurate tau computation requires close to 0% divergence. \n","”\n"]}]},{"cell_type":"markdown","metadata":{"id":"XfoYrs4Z-hDB"},"source":["## 2. Parallelization with Multiple CPU Cores\n","The GESSs from the previous example can be accelerated by taking advantage of multiple CPU cores available on a single computer system. The parallel evaluation happens in the below bplapply loop defined by the BiocParallel package. For this approach, all processing instructions are encapsulated in a function named f_bp that will be executed in the bplapply loop. As before, the search results are written to tab-delimited tabular files under a directory called batch_res. The name and path of this directory can be changed as needed. For more background information on this and the following parallelization options, users want to consult the vignette of the BiocParallel package."]},{"cell_type":"code","metadata":{"id":"BJibXMr0-nMn","executionInfo":{"status":"ok","timestamp":1636338235487,"user_tz":-480,"elapsed":20,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":["# library(BiocParallel)\n","# f_bp <- function(i){\n","#     qsig_lincs <- qSig(query = batch_queries[[i]], \n","#                    gess_method=\"LINCS\", refdb=refdb)\n","#     lincs <- gess_lincs(qsig_lincs, sortby=\"NCS\", tau=TRUE)\n","#     if(!dir.exists(\"batch_res\")){\n","#         dir.create(\"batch_res\")\n","#     }\n","#     write_tsv(result(lincs), paste0(\"batch_res/lincs_res_\", i, \".tsv\"))\n","#     return(result(lincs))\n","# }\n","# gess_list <- bplapply(seq_along(batch_queries), f_bp, BPPARAM = MulticoreParam(workers = 2))"],"execution_count":21,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"QNA6dDPD-pJG"},"source":["## 3. Parallelization with Multiple Computer Systems\n","In addition to utilizing multiple CPU cores of a single machine, one can further accelerate the processing by taking advantage of multiple computer systems (nodes) available on a computer cluster, where a queueing systems takes care of the load balancing.\n","\n","In the following example, Njobs sets the number of independent processes to be run on the cluster, and ncpus defines the number of CPU cores to be used by each process. The chosen example will run 2 processes each utilizing 4 CPU cores. If batch_queries contains sufficient GESs and the corresponding computing resources are available on a cluster, then the given example process will utilize in total 8 CPU cores. Note, the given sample code will work on most queueing systems as it is based on utilities from the batchtools package. The latter supports template files (*.tmpl) for defining the run parameters of different schedulers. To run this code, one needs to have both a conf file (see .batchtools.conf.R samples here) and a template file (see *.tmpl samples here) for the queueing system available on a cluster. The following example uses the sample conf and template files for the Slurm scheduler.\n","\n","For additional details on parallelizing computations on clusters, users want to consult the vignettes of the batchtools and BiocParallel packages."]},{"cell_type":"code","metadata":{"id":"PiNULPA3-wcf","executionInfo":{"status":"ok","timestamp":1636338235488,"user_tz":-480,"elapsed":17,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":["# library(batchtools)\n","# batch_queries <- list(q1=list(upset=c(\"23645\", \"5290\"), downset=c(\"54957\", \"2767\")),\n","#                       q2=list(upset=c(\"27101\",\"65083\"), downset=c(\"5813\", \"84\")))\n","# refdb <- system.file(\"extdata\", \"sample_db.h5\", package=\"signatureSearch\")\n","\n","# f_bt <- function(i, batch_queries, refdb){\n","#     library(signatureSearch)\n","#     library(readr)\n","#     qsig_lincs <- qSig(query = batch_queries[[i]], \n","#                    gess_method=\"LINCS\", refdb=refdb)\n","#     lincs <- gess_lincs(qsig_lincs, sortby=\"NCS\", tau=TRUE)\n","#     if(!dir.exists(\"batch_res\")){\n","#         dir.create(\"batch_res\")\n","#     }\n","#     write_tsv(result(lincs), paste0(\"batch_res/lincs_res_\", i, \".tsv\"))\n","#     return(result(lincs)) # or return()\n","# }"],"execution_count":22,"outputs":[]},{"cell_type":"code","metadata":{"id":"Y-09av1z-yoT","executionInfo":{"status":"ok","timestamp":1636338235489,"user_tz":-480,"elapsed":16,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":["# file.copy(system.file(\"extdata\", \".batchtools.conf.R\", package=\"signatureSearch\"), \".\")\n","# file.copy(system.file(\"extdata\", \"slurm.tmpl\", package=\"signatureSearch\"), \".\")"],"execution_count":23,"outputs":[]},{"cell_type":"code","metadata":{"id":"gNcV54Gk-0ct","executionInfo":{"status":"ok","timestamp":1636338235494,"user_tz":-480,"elapsed":19,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":["# reg <- makeRegistry(file.dir=\"reg_batch\", conf.file=\".batchtools.conf.R\")\n","# # reg <- loadRegistry(file.dir=\"reg_batch\", conf.file=\".batchtools.conf.R\", writeable=TRUE)\n","# Njobs <- 1:2\n","# ids <- batchMap(fun=f_bt, Njobs, more.args = list(\n","#           batch_queries=batch_queries, refdb=refdb))\n","# submitJobs(ids, reg=reg, resources=list(\n","#       partition=\"intel\", walltime=120, ntasks=1, ncpus=4, memory=10240))\n","# getStatus()\n","# waitForJobs() # Wait until all jobs are completed\n","# res1 <- loadResult(1)\n","# unlink(c(\".batchtools.conf.R\", \"slurm.tmpl\"))\n"],"execution_count":24,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"uPcTFMLE-2dB"},"source":["# Functional Enrichment\n","GESS results are lists of perturbagens (here drugs) ranked by their signature similarity to a GES-Q of interest. Interpreting these search results with respect to the cellular networks and pathways affected by the top ranking drugs is difficult. To overcome this challenge, the knowledge of the target proteins of the top ranking drugs can be used to perform functional enrichment analysis (FEA) based on community annotation systems, such as Gene Ontologies (GO), pathways (e.g. KEGG, Reactome), drug MOAs or Pfam domains. For this, the ranked drug sets are converted into target gene/protein sets to perform Target Set Enrichment Analysis (TSEA) based on a chosen annotation system. Alternatively, the functional annotation categories of the targets can be assigned to the drugs directly to perform Drug Set Enrichment Analysis (DSEA). Although TSEA and DSEA are related, their enrichment results can be distinct. This is mainly due to duplicated targets present in the test sets of the TSEA methods, whereas the drugs in the test sets of DSEA are usually unique. Additional reasons include differences in the universe sizes used for TSEA and DSEA.\n","\n","Importantly, the duplications in the test sets of the TSEA are due to the fact that many drugs share the same target proteins. Standard enrichment methods would eliminate these duplications since they assume uniqueness in the test sets. Removing duplications in TSEA would be inappropriate since it would erase one of the most important pieces of information of this approach. To solve this problem, we have developed and implemented in the signatureSearch package a weighting method for duplicated targets, where the weighting is proportional to the frequency of the targets in the test set.\n","\n","To perform TSEA and DSEA, drug-target annotations are essential. They can be obtained from several sources, including DrugBank, ChEMBL, STITCH, and the Touchstone dataset from the LINCS project (Wishart et al. 2018; Gaulton et al. 2017; Kuhn et al. 2010; Subramanian et al. 2017). Most drug-target annotations provide UniProt identifiers for the target proteins. They can be mapped, if necessary via their encoding genes, to the chosen functional annotation categories, such as GO or KEGG. To minimize bias in TSEA or DSEA, often caused by promiscuous binders, it can be beneficial to remove drugs or targets that bind to large numbers of distinct proteins or drugs, respectively. To conduct TSEA and DSEA efficiently, signatureSearch and its helper package signatureSearchData provide several convenience utilities along with drug-target lookup resources for automating the mapping from drug sets to target sets to functional categories.\n","\n","Note, most FEA tests involving proteins in their test sets are performed on the gene level in signatureSearch. This way one can avoid additional duplications due to many-to-one relationships among proteins and their encoding genes. For this, the corresponding functions in signatureSearch will usually translate target protein sets into their encoding gene sets using identifier mapping resources from R/Bioconductor, such as the org.Hs.eg.db annotation package. Because of this as well as simplicity, the text in the vignette and help files of this package will refer to the targets of drugs almost interchangeably as proteins or genes, even though the former are the direct targets and the latter only the indirect targets of drugs.\n","\n","\n","## 1. TSEA\n","- perform TSEA on drug-based GESS results using as functional annotation systems GO, KEGG and Reactome pathways. The enrichment tests are performed w/ 3 widely used algos that have been modified in `signatureSearch` to take advantage of duplication information present in the test sets used for TSEA.\n","\n","### Hypergeometric test\n","$p = \\sum_{k = x}^n \\frac{{D \\choose k} {N-D \\choose n-k}}{N \\choose n}$\n","In case of GO term enrichment analysis the individual variables are assigned the following components. N\n"," is the total number of genes/proteins contained in the entire annotation universe; D\n"," is the number of genes annotated at a specific GO node; n\n"," is the total number of genes in the test set; and x\n"," is the number of genes in the test set annotated at a specific GO node. To maintain the duplication information in the test sets used for TSEA, the values of n\n"," and x\n"," in the above equation are adjusted by the frequency of the target proteins in the test set. Effectively, the approach removes the duplications, but maintains their frequency information in form of weighting values."]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"KOUh8eZJ35eu","executionInfo":{"status":"ok","timestamp":1636338266467,"user_tz":-480,"elapsed":30991,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"dff7f5dc-0514-4939-8687-4ffbce98d5ac"},"source":["BiocManager::install('org.Hs.eg.db')"],"execution_count":25,"outputs":[{"output_type":"stream","name":"stderr","text":["'getOption(\"repos\")' replaces Bioconductor standard repositories, see\n","'?repositories' for details\n","\n","replacement repositories:\n","    CRAN: https://cran.rstudio.com\n","\n","\n","Bioconductor version 3.14 (BiocManager 1.30.16), R 4.1.1 (2021-08-10)\n","\n","Installing package(s) 'org.Hs.eg.db'\n","\n","Old packages: 'signatureSearch', 'broom', 'cpp11', 'gert', 'glue', 'openssl',\n","  'sessioninfo', 'tibble', 'tinytex', 'uuid', 'xfun', 'nlme'\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":543},"id":"DKcM8j7d34TW","executionInfo":{"status":"ok","timestamp":1636338274309,"user_tz":-480,"elapsed":7847,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"59a71e4f-2ef7-44ab-d74c-07b921ad95c5"},"source":["# with GO\n","drugs <- unique(result(lincs)$pert[1:10])\n","dup_hyperG_res <- tsea_dup_hyperG(drugs = drugs, universe = \"Default\", \n","                                  type = \"GO\", ont=\"MF\", pvalueCutoff=0.05, \n","                                  pAdjustMethod=\"BH\", qvalueCutoff = 0.1, \n","                                  minGSSize = 10, maxGSSize = 500)\n","dup_hyperG_res"],"execution_count":26,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n","Loading required package: org.Hs.eg.db\n","\n","Loading required package: AnnotationDbi\n","\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["#\n","# Functional Enrichment Analysis \n","#\n","#...@organism \t Homo sapiens \n","#...@ontology \t MF \n","#...@drugs \t chr [1:10] \"vorinostat\" \"trichostatin-a\" \"hc-toxin\" \"pyroxamide\" ...\n","#...@targets \t chr [1:41] \"HDAC1\" \"HDAC10\" \"HDAC11\" \"HDAC2\" \"HDAC3\" \"HDAC4\" \"HDAC5\" ...\n","#...71 enriched terms found\n","\u001b[90m# A tibble: 71 × 10\u001b[39m\n","   ont   ID     Description  GeneRatio BgRatio   pvalue p.adjust   qvalue itemID\n","   \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m  \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m        \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m     \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m      \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m    \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m    \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \n","\u001b[90m 1\u001b[39m MF    GO:00… NAD-depende… 26/41     16/193… 0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    HDAC1…\n","\u001b[90m 2\u001b[39m MF    GO:00… histone dea… 26/41     11/193… 0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    HDAC1…\n","\u001b[90m 3\u001b[39m MF    GO:00… NAD-depende… 26/41     11/193… 0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    HDAC1…\n","\u001b[90m 4\u001b[39m MF    GO:00… NAD-depende… 26/41     17/193… 0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    0   \u001b[90m \u001b[39m    HDAC1…\n","\u001b[90m 5\u001b[39m MF    GO:00… histone dea… 26/41     44/193… 9.55\u001b[90me\u001b[39m\u001b[31m-63\u001b[39m 1.65\u001b[90me\u001b[39m\u001b[31m-60\u001b[39m 5.49\u001b[90me\u001b[39m\u001b[31m-61\u001b[39m HDAC1…\n","\u001b[90m 6\u001b[39m MF    GO:00… protein dea… 26/41     45/193… 2.26\u001b[90me\u001b[39m\u001b[31m-62\u001b[39m 3.41\u001b[90me\u001b[39m\u001b[31m-60\u001b[39m 1.14\u001b[90me\u001b[39m\u001b[31m-60\u001b[39m HDAC1…\n","\u001b[90m 7\u001b[39m MF    GO:00… deacetylase… 26/41     58/193… 2.03\u001b[90me\u001b[39m\u001b[31m-58\u001b[39m 2.72\u001b[90me\u001b[39m\u001b[31m-56\u001b[39m 9.08\u001b[90me\u001b[39m\u001b[31m-57\u001b[39m HDAC1…\n","\u001b[90m 8\u001b[39m MF    GO:00… hydrolase a… 26/41     89/193… 1.85\u001b[90me\u001b[39m\u001b[31m-52\u001b[39m 1.86\u001b[90me\u001b[39m\u001b[31m-50\u001b[39m 6.20\u001b[90me\u001b[39m\u001b[31m-51\u001b[39m HDAC1…\n","\u001b[90m 9\u001b[39m MF    GO:00… hydrolase a… 26/41     147/19… 4.54\u001b[90me\u001b[39m\u001b[31m-46\u001b[39m 3.42\u001b[90me\u001b[39m\u001b[31m-44\u001b[39m 1.14\u001b[90me\u001b[39m\u001b[31m-44\u001b[39m HDAC1…\n","\u001b[90m10\u001b[39m MF    GO:00… histone dea… 20/41     112/19… 7.39\u001b[90me\u001b[39m\u001b[31m-35\u001b[39m 5.24\u001b[90me\u001b[39m\u001b[31m-33\u001b[39m 1.75\u001b[90me\u001b[39m\u001b[31m-33\u001b[39m HDAC1…\n","\u001b[90m# … with 61 more rows, and 1 more variable: Count <int>\u001b[39m"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"uLbi77pj4RDH","executionInfo":{"status":"ok","timestamp":1636338274310,"user_tz":-480,"elapsed":11,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"abb0e3aa-79b8-4e90-dce6-321a798f93f0"},"source":["result(dup_hyperG_res)"],"execution_count":27,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ont ID        \n","1  MF  GO:0017136\n","2  MF  GO:0031078\n","3  MF  GO:0032041\n","4  MF  GO:0034979\n","5  MF  GO:0004407\n","6  MF  GO:0033558\n","7  MF  GO:0019213\n","8  MF  GO:0016811\n","9  MF  GO:0016810\n","10 MF  GO:0042826\n","11 MF  GO:0070491\n","12 MF  GO:0051059\n","13 MF  GO:0005200\n","14 MF  GO:0003714\n","15 MF  GO:1990841\n","16 MF  GO:0001085\n","17 MF  GO:0033613\n","18 MF  GO:0003924\n","19 MF  GO:0031072\n","20 MF  GO:0001103\n","21 MF  GO:0051879\n","22 MF  GO:0005525\n","23 MF  GO:0032550\n","24 MF  GO:0001883\n","25 MF  GO:0032549\n","26 MF  GO:0001882\n","27 MF  GO:0019001\n","28 MF  GO:0032561\n","29 MF  GO:0005080\n","30 MF  GO:0031492\n","⋮  ⋮   ⋮         \n","42 MF  GO:0070840\n","43 MF  GO:0051787\n","44 MF  GO:0030332\n","45 MF  GO:0043014\n","46 MF  GO:0048487\n","47 MF  GO:0030544\n","48 MF  GO:0047485\n","49 MF  GO:0031593\n","50 MF  GO:0030955\n","51 MF  GO:0031625\n","52 MF  GO:0044389\n","53 MF  GO:0031420\n","54 MF  GO:0043130\n","55 MF  GO:0008013\n","56 MF  GO:0042288\n","57 MF  GO:0032182\n","58 MF  GO:0071889\n","59 MF  GO:0042287\n","60 MF  GO:0140030\n","61 MF  GO:0008227\n","62 MF  GO:0003725\n","63 MF  GO:0019787\n","64 MF  GO:0008017\n","65 MF  GO:0004952\n","66 MF  GO:0008239\n","67 MF  GO:0030594\n","68 MF  GO:0031404\n","69 MF  GO:0032794\n","70 MF  GO:0035240\n","71 MF  GO:0031434\n","   Description                                                                            \n","1  NAD-dependent histone deacetylase activity                                             \n","2  histone deacetylase activity (H3-K14 specific)                                         \n","3  NAD-dependent histone deacetylase activity (H3-K14 specific)                           \n","4  NAD-dependent protein deacetylase activity                                             \n","5  histone deacetylase activity                                                           \n","6  protein deacetylase activity                                                           \n","7  deacetylase activity                                                                   \n","8  hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides\n","9  hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  \n","10 histone deacetylase binding                                                            \n","11 repressing transcription factor binding                                                \n","12 NF-kappaB binding                                                                      \n","13 structural constituent of cytoskeleton                                                 \n","14 transcription corepressor activity                                                     \n","15 promoter-specific chromatin binding                                                    \n","16 RNA polymerase II transcription factor binding                                         \n","17 activating transcription factor binding                                                \n","18 GTPase activity                                                                        \n","19 heat shock protein binding                                                             \n","20 RNA polymerase II repressing transcription factor binding                              \n","21 Hsp90 protein binding                                                                  \n","22 GTP binding                                                                            \n","23 purine ribonucleoside binding                                                          \n","24 purine nucleoside binding                                                              \n","25 ribonucleoside binding                                                                 \n","26 nucleoside binding                                                                     \n","27 guanyl nucleotide binding                                                              \n","28 guanyl ribonucleotide binding                                                          \n","29 protein kinase C binding                                                               \n","30 nucleosomal DNA binding                                                                \n","⋮  ⋮                                                                                      \n","42 dynein complex binding                                                                 \n","43 misfolded protein binding                                                              \n","44 cyclin binding                                                                         \n","45 alpha-tubulin binding                                                                  \n","46 beta-tubulin binding                                                                   \n","47 Hsp70 protein binding                                                                  \n","48 protein N-terminus binding                                                             \n","49 polyubiquitin modification-dependent protein binding                                   \n","50 potassium ion binding                                                                  \n","51 ubiquitin protein ligase binding                                                       \n","52 ubiquitin-like protein ligase binding                                                  \n","53 alkali metal ion binding                                                               \n","54 ubiquitin binding                                                                      \n","55 beta-catenin binding                                                                   \n","56 MHC class I protein binding                                                            \n","57 ubiquitin-like protein binding                                                         \n","58 14-3-3 protein binding                                                                 \n","59 MHC protein binding                                                                    \n","60 modification-dependent protein binding                                                 \n","61 G protein-coupled amine receptor activity                                              \n","62 double-stranded RNA binding                                                            \n","63 ubiquitin-like protein transferase activity                                            \n","64 microtubule binding                                                                    \n","65 dopamine neurotransmitter receptor activity                                            \n","66 dipeptidyl-peptidase activity                                                          \n","67 neurotransmitter receptor activity                                                     \n","68 chloride ion binding                                                                   \n","69 GTPase activating protein binding                                                      \n","70 dopamine binding                                                                       \n","71 mitogen-activated protein kinase kinase binding                                        \n","   GeneRatio BgRatio   pvalue       p.adjust     qvalue      \n","1  26/41     16/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","2  26/41     11/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","3  26/41     11/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","4  26/41     17/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","5  26/41     44/19330  9.549739e-63 1.645284e-60 5.485715e-61\n","6  26/41     45/19330  2.260086e-62 3.407080e-60 1.135991e-60\n","7  26/41     58/19330  2.033182e-58 2.724464e-56 9.083926e-57\n","8  26/41     89/19330  1.851535e-52 1.860793e-50 6.204266e-51\n","9  26/41     147/19330 4.542664e-46 3.424033e-44 1.141643e-44\n","10 20/41     112/19330 7.392545e-35 5.244358e-33 1.748577e-33\n","11 14/41     74/19330  1.279829e-24 7.717370e-23 2.573130e-23\n","12 9/41      28/19330  2.269604e-18 1.140476e-16 3.802581e-17\n","13 11/41     102/19330 1.405575e-16 6.519707e-15 2.173805e-15\n","14 13/41     238/19330 1.396793e-15 6.239009e-14 2.080214e-14\n","15 8/41      46/19330  4.874841e-14 2.099664e-12 7.000712e-13\n","16 10/41     140/19330 2.655530e-13 8.655593e-12 2.885953e-12\n","17 8/41      76/19330  3.365547e-12 9.224657e-11 3.075691e-11\n","18 11/41     300/19330 2.189293e-11 5.739754e-10 1.913752e-10\n","19 8/41      115/19330 9.948535e-11 2.399587e-09 8.000717e-10\n","20 6/41      38/19330  1.631406e-10 3.451711e-09 1.150872e-09\n","21 6/41      38/19330  1.631406e-10 3.451711e-09 1.150872e-09\n","22 11/41     374/19330 2.308380e-10 4.639844e-09 1.547020e-09\n","23 11/41     379/19330 2.657502e-10 5.254013e-09 1.751796e-09\n","24 11/41     382/19330 2.889095e-10 5.586183e-09 1.862548e-09\n","25 11/41     383/19330 2.970231e-10 5.597030e-09 1.866165e-09\n","26 11/41     390/19330 3.598012e-10 6.675696e-09 2.225815e-09\n","27 11/41     395/19330 4.116912e-10 7.410441e-09 2.470794e-09\n","28 11/41     395/19330 4.116912e-10 7.410441e-09 2.470794e-09\n","29 6/41      49/19330  8.123547e-10 1.419855e-08 4.734088e-09\n","30 6/41      55/19330  1.668447e-09 2.834011e-08 9.449175e-09\n","⋮  ⋮         ⋮         ⋮            ⋮            ⋮           \n","42 3/41      22/19330  1.326265e-05 7.544697e-05 2.515558e-05\n","43 3/41      23/19330  1.522958e-05 8.565297e-05 2.855846e-05\n","44 3/41      29/19330  3.114567e-05 1.558576e-04 5.196612e-05\n","45 3/41      34/19330  5.063157e-05 2.394575e-04 7.984008e-05\n","46 3/41      36/19330  6.023495e-05 2.793975e-04 9.315689e-05\n","47 3/41      38/19330  7.095902e-05 3.181286e-04 1.060706e-04\n","48 4/41      107/19330 7.675591e-05 3.378523e-04 1.126469e-04\n","49 3/41      46/19330  1.261906e-04 5.039269e-04 1.680196e-04\n","50 2/41      10/19330  1.954071e-04 7.434101e-04 2.478682e-04\n","51 5/41      285/19330 3.264486e-04 1.154537e-03 3.849463e-04\n","52 5/41      300/19330 4.129095e-04 1.364298e-03 4.548851e-04\n","53 2/41      15/19330  4.528955e-04 1.478760e-03 4.930491e-04\n","54 3/41      73/19330  4.969016e-04 1.598036e-03 5.328180e-04\n","55 3/41      82/19330  6.982367e-04 2.058859e-03 6.864662e-04\n","56 2/41      19/19330  7.336193e-04 2.147439e-03 7.160005e-04\n","57 3/41      91/19330  9.452529e-04 2.707779e-03 9.028294e-04\n","58 2/41      28/19330  1.602210e-03 4.191465e-03 1.397521e-03\n","59 2/41      35/19330  2.498434e-03 6.136683e-03 2.046097e-03\n","60 3/41      142/19330 3.373227e-03 8.023889e-03 2.675330e-03\n","61 2/41      59/19330  6.957486e-03 1.485904e-02 4.954310e-03\n","62 2/41      75/19330  1.104565e-02 2.209130e-02 7.365695e-03\n","63 4/41      417/19330 1.152057e-02 2.292708e-02 7.644362e-03\n","64 3/41      238/19330 1.392617e-02 2.678622e-02 8.931077e-03\n","65 1/41      10/19330  2.101409e-02 3.732400e-02 1.244459e-02\n","66 1/41      12/19330  2.516491e-02 4.274490e-02 1.425203e-02\n","67 2/41      117/19330 2.554432e-02 4.326749e-02 1.442627e-02\n","68 1/41      13/19330  2.723387e-02 4.555346e-02 1.518846e-02\n","69 1/41      13/19330  2.723387e-02 4.555346e-02 1.518846e-02\n","70 1/41      13/19330  2.723387e-02 4.555346e-02 1.518846e-02\n","71 1/41      14/19330  2.929855e-02 4.820471e-02 1.607244e-02\n","   itemID                                                                                                                                                        \n","1  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","2  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","3  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","4  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","5  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","6  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","7  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","8  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","9  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","10 HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6                                     \n","11 HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC1                                                                           \n","12 HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         \n","13 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","14 HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC1/HDAC3                                                                                 \n","15 HDAC1/HDAC2/HDAC4/HDAC1/HDAC2/HDAC4/HDAC1/HDAC1                                                                                                               \n","16 HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                   \n","17 HDAC1/HDAC4/HDAC7/HDAC1/HDAC4/HDAC7/HDAC1/HDAC1                                                                                                               \n","18 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","19 HDAC2/HDAC6/HDAC8/HDAC2/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                               \n","20 HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                           \n","21 HDAC6/HDAC8/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                           \n","22 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","23 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","24 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","25 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","26 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","27 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","28 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       \n","29 HDAC5/HDAC7/HDAC9/HDAC5/HDAC7/HDAC9                                                                                                                           \n","30 HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                           \n","⋮  ⋮                                                                                                                                                             \n","42 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","43 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","44 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","45 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","46 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","47 HDAC8/HDAC8/HDAC8                                                                                                                                             \n","48 HDAC1/HDAC1/HDAC1/HDAC1                                                                                                                                       \n","49 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","50 HDAC4/HDAC4                                                                                                                                                   \n","51 HDAC6/HDAC6/HDAC6/TUBA1B/TUBB                                                                                                                                 \n","52 HDAC6/HDAC6/HDAC6/TUBA1B/TUBB                                                                                                                                 \n","53 HDAC4/HDAC4                                                                                                                                                   \n","54 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","55 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","56 TUBB/TUBB4B                                                                                                                                                   \n","57 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","58 HDAC7/HDAC7                                                                                                                                                   \n","59 TUBB/TUBB4B                                                                                                                                                   \n","60 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","61 ADRA1A/HRH1                                                                                                                                                   \n","62 TUBA1B/TUBB4B                                                                                                                                                 \n","63 HDAC4/HDAC7/HDAC4/HDAC7                                                                                                                                       \n","64 HDAC6/HDAC6/HDAC6                                                                                                                                             \n","65 DRD1                                                                                                                                                          \n","66 ACE                                                                                                                                                           \n","67 DRD1/HRH1                                                                                                                                                     \n","68 ACE                                                                                                                                                           \n","69 TUBB                                                                                                                                                          \n","70 DRD1                                                                                                                                                          \n","71 ACE                                                                                                                                                           \n","   Count\n","1  26   \n","2  26   \n","3  26   \n","4  26   \n","5  26   \n","6  26   \n","7  26   \n","8  26   \n","9  26   \n","10 20   \n","11 14   \n","12  9   \n","13 11   \n","14 13   \n","15  8   \n","16 10   \n","17  8   \n","18 11   \n","19  8   \n","20  6   \n","21  6   \n","22 11   \n","23 11   \n","24 11   \n","25 11   \n","26 11   \n","27 11   \n","28 11   \n","29  6   \n","30  6   \n","⋮  ⋮    \n","42 3    \n","43 3    \n","44 3    \n","45 3    \n","46 3    \n","47 3    \n","48 4    \n","49 3    \n","50 2    \n","51 5    \n","52 5    \n","53 2    \n","54 3    \n","55 3    \n","56 2    \n","57 3    \n","58 2    \n","59 2    \n","60 3    \n","61 2    \n","62 2    \n","63 4    \n","64 3    \n","65 1    \n","66 1    \n","67 2    \n","68 1    \n","69 1    \n","70 1    \n","71 1    "],"text/latex":"A tibble: 71 × 10\n\\begin{tabular}{llllllllll}\n ont & ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <int>\\\\\n\\hline\n\t MF & GO:0017136 & NAD-dependent histone deacetylase activity                                              & 26/41 & 16/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0031078 & histone deacetylase activity (H3-K14 specific)                                          & 26/41 & 11/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0032041 & NAD-dependent histone deacetylase activity (H3-K14 specific)                            & 26/41 & 11/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0034979 & NAD-dependent protein deacetylase activity                                              & 26/41 & 17/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0004407 & histone deacetylase activity                                                            & 26/41 & 44/19330  & 9.549739e-63 & 1.645284e-60 & 5.485715e-61 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0033558 & protein deacetylase activity                                                            & 26/41 & 45/19330  & 2.260086e-62 & 3.407080e-60 & 1.135991e-60 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0019213 & deacetylase activity                                                                    & 26/41 & 58/19330  & 2.033182e-58 & 2.724464e-56 & 9.083926e-57 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0016811 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides & 26/41 & 89/19330  & 1.851535e-52 & 1.860793e-50 & 6.204266e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0016810 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   & 26/41 & 147/19330 & 4.542664e-46 & 3.424033e-44 & 1.141643e-44 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t MF & GO:0042826 & histone deacetylase binding                                                             & 20/41 & 112/19330 & 7.392545e-35 & 5.244358e-33 & 1.748577e-33 & HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6                                      & 20\\\\\n\t MF & GO:0070491 & repressing transcription factor binding                                                 & 14/41 & 74/19330  & 1.279829e-24 & 7.717370e-23 & 2.573130e-23 & HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC1                                                                            & 14\\\\\n\t MF & GO:0051059 & NF-kappaB binding                                                                       & 9/41  & 28/19330  & 2.269604e-18 & 1.140476e-16 & 3.802581e-17 & HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          &  9\\\\\n\t MF & GO:0005200 & structural constituent of cytoskeleton                                                  & 11/41 & 102/19330 & 1.405575e-16 & 6.519707e-15 & 2.173805e-15 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0003714 & transcription corepressor activity                                                      & 13/41 & 238/19330 & 1.396793e-15 & 6.239009e-14 & 2.080214e-14 & HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC1/HDAC3                                                                                  & 13\\\\\n\t MF & GO:1990841 & promoter-specific chromatin binding                                                     & 8/41  & 46/19330  & 4.874841e-14 & 2.099664e-12 & 7.000712e-13 & HDAC1/HDAC2/HDAC4/HDAC1/HDAC2/HDAC4/HDAC1/HDAC1                                                                                                                &  8\\\\\n\t MF & GO:0001085 & RNA polymerase II transcription factor binding                                          & 10/41 & 140/19330 & 2.655530e-13 & 8.655593e-12 & 2.885953e-12 & HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                    & 10\\\\\n\t MF & GO:0033613 & activating transcription factor binding                                                 & 8/41  & 76/19330  & 3.365547e-12 & 9.224657e-11 & 3.075691e-11 & HDAC1/HDAC4/HDAC7/HDAC1/HDAC4/HDAC7/HDAC1/HDAC1                                                                                                                &  8\\\\\n\t MF & GO:0003924 & GTPase activity                                                                         & 11/41 & 300/19330 & 2.189293e-11 & 5.739754e-10 & 1.913752e-10 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0031072 & heat shock protein binding                                                              & 8/41  & 115/19330 & 9.948535e-11 & 2.399587e-09 & 8.000717e-10 & HDAC2/HDAC6/HDAC8/HDAC2/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                &  8\\\\\n\t MF & GO:0001103 & RNA polymerase II repressing transcription factor binding                               & 6/41  & 38/19330  & 1.631406e-10 & 3.451711e-09 & 1.150872e-09 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                            &  6\\\\\n\t MF & GO:0051879 & Hsp90 protein binding                                                                   & 6/41  & 38/19330  & 1.631406e-10 & 3.451711e-09 & 1.150872e-09 & HDAC6/HDAC8/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                            &  6\\\\\n\t MF & GO:0005525 & GTP binding                                                                             & 11/41 & 374/19330 & 2.308380e-10 & 4.639844e-09 & 1.547020e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0032550 & purine ribonucleoside binding                                                           & 11/41 & 379/19330 & 2.657502e-10 & 5.254013e-09 & 1.751796e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0001883 & purine nucleoside binding                                                               & 11/41 & 382/19330 & 2.889095e-10 & 5.586183e-09 & 1.862548e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0032549 & ribonucleoside binding                                                                  & 11/41 & 383/19330 & 2.970231e-10 & 5.597030e-09 & 1.866165e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0001882 & nucleoside binding                                                                      & 11/41 & 390/19330 & 3.598012e-10 & 6.675696e-09 & 2.225815e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0019001 & guanyl nucleotide binding                                                               & 11/41 & 395/19330 & 4.116912e-10 & 7.410441e-09 & 2.470794e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0032561 & guanyl ribonucleotide binding                                                           & 11/41 & 395/19330 & 4.116912e-10 & 7.410441e-09 & 2.470794e-09 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        & 11\\\\\n\t MF & GO:0005080 & protein kinase C binding                                                                & 6/41  & 49/19330  & 8.123547e-10 & 1.419855e-08 & 4.734088e-09 & HDAC5/HDAC7/HDAC9/HDAC5/HDAC7/HDAC9                                                                                                                            &  6\\\\\n\t MF & GO:0031492 & nucleosomal DNA binding                                                                 & 6/41  & 55/19330  & 1.668447e-09 & 2.834011e-08 & 9.449175e-09 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                            &  6\\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t MF & GO:0070840 & dynein complex binding                               & 3/41 & 22/19330  & 1.326265e-05 & 7.544697e-05 & 2.515558e-05 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0051787 & misfolded protein binding                            & 3/41 & 23/19330  & 1.522958e-05 & 8.565297e-05 & 2.855846e-05 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0030332 & cyclin binding                                       & 3/41 & 29/19330  & 3.114567e-05 & 1.558576e-04 & 5.196612e-05 & HDAC3/HDAC3/HDAC3             & 3\\\\\n\t MF & GO:0043014 & alpha-tubulin binding                                & 3/41 & 34/19330  & 5.063157e-05 & 2.394575e-04 & 7.984008e-05 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0048487 & beta-tubulin binding                                 & 3/41 & 36/19330  & 6.023495e-05 & 2.793975e-04 & 9.315689e-05 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0030544 & Hsp70 protein binding                                & 3/41 & 38/19330  & 7.095902e-05 & 3.181286e-04 & 1.060706e-04 & HDAC8/HDAC8/HDAC8             & 3\\\\\n\t MF & GO:0047485 & protein N-terminus binding                           & 4/41 & 107/19330 & 7.675591e-05 & 3.378523e-04 & 1.126469e-04 & HDAC1/HDAC1/HDAC1/HDAC1       & 4\\\\\n\t MF & GO:0031593 & polyubiquitin modification-dependent protein binding & 3/41 & 46/19330  & 1.261906e-04 & 5.039269e-04 & 1.680196e-04 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0030955 & potassium ion binding                                & 2/41 & 10/19330  & 1.954071e-04 & 7.434101e-04 & 2.478682e-04 & HDAC4/HDAC4                   & 2\\\\\n\t MF & GO:0031625 & ubiquitin protein ligase binding                     & 5/41 & 285/19330 & 3.264486e-04 & 1.154537e-03 & 3.849463e-04 & HDAC6/HDAC6/HDAC6/TUBA1B/TUBB & 5\\\\\n\t MF & GO:0044389 & ubiquitin-like protein ligase binding                & 5/41 & 300/19330 & 4.129095e-04 & 1.364298e-03 & 4.548851e-04 & HDAC6/HDAC6/HDAC6/TUBA1B/TUBB & 5\\\\\n\t MF & GO:0031420 & alkali metal ion binding                             & 2/41 & 15/19330  & 4.528955e-04 & 1.478760e-03 & 4.930491e-04 & HDAC4/HDAC4                   & 2\\\\\n\t MF & GO:0043130 & ubiquitin binding                                    & 3/41 & 73/19330  & 4.969016e-04 & 1.598036e-03 & 5.328180e-04 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0008013 & beta-catenin binding                                 & 3/41 & 82/19330  & 6.982367e-04 & 2.058859e-03 & 6.864662e-04 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0042288 & MHC class I protein binding                          & 2/41 & 19/19330  & 7.336193e-04 & 2.147439e-03 & 7.160005e-04 & TUBB/TUBB4B                   & 2\\\\\n\t MF & GO:0032182 & ubiquitin-like protein binding                       & 3/41 & 91/19330  & 9.452529e-04 & 2.707779e-03 & 9.028294e-04 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0071889 & 14-3-3 protein binding                               & 2/41 & 28/19330  & 1.602210e-03 & 4.191465e-03 & 1.397521e-03 & HDAC7/HDAC7                   & 2\\\\\n\t MF & GO:0042287 & MHC protein binding                                  & 2/41 & 35/19330  & 2.498434e-03 & 6.136683e-03 & 2.046097e-03 & TUBB/TUBB4B                   & 2\\\\\n\t MF & GO:0140030 & modification-dependent protein binding               & 3/41 & 142/19330 & 3.373227e-03 & 8.023889e-03 & 2.675330e-03 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0008227 & G protein-coupled amine receptor activity            & 2/41 & 59/19330  & 6.957486e-03 & 1.485904e-02 & 4.954310e-03 & ADRA1A/HRH1                   & 2\\\\\n\t MF & GO:0003725 & double-stranded RNA binding                          & 2/41 & 75/19330  & 1.104565e-02 & 2.209130e-02 & 7.365695e-03 & TUBA1B/TUBB4B                 & 2\\\\\n\t MF & GO:0019787 & ubiquitin-like protein transferase activity          & 4/41 & 417/19330 & 1.152057e-02 & 2.292708e-02 & 7.644362e-03 & HDAC4/HDAC7/HDAC4/HDAC7       & 4\\\\\n\t MF & GO:0008017 & microtubule binding                                  & 3/41 & 238/19330 & 1.392617e-02 & 2.678622e-02 & 8.931077e-03 & HDAC6/HDAC6/HDAC6             & 3\\\\\n\t MF & GO:0004952 & dopamine neurotransmitter receptor activity          & 1/41 & 10/19330  & 2.101409e-02 & 3.732400e-02 & 1.244459e-02 & DRD1                          & 1\\\\\n\t MF & GO:0008239 & dipeptidyl-peptidase activity                        & 1/41 & 12/19330  & 2.516491e-02 & 4.274490e-02 & 1.425203e-02 & ACE                           & 1\\\\\n\t MF & GO:0030594 & neurotransmitter receptor activity                   & 2/41 & 117/19330 & 2.554432e-02 & 4.326749e-02 & 1.442627e-02 & DRD1/HRH1                     & 2\\\\\n\t MF & GO:0031404 & chloride ion binding                                 & 1/41 & 13/19330  & 2.723387e-02 & 4.555346e-02 & 1.518846e-02 & ACE                           & 1\\\\\n\t MF & GO:0032794 & GTPase activating protein binding                    & 1/41 & 13/19330  & 2.723387e-02 & 4.555346e-02 & 1.518846e-02 & TUBB                          & 1\\\\\n\t MF & GO:0035240 & dopamine binding                                     & 1/41 & 13/19330  & 2.723387e-02 & 4.555346e-02 & 1.518846e-02 & DRD1                          & 1\\\\\n\t MF & GO:0031434 & mitogen-activated protein kinase kinase binding      & 1/41 & 14/19330  & 2.929855e-02 & 4.820471e-02 & 1.607244e-02 & ACE                           & 1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 71 × 10\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| MF | GO:0017136 | NAD-dependent histone deacetylase activity                                              | 26/41 | 16/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0031078 | histone deacetylase activity (H3-K14 specific)                                          | 26/41 | 11/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific)                            | 26/41 | 11/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0034979 | NAD-dependent protein deacetylase activity                                              | 26/41 | 17/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0004407 | histone deacetylase activity                                                            | 26/41 | 44/19330  | 9.549739e-63 | 1.645284e-60 | 5.485715e-61 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0033558 | protein deacetylase activity                                                            | 26/41 | 45/19330  | 2.260086e-62 | 3.407080e-60 | 1.135991e-60 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0019213 | deacetylase activity                                                                    | 26/41 | 58/19330  | 2.033182e-58 | 2.724464e-56 | 9.083926e-57 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 26/41 | 89/19330  | 1.851535e-52 | 1.860793e-50 | 6.204266e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   | 26/41 | 147/19330 | 4.542664e-46 | 3.424033e-44 | 1.141643e-44 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| MF | GO:0042826 | histone deacetylase binding                                                             | 20/41 | 112/19330 | 7.392545e-35 | 5.244358e-33 | 1.748577e-33 | HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6                                      | 20 |\n| MF | GO:0070491 | repressing transcription factor binding                                                 | 14/41 | 74/19330  | 1.279829e-24 | 7.717370e-23 | 2.573130e-23 | HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC1                                                                            | 14 |\n| MF | GO:0051059 | NF-kappaB binding                                                                       | 9/41  | 28/19330  | 2.269604e-18 | 1.140476e-16 | 3.802581e-17 | HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          |  9 |\n| MF | GO:0005200 | structural constituent of cytoskeleton                                                  | 11/41 | 102/19330 | 1.405575e-16 | 6.519707e-15 | 2.173805e-15 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0003714 | transcription corepressor activity                                                      | 13/41 | 238/19330 | 1.396793e-15 | 6.239009e-14 | 2.080214e-14 | HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC1/HDAC3                                                                                  | 13 |\n| MF | GO:1990841 | promoter-specific chromatin binding                                                     | 8/41  | 46/19330  | 4.874841e-14 | 2.099664e-12 | 7.000712e-13 | HDAC1/HDAC2/HDAC4/HDAC1/HDAC2/HDAC4/HDAC1/HDAC1                                                                                                                |  8 |\n| MF | GO:0001085 | RNA polymerase II transcription factor binding                                          | 10/41 | 140/19330 | 2.655530e-13 | 8.655593e-12 | 2.885953e-12 | HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                    | 10 |\n| MF | GO:0033613 | activating transcription factor binding                                                 | 8/41  | 76/19330  | 3.365547e-12 | 9.224657e-11 | 3.075691e-11 | HDAC1/HDAC4/HDAC7/HDAC1/HDAC4/HDAC7/HDAC1/HDAC1                                                                                                                |  8 |\n| MF | GO:0003924 | GTPase activity                                                                         | 11/41 | 300/19330 | 2.189293e-11 | 5.739754e-10 | 1.913752e-10 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0031072 | heat shock protein binding                                                              | 8/41  | 115/19330 | 9.948535e-11 | 2.399587e-09 | 8.000717e-10 | HDAC2/HDAC6/HDAC8/HDAC2/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                |  8 |\n| MF | GO:0001103 | RNA polymerase II repressing transcription factor binding                               | 6/41  | 38/19330  | 1.631406e-10 | 3.451711e-09 | 1.150872e-09 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                            |  6 |\n| MF | GO:0051879 | Hsp90 protein binding                                                                   | 6/41  | 38/19330  | 1.631406e-10 | 3.451711e-09 | 1.150872e-09 | HDAC6/HDAC8/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                            |  6 |\n| MF | GO:0005525 | GTP binding                                                                             | 11/41 | 374/19330 | 2.308380e-10 | 4.639844e-09 | 1.547020e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0032550 | purine ribonucleoside binding                                                           | 11/41 | 379/19330 | 2.657502e-10 | 5.254013e-09 | 1.751796e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0001883 | purine nucleoside binding                                                               | 11/41 | 382/19330 | 2.889095e-10 | 5.586183e-09 | 1.862548e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0032549 | ribonucleoside binding                                                                  | 11/41 | 383/19330 | 2.970231e-10 | 5.597030e-09 | 1.866165e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0001882 | nucleoside binding                                                                      | 11/41 | 390/19330 | 3.598012e-10 | 6.675696e-09 | 2.225815e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0019001 | guanyl nucleotide binding                                                               | 11/41 | 395/19330 | 4.116912e-10 | 7.410441e-09 | 2.470794e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0032561 | guanyl ribonucleotide binding                                                           | 11/41 | 395/19330 | 4.116912e-10 | 7.410441e-09 | 2.470794e-09 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                        | 11 |\n| MF | GO:0005080 | protein kinase C binding                                                                | 6/41  | 49/19330  | 8.123547e-10 | 1.419855e-08 | 4.734088e-09 | HDAC5/HDAC7/HDAC9/HDAC5/HDAC7/HDAC9                                                                                                                            |  6 |\n| MF | GO:0031492 | nucleosomal DNA binding                                                                 | 6/41  | 55/19330  | 1.668447e-09 | 2.834011e-08 | 9.449175e-09 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                            |  6 |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| MF | GO:0070840 | dynein complex binding                               | 3/41 | 22/19330  | 1.326265e-05 | 7.544697e-05 | 2.515558e-05 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0051787 | misfolded protein binding                            | 3/41 | 23/19330  | 1.522958e-05 | 8.565297e-05 | 2.855846e-05 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0030332 | cyclin binding                                       | 3/41 | 29/19330  | 3.114567e-05 | 1.558576e-04 | 5.196612e-05 | HDAC3/HDAC3/HDAC3             | 3 |\n| MF | GO:0043014 | alpha-tubulin binding                                | 3/41 | 34/19330  | 5.063157e-05 | 2.394575e-04 | 7.984008e-05 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0048487 | beta-tubulin binding                                 | 3/41 | 36/19330  | 6.023495e-05 | 2.793975e-04 | 9.315689e-05 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0030544 | Hsp70 protein binding                                | 3/41 | 38/19330  | 7.095902e-05 | 3.181286e-04 | 1.060706e-04 | HDAC8/HDAC8/HDAC8             | 3 |\n| MF | GO:0047485 | protein N-terminus binding                           | 4/41 | 107/19330 | 7.675591e-05 | 3.378523e-04 | 1.126469e-04 | HDAC1/HDAC1/HDAC1/HDAC1       | 4 |\n| MF | GO:0031593 | polyubiquitin modification-dependent protein binding | 3/41 | 46/19330  | 1.261906e-04 | 5.039269e-04 | 1.680196e-04 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0030955 | potassium ion binding                                | 2/41 | 10/19330  | 1.954071e-04 | 7.434101e-04 | 2.478682e-04 | HDAC4/HDAC4                   | 2 |\n| MF | GO:0031625 | ubiquitin protein ligase binding                     | 5/41 | 285/19330 | 3.264486e-04 | 1.154537e-03 | 3.849463e-04 | HDAC6/HDAC6/HDAC6/TUBA1B/TUBB | 5 |\n| MF | GO:0044389 | ubiquitin-like protein ligase binding                | 5/41 | 300/19330 | 4.129095e-04 | 1.364298e-03 | 4.548851e-04 | HDAC6/HDAC6/HDAC6/TUBA1B/TUBB | 5 |\n| MF | GO:0031420 | alkali metal ion binding                             | 2/41 | 15/19330  | 4.528955e-04 | 1.478760e-03 | 4.930491e-04 | HDAC4/HDAC4                   | 2 |\n| MF | GO:0043130 | ubiquitin binding                                    | 3/41 | 73/19330  | 4.969016e-04 | 1.598036e-03 | 5.328180e-04 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0008013 | beta-catenin binding                                 | 3/41 | 82/19330  | 6.982367e-04 | 2.058859e-03 | 6.864662e-04 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0042288 | MHC class I protein binding                          | 2/41 | 19/19330  | 7.336193e-04 | 2.147439e-03 | 7.160005e-04 | TUBB/TUBB4B                   | 2 |\n| MF | GO:0032182 | ubiquitin-like protein binding                       | 3/41 | 91/19330  | 9.452529e-04 | 2.707779e-03 | 9.028294e-04 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0071889 | 14-3-3 protein binding                               | 2/41 | 28/19330  | 1.602210e-03 | 4.191465e-03 | 1.397521e-03 | HDAC7/HDAC7                   | 2 |\n| MF | GO:0042287 | MHC protein binding                                  | 2/41 | 35/19330  | 2.498434e-03 | 6.136683e-03 | 2.046097e-03 | TUBB/TUBB4B                   | 2 |\n| MF | GO:0140030 | modification-dependent protein binding               | 3/41 | 142/19330 | 3.373227e-03 | 8.023889e-03 | 2.675330e-03 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0008227 | G protein-coupled amine receptor activity            | 2/41 | 59/19330  | 6.957486e-03 | 1.485904e-02 | 4.954310e-03 | ADRA1A/HRH1                   | 2 |\n| MF | GO:0003725 | double-stranded RNA binding                          | 2/41 | 75/19330  | 1.104565e-02 | 2.209130e-02 | 7.365695e-03 | TUBA1B/TUBB4B                 | 2 |\n| MF | GO:0019787 | ubiquitin-like protein transferase activity          | 4/41 | 417/19330 | 1.152057e-02 | 2.292708e-02 | 7.644362e-03 | HDAC4/HDAC7/HDAC4/HDAC7       | 4 |\n| MF | GO:0008017 | microtubule binding                                  | 3/41 | 238/19330 | 1.392617e-02 | 2.678622e-02 | 8.931077e-03 | HDAC6/HDAC6/HDAC6             | 3 |\n| MF | GO:0004952 | dopamine neurotransmitter receptor activity          | 1/41 | 10/19330  | 2.101409e-02 | 3.732400e-02 | 1.244459e-02 | DRD1                          | 1 |\n| MF | GO:0008239 | dipeptidyl-peptidase activity                        | 1/41 | 12/19330  | 2.516491e-02 | 4.274490e-02 | 1.425203e-02 | ACE                           | 1 |\n| MF | GO:0030594 | neurotransmitter receptor activity                   | 2/41 | 117/19330 | 2.554432e-02 | 4.326749e-02 | 1.442627e-02 | DRD1/HRH1                     | 2 |\n| MF | GO:0031404 | chloride ion binding                                 | 1/41 | 13/19330  | 2.723387e-02 | 4.555346e-02 | 1.518846e-02 | ACE                           | 1 |\n| MF | GO:0032794 | GTPase activating protein binding                    | 1/41 | 13/19330  | 2.723387e-02 | 4.555346e-02 | 1.518846e-02 | TUBB                          | 1 |\n| MF | GO:0035240 | dopamine binding                                     | 1/41 | 13/19330  | 2.723387e-02 | 4.555346e-02 | 1.518846e-02 | DRD1                          | 1 |\n| MF | GO:0031434 | mitogen-activated protein kinase kinase binding      | 1/41 | 14/19330  | 2.929855e-02 | 4.820471e-02 | 1.607244e-02 | ACE                           | 1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 71 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>MF</td><td>GO:0017136</td><td>NAD-dependent histone deacetylase activity                                             </td><td>26/41</td><td>16/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0031078</td><td>histone deacetylase activity (H3-K14 specific)                                         </td><td>26/41</td><td>11/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0032041</td><td>NAD-dependent histone deacetylase activity (H3-K14 specific)                           </td><td>26/41</td><td>11/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0034979</td><td>NAD-dependent protein deacetylase activity                                             </td><td>26/41</td><td>17/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0004407</td><td>histone deacetylase activity                                                           </td><td>26/41</td><td>44/19330 </td><td>9.549739e-63</td><td>1.645284e-60</td><td>5.485715e-61</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0033558</td><td>protein deacetylase activity                                                           </td><td>26/41</td><td>45/19330 </td><td>2.260086e-62</td><td>3.407080e-60</td><td>1.135991e-60</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0019213</td><td>deacetylase activity                                                                   </td><td>26/41</td><td>58/19330 </td><td>2.033182e-58</td><td>2.724464e-56</td><td>9.083926e-57</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0016811</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</td><td>26/41</td><td>89/19330 </td><td>1.851535e-52</td><td>1.860793e-50</td><td>6.204266e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0016810</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  </td><td>26/41</td><td>147/19330</td><td>4.542664e-46</td><td>3.424033e-44</td><td>1.141643e-44</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>MF</td><td>GO:0042826</td><td>histone deacetylase binding                                                            </td><td>20/41</td><td>112/19330</td><td>7.392545e-35</td><td>5.244358e-33</td><td>1.748577e-33</td><td>HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6                                     </td><td>20</td></tr>\n","\t<tr><td>MF</td><td>GO:0070491</td><td>repressing transcription factor binding                                                </td><td>14/41</td><td>74/19330 </td><td>1.279829e-24</td><td>7.717370e-23</td><td>2.573130e-23</td><td>HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC1/HDAC1                                                                           </td><td>14</td></tr>\n","\t<tr><td>MF</td><td>GO:0051059</td><td>NF-kappaB binding                                                                      </td><td>9/41 </td><td>28/19330 </td><td>2.269604e-18</td><td>1.140476e-16</td><td>3.802581e-17</td><td>HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         </td><td> 9</td></tr>\n","\t<tr><td>MF</td><td>GO:0005200</td><td>structural constituent of cytoskeleton                                                 </td><td>11/41</td><td>102/19330</td><td>1.405575e-16</td><td>6.519707e-15</td><td>2.173805e-15</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0003714</td><td>transcription corepressor activity                                                     </td><td>13/41</td><td>238/19330</td><td>1.396793e-15</td><td>6.239009e-14</td><td>2.080214e-14</td><td>HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC3/HDAC4/HDAC7/HDAC9/HDAC1/HDAC1/HDAC3                                                                                 </td><td>13</td></tr>\n","\t<tr><td>MF</td><td>GO:1990841</td><td>promoter-specific chromatin binding                                                    </td><td>8/41 </td><td>46/19330 </td><td>4.874841e-14</td><td>2.099664e-12</td><td>7.000712e-13</td><td>HDAC1/HDAC2/HDAC4/HDAC1/HDAC2/HDAC4/HDAC1/HDAC1                                                                                                               </td><td> 8</td></tr>\n","\t<tr><td>MF</td><td>GO:0001085</td><td>RNA polymerase II transcription factor binding                                         </td><td>10/41</td><td>140/19330</td><td>2.655530e-13</td><td>8.655593e-12</td><td>2.885953e-12</td><td>HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                   </td><td>10</td></tr>\n","\t<tr><td>MF</td><td>GO:0033613</td><td>activating transcription factor binding                                                </td><td>8/41 </td><td>76/19330 </td><td>3.365547e-12</td><td>9.224657e-11</td><td>3.075691e-11</td><td>HDAC1/HDAC4/HDAC7/HDAC1/HDAC4/HDAC7/HDAC1/HDAC1                                                                                                               </td><td> 8</td></tr>\n","\t<tr><td>MF</td><td>GO:0003924</td><td>GTPase activity                                                                        </td><td>11/41</td><td>300/19330</td><td>2.189293e-11</td><td>5.739754e-10</td><td>1.913752e-10</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0031072</td><td>heat shock protein binding                                                             </td><td>8/41 </td><td>115/19330</td><td>9.948535e-11</td><td>2.399587e-09</td><td>8.000717e-10</td><td>HDAC2/HDAC6/HDAC8/HDAC2/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                               </td><td> 8</td></tr>\n","\t<tr><td>MF</td><td>GO:0001103</td><td>RNA polymerase II repressing transcription factor binding                              </td><td>6/41 </td><td>38/19330 </td><td>1.631406e-10</td><td>3.451711e-09</td><td>1.150872e-09</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                           </td><td> 6</td></tr>\n","\t<tr><td>MF</td><td>GO:0051879</td><td>Hsp90 protein binding                                                                  </td><td>6/41 </td><td>38/19330 </td><td>1.631406e-10</td><td>3.451711e-09</td><td>1.150872e-09</td><td>HDAC6/HDAC8/HDAC6/HDAC8/HDAC6/HDAC8                                                                                                                           </td><td> 6</td></tr>\n","\t<tr><td>MF</td><td>GO:0005525</td><td>GTP binding                                                                            </td><td>11/41</td><td>374/19330</td><td>2.308380e-10</td><td>4.639844e-09</td><td>1.547020e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0032550</td><td>purine ribonucleoside binding                                                          </td><td>11/41</td><td>379/19330</td><td>2.657502e-10</td><td>5.254013e-09</td><td>1.751796e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0001883</td><td>purine nucleoside binding                                                              </td><td>11/41</td><td>382/19330</td><td>2.889095e-10</td><td>5.586183e-09</td><td>1.862548e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0032549</td><td>ribonucleoside binding                                                                 </td><td>11/41</td><td>383/19330</td><td>2.970231e-10</td><td>5.597030e-09</td><td>1.866165e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0001882</td><td>nucleoside binding                                                                     </td><td>11/41</td><td>390/19330</td><td>3.598012e-10</td><td>6.675696e-09</td><td>2.225815e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0019001</td><td>guanyl nucleotide binding                                                              </td><td>11/41</td><td>395/19330</td><td>4.116912e-10</td><td>7.410441e-09</td><td>2.470794e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0032561</td><td>guanyl ribonucleotide binding                                                          </td><td>11/41</td><td>395/19330</td><td>4.116912e-10</td><td>7.410441e-09</td><td>2.470794e-09</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                       </td><td>11</td></tr>\n","\t<tr><td>MF</td><td>GO:0005080</td><td>protein kinase C binding                                                               </td><td>6/41 </td><td>49/19330 </td><td>8.123547e-10</td><td>1.419855e-08</td><td>4.734088e-09</td><td>HDAC5/HDAC7/HDAC9/HDAC5/HDAC7/HDAC9                                                                                                                           </td><td> 6</td></tr>\n","\t<tr><td>MF</td><td>GO:0031492</td><td>nucleosomal DNA binding                                                                </td><td>6/41 </td><td>55/19330 </td><td>1.668447e-09</td><td>2.834011e-08</td><td>9.449175e-09</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                           </td><td> 6</td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>MF</td><td>GO:0070840</td><td>dynein complex binding                              </td><td>3/41</td><td>22/19330 </td><td>1.326265e-05</td><td>7.544697e-05</td><td>2.515558e-05</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0051787</td><td>misfolded protein binding                           </td><td>3/41</td><td>23/19330 </td><td>1.522958e-05</td><td>8.565297e-05</td><td>2.855846e-05</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0030332</td><td>cyclin binding                                      </td><td>3/41</td><td>29/19330 </td><td>3.114567e-05</td><td>1.558576e-04</td><td>5.196612e-05</td><td>HDAC3/HDAC3/HDAC3            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0043014</td><td>alpha-tubulin binding                               </td><td>3/41</td><td>34/19330 </td><td>5.063157e-05</td><td>2.394575e-04</td><td>7.984008e-05</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0048487</td><td>beta-tubulin binding                                </td><td>3/41</td><td>36/19330 </td><td>6.023495e-05</td><td>2.793975e-04</td><td>9.315689e-05</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0030544</td><td>Hsp70 protein binding                               </td><td>3/41</td><td>38/19330 </td><td>7.095902e-05</td><td>3.181286e-04</td><td>1.060706e-04</td><td>HDAC8/HDAC8/HDAC8            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0047485</td><td>protein N-terminus binding                          </td><td>4/41</td><td>107/19330</td><td>7.675591e-05</td><td>3.378523e-04</td><td>1.126469e-04</td><td>HDAC1/HDAC1/HDAC1/HDAC1      </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0031593</td><td>polyubiquitin modification-dependent protein binding</td><td>3/41</td><td>46/19330 </td><td>1.261906e-04</td><td>5.039269e-04</td><td>1.680196e-04</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0030955</td><td>potassium ion binding                               </td><td>2/41</td><td>10/19330 </td><td>1.954071e-04</td><td>7.434101e-04</td><td>2.478682e-04</td><td>HDAC4/HDAC4                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0031625</td><td>ubiquitin protein ligase binding                    </td><td>5/41</td><td>285/19330</td><td>3.264486e-04</td><td>1.154537e-03</td><td>3.849463e-04</td><td>HDAC6/HDAC6/HDAC6/TUBA1B/TUBB</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0044389</td><td>ubiquitin-like protein ligase binding               </td><td>5/41</td><td>300/19330</td><td>4.129095e-04</td><td>1.364298e-03</td><td>4.548851e-04</td><td>HDAC6/HDAC6/HDAC6/TUBA1B/TUBB</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0031420</td><td>alkali metal ion binding                            </td><td>2/41</td><td>15/19330 </td><td>4.528955e-04</td><td>1.478760e-03</td><td>4.930491e-04</td><td>HDAC4/HDAC4                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0043130</td><td>ubiquitin binding                                   </td><td>3/41</td><td>73/19330 </td><td>4.969016e-04</td><td>1.598036e-03</td><td>5.328180e-04</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0008013</td><td>beta-catenin binding                                </td><td>3/41</td><td>82/19330 </td><td>6.982367e-04</td><td>2.058859e-03</td><td>6.864662e-04</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0042288</td><td>MHC class I protein binding                         </td><td>2/41</td><td>19/19330 </td><td>7.336193e-04</td><td>2.147439e-03</td><td>7.160005e-04</td><td>TUBB/TUBB4B                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0032182</td><td>ubiquitin-like protein binding                      </td><td>3/41</td><td>91/19330 </td><td>9.452529e-04</td><td>2.707779e-03</td><td>9.028294e-04</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0071889</td><td>14-3-3 protein binding                              </td><td>2/41</td><td>28/19330 </td><td>1.602210e-03</td><td>4.191465e-03</td><td>1.397521e-03</td><td>HDAC7/HDAC7                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0042287</td><td>MHC protein binding                                 </td><td>2/41</td><td>35/19330 </td><td>2.498434e-03</td><td>6.136683e-03</td><td>2.046097e-03</td><td>TUBB/TUBB4B                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0140030</td><td>modification-dependent protein binding              </td><td>3/41</td><td>142/19330</td><td>3.373227e-03</td><td>8.023889e-03</td><td>2.675330e-03</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0008227</td><td>G protein-coupled amine receptor activity           </td><td>2/41</td><td>59/19330 </td><td>6.957486e-03</td><td>1.485904e-02</td><td>4.954310e-03</td><td>ADRA1A/HRH1                  </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0003725</td><td>double-stranded RNA binding                         </td><td>2/41</td><td>75/19330 </td><td>1.104565e-02</td><td>2.209130e-02</td><td>7.365695e-03</td><td>TUBA1B/TUBB4B                </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0019787</td><td>ubiquitin-like protein transferase activity         </td><td>4/41</td><td>417/19330</td><td>1.152057e-02</td><td>2.292708e-02</td><td>7.644362e-03</td><td>HDAC4/HDAC7/HDAC4/HDAC7      </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0008017</td><td>microtubule binding                                 </td><td>3/41</td><td>238/19330</td><td>1.392617e-02</td><td>2.678622e-02</td><td>8.931077e-03</td><td>HDAC6/HDAC6/HDAC6            </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0004952</td><td>dopamine neurotransmitter receptor activity         </td><td>1/41</td><td>10/19330 </td><td>2.101409e-02</td><td>3.732400e-02</td><td>1.244459e-02</td><td>DRD1                         </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0008239</td><td>dipeptidyl-peptidase activity                       </td><td>1/41</td><td>12/19330 </td><td>2.516491e-02</td><td>4.274490e-02</td><td>1.425203e-02</td><td>ACE                          </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0030594</td><td>neurotransmitter receptor activity                  </td><td>2/41</td><td>117/19330</td><td>2.554432e-02</td><td>4.326749e-02</td><td>1.442627e-02</td><td>DRD1/HRH1                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0031404</td><td>chloride ion binding                                </td><td>1/41</td><td>13/19330 </td><td>2.723387e-02</td><td>4.555346e-02</td><td>1.518846e-02</td><td>ACE                          </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0032794</td><td>GTPase activating protein binding                   </td><td>1/41</td><td>13/19330 </td><td>2.723387e-02</td><td>4.555346e-02</td><td>1.518846e-02</td><td>TUBB                         </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0035240</td><td>dopamine binding                                    </td><td>1/41</td><td>13/19330 </td><td>2.723387e-02</td><td>4.555346e-02</td><td>1.518846e-02</td><td>DRD1                         </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0031434</td><td>mitogen-activated protein kinase kinase binding     </td><td>1/41</td><td>14/19330 </td><td>2.929855e-02</td><td>4.820471e-02</td><td>1.607244e-02</td><td>ACE                          </td><td>1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"ZoFYa9Ys4ht6","executionInfo":{"status":"ok","timestamp":1636338281764,"user_tz":-480,"elapsed":7462,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"ffedc036-e3bf-4465-f315-bfac277a19d4"},"source":["# KEGG\n","dup_hyperG_k_res <- tsea_dup_hyperG(drugs = drugs, universe = \"Default\", \n","                                    type = \"KEGG\", pvalueCutoff=0.5, \n","                                    pAdjustMethod=\"BH\", qvalueCutoff = 0.5, \n","                                    minGSSize = 10, maxGSSize = 500)\n","result(dup_hyperG_k_res)"],"execution_count":28,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n","Reading KEGG annotation online:\n","\n","\n","Reading KEGG annotation online:\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["   ID       Description                                       GeneRatio\n","1  hsa05034 Alcoholism                                        27/41    \n","2  hsa04613 Neutrophil extracellular trap formation           26/41    \n","3  hsa05203 Viral carcinogenesis                              26/41    \n","4  hsa04540 Gap junction                                      12/41    \n","5  hsa05016 Huntington disease                                17/41    \n","6  hsa04145 Phagosome                                         11/41    \n","7  hsa05014 Amyotrophic lateral sclerosis                     14/41    \n","8  hsa05130 Pathogenic Escherichia coli infection             11/41    \n","9  hsa05012 Parkinson disease                                 12/41    \n","10 hsa04919 Thyroid hormone signaling pathway                 9/41     \n","11 hsa05132 Salmonella infection                              11/41    \n","12 hsa05031 Amphetamine addiction                             7/41     \n","13 hsa05020 Prion disease                                     11/41    \n","14 hsa04330 Notch signaling pathway                           6/41     \n","15 hsa04213 Longevity regulating pathway - multiple species   6/41     \n","16 hsa05220 Chronic myeloid leukemia                          6/41     \n","17 hsa05010 Alzheimer disease                                 11/41    \n","18 hsa05206 MicroRNAs in cancer                               10/41    \n","19 hsa05022 Pathways of neurodegeneration - multiple diseases 11/41    \n","20 hsa04110 Cell cycle                                        6/41     \n","21 hsa04210 Apoptosis                                         6/41     \n","22 hsa04530 Tight junction                                    6/41     \n","23 hsa05202 Transcriptional misregulation in cancer           6/41     \n","24 hsa05169 Epstein-Barr virus infection                      6/41     \n","25 hsa04371 Apelin signaling pathway                          4/41     \n","26 hsa05165 Human papillomavirus infection                    6/41     \n","27 hsa04614 Renin-angiotensin system                          1/41     \n","28 hsa04020 Calcium signaling pathway                         3/41     \n","29 hsa05030 Cocaine addiction                                 1/41     \n","30 hsa04080 Neuroactive ligand-receptor interaction           3/41     \n","31 hsa04924 Renin secretion                                   1/41     \n","32 hsa05410 Hypertrophic cardiomyopathy                       1/41     \n","33 hsa05032 Morphine addiction                                1/41     \n","34 hsa04970 Salivary secretion                                1/41     \n","35 hsa04750 Inflammatory mediator regulation of TRP channels  1/41     \n","36 hsa05142 Chagas disease                                    1/41     \n","   BgRatio  pvalue       p.adjust     qvalue      \n","1  187/8105 2.484687e-35 1.093262e-33 4.707828e-34\n","2  190/8105 3.408313e-33 7.498290e-32 3.228929e-32\n","3  204/8105 2.399346e-32 3.519041e-31 1.515377e-31\n","4  88/8105  7.571574e-15 8.328732e-14 3.586535e-14\n","5  306/8105 2.766830e-14 2.434810e-13 1.048483e-13\n","6  152/8105 1.367536e-10 1.002860e-09 4.318534e-10\n","7  364/8105 1.236296e-09 7.771005e-09 3.346366e-09\n","8  197/8105 2.211707e-09 1.216439e-08 5.238254e-09\n","9  266/8105 4.124709e-09 2.016524e-08 8.683598e-09\n","10 121/8105 6.401758e-09 2.816773e-08 1.212965e-08\n","11 249/8105 2.580020e-08 1.032008e-07 4.444054e-08\n","12 69/8105  4.244674e-08 1.556380e-07 6.702117e-08\n","13 273/8105 6.662155e-08 2.254883e-07 9.710024e-08\n","14 59/8105  4.234135e-07 1.330728e-06 5.730408e-07\n","15 62/8105  5.712819e-07 1.675760e-06 7.216192e-07\n","16 76/8105  1.928589e-06 5.291583e-06 2.278672e-06\n","17 384/8105 2.044475e-06 5.291583e-06 2.278672e-06\n","18 310/8105 2.261556e-06 5.528247e-06 2.380585e-06\n","19 476/8105 1.613424e-05 3.736351e-05 1.608955e-05\n","20 126/8105 3.607309e-05 7.936080e-05 3.417451e-05\n","21 136/8105 5.545450e-05 1.161904e-04 5.003413e-05\n","22 169/8105 1.846005e-04 3.692010e-04 1.589861e-04\n","23 192/8105 3.683098e-04 7.045927e-04 3.034131e-04\n","24 202/8105 4.831020e-04 8.856869e-04 3.813963e-04\n","25 139/8105 5.130563e-03 9.029791e-03 3.888427e-03\n","26 331/8105 5.952511e-03 1.007348e-02 4.337862e-03\n","27 23/8105  1.102388e-01 1.796485e-01 7.736059e-02\n","28 240/8105 1.204986e-01 1.893550e-01 8.154041e-02\n","29 49/8105  2.206082e-01 3.347159e-01 1.441360e-01\n","30 350/8105 2.598915e-01 3.811742e-01 1.641420e-01\n","31 69/8105  2.963046e-01 4.205613e-01 1.811030e-01\n","32 90/8105  3.680601e-01 4.888008e-01 2.104884e-01\n","33 91/8105  3.712927e-01 4.888008e-01 2.104884e-01\n","34 93/8105  3.777097e-01 4.888008e-01 2.104884e-01\n","35 98/8105  3.934738e-01 4.946527e-01 2.130083e-01\n","36 102/8105 4.058039e-01 4.959825e-01 2.135810e-01\n","   itemID                                                                                                                                             \n","1  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869\n","2  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     \n","3  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     \n","4  1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               \n","5  3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                      \n","6  7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","7  10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                  \n","8  7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","9  1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               \n","10 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                       \n","11 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","12 3065/3066/3065/3066/3065/3065/1812                                                                                                                 \n","13 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","14 3065/3066/3065/3066/3065/3065                                                                                                                      \n","15 3065/3066/3065/3066/3065/3065                                                                                                                      \n","16 3065/3066/3065/3066/3065/3065                                                                                                                      \n","17 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","18 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                \n","19 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","20 3065/3066/3065/3066/3065/3065                                                                                                                      \n","21 7846/10376/84790/7278/7277/51807                                                                                                                   \n","22 7846/10376/84790/7278/7277/51807                                                                                                                   \n","23 3065/3066/3065/3066/3065/3065                                                                                                                      \n","24 3065/3066/3065/3066/3065/3065                                                                                                                      \n","25 9759/10014/9759/10014                                                                                                                              \n","26 3065/3066/3065/3066/3065/3065                                                                                                                      \n","27 1636                                                                                                                                               \n","28 148/1812/3269                                                                                                                                      \n","29 1812                                                                                                                                               \n","30 148/1812/3269                                                                                                                                      \n","31 1636                                                                                                                                               \n","32 1636                                                                                                                                               \n","33 1812                                                                                                                                               \n","34 148                                                                                                                                                \n","35 3269                                                                                                                                               \n","36 1636                                                                                                                                               \n","   Count\n","1  27   \n","2  26   \n","3  26   \n","4  12   \n","5  17   \n","6  11   \n","7  14   \n","8  11   \n","9  12   \n","10  9   \n","11 11   \n","12  7   \n","13 11   \n","14  6   \n","15  6   \n","16  6   \n","17 11   \n","18 10   \n","19 11   \n","20  6   \n","21  6   \n","22  6   \n","23  6   \n","24  6   \n","25  4   \n","26  6   \n","27  1   \n","28  3   \n","29  1   \n","30  3   \n","31  1   \n","32  1   \n","33  1   \n","34  1   \n","35  1   \n","36  1   "],"text/latex":"A tibble: 36 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <int>\\\\\n\\hline\n\t hsa05034 & Alcoholism                                        & 27/41 & 187/8105 & 2.484687e-35 & 1.093262e-33 & 4.707828e-34 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869 & 27\\\\\n\t hsa04613 & Neutrophil extracellular trap formation           & 26/41 & 190/8105 & 3.408313e-33 & 7.498290e-32 & 3.228929e-32 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      & 26\\\\\n\t hsa05203 & Viral carcinogenesis                              & 26/41 & 204/8105 & 2.399346e-32 & 3.519041e-31 & 1.515377e-31 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      & 26\\\\\n\t hsa04540 & Gap junction                                      & 12/41 & 88/8105  & 7.571574e-15 & 8.328732e-14 & 3.586535e-14 & 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                & 12\\\\\n\t hsa05016 & Huntington disease                                & 17/41 & 306/8105 & 2.766830e-14 & 2.434810e-13 & 1.048483e-13 & 3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                       & 17\\\\\n\t hsa04145 & Phagosome                                         & 11/41 & 152/8105 & 1.367536e-10 & 1.002860e-09 & 4.318534e-10 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                     & 14/41 & 364/8105 & 1.236296e-09 & 7.771005e-09 & 3.346366e-09 & 10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                   & 14\\\\\n\t hsa05130 & Pathogenic Escherichia coli infection             & 11/41 & 197/8105 & 2.211707e-09 & 1.216439e-08 & 5.238254e-09 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05012 & Parkinson disease                                 & 12/41 & 266/8105 & 4.124709e-09 & 2.016524e-08 & 8.683598e-09 & 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                & 12\\\\\n\t hsa04919 & Thyroid hormone signaling pathway                 & 9/41  & 121/8105 & 6.401758e-09 & 2.816773e-08 & 1.212965e-08 & 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                        &  9\\\\\n\t hsa05132 & Salmonella infection                              & 11/41 & 249/8105 & 2.580020e-08 & 1.032008e-07 & 4.444054e-08 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05031 & Amphetamine addiction                             & 7/41  & 69/8105  & 4.244674e-08 & 1.556380e-07 & 6.702117e-08 & 3065/3066/3065/3066/3065/3065/1812                                                                                                                  &  7\\\\\n\t hsa05020 & Prion disease                                     & 11/41 & 273/8105 & 6.662155e-08 & 2.254883e-07 & 9.710024e-08 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa04330 & Notch signaling pathway                           & 6/41  & 59/8105  & 4.234135e-07 & 1.330728e-06 & 5.730408e-07 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04213 & Longevity regulating pathway - multiple species   & 6/41  & 62/8105  & 5.712819e-07 & 1.675760e-06 & 7.216192e-07 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05220 & Chronic myeloid leukemia                          & 6/41  & 76/8105  & 1.928589e-06 & 5.291583e-06 & 2.278672e-06 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05010 & Alzheimer disease                                 & 11/41 & 384/8105 & 2.044475e-06 & 5.291583e-06 & 2.278672e-06 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05206 & MicroRNAs in cancer                               & 10/41 & 310/8105 & 2.261556e-06 & 5.528247e-06 & 2.380585e-06 & 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                 & 10\\\\\n\t hsa05022 & Pathways of neurodegeneration - multiple diseases & 11/41 & 476/8105 & 1.613424e-05 & 3.736351e-05 & 1.608955e-05 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa04110 & Cell cycle                                        & 6/41  & 126/8105 & 3.607309e-05 & 7.936080e-05 & 3.417451e-05 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04210 & Apoptosis                                         & 6/41  & 136/8105 & 5.545450e-05 & 1.161904e-04 & 5.003413e-05 & 7846/10376/84790/7278/7277/51807                                                                                                                    &  6\\\\\n\t hsa04530 & Tight junction                                    & 6/41  & 169/8105 & 1.846005e-04 & 3.692010e-04 & 1.589861e-04 & 7846/10376/84790/7278/7277/51807                                                                                                                    &  6\\\\\n\t hsa05202 & Transcriptional misregulation in cancer           & 6/41  & 192/8105 & 3.683098e-04 & 7.045927e-04 & 3.034131e-04 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05169 & Epstein-Barr virus infection                      & 6/41  & 202/8105 & 4.831020e-04 & 8.856869e-04 & 3.813963e-04 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04371 & Apelin signaling pathway                          & 4/41  & 139/8105 & 5.130563e-03 & 9.029791e-03 & 3.888427e-03 & 9759/10014/9759/10014                                                                                                                               &  4\\\\\n\t hsa05165 & Human papillomavirus infection                    & 6/41  & 331/8105 & 5.952511e-03 & 1.007348e-02 & 4.337862e-03 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04614 & Renin-angiotensin system                          & 1/41  & 23/8105  & 1.102388e-01 & 1.796485e-01 & 7.736059e-02 & 1636                                                                                                                                                &  1\\\\\n\t hsa04020 & Calcium signaling pathway                         & 3/41  & 240/8105 & 1.204986e-01 & 1.893550e-01 & 8.154041e-02 & 148/1812/3269                                                                                                                                       &  3\\\\\n\t hsa05030 & Cocaine addiction                                 & 1/41  & 49/8105  & 2.206082e-01 & 3.347159e-01 & 1.441360e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa04080 & Neuroactive ligand-receptor interaction           & 3/41  & 350/8105 & 2.598915e-01 & 3.811742e-01 & 1.641420e-01 & 148/1812/3269                                                                                                                                       &  3\\\\\n\t hsa04924 & Renin secretion                                   & 1/41  & 69/8105  & 2.963046e-01 & 4.205613e-01 & 1.811030e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa05410 & Hypertrophic cardiomyopathy                       & 1/41  & 90/8105  & 3.680601e-01 & 4.888008e-01 & 2.104884e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa05032 & Morphine addiction                                & 1/41  & 91/8105  & 3.712927e-01 & 4.888008e-01 & 2.104884e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa04970 & Salivary secretion                                & 1/41  & 93/8105  & 3.777097e-01 & 4.888008e-01 & 2.104884e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels  & 1/41  & 98/8105  & 3.934738e-01 & 4.946527e-01 & 2.130083e-01 & 3269                                                                                                                                                &  1\\\\\n\t hsa05142 & Chagas disease                                    & 1/41  & 102/8105 & 4.058039e-01 & 4.959825e-01 & 2.135810e-01 & 1636                                                                                                                                                &  1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 36 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|\n| hsa05034 | Alcoholism                                        | 27/41 | 187/8105 | 2.484687e-35 | 1.093262e-33 | 4.707828e-34 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869 | 27 |\n| hsa04613 | Neutrophil extracellular trap formation           | 26/41 | 190/8105 | 3.408313e-33 | 7.498290e-32 | 3.228929e-32 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      | 26 |\n| hsa05203 | Viral carcinogenesis                              | 26/41 | 204/8105 | 2.399346e-32 | 3.519041e-31 | 1.515377e-31 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      | 26 |\n| hsa04540 | Gap junction                                      | 12/41 | 88/8105  | 7.571574e-15 | 8.328732e-14 | 3.586535e-14 | 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                | 12 |\n| hsa05016 | Huntington disease                                | 17/41 | 306/8105 | 2.766830e-14 | 2.434810e-13 | 1.048483e-13 | 3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                       | 17 |\n| hsa04145 | Phagosome                                         | 11/41 | 152/8105 | 1.367536e-10 | 1.002860e-09 | 4.318534e-10 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05014 | Amyotrophic lateral sclerosis                     | 14/41 | 364/8105 | 1.236296e-09 | 7.771005e-09 | 3.346366e-09 | 10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                   | 14 |\n| hsa05130 | Pathogenic Escherichia coli infection             | 11/41 | 197/8105 | 2.211707e-09 | 1.216439e-08 | 5.238254e-09 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05012 | Parkinson disease                                 | 12/41 | 266/8105 | 4.124709e-09 | 2.016524e-08 | 8.683598e-09 | 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                | 12 |\n| hsa04919 | Thyroid hormone signaling pathway                 | 9/41  | 121/8105 | 6.401758e-09 | 2.816773e-08 | 1.212965e-08 | 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                        |  9 |\n| hsa05132 | Salmonella infection                              | 11/41 | 249/8105 | 2.580020e-08 | 1.032008e-07 | 4.444054e-08 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05031 | Amphetamine addiction                             | 7/41  | 69/8105  | 4.244674e-08 | 1.556380e-07 | 6.702117e-08 | 3065/3066/3065/3066/3065/3065/1812                                                                                                                  |  7 |\n| hsa05020 | Prion disease                                     | 11/41 | 273/8105 | 6.662155e-08 | 2.254883e-07 | 9.710024e-08 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa04330 | Notch signaling pathway                           | 6/41  | 59/8105  | 4.234135e-07 | 1.330728e-06 | 5.730408e-07 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04213 | Longevity regulating pathway - multiple species   | 6/41  | 62/8105  | 5.712819e-07 | 1.675760e-06 | 7.216192e-07 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05220 | Chronic myeloid leukemia                          | 6/41  | 76/8105  | 1.928589e-06 | 5.291583e-06 | 2.278672e-06 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05010 | Alzheimer disease                                 | 11/41 | 384/8105 | 2.044475e-06 | 5.291583e-06 | 2.278672e-06 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05206 | MicroRNAs in cancer                               | 10/41 | 310/8105 | 2.261556e-06 | 5.528247e-06 | 2.380585e-06 | 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                 | 10 |\n| hsa05022 | Pathways of neurodegeneration - multiple diseases | 11/41 | 476/8105 | 1.613424e-05 | 3.736351e-05 | 1.608955e-05 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa04110 | Cell cycle                                        | 6/41  | 126/8105 | 3.607309e-05 | 7.936080e-05 | 3.417451e-05 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04210 | Apoptosis                                         | 6/41  | 136/8105 | 5.545450e-05 | 1.161904e-04 | 5.003413e-05 | 7846/10376/84790/7278/7277/51807                                                                                                                    |  6 |\n| hsa04530 | Tight junction                                    | 6/41  | 169/8105 | 1.846005e-04 | 3.692010e-04 | 1.589861e-04 | 7846/10376/84790/7278/7277/51807                                                                                                                    |  6 |\n| hsa05202 | Transcriptional misregulation in cancer           | 6/41  | 192/8105 | 3.683098e-04 | 7.045927e-04 | 3.034131e-04 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05169 | Epstein-Barr virus infection                      | 6/41  | 202/8105 | 4.831020e-04 | 8.856869e-04 | 3.813963e-04 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04371 | Apelin signaling pathway                          | 4/41  | 139/8105 | 5.130563e-03 | 9.029791e-03 | 3.888427e-03 | 9759/10014/9759/10014                                                                                                                               |  4 |\n| hsa05165 | Human papillomavirus infection                    | 6/41  | 331/8105 | 5.952511e-03 | 1.007348e-02 | 4.337862e-03 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04614 | Renin-angiotensin system                          | 1/41  | 23/8105  | 1.102388e-01 | 1.796485e-01 | 7.736059e-02 | 1636                                                                                                                                                |  1 |\n| hsa04020 | Calcium signaling pathway                         | 3/41  | 240/8105 | 1.204986e-01 | 1.893550e-01 | 8.154041e-02 | 148/1812/3269                                                                                                                                       |  3 |\n| hsa05030 | Cocaine addiction                                 | 1/41  | 49/8105  | 2.206082e-01 | 3.347159e-01 | 1.441360e-01 | 1812                                                                                                                                                |  1 |\n| hsa04080 | Neuroactive ligand-receptor interaction           | 3/41  | 350/8105 | 2.598915e-01 | 3.811742e-01 | 1.641420e-01 | 148/1812/3269                                                                                                                                       |  3 |\n| hsa04924 | Renin secretion                                   | 1/41  | 69/8105  | 2.963046e-01 | 4.205613e-01 | 1.811030e-01 | 1636                                                                                                                                                |  1 |\n| hsa05410 | Hypertrophic cardiomyopathy                       | 1/41  | 90/8105  | 3.680601e-01 | 4.888008e-01 | 2.104884e-01 | 1636                                                                                                                                                |  1 |\n| hsa05032 | Morphine addiction                                | 1/41  | 91/8105  | 3.712927e-01 | 4.888008e-01 | 2.104884e-01 | 1812                                                                                                                                                |  1 |\n| hsa04970 | Salivary secretion                                | 1/41  | 93/8105  | 3.777097e-01 | 4.888008e-01 | 2.104884e-01 | 148                                                                                                                                                 |  1 |\n| hsa04750 | Inflammatory mediator regulation of TRP channels  | 1/41  | 98/8105  | 3.934738e-01 | 4.946527e-01 | 2.130083e-01 | 3269                                                                                                                                                |  1 |\n| hsa05142 | Chagas disease                                    | 1/41  | 102/8105 | 4.058039e-01 | 4.959825e-01 | 2.135810e-01 | 1636                                                                                                                                                |  1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 36 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                       </td><td>27/41</td><td>187/8105</td><td>2.484687e-35</td><td>1.093262e-33</td><td>4.707828e-34</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869</td><td>27</td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation          </td><td>26/41</td><td>190/8105</td><td>3.408313e-33</td><td>7.498290e-32</td><td>3.228929e-32</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     </td><td>26</td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                             </td><td>26/41</td><td>204/8105</td><td>2.399346e-32</td><td>3.519041e-31</td><td>1.515377e-31</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     </td><td>26</td></tr>\n","\t<tr><td>hsa04540</td><td>Gap junction                                     </td><td>12/41</td><td>88/8105 </td><td>7.571574e-15</td><td>8.328732e-14</td><td>3.586535e-14</td><td>1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               </td><td>12</td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                               </td><td>17/41</td><td>306/8105</td><td>2.766830e-14</td><td>2.434810e-13</td><td>1.048483e-13</td><td>3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                      </td><td>17</td></tr>\n","\t<tr><td>hsa04145</td><td>Phagosome                                        </td><td>11/41</td><td>152/8105</td><td>1.367536e-10</td><td>1.002860e-09</td><td>4.318534e-10</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                    </td><td>14/41</td><td>364/8105</td><td>1.236296e-09</td><td>7.771005e-09</td><td>3.346366e-09</td><td>10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                  </td><td>14</td></tr>\n","\t<tr><td>hsa05130</td><td>Pathogenic Escherichia coli infection            </td><td>11/41</td><td>197/8105</td><td>2.211707e-09</td><td>1.216439e-08</td><td>5.238254e-09</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                                </td><td>12/41</td><td>266/8105</td><td>4.124709e-09</td><td>2.016524e-08</td><td>8.683598e-09</td><td>1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               </td><td>12</td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway                </td><td>9/41 </td><td>121/8105</td><td>6.401758e-09</td><td>2.816773e-08</td><td>1.212965e-08</td><td>3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                       </td><td> 9</td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                             </td><td>11/41</td><td>249/8105</td><td>2.580020e-08</td><td>1.032008e-07</td><td>4.444054e-08</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                            </td><td>7/41 </td><td>69/8105 </td><td>4.244674e-08</td><td>1.556380e-07</td><td>6.702117e-08</td><td>3065/3066/3065/3066/3065/3065/1812                                                                                                                 </td><td> 7</td></tr>\n","\t<tr><td>hsa05020</td><td>Prion disease                                    </td><td>11/41</td><td>273/8105</td><td>6.662155e-08</td><td>2.254883e-07</td><td>9.710024e-08</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa04330</td><td>Notch signaling pathway                          </td><td>6/41 </td><td>59/8105 </td><td>4.234135e-07</td><td>1.330728e-06</td><td>5.730408e-07</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species  </td><td>6/41 </td><td>62/8105 </td><td>5.712819e-07</td><td>1.675760e-06</td><td>7.216192e-07</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                         </td><td>6/41 </td><td>76/8105 </td><td>1.928589e-06</td><td>5.291583e-06</td><td>2.278672e-06</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05010</td><td>Alzheimer disease                                </td><td>11/41</td><td>384/8105</td><td>2.044475e-06</td><td>5.291583e-06</td><td>2.278672e-06</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                              </td><td>10/41</td><td>310/8105</td><td>2.261556e-06</td><td>5.528247e-06</td><td>2.380585e-06</td><td>3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                </td><td>10</td></tr>\n","\t<tr><td>hsa05022</td><td>Pathways of neurodegeneration - multiple diseases</td><td>11/41</td><td>476/8105</td><td>1.613424e-05</td><td>3.736351e-05</td><td>1.608955e-05</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                       </td><td>6/41 </td><td>126/8105</td><td>3.607309e-05</td><td>7.936080e-05</td><td>3.417451e-05</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04210</td><td>Apoptosis                                        </td><td>6/41 </td><td>136/8105</td><td>5.545450e-05</td><td>1.161904e-04</td><td>5.003413e-05</td><td>7846/10376/84790/7278/7277/51807                                                                                                                   </td><td> 6</td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                   </td><td>6/41 </td><td>169/8105</td><td>1.846005e-04</td><td>3.692010e-04</td><td>1.589861e-04</td><td>7846/10376/84790/7278/7277/51807                                                                                                                   </td><td> 6</td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer          </td><td>6/41 </td><td>192/8105</td><td>3.683098e-04</td><td>7.045927e-04</td><td>3.034131e-04</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                     </td><td>6/41 </td><td>202/8105</td><td>4.831020e-04</td><td>8.856869e-04</td><td>3.813963e-04</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                         </td><td>4/41 </td><td>139/8105</td><td>5.130563e-03</td><td>9.029791e-03</td><td>3.888427e-03</td><td>9759/10014/9759/10014                                                                                                                              </td><td> 4</td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                   </td><td>6/41 </td><td>331/8105</td><td>5.952511e-03</td><td>1.007348e-02</td><td>4.337862e-03</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04614</td><td>Renin-angiotensin system                         </td><td>1/41 </td><td>23/8105 </td><td>1.102388e-01</td><td>1.796485e-01</td><td>7.736059e-02</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04020</td><td>Calcium signaling pathway                        </td><td>3/41 </td><td>240/8105</td><td>1.204986e-01</td><td>1.893550e-01</td><td>8.154041e-02</td><td>148/1812/3269                                                                                                                                      </td><td> 3</td></tr>\n","\t<tr><td>hsa05030</td><td>Cocaine addiction                                </td><td>1/41 </td><td>49/8105 </td><td>2.206082e-01</td><td>3.347159e-01</td><td>1.441360e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04080</td><td>Neuroactive ligand-receptor interaction          </td><td>3/41 </td><td>350/8105</td><td>2.598915e-01</td><td>3.811742e-01</td><td>1.641420e-01</td><td>148/1812/3269                                                                                                                                      </td><td> 3</td></tr>\n","\t<tr><td>hsa04924</td><td>Renin secretion                                  </td><td>1/41 </td><td>69/8105 </td><td>2.963046e-01</td><td>4.205613e-01</td><td>1.811030e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05410</td><td>Hypertrophic cardiomyopathy                      </td><td>1/41 </td><td>90/8105 </td><td>3.680601e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                               </td><td>1/41 </td><td>91/8105 </td><td>3.712927e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                               </td><td>1/41 </td><td>93/8105 </td><td>3.777097e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels </td><td>1/41 </td><td>98/8105 </td><td>3.934738e-01</td><td>4.946527e-01</td><td>2.130083e-01</td><td>3269                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05142</td><td>Chagas disease                                   </td><td>1/41 </td><td>102/8105</td><td>4.058039e-01</td><td>4.959825e-01</td><td>2.135810e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"z_xCeaV94pJ3","executionInfo":{"status":"ok","timestamp":1636338303981,"user_tz":-480,"elapsed":22221,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"d56b8c72-b280-4074-88e3-7465cb396dde"},"source":["# Reactome\n","dup_rct_res <- tsea_dup_hyperG(drugs=drugs, type=\"Reactome\",\n","                               pvalueCutoff=0.5, qvalueCutoff=0.5, readable=TRUE)\n","result(dup_rct_res)"],"execution_count":29,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["    ID           \n","1   R-HSA-193670 \n","2   R-HSA-350054 \n","3   R-HSA-2122947\n","4   R-HSA-2644602\n","5   R-HSA-2644603\n","6   R-HSA-2644606\n","7   R-HSA-2894858\n","8   R-HSA-2894862\n","9   R-HSA-1980143\n","10  R-HSA-157118 \n","11  R-HSA-5663202\n","12  R-HSA-9646399\n","13  R-HSA-9701898\n","14  R-HSA-190840 \n","15  R-HSA-190872 \n","16  R-HSA-8943724\n","17  R-HSA-389977 \n","18  R-HSA-3214815\n","19  R-HSA-983231 \n","20  R-HSA-389960 \n","21  R-HSA-9663891\n","22  R-HSA-9619483\n","23  R-HSA-390466 \n","24  R-HSA-9668328\n","25  R-HSA-389958 \n","26  R-HSA-5626467\n","27  R-HSA-391251 \n","28  R-HSA-190861 \n","29  R-HSA-1852241\n","30  R-HSA-9609736\n","⋮   ⋮            \n","153 R-HSA-9619665\n","154 R-HSA-1592230\n","155 R-HSA-4090294\n","156 R-HSA-1989781\n","157 R-HSA-8939211\n","158 R-HSA-400206 \n","159 R-HSA-5617472\n","160 R-HSA-5619507\n","161 R-HSA-201681 \n","162 R-HSA-9707564\n","163 R-HSA-8878171\n","164 R-HSA-390651 \n","165 R-HSA-9711123\n","166 R-HSA-390696 \n","167 R-HSA-3108214\n","168 R-HSA-195721 \n","169 R-HSA-8878159\n","170 R-HSA-2022377\n","171 R-HSA-373076 \n","172 R-HSA-9013407\n","173 R-HSA-416476 \n","174 R-HSA-500792 \n","175 R-HSA-416482 \n","176 R-HSA-2980736\n","177 R-HSA-114608 \n","178 R-HSA-76005  \n","179 R-HSA-9660821\n","180 R-HSA-418555 \n","181 R-HSA-9662851\n","182 R-HSA-9664433\n","    Description                                                                         \n","1   p75NTR negatively regulates cell cycle via SC1                                      \n","2   Notch-HLH transcription pathway                                                     \n","3   NOTCH1 Intracellular Domain Regulates Transcription                                 \n","4   Signaling by NOTCH1 PEST Domain Mutants in Cancer                                   \n","5   Signaling by NOTCH1 in Cancer                                                       \n","6   Constitutive Signaling by NOTCH1 PEST Domain Mutants                                \n","7   Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                                \n","8   Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                             \n","9   Signaling by NOTCH1                                                                 \n","10  Signaling by NOTCH                                                                  \n","11  Diseases of signal transduction by growth factor receptors and second messengers    \n","12  Aggrephagy                                                                          \n","13  STAT3 nuclear events downstream of ALK signaling                                    \n","14  Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane    \n","15  Transport of connexons to the plasma membrane                                       \n","16  Regulation of PTEN gene transcription                                               \n","17  Post-chaperonin tubulin folding pathway                                             \n","18  HDACs deacetylate histones                                                          \n","19  Factors involved in megakaryocyte development and platelet production               \n","20  Formation of tubulin folding intermediates by CCT/TriC                              \n","21  Selective autophagy                                                                 \n","22  Activation of AMPK downstream of NMDARs                                             \n","23  Chaperonin-mediated protein folding                                                 \n","24  Sealing of the nuclear envelope (NE) by ESCRT-III                                   \n","25  Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding                 \n","26  RHO GTPases activate IQGAPs                                                         \n","27  Protein folding                                                                     \n","28  Gap junction assembly                                                               \n","29  Organelle biogenesis and maintenance                                                \n","30  Assembly and cell surface presentation of NMDA receptors                            \n","⋮   ⋮                                                                                   \n","153 EGR2 and SOX10-mediated initiation of Schwann cell myelination                      \n","154 Mitochondrial biogenesis                                                            \n","155 SUMOylation of intracellular receptors                                              \n","156 PPARA activates gene expression                                                     \n","157 ESR-mediated signaling                                                              \n","158 Regulation of lipid metabolism by PPARalpha                                         \n","159 Activation of anterior HOX genes in hindbrain development during early embryogenesis\n","160 Activation of HOX genes during differentiation                                      \n","161 TCF dependent signaling in response to WNT                                          \n","162 Cytoprotection by HMOX1                                                             \n","163 Transcriptional regulation by RUNX1                                                 \n","164 Dopamine receptors                                                                  \n","165 Cellular response to chemical stress                                                \n","166 Adrenoceptors                                                                       \n","167 SUMOylation of DNA damage response and repair proteins                              \n","168 Signaling by WNT                                                                    \n","169 Transcriptional regulation by RUNX3                                                 \n","170 Metabolism of Angiotensinogen to Angiotensins                                       \n","171 Class A/1 (Rhodopsin-like receptors)                                                \n","172 RHOH GTPase cycle                                                                   \n","173 G alpha (q) signalling events                                                       \n","174 GPCR ligand binding                                                                 \n","175 G alpha (12/13) signalling events                                                   \n","176 Peptide hormone metabolism                                                          \n","177 Platelet degranulation                                                              \n","178 Response to elevated platelet cytosolic Ca2+                                        \n","179 ADORA2B mediated anti-inflammatory cytokines production                             \n","180 G alpha (s) signalling events                                                       \n","181 Anti-inflammatory response favouring Leishmania parasite infection                  \n","182 Leishmania parasite growth and survival                                             \n","    GeneRatio BgRatio   pvalue       p.adjust     qvalue      \n","1   9/41      6/10867   0.000000e+00 0.000000e+00 0.000000e+00\n","2   26/41     28/10867  1.143959e-65 1.063881e-63 1.083750e-64\n","3   26/41     48/10867  8.069550e-55 5.003121e-53 5.096558e-54\n","4   26/41     58/10867  6.440257e-52 1.497360e-50 1.525324e-51\n","5   26/41     58/10867  6.440257e-52 1.497360e-50 1.525324e-51\n","6   26/41     58/10867  6.440257e-52 1.497360e-50 1.525324e-51\n","7   26/41     58/10867  6.440257e-52 1.497360e-50 1.525324e-51\n","8   26/41     58/10867  6.440257e-52 1.497360e-50 1.525324e-51\n","9   26/41     74/10867  1.880392e-48 3.886144e-47 3.958721e-48\n","10  26/41     236/10867 6.738928e-34 1.253441e-32 1.276850e-33\n","11  26/41     433/10867 7.122644e-27 1.204374e-25 1.226867e-26\n","12  13/41     43/10867  1.276164e-22 1.978055e-21 2.014996e-22\n","13  9/41      10/10867  6.019436e-22 8.612424e-21 8.773267e-22\n","14  10/41     18/10867  7.623154e-21 1.012790e-19 1.031705e-20\n","15  10/41     19/10867  1.605153e-20 1.990390e-19 2.027562e-20\n","16  13/41     61/10867  2.193887e-20 2.550394e-19 2.598024e-20\n","17  10/41     22/10867  1.114875e-19 1.219804e-18 1.242585e-19\n","18  14/41     94/10867  1.398876e-19 1.445505e-18 1.472501e-19\n","19  16/41     168/10867 3.808685e-19 3.728502e-18 3.798135e-19\n","20  10/41     25/10867  5.591822e-19 5.200395e-18 5.297516e-19\n","21  13/41     81/10867  1.195235e-18 1.058637e-17 1.078408e-18\n","22  10/41     29/10867  3.391031e-18 2.866962e-17 2.920505e-18\n","23  13/41     91/10867  5.959276e-18 4.819240e-17 4.909243e-18\n","24  10/41     31/10867  7.469733e-18 5.789043e-17 5.897157e-18\n","25  10/41     32/10867  1.083683e-17 7.752498e-17 7.897282e-18\n","26  10/41     32/10867  1.083683e-17 7.752498e-17 7.897282e-18\n","27  13/41     97/10867  1.427903e-17 9.836665e-17 1.002037e-17\n","28  10/41     36/10867  4.225628e-17 2.807025e-16 2.859448e-17\n","29  17/41     296/10867 1.332142e-16 8.544082e-16 8.703648e-17\n","30  10/41     41/10867  1.839622e-16 1.140565e-15 1.161866e-16\n","⋮   ⋮         ⋮         ⋮            ⋮            ⋮           \n","153 2/41      28/10867  0.004933802  0.005997955  0.0006109971\n","154 3/41      95/10867  0.005425479  0.006552852  0.0006675231\n","155 2/41      30/10867  0.005650814  0.006780977  0.0006907617\n","156 3/41      117/10867 0.009630098  0.011431917  0.0011645416\n","157 4/41      223/10867 0.009649521  0.011431917  0.0011645416\n","158 3/41      119/10867 0.010084427  0.011871541  0.0012093251\n","159 3/41      121/10867 0.010551104  0.012265659  0.0012494729\n","160 3/41      121/10867 0.010551104  0.012265659  0.0012494729\n","161 4/41      233/10867 0.011207183  0.012944695  0.0013186447\n","162 3/41      124/10867 0.011274412  0.012944695  0.0013186447\n","163 4/41      239/10867 0.012215727  0.013939419  0.0014199748\n","164 1/41      5/10867   0.018726062  0.021238094  0.0021634731\n","165 3/41      160/10867 0.022189887  0.025014054  0.0025481209\n","166 1/41      9/10867   0.033460183  0.037491530  0.0038191712\n","167 2/41      77/10867  0.034008228  0.037877428  0.0038584816\n","168 4/41      332/10867 0.035676174  0.039498622  0.0040236287\n","169 2/41      96/10867  0.050687943  0.055786730  0.0056828587\n","170 1/41      18/10867  0.065827194  0.072022695  0.0073367771\n","171 3/41      335/10867 0.131687405  0.143238932  0.0145914022\n","172 1/41      38/10867  0.134014003  0.144922120  0.0147628645\n","173 2/41      216/10867 0.195759615  0.210469876  0.0214400552\n","174 3/41      467/10867 0.257607503  0.275373537  0.0280516337\n","175 1/41      80/10867  0.261776560  0.278231087  0.0283427253\n","176 1/41      91/10867  0.292075229  0.308670412  0.0314435055\n","177 1/41      129/10867 0.387694221  0.407407487  0.0415016116\n","178 1/41      134/10867 0.399297017  0.414911985  0.0422660765\n","179 1/41      134/10867 0.399297017  0.414911985  0.0422660765\n","180 1/41      145/10867 0.424073215  0.438208989  0.0446392858\n","181 1/41      169/10867 0.474719846  0.485153249  0.0494213836\n","182 1/41      169/10867 0.474719846  0.485153249  0.0494213836\n","    itemID                                                                                                                                                        \n","1   HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         \n","2   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","3   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","4   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","5   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","6   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","7   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","8   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","9   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","10  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","11  HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8\n","12  HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          \n","13  HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         \n","14  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","15  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","16  HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC1/HDAC3                                                                                 \n","17  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","18  HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC1/HDAC3/HDAC8                                                                         \n","19  HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                        \n","20  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","21  HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          \n","22  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","23  HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          \n","24  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","25  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","26  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","27  HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          \n","28  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","29  HDAC3/HDAC6/HDAC3/HDAC6/HDAC3/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                   \n","30  TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            \n","⋮   ⋮                                                                                                                                                             \n","153 HDAC2/HDAC2                                                                                                                                                   \n","154 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","155 HDAC4/HDAC4                                                                                                                                                   \n","156 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","157 HDAC1/HDAC1/HDAC1/HDAC1                                                                                                                                       \n","158 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","159 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","160 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","161 HDAC1/HDAC1/HDAC1/HDAC1                                                                                                                                       \n","162 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","163 HDAC1/HDAC1/HDAC1/HDAC1                                                                                                                                       \n","164 DRD1                                                                                                                                                          \n","165 HDAC3/HDAC3/HDAC3                                                                                                                                             \n","166 ADRA1A                                                                                                                                                        \n","167 HDAC7/HDAC7                                                                                                                                                   \n","168 HDAC1/HDAC1/HDAC1/HDAC1                                                                                                                                       \n","169 HDAC4/HDAC4                                                                                                                                                   \n","170 ACE                                                                                                                                                           \n","171 ADRA1A/DRD1/HRH1                                                                                                                                              \n","172 TUBA1B                                                                                                                                                        \n","173 ADRA1A/HRH1                                                                                                                                                   \n","174 ADRA1A/DRD1/HRH1                                                                                                                                              \n","175 ADRA1A                                                                                                                                                        \n","176 ACE                                                                                                                                                           \n","177 TUBA4A                                                                                                                                                        \n","178 TUBA4A                                                                                                                                                        \n","179 DRD1                                                                                                                                                          \n","180 DRD1                                                                                                                                                          \n","181 DRD1                                                                                                                                                          \n","182 DRD1                                                                                                                                                          \n","    Count\n","1    9   \n","2   26   \n","3   26   \n","4   26   \n","5   26   \n","6   26   \n","7   26   \n","8   26   \n","9   26   \n","10  26   \n","11  26   \n","12  13   \n","13   9   \n","14  10   \n","15  10   \n","16  13   \n","17  10   \n","18  14   \n","19  16   \n","20  10   \n","21  13   \n","22  10   \n","23  13   \n","24  10   \n","25  10   \n","26  10   \n","27  13   \n","28  10   \n","29  17   \n","30  10   \n","⋮   ⋮    \n","153 2    \n","154 3    \n","155 2    \n","156 3    \n","157 4    \n","158 3    \n","159 3    \n","160 3    \n","161 4    \n","162 3    \n","163 4    \n","164 1    \n","165 3    \n","166 1    \n","167 2    \n","168 4    \n","169 2    \n","170 1    \n","171 3    \n","172 1    \n","173 2    \n","174 3    \n","175 1    \n","176 1    \n","177 1    \n","178 1    \n","179 1    \n","180 1    \n","181 1    \n","182 1    "],"text/latex":"A tibble: 182 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <int>\\\\\n\\hline\n\t R-HSA-193670  & p75NTR negatively regulates cell cycle via SC1                                   & 9/41  & 6/10867   & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          &  9\\\\\n\t R-HSA-350054  & Notch-HLH transcription pathway                                                  & 26/41 & 28/10867  & 1.143959e-65 & 1.063881e-63 & 1.083750e-64 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2122947 & NOTCH1 Intracellular Domain Regulates Transcription                              & 26/41 & 48/10867  & 8.069550e-55 & 5.003121e-53 & 5.096558e-54 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2644602 & Signaling by NOTCH1 PEST Domain Mutants in Cancer                                & 26/41 & 58/10867  & 6.440257e-52 & 1.497360e-50 & 1.525324e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2644603 & Signaling by NOTCH1 in Cancer                                                    & 26/41 & 58/10867  & 6.440257e-52 & 1.497360e-50 & 1.525324e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2644606 & Constitutive Signaling by NOTCH1 PEST Domain Mutants                             & 26/41 & 58/10867  & 6.440257e-52 & 1.497360e-50 & 1.525324e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2894858 & Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             & 26/41 & 58/10867  & 6.440257e-52 & 1.497360e-50 & 1.525324e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-2894862 & Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          & 26/41 & 58/10867  & 6.440257e-52 & 1.497360e-50 & 1.525324e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-1980143 & Signaling by NOTCH1                                                              & 26/41 & 74/10867  & 1.880392e-48 & 3.886144e-47 & 3.958721e-48 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-157118  & Signaling by NOTCH                                                               & 26/41 & 236/10867 & 6.738928e-34 & 1.253441e-32 & 1.276850e-33 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-5663202 & Diseases of signal transduction by growth factor receptors and second messengers & 26/41 & 433/10867 & 7.122644e-27 & 1.204374e-25 & 1.226867e-26 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 & 26\\\\\n\t R-HSA-9646399 & Aggrephagy                                                                       & 13/41 & 43/10867  & 1.276164e-22 & 1.978055e-21 & 2.014996e-22 & HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           & 13\\\\\n\t R-HSA-9701898 & STAT3 nuclear events downstream of ALK signaling                                 & 9/41  & 10/10867  & 6.019436e-22 & 8.612424e-21 & 8.773267e-22 & HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          &  9\\\\\n\t R-HSA-190840  & Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane & 10/41 & 18/10867  & 7.623154e-21 & 1.012790e-19 & 1.031705e-20 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-190872  & Transport of connexons to the plasma membrane                                    & 10/41 & 19/10867  & 1.605153e-20 & 1.990390e-19 & 2.027562e-20 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-8943724 & Regulation of PTEN gene transcription                                            & 13/41 & 61/10867  & 2.193887e-20 & 2.550394e-19 & 2.598024e-20 & HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC1/HDAC3                                                                                  & 13\\\\\n\t R-HSA-389977  & Post-chaperonin tubulin folding pathway                                          & 10/41 & 22/10867  & 1.114875e-19 & 1.219804e-18 & 1.242585e-19 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-3214815 & HDACs deacetylate histones                                                       & 14/41 & 94/10867  & 1.398876e-19 & 1.445505e-18 & 1.472501e-19 & HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC1/HDAC3/HDAC8                                                                          & 14\\\\\n\t R-HSA-983231  & Factors involved in megakaryocyte development and platelet production            & 16/41 & 168/10867 & 3.808685e-19 & 3.728502e-18 & 3.798135e-19 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                         & 16\\\\\n\t R-HSA-389960  & Formation of tubulin folding intermediates by CCT/TriC                           & 10/41 & 25/10867  & 5.591822e-19 & 5.200395e-18 & 5.297516e-19 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-9663891 & Selective autophagy                                                              & 13/41 & 81/10867  & 1.195235e-18 & 1.058637e-17 & 1.078408e-18 & HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           & 13\\\\\n\t R-HSA-9619483 & Activation of AMPK downstream of NMDARs                                          & 10/41 & 29/10867  & 3.391031e-18 & 2.866962e-17 & 2.920505e-18 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-390466  & Chaperonin-mediated protein folding                                              & 13/41 & 91/10867  & 5.959276e-18 & 4.819240e-17 & 4.909243e-18 & HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           & 13\\\\\n\t R-HSA-9668328 & Sealing of the nuclear envelope (NE) by ESCRT-III                                & 10/41 & 31/10867  & 7.469733e-18 & 5.789043e-17 & 5.897157e-18 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-389958  & Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              & 10/41 & 32/10867  & 1.083683e-17 & 7.752498e-17 & 7.897282e-18 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-5626467 & RHO GTPases activate IQGAPs                                                      & 10/41 & 32/10867  & 1.083683e-17 & 7.752498e-17 & 7.897282e-18 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-391251  & Protein folding                                                                  & 13/41 & 97/10867  & 1.427903e-17 & 9.836665e-17 & 1.002037e-17 & HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           & 13\\\\\n\t R-HSA-190861  & Gap junction assembly                                                            & 10/41 & 36/10867  & 4.225628e-17 & 2.807025e-16 & 2.859448e-17 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t R-HSA-1852241 & Organelle biogenesis and maintenance                                             & 17/41 & 296/10867 & 1.332142e-16 & 8.544082e-16 & 8.703648e-17 & HDAC3/HDAC6/HDAC3/HDAC6/HDAC3/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                    & 17\\\\\n\t R-HSA-9609736 & Assembly and cell surface presentation of NMDA receptors                         & 10/41 & 41/10867  & 1.839622e-16 & 1.140565e-15 & 1.161866e-16 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             & 10\\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t R-HSA-9619665 & EGR2 and SOX10-mediated initiation of Schwann cell myelination                       & 2/41 & 28/10867  & 0.004933802 & 0.005997955 & 0.0006109971 & HDAC2/HDAC2             & 2\\\\\n\t R-HSA-1592230 & Mitochondrial biogenesis                                                             & 3/41 & 95/10867  & 0.005425479 & 0.006552852 & 0.0006675231 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-4090294 & SUMOylation of intracellular receptors                                               & 2/41 & 30/10867  & 0.005650814 & 0.006780977 & 0.0006907617 & HDAC4/HDAC4             & 2\\\\\n\t R-HSA-1989781 & PPARA activates gene expression                                                      & 3/41 & 117/10867 & 0.009630098 & 0.011431917 & 0.0011645416 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-8939211 & ESR-mediated signaling                                                               & 4/41 & 223/10867 & 0.009649521 & 0.011431917 & 0.0011645416 & HDAC1/HDAC1/HDAC1/HDAC1 & 4\\\\\n\t R-HSA-400206  & Regulation of lipid metabolism by PPARalpha                                          & 3/41 & 119/10867 & 0.010084427 & 0.011871541 & 0.0012093251 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-5617472 & Activation of anterior HOX genes in hindbrain development during early embryogenesis & 3/41 & 121/10867 & 0.010551104 & 0.012265659 & 0.0012494729 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-5619507 & Activation of HOX genes during differentiation                                       & 3/41 & 121/10867 & 0.010551104 & 0.012265659 & 0.0012494729 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-201681  & TCF dependent signaling in response to WNT                                           & 4/41 & 233/10867 & 0.011207183 & 0.012944695 & 0.0013186447 & HDAC1/HDAC1/HDAC1/HDAC1 & 4\\\\\n\t R-HSA-9707564 & Cytoprotection by HMOX1                                                              & 3/41 & 124/10867 & 0.011274412 & 0.012944695 & 0.0013186447 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-8878171 & Transcriptional regulation by RUNX1                                                  & 4/41 & 239/10867 & 0.012215727 & 0.013939419 & 0.0014199748 & HDAC1/HDAC1/HDAC1/HDAC1 & 4\\\\\n\t R-HSA-390651  & Dopamine receptors                                                                   & 1/41 & 5/10867   & 0.018726062 & 0.021238094 & 0.0021634731 & DRD1                    & 1\\\\\n\t R-HSA-9711123 & Cellular response to chemical stress                                                 & 3/41 & 160/10867 & 0.022189887 & 0.025014054 & 0.0025481209 & HDAC3/HDAC3/HDAC3       & 3\\\\\n\t R-HSA-390696  & Adrenoceptors                                                                        & 1/41 & 9/10867   & 0.033460183 & 0.037491530 & 0.0038191712 & ADRA1A                  & 1\\\\\n\t R-HSA-3108214 & SUMOylation of DNA damage response and repair proteins                               & 2/41 & 77/10867  & 0.034008228 & 0.037877428 & 0.0038584816 & HDAC7/HDAC7             & 2\\\\\n\t R-HSA-195721  & Signaling by WNT                                                                     & 4/41 & 332/10867 & 0.035676174 & 0.039498622 & 0.0040236287 & HDAC1/HDAC1/HDAC1/HDAC1 & 4\\\\\n\t R-HSA-8878159 & Transcriptional regulation by RUNX3                                                  & 2/41 & 96/10867  & 0.050687943 & 0.055786730 & 0.0056828587 & HDAC4/HDAC4             & 2\\\\\n\t R-HSA-2022377 & Metabolism of Angiotensinogen to Angiotensins                                        & 1/41 & 18/10867  & 0.065827194 & 0.072022695 & 0.0073367771 & ACE                     & 1\\\\\n\t R-HSA-373076  & Class A/1 (Rhodopsin-like receptors)                                                 & 3/41 & 335/10867 & 0.131687405 & 0.143238932 & 0.0145914022 & ADRA1A/DRD1/HRH1        & 3\\\\\n\t R-HSA-9013407 & RHOH GTPase cycle                                                                    & 1/41 & 38/10867  & 0.134014003 & 0.144922120 & 0.0147628645 & TUBA1B                  & 1\\\\\n\t R-HSA-416476  & G alpha (q) signalling events                                                        & 2/41 & 216/10867 & 0.195759615 & 0.210469876 & 0.0214400552 & ADRA1A/HRH1             & 2\\\\\n\t R-HSA-500792  & GPCR ligand binding                                                                  & 3/41 & 467/10867 & 0.257607503 & 0.275373537 & 0.0280516337 & ADRA1A/DRD1/HRH1        & 3\\\\\n\t R-HSA-416482  & G alpha (12/13) signalling events                                                    & 1/41 & 80/10867  & 0.261776560 & 0.278231087 & 0.0283427253 & ADRA1A                  & 1\\\\\n\t R-HSA-2980736 & Peptide hormone metabolism                                                           & 1/41 & 91/10867  & 0.292075229 & 0.308670412 & 0.0314435055 & ACE                     & 1\\\\\n\t R-HSA-114608  & Platelet degranulation                                                               & 1/41 & 129/10867 & 0.387694221 & 0.407407487 & 0.0415016116 & TUBA4A                  & 1\\\\\n\t R-HSA-76005   & Response to elevated platelet cytosolic Ca2+                                         & 1/41 & 134/10867 & 0.399297017 & 0.414911985 & 0.0422660765 & TUBA4A                  & 1\\\\\n\t R-HSA-9660821 & ADORA2B mediated anti-inflammatory cytokines production                              & 1/41 & 134/10867 & 0.399297017 & 0.414911985 & 0.0422660765 & DRD1                    & 1\\\\\n\t R-HSA-418555  & G alpha (s) signalling events                                                        & 1/41 & 145/10867 & 0.424073215 & 0.438208989 & 0.0446392858 & DRD1                    & 1\\\\\n\t R-HSA-9662851 & Anti-inflammatory response favouring Leishmania parasite infection                   & 1/41 & 169/10867 & 0.474719846 & 0.485153249 & 0.0494213836 & DRD1                    & 1\\\\\n\t R-HSA-9664433 & Leishmania parasite growth and survival                                              & 1/41 & 169/10867 & 0.474719846 & 0.485153249 & 0.0494213836 & DRD1                    & 1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 182 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|\n| R-HSA-193670  | p75NTR negatively regulates cell cycle via SC1                                   | 9/41  | 6/10867   | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          |  9 |\n| R-HSA-350054  | Notch-HLH transcription pathway                                                  | 26/41 | 28/10867  | 1.143959e-65 | 1.063881e-63 | 1.083750e-64 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription                              | 26/41 | 48/10867  | 8.069550e-55 | 5.003121e-53 | 5.096558e-54 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer                                | 26/41 | 58/10867  | 6.440257e-52 | 1.497360e-50 | 1.525324e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2644603 | Signaling by NOTCH1 in Cancer                                                    | 26/41 | 58/10867  | 6.440257e-52 | 1.497360e-50 | 1.525324e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants                             | 26/41 | 58/10867  | 6.440257e-52 | 1.497360e-50 | 1.525324e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             | 26/41 | 58/10867  | 6.440257e-52 | 1.497360e-50 | 1.525324e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          | 26/41 | 58/10867  | 6.440257e-52 | 1.497360e-50 | 1.525324e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-1980143 | Signaling by NOTCH1                                                              | 26/41 | 74/10867  | 1.880392e-48 | 3.886144e-47 | 3.958721e-48 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-157118  | Signaling by NOTCH                                                               | 26/41 | 236/10867 | 6.738928e-34 | 1.253441e-32 | 1.276850e-33 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 26/41 | 433/10867 | 7.122644e-27 | 1.204374e-25 | 1.226867e-26 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8 | 26 |\n| R-HSA-9646399 | Aggrephagy                                                                       | 13/41 | 43/10867  | 1.276164e-22 | 1.978055e-21 | 2.014996e-22 | HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           | 13 |\n| R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling                                 | 9/41  | 10/10867  | 6.019436e-22 | 8.612424e-21 | 8.773267e-22 | HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                          |  9 |\n| R-HSA-190840  | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 10/41 | 18/10867  | 7.623154e-21 | 1.012790e-19 | 1.031705e-20 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-190872  | Transport of connexons to the plasma membrane                                    | 10/41 | 19/10867  | 1.605153e-20 | 1.990390e-19 | 2.027562e-20 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-8943724 | Regulation of PTEN gene transcription                                            | 13/41 | 61/10867  | 2.193887e-20 | 2.550394e-19 | 2.598024e-20 | HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC1/HDAC3                                                                                  | 13 |\n| R-HSA-389977  | Post-chaperonin tubulin folding pathway                                          | 10/41 | 22/10867  | 1.114875e-19 | 1.219804e-18 | 1.242585e-19 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-3214815 | HDACs deacetylate histones                                                       | 14/41 | 94/10867  | 1.398876e-19 | 1.445505e-18 | 1.472501e-19 | HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC1/HDAC3/HDAC8                                                                          | 14 |\n| R-HSA-983231  | Factors involved in megakaryocyte development and platelet production            | 16/41 | 168/10867 | 3.808685e-19 | 3.728502e-18 | 3.798135e-19 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                         | 16 |\n| R-HSA-389960  | Formation of tubulin folding intermediates by CCT/TriC                           | 10/41 | 25/10867  | 5.591822e-19 | 5.200395e-18 | 5.297516e-19 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-9663891 | Selective autophagy                                                              | 13/41 | 81/10867  | 1.195235e-18 | 1.058637e-17 | 1.078408e-18 | HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           | 13 |\n| R-HSA-9619483 | Activation of AMPK downstream of NMDARs                                          | 10/41 | 29/10867  | 3.391031e-18 | 2.866962e-17 | 2.920505e-18 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-390466  | Chaperonin-mediated protein folding                                              | 13/41 | 91/10867  | 5.959276e-18 | 4.819240e-17 | 4.909243e-18 | HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           | 13 |\n| R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III                                | 10/41 | 31/10867  | 7.469733e-18 | 5.789043e-17 | 5.897157e-18 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-389958  | Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              | 10/41 | 32/10867  | 1.083683e-17 | 7.752498e-17 | 7.897282e-18 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-5626467 | RHO GTPases activate IQGAPs                                                      | 10/41 | 32/10867  | 1.083683e-17 | 7.752498e-17 | 7.897282e-18 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-391251  | Protein folding                                                                  | 13/41 | 97/10867  | 1.427903e-17 | 9.836665e-17 | 1.002037e-17 | HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                           | 13 |\n| R-HSA-190861  | Gap junction assembly                                                            | 10/41 | 36/10867  | 4.225628e-17 | 2.807025e-16 | 2.859448e-17 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| R-HSA-1852241 | Organelle biogenesis and maintenance                                             | 17/41 | 296/10867 | 1.332142e-16 | 8.544082e-16 | 8.703648e-17 | HDAC3/HDAC6/HDAC3/HDAC6/HDAC3/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                    | 17 |\n| R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors                         | 10/41 | 41/10867  | 1.839622e-16 | 1.140565e-15 | 1.161866e-16 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                             | 10 |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| R-HSA-9619665 | EGR2 and SOX10-mediated initiation of Schwann cell myelination                       | 2/41 | 28/10867  | 0.004933802 | 0.005997955 | 0.0006109971 | HDAC2/HDAC2             | 2 |\n| R-HSA-1592230 | Mitochondrial biogenesis                                                             | 3/41 | 95/10867  | 0.005425479 | 0.006552852 | 0.0006675231 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-4090294 | SUMOylation of intracellular receptors                                               | 2/41 | 30/10867  | 0.005650814 | 0.006780977 | 0.0006907617 | HDAC4/HDAC4             | 2 |\n| R-HSA-1989781 | PPARA activates gene expression                                                      | 3/41 | 117/10867 | 0.009630098 | 0.011431917 | 0.0011645416 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-8939211 | ESR-mediated signaling                                                               | 4/41 | 223/10867 | 0.009649521 | 0.011431917 | 0.0011645416 | HDAC1/HDAC1/HDAC1/HDAC1 | 4 |\n| R-HSA-400206  | Regulation of lipid metabolism by PPARalpha                                          | 3/41 | 119/10867 | 0.010084427 | 0.011871541 | 0.0012093251 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 3/41 | 121/10867 | 0.010551104 | 0.012265659 | 0.0012494729 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-5619507 | Activation of HOX genes during differentiation                                       | 3/41 | 121/10867 | 0.010551104 | 0.012265659 | 0.0012494729 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-201681  | TCF dependent signaling in response to WNT                                           | 4/41 | 233/10867 | 0.011207183 | 0.012944695 | 0.0013186447 | HDAC1/HDAC1/HDAC1/HDAC1 | 4 |\n| R-HSA-9707564 | Cytoprotection by HMOX1                                                              | 3/41 | 124/10867 | 0.011274412 | 0.012944695 | 0.0013186447 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-8878171 | Transcriptional regulation by RUNX1                                                  | 4/41 | 239/10867 | 0.012215727 | 0.013939419 | 0.0014199748 | HDAC1/HDAC1/HDAC1/HDAC1 | 4 |\n| R-HSA-390651  | Dopamine receptors                                                                   | 1/41 | 5/10867   | 0.018726062 | 0.021238094 | 0.0021634731 | DRD1                    | 1 |\n| R-HSA-9711123 | Cellular response to chemical stress                                                 | 3/41 | 160/10867 | 0.022189887 | 0.025014054 | 0.0025481209 | HDAC3/HDAC3/HDAC3       | 3 |\n| R-HSA-390696  | Adrenoceptors                                                                        | 1/41 | 9/10867   | 0.033460183 | 0.037491530 | 0.0038191712 | ADRA1A                  | 1 |\n| R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins                               | 2/41 | 77/10867  | 0.034008228 | 0.037877428 | 0.0038584816 | HDAC7/HDAC7             | 2 |\n| R-HSA-195721  | Signaling by WNT                                                                     | 4/41 | 332/10867 | 0.035676174 | 0.039498622 | 0.0040236287 | HDAC1/HDAC1/HDAC1/HDAC1 | 4 |\n| R-HSA-8878159 | Transcriptional regulation by RUNX3                                                  | 2/41 | 96/10867  | 0.050687943 | 0.055786730 | 0.0056828587 | HDAC4/HDAC4             | 2 |\n| R-HSA-2022377 | Metabolism of Angiotensinogen to Angiotensins                                        | 1/41 | 18/10867  | 0.065827194 | 0.072022695 | 0.0073367771 | ACE                     | 1 |\n| R-HSA-373076  | Class A/1 (Rhodopsin-like receptors)                                                 | 3/41 | 335/10867 | 0.131687405 | 0.143238932 | 0.0145914022 | ADRA1A/DRD1/HRH1        | 3 |\n| R-HSA-9013407 | RHOH GTPase cycle                                                                    | 1/41 | 38/10867  | 0.134014003 | 0.144922120 | 0.0147628645 | TUBA1B                  | 1 |\n| R-HSA-416476  | G alpha (q) signalling events                                                        | 2/41 | 216/10867 | 0.195759615 | 0.210469876 | 0.0214400552 | ADRA1A/HRH1             | 2 |\n| R-HSA-500792  | GPCR ligand binding                                                                  | 3/41 | 467/10867 | 0.257607503 | 0.275373537 | 0.0280516337 | ADRA1A/DRD1/HRH1        | 3 |\n| R-HSA-416482  | G alpha (12/13) signalling events                                                    | 1/41 | 80/10867  | 0.261776560 | 0.278231087 | 0.0283427253 | ADRA1A                  | 1 |\n| R-HSA-2980736 | Peptide hormone metabolism                                                           | 1/41 | 91/10867  | 0.292075229 | 0.308670412 | 0.0314435055 | ACE                     | 1 |\n| R-HSA-114608  | Platelet degranulation                                                               | 1/41 | 129/10867 | 0.387694221 | 0.407407487 | 0.0415016116 | TUBA4A                  | 1 |\n| R-HSA-76005   | Response to elevated platelet cytosolic Ca2+                                         | 1/41 | 134/10867 | 0.399297017 | 0.414911985 | 0.0422660765 | TUBA4A                  | 1 |\n| R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production                              | 1/41 | 134/10867 | 0.399297017 | 0.414911985 | 0.0422660765 | DRD1                    | 1 |\n| R-HSA-418555  | G alpha (s) signalling events                                                        | 1/41 | 145/10867 | 0.424073215 | 0.438208989 | 0.0446392858 | DRD1                    | 1 |\n| R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection                   | 1/41 | 169/10867 | 0.474719846 | 0.485153249 | 0.0494213836 | DRD1                    | 1 |\n| R-HSA-9664433 | Leishmania parasite growth and survival                                              | 1/41 | 169/10867 | 0.474719846 | 0.485153249 | 0.0494213836 | DRD1                    | 1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 182 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>R-HSA-193670 </td><td>p75NTR negatively regulates cell cycle via SC1                                  </td><td>9/41 </td><td>6/10867  </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         </td><td> 9</td></tr>\n","\t<tr><td>R-HSA-350054 </td><td>Notch-HLH transcription pathway                                                 </td><td>26/41</td><td>28/10867 </td><td>1.143959e-65</td><td>1.063881e-63</td><td>1.083750e-64</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2122947</td><td>NOTCH1 Intracellular Domain Regulates Transcription                             </td><td>26/41</td><td>48/10867 </td><td>8.069550e-55</td><td>5.003121e-53</td><td>5.096558e-54</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2644602</td><td>Signaling by NOTCH1 PEST Domain Mutants in Cancer                               </td><td>26/41</td><td>58/10867 </td><td>6.440257e-52</td><td>1.497360e-50</td><td>1.525324e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2644603</td><td>Signaling by NOTCH1 in Cancer                                                   </td><td>26/41</td><td>58/10867 </td><td>6.440257e-52</td><td>1.497360e-50</td><td>1.525324e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2644606</td><td>Constitutive Signaling by NOTCH1 PEST Domain Mutants                            </td><td>26/41</td><td>58/10867 </td><td>6.440257e-52</td><td>1.497360e-50</td><td>1.525324e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2894858</td><td>Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                            </td><td>26/41</td><td>58/10867 </td><td>6.440257e-52</td><td>1.497360e-50</td><td>1.525324e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-2894862</td><td>Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                         </td><td>26/41</td><td>58/10867 </td><td>6.440257e-52</td><td>1.497360e-50</td><td>1.525324e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-1980143</td><td>Signaling by NOTCH1                                                             </td><td>26/41</td><td>74/10867 </td><td>1.880392e-48</td><td>3.886144e-47</td><td>3.958721e-48</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-157118 </td><td>Signaling by NOTCH                                                              </td><td>26/41</td><td>236/10867</td><td>6.738928e-34</td><td>1.253441e-32</td><td>1.276850e-33</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-5663202</td><td>Diseases of signal transduction by growth factor receptors and second messengers</td><td>26/41</td><td>433/10867</td><td>7.122644e-27</td><td>1.204374e-25</td><td>1.226867e-26</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8</td><td>26</td></tr>\n","\t<tr><td>R-HSA-9646399</td><td>Aggrephagy                                                                      </td><td>13/41</td><td>43/10867 </td><td>1.276164e-22</td><td>1.978055e-21</td><td>2.014996e-22</td><td>HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          </td><td>13</td></tr>\n","\t<tr><td>R-HSA-9701898</td><td>STAT3 nuclear events downstream of ALK signaling                                </td><td>9/41 </td><td>10/10867 </td><td>6.019436e-22</td><td>8.612424e-21</td><td>8.773267e-22</td><td>HDAC1/HDAC2/HDAC3/HDAC1/HDAC2/HDAC3/HDAC1/HDAC1/HDAC3                                                                                                         </td><td> 9</td></tr>\n","\t<tr><td>R-HSA-190840 </td><td>Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane</td><td>10/41</td><td>18/10867 </td><td>7.623154e-21</td><td>1.012790e-19</td><td>1.031705e-20</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-190872 </td><td>Transport of connexons to the plasma membrane                                   </td><td>10/41</td><td>19/10867 </td><td>1.605153e-20</td><td>1.990390e-19</td><td>2.027562e-20</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-8943724</td><td>Regulation of PTEN gene transcription                                           </td><td>13/41</td><td>61/10867 </td><td>2.193887e-20</td><td>2.550394e-19</td><td>2.598024e-20</td><td>HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC2/HDAC3/HDAC5/HDAC7/HDAC1/HDAC1/HDAC3                                                                                 </td><td>13</td></tr>\n","\t<tr><td>R-HSA-389977 </td><td>Post-chaperonin tubulin folding pathway                                         </td><td>10/41</td><td>22/10867 </td><td>1.114875e-19</td><td>1.219804e-18</td><td>1.242585e-19</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-3214815</td><td>HDACs deacetylate histones                                                      </td><td>14/41</td><td>94/10867 </td><td>1.398876e-19</td><td>1.445505e-18</td><td>1.472501e-19</td><td>HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC10/HDAC2/HDAC3/HDAC8/HDAC1/HDAC1/HDAC3/HDAC8                                                                         </td><td>14</td></tr>\n","\t<tr><td>R-HSA-983231 </td><td>Factors involved in megakaryocyte development and platelet production           </td><td>16/41</td><td>168/10867</td><td>3.808685e-19</td><td>3.728502e-18</td><td>3.798135e-19</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                        </td><td>16</td></tr>\n","\t<tr><td>R-HSA-389960 </td><td>Formation of tubulin folding intermediates by CCT/TriC                          </td><td>10/41</td><td>25/10867 </td><td>5.591822e-19</td><td>5.200395e-18</td><td>5.297516e-19</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-9663891</td><td>Selective autophagy                                                             </td><td>13/41</td><td>81/10867 </td><td>1.195235e-18</td><td>1.058637e-17</td><td>1.078408e-18</td><td>HDAC6/HDAC6/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          </td><td>13</td></tr>\n","\t<tr><td>R-HSA-9619483</td><td>Activation of AMPK downstream of NMDARs                                         </td><td>10/41</td><td>29/10867 </td><td>3.391031e-18</td><td>2.866962e-17</td><td>2.920505e-18</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-390466 </td><td>Chaperonin-mediated protein folding                                             </td><td>13/41</td><td>91/10867 </td><td>5.959276e-18</td><td>4.819240e-17</td><td>4.909243e-18</td><td>HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          </td><td>13</td></tr>\n","\t<tr><td>R-HSA-9668328</td><td>Sealing of the nuclear envelope (NE) by ESCRT-III                               </td><td>10/41</td><td>31/10867 </td><td>7.469733e-18</td><td>5.789043e-17</td><td>5.897157e-18</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-389958 </td><td>Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding             </td><td>10/41</td><td>32/10867 </td><td>1.083683e-17</td><td>7.752498e-17</td><td>7.897282e-18</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-5626467</td><td>RHO GTPases activate IQGAPs                                                     </td><td>10/41</td><td>32/10867 </td><td>1.083683e-17</td><td>7.752498e-17</td><td>7.897282e-18</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-391251 </td><td>Protein folding                                                                 </td><td>13/41</td><td>97/10867 </td><td>1.427903e-17</td><td>9.836665e-17</td><td>1.002037e-17</td><td>HDAC3/HDAC3/HDAC3/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                          </td><td>13</td></tr>\n","\t<tr><td>R-HSA-190861 </td><td>Gap junction assembly                                                           </td><td>10/41</td><td>36/10867 </td><td>4.225628e-17</td><td>2.807025e-16</td><td>2.859448e-17</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>R-HSA-1852241</td><td>Organelle biogenesis and maintenance                                            </td><td>17/41</td><td>296/10867</td><td>1.332142e-16</td><td>8.544082e-16</td><td>8.703648e-17</td><td>HDAC3/HDAC6/HDAC3/HDAC6/HDAC3/HDAC6/TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B                                                   </td><td>17</td></tr>\n","\t<tr><td>R-HSA-9609736</td><td>Assembly and cell surface presentation of NMDA receptors                        </td><td>10/41</td><td>41/10867 </td><td>1.839622e-16</td><td>1.140565e-15</td><td>1.161866e-16</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB1/TUBB3/TUBB4A/TUBB4B                                                                                            </td><td>10</td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>R-HSA-9619665</td><td>EGR2 and SOX10-mediated initiation of Schwann cell myelination                      </td><td>2/41</td><td>28/10867 </td><td>0.004933802</td><td>0.005997955</td><td>0.0006109971</td><td>HDAC2/HDAC2            </td><td>2</td></tr>\n","\t<tr><td>R-HSA-1592230</td><td>Mitochondrial biogenesis                                                            </td><td>3/41</td><td>95/10867 </td><td>0.005425479</td><td>0.006552852</td><td>0.0006675231</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-4090294</td><td>SUMOylation of intracellular receptors                                              </td><td>2/41</td><td>30/10867 </td><td>0.005650814</td><td>0.006780977</td><td>0.0006907617</td><td>HDAC4/HDAC4            </td><td>2</td></tr>\n","\t<tr><td>R-HSA-1989781</td><td>PPARA activates gene expression                                                     </td><td>3/41</td><td>117/10867</td><td>0.009630098</td><td>0.011431917</td><td>0.0011645416</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-8939211</td><td>ESR-mediated signaling                                                              </td><td>4/41</td><td>223/10867</td><td>0.009649521</td><td>0.011431917</td><td>0.0011645416</td><td>HDAC1/HDAC1/HDAC1/HDAC1</td><td>4</td></tr>\n","\t<tr><td>R-HSA-400206 </td><td>Regulation of lipid metabolism by PPARalpha                                         </td><td>3/41</td><td>119/10867</td><td>0.010084427</td><td>0.011871541</td><td>0.0012093251</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-5617472</td><td>Activation of anterior HOX genes in hindbrain development during early embryogenesis</td><td>3/41</td><td>121/10867</td><td>0.010551104</td><td>0.012265659</td><td>0.0012494729</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-5619507</td><td>Activation of HOX genes during differentiation                                      </td><td>3/41</td><td>121/10867</td><td>0.010551104</td><td>0.012265659</td><td>0.0012494729</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-201681 </td><td>TCF dependent signaling in response to WNT                                          </td><td>4/41</td><td>233/10867</td><td>0.011207183</td><td>0.012944695</td><td>0.0013186447</td><td>HDAC1/HDAC1/HDAC1/HDAC1</td><td>4</td></tr>\n","\t<tr><td>R-HSA-9707564</td><td>Cytoprotection by HMOX1                                                             </td><td>3/41</td><td>124/10867</td><td>0.011274412</td><td>0.012944695</td><td>0.0013186447</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-8878171</td><td>Transcriptional regulation by RUNX1                                                 </td><td>4/41</td><td>239/10867</td><td>0.012215727</td><td>0.013939419</td><td>0.0014199748</td><td>HDAC1/HDAC1/HDAC1/HDAC1</td><td>4</td></tr>\n","\t<tr><td>R-HSA-390651 </td><td>Dopamine receptors                                                                  </td><td>1/41</td><td>5/10867  </td><td>0.018726062</td><td>0.021238094</td><td>0.0021634731</td><td>DRD1                   </td><td>1</td></tr>\n","\t<tr><td>R-HSA-9711123</td><td>Cellular response to chemical stress                                                </td><td>3/41</td><td>160/10867</td><td>0.022189887</td><td>0.025014054</td><td>0.0025481209</td><td>HDAC3/HDAC3/HDAC3      </td><td>3</td></tr>\n","\t<tr><td>R-HSA-390696 </td><td>Adrenoceptors                                                                       </td><td>1/41</td><td>9/10867  </td><td>0.033460183</td><td>0.037491530</td><td>0.0038191712</td><td>ADRA1A                 </td><td>1</td></tr>\n","\t<tr><td>R-HSA-3108214</td><td>SUMOylation of DNA damage response and repair proteins                              </td><td>2/41</td><td>77/10867 </td><td>0.034008228</td><td>0.037877428</td><td>0.0038584816</td><td>HDAC7/HDAC7            </td><td>2</td></tr>\n","\t<tr><td>R-HSA-195721 </td><td>Signaling by WNT                                                                    </td><td>4/41</td><td>332/10867</td><td>0.035676174</td><td>0.039498622</td><td>0.0040236287</td><td>HDAC1/HDAC1/HDAC1/HDAC1</td><td>4</td></tr>\n","\t<tr><td>R-HSA-8878159</td><td>Transcriptional regulation by RUNX3                                                 </td><td>2/41</td><td>96/10867 </td><td>0.050687943</td><td>0.055786730</td><td>0.0056828587</td><td>HDAC4/HDAC4            </td><td>2</td></tr>\n","\t<tr><td>R-HSA-2022377</td><td>Metabolism of Angiotensinogen to Angiotensins                                       </td><td>1/41</td><td>18/10867 </td><td>0.065827194</td><td>0.072022695</td><td>0.0073367771</td><td>ACE                    </td><td>1</td></tr>\n","\t<tr><td>R-HSA-373076 </td><td>Class A/1 (Rhodopsin-like receptors)                                                </td><td>3/41</td><td>335/10867</td><td>0.131687405</td><td>0.143238932</td><td>0.0145914022</td><td>ADRA1A/DRD1/HRH1       </td><td>3</td></tr>\n","\t<tr><td>R-HSA-9013407</td><td>RHOH GTPase cycle                                                                   </td><td>1/41</td><td>38/10867 </td><td>0.134014003</td><td>0.144922120</td><td>0.0147628645</td><td>TUBA1B                 </td><td>1</td></tr>\n","\t<tr><td>R-HSA-416476 </td><td>G alpha (q) signalling events                                                       </td><td>2/41</td><td>216/10867</td><td>0.195759615</td><td>0.210469876</td><td>0.0214400552</td><td>ADRA1A/HRH1            </td><td>2</td></tr>\n","\t<tr><td>R-HSA-500792 </td><td>GPCR ligand binding                                                                 </td><td>3/41</td><td>467/10867</td><td>0.257607503</td><td>0.275373537</td><td>0.0280516337</td><td>ADRA1A/DRD1/HRH1       </td><td>3</td></tr>\n","\t<tr><td>R-HSA-416482 </td><td>G alpha (12/13) signalling events                                                   </td><td>1/41</td><td>80/10867 </td><td>0.261776560</td><td>0.278231087</td><td>0.0283427253</td><td>ADRA1A                 </td><td>1</td></tr>\n","\t<tr><td>R-HSA-2980736</td><td>Peptide hormone metabolism                                                          </td><td>1/41</td><td>91/10867 </td><td>0.292075229</td><td>0.308670412</td><td>0.0314435055</td><td>ACE                    </td><td>1</td></tr>\n","\t<tr><td>R-HSA-114608 </td><td>Platelet degranulation                                                              </td><td>1/41</td><td>129/10867</td><td>0.387694221</td><td>0.407407487</td><td>0.0415016116</td><td>TUBA4A                 </td><td>1</td></tr>\n","\t<tr><td>R-HSA-76005  </td><td>Response to elevated platelet cytosolic Ca2+                                        </td><td>1/41</td><td>134/10867</td><td>0.399297017</td><td>0.414911985</td><td>0.0422660765</td><td>TUBA4A                 </td><td>1</td></tr>\n","\t<tr><td>R-HSA-9660821</td><td>ADORA2B mediated anti-inflammatory cytokines production                             </td><td>1/41</td><td>134/10867</td><td>0.399297017</td><td>0.414911985</td><td>0.0422660765</td><td>DRD1                   </td><td>1</td></tr>\n","\t<tr><td>R-HSA-418555 </td><td>G alpha (s) signalling events                                                       </td><td>1/41</td><td>145/10867</td><td>0.424073215</td><td>0.438208989</td><td>0.0446392858</td><td>DRD1                   </td><td>1</td></tr>\n","\t<tr><td>R-HSA-9662851</td><td>Anti-inflammatory response favouring Leishmania parasite infection                  </td><td>1/41</td><td>169/10867</td><td>0.474719846</td><td>0.485153249</td><td>0.0494213836</td><td>DRD1                   </td><td>1</td></tr>\n","\t<tr><td>R-HSA-9664433</td><td>Leishmania parasite growth and survival                                             </td><td>1/41</td><td>169/10867</td><td>0.474719846</td><td>0.485153249</td><td>0.0494213836</td><td>DRD1                   </td><td>1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"H5oX40Ku4sCw"},"source":["## 2. mGSEA method\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"0vJO2F-2KMlG","executionInfo":{"status":"ok","timestamp":1636338311866,"user_tz":-480,"elapsed":7890,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"f50c66bb-23bf-4254-e39c-fb190fa30c5c"},"source":["# GO\n","mgsea_res <- tsea_mGSEA(drugs = drugs, type='GO', ont='MF', exponent=1,\n","                        nPerm = 1000, pvalueCutoff = 1, minGSSize=5)\n","result(mgsea_res)                      "],"execution_count":30,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["   ont ID        \n","1  MF  GO:0031078\n","2  MF  GO:0032041\n","3  MF  GO:0017136\n","4  MF  GO:0034979\n","5  MF  GO:0004407\n","6  MF  GO:0033558\n","7  MF  GO:0019213\n","8  MF  GO:0051059\n","9  MF  GO:0016811\n","10 MF  GO:0030955\n","11 MF  GO:0070491\n","12 MF  GO:0004936\n","13 MF  GO:0004969\n","14 MF  GO:0042826\n","15 MF  GO:0016810\n","16 MF  GO:1990841\n","17 MF  GO:0019789\n","18 MF  GO:0048156\n","19 MF  GO:0051879\n","20 MF  GO:0001103\n","21 MF  GO:0070840\n","22 MF  GO:0031420\n","23 MF  GO:0051787\n","24 MF  GO:0005080\n","25 MF  GO:0005200\n","26 MF  GO:0042288\n","27 MF  GO:0031492\n","28 MF  GO:0004952\n","29 MF  GO:0033613\n","30 MF  GO:0001046\n","⋮  ⋮   ⋮         \n","64 MF  GO:0032182\n","65 MF  GO:0004993\n","66 MF  GO:0099589\n","67 MF  GO:0005525\n","68 MF  GO:0032550\n","69 MF  GO:0001883\n","70 MF  GO:0032549\n","71 MF  GO:0001882\n","72 MF  GO:0019001\n","73 MF  GO:0032561\n","74 MF  GO:0003725\n","75 MF  GO:0099528\n","76 MF  GO:0004180\n","77 MF  GO:0004177\n","78 MF  GO:0140030\n","79 MF  GO:0031625\n","80 MF  GO:0030594\n","81 MF  GO:0044389\n","82 MF  GO:0008235\n","83 MF  GO:0070405\n","84 MF  GO:0008017\n","85 MF  GO:0019787\n","86 MF  GO:0015631\n","87 MF  GO:0008238\n","88 MF  GO:0003779\n","89 MF  GO:0051082\n","90 MF  GO:0008237\n","91 MF  GO:0008236\n","92 MF  GO:0001664\n","93 MF  GO:0017171\n","   Description                                                                            \n","1  histone deacetylase activity (H3-K14 specific)                                         \n","2  NAD-dependent histone deacetylase activity (H3-K14 specific)                           \n","3  NAD-dependent histone deacetylase activity                                             \n","4  NAD-dependent protein deacetylase activity                                             \n","5  histone deacetylase activity                                                           \n","6  protein deacetylase activity                                                           \n","7  deacetylase activity                                                                   \n","8  NF-kappaB binding                                                                      \n","9  hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides\n","10 potassium ion binding                                                                  \n","11 repressing transcription factor binding                                                \n","12 alpha-adrenergic receptor activity                                                     \n","13 histamine receptor activity                                                            \n","14 histone deacetylase binding                                                            \n","15 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  \n","16 promoter-specific chromatin binding                                                    \n","17 SUMO transferase activity                                                              \n","18 tau protein binding                                                                    \n","19 Hsp90 protein binding                                                                  \n","20 RNA polymerase II repressing transcription factor binding                              \n","21 dynein complex binding                                                                 \n","22 alkali metal ion binding                                                               \n","23 misfolded protein binding                                                              \n","24 protein kinase C binding                                                               \n","25 structural constituent of cytoskeleton                                                 \n","26 MHC class I protein binding                                                            \n","27 nucleosomal DNA binding                                                                \n","28 dopamine neurotransmitter receptor activity                                            \n","29 activating transcription factor binding                                                \n","30 core promoter sequence-specific DNA binding                                            \n","⋮  ⋮                                                                                      \n","64 ubiquitin-like protein binding                                                         \n","65 G protein-coupled serotonin receptor activity                                          \n","66 serotonin receptor activity                                                            \n","67 GTP binding                                                                            \n","68 purine ribonucleoside binding                                                          \n","69 purine nucleoside binding                                                              \n","70 ribonucleoside binding                                                                 \n","71 nucleoside binding                                                                     \n","72 guanyl nucleotide binding                                                              \n","73 guanyl ribonucleotide binding                                                          \n","74 double-stranded RNA binding                                                            \n","75 G protein-coupled neurotransmitter receptor activity                                   \n","76 carboxypeptidase activity                                                              \n","77 aminopeptidase activity                                                                \n","78 modification-dependent protein binding                                                 \n","79 ubiquitin protein ligase binding                                                       \n","80 neurotransmitter receptor activity                                                     \n","81 ubiquitin-like protein ligase binding                                                  \n","82 metalloexopeptidase activity                                                           \n","83 ammonium ion binding                                                                   \n","84 microtubule binding                                                                    \n","85 ubiquitin-like protein transferase activity                                            \n","86 tubulin binding                                                                        \n","87 exopeptidase activity                                                                  \n","88 actin binding                                                                          \n","89 unfolded protein binding                                                               \n","90 metallopeptidase activity                                                              \n","91 serine-type peptidase activity                                                         \n","92 G protein-coupled receptor binding                                                     \n","93 serine hydrolase activity                                                              \n","   setSize enrichmentScore NES        pvalue p.adjust  qvalues  \n","1   11     0.99984572      3.8672302  0.001  0.6275000 0.6275000\n","2   11     0.99984572      3.8672302  0.001  0.6275000 0.6275000\n","3   16     0.83855536      3.7836720  0.011  0.7172965 0.7172965\n","4   17     0.81234567      3.7626916  0.013  0.7172965 0.7172965\n","5   44     0.44052342      2.7995162  0.033  0.7172965 0.7172965\n","6   45     0.43317878      2.7163464  0.037  0.7172965 0.7172965\n","7   58     0.35600973      2.2812622  0.049  0.7172965 0.7172965\n","8   28     0.26455147      1.4505699  0.043  0.7172965 0.7172965\n","9   89     0.24984510      1.4659929  0.087  0.7172965 0.7172965\n","10  10     0.18150964      0.6747153  0.401  0.7172965 0.7172965\n","11  74     0.17052533      1.0575305  0.077  0.7172965 0.7172965\n","12   6     0.16610111      0.4901962  0.479  0.7172965 0.7172965\n","13   6     0.16594687      0.4897410  0.479  0.7172965 0.7172965\n","14 112     0.16118693      0.9178398  0.108  0.7172965 0.7172965\n","15 147     0.16033846      0.8090097  0.137  0.7172965 0.7172965\n","16  46     0.15665667      0.9912932  0.117  0.7172965 0.7172965\n","17  24     0.15348592      0.8006033  0.313  0.7172965 0.7172965\n","18  19     0.14275425      0.6794700  0.394  0.7172965 0.7172965\n","19  38     0.14275415      0.8645490  0.228  0.7172965 0.7172965\n","20  38     0.14265115      0.8639252  0.228  0.7172965 0.7172965\n","21  22     0.12489709      0.6358432  0.431  0.7172965 0.7172965\n","22  15     0.12469137      0.5475600  0.481  0.7172965 0.7172965\n","23  23     0.11989708      0.6151019  0.427  0.7172965 0.7172965\n","24  49     0.11502392      0.7303855  0.270  0.7172965 0.7172965\n","25 102     0.10706810      0.6190346  0.166  0.7172965 0.7172965\n","26  19     0.10402840      0.4951459  0.477  0.7172965 0.7172965\n","27  55     0.10148874      0.6468140  0.324  0.7172965 0.7172965\n","28  10     0.09938291      0.3694304  0.485  0.7172965 0.7172965\n","29  76     0.09845583      0.6011904  0.270  0.7172965 0.7172965\n","30  38     0.09756098      0.5908497  0.432  0.7172965 0.7172965\n","⋮  ⋮       ⋮               ⋮          ⋮      ⋮         ⋮        \n","64  91     0.032154785     0.18831241 0.556  0.7172965 0.7172965\n","65  34     0.028690933     0.16806346 0.498  0.7172965 0.7172965\n","66  34     0.028690933     0.16806346 0.498  0.7172965 0.7172965\n","67 374     0.028625684     0.07578614 0.638  0.7172965 0.7172965\n","68 379     0.028237460     0.07330235 0.646  0.7172965 0.7172965\n","69 382     0.028009401     0.07202489 0.650  0.7172965 0.7172965\n","70 383     0.027934175     0.07183819 0.650  0.7172965 0.7172965\n","71 390     0.027418387     0.06969815 0.658  0.7172965 0.7172965\n","72 395     0.027061154     0.06880283 0.663  0.7172965 0.7172965\n","73 395     0.027061154     0.06880283 0.663  0.7172965 0.7172965\n","74  75     0.025428340     0.15735374 0.536  0.7172965 0.7172965\n","75  41     0.023669152     0.14743885 0.501  0.7172965 0.7172965\n","76  45     0.021707050     0.13611901 0.513  0.7172965 0.7172965\n","77  46     0.021223932     0.13430095 0.512  0.7172965 0.7172965\n","78 142     0.020729782     0.10763276 0.587  0.7172965 0.7172965\n","79 285     0.016430523     0.05244694 0.633  0.7172965 0.7172965\n","80 117     0.016421800     0.09111118 0.565  0.7172965 0.7172965\n","81 300     0.015564435     0.04888010 0.630  0.7172965 0.7172965\n","82  63     0.015357366     0.09701678 0.542  0.7172965 0.7172965\n","83  74     0.012894382     0.07996585 0.531  0.7172965 0.7172965\n","84 238     0.012395931     0.04564450 0.611  0.7172965 0.7172965\n","85 417     0.009178873     0.02229048 0.686  0.7223605 0.7223605\n","86 323     0.009126238     0.02610302 0.653  0.7172965 0.7172965\n","87 113     0.008332575     0.04732544 0.545  0.7172965 0.7172965\n","88 418     0.007037804     0.01709168 0.685  0.7223605 0.7223605\n","89 127     0.006580622     0.03589350 0.576  0.7172965 0.7172965\n","90 188     0.004800154     0.02079953 0.587  0.7172965 0.7172965\n","91 272     0.003155203     0.01058371 0.620  0.7172965 0.7172965\n","92 274     0.003128313     0.01029661 0.630  0.7172965 0.7172965\n","93 276     0.003101812     0.01015414 0.632  0.7172965 0.7172965\n","   leadingEdge                                                            \n","1  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","2  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","3  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","4  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","5  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","6  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","7  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","8  HDAC1/HDAC3/HDAC2                                                      \n","9  HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","10 HDAC4                                                                  \n","11 HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9                                    \n","12 ADRA1A                                                                 \n","13 HRH1                                                                   \n","14 HDAC1/HDAC3/HDAC6/HDAC10/HDAC2/HDAC4/HDAC5/HDAC9                       \n","15 HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    \n","16 HDAC1/HDAC2/HDAC4                                                      \n","17 HDAC4/HDAC7                                                            \n","18 HDAC6                                                                  \n","19 HDAC6/HDAC8                                                            \n","20 HDAC1/HDAC2                                                            \n","21 HDAC6                                                                  \n","22 HDAC4                                                                  \n","23 HDAC6                                                                  \n","24 HDAC5/HDAC7/HDAC9                                                      \n","25 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","26 TUBB/TUBB4B                                                            \n","27 HDAC1/HDAC2                                                            \n","28 DRD1                                                                   \n","29 HDAC1/HDAC4/HDAC7                                                      \n","30 HDAC1                                                                  \n","⋮  ⋮                                                                      \n","64 HDAC6                                                                  \n","65 HRH1                                                                   \n","66 HRH1                                                                   \n","67 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","68 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","69 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","70 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","71 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","72 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","73 TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B\n","74 TUBA1B/TUBB4B                                                          \n","75 HRH1                                                                   \n","76 ACE                                                                    \n","77 ACE                                                                    \n","78 HDAC6                                                                  \n","79 HDAC6/TUBA1B/TUBB                                                      \n","80 DRD1/HRH1                                                              \n","81 HDAC6/TUBA1B/TUBB                                                      \n","82 ACE                                                                    \n","83 DRD1                                                                   \n","84 HDAC6                                                                  \n","85 HDAC4/HDAC7                                                            \n","86 HDAC6                                                                  \n","87 ACE                                                                    \n","88 HDAC6                                                                  \n","89 TUBB4B                                                                 \n","90 ACE                                                                    \n","91 ACE                                                                    \n","92 ACE                                                                    \n","93 ACE                                                                    \n","   ledge_rank                      \n","1  1/2/3/4/5/6/7/8/9/10/14         \n","2  1/2/3/4/5/6/7/8/9/10/14         \n","3  1/2/3/4/5/6/7/8/9/10/14         \n","4  1/2/3/4/5/6/7/8/9/10/14         \n","5  1/2/3/4/5/6/7/8/9/10/14         \n","6  1/2/3/4/5/6/7/8/9/10/14         \n","7  1/2/3/4/5/6/7/8/9/10/14         \n","8  1/2/6                           \n","9  1/2/3/4/5/6/7/8/9/10/14         \n","10 7                               \n","11 1/6/7/8/9/10                    \n","12 12                              \n","13 15                              \n","14 1/2/3/5/6/7/8/10                \n","15 1/2/3/4/5/6/7/8/9/10/14         \n","16 1/6/7                           \n","17 7/9                             \n","18 3                               \n","19 3/4                             \n","20 1/6                             \n","21 3                               \n","22 7                               \n","23 3                               \n","24 8/9/10                          \n","25 16/17/18/19/20/21/22/23/24/25/26\n","26 22/26                           \n","27 1/6                             \n","28 13                              \n","29 1/7/9                           \n","30 1                               \n","⋮  ⋮                               \n","64 3                               \n","65 15                              \n","66 15                              \n","67 16/17/18/19/20/21/22/23/24/25/26\n","68 16/17/18/19/20/21/22/23/24/25/26\n","69 16/17/18/19/20/21/22/23/24/25/26\n","70 16/17/18/19/20/21/22/23/24/25/26\n","71 16/17/18/19/20/21/22/23/24/25/26\n","72 16/17/18/19/20/21/22/23/24/25/26\n","73 16/17/18/19/20/21/22/23/24/25/26\n","74 17/26                           \n","75 15                              \n","76 11                              \n","77 11                              \n","78 3                               \n","79 3/17/22                         \n","80 13/15                           \n","81 3/17/22                         \n","82 11                              \n","83 13                              \n","84 3                               \n","85 7/9                             \n","86 3                               \n","87 11                              \n","88 3                               \n","89 26                              \n","90 11                              \n","91 11                              \n","92 11                              \n","93 11                              "],"text/latex":"A tibble: 93 × 11\n\\begin{tabular}{lllllllllll}\n ont & ID & Description & setSize & enrichmentScore & NES & pvalue & p.adjust & qvalues & leadingEdge & ledge\\_rank\\\\\n <chr> & <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <chr>\\\\\n\\hline\n\t MF & GO:0031078 & histone deacetylase activity (H3-K14 specific)                                          &  11 & 0.99984572 & 3.8672302 & 0.001 & 0.6275000 & 0.6275000 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0032041 & NAD-dependent histone deacetylase activity (H3-K14 specific)                            &  11 & 0.99984572 & 3.8672302 & 0.001 & 0.6275000 & 0.6275000 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0017136 & NAD-dependent histone deacetylase activity                                              &  16 & 0.83855536 & 3.7836720 & 0.011 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0034979 & NAD-dependent protein deacetylase activity                                              &  17 & 0.81234567 & 3.7626916 & 0.013 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0004407 & histone deacetylase activity                                                            &  44 & 0.44052342 & 2.7995162 & 0.033 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0033558 & protein deacetylase activity                                                            &  45 & 0.43317878 & 2.7163464 & 0.037 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0019213 & deacetylase activity                                                                    &  58 & 0.35600973 & 2.2812622 & 0.049 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0051059 & NF-kappaB binding                                                                       &  28 & 0.26455147 & 1.4505699 & 0.043 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC2                                                       & 1/2/6                           \\\\\n\t MF & GO:0016811 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides &  89 & 0.24984510 & 1.4659929 & 0.087 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:0030955 & potassium ion binding                                                                   &  10 & 0.18150964 & 0.6747153 & 0.401 & 0.7172965 & 0.7172965 & HDAC4                                                                   & 7                               \\\\\n\t MF & GO:0070491 & repressing transcription factor binding                                                 &  74 & 0.17052533 & 1.0575305 & 0.077 & 0.7172965 & 0.7172965 & HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9                                     & 1/6/7/8/9/10                    \\\\\n\t MF & GO:0004936 & alpha-adrenergic receptor activity                                                      &   6 & 0.16610111 & 0.4901962 & 0.479 & 0.7172965 & 0.7172965 & ADRA1A                                                                  & 12                              \\\\\n\t MF & GO:0004969 & histamine receptor activity                                                             &   6 & 0.16594687 & 0.4897410 & 0.479 & 0.7172965 & 0.7172965 & HRH1                                                                    & 15                              \\\\\n\t MF & GO:0042826 & histone deacetylase binding                                                             & 112 & 0.16118693 & 0.9178398 & 0.108 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC10/HDAC2/HDAC4/HDAC5/HDAC9                        & 1/2/3/5/6/7/8/10                \\\\\n\t MF & GO:0016810 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   & 147 & 0.16033846 & 0.8090097 & 0.137 & 0.7172965 & 0.7172965 & HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     & 1/2/3/4/5/6/7/8/9/10/14         \\\\\n\t MF & GO:1990841 & promoter-specific chromatin binding                                                     &  46 & 0.15665667 & 0.9912932 & 0.117 & 0.7172965 & 0.7172965 & HDAC1/HDAC2/HDAC4                                                       & 1/6/7                           \\\\\n\t MF & GO:0019789 & SUMO transferase activity                                                               &  24 & 0.15348592 & 0.8006033 & 0.313 & 0.7172965 & 0.7172965 & HDAC4/HDAC7                                                             & 7/9                             \\\\\n\t MF & GO:0048156 & tau protein binding                                                                     &  19 & 0.14275425 & 0.6794700 & 0.394 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0051879 & Hsp90 protein binding                                                                   &  38 & 0.14275415 & 0.8645490 & 0.228 & 0.7172965 & 0.7172965 & HDAC6/HDAC8                                                             & 3/4                             \\\\\n\t MF & GO:0001103 & RNA polymerase II repressing transcription factor binding                               &  38 & 0.14265115 & 0.8639252 & 0.228 & 0.7172965 & 0.7172965 & HDAC1/HDAC2                                                             & 1/6                             \\\\\n\t MF & GO:0070840 & dynein complex binding                                                                  &  22 & 0.12489709 & 0.6358432 & 0.431 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0031420 & alkali metal ion binding                                                                &  15 & 0.12469137 & 0.5475600 & 0.481 & 0.7172965 & 0.7172965 & HDAC4                                                                   & 7                               \\\\\n\t MF & GO:0051787 & misfolded protein binding                                                               &  23 & 0.11989708 & 0.6151019 & 0.427 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0005080 & protein kinase C binding                                                                &  49 & 0.11502392 & 0.7303855 & 0.270 & 0.7172965 & 0.7172965 & HDAC5/HDAC7/HDAC9                                                       & 8/9/10                          \\\\\n\t MF & GO:0005200 & structural constituent of cytoskeleton                                                  & 102 & 0.10706810 & 0.6190346 & 0.166 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0042288 & MHC class I protein binding                                                             &  19 & 0.10402840 & 0.4951459 & 0.477 & 0.7172965 & 0.7172965 & TUBB/TUBB4B                                                             & 22/26                           \\\\\n\t MF & GO:0031492 & nucleosomal DNA binding                                                                 &  55 & 0.10148874 & 0.6468140 & 0.324 & 0.7172965 & 0.7172965 & HDAC1/HDAC2                                                             & 1/6                             \\\\\n\t MF & GO:0004952 & dopamine neurotransmitter receptor activity                                             &  10 & 0.09938291 & 0.3694304 & 0.485 & 0.7172965 & 0.7172965 & DRD1                                                                    & 13                              \\\\\n\t MF & GO:0033613 & activating transcription factor binding                                                 &  76 & 0.09845583 & 0.6011904 & 0.270 & 0.7172965 & 0.7172965 & HDAC1/HDAC4/HDAC7                                                       & 1/7/9                           \\\\\n\t MF & GO:0001046 & core promoter sequence-specific DNA binding                                             &  38 & 0.09756098 & 0.5908497 & 0.432 & 0.7172965 & 0.7172965 & HDAC1                                                                   & 1                               \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t MF & GO:0032182 & ubiquitin-like protein binding                       &  91 & 0.032154785 & 0.18831241 & 0.556 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0004993 & G protein-coupled serotonin receptor activity        &  34 & 0.028690933 & 0.16806346 & 0.498 & 0.7172965 & 0.7172965 & HRH1                                                                    & 15                              \\\\\n\t MF & GO:0099589 & serotonin receptor activity                          &  34 & 0.028690933 & 0.16806346 & 0.498 & 0.7172965 & 0.7172965 & HRH1                                                                    & 15                              \\\\\n\t MF & GO:0005525 & GTP binding                                          & 374 & 0.028625684 & 0.07578614 & 0.638 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0032550 & purine ribonucleoside binding                        & 379 & 0.028237460 & 0.07330235 & 0.646 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0001883 & purine nucleoside binding                            & 382 & 0.028009401 & 0.07202489 & 0.650 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0032549 & ribonucleoside binding                               & 383 & 0.027934175 & 0.07183819 & 0.650 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0001882 & nucleoside binding                                   & 390 & 0.027418387 & 0.06969815 & 0.658 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0019001 & guanyl nucleotide binding                            & 395 & 0.027061154 & 0.06880283 & 0.663 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0032561 & guanyl ribonucleotide binding                        & 395 & 0.027061154 & 0.06880283 & 0.663 & 0.7172965 & 0.7172965 & TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B & 16/17/18/19/20/21/22/23/24/25/26\\\\\n\t MF & GO:0003725 & double-stranded RNA binding                          &  75 & 0.025428340 & 0.15735374 & 0.536 & 0.7172965 & 0.7172965 & TUBA1B/TUBB4B                                                           & 17/26                           \\\\\n\t MF & GO:0099528 & G protein-coupled neurotransmitter receptor activity &  41 & 0.023669152 & 0.14743885 & 0.501 & 0.7172965 & 0.7172965 & HRH1                                                                    & 15                              \\\\\n\t MF & GO:0004180 & carboxypeptidase activity                            &  45 & 0.021707050 & 0.13611901 & 0.513 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0004177 & aminopeptidase activity                              &  46 & 0.021223932 & 0.13430095 & 0.512 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0140030 & modification-dependent protein binding               & 142 & 0.020729782 & 0.10763276 & 0.587 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0031625 & ubiquitin protein ligase binding                     & 285 & 0.016430523 & 0.05244694 & 0.633 & 0.7172965 & 0.7172965 & HDAC6/TUBA1B/TUBB                                                       & 3/17/22                         \\\\\n\t MF & GO:0030594 & neurotransmitter receptor activity                   & 117 & 0.016421800 & 0.09111118 & 0.565 & 0.7172965 & 0.7172965 & DRD1/HRH1                                                               & 13/15                           \\\\\n\t MF & GO:0044389 & ubiquitin-like protein ligase binding                & 300 & 0.015564435 & 0.04888010 & 0.630 & 0.7172965 & 0.7172965 & HDAC6/TUBA1B/TUBB                                                       & 3/17/22                         \\\\\n\t MF & GO:0008235 & metalloexopeptidase activity                         &  63 & 0.015357366 & 0.09701678 & 0.542 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0070405 & ammonium ion binding                                 &  74 & 0.012894382 & 0.07996585 & 0.531 & 0.7172965 & 0.7172965 & DRD1                                                                    & 13                              \\\\\n\t MF & GO:0008017 & microtubule binding                                  & 238 & 0.012395931 & 0.04564450 & 0.611 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0019787 & ubiquitin-like protein transferase activity          & 417 & 0.009178873 & 0.02229048 & 0.686 & 0.7223605 & 0.7223605 & HDAC4/HDAC7                                                             & 7/9                             \\\\\n\t MF & GO:0015631 & tubulin binding                                      & 323 & 0.009126238 & 0.02610302 & 0.653 & 0.7172965 & 0.7172965 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0008238 & exopeptidase activity                                & 113 & 0.008332575 & 0.04732544 & 0.545 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0003779 & actin binding                                        & 418 & 0.007037804 & 0.01709168 & 0.685 & 0.7223605 & 0.7223605 & HDAC6                                                                   & 3                               \\\\\n\t MF & GO:0051082 & unfolded protein binding                             & 127 & 0.006580622 & 0.03589350 & 0.576 & 0.7172965 & 0.7172965 & TUBB4B                                                                  & 26                              \\\\\n\t MF & GO:0008237 & metallopeptidase activity                            & 188 & 0.004800154 & 0.02079953 & 0.587 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0008236 & serine-type peptidase activity                       & 272 & 0.003155203 & 0.01058371 & 0.620 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0001664 & G protein-coupled receptor binding                   & 274 & 0.003128313 & 0.01029661 & 0.630 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\t MF & GO:0017171 & serine hydrolase activity                            & 276 & 0.003101812 & 0.01015414 & 0.632 & 0.7172965 & 0.7172965 & ACE                                                                     & 11                              \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 93 × 11\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | enrichmentScore &lt;dbl&gt; | NES &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | leadingEdge &lt;chr&gt; | ledge_rank &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|\n| MF | GO:0031078 | histone deacetylase activity (H3-K14 specific)                                          |  11 | 0.99984572 | 3.8672302 | 0.001 | 0.6275000 | 0.6275000 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific)                            |  11 | 0.99984572 | 3.8672302 | 0.001 | 0.6275000 | 0.6275000 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0017136 | NAD-dependent histone deacetylase activity                                              |  16 | 0.83855536 | 3.7836720 | 0.011 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0034979 | NAD-dependent protein deacetylase activity                                              |  17 | 0.81234567 | 3.7626916 | 0.013 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0004407 | histone deacetylase activity                                                            |  44 | 0.44052342 | 2.7995162 | 0.033 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0033558 | protein deacetylase activity                                                            |  45 | 0.43317878 | 2.7163464 | 0.037 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0019213 | deacetylase activity                                                                    |  58 | 0.35600973 | 2.2812622 | 0.049 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0051059 | NF-kappaB binding                                                                       |  28 | 0.26455147 | 1.4505699 | 0.043 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC2                                                       | 1/2/6                            |\n| MF | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |  89 | 0.24984510 | 1.4659929 | 0.087 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:0030955 | potassium ion binding                                                                   |  10 | 0.18150964 | 0.6747153 | 0.401 | 0.7172965 | 0.7172965 | HDAC4                                                                   | 7                                |\n| MF | GO:0070491 | repressing transcription factor binding                                                 |  74 | 0.17052533 | 1.0575305 | 0.077 | 0.7172965 | 0.7172965 | HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9                                     | 1/6/7/8/9/10                     |\n| MF | GO:0004936 | alpha-adrenergic receptor activity                                                      |   6 | 0.16610111 | 0.4901962 | 0.479 | 0.7172965 | 0.7172965 | ADRA1A                                                                  | 12                               |\n| MF | GO:0004969 | histamine receptor activity                                                             |   6 | 0.16594687 | 0.4897410 | 0.479 | 0.7172965 | 0.7172965 | HRH1                                                                    | 15                               |\n| MF | GO:0042826 | histone deacetylase binding                                                             | 112 | 0.16118693 | 0.9178398 | 0.108 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC10/HDAC2/HDAC4/HDAC5/HDAC9                        | 1/2/3/5/6/7/8/10                 |\n| MF | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   | 147 | 0.16033846 | 0.8090097 | 0.137 | 0.7172965 | 0.7172965 | HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11     | 1/2/3/4/5/6/7/8/9/10/14          |\n| MF | GO:1990841 | promoter-specific chromatin binding                                                     |  46 | 0.15665667 | 0.9912932 | 0.117 | 0.7172965 | 0.7172965 | HDAC1/HDAC2/HDAC4                                                       | 1/6/7                            |\n| MF | GO:0019789 | SUMO transferase activity                                                               |  24 | 0.15348592 | 0.8006033 | 0.313 | 0.7172965 | 0.7172965 | HDAC4/HDAC7                                                             | 7/9                              |\n| MF | GO:0048156 | tau protein binding                                                                     |  19 | 0.14275425 | 0.6794700 | 0.394 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0051879 | Hsp90 protein binding                                                                   |  38 | 0.14275415 | 0.8645490 | 0.228 | 0.7172965 | 0.7172965 | HDAC6/HDAC8                                                             | 3/4                              |\n| MF | GO:0001103 | RNA polymerase II repressing transcription factor binding                               |  38 | 0.14265115 | 0.8639252 | 0.228 | 0.7172965 | 0.7172965 | HDAC1/HDAC2                                                             | 1/6                              |\n| MF | GO:0070840 | dynein complex binding                                                                  |  22 | 0.12489709 | 0.6358432 | 0.431 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0031420 | alkali metal ion binding                                                                |  15 | 0.12469137 | 0.5475600 | 0.481 | 0.7172965 | 0.7172965 | HDAC4                                                                   | 7                                |\n| MF | GO:0051787 | misfolded protein binding                                                               |  23 | 0.11989708 | 0.6151019 | 0.427 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0005080 | protein kinase C binding                                                                |  49 | 0.11502392 | 0.7303855 | 0.270 | 0.7172965 | 0.7172965 | HDAC5/HDAC7/HDAC9                                                       | 8/9/10                           |\n| MF | GO:0005200 | structural constituent of cytoskeleton                                                  | 102 | 0.10706810 | 0.6190346 | 0.166 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0042288 | MHC class I protein binding                                                             |  19 | 0.10402840 | 0.4951459 | 0.477 | 0.7172965 | 0.7172965 | TUBB/TUBB4B                                                             | 22/26                            |\n| MF | GO:0031492 | nucleosomal DNA binding                                                                 |  55 | 0.10148874 | 0.6468140 | 0.324 | 0.7172965 | 0.7172965 | HDAC1/HDAC2                                                             | 1/6                              |\n| MF | GO:0004952 | dopamine neurotransmitter receptor activity                                             |  10 | 0.09938291 | 0.3694304 | 0.485 | 0.7172965 | 0.7172965 | DRD1                                                                    | 13                               |\n| MF | GO:0033613 | activating transcription factor binding                                                 |  76 | 0.09845583 | 0.6011904 | 0.270 | 0.7172965 | 0.7172965 | HDAC1/HDAC4/HDAC7                                                       | 1/7/9                            |\n| MF | GO:0001046 | core promoter sequence-specific DNA binding                                             |  38 | 0.09756098 | 0.5908497 | 0.432 | 0.7172965 | 0.7172965 | HDAC1                                                                   | 1                                |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| MF | GO:0032182 | ubiquitin-like protein binding                       |  91 | 0.032154785 | 0.18831241 | 0.556 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0004993 | G protein-coupled serotonin receptor activity        |  34 | 0.028690933 | 0.16806346 | 0.498 | 0.7172965 | 0.7172965 | HRH1                                                                    | 15                               |\n| MF | GO:0099589 | serotonin receptor activity                          |  34 | 0.028690933 | 0.16806346 | 0.498 | 0.7172965 | 0.7172965 | HRH1                                                                    | 15                               |\n| MF | GO:0005525 | GTP binding                                          | 374 | 0.028625684 | 0.07578614 | 0.638 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0032550 | purine ribonucleoside binding                        | 379 | 0.028237460 | 0.07330235 | 0.646 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0001883 | purine nucleoside binding                            | 382 | 0.028009401 | 0.07202489 | 0.650 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0032549 | ribonucleoside binding                               | 383 | 0.027934175 | 0.07183819 | 0.650 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0001882 | nucleoside binding                                   | 390 | 0.027418387 | 0.06969815 | 0.658 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0019001 | guanyl nucleotide binding                            | 395 | 0.027061154 | 0.06880283 | 0.663 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0032561 | guanyl ribonucleotide binding                        | 395 | 0.027061154 | 0.06880283 | 0.663 | 0.7172965 | 0.7172965 | TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B | 16/17/18/19/20/21/22/23/24/25/26 |\n| MF | GO:0003725 | double-stranded RNA binding                          |  75 | 0.025428340 | 0.15735374 | 0.536 | 0.7172965 | 0.7172965 | TUBA1B/TUBB4B                                                           | 17/26                            |\n| MF | GO:0099528 | G protein-coupled neurotransmitter receptor activity |  41 | 0.023669152 | 0.14743885 | 0.501 | 0.7172965 | 0.7172965 | HRH1                                                                    | 15                               |\n| MF | GO:0004180 | carboxypeptidase activity                            |  45 | 0.021707050 | 0.13611901 | 0.513 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0004177 | aminopeptidase activity                              |  46 | 0.021223932 | 0.13430095 | 0.512 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0140030 | modification-dependent protein binding               | 142 | 0.020729782 | 0.10763276 | 0.587 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0031625 | ubiquitin protein ligase binding                     | 285 | 0.016430523 | 0.05244694 | 0.633 | 0.7172965 | 0.7172965 | HDAC6/TUBA1B/TUBB                                                       | 3/17/22                          |\n| MF | GO:0030594 | neurotransmitter receptor activity                   | 117 | 0.016421800 | 0.09111118 | 0.565 | 0.7172965 | 0.7172965 | DRD1/HRH1                                                               | 13/15                            |\n| MF | GO:0044389 | ubiquitin-like protein ligase binding                | 300 | 0.015564435 | 0.04888010 | 0.630 | 0.7172965 | 0.7172965 | HDAC6/TUBA1B/TUBB                                                       | 3/17/22                          |\n| MF | GO:0008235 | metalloexopeptidase activity                         |  63 | 0.015357366 | 0.09701678 | 0.542 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0070405 | ammonium ion binding                                 |  74 | 0.012894382 | 0.07996585 | 0.531 | 0.7172965 | 0.7172965 | DRD1                                                                    | 13                               |\n| MF | GO:0008017 | microtubule binding                                  | 238 | 0.012395931 | 0.04564450 | 0.611 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0019787 | ubiquitin-like protein transferase activity          | 417 | 0.009178873 | 0.02229048 | 0.686 | 0.7223605 | 0.7223605 | HDAC4/HDAC7                                                             | 7/9                              |\n| MF | GO:0015631 | tubulin binding                                      | 323 | 0.009126238 | 0.02610302 | 0.653 | 0.7172965 | 0.7172965 | HDAC6                                                                   | 3                                |\n| MF | GO:0008238 | exopeptidase activity                                | 113 | 0.008332575 | 0.04732544 | 0.545 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0003779 | actin binding                                        | 418 | 0.007037804 | 0.01709168 | 0.685 | 0.7223605 | 0.7223605 | HDAC6                                                                   | 3                                |\n| MF | GO:0051082 | unfolded protein binding                             | 127 | 0.006580622 | 0.03589350 | 0.576 | 0.7172965 | 0.7172965 | TUBB4B                                                                  | 26                               |\n| MF | GO:0008237 | metallopeptidase activity                            | 188 | 0.004800154 | 0.02079953 | 0.587 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0008236 | serine-type peptidase activity                       | 272 | 0.003155203 | 0.01058371 | 0.620 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0001664 | G protein-coupled receptor binding                   | 274 | 0.003128313 | 0.01029661 | 0.630 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n| MF | GO:0017171 | serine hydrolase activity                            | 276 | 0.003101812 | 0.01015414 | 0.632 | 0.7172965 | 0.7172965 | ACE                                                                     | 11                               |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 93 × 11</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>enrichmentScore</th><th scope=col>NES</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>leadingEdge</th><th scope=col>ledge_rank</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>MF</td><td>GO:0031078</td><td>histone deacetylase activity (H3-K14 specific)                                         </td><td> 11</td><td>0.99984572</td><td>3.8672302</td><td>0.001</td><td>0.6275000</td><td>0.6275000</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0032041</td><td>NAD-dependent histone deacetylase activity (H3-K14 specific)                           </td><td> 11</td><td>0.99984572</td><td>3.8672302</td><td>0.001</td><td>0.6275000</td><td>0.6275000</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0017136</td><td>NAD-dependent histone deacetylase activity                                             </td><td> 16</td><td>0.83855536</td><td>3.7836720</td><td>0.011</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0034979</td><td>NAD-dependent protein deacetylase activity                                             </td><td> 17</td><td>0.81234567</td><td>3.7626916</td><td>0.013</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0004407</td><td>histone deacetylase activity                                                           </td><td> 44</td><td>0.44052342</td><td>2.7995162</td><td>0.033</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0033558</td><td>protein deacetylase activity                                                           </td><td> 45</td><td>0.43317878</td><td>2.7163464</td><td>0.037</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0019213</td><td>deacetylase activity                                                                   </td><td> 58</td><td>0.35600973</td><td>2.2812622</td><td>0.049</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0051059</td><td>NF-kappaB binding                                                                      </td><td> 28</td><td>0.26455147</td><td>1.4505699</td><td>0.043</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC2                                                      </td><td>1/2/6                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0016811</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</td><td> 89</td><td>0.24984510</td><td>1.4659929</td><td>0.087</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:0030955</td><td>potassium ion binding                                                                  </td><td> 10</td><td>0.18150964</td><td>0.6747153</td><td>0.401</td><td>0.7172965</td><td>0.7172965</td><td>HDAC4                                                                  </td><td>7                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0070491</td><td>repressing transcription factor binding                                                </td><td> 74</td><td>0.17052533</td><td>1.0575305</td><td>0.077</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9                                    </td><td>1/6/7/8/9/10                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0004936</td><td>alpha-adrenergic receptor activity                                                     </td><td>  6</td><td>0.16610111</td><td>0.4901962</td><td>0.479</td><td>0.7172965</td><td>0.7172965</td><td>ADRA1A                                                                 </td><td>12                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0004969</td><td>histamine receptor activity                                                            </td><td>  6</td><td>0.16594687</td><td>0.4897410</td><td>0.479</td><td>0.7172965</td><td>0.7172965</td><td>HRH1                                                                   </td><td>15                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0042826</td><td>histone deacetylase binding                                                            </td><td>112</td><td>0.16118693</td><td>0.9178398</td><td>0.108</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC10/HDAC2/HDAC4/HDAC5/HDAC9                       </td><td>1/2/3/5/6/7/8/10                </td></tr>\n","\t<tr><td>MF</td><td>GO:0016810</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  </td><td>147</td><td>0.16033846</td><td>0.8090097</td><td>0.137</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC3/HDAC6/HDAC8/HDAC10/HDAC2/HDAC4/HDAC5/HDAC7/HDAC9/HDAC11    </td><td>1/2/3/4/5/6/7/8/9/10/14         </td></tr>\n","\t<tr><td>MF</td><td>GO:1990841</td><td>promoter-specific chromatin binding                                                    </td><td> 46</td><td>0.15665667</td><td>0.9912932</td><td>0.117</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC2/HDAC4                                                      </td><td>1/6/7                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0019789</td><td>SUMO transferase activity                                                              </td><td> 24</td><td>0.15348592</td><td>0.8006033</td><td>0.313</td><td>0.7172965</td><td>0.7172965</td><td>HDAC4/HDAC7                                                            </td><td>7/9                             </td></tr>\n","\t<tr><td>MF</td><td>GO:0048156</td><td>tau protein binding                                                                    </td><td> 19</td><td>0.14275425</td><td>0.6794700</td><td>0.394</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0051879</td><td>Hsp90 protein binding                                                                  </td><td> 38</td><td>0.14275415</td><td>0.8645490</td><td>0.228</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6/HDAC8                                                            </td><td>3/4                             </td></tr>\n","\t<tr><td>MF</td><td>GO:0001103</td><td>RNA polymerase II repressing transcription factor binding                              </td><td> 38</td><td>0.14265115</td><td>0.8639252</td><td>0.228</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC2                                                            </td><td>1/6                             </td></tr>\n","\t<tr><td>MF</td><td>GO:0070840</td><td>dynein complex binding                                                                 </td><td> 22</td><td>0.12489709</td><td>0.6358432</td><td>0.431</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0031420</td><td>alkali metal ion binding                                                               </td><td> 15</td><td>0.12469137</td><td>0.5475600</td><td>0.481</td><td>0.7172965</td><td>0.7172965</td><td>HDAC4                                                                  </td><td>7                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0051787</td><td>misfolded protein binding                                                              </td><td> 23</td><td>0.11989708</td><td>0.6151019</td><td>0.427</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0005080</td><td>protein kinase C binding                                                               </td><td> 49</td><td>0.11502392</td><td>0.7303855</td><td>0.270</td><td>0.7172965</td><td>0.7172965</td><td>HDAC5/HDAC7/HDAC9                                                      </td><td>8/9/10                          </td></tr>\n","\t<tr><td>MF</td><td>GO:0005200</td><td>structural constituent of cytoskeleton                                                 </td><td>102</td><td>0.10706810</td><td>0.6190346</td><td>0.166</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0042288</td><td>MHC class I protein binding                                                            </td><td> 19</td><td>0.10402840</td><td>0.4951459</td><td>0.477</td><td>0.7172965</td><td>0.7172965</td><td>TUBB/TUBB4B                                                            </td><td>22/26                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0031492</td><td>nucleosomal DNA binding                                                                </td><td> 55</td><td>0.10148874</td><td>0.6468140</td><td>0.324</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC2                                                            </td><td>1/6                             </td></tr>\n","\t<tr><td>MF</td><td>GO:0004952</td><td>dopamine neurotransmitter receptor activity                                            </td><td> 10</td><td>0.09938291</td><td>0.3694304</td><td>0.485</td><td>0.7172965</td><td>0.7172965</td><td>DRD1                                                                   </td><td>13                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0033613</td><td>activating transcription factor binding                                                </td><td> 76</td><td>0.09845583</td><td>0.6011904</td><td>0.270</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1/HDAC4/HDAC7                                                      </td><td>1/7/9                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0001046</td><td>core promoter sequence-specific DNA binding                                            </td><td> 38</td><td>0.09756098</td><td>0.5908497</td><td>0.432</td><td>0.7172965</td><td>0.7172965</td><td>HDAC1                                                                  </td><td>1                               </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>MF</td><td>GO:0032182</td><td>ubiquitin-like protein binding                      </td><td> 91</td><td>0.032154785</td><td>0.18831241</td><td>0.556</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0004993</td><td>G protein-coupled serotonin receptor activity       </td><td> 34</td><td>0.028690933</td><td>0.16806346</td><td>0.498</td><td>0.7172965</td><td>0.7172965</td><td>HRH1                                                                   </td><td>15                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0099589</td><td>serotonin receptor activity                         </td><td> 34</td><td>0.028690933</td><td>0.16806346</td><td>0.498</td><td>0.7172965</td><td>0.7172965</td><td>HRH1                                                                   </td><td>15                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0005525</td><td>GTP binding                                         </td><td>374</td><td>0.028625684</td><td>0.07578614</td><td>0.638</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0032550</td><td>purine ribonucleoside binding                       </td><td>379</td><td>0.028237460</td><td>0.07330235</td><td>0.646</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0001883</td><td>purine nucleoside binding                           </td><td>382</td><td>0.028009401</td><td>0.07202489</td><td>0.650</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0032549</td><td>ribonucleoside binding                              </td><td>383</td><td>0.027934175</td><td>0.07183819</td><td>0.650</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0001882</td><td>nucleoside binding                                  </td><td>390</td><td>0.027418387</td><td>0.06969815</td><td>0.658</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0019001</td><td>guanyl nucleotide binding                           </td><td>395</td><td>0.027061154</td><td>0.06880283</td><td>0.663</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0032561</td><td>guanyl ribonucleotide binding                       </td><td>395</td><td>0.027061154</td><td>0.06880283</td><td>0.663</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1A/TUBA1B/TUBA1C/TUBA3C/TUBA4A/TUBA8/TUBB/TUBB1/TUBB3/TUBB4A/TUBB4B</td><td>16/17/18/19/20/21/22/23/24/25/26</td></tr>\n","\t<tr><td>MF</td><td>GO:0003725</td><td>double-stranded RNA binding                         </td><td> 75</td><td>0.025428340</td><td>0.15735374</td><td>0.536</td><td>0.7172965</td><td>0.7172965</td><td>TUBA1B/TUBB4B                                                          </td><td>17/26                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0099528</td><td>G protein-coupled neurotransmitter receptor activity</td><td> 41</td><td>0.023669152</td><td>0.14743885</td><td>0.501</td><td>0.7172965</td><td>0.7172965</td><td>HRH1                                                                   </td><td>15                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0004180</td><td>carboxypeptidase activity                           </td><td> 45</td><td>0.021707050</td><td>0.13611901</td><td>0.513</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0004177</td><td>aminopeptidase activity                             </td><td> 46</td><td>0.021223932</td><td>0.13430095</td><td>0.512</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0140030</td><td>modification-dependent protein binding              </td><td>142</td><td>0.020729782</td><td>0.10763276</td><td>0.587</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0031625</td><td>ubiquitin protein ligase binding                    </td><td>285</td><td>0.016430523</td><td>0.05244694</td><td>0.633</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6/TUBA1B/TUBB                                                      </td><td>3/17/22                         </td></tr>\n","\t<tr><td>MF</td><td>GO:0030594</td><td>neurotransmitter receptor activity                  </td><td>117</td><td>0.016421800</td><td>0.09111118</td><td>0.565</td><td>0.7172965</td><td>0.7172965</td><td>DRD1/HRH1                                                              </td><td>13/15                           </td></tr>\n","\t<tr><td>MF</td><td>GO:0044389</td><td>ubiquitin-like protein ligase binding               </td><td>300</td><td>0.015564435</td><td>0.04888010</td><td>0.630</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6/TUBA1B/TUBB                                                      </td><td>3/17/22                         </td></tr>\n","\t<tr><td>MF</td><td>GO:0008235</td><td>metalloexopeptidase activity                        </td><td> 63</td><td>0.015357366</td><td>0.09701678</td><td>0.542</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0070405</td><td>ammonium ion binding                                </td><td> 74</td><td>0.012894382</td><td>0.07996585</td><td>0.531</td><td>0.7172965</td><td>0.7172965</td><td>DRD1                                                                   </td><td>13                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0008017</td><td>microtubule binding                                 </td><td>238</td><td>0.012395931</td><td>0.04564450</td><td>0.611</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0019787</td><td>ubiquitin-like protein transferase activity         </td><td>417</td><td>0.009178873</td><td>0.02229048</td><td>0.686</td><td>0.7223605</td><td>0.7223605</td><td>HDAC4/HDAC7                                                            </td><td>7/9                             </td></tr>\n","\t<tr><td>MF</td><td>GO:0015631</td><td>tubulin binding                                     </td><td>323</td><td>0.009126238</td><td>0.02610302</td><td>0.653</td><td>0.7172965</td><td>0.7172965</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0008238</td><td>exopeptidase activity                               </td><td>113</td><td>0.008332575</td><td>0.04732544</td><td>0.545</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0003779</td><td>actin binding                                       </td><td>418</td><td>0.007037804</td><td>0.01709168</td><td>0.685</td><td>0.7223605</td><td>0.7223605</td><td>HDAC6                                                                  </td><td>3                               </td></tr>\n","\t<tr><td>MF</td><td>GO:0051082</td><td>unfolded protein binding                            </td><td>127</td><td>0.006580622</td><td>0.03589350</td><td>0.576</td><td>0.7172965</td><td>0.7172965</td><td>TUBB4B                                                                 </td><td>26                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0008237</td><td>metallopeptidase activity                           </td><td>188</td><td>0.004800154</td><td>0.02079953</td><td>0.587</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0008236</td><td>serine-type peptidase activity                      </td><td>272</td><td>0.003155203</td><td>0.01058371</td><td>0.620</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0001664</td><td>G protein-coupled receptor binding                  </td><td>274</td><td>0.003128313</td><td>0.01029661</td><td>0.630</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0017171</td><td>serine hydrolase activity                           </td><td>276</td><td>0.003101812</td><td>0.01015414</td><td>0.632</td><td>0.7172965</td><td>0.7172965</td><td>ACE                                                                    </td><td>11                              </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"1gq9h8sLNFoG","executionInfo":{"status":"ok","timestamp":1636338315374,"user_tz":-480,"elapsed":3516,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"025f8485-7166-4d9d-9c44-7933806b7853"},"source":["mgsea_k_res <- tsea_mGSEA(drugs=drugs, type=\"KEGG\", exponent=1, \n","                          nPerm=1000, pvalueCutoff=1, minGSSize=2)\n","result(mgsea_k_res)"],"execution_count":31,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["   ID       Description                                       setSize\n","1  hsa04540 Gap junction                                       88    \n","2  hsa05034 Alcoholism                                        187    \n","3  hsa04613 Neutrophil extracellular trap formation           190    \n","4  hsa05203 Viral carcinogenesis                              204    \n","5  hsa04330 Notch signaling pathway                            59    \n","6  hsa05031 Amphetamine addiction                              69    \n","7  hsa04213 Longevity regulating pathway - multiple species    62    \n","8  hsa05220 Chronic myeloid leukemia                           76    \n","9  hsa04919 Thyroid hormone signaling pathway                 121    \n","10 hsa04145 Phagosome                                         152    \n","11 hsa05130 Pathogenic Escherichia coli infection             197    \n","12 hsa05016 Huntington disease                                306    \n","13 hsa04110 Cell cycle                                        126    \n","14 hsa05012 Parkinson disease                                 266    \n","15 hsa05132 Salmonella infection                              249    \n","16 hsa04614 Renin-angiotensin system                           23    \n","17 hsa04210 Apoptosis                                         136    \n","18 hsa05020 Prion disease                                     273    \n","19 hsa05014 Amyotrophic lateral sclerosis                     364    \n","20 hsa04530 Tight junction                                    169    \n","21 hsa05206 MicroRNAs in cancer                               310    \n","22 hsa05202 Transcriptional misregulation in cancer           192    \n","23 hsa05169 Epstein-Barr virus infection                      202    \n","24 hsa04371 Apelin signaling pathway                          139    \n","25 hsa05010 Alzheimer disease                                 384    \n","26 hsa05022 Pathways of neurodegeneration - multiple diseases 476    \n","27 hsa05030 Cocaine addiction                                  49    \n","28 hsa05165 Human papillomavirus infection                    331    \n","29 hsa04924 Renin secretion                                    69    \n","30 hsa04020 Calcium signaling pathway                         240    \n","31 hsa05410 Hypertrophic cardiomyopathy                        90    \n","32 hsa04970 Salivary secretion                                 93    \n","33 hsa05032 Morphine addiction                                 91    \n","34 hsa04750 Inflammatory mediator regulation of TRP channels   98    \n","35 hsa05142 Chagas disease                                    102    \n","36 hsa04152 AMPK signaling pathway                            120    \n","37 hsa04080 Neuroactive ligand-receptor interaction           350    \n","38 hsa04270 Vascular smooth muscle contraction                134    \n","39 hsa04728 Dopaminergic synapse                              132    \n","40 hsa04261 Adrenergic signaling in cardiomyocytes            150    \n","41 hsa04022 cGMP-PKG signaling pathway                        167    \n","42 hsa05415 Diabetic cardiomyopathy                           203    \n","43 hsa04024 cAMP signaling pathway                            219    \n","44 hsa05171 Coronavirus disease - COVID-19                    232    \n","   enrichmentScore NES         pvalue p.adjust  qvalues  \n","1  0.134617347     0.414849102 0.280  0.8626047 0.8626047\n","2  0.132147832     0.268122939 0.460  0.8626047 0.8626047\n","3  0.125186817     0.253143631 0.463  0.8626047 0.8626047\n","4  0.117076100     0.226183329 0.490  0.8626047 0.8626047\n","5  0.094740954     0.353012684 0.426  0.8626047 0.8626047\n","6  0.094148251     0.327762767 0.409  0.8626047 0.8626047\n","7  0.090411764     0.329760785 0.452  0.8626047 0.8626047\n","8  0.074501806     0.245790212 0.512  0.8626047 0.8626047\n","9  0.070490390     0.187560321 0.518  0.8626047 0.8626047\n","10 0.070482340     0.161666063 0.515  0.8626047 0.8626047\n","11 0.053940750     0.105999915 0.623  0.8626047 0.8626047\n","12 0.053171829     0.082203291 0.680  0.8626047 0.8626047\n","13 0.045652530     0.118639284 0.654  0.8626047 0.8626047\n","14 0.043326840     0.072409776 0.715  0.8626047 0.8626047\n","15 0.042267338     0.072974234 0.712  0.8626047 0.8626047\n","16 0.041622285     0.182209795 0.515  0.8626047 0.8626047\n","17 0.041607922     0.104549740 0.666  0.8626047 0.8626047\n","18 0.038377821     0.063267442 0.746  0.8626047 0.8626047\n","19 0.036442814     0.051221086 0.799  0.8626047 0.8626047\n","20 0.032982797     0.070444108 0.694  0.8626047 0.8626047\n","21 0.030875845     0.047663175 0.778  0.8626047 0.8626047\n","22 0.030106748     0.060442964 0.714  0.8626047 0.8626047\n","23 0.028620077     0.055572633 0.717  0.8626047 0.8626047\n","24 0.027364526     0.067727509 0.675  0.8626047 0.8626047\n","25 0.026703080     0.036566233 0.843  0.8626047 0.8626047\n","26 0.021143062     0.026433619 0.878  0.8780000 0.8780000\n","27 0.018422066     0.074006541 0.554  0.8626047 0.8626047\n","28 0.017395912     0.025957874 0.811  0.8626047 0.8626047\n","29 0.012626153     0.043956026 0.593  0.8626047 0.8626047\n","30 0.010465671     0.018537891 0.755  0.8626047 0.8626047\n","31 0.009239620     0.028381742 0.624  0.8626047 0.8626047\n","32 0.009005309     0.027155438 0.640  0.8626047 0.8626047\n","33 0.008992505     0.027427713 0.630  0.8626047 0.8626047\n","34 0.007956049     0.023472873 0.639  0.8626047 0.8626047\n","35 0.007929624     0.022910681 0.638  0.8626047 0.8626047\n","36 0.006580046     0.017542717 0.673  0.8626047 0.8626047\n","37 0.006508244     0.009372621 0.824  0.8626047 0.8626047\n","38 0.005706320     0.014463371 0.673  0.8626047 0.8626047\n","39 0.005568985     0.014203899 0.677  0.8626047 0.8626047\n","40 0.004906767     0.011369766 0.676  0.8626047 0.8626047\n","41 0.004224356     0.009106499 0.691  0.8626047 0.8626047\n","42 0.003027855     0.005880150 0.720  0.8626047 0.8626047\n","43 0.002537298     0.004728552 0.732  0.8626047 0.8626047\n","44 0.002405099     0.004313853 0.749  0.8626047 0.8626047\n","   leadingEdge                                                              \n","1  10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \n","2  3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/1812/79885        \n","3  3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885             \n","4  3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885             \n","5  3065/3066                                                                \n","6  3065/3066/1812                                                           \n","7  3065/3066                                                                \n","8  3065/3066                                                                \n","9  3065/8841/3066                                                           \n","10 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","11 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","12 3065/3066/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790\n","13 3065/3066                                                                \n","14 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \n","15 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","16 1636                                                                     \n","17 10376/51807/7277/7278/7846/84790                                         \n","18 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","19 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790    \n","20 10376/51807/7277/7278/7846/84790                                         \n","21 3065/10014/3066/9759                                                     \n","22 3065/3066                                                                \n","23 3065/3066                                                                \n","24 10014/9759                                                               \n","25 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","26 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","27 1812                                                                     \n","28 3065/3066                                                                \n","29 1636                                                                     \n","30 148/1812/3269                                                            \n","31 1636                                                                     \n","32 148                                                                      \n","33 1812                                                                     \n","34 3269                                                                     \n","35 1636                                                                     \n","36 148                                                                      \n","37 148/1812/3269                                                            \n","38 148                                                                      \n","39 1812                                                                     \n","40 148                                                                      \n","41 148                                                                      \n","42 1636                                                                     \n","43 1812                                                                     \n","44 1636                                                                     \n","   ledge_rank                          \n","1  11/12/13/14/17/18/20/21/22/23/25/26 \n","2  1/2/3/4/5/6/7/8/9/10/17/24          \n","3  1/2/3/4/5/6/7/8/9/10/24             \n","4  1/2/3/4/5/6/7/8/9/10/24             \n","5  1/6                                 \n","6  1/6/17                              \n","7  1/6                                 \n","8  1/6                                 \n","9  1/4/6                               \n","10 11/12/13/14/18/20/21/22/23/25/26    \n","11 11/12/13/14/18/20/21/22/23/25/26    \n","12 1/6/11/12/13/14/18/20/21/22/23/25/26\n","13 1/6                                 \n","14 11/12/13/14/17/18/20/21/22/23/25/26 \n","15 11/12/13/14/18/20/21/22/23/25/26    \n","16 16                                  \n","17 11/20/21/22/23/26                   \n","18 11/12/13/14/18/20/21/22/23/25/26    \n","19 2/11/12/13/14/18/20/21/22/23/25/26  \n","20 11/20/21/22/23/26                   \n","21 1/5/6/10                            \n","22 1/6                                 \n","23 1/6                                 \n","24 5/10                                \n","25 11/12/13/14/18/20/21/22/23/25/26    \n","26 11/12/13/14/18/20/21/22/23/25/26    \n","27 17                                  \n","28 1/6                                 \n","29 16                                  \n","30 15/17/19                            \n","31 16                                  \n","32 15                                  \n","33 17                                  \n","34 19                                  \n","35 16                                  \n","36 15                                  \n","37 15/17/19                            \n","38 15                                  \n","39 17                                  \n","40 15                                  \n","41 15                                  \n","42 16                                  \n","43 17                                  \n","44 16                                  "],"text/latex":"A tibble: 44 × 10\n\\begin{tabular}{llllllllll}\n ID & Description & setSize & enrichmentScore & NES & pvalue & p.adjust & qvalues & leadingEdge & ledge\\_rank\\\\\n <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <chr>\\\\\n\\hline\n\t hsa04540 & Gap junction                                      &  88 & 0.134617347 & 0.414849102 & 0.280 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      & 11/12/13/14/17/18/20/21/22/23/25/26 \\\\\n\t hsa05034 & Alcoholism                                        & 187 & 0.132147832 & 0.268122939 & 0.460 & 0.8626047 & 0.8626047 & 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/1812/79885         & 1/2/3/4/5/6/7/8/9/10/17/24          \\\\\n\t hsa04613 & Neutrophil extracellular trap formation           & 190 & 0.125186817 & 0.253143631 & 0.463 & 0.8626047 & 0.8626047 & 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885              & 1/2/3/4/5/6/7/8/9/10/24             \\\\\n\t hsa05203 & Viral carcinogenesis                              & 204 & 0.117076100 & 0.226183329 & 0.490 & 0.8626047 & 0.8626047 & 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885              & 1/2/3/4/5/6/7/8/9/10/24             \\\\\n\t hsa04330 & Notch signaling pathway                           &  59 & 0.094740954 & 0.353012684 & 0.426 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa05031 & Amphetamine addiction                             &  69 & 0.094148251 & 0.327762767 & 0.409 & 0.8626047 & 0.8626047 & 3065/3066/1812                                                            & 1/6/17                              \\\\\n\t hsa04213 & Longevity regulating pathway - multiple species   &  62 & 0.090411764 & 0.329760785 & 0.452 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa05220 & Chronic myeloid leukemia                          &  76 & 0.074501806 & 0.245790212 & 0.512 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa04919 & Thyroid hormone signaling pathway                 & 121 & 0.070490390 & 0.187560321 & 0.518 & 0.8626047 & 0.8626047 & 3065/8841/3066                                                            & 1/4/6                               \\\\\n\t hsa04145 & Phagosome                                         & 152 & 0.070482340 & 0.161666063 & 0.515 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa05130 & Pathogenic Escherichia coli infection             & 197 & 0.053940750 & 0.105999915 & 0.623 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa05016 & Huntington disease                                & 306 & 0.053171829 & 0.082203291 & 0.680 & 0.8626047 & 0.8626047 & 3065/3066/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790 & 1/6/11/12/13/14/18/20/21/22/23/25/26\\\\\n\t hsa04110 & Cell cycle                                        & 126 & 0.045652530 & 0.118639284 & 0.654 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa05012 & Parkinson disease                                 & 266 & 0.043326840 & 0.072409776 & 0.715 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      & 11/12/13/14/17/18/20/21/22/23/25/26 \\\\\n\t hsa05132 & Salmonella infection                              & 249 & 0.042267338 & 0.072974234 & 0.712 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa04614 & Renin-angiotensin system                          &  23 & 0.041622285 & 0.182209795 & 0.515 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\t hsa04210 & Apoptosis                                         & 136 & 0.041607922 & 0.104549740 & 0.666 & 0.8626047 & 0.8626047 & 10376/51807/7277/7278/7846/84790                                          & 11/20/21/22/23/26                   \\\\\n\t hsa05020 & Prion disease                                     & 273 & 0.038377821 & 0.063267442 & 0.746 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                     & 364 & 0.036442814 & 0.051221086 & 0.799 & 0.8626047 & 0.8626047 & 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790     & 2/11/12/13/14/18/20/21/22/23/25/26  \\\\\n\t hsa04530 & Tight junction                                    & 169 & 0.032982797 & 0.070444108 & 0.694 & 0.8626047 & 0.8626047 & 10376/51807/7277/7278/7846/84790                                          & 11/20/21/22/23/26                   \\\\\n\t hsa05206 & MicroRNAs in cancer                               & 310 & 0.030875845 & 0.047663175 & 0.778 & 0.8626047 & 0.8626047 & 3065/10014/3066/9759                                                      & 1/5/6/10                            \\\\\n\t hsa05202 & Transcriptional misregulation in cancer           & 192 & 0.030106748 & 0.060442964 & 0.714 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa05169 & Epstein-Barr virus infection                      & 202 & 0.028620077 & 0.055572633 & 0.717 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa04371 & Apelin signaling pathway                          & 139 & 0.027364526 & 0.067727509 & 0.675 & 0.8626047 & 0.8626047 & 10014/9759                                                                & 5/10                                \\\\\n\t hsa05010 & Alzheimer disease                                 & 384 & 0.026703080 & 0.036566233 & 0.843 & 0.8626047 & 0.8626047 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa05022 & Pathways of neurodegeneration - multiple diseases & 476 & 0.021143062 & 0.026433619 & 0.878 & 0.8780000 & 0.8780000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           & 11/12/13/14/18/20/21/22/23/25/26    \\\\\n\t hsa05030 & Cocaine addiction                                 &  49 & 0.018422066 & 0.074006541 & 0.554 & 0.8626047 & 0.8626047 & 1812                                                                      & 17                                  \\\\\n\t hsa05165 & Human papillomavirus infection                    & 331 & 0.017395912 & 0.025957874 & 0.811 & 0.8626047 & 0.8626047 & 3065/3066                                                                 & 1/6                                 \\\\\n\t hsa04924 & Renin secretion                                   &  69 & 0.012626153 & 0.043956026 & 0.593 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\t hsa04020 & Calcium signaling pathway                         & 240 & 0.010465671 & 0.018537891 & 0.755 & 0.8626047 & 0.8626047 & 148/1812/3269                                                             & 15/17/19                            \\\\\n\t hsa05410 & Hypertrophic cardiomyopathy                       &  90 & 0.009239620 & 0.028381742 & 0.624 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\t hsa04970 & Salivary secretion                                &  93 & 0.009005309 & 0.027155438 & 0.640 & 0.8626047 & 0.8626047 & 148                                                                       & 15                                  \\\\\n\t hsa05032 & Morphine addiction                                &  91 & 0.008992505 & 0.027427713 & 0.630 & 0.8626047 & 0.8626047 & 1812                                                                      & 17                                  \\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels  &  98 & 0.007956049 & 0.023472873 & 0.639 & 0.8626047 & 0.8626047 & 3269                                                                      & 19                                  \\\\\n\t hsa05142 & Chagas disease                                    & 102 & 0.007929624 & 0.022910681 & 0.638 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\t hsa04152 & AMPK signaling pathway                            & 120 & 0.006580046 & 0.017542717 & 0.673 & 0.8626047 & 0.8626047 & 148                                                                       & 15                                  \\\\\n\t hsa04080 & Neuroactive ligand-receptor interaction           & 350 & 0.006508244 & 0.009372621 & 0.824 & 0.8626047 & 0.8626047 & 148/1812/3269                                                             & 15/17/19                            \\\\\n\t hsa04270 & Vascular smooth muscle contraction                & 134 & 0.005706320 & 0.014463371 & 0.673 & 0.8626047 & 0.8626047 & 148                                                                       & 15                                  \\\\\n\t hsa04728 & Dopaminergic synapse                              & 132 & 0.005568985 & 0.014203899 & 0.677 & 0.8626047 & 0.8626047 & 1812                                                                      & 17                                  \\\\\n\t hsa04261 & Adrenergic signaling in cardiomyocytes            & 150 & 0.004906767 & 0.011369766 & 0.676 & 0.8626047 & 0.8626047 & 148                                                                       & 15                                  \\\\\n\t hsa04022 & cGMP-PKG signaling pathway                        & 167 & 0.004224356 & 0.009106499 & 0.691 & 0.8626047 & 0.8626047 & 148                                                                       & 15                                  \\\\\n\t hsa05415 & Diabetic cardiomyopathy                           & 203 & 0.003027855 & 0.005880150 & 0.720 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\t hsa04024 & cAMP signaling pathway                            & 219 & 0.002537298 & 0.004728552 & 0.732 & 0.8626047 & 0.8626047 & 1812                                                                      & 17                                  \\\\\n\t hsa05171 & Coronavirus disease - COVID-19                    & 232 & 0.002405099 & 0.004313853 & 0.749 & 0.8626047 & 0.8626047 & 1636                                                                      & 16                                  \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 44 × 10\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | enrichmentScore &lt;dbl&gt; | NES &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | leadingEdge &lt;chr&gt; | ledge_rank &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| hsa04540 | Gap junction                                      |  88 | 0.134617347 | 0.414849102 | 0.280 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      | 11/12/13/14/17/18/20/21/22/23/25/26  |\n| hsa05034 | Alcoholism                                        | 187 | 0.132147832 | 0.268122939 | 0.460 | 0.8626047 | 0.8626047 | 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/1812/79885         | 1/2/3/4/5/6/7/8/9/10/17/24           |\n| hsa04613 | Neutrophil extracellular trap formation           | 190 | 0.125186817 | 0.253143631 | 0.463 | 0.8626047 | 0.8626047 | 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885              | 1/2/3/4/5/6/7/8/9/10/24              |\n| hsa05203 | Viral carcinogenesis                              | 204 | 0.117076100 | 0.226183329 | 0.490 | 0.8626047 | 0.8626047 | 3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885              | 1/2/3/4/5/6/7/8/9/10/24              |\n| hsa04330 | Notch signaling pathway                           |  59 | 0.094740954 | 0.353012684 | 0.426 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa05031 | Amphetamine addiction                             |  69 | 0.094148251 | 0.327762767 | 0.409 | 0.8626047 | 0.8626047 | 3065/3066/1812                                                            | 1/6/17                               |\n| hsa04213 | Longevity regulating pathway - multiple species   |  62 | 0.090411764 | 0.329760785 | 0.452 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa05220 | Chronic myeloid leukemia                          |  76 | 0.074501806 | 0.245790212 | 0.512 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa04919 | Thyroid hormone signaling pathway                 | 121 | 0.070490390 | 0.187560321 | 0.518 | 0.8626047 | 0.8626047 | 3065/8841/3066                                                            | 1/4/6                                |\n| hsa04145 | Phagosome                                         | 152 | 0.070482340 | 0.161666063 | 0.515 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa05130 | Pathogenic Escherichia coli infection             | 197 | 0.053940750 | 0.105999915 | 0.623 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa05016 | Huntington disease                                | 306 | 0.053171829 | 0.082203291 | 0.680 | 0.8626047 | 0.8626047 | 3065/3066/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790 | 1/6/11/12/13/14/18/20/21/22/23/25/26 |\n| hsa04110 | Cell cycle                                        | 126 | 0.045652530 | 0.118639284 | 0.654 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa05012 | Parkinson disease                                 | 266 | 0.043326840 | 0.072409776 | 0.715 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      | 11/12/13/14/17/18/20/21/22/23/25/26  |\n| hsa05132 | Salmonella infection                              | 249 | 0.042267338 | 0.072974234 | 0.712 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa04614 | Renin-angiotensin system                          |  23 | 0.041622285 | 0.182209795 | 0.515 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n| hsa04210 | Apoptosis                                         | 136 | 0.041607922 | 0.104549740 | 0.666 | 0.8626047 | 0.8626047 | 10376/51807/7277/7278/7846/84790                                          | 11/20/21/22/23/26                    |\n| hsa05020 | Prion disease                                     | 273 | 0.038377821 | 0.063267442 | 0.746 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa05014 | Amyotrophic lateral sclerosis                     | 364 | 0.036442814 | 0.051221086 | 0.799 | 0.8626047 | 0.8626047 | 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790     | 2/11/12/13/14/18/20/21/22/23/25/26   |\n| hsa04530 | Tight junction                                    | 169 | 0.032982797 | 0.070444108 | 0.694 | 0.8626047 | 0.8626047 | 10376/51807/7277/7278/7846/84790                                          | 11/20/21/22/23/26                    |\n| hsa05206 | MicroRNAs in cancer                               | 310 | 0.030875845 | 0.047663175 | 0.778 | 0.8626047 | 0.8626047 | 3065/10014/3066/9759                                                      | 1/5/6/10                             |\n| hsa05202 | Transcriptional misregulation in cancer           | 192 | 0.030106748 | 0.060442964 | 0.714 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa05169 | Epstein-Barr virus infection                      | 202 | 0.028620077 | 0.055572633 | 0.717 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa04371 | Apelin signaling pathway                          | 139 | 0.027364526 | 0.067727509 | 0.675 | 0.8626047 | 0.8626047 | 10014/9759                                                                | 5/10                                 |\n| hsa05010 | Alzheimer disease                                 | 384 | 0.026703080 | 0.036566233 | 0.843 | 0.8626047 | 0.8626047 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa05022 | Pathways of neurodegeneration - multiple diseases | 476 | 0.021143062 | 0.026433619 | 0.878 | 0.8780000 | 0.8780000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           | 11/12/13/14/18/20/21/22/23/25/26     |\n| hsa05030 | Cocaine addiction                                 |  49 | 0.018422066 | 0.074006541 | 0.554 | 0.8626047 | 0.8626047 | 1812                                                                      | 17                                   |\n| hsa05165 | Human papillomavirus infection                    | 331 | 0.017395912 | 0.025957874 | 0.811 | 0.8626047 | 0.8626047 | 3065/3066                                                                 | 1/6                                  |\n| hsa04924 | Renin secretion                                   |  69 | 0.012626153 | 0.043956026 | 0.593 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n| hsa04020 | Calcium signaling pathway                         | 240 | 0.010465671 | 0.018537891 | 0.755 | 0.8626047 | 0.8626047 | 148/1812/3269                                                             | 15/17/19                             |\n| hsa05410 | Hypertrophic cardiomyopathy                       |  90 | 0.009239620 | 0.028381742 | 0.624 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n| hsa04970 | Salivary secretion                                |  93 | 0.009005309 | 0.027155438 | 0.640 | 0.8626047 | 0.8626047 | 148                                                                       | 15                                   |\n| hsa05032 | Morphine addiction                                |  91 | 0.008992505 | 0.027427713 | 0.630 | 0.8626047 | 0.8626047 | 1812                                                                      | 17                                   |\n| hsa04750 | Inflammatory mediator regulation of TRP channels  |  98 | 0.007956049 | 0.023472873 | 0.639 | 0.8626047 | 0.8626047 | 3269                                                                      | 19                                   |\n| hsa05142 | Chagas disease                                    | 102 | 0.007929624 | 0.022910681 | 0.638 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n| hsa04152 | AMPK signaling pathway                            | 120 | 0.006580046 | 0.017542717 | 0.673 | 0.8626047 | 0.8626047 | 148                                                                       | 15                                   |\n| hsa04080 | Neuroactive ligand-receptor interaction           | 350 | 0.006508244 | 0.009372621 | 0.824 | 0.8626047 | 0.8626047 | 148/1812/3269                                                             | 15/17/19                             |\n| hsa04270 | Vascular smooth muscle contraction                | 134 | 0.005706320 | 0.014463371 | 0.673 | 0.8626047 | 0.8626047 | 148                                                                       | 15                                   |\n| hsa04728 | Dopaminergic synapse                              | 132 | 0.005568985 | 0.014203899 | 0.677 | 0.8626047 | 0.8626047 | 1812                                                                      | 17                                   |\n| hsa04261 | Adrenergic signaling in cardiomyocytes            | 150 | 0.004906767 | 0.011369766 | 0.676 | 0.8626047 | 0.8626047 | 148                                                                       | 15                                   |\n| hsa04022 | cGMP-PKG signaling pathway                        | 167 | 0.004224356 | 0.009106499 | 0.691 | 0.8626047 | 0.8626047 | 148                                                                       | 15                                   |\n| hsa05415 | Diabetic cardiomyopathy                           | 203 | 0.003027855 | 0.005880150 | 0.720 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n| hsa04024 | cAMP signaling pathway                            | 219 | 0.002537298 | 0.004728552 | 0.732 | 0.8626047 | 0.8626047 | 1812                                                                      | 17                                   |\n| hsa05171 | Coronavirus disease - COVID-19                    | 232 | 0.002405099 | 0.004313853 | 0.749 | 0.8626047 | 0.8626047 | 1636                                                                      | 16                                   |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 44 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>enrichmentScore</th><th scope=col>NES</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>leadingEdge</th><th scope=col>ledge_rank</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa04540</td><td>Gap junction                                     </td><td> 88</td><td>0.134617347</td><td>0.414849102</td><td>0.280</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     </td><td>11/12/13/14/17/18/20/21/22/23/25/26 </td></tr>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                       </td><td>187</td><td>0.132147832</td><td>0.268122939</td><td>0.460</td><td>0.8626047</td><td>0.8626047</td><td>3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/1812/79885        </td><td>1/2/3/4/5/6/7/8/9/10/17/24          </td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation          </td><td>190</td><td>0.125186817</td><td>0.253143631</td><td>0.463</td><td>0.8626047</td><td>0.8626047</td><td>3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885             </td><td>1/2/3/4/5/6/7/8/9/10/24             </td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                             </td><td>204</td><td>0.117076100</td><td>0.226183329</td><td>0.490</td><td>0.8626047</td><td>0.8626047</td><td>3065/10013/55869/8841/10014/3066/51564/83933/9734/9759/79885             </td><td>1/2/3/4/5/6/7/8/9/10/24             </td></tr>\n","\t<tr><td>hsa04330</td><td>Notch signaling pathway                          </td><td> 59</td><td>0.094740954</td><td>0.353012684</td><td>0.426</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                            </td><td> 69</td><td>0.094148251</td><td>0.327762767</td><td>0.409</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066/1812                                                           </td><td>1/6/17                              </td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species  </td><td> 62</td><td>0.090411764</td><td>0.329760785</td><td>0.452</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                         </td><td> 76</td><td>0.074501806</td><td>0.245790212</td><td>0.512</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway                </td><td>121</td><td>0.070490390</td><td>0.187560321</td><td>0.518</td><td>0.8626047</td><td>0.8626047</td><td>3065/8841/3066                                                           </td><td>1/4/6                               </td></tr>\n","\t<tr><td>hsa04145</td><td>Phagosome                                        </td><td>152</td><td>0.070482340</td><td>0.161666063</td><td>0.515</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa05130</td><td>Pathogenic Escherichia coli infection            </td><td>197</td><td>0.053940750</td><td>0.105999915</td><td>0.623</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                               </td><td>306</td><td>0.053171829</td><td>0.082203291</td><td>0.680</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790</td><td>1/6/11/12/13/14/18/20/21/22/23/25/26</td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                       </td><td>126</td><td>0.045652530</td><td>0.118639284</td><td>0.654</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                                </td><td>266</td><td>0.043326840</td><td>0.072409776</td><td>0.715</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     </td><td>11/12/13/14/17/18/20/21/22/23/25/26 </td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                             </td><td>249</td><td>0.042267338</td><td>0.072974234</td><td>0.712</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa04614</td><td>Renin-angiotensin system                         </td><td> 23</td><td>0.041622285</td><td>0.182209795</td><td>0.515</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","\t<tr><td>hsa04210</td><td>Apoptosis                                        </td><td>136</td><td>0.041607922</td><td>0.104549740</td><td>0.666</td><td>0.8626047</td><td>0.8626047</td><td>10376/51807/7277/7278/7846/84790                                         </td><td>11/20/21/22/23/26                   </td></tr>\n","\t<tr><td>hsa05020</td><td>Prion disease                                    </td><td>273</td><td>0.038377821</td><td>0.063267442</td><td>0.746</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                    </td><td>364</td><td>0.036442814</td><td>0.051221086</td><td>0.799</td><td>0.8626047</td><td>0.8626047</td><td>10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790    </td><td>2/11/12/13/14/18/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                   </td><td>169</td><td>0.032982797</td><td>0.070444108</td><td>0.694</td><td>0.8626047</td><td>0.8626047</td><td>10376/51807/7277/7278/7846/84790                                         </td><td>11/20/21/22/23/26                   </td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                              </td><td>310</td><td>0.030875845</td><td>0.047663175</td><td>0.778</td><td>0.8626047</td><td>0.8626047</td><td>3065/10014/3066/9759                                                     </td><td>1/5/6/10                            </td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer          </td><td>192</td><td>0.030106748</td><td>0.060442964</td><td>0.714</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                     </td><td>202</td><td>0.028620077</td><td>0.055572633</td><td>0.717</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                         </td><td>139</td><td>0.027364526</td><td>0.067727509</td><td>0.675</td><td>0.8626047</td><td>0.8626047</td><td>10014/9759                                                               </td><td>5/10                                </td></tr>\n","\t<tr><td>hsa05010</td><td>Alzheimer disease                                </td><td>384</td><td>0.026703080</td><td>0.036566233</td><td>0.843</td><td>0.8626047</td><td>0.8626047</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa05022</td><td>Pathways of neurodegeneration - multiple diseases</td><td>476</td><td>0.021143062</td><td>0.026433619</td><td>0.878</td><td>0.8780000</td><td>0.8780000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td><td>11/12/13/14/18/20/21/22/23/25/26    </td></tr>\n","\t<tr><td>hsa05030</td><td>Cocaine addiction                                </td><td> 49</td><td>0.018422066</td><td>0.074006541</td><td>0.554</td><td>0.8626047</td><td>0.8626047</td><td>1812                                                                     </td><td>17                                  </td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                   </td><td>331</td><td>0.017395912</td><td>0.025957874</td><td>0.811</td><td>0.8626047</td><td>0.8626047</td><td>3065/3066                                                                </td><td>1/6                                 </td></tr>\n","\t<tr><td>hsa04924</td><td>Renin secretion                                  </td><td> 69</td><td>0.012626153</td><td>0.043956026</td><td>0.593</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","\t<tr><td>hsa04020</td><td>Calcium signaling pathway                        </td><td>240</td><td>0.010465671</td><td>0.018537891</td><td>0.755</td><td>0.8626047</td><td>0.8626047</td><td>148/1812/3269                                                            </td><td>15/17/19                            </td></tr>\n","\t<tr><td>hsa05410</td><td>Hypertrophic cardiomyopathy                      </td><td> 90</td><td>0.009239620</td><td>0.028381742</td><td>0.624</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                               </td><td> 93</td><td>0.009005309</td><td>0.027155438</td><td>0.640</td><td>0.8626047</td><td>0.8626047</td><td>148                                                                      </td><td>15                                  </td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                               </td><td> 91</td><td>0.008992505</td><td>0.027427713</td><td>0.630</td><td>0.8626047</td><td>0.8626047</td><td>1812                                                                     </td><td>17                                  </td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels </td><td> 98</td><td>0.007956049</td><td>0.023472873</td><td>0.639</td><td>0.8626047</td><td>0.8626047</td><td>3269                                                                     </td><td>19                                  </td></tr>\n","\t<tr><td>hsa05142</td><td>Chagas disease                                   </td><td>102</td><td>0.007929624</td><td>0.022910681</td><td>0.638</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","\t<tr><td>hsa04152</td><td>AMPK signaling pathway                           </td><td>120</td><td>0.006580046</td><td>0.017542717</td><td>0.673</td><td>0.8626047</td><td>0.8626047</td><td>148                                                                      </td><td>15                                  </td></tr>\n","\t<tr><td>hsa04080</td><td>Neuroactive ligand-receptor interaction          </td><td>350</td><td>0.006508244</td><td>0.009372621</td><td>0.824</td><td>0.8626047</td><td>0.8626047</td><td>148/1812/3269                                                            </td><td>15/17/19                            </td></tr>\n","\t<tr><td>hsa04270</td><td>Vascular smooth muscle contraction               </td><td>134</td><td>0.005706320</td><td>0.014463371</td><td>0.673</td><td>0.8626047</td><td>0.8626047</td><td>148                                                                      </td><td>15                                  </td></tr>\n","\t<tr><td>hsa04728</td><td>Dopaminergic synapse                             </td><td>132</td><td>0.005568985</td><td>0.014203899</td><td>0.677</td><td>0.8626047</td><td>0.8626047</td><td>1812                                                                     </td><td>17                                  </td></tr>\n","\t<tr><td>hsa04261</td><td>Adrenergic signaling in cardiomyocytes           </td><td>150</td><td>0.004906767</td><td>0.011369766</td><td>0.676</td><td>0.8626047</td><td>0.8626047</td><td>148                                                                      </td><td>15                                  </td></tr>\n","\t<tr><td>hsa04022</td><td>cGMP-PKG signaling pathway                       </td><td>167</td><td>0.004224356</td><td>0.009106499</td><td>0.691</td><td>0.8626047</td><td>0.8626047</td><td>148                                                                      </td><td>15                                  </td></tr>\n","\t<tr><td>hsa05415</td><td>Diabetic cardiomyopathy                          </td><td>203</td><td>0.003027855</td><td>0.005880150</td><td>0.720</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","\t<tr><td>hsa04024</td><td>cAMP signaling pathway                           </td><td>219</td><td>0.002537298</td><td>0.004728552</td><td>0.732</td><td>0.8626047</td><td>0.8626047</td><td>1812                                                                     </td><td>17                                  </td></tr>\n","\t<tr><td>hsa05171</td><td>Coronavirus disease - COVID-19                   </td><td>232</td><td>0.002405099</td><td>0.004313853</td><td>0.749</td><td>0.8626047</td><td>0.8626047</td><td>1636                                                                     </td><td>16                                  </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":32},"id":"uN1TBgVIKYeD","executionInfo":{"status":"ok","timestamp":1636338315375,"user_tz":-480,"elapsed":14,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"030b939e-a695-406a-b573-47bef7af849f"},"source":["drugs"],"execution_count":32,"outputs":[{"output_type":"display_data","data":{"text/plain":[" [1] \"vorinostat\"          \"trichostatin-a\"      \"HC-toxin\"           \n"," [4] \"pyroxamide\"          \"zuclopenthixol\"      \"rescinnamine\"       \n"," [7] \"APHA-compound-8\"     \"epothilone\"          \"scopolamine-n-oxide\"\n","[10] \"I-070759\"           "],"text/latex":"\\begin{enumerate*}\n\\item 'vorinostat'\n\\item 'trichostatin-a'\n\\item 'HC-toxin'\n\\item 'pyroxamide'\n\\item 'zuclopenthixol'\n\\item 'rescinnamine'\n\\item 'APHA-compound-8'\n\\item 'epothilone'\n\\item 'scopolamine-n-oxide'\n\\item 'I-070759'\n\\end{enumerate*}\n","text/markdown":"1. 'vorinostat'\n2. 'trichostatin-a'\n3. 'HC-toxin'\n4. 'pyroxamide'\n5. 'zuclopenthixol'\n6. 'rescinnamine'\n7. 'APHA-compound-8'\n8. 'epothilone'\n9. 'scopolamine-n-oxide'\n10. 'I-070759'\n\n\n","text/html":["<style>\n",".list-inline {list-style: none; margin:0; padding: 0}\n",".list-inline>li {display: inline-block}\n",".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n","</style>\n","<ol class=list-inline><li>'vorinostat'</li><li>'trichostatin-a'</li><li>'HC-toxin'</li><li>'pyroxamide'</li><li>'zuclopenthixol'</li><li>'rescinnamine'</li><li>'APHA-compound-8'</li><li>'epothilone'</li><li>'scopolamine-n-oxide'</li><li>'I-070759'</li></ol>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"kTudoWI2KhYf","executionInfo":{"status":"ok","timestamp":1636338336187,"user_tz":-480,"elapsed":20822,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"4c3b5e43-3f78-4b0e-faab-b788920f987a"},"source":["# KEGG\n","mgsea_rct_res <- tsea_mGSEA(drugs=drugs, type=\"Reactome\", pvalueCutoff=1,\n","                            readable=TRUE)\n","result(mgsea_rct_res)"],"execution_count":33,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["    ID           \n","1   R-HSA-193670 \n","2   R-HSA-350054 \n","3   R-HSA-9701898\n","4   R-HSA-190840 \n","5   R-HSA-190872 \n","6   R-HSA-389977 \n","7   R-HSA-2122947\n","8   R-HSA-389960 \n","9   R-HSA-9005891\n","10  R-HSA-9005895\n","11  R-HSA-9675151\n","12  R-HSA-9697154\n","13  R-HSA-9022702\n","14  R-HSA-2644602\n","15  R-HSA-2644603\n","16  R-HSA-2644606\n","17  R-HSA-2894858\n","18  R-HSA-2894862\n","19  R-HSA-9619483\n","20  R-HSA-9022537\n","21  R-HSA-8941284\n","22  R-HSA-9668328\n","23  R-HSA-389958 \n","24  R-HSA-5626467\n","25  R-HSA-1980143\n","26  R-HSA-9646399\n","27  R-HSA-9022699\n","28  R-HSA-389957 \n","29  R-HSA-190861 \n","30  R-HSA-201556 \n","⋮   ⋮            \n","157 R-HSA-3108214\n","158 R-HSA-1989781\n","159 R-HSA-400206 \n","160 R-HSA-5617472\n","161 R-HSA-5619507\n","162 R-HSA-9707564\n","163 R-HSA-112316 \n","164 R-HSA-9006931\n","165 R-HSA-8878159\n","166 R-HSA-9711123\n","167 R-HSA-8939211\n","168 R-HSA-201681 \n","169 R-HSA-8878171\n","170 R-HSA-3700989\n","171 R-HSA-195721 \n","172 R-HSA-416482 \n","173 R-HSA-2980736\n","174 R-HSA-416476 \n","175 R-HSA-373076 \n","176 R-HSA-9660821\n","177 R-HSA-114608 \n","178 R-HSA-76005  \n","179 R-HSA-418555 \n","180 R-HSA-500792 \n","181 R-HSA-9662851\n","182 R-HSA-9664433\n","183 R-HSA-6798695\n","184 R-HSA-9658195\n","185 R-HSA-76002  \n","186 R-HSA-9012999\n","    Description                                                                         \n","1   p75NTR negatively regulates cell cycle via SC1                                      \n","2   Notch-HLH transcription pathway                                                     \n","3   STAT3 nuclear events downstream of ALK signaling                                    \n","4   Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane    \n","5   Transport of connexons to the plasma membrane                                       \n","6   Post-chaperonin tubulin folding pathway                                             \n","7   NOTCH1 Intracellular Domain Regulates Transcription                                 \n","8   Formation of tubulin folding intermediates by CCT/TriC                              \n","9   Loss of function of MECP2 in Rett syndrome                                          \n","10  Pervasive developmental disorders                                                   \n","11  Disorders of Developmental Biology                                                  \n","12  Disorders of Nervous System Development                                             \n","13  MECP2 regulates transcription of neuronal ligands                                   \n","14  Signaling by NOTCH1 PEST Domain Mutants in Cancer                                   \n","15  Signaling by NOTCH1 in Cancer                                                       \n","16  Constitutive Signaling by NOTCH1 PEST Domain Mutants                                \n","17  Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                                \n","18  Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                             \n","19  Activation of AMPK downstream of NMDARs                                             \n","20  Loss of MECP2 binding ability to the NCoR/SMRT complex                              \n","21  RUNX2 regulates chondrocyte maturation                                              \n","22  Sealing of the nuclear envelope (NE) by ESCRT-III                                   \n","23  Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding                 \n","24  RHO GTPases activate IQGAPs                                                         \n","25  Signaling by NOTCH1                                                                 \n","26  Aggrephagy                                                                          \n","27  MECP2 regulates neuronal receptors and channels                                     \n","28  Prefoldin mediated transfer of substrate  to CCT/TriC                               \n","29  Gap junction assembly                                                               \n","30  Signaling by ALK                                                                    \n","⋮   ⋮                                                                                   \n","157 SUMOylation of DNA damage response and repair proteins                              \n","158 PPARA activates gene expression                                                     \n","159 Regulation of lipid metabolism by PPARalpha                                         \n","160 Activation of anterior HOX genes in hindbrain development during early embryogenesis\n","161 Activation of HOX genes during differentiation                                      \n","162 Cytoprotection by HMOX1                                                             \n","163 Neuronal System                                                                     \n","164 Signaling by Nuclear Receptors                                                      \n","165 Transcriptional regulation by RUNX3                                                 \n","166 Cellular response to chemical stress                                                \n","167 ESR-mediated signaling                                                              \n","168 TCF dependent signaling in response to WNT                                          \n","169 Transcriptional regulation by RUNX1                                                 \n","170 Transcriptional Regulation by TP53                                                  \n","171 Signaling by WNT                                                                    \n","172 G alpha (12/13) signalling events                                                   \n","173 Peptide hormone metabolism                                                          \n","174 G alpha (q) signalling events                                                       \n","175 Class A/1 (Rhodopsin-like receptors)                                                \n","176 ADORA2B mediated anti-inflammatory cytokines production                             \n","177 Platelet degranulation                                                              \n","178 Response to elevated platelet cytosolic Ca2+                                        \n","179 G alpha (s) signalling events                                                       \n","180 GPCR ligand binding                                                                 \n","181 Anti-inflammatory response favouring Leishmania parasite infection                  \n","182 Leishmania parasite growth and survival                                             \n","183 Neutrophil degranulation                                                            \n","184 Leishmania infection                                                                \n","185 Platelet activation, signaling and aggregation                                      \n","186 RHO GTPase cycle                                                                    \n","    setSize enrichmentScore NES         pvalue p.adjust  qvalues  \n","1    6      0.7497238       2.216827    0.018  0.736061  0.736061 \n","2   28      0.6034518       2.724265    0.073  0.736061  0.736061 \n","3   10      0.5622237       1.999238    0.030  0.736061  0.736061 \n","4   18      0.5540808       2.365466    0.045  0.736061  0.736061 \n","5   19      0.5248409       2.248782    0.049  0.736061  0.736061 \n","6   22      0.4530701       2.032002    0.054  0.736061  0.736061 \n","7   48      0.4114968       1.820911    0.117  0.736061  0.736061 \n","8   25      0.3985243       1.800652    0.063  0.736061  0.736061 \n","9   14      0.3682368       1.452392    0.048  0.736061  0.736061 \n","10  14      0.3682368       1.452392    0.048  0.736061  0.736061 \n","11  14      0.3682368       1.452392    0.048  0.736061  0.736061 \n","12  14      0.3682368       1.452392    0.048  0.736061  0.736061 \n","13   8      0.3636364       1.195062    0.110  0.736061  0.736061 \n","14  58      0.3549617       1.500281    0.139  0.736061  0.736061 \n","15  58      0.3549617       1.500281    0.139  0.736061  0.736061 \n","16  58      0.3549617       1.500281    0.139  0.736061  0.736061 \n","17  58      0.3549617       1.500281    0.139  0.736061  0.736061 \n","18  58      0.3549617       1.500281    0.139  0.736061  0.736061 \n","19  29      0.3433513       1.550626    0.077  0.736061  0.736061 \n","20   7      0.3330571       1.051147    0.183  0.736061  0.736061 \n","21   5      0.3325048       0.915295    0.263  0.736061  0.736061 \n","22  31      0.3211041       1.458696    0.081  0.736061  0.736061 \n","23  32      0.3110233       1.417064    0.084  0.736061  0.736061 \n","24  32      0.3110233       1.417064    0.084  0.736061  0.736061 \n","25  74      0.2909303       1.122948    0.176  0.736061  0.736061 \n","26  43      0.2875031       1.289229    0.110  0.736061  0.736061 \n","27  17      0.2853456       1.193952    0.090  0.736061  0.736061 \n","28  28      0.2840536       1.282351    0.084  0.736061  0.736061 \n","29  36      0.2763005       1.241645    0.098  0.736061  0.736061 \n","30  27      0.2724505       1.226190    0.089  0.736061  0.736061 \n","⋮   ⋮       ⋮               ⋮           ⋮      ⋮         ⋮        \n","157  77     0.025084955     0.096547442 0.564  0.7360610 0.7360610\n","158 117     0.024931014     0.080324400 0.602  0.7360610 0.7360610\n","159 119     0.024514267     0.078444182 0.601  0.7360610 0.7360610\n","160 121     0.024111070     0.076587977 0.602  0.7360610 0.7360610\n","161 121     0.024111070     0.076587977 0.602  0.7360610 0.7360610\n","162 124     0.023530272     0.072938786 0.606  0.7360610 0.7360610\n","163 410     0.022860168     0.033987572 0.818  0.8314098 0.8314098\n","164 299     0.022837065     0.041510356 0.754  0.7923390 0.7923390\n","165  96     0.019782980     0.069288604 0.573  0.7360610 0.7360610\n","166 160     0.018238328     0.047451602 0.648  0.7360610 0.7360610\n","167 223     0.017699115     0.037904684 0.710  0.7710349 0.7710349\n","168 233     0.016949153     0.035499561 0.713  0.7710349 0.7710349\n","169 239     0.016528926     0.034172270 0.722  0.7762543 0.7762543\n","170 365     0.015879283     0.025451474 0.797  0.8145165 0.8145165\n","171 332     0.011940299     0.020617351 0.777  0.8015470 0.8015470\n","172  80     0.011202141     0.042342490 0.556  0.7360610 0.7360610\n","173  91     0.009597029     0.034231543 0.572  0.7360610 0.7360610\n","174 216     0.007663165     0.016555644 0.708  0.7710349 0.7710349\n","175 335     0.007436044     0.012800154 0.780  0.8015470 0.8015470\n","176 134     0.005971957     0.017965955 0.613  0.7360610 0.7360610\n","177 129     0.005889394     0.017862145 0.616  0.7360610 0.7360610\n","178 134     0.005599275     0.016844782 0.613  0.7360610 0.7360610\n","179 145     0.005404293     0.015174118 0.634  0.7360610 0.7360610\n","180 467     0.004885521     0.006822038 0.844  0.8440000 0.8440000\n","181 169     0.004421553     0.011184126 0.660  0.7395181 0.7395181\n","182 169     0.004421553     0.011184126 0.660  0.7395181 0.7395181\n","183 480     0.002626280     0.003634032 0.844  0.8440000 0.8440000\n","184 254     0.002429423     0.004827834 0.736  0.7809886 0.7809886\n","185 263     0.001916201     0.003734587 0.736  0.7809886 0.7809886\n","186 449     0.001267294     0.001800966 0.834  0.8430652 0.8430652\n","    leadingEdge                                                             \n","1   HDAC1/HDAC3/HDAC2                                                       \n","2   HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","3   HDAC1/HDAC3/HDAC2                                                       \n","4   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","5   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","6   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","7   HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","8   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","9   HDAC1/HDAC3                                                             \n","10  HDAC1/HDAC3                                                             \n","11  HDAC1/HDAC3                                                             \n","12  HDAC1/HDAC3                                                             \n","13  HDAC1                                                                   \n","14  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","15  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","16  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","17  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","18  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","19  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","20  HDAC3                                                                   \n","21  HDAC4                                                                   \n","22  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","23  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","24  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","25  HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     \n","26  HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C\n","27  HDAC1/HDAC2                                                             \n","28  TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                   \n","29  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","30  HDAC1/HDAC3/HDAC2                                                       \n","⋮   ⋮                                                                       \n","157 HDAC7                                                                   \n","158 HDAC3                                                                   \n","159 HDAC3                                                                   \n","160 HDAC3                                                                   \n","161 HDAC3                                                                   \n","162 HDAC3                                                                   \n","163 TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","164 HDAC1/HDAC3                                                             \n","165 HDAC4                                                                   \n","166 HDAC3                                                                   \n","167 HDAC1                                                                   \n","168 HDAC1                                                                   \n","169 HDAC1                                                                   \n","170 HDAC1/HDAC2                                                             \n","171 HDAC1                                                                   \n","172 ADRA1A                                                                  \n","173 ACE                                                                     \n","174 ADRA1A/HRH1                                                             \n","175 ADRA1A/DRD1/HRH1                                                        \n","176 DRD1                                                                    \n","177 TUBA4A                                                                  \n","178 TUBA4A                                                                  \n","179 DRD1                                                                    \n","180 ADRA1A/DRD1/HRH1                                                        \n","181 DRD1                                                                    \n","182 DRD1                                                                    \n","183 TUBB4B/TUBB                                                             \n","184 DRD1                                                                    \n","185 TUBA4A                                                                  \n","186 TUBA1B                                                                  \n","    ledge_rank                     \n","1   1/4/6                          \n","2   1/2/3/4/5/6/7/8/9/10/24        \n","3   1/4/6                          \n","4   11/12/13/14/20/21/22/23/25/26  \n","5   11/12/13/14/20/21/22/23/25/26  \n","6   11/12/13/14/20/21/22/23/25/26  \n","7   1/2/3/4/5/6/7/8/9/10/24        \n","8   11/12/13/14/20/21/22/23/25/26  \n","9   1/4                            \n","10  1/4                            \n","11  1/4                            \n","12  1/4                            \n","13  1                              \n","14  1/2/3/4/5/6/7/8/9/10/24        \n","15  1/2/3/4/5/6/7/8/9/10/24        \n","16  1/2/3/4/5/6/7/8/9/10/24        \n","17  1/2/3/4/5/6/7/8/9/10/24        \n","18  1/2/3/4/5/6/7/8/9/10/24        \n","19  11/12/13/14/20/21/22/23/25/26  \n","20  4                              \n","21  10                             \n","22  11/12/13/14/20/21/22/23/25/26  \n","23  11/12/13/14/20/21/22/23/25/26  \n","24  11/12/13/14/20/21/22/23/25/26  \n","25  1/2/3/4/5/6/7/8/9/10/24        \n","26  2/11/12/13/14/20/21/22/23/25/26\n","27  1/6                            \n","28  12/13/14/21/22/23/25/26        \n","29  11/12/13/14/20/21/22/23/25/26  \n","30  1/4/6                          \n","⋮   ⋮                              \n","157 7                              \n","158 4                              \n","159 4                              \n","160 4                              \n","161 4                              \n","162 4                              \n","163 11/12/13/14/20/21/22/23/25/26  \n","164 1/4                            \n","165 10                             \n","166 4                              \n","167 1                              \n","168 1                              \n","169 1                              \n","170 1/6                            \n","171 1                              \n","172 15                             \n","173 16                             \n","174 15/19                          \n","175 15/17/19                       \n","176 17                             \n","177 21                             \n","178 21                             \n","179 17                             \n","180 15/17/19                       \n","181 17                             \n","182 17                             \n","183 14/18                          \n","184 17                             \n","185 21                             \n","186 11                             "],"text/latex":"A tibble: 186 × 10\n\\begin{tabular}{llllllllll}\n ID & Description & setSize & enrichmentScore & NES & pvalue & p.adjust & qvalues & leadingEdge & ledge\\_rank\\\\\n <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <chr>\\\\\n\\hline\n\t R-HSA-193670  & p75NTR negatively regulates cell cycle via SC1                                   &  6 & 0.7497238 & 2.216827 & 0.018 & 0.736061 & 0.736061 & HDAC1/HDAC3/HDAC2                                                        & 1/4/6                          \\\\\n\t R-HSA-350054  & Notch-HLH transcription pathway                                                  & 28 & 0.6034518 & 2.724265 & 0.073 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-9701898 & STAT3 nuclear events downstream of ALK signaling                                 & 10 & 0.5622237 & 1.999238 & 0.030 & 0.736061 & 0.736061 & HDAC1/HDAC3/HDAC2                                                        & 1/4/6                          \\\\\n\t R-HSA-190840  & Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane & 18 & 0.5540808 & 2.365466 & 0.045 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-190872  & Transport of connexons to the plasma membrane                                    & 19 & 0.5248409 & 2.248782 & 0.049 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-389977  & Post-chaperonin tubulin folding pathway                                          & 22 & 0.4530701 & 2.032002 & 0.054 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-2122947 & NOTCH1 Intracellular Domain Regulates Transcription                              & 48 & 0.4114968 & 1.820911 & 0.117 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-389960  & Formation of tubulin folding intermediates by CCT/TriC                           & 25 & 0.3985243 & 1.800652 & 0.063 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-9005891 & Loss of function of MECP2 in Rett syndrome                                       & 14 & 0.3682368 & 1.452392 & 0.048 & 0.736061 & 0.736061 & HDAC1/HDAC3                                                              & 1/4                            \\\\\n\t R-HSA-9005895 & Pervasive developmental disorders                                                & 14 & 0.3682368 & 1.452392 & 0.048 & 0.736061 & 0.736061 & HDAC1/HDAC3                                                              & 1/4                            \\\\\n\t R-HSA-9675151 & Disorders of Developmental Biology                                               & 14 & 0.3682368 & 1.452392 & 0.048 & 0.736061 & 0.736061 & HDAC1/HDAC3                                                              & 1/4                            \\\\\n\t R-HSA-9697154 & Disorders of Nervous System Development                                          & 14 & 0.3682368 & 1.452392 & 0.048 & 0.736061 & 0.736061 & HDAC1/HDAC3                                                              & 1/4                            \\\\\n\t R-HSA-9022702 & MECP2 regulates transcription of neuronal ligands                                &  8 & 0.3636364 & 1.195062 & 0.110 & 0.736061 & 0.736061 & HDAC1                                                                    & 1                              \\\\\n\t R-HSA-2644602 & Signaling by NOTCH1 PEST Domain Mutants in Cancer                                & 58 & 0.3549617 & 1.500281 & 0.139 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-2644603 & Signaling by NOTCH1 in Cancer                                                    & 58 & 0.3549617 & 1.500281 & 0.139 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-2644606 & Constitutive Signaling by NOTCH1 PEST Domain Mutants                             & 58 & 0.3549617 & 1.500281 & 0.139 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-2894858 & Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             & 58 & 0.3549617 & 1.500281 & 0.139 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-2894862 & Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          & 58 & 0.3549617 & 1.500281 & 0.139 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-9619483 & Activation of AMPK downstream of NMDARs                                          & 29 & 0.3433513 & 1.550626 & 0.077 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-9022537 & Loss of MECP2 binding ability to the NCoR/SMRT complex                           &  7 & 0.3330571 & 1.051147 & 0.183 & 0.736061 & 0.736061 & HDAC3                                                                    & 4                              \\\\\n\t R-HSA-8941284 & RUNX2 regulates chondrocyte maturation                                           &  5 & 0.3325048 & 0.915295 & 0.263 & 0.736061 & 0.736061 & HDAC4                                                                    & 10                             \\\\\n\t R-HSA-9668328 & Sealing of the nuclear envelope (NE) by ESCRT-III                                & 31 & 0.3211041 & 1.458696 & 0.081 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-389958  & Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              & 32 & 0.3110233 & 1.417064 & 0.084 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-5626467 & RHO GTPases activate IQGAPs                                                      & 32 & 0.3110233 & 1.417064 & 0.084 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-1980143 & Signaling by NOTCH1                                                              & 74 & 0.2909303 & 1.122948 & 0.176 & 0.736061 & 0.736061 & HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      & 1/2/3/4/5/6/7/8/9/10/24        \\\\\n\t R-HSA-9646399 & Aggrephagy                                                                       & 43 & 0.2875031 & 1.289229 & 0.110 & 0.736061 & 0.736061 & HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C & 2/11/12/13/14/20/21/22/23/25/26\\\\\n\t R-HSA-9022699 & MECP2 regulates neuronal receptors and channels                                  & 17 & 0.2853456 & 1.193952 & 0.090 & 0.736061 & 0.736061 & HDAC1/HDAC2                                                              & 1/6                            \\\\\n\t R-HSA-389957  & Prefoldin mediated transfer of substrate  to CCT/TriC                            & 28 & 0.2840536 & 1.282351 & 0.084 & 0.736061 & 0.736061 & TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                    & 12/13/14/21/22/23/25/26        \\\\\n\t R-HSA-190861  & Gap junction assembly                                                            & 36 & 0.2763005 & 1.241645 & 0.098 & 0.736061 & 0.736061 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       & 11/12/13/14/20/21/22/23/25/26  \\\\\n\t R-HSA-201556  & Signaling by ALK                                                                 & 27 & 0.2724505 & 1.226190 & 0.089 & 0.736061 & 0.736061 & HDAC1/HDAC3/HDAC2                                                        & 1/4/6                          \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t R-HSA-3108214 & SUMOylation of DNA damage response and repair proteins                               &  77 & 0.025084955 & 0.096547442 & 0.564 & 0.7360610 & 0.7360610 & HDAC7                                                              & 7                            \\\\\n\t R-HSA-1989781 & PPARA activates gene expression                                                      & 117 & 0.024931014 & 0.080324400 & 0.602 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-400206  & Regulation of lipid metabolism by PPARalpha                                          & 119 & 0.024514267 & 0.078444182 & 0.601 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-5617472 & Activation of anterior HOX genes in hindbrain development during early embryogenesis & 121 & 0.024111070 & 0.076587977 & 0.602 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-5619507 & Activation of HOX genes during differentiation                                       & 121 & 0.024111070 & 0.076587977 & 0.602 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-9707564 & Cytoprotection by HMOX1                                                              & 124 & 0.023530272 & 0.072938786 & 0.606 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-112316  & Neuronal System                                                                      & 410 & 0.022860168 & 0.033987572 & 0.818 & 0.8314098 & 0.8314098 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C & 11/12/13/14/20/21/22/23/25/26\\\\\n\t R-HSA-9006931 & Signaling by Nuclear Receptors                                                       & 299 & 0.022837065 & 0.041510356 & 0.754 & 0.7923390 & 0.7923390 & HDAC1/HDAC3                                                        & 1/4                          \\\\\n\t R-HSA-8878159 & Transcriptional regulation by RUNX3                                                  &  96 & 0.019782980 & 0.069288604 & 0.573 & 0.7360610 & 0.7360610 & HDAC4                                                              & 10                           \\\\\n\t R-HSA-9711123 & Cellular response to chemical stress                                                 & 160 & 0.018238328 & 0.047451602 & 0.648 & 0.7360610 & 0.7360610 & HDAC3                                                              & 4                            \\\\\n\t R-HSA-8939211 & ESR-mediated signaling                                                               & 223 & 0.017699115 & 0.037904684 & 0.710 & 0.7710349 & 0.7710349 & HDAC1                                                              & 1                            \\\\\n\t R-HSA-201681  & TCF dependent signaling in response to WNT                                           & 233 & 0.016949153 & 0.035499561 & 0.713 & 0.7710349 & 0.7710349 & HDAC1                                                              & 1                            \\\\\n\t R-HSA-8878171 & Transcriptional regulation by RUNX1                                                  & 239 & 0.016528926 & 0.034172270 & 0.722 & 0.7762543 & 0.7762543 & HDAC1                                                              & 1                            \\\\\n\t R-HSA-3700989 & Transcriptional Regulation by TP53                                                   & 365 & 0.015879283 & 0.025451474 & 0.797 & 0.8145165 & 0.8145165 & HDAC1/HDAC2                                                        & 1/6                          \\\\\n\t R-HSA-195721  & Signaling by WNT                                                                     & 332 & 0.011940299 & 0.020617351 & 0.777 & 0.8015470 & 0.8015470 & HDAC1                                                              & 1                            \\\\\n\t R-HSA-416482  & G alpha (12/13) signalling events                                                    &  80 & 0.011202141 & 0.042342490 & 0.556 & 0.7360610 & 0.7360610 & ADRA1A                                                             & 15                           \\\\\n\t R-HSA-2980736 & Peptide hormone metabolism                                                           &  91 & 0.009597029 & 0.034231543 & 0.572 & 0.7360610 & 0.7360610 & ACE                                                                & 16                           \\\\\n\t R-HSA-416476  & G alpha (q) signalling events                                                        & 216 & 0.007663165 & 0.016555644 & 0.708 & 0.7710349 & 0.7710349 & ADRA1A/HRH1                                                        & 15/19                        \\\\\n\t R-HSA-373076  & Class A/1 (Rhodopsin-like receptors)                                                 & 335 & 0.007436044 & 0.012800154 & 0.780 & 0.8015470 & 0.8015470 & ADRA1A/DRD1/HRH1                                                   & 15/17/19                     \\\\\n\t R-HSA-9660821 & ADORA2B mediated anti-inflammatory cytokines production                              & 134 & 0.005971957 & 0.017965955 & 0.613 & 0.7360610 & 0.7360610 & DRD1                                                               & 17                           \\\\\n\t R-HSA-114608  & Platelet degranulation                                                               & 129 & 0.005889394 & 0.017862145 & 0.616 & 0.7360610 & 0.7360610 & TUBA4A                                                             & 21                           \\\\\n\t R-HSA-76005   & Response to elevated platelet cytosolic Ca2+                                         & 134 & 0.005599275 & 0.016844782 & 0.613 & 0.7360610 & 0.7360610 & TUBA4A                                                             & 21                           \\\\\n\t R-HSA-418555  & G alpha (s) signalling events                                                        & 145 & 0.005404293 & 0.015174118 & 0.634 & 0.7360610 & 0.7360610 & DRD1                                                               & 17                           \\\\\n\t R-HSA-500792  & GPCR ligand binding                                                                  & 467 & 0.004885521 & 0.006822038 & 0.844 & 0.8440000 & 0.8440000 & ADRA1A/DRD1/HRH1                                                   & 15/17/19                     \\\\\n\t R-HSA-9662851 & Anti-inflammatory response favouring Leishmania parasite infection                   & 169 & 0.004421553 & 0.011184126 & 0.660 & 0.7395181 & 0.7395181 & DRD1                                                               & 17                           \\\\\n\t R-HSA-9664433 & Leishmania parasite growth and survival                                              & 169 & 0.004421553 & 0.011184126 & 0.660 & 0.7395181 & 0.7395181 & DRD1                                                               & 17                           \\\\\n\t R-HSA-6798695 & Neutrophil degranulation                                                             & 480 & 0.002626280 & 0.003634032 & 0.844 & 0.8440000 & 0.8440000 & TUBB4B/TUBB                                                        & 14/18                        \\\\\n\t R-HSA-9658195 & Leishmania infection                                                                 & 254 & 0.002429423 & 0.004827834 & 0.736 & 0.7809886 & 0.7809886 & DRD1                                                               & 17                           \\\\\n\t R-HSA-76002   & Platelet activation, signaling and aggregation                                       & 263 & 0.001916201 & 0.003734587 & 0.736 & 0.7809886 & 0.7809886 & TUBA4A                                                             & 21                           \\\\\n\t R-HSA-9012999 & RHO GTPase cycle                                                                     & 449 & 0.001267294 & 0.001800966 & 0.834 & 0.8430652 & 0.8430652 & TUBA1B                                                             & 11                           \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 186 × 10\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | enrichmentScore &lt;dbl&gt; | NES &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | leadingEdge &lt;chr&gt; | ledge_rank &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| R-HSA-193670  | p75NTR negatively regulates cell cycle via SC1                                   |  6 | 0.7497238 | 2.216827 | 0.018 | 0.736061 | 0.736061 | HDAC1/HDAC3/HDAC2                                                        | 1/4/6                           |\n| R-HSA-350054  | Notch-HLH transcription pathway                                                  | 28 | 0.6034518 | 2.724265 | 0.073 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling                                 | 10 | 0.5622237 | 1.999238 | 0.030 | 0.736061 | 0.736061 | HDAC1/HDAC3/HDAC2                                                        | 1/4/6                           |\n| R-HSA-190840  | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 18 | 0.5540808 | 2.365466 | 0.045 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-190872  | Transport of connexons to the plasma membrane                                    | 19 | 0.5248409 | 2.248782 | 0.049 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-389977  | Post-chaperonin tubulin folding pathway                                          | 22 | 0.4530701 | 2.032002 | 0.054 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription                              | 48 | 0.4114968 | 1.820911 | 0.117 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-389960  | Formation of tubulin folding intermediates by CCT/TriC                           | 25 | 0.3985243 | 1.800652 | 0.063 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome                                       | 14 | 0.3682368 | 1.452392 | 0.048 | 0.736061 | 0.736061 | HDAC1/HDAC3                                                              | 1/4                             |\n| R-HSA-9005895 | Pervasive developmental disorders                                                | 14 | 0.3682368 | 1.452392 | 0.048 | 0.736061 | 0.736061 | HDAC1/HDAC3                                                              | 1/4                             |\n| R-HSA-9675151 | Disorders of Developmental Biology                                               | 14 | 0.3682368 | 1.452392 | 0.048 | 0.736061 | 0.736061 | HDAC1/HDAC3                                                              | 1/4                             |\n| R-HSA-9697154 | Disorders of Nervous System Development                                          | 14 | 0.3682368 | 1.452392 | 0.048 | 0.736061 | 0.736061 | HDAC1/HDAC3                                                              | 1/4                             |\n| R-HSA-9022702 | MECP2 regulates transcription of neuronal ligands                                |  8 | 0.3636364 | 1.195062 | 0.110 | 0.736061 | 0.736061 | HDAC1                                                                    | 1                               |\n| R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer                                | 58 | 0.3549617 | 1.500281 | 0.139 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-2644603 | Signaling by NOTCH1 in Cancer                                                    | 58 | 0.3549617 | 1.500281 | 0.139 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants                             | 58 | 0.3549617 | 1.500281 | 0.139 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             | 58 | 0.3549617 | 1.500281 | 0.139 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          | 58 | 0.3549617 | 1.500281 | 0.139 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-9619483 | Activation of AMPK downstream of NMDARs                                          | 29 | 0.3433513 | 1.550626 | 0.077 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex                           |  7 | 0.3330571 | 1.051147 | 0.183 | 0.736061 | 0.736061 | HDAC3                                                                    | 4                               |\n| R-HSA-8941284 | RUNX2 regulates chondrocyte maturation                                           |  5 | 0.3325048 | 0.915295 | 0.263 | 0.736061 | 0.736061 | HDAC4                                                                    | 10                              |\n| R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III                                | 31 | 0.3211041 | 1.458696 | 0.081 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-389958  | Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              | 32 | 0.3110233 | 1.417064 | 0.084 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-5626467 | RHO GTPases activate IQGAPs                                                      | 32 | 0.3110233 | 1.417064 | 0.084 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-1980143 | Signaling by NOTCH1                                                              | 74 | 0.2909303 | 1.122948 | 0.176 | 0.736061 | 0.736061 | HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11      | 1/2/3/4/5/6/7/8/9/10/24         |\n| R-HSA-9646399 | Aggrephagy                                                                       | 43 | 0.2875031 | 1.289229 | 0.110 | 0.736061 | 0.736061 | HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C | 2/11/12/13/14/20/21/22/23/25/26 |\n| R-HSA-9022699 | MECP2 regulates neuronal receptors and channels                                  | 17 | 0.2853456 | 1.193952 | 0.090 | 0.736061 | 0.736061 | HDAC1/HDAC2                                                              | 1/6                             |\n| R-HSA-389957  | Prefoldin mediated transfer of substrate  to CCT/TriC                            | 28 | 0.2840536 | 1.282351 | 0.084 | 0.736061 | 0.736061 | TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                    | 12/13/14/21/22/23/25/26         |\n| R-HSA-190861  | Gap junction assembly                                                            | 36 | 0.2763005 | 1.241645 | 0.098 | 0.736061 | 0.736061 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       | 11/12/13/14/20/21/22/23/25/26   |\n| R-HSA-201556  | Signaling by ALK                                                                 | 27 | 0.2724505 | 1.226190 | 0.089 | 0.736061 | 0.736061 | HDAC1/HDAC3/HDAC2                                                        | 1/4/6                           |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins                               |  77 | 0.025084955 | 0.096547442 | 0.564 | 0.7360610 | 0.7360610 | HDAC7                                                              | 7                             |\n| R-HSA-1989781 | PPARA activates gene expression                                                      | 117 | 0.024931014 | 0.080324400 | 0.602 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-400206  | Regulation of lipid metabolism by PPARalpha                                          | 119 | 0.024514267 | 0.078444182 | 0.601 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 121 | 0.024111070 | 0.076587977 | 0.602 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-5619507 | Activation of HOX genes during differentiation                                       | 121 | 0.024111070 | 0.076587977 | 0.602 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-9707564 | Cytoprotection by HMOX1                                                              | 124 | 0.023530272 | 0.072938786 | 0.606 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-112316  | Neuronal System                                                                      | 410 | 0.022860168 | 0.033987572 | 0.818 | 0.8314098 | 0.8314098 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C | 11/12/13/14/20/21/22/23/25/26 |\n| R-HSA-9006931 | Signaling by Nuclear Receptors                                                       | 299 | 0.022837065 | 0.041510356 | 0.754 | 0.7923390 | 0.7923390 | HDAC1/HDAC3                                                        | 1/4                           |\n| R-HSA-8878159 | Transcriptional regulation by RUNX3                                                  |  96 | 0.019782980 | 0.069288604 | 0.573 | 0.7360610 | 0.7360610 | HDAC4                                                              | 10                            |\n| R-HSA-9711123 | Cellular response to chemical stress                                                 | 160 | 0.018238328 | 0.047451602 | 0.648 | 0.7360610 | 0.7360610 | HDAC3                                                              | 4                             |\n| R-HSA-8939211 | ESR-mediated signaling                                                               | 223 | 0.017699115 | 0.037904684 | 0.710 | 0.7710349 | 0.7710349 | HDAC1                                                              | 1                             |\n| R-HSA-201681  | TCF dependent signaling in response to WNT                                           | 233 | 0.016949153 | 0.035499561 | 0.713 | 0.7710349 | 0.7710349 | HDAC1                                                              | 1                             |\n| R-HSA-8878171 | Transcriptional regulation by RUNX1                                                  | 239 | 0.016528926 | 0.034172270 | 0.722 | 0.7762543 | 0.7762543 | HDAC1                                                              | 1                             |\n| R-HSA-3700989 | Transcriptional Regulation by TP53                                                   | 365 | 0.015879283 | 0.025451474 | 0.797 | 0.8145165 | 0.8145165 | HDAC1/HDAC2                                                        | 1/6                           |\n| R-HSA-195721  | Signaling by WNT                                                                     | 332 | 0.011940299 | 0.020617351 | 0.777 | 0.8015470 | 0.8015470 | HDAC1                                                              | 1                             |\n| R-HSA-416482  | G alpha (12/13) signalling events                                                    |  80 | 0.011202141 | 0.042342490 | 0.556 | 0.7360610 | 0.7360610 | ADRA1A                                                             | 15                            |\n| R-HSA-2980736 | Peptide hormone metabolism                                                           |  91 | 0.009597029 | 0.034231543 | 0.572 | 0.7360610 | 0.7360610 | ACE                                                                | 16                            |\n| R-HSA-416476  | G alpha (q) signalling events                                                        | 216 | 0.007663165 | 0.016555644 | 0.708 | 0.7710349 | 0.7710349 | ADRA1A/HRH1                                                        | 15/19                         |\n| R-HSA-373076  | Class A/1 (Rhodopsin-like receptors)                                                 | 335 | 0.007436044 | 0.012800154 | 0.780 | 0.8015470 | 0.8015470 | ADRA1A/DRD1/HRH1                                                   | 15/17/19                      |\n| R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production                              | 134 | 0.005971957 | 0.017965955 | 0.613 | 0.7360610 | 0.7360610 | DRD1                                                               | 17                            |\n| R-HSA-114608  | Platelet degranulation                                                               | 129 | 0.005889394 | 0.017862145 | 0.616 | 0.7360610 | 0.7360610 | TUBA4A                                                             | 21                            |\n| R-HSA-76005   | Response to elevated platelet cytosolic Ca2+                                         | 134 | 0.005599275 | 0.016844782 | 0.613 | 0.7360610 | 0.7360610 | TUBA4A                                                             | 21                            |\n| R-HSA-418555  | G alpha (s) signalling events                                                        | 145 | 0.005404293 | 0.015174118 | 0.634 | 0.7360610 | 0.7360610 | DRD1                                                               | 17                            |\n| R-HSA-500792  | GPCR ligand binding                                                                  | 467 | 0.004885521 | 0.006822038 | 0.844 | 0.8440000 | 0.8440000 | ADRA1A/DRD1/HRH1                                                   | 15/17/19                      |\n| R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection                   | 169 | 0.004421553 | 0.011184126 | 0.660 | 0.7395181 | 0.7395181 | DRD1                                                               | 17                            |\n| R-HSA-9664433 | Leishmania parasite growth and survival                                              | 169 | 0.004421553 | 0.011184126 | 0.660 | 0.7395181 | 0.7395181 | DRD1                                                               | 17                            |\n| R-HSA-6798695 | Neutrophil degranulation                                                             | 480 | 0.002626280 | 0.003634032 | 0.844 | 0.8440000 | 0.8440000 | TUBB4B/TUBB                                                        | 14/18                         |\n| R-HSA-9658195 | Leishmania infection                                                                 | 254 | 0.002429423 | 0.004827834 | 0.736 | 0.7809886 | 0.7809886 | DRD1                                                               | 17                            |\n| R-HSA-76002   | Platelet activation, signaling and aggregation                                       | 263 | 0.001916201 | 0.003734587 | 0.736 | 0.7809886 | 0.7809886 | TUBA4A                                                             | 21                            |\n| R-HSA-9012999 | RHO GTPase cycle                                                                     | 449 | 0.001267294 | 0.001800966 | 0.834 | 0.8430652 | 0.8430652 | TUBA1B                                                             | 11                            |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 186 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>enrichmentScore</th><th scope=col>NES</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>leadingEdge</th><th scope=col>ledge_rank</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>R-HSA-193670 </td><td>p75NTR negatively regulates cell cycle via SC1                                  </td><td> 6</td><td>0.7497238</td><td>2.216827</td><td>0.018</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3/HDAC2                                                       </td><td>1/4/6                          </td></tr>\n","\t<tr><td>R-HSA-350054 </td><td>Notch-HLH transcription pathway                                                 </td><td>28</td><td>0.6034518</td><td>2.724265</td><td>0.073</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-9701898</td><td>STAT3 nuclear events downstream of ALK signaling                                </td><td>10</td><td>0.5622237</td><td>1.999238</td><td>0.030</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3/HDAC2                                                       </td><td>1/4/6                          </td></tr>\n","\t<tr><td>R-HSA-190840 </td><td>Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane</td><td>18</td><td>0.5540808</td><td>2.365466</td><td>0.045</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-190872 </td><td>Transport of connexons to the plasma membrane                                   </td><td>19</td><td>0.5248409</td><td>2.248782</td><td>0.049</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-389977 </td><td>Post-chaperonin tubulin folding pathway                                         </td><td>22</td><td>0.4530701</td><td>2.032002</td><td>0.054</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-2122947</td><td>NOTCH1 Intracellular Domain Regulates Transcription                             </td><td>48</td><td>0.4114968</td><td>1.820911</td><td>0.117</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-389960 </td><td>Formation of tubulin folding intermediates by CCT/TriC                          </td><td>25</td><td>0.3985243</td><td>1.800652</td><td>0.063</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-9005891</td><td>Loss of function of MECP2 in Rett syndrome                                      </td><td>14</td><td>0.3682368</td><td>1.452392</td><td>0.048</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3                                                             </td><td>1/4                            </td></tr>\n","\t<tr><td>R-HSA-9005895</td><td>Pervasive developmental disorders                                               </td><td>14</td><td>0.3682368</td><td>1.452392</td><td>0.048</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3                                                             </td><td>1/4                            </td></tr>\n","\t<tr><td>R-HSA-9675151</td><td>Disorders of Developmental Biology                                              </td><td>14</td><td>0.3682368</td><td>1.452392</td><td>0.048</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3                                                             </td><td>1/4                            </td></tr>\n","\t<tr><td>R-HSA-9697154</td><td>Disorders of Nervous System Development                                         </td><td>14</td><td>0.3682368</td><td>1.452392</td><td>0.048</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3                                                             </td><td>1/4                            </td></tr>\n","\t<tr><td>R-HSA-9022702</td><td>MECP2 regulates transcription of neuronal ligands                               </td><td> 8</td><td>0.3636364</td><td>1.195062</td><td>0.110</td><td>0.736061</td><td>0.736061</td><td>HDAC1                                                                   </td><td>1                              </td></tr>\n","\t<tr><td>R-HSA-2644602</td><td>Signaling by NOTCH1 PEST Domain Mutants in Cancer                               </td><td>58</td><td>0.3549617</td><td>1.500281</td><td>0.139</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-2644603</td><td>Signaling by NOTCH1 in Cancer                                                   </td><td>58</td><td>0.3549617</td><td>1.500281</td><td>0.139</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-2644606</td><td>Constitutive Signaling by NOTCH1 PEST Domain Mutants                            </td><td>58</td><td>0.3549617</td><td>1.500281</td><td>0.139</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-2894858</td><td>Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                            </td><td>58</td><td>0.3549617</td><td>1.500281</td><td>0.139</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-2894862</td><td>Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                         </td><td>58</td><td>0.3549617</td><td>1.500281</td><td>0.139</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-9619483</td><td>Activation of AMPK downstream of NMDARs                                         </td><td>29</td><td>0.3433513</td><td>1.550626</td><td>0.077</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-9022537</td><td>Loss of MECP2 binding ability to the NCoR/SMRT complex                          </td><td> 7</td><td>0.3330571</td><td>1.051147</td><td>0.183</td><td>0.736061</td><td>0.736061</td><td>HDAC3                                                                   </td><td>4                              </td></tr>\n","\t<tr><td>R-HSA-8941284</td><td>RUNX2 regulates chondrocyte maturation                                          </td><td> 5</td><td>0.3325048</td><td>0.915295</td><td>0.263</td><td>0.736061</td><td>0.736061</td><td>HDAC4                                                                   </td><td>10                             </td></tr>\n","\t<tr><td>R-HSA-9668328</td><td>Sealing of the nuclear envelope (NE) by ESCRT-III                               </td><td>31</td><td>0.3211041</td><td>1.458696</td><td>0.081</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-389958 </td><td>Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding             </td><td>32</td><td>0.3110233</td><td>1.417064</td><td>0.084</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-5626467</td><td>RHO GTPases activate IQGAPs                                                     </td><td>32</td><td>0.3110233</td><td>1.417064</td><td>0.084</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-1980143</td><td>Signaling by NOTCH1                                                             </td><td>74</td><td>0.2909303</td><td>1.122948</td><td>0.176</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC6/HDAC8/HDAC3/HDAC5/HDAC2/HDAC7/HDAC10/HDAC9/HDAC4/HDAC11     </td><td>1/2/3/4/5/6/7/8/9/10/24        </td></tr>\n","\t<tr><td>R-HSA-9646399</td><td>Aggrephagy                                                                      </td><td>43</td><td>0.2875031</td><td>1.289229</td><td>0.110</td><td>0.736061</td><td>0.736061</td><td>HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C</td><td>2/11/12/13/14/20/21/22/23/25/26</td></tr>\n","\t<tr><td>R-HSA-9022699</td><td>MECP2 regulates neuronal receptors and channels                                 </td><td>17</td><td>0.2853456</td><td>1.193952</td><td>0.090</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC2                                                             </td><td>1/6                            </td></tr>\n","\t<tr><td>R-HSA-389957 </td><td>Prefoldin mediated transfer of substrate  to CCT/TriC                           </td><td>28</td><td>0.2840536</td><td>1.282351</td><td>0.084</td><td>0.736061</td><td>0.736061</td><td>TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                   </td><td>12/13/14/21/22/23/25/26        </td></tr>\n","\t<tr><td>R-HSA-190861 </td><td>Gap junction assembly                                                           </td><td>36</td><td>0.2763005</td><td>1.241645</td><td>0.098</td><td>0.736061</td><td>0.736061</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td><td>11/12/13/14/20/21/22/23/25/26  </td></tr>\n","\t<tr><td>R-HSA-201556 </td><td>Signaling by ALK                                                                </td><td>27</td><td>0.2724505</td><td>1.226190</td><td>0.089</td><td>0.736061</td><td>0.736061</td><td>HDAC1/HDAC3/HDAC2                                                       </td><td>1/4/6                          </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>R-HSA-3108214</td><td>SUMOylation of DNA damage response and repair proteins                              </td><td> 77</td><td>0.025084955</td><td>0.096547442</td><td>0.564</td><td>0.7360610</td><td>0.7360610</td><td>HDAC7                                                             </td><td>7                            </td></tr>\n","\t<tr><td>R-HSA-1989781</td><td>PPARA activates gene expression                                                     </td><td>117</td><td>0.024931014</td><td>0.080324400</td><td>0.602</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-400206 </td><td>Regulation of lipid metabolism by PPARalpha                                         </td><td>119</td><td>0.024514267</td><td>0.078444182</td><td>0.601</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-5617472</td><td>Activation of anterior HOX genes in hindbrain development during early embryogenesis</td><td>121</td><td>0.024111070</td><td>0.076587977</td><td>0.602</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-5619507</td><td>Activation of HOX genes during differentiation                                      </td><td>121</td><td>0.024111070</td><td>0.076587977</td><td>0.602</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-9707564</td><td>Cytoprotection by HMOX1                                                             </td><td>124</td><td>0.023530272</td><td>0.072938786</td><td>0.606</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-112316 </td><td>Neuronal System                                                                     </td><td>410</td><td>0.022860168</td><td>0.033987572</td><td>0.818</td><td>0.8314098</td><td>0.8314098</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C</td><td>11/12/13/14/20/21/22/23/25/26</td></tr>\n","\t<tr><td>R-HSA-9006931</td><td>Signaling by Nuclear Receptors                                                      </td><td>299</td><td>0.022837065</td><td>0.041510356</td><td>0.754</td><td>0.7923390</td><td>0.7923390</td><td>HDAC1/HDAC3                                                       </td><td>1/4                          </td></tr>\n","\t<tr><td>R-HSA-8878159</td><td>Transcriptional regulation by RUNX3                                                 </td><td> 96</td><td>0.019782980</td><td>0.069288604</td><td>0.573</td><td>0.7360610</td><td>0.7360610</td><td>HDAC4                                                             </td><td>10                           </td></tr>\n","\t<tr><td>R-HSA-9711123</td><td>Cellular response to chemical stress                                                </td><td>160</td><td>0.018238328</td><td>0.047451602</td><td>0.648</td><td>0.7360610</td><td>0.7360610</td><td>HDAC3                                                             </td><td>4                            </td></tr>\n","\t<tr><td>R-HSA-8939211</td><td>ESR-mediated signaling                                                              </td><td>223</td><td>0.017699115</td><td>0.037904684</td><td>0.710</td><td>0.7710349</td><td>0.7710349</td><td>HDAC1                                                             </td><td>1                            </td></tr>\n","\t<tr><td>R-HSA-201681 </td><td>TCF dependent signaling in response to WNT                                          </td><td>233</td><td>0.016949153</td><td>0.035499561</td><td>0.713</td><td>0.7710349</td><td>0.7710349</td><td>HDAC1                                                             </td><td>1                            </td></tr>\n","\t<tr><td>R-HSA-8878171</td><td>Transcriptional regulation by RUNX1                                                 </td><td>239</td><td>0.016528926</td><td>0.034172270</td><td>0.722</td><td>0.7762543</td><td>0.7762543</td><td>HDAC1                                                             </td><td>1                            </td></tr>\n","\t<tr><td>R-HSA-3700989</td><td>Transcriptional Regulation by TP53                                                  </td><td>365</td><td>0.015879283</td><td>0.025451474</td><td>0.797</td><td>0.8145165</td><td>0.8145165</td><td>HDAC1/HDAC2                                                       </td><td>1/6                          </td></tr>\n","\t<tr><td>R-HSA-195721 </td><td>Signaling by WNT                                                                    </td><td>332</td><td>0.011940299</td><td>0.020617351</td><td>0.777</td><td>0.8015470</td><td>0.8015470</td><td>HDAC1                                                             </td><td>1                            </td></tr>\n","\t<tr><td>R-HSA-416482 </td><td>G alpha (12/13) signalling events                                                   </td><td> 80</td><td>0.011202141</td><td>0.042342490</td><td>0.556</td><td>0.7360610</td><td>0.7360610</td><td>ADRA1A                                                            </td><td>15                           </td></tr>\n","\t<tr><td>R-HSA-2980736</td><td>Peptide hormone metabolism                                                          </td><td> 91</td><td>0.009597029</td><td>0.034231543</td><td>0.572</td><td>0.7360610</td><td>0.7360610</td><td>ACE                                                               </td><td>16                           </td></tr>\n","\t<tr><td>R-HSA-416476 </td><td>G alpha (q) signalling events                                                       </td><td>216</td><td>0.007663165</td><td>0.016555644</td><td>0.708</td><td>0.7710349</td><td>0.7710349</td><td>ADRA1A/HRH1                                                       </td><td>15/19                        </td></tr>\n","\t<tr><td>R-HSA-373076 </td><td>Class A/1 (Rhodopsin-like receptors)                                                </td><td>335</td><td>0.007436044</td><td>0.012800154</td><td>0.780</td><td>0.8015470</td><td>0.8015470</td><td>ADRA1A/DRD1/HRH1                                                  </td><td>15/17/19                     </td></tr>\n","\t<tr><td>R-HSA-9660821</td><td>ADORA2B mediated anti-inflammatory cytokines production                             </td><td>134</td><td>0.005971957</td><td>0.017965955</td><td>0.613</td><td>0.7360610</td><td>0.7360610</td><td>DRD1                                                              </td><td>17                           </td></tr>\n","\t<tr><td>R-HSA-114608 </td><td>Platelet degranulation                                                              </td><td>129</td><td>0.005889394</td><td>0.017862145</td><td>0.616</td><td>0.7360610</td><td>0.7360610</td><td>TUBA4A                                                            </td><td>21                           </td></tr>\n","\t<tr><td>R-HSA-76005  </td><td>Response to elevated platelet cytosolic Ca2+                                        </td><td>134</td><td>0.005599275</td><td>0.016844782</td><td>0.613</td><td>0.7360610</td><td>0.7360610</td><td>TUBA4A                                                            </td><td>21                           </td></tr>\n","\t<tr><td>R-HSA-418555 </td><td>G alpha (s) signalling events                                                       </td><td>145</td><td>0.005404293</td><td>0.015174118</td><td>0.634</td><td>0.7360610</td><td>0.7360610</td><td>DRD1                                                              </td><td>17                           </td></tr>\n","\t<tr><td>R-HSA-500792 </td><td>GPCR ligand binding                                                                 </td><td>467</td><td>0.004885521</td><td>0.006822038</td><td>0.844</td><td>0.8440000</td><td>0.8440000</td><td>ADRA1A/DRD1/HRH1                                                  </td><td>15/17/19                     </td></tr>\n","\t<tr><td>R-HSA-9662851</td><td>Anti-inflammatory response favouring Leishmania parasite infection                  </td><td>169</td><td>0.004421553</td><td>0.011184126</td><td>0.660</td><td>0.7395181</td><td>0.7395181</td><td>DRD1                                                              </td><td>17                           </td></tr>\n","\t<tr><td>R-HSA-9664433</td><td>Leishmania parasite growth and survival                                             </td><td>169</td><td>0.004421553</td><td>0.011184126</td><td>0.660</td><td>0.7395181</td><td>0.7395181</td><td>DRD1                                                              </td><td>17                           </td></tr>\n","\t<tr><td>R-HSA-6798695</td><td>Neutrophil degranulation                                                            </td><td>480</td><td>0.002626280</td><td>0.003634032</td><td>0.844</td><td>0.8440000</td><td>0.8440000</td><td>TUBB4B/TUBB                                                       </td><td>14/18                        </td></tr>\n","\t<tr><td>R-HSA-9658195</td><td>Leishmania infection                                                                </td><td>254</td><td>0.002429423</td><td>0.004827834</td><td>0.736</td><td>0.7809886</td><td>0.7809886</td><td>DRD1                                                              </td><td>17                           </td></tr>\n","\t<tr><td>R-HSA-76002  </td><td>Platelet activation, signaling and aggregation                                      </td><td>263</td><td>0.001916201</td><td>0.003734587</td><td>0.736</td><td>0.7809886</td><td>0.7809886</td><td>TUBA4A                                                            </td><td>21                           </td></tr>\n","\t<tr><td>R-HSA-9012999</td><td>RHO GTPase cycle                                                                    </td><td>449</td><td>0.001267294</td><td>0.001800966</td><td>0.834</td><td>0.8430652</td><td>0.8430652</td><td>TUBA1B                                                            </td><td>11                           </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"dAlDA8NGMZhu"},"source":["### 3. MeanAbs"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"c5cbmMO3McNf","executionInfo":{"status":"ok","timestamp":1636338393123,"user_tz":-480,"elapsed":56945,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"be12d475-ed89-4617-b1bc-e1ef57acdac3"},"source":["mabs_res <- tsea_mabs(drugs=drugs, type=\"GO\", ont=\"MF\", nPerm=1000, \n","                      pvalueCutoff=0.05, minGSSize=5)\n","result(mabs_res)\n","\n","mabs_k_res <- tsea_mabs(drugs=drugs, type=\"KEGG\", nPerm=1000, \n","                        pvalueCutoff=0.2, minGSSize=5)\n","result(mabs_k_res)\n","\n","mabs_rct_res <- tsea_mabs(drugs=drugs, type=\"Reactome\", pvalueCutoff=1,\n","                          readable=TRUE)\n","result(mabs_rct_res)"],"execution_count":34,"outputs":[{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["   ont ID        \n","1  MF  GO:0031078\n","2  MF  GO:0032041\n","3  MF  GO:0017136\n","4  MF  GO:0034979\n","5  MF  GO:0004407\n","6  MF  GO:0033558\n","7  MF  GO:0019213\n","8  MF  GO:0051059\n","9  MF  GO:0016811\n","10 MF  GO:0030955\n","11 MF  GO:0070491\n","12 MF  GO:0042826\n","13 MF  GO:0016810\n","14 MF  GO:1990841\n","15 MF  GO:0004936\n","16 MF  GO:0004969\n","17 MF  GO:0019789\n","18 MF  GO:0001103\n","19 MF  GO:0048156\n","20 MF  GO:0051879\n","21 MF  GO:0070840\n","22 MF  GO:0031420\n","23 MF  GO:0051787\n","24 MF  GO:0005080\n","25 MF  GO:0031492\n","26 MF  GO:0005200\n","27 MF  GO:0001046\n","28 MF  GO:0033613\n","29 MF  GO:0042288\n","30 MF  GO:0030332\n","⋮  ⋮   ⋮         \n","56 MF  GO:0001965\n","57 MF  GO:0035326\n","58 MF  GO:0043130\n","59 MF  GO:0047485\n","60 MF  GO:0051019\n","61 MF  GO:0003924\n","62 MF  GO:0008013\n","63 MF  GO:0008227\n","64 MF  GO:0032182\n","65 MF  GO:0004993\n","66 MF  GO:0005525\n","67 MF  GO:0099589\n","68 MF  GO:0032550\n","69 MF  GO:0001883\n","70 MF  GO:0032549\n","71 MF  GO:0001882\n","72 MF  GO:0019001\n","73 MF  GO:0032561\n","74 MF  GO:0003725\n","75 MF  GO:0099528\n","76 MF  GO:0004180\n","77 MF  GO:0004177\n","78 MF  GO:0140030\n","79 MF  GO:0031625\n","80 MF  GO:0030594\n","81 MF  GO:0044389\n","82 MF  GO:0008235\n","83 MF  GO:0070405\n","84 MF  GO:0008017\n","85 MF  GO:0019787\n","   Description                                                                            \n","1  histone deacetylase activity (H3-K14 specific)                                         \n","2  NAD-dependent histone deacetylase activity (H3-K14 specific)                           \n","3  NAD-dependent histone deacetylase activity                                             \n","4  NAD-dependent protein deacetylase activity                                             \n","5  histone deacetylase activity                                                           \n","6  protein deacetylase activity                                                           \n","7  deacetylase activity                                                                   \n","8  NF-kappaB binding                                                                      \n","9  hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides\n","10 potassium ion binding                                                                  \n","11 repressing transcription factor binding                                                \n","12 histone deacetylase binding                                                            \n","13 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  \n","14 promoter-specific chromatin binding                                                    \n","15 alpha-adrenergic receptor activity                                                     \n","16 histamine receptor activity                                                            \n","17 SUMO transferase activity                                                              \n","18 RNA polymerase II repressing transcription factor binding                              \n","19 tau protein binding                                                                    \n","20 Hsp90 protein binding                                                                  \n","21 dynein complex binding                                                                 \n","22 alkali metal ion binding                                                               \n","23 misfolded protein binding                                                              \n","24 protein kinase C binding                                                               \n","25 nucleosomal DNA binding                                                                \n","26 structural constituent of cytoskeleton                                                 \n","27 core promoter sequence-specific DNA binding                                            \n","28 activating transcription factor binding                                                \n","29 MHC class I protein binding                                                            \n","30 cyclin binding                                                                         \n","⋮  ⋮                                                                                      \n","56 G-protein alpha-subunit binding                                                        \n","57 enhancer binding                                                                       \n","58 ubiquitin binding                                                                      \n","59 protein N-terminus binding                                                             \n","60 mitogen-activated protein kinase binding                                               \n","61 GTPase activity                                                                        \n","62 beta-catenin binding                                                                   \n","63 G protein-coupled amine receptor activity                                              \n","64 ubiquitin-like protein binding                                                         \n","65 G protein-coupled serotonin receptor activity                                          \n","66 GTP binding                                                                            \n","67 serotonin receptor activity                                                            \n","68 purine ribonucleoside binding                                                          \n","69 purine nucleoside binding                                                              \n","70 ribonucleoside binding                                                                 \n","71 nucleoside binding                                                                     \n","72 guanyl nucleotide binding                                                              \n","73 guanyl ribonucleotide binding                                                          \n","74 double-stranded RNA binding                                                            \n","75 G protein-coupled neurotransmitter receptor activity                                   \n","76 carboxypeptidase activity                                                              \n","77 aminopeptidase activity                                                                \n","78 modification-dependent protein binding                                                 \n","79 ubiquitin protein ligase binding                                                       \n","80 neurotransmitter receptor activity                                                     \n","81 ubiquitin-like protein ligase binding                                                  \n","82 metalloexopeptidase activity                                                           \n","83 ammonium ion binding                                                                   \n","84 microtubule binding                                                                    \n","85 ubiquitin-like protein transferase activity                                            \n","   setSize mabs         Nmabs     pvalue p.adjust    qvalues    \n","1   11     0.057649667  29.771860 0.000  0.000000000 0.000000000\n","2   11     0.057649667  29.771860 0.000  0.000000000 0.000000000\n","3   16     0.039634146  28.869879 0.000  0.000000000 0.000000000\n","4   17     0.037302726  28.805178 0.000  0.000000000 0.000000000\n","5   44     0.014412417  26.933146 0.000  0.000000000 0.000000000\n","6   45     0.014092141  26.884444 0.000  0.000000000 0.000000000\n","7   58     0.010933558  26.178752 0.000  0.000000000 0.000000000\n","8   28     0.007839721  20.595129 0.000  0.000000000 0.000000000\n","9   89     0.007125240  24.705862 0.000  0.000000000 0.000000000\n","10  10     0.004878049   8.525624 0.003  0.009703608 0.001904504\n","11  74     0.004614370  20.023719 0.000  0.000000000 0.000000000\n","12 112     0.004355401  21.625485 0.000  0.000000000 0.000000000\n","13 147     0.004313921  22.768306 0.000  0.000000000 0.000000000\n","14  46     0.004241782  17.143803 0.000  0.000000000 0.000000000\n","15   6     0.004065041   7.479812 0.001  0.004700375 0.000922531\n","16   6     0.004065041   6.925126 0.002  0.007770898 0.001525175\n","17  24     0.004065041  11.618950 0.000  0.000000000 0.000000000\n","18  38     0.003851091  13.257967 0.000  0.000000000 0.000000000\n","19  19     0.003851091  10.504640 0.000  0.000000000 0.000000000\n","20  38     0.003851091  13.361981 0.000  0.000000000 0.000000000\n","21  22     0.003325942   9.703984 0.002  0.007770898 0.001525175\n","22  15     0.003252033   7.345294 0.004  0.011784038 0.002312824\n","23  23     0.003181336   9.411763 0.001  0.004700375 0.000922531\n","24  49     0.002986560  11.730107 0.000  0.000000000 0.000000000\n","25  55     0.002660754  11.638539 0.000  0.000000000 0.000000000\n","26 102     0.002630320  14.148821 0.000  0.000000000 0.000000000\n","27  38     0.002567394  10.537154 0.000  0.000000000 0.000000000\n","28  76     0.002567394  14.571480 0.000  0.000000000 0.000000000\n","29  19     0.002567394   7.189019 0.004  0.011784038 0.002312824\n","30  29     0.002523129   8.963574 0.000  0.000000000 0.000000000\n","⋮  ⋮       ⋮            ⋮         ⋮      ⋮           ⋮          \n","56  21     0.0011614402 3.619951  0.009  0.019609375 0.003848684\n","57 133     0.0011003118 7.445978  0.000  0.000000000 0.000000000\n","58  73     0.0010023388 5.618923  0.006  0.015304878 0.003003851\n","59 107     0.0009117848 5.590891  0.001  0.004700375 0.000922531\n","60  27     0.0009033424 2.769569  0.018  0.029606815 0.005810857\n","61 300     0.0008943089 9.233977  0.000  0.000000000 0.000000000\n","62  82     0.0008923260 4.804455  0.007  0.016638258 0.003265550\n","63  59     0.0008267879 3.661295  0.019  0.030728093 0.006030928\n","64  91     0.0008040740 5.119257  0.007  0.016638258 0.003265550\n","65  34     0.0007173601 2.356498  0.021  0.032657993 0.006409705\n","66 374     0.0007173601 8.413829  0.000  0.000000000 0.000000000\n","67  34     0.0007173601 2.356498  0.021  0.032657993 0.006409705\n","68 379     0.0007078963 8.403598  0.000  0.000000000 0.000000000\n","69 382     0.0007023369 8.345043  0.000  0.000000000 0.000000000\n","70 383     0.0007005031 8.330657  0.000  0.000000000 0.000000000\n","71 390     0.0006879300 8.206680  0.000  0.000000000 0.000000000\n","72 395     0.0006792220 8.295904  0.000  0.000000000 0.000000000\n","73 395     0.0006792220 8.295904  0.000  0.000000000 0.000000000\n","74  75     0.0006504065 3.520588  0.016  0.027811634 0.005458522\n","75  41     0.0005948840 2.183189  0.024  0.035602837 0.006987682\n","76  45     0.0005420054 2.273947  0.022  0.033711844 0.006616541\n","77  46     0.0005302227 2.007145  0.032  0.043604777 0.008558203\n","78 142     0.0005152868 3.889880  0.020  0.031772152 0.006235843\n","79 285     0.0004278990 5.303349  0.002  0.007770898 0.001525175\n","80 117     0.0004169272 2.784576  0.031  0.042658991 0.008372576\n","81 300     0.0004065041 5.262555  0.002  0.007770898 0.001525175\n","82  63     0.0003871467 1.967474  0.031  0.042658991 0.008372576\n","83  74     0.0003295979 1.691824  0.039  0.049994893 0.009812376\n","84 238     0.0003074400 3.151055  0.026  0.037505747 0.007361162\n","85 417     0.0002339592 3.112221  0.019  0.030728093 0.006030928\n","   itemID                                                                 \n","1  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","2  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","3  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","4  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","5  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","6  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","7  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","8  HDAC1/HDAC2/HDAC3                                                      \n","9  HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","10 HDAC4                                                                  \n","11 HDAC1/HDAC2/HDAC9/HDAC4/HDAC5/HDAC7                                    \n","12 HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC10                       \n","13 HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \n","14 HDAC1/HDAC2/HDAC4                                                      \n","15 ADRA1A                                                                 \n","16 HRH1                                                                   \n","17 HDAC4/HDAC7                                                            \n","18 HDAC1/HDAC2                                                            \n","19 HDAC6                                                                  \n","20 HDAC6/HDAC8                                                            \n","21 HDAC6                                                                  \n","22 HDAC4                                                                  \n","23 HDAC6                                                                  \n","24 HDAC9/HDAC5/HDAC7                                                      \n","25 HDAC1/HDAC2                                                            \n","26 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","27 HDAC1                                                                  \n","28 HDAC1/HDAC4/HDAC7                                                      \n","29 TUBB4B/TUBB                                                            \n","30 HDAC3                                                                  \n","⋮  ⋮                                                                      \n","56 DRD1                                                                   \n","57 HDAC1/HDAC2                                                            \n","58 HDAC6                                                                  \n","59 HDAC1                                                                  \n","60 ACE                                                                    \n","61 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","62 HDAC6                                                                  \n","63 ADRA1A/HRH1                                                            \n","64 HDAC6                                                                  \n","65 HRH1                                                                   \n","66 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","67 HRH1                                                                   \n","68 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","69 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","70 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","71 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","72 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","73 TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\n","74 TUBA1B/TUBB4B                                                          \n","75 HRH1                                                                   \n","76 ACE                                                                    \n","77 ACE                                                                    \n","78 HDAC6                                                                  \n","79 HDAC6/TUBA1B/TUBB                                                      \n","80 DRD1/HRH1                                                              \n","81 HDAC6/TUBA1B/TUBB                                                      \n","82 ACE                                                                    \n","83 DRD1                                                                   \n","84 HDAC6                                                                  \n","85 HDAC4/HDAC7                                                            "],"text/latex":"A tibble: 85 × 10\n\\begin{tabular}{llllllllll}\n ont & ID & Description & setSize & mabs & Nmabs & pvalue & p.adjust & qvalues & itemID\\\\\n <chr> & <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr>\\\\\n\\hline\n\t MF & GO:0031078 & histone deacetylase activity (H3-K14 specific)                                          &  11 & 0.057649667 & 29.771860 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0032041 & NAD-dependent histone deacetylase activity (H3-K14 specific)                            &  11 & 0.057649667 & 29.771860 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0017136 & NAD-dependent histone deacetylase activity                                              &  16 & 0.039634146 & 28.869879 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0034979 & NAD-dependent protein deacetylase activity                                              &  17 & 0.037302726 & 28.805178 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0004407 & histone deacetylase activity                                                            &  44 & 0.014412417 & 26.933146 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0033558 & protein deacetylase activity                                                            &  45 & 0.014092141 & 26.884444 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0019213 & deacetylase activity                                                                    &  58 & 0.010933558 & 26.178752 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0051059 & NF-kappaB binding                                                                       &  28 & 0.007839721 & 20.595129 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3                                                      \\\\\n\t MF & GO:0016811 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides &  89 & 0.007125240 & 24.705862 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:0030955 & potassium ion binding                                                                   &  10 & 0.004878049 &  8.525624 & 0.003 & 0.009703608 & 0.001904504 & HDAC4                                                                  \\\\\n\t MF & GO:0070491 & repressing transcription factor binding                                                 &  74 & 0.004614370 & 20.023719 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC9/HDAC4/HDAC5/HDAC7                                    \\\\\n\t MF & GO:0042826 & histone deacetylase binding                                                             & 112 & 0.004355401 & 21.625485 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC10                       \\\\\n\t MF & GO:0016810 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   & 147 & 0.004313921 & 22.768306 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    \\\\\n\t MF & GO:1990841 & promoter-specific chromatin binding                                                     &  46 & 0.004241782 & 17.143803 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2/HDAC4                                                      \\\\\n\t MF & GO:0004936 & alpha-adrenergic receptor activity                                                      &   6 & 0.004065041 &  7.479812 & 0.001 & 0.004700375 & 0.000922531 & ADRA1A                                                                 \\\\\n\t MF & GO:0004969 & histamine receptor activity                                                             &   6 & 0.004065041 &  6.925126 & 0.002 & 0.007770898 & 0.001525175 & HRH1                                                                   \\\\\n\t MF & GO:0019789 & SUMO transferase activity                                                               &  24 & 0.004065041 & 11.618950 & 0.000 & 0.000000000 & 0.000000000 & HDAC4/HDAC7                                                            \\\\\n\t MF & GO:0001103 & RNA polymerase II repressing transcription factor binding                               &  38 & 0.003851091 & 13.257967 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2                                                            \\\\\n\t MF & GO:0048156 & tau protein binding                                                                     &  19 & 0.003851091 & 10.504640 & 0.000 & 0.000000000 & 0.000000000 & HDAC6                                                                  \\\\\n\t MF & GO:0051879 & Hsp90 protein binding                                                                   &  38 & 0.003851091 & 13.361981 & 0.000 & 0.000000000 & 0.000000000 & HDAC6/HDAC8                                                            \\\\\n\t MF & GO:0070840 & dynein complex binding                                                                  &  22 & 0.003325942 &  9.703984 & 0.002 & 0.007770898 & 0.001525175 & HDAC6                                                                  \\\\\n\t MF & GO:0031420 & alkali metal ion binding                                                                &  15 & 0.003252033 &  7.345294 & 0.004 & 0.011784038 & 0.002312824 & HDAC4                                                                  \\\\\n\t MF & GO:0051787 & misfolded protein binding                                                               &  23 & 0.003181336 &  9.411763 & 0.001 & 0.004700375 & 0.000922531 & HDAC6                                                                  \\\\\n\t MF & GO:0005080 & protein kinase C binding                                                                &  49 & 0.002986560 & 11.730107 & 0.000 & 0.000000000 & 0.000000000 & HDAC9/HDAC5/HDAC7                                                      \\\\\n\t MF & GO:0031492 & nucleosomal DNA binding                                                                 &  55 & 0.002660754 & 11.638539 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2                                                            \\\\\n\t MF & GO:0005200 & structural constituent of cytoskeleton                                                  & 102 & 0.002630320 & 14.148821 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0001046 & core promoter sequence-specific DNA binding                                             &  38 & 0.002567394 & 10.537154 & 0.000 & 0.000000000 & 0.000000000 & HDAC1                                                                  \\\\\n\t MF & GO:0033613 & activating transcription factor binding                                                 &  76 & 0.002567394 & 14.571480 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC4/HDAC7                                                      \\\\\n\t MF & GO:0042288 & MHC class I protein binding                                                             &  19 & 0.002567394 &  7.189019 & 0.004 & 0.011784038 & 0.002312824 & TUBB4B/TUBB                                                            \\\\\n\t MF & GO:0030332 & cyclin binding                                                                          &  29 & 0.002523129 &  8.963574 & 0.000 & 0.000000000 & 0.000000000 & HDAC3                                                                  \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t MF & GO:0001965 & G-protein alpha-subunit binding                      &  21 & 0.0011614402 & 3.619951 & 0.009 & 0.019609375 & 0.003848684 & DRD1                                                                   \\\\\n\t MF & GO:0035326 & enhancer binding                                     & 133 & 0.0011003118 & 7.445978 & 0.000 & 0.000000000 & 0.000000000 & HDAC1/HDAC2                                                            \\\\\n\t MF & GO:0043130 & ubiquitin binding                                    &  73 & 0.0010023388 & 5.618923 & 0.006 & 0.015304878 & 0.003003851 & HDAC6                                                                  \\\\\n\t MF & GO:0047485 & protein N-terminus binding                           & 107 & 0.0009117848 & 5.590891 & 0.001 & 0.004700375 & 0.000922531 & HDAC1                                                                  \\\\\n\t MF & GO:0051019 & mitogen-activated protein kinase binding             &  27 & 0.0009033424 & 2.769569 & 0.018 & 0.029606815 & 0.005810857 & ACE                                                                    \\\\\n\t MF & GO:0003924 & GTPase activity                                      & 300 & 0.0008943089 & 9.233977 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0008013 & beta-catenin binding                                 &  82 & 0.0008923260 & 4.804455 & 0.007 & 0.016638258 & 0.003265550 & HDAC6                                                                  \\\\\n\t MF & GO:0008227 & G protein-coupled amine receptor activity            &  59 & 0.0008267879 & 3.661295 & 0.019 & 0.030728093 & 0.006030928 & ADRA1A/HRH1                                                            \\\\\n\t MF & GO:0032182 & ubiquitin-like protein binding                       &  91 & 0.0008040740 & 5.119257 & 0.007 & 0.016638258 & 0.003265550 & HDAC6                                                                  \\\\\n\t MF & GO:0004993 & G protein-coupled serotonin receptor activity        &  34 & 0.0007173601 & 2.356498 & 0.021 & 0.032657993 & 0.006409705 & HRH1                                                                   \\\\\n\t MF & GO:0005525 & GTP binding                                          & 374 & 0.0007173601 & 8.413829 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0099589 & serotonin receptor activity                          &  34 & 0.0007173601 & 2.356498 & 0.021 & 0.032657993 & 0.006409705 & HRH1                                                                   \\\\\n\t MF & GO:0032550 & purine ribonucleoside binding                        & 379 & 0.0007078963 & 8.403598 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0001883 & purine nucleoside binding                            & 382 & 0.0007023369 & 8.345043 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0032549 & ribonucleoside binding                               & 383 & 0.0007005031 & 8.330657 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0001882 & nucleoside binding                                   & 390 & 0.0006879300 & 8.206680 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0019001 & guanyl nucleotide binding                            & 395 & 0.0006792220 & 8.295904 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0032561 & guanyl ribonucleotide binding                        & 395 & 0.0006792220 & 8.295904 & 0.000 & 0.000000000 & 0.000000000 & TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB\\\\\n\t MF & GO:0003725 & double-stranded RNA binding                          &  75 & 0.0006504065 & 3.520588 & 0.016 & 0.027811634 & 0.005458522 & TUBA1B/TUBB4B                                                          \\\\\n\t MF & GO:0099528 & G protein-coupled neurotransmitter receptor activity &  41 & 0.0005948840 & 2.183189 & 0.024 & 0.035602837 & 0.006987682 & HRH1                                                                   \\\\\n\t MF & GO:0004180 & carboxypeptidase activity                            &  45 & 0.0005420054 & 2.273947 & 0.022 & 0.033711844 & 0.006616541 & ACE                                                                    \\\\\n\t MF & GO:0004177 & aminopeptidase activity                              &  46 & 0.0005302227 & 2.007145 & 0.032 & 0.043604777 & 0.008558203 & ACE                                                                    \\\\\n\t MF & GO:0140030 & modification-dependent protein binding               & 142 & 0.0005152868 & 3.889880 & 0.020 & 0.031772152 & 0.006235843 & HDAC6                                                                  \\\\\n\t MF & GO:0031625 & ubiquitin protein ligase binding                     & 285 & 0.0004278990 & 5.303349 & 0.002 & 0.007770898 & 0.001525175 & HDAC6/TUBA1B/TUBB                                                      \\\\\n\t MF & GO:0030594 & neurotransmitter receptor activity                   & 117 & 0.0004169272 & 2.784576 & 0.031 & 0.042658991 & 0.008372576 & DRD1/HRH1                                                              \\\\\n\t MF & GO:0044389 & ubiquitin-like protein ligase binding                & 300 & 0.0004065041 & 5.262555 & 0.002 & 0.007770898 & 0.001525175 & HDAC6/TUBA1B/TUBB                                                      \\\\\n\t MF & GO:0008235 & metalloexopeptidase activity                         &  63 & 0.0003871467 & 1.967474 & 0.031 & 0.042658991 & 0.008372576 & ACE                                                                    \\\\\n\t MF & GO:0070405 & ammonium ion binding                                 &  74 & 0.0003295979 & 1.691824 & 0.039 & 0.049994893 & 0.009812376 & DRD1                                                                   \\\\\n\t MF & GO:0008017 & microtubule binding                                  & 238 & 0.0003074400 & 3.151055 & 0.026 & 0.037505747 & 0.007361162 & HDAC6                                                                  \\\\\n\t MF & GO:0019787 & ubiquitin-like protein transferase activity          & 417 & 0.0002339592 & 3.112221 & 0.019 & 0.030728093 & 0.006030928 & HDAC4/HDAC7                                                            \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 85 × 10\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | mabs &lt;dbl&gt; | Nmabs &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | itemID &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| MF | GO:0031078 | histone deacetylase activity (H3-K14 specific)                                          |  11 | 0.057649667 | 29.771860 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific)                            |  11 | 0.057649667 | 29.771860 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0017136 | NAD-dependent histone deacetylase activity                                              |  16 | 0.039634146 | 28.869879 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0034979 | NAD-dependent protein deacetylase activity                                              |  17 | 0.037302726 | 28.805178 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0004407 | histone deacetylase activity                                                            |  44 | 0.014412417 | 26.933146 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0033558 | protein deacetylase activity                                                            |  45 | 0.014092141 | 26.884444 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0019213 | deacetylase activity                                                                    |  58 | 0.010933558 | 26.178752 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0051059 | NF-kappaB binding                                                                       |  28 | 0.007839721 | 20.595129 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3                                                       |\n| MF | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |  89 | 0.007125240 | 24.705862 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:0030955 | potassium ion binding                                                                   |  10 | 0.004878049 |  8.525624 | 0.003 | 0.009703608 | 0.001904504 | HDAC4                                                                   |\n| MF | GO:0070491 | repressing transcription factor binding                                                 |  74 | 0.004614370 | 20.023719 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC9/HDAC4/HDAC5/HDAC7                                     |\n| MF | GO:0042826 | histone deacetylase binding                                                             | 112 | 0.004355401 | 21.625485 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC10                        |\n| MF | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   | 147 | 0.004313921 | 22.768306 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10     |\n| MF | GO:1990841 | promoter-specific chromatin binding                                                     |  46 | 0.004241782 | 17.143803 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2/HDAC4                                                       |\n| MF | GO:0004936 | alpha-adrenergic receptor activity                                                      |   6 | 0.004065041 |  7.479812 | 0.001 | 0.004700375 | 0.000922531 | ADRA1A                                                                  |\n| MF | GO:0004969 | histamine receptor activity                                                             |   6 | 0.004065041 |  6.925126 | 0.002 | 0.007770898 | 0.001525175 | HRH1                                                                    |\n| MF | GO:0019789 | SUMO transferase activity                                                               |  24 | 0.004065041 | 11.618950 | 0.000 | 0.000000000 | 0.000000000 | HDAC4/HDAC7                                                             |\n| MF | GO:0001103 | RNA polymerase II repressing transcription factor binding                               |  38 | 0.003851091 | 13.257967 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2                                                             |\n| MF | GO:0048156 | tau protein binding                                                                     |  19 | 0.003851091 | 10.504640 | 0.000 | 0.000000000 | 0.000000000 | HDAC6                                                                   |\n| MF | GO:0051879 | Hsp90 protein binding                                                                   |  38 | 0.003851091 | 13.361981 | 0.000 | 0.000000000 | 0.000000000 | HDAC6/HDAC8                                                             |\n| MF | GO:0070840 | dynein complex binding                                                                  |  22 | 0.003325942 |  9.703984 | 0.002 | 0.007770898 | 0.001525175 | HDAC6                                                                   |\n| MF | GO:0031420 | alkali metal ion binding                                                                |  15 | 0.003252033 |  7.345294 | 0.004 | 0.011784038 | 0.002312824 | HDAC4                                                                   |\n| MF | GO:0051787 | misfolded protein binding                                                               |  23 | 0.003181336 |  9.411763 | 0.001 | 0.004700375 | 0.000922531 | HDAC6                                                                   |\n| MF | GO:0005080 | protein kinase C binding                                                                |  49 | 0.002986560 | 11.730107 | 0.000 | 0.000000000 | 0.000000000 | HDAC9/HDAC5/HDAC7                                                       |\n| MF | GO:0031492 | nucleosomal DNA binding                                                                 |  55 | 0.002660754 | 11.638539 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2                                                             |\n| MF | GO:0005200 | structural constituent of cytoskeleton                                                  | 102 | 0.002630320 | 14.148821 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0001046 | core promoter sequence-specific DNA binding                                             |  38 | 0.002567394 | 10.537154 | 0.000 | 0.000000000 | 0.000000000 | HDAC1                                                                   |\n| MF | GO:0033613 | activating transcription factor binding                                                 |  76 | 0.002567394 | 14.571480 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC4/HDAC7                                                       |\n| MF | GO:0042288 | MHC class I protein binding                                                             |  19 | 0.002567394 |  7.189019 | 0.004 | 0.011784038 | 0.002312824 | TUBB4B/TUBB                                                             |\n| MF | GO:0030332 | cyclin binding                                                                          |  29 | 0.002523129 |  8.963574 | 0.000 | 0.000000000 | 0.000000000 | HDAC3                                                                   |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| MF | GO:0001965 | G-protein alpha-subunit binding                      |  21 | 0.0011614402 | 3.619951 | 0.009 | 0.019609375 | 0.003848684 | DRD1                                                                    |\n| MF | GO:0035326 | enhancer binding                                     | 133 | 0.0011003118 | 7.445978 | 0.000 | 0.000000000 | 0.000000000 | HDAC1/HDAC2                                                             |\n| MF | GO:0043130 | ubiquitin binding                                    |  73 | 0.0010023388 | 5.618923 | 0.006 | 0.015304878 | 0.003003851 | HDAC6                                                                   |\n| MF | GO:0047485 | protein N-terminus binding                           | 107 | 0.0009117848 | 5.590891 | 0.001 | 0.004700375 | 0.000922531 | HDAC1                                                                   |\n| MF | GO:0051019 | mitogen-activated protein kinase binding             |  27 | 0.0009033424 | 2.769569 | 0.018 | 0.029606815 | 0.005810857 | ACE                                                                     |\n| MF | GO:0003924 | GTPase activity                                      | 300 | 0.0008943089 | 9.233977 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0008013 | beta-catenin binding                                 |  82 | 0.0008923260 | 4.804455 | 0.007 | 0.016638258 | 0.003265550 | HDAC6                                                                   |\n| MF | GO:0008227 | G protein-coupled amine receptor activity            |  59 | 0.0008267879 | 3.661295 | 0.019 | 0.030728093 | 0.006030928 | ADRA1A/HRH1                                                             |\n| MF | GO:0032182 | ubiquitin-like protein binding                       |  91 | 0.0008040740 | 5.119257 | 0.007 | 0.016638258 | 0.003265550 | HDAC6                                                                   |\n| MF | GO:0004993 | G protein-coupled serotonin receptor activity        |  34 | 0.0007173601 | 2.356498 | 0.021 | 0.032657993 | 0.006409705 | HRH1                                                                    |\n| MF | GO:0005525 | GTP binding                                          | 374 | 0.0007173601 | 8.413829 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0099589 | serotonin receptor activity                          |  34 | 0.0007173601 | 2.356498 | 0.021 | 0.032657993 | 0.006409705 | HRH1                                                                    |\n| MF | GO:0032550 | purine ribonucleoside binding                        | 379 | 0.0007078963 | 8.403598 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0001883 | purine nucleoside binding                            | 382 | 0.0007023369 | 8.345043 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0032549 | ribonucleoside binding                               | 383 | 0.0007005031 | 8.330657 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0001882 | nucleoside binding                                   | 390 | 0.0006879300 | 8.206680 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0019001 | guanyl nucleotide binding                            | 395 | 0.0006792220 | 8.295904 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0032561 | guanyl ribonucleotide binding                        | 395 | 0.0006792220 | 8.295904 | 0.000 | 0.000000000 | 0.000000000 | TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB |\n| MF | GO:0003725 | double-stranded RNA binding                          |  75 | 0.0006504065 | 3.520588 | 0.016 | 0.027811634 | 0.005458522 | TUBA1B/TUBB4B                                                           |\n| MF | GO:0099528 | G protein-coupled neurotransmitter receptor activity |  41 | 0.0005948840 | 2.183189 | 0.024 | 0.035602837 | 0.006987682 | HRH1                                                                    |\n| MF | GO:0004180 | carboxypeptidase activity                            |  45 | 0.0005420054 | 2.273947 | 0.022 | 0.033711844 | 0.006616541 | ACE                                                                     |\n| MF | GO:0004177 | aminopeptidase activity                              |  46 | 0.0005302227 | 2.007145 | 0.032 | 0.043604777 | 0.008558203 | ACE                                                                     |\n| MF | GO:0140030 | modification-dependent protein binding               | 142 | 0.0005152868 | 3.889880 | 0.020 | 0.031772152 | 0.006235843 | HDAC6                                                                   |\n| MF | GO:0031625 | ubiquitin protein ligase binding                     | 285 | 0.0004278990 | 5.303349 | 0.002 | 0.007770898 | 0.001525175 | HDAC6/TUBA1B/TUBB                                                       |\n| MF | GO:0030594 | neurotransmitter receptor activity                   | 117 | 0.0004169272 | 2.784576 | 0.031 | 0.042658991 | 0.008372576 | DRD1/HRH1                                                               |\n| MF | GO:0044389 | ubiquitin-like protein ligase binding                | 300 | 0.0004065041 | 5.262555 | 0.002 | 0.007770898 | 0.001525175 | HDAC6/TUBA1B/TUBB                                                       |\n| MF | GO:0008235 | metalloexopeptidase activity                         |  63 | 0.0003871467 | 1.967474 | 0.031 | 0.042658991 | 0.008372576 | ACE                                                                     |\n| MF | GO:0070405 | ammonium ion binding                                 |  74 | 0.0003295979 | 1.691824 | 0.039 | 0.049994893 | 0.009812376 | DRD1                                                                    |\n| MF | GO:0008017 | microtubule binding                                  | 238 | 0.0003074400 | 3.151055 | 0.026 | 0.037505747 | 0.007361162 | HDAC6                                                                   |\n| MF | GO:0019787 | ubiquitin-like protein transferase activity          | 417 | 0.0002339592 | 3.112221 | 0.019 | 0.030728093 | 0.006030928 | HDAC4/HDAC7                                                             |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 85 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>mabs</th><th scope=col>Nmabs</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>itemID</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>MF</td><td>GO:0031078</td><td>histone deacetylase activity (H3-K14 specific)                                         </td><td> 11</td><td>0.057649667</td><td>29.771860</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0032041</td><td>NAD-dependent histone deacetylase activity (H3-K14 specific)                           </td><td> 11</td><td>0.057649667</td><td>29.771860</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0017136</td><td>NAD-dependent histone deacetylase activity                                             </td><td> 16</td><td>0.039634146</td><td>28.869879</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0034979</td><td>NAD-dependent protein deacetylase activity                                             </td><td> 17</td><td>0.037302726</td><td>28.805178</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0004407</td><td>histone deacetylase activity                                                           </td><td> 44</td><td>0.014412417</td><td>26.933146</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0033558</td><td>protein deacetylase activity                                                           </td><td> 45</td><td>0.014092141</td><td>26.884444</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0019213</td><td>deacetylase activity                                                                   </td><td> 58</td><td>0.010933558</td><td>26.178752</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0051059</td><td>NF-kappaB binding                                                                      </td><td> 28</td><td>0.007839721</td><td>20.595129</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0016811</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</td><td> 89</td><td>0.007125240</td><td>24.705862</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:0030955</td><td>potassium ion binding                                                                  </td><td> 10</td><td>0.004878049</td><td> 8.525624</td><td>0.003</td><td>0.009703608</td><td>0.001904504</td><td>HDAC4                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0070491</td><td>repressing transcription factor binding                                                </td><td> 74</td><td>0.004614370</td><td>20.023719</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC9/HDAC4/HDAC5/HDAC7                                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0042826</td><td>histone deacetylase binding                                                            </td><td>112</td><td>0.004355401</td><td>21.625485</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC10                       </td></tr>\n","\t<tr><td>MF</td><td>GO:0016810</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  </td><td>147</td><td>0.004313921</td><td>22.768306</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC3/HDAC9/HDAC4/HDAC6/HDAC5/HDAC7/HDAC8/HDAC11/HDAC10    </td></tr>\n","\t<tr><td>MF</td><td>GO:1990841</td><td>promoter-specific chromatin binding                                                    </td><td> 46</td><td>0.004241782</td><td>17.143803</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2/HDAC4                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0004936</td><td>alpha-adrenergic receptor activity                                                     </td><td>  6</td><td>0.004065041</td><td> 7.479812</td><td>0.001</td><td>0.004700375</td><td>0.000922531</td><td>ADRA1A                                                                 </td></tr>\n","\t<tr><td>MF</td><td>GO:0004969</td><td>histamine receptor activity                                                            </td><td>  6</td><td>0.004065041</td><td> 6.925126</td><td>0.002</td><td>0.007770898</td><td>0.001525175</td><td>HRH1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0019789</td><td>SUMO transferase activity                                                              </td><td> 24</td><td>0.004065041</td><td>11.618950</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC4/HDAC7                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0001103</td><td>RNA polymerase II repressing transcription factor binding                              </td><td> 38</td><td>0.003851091</td><td>13.257967</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0048156</td><td>tau protein binding                                                                    </td><td> 19</td><td>0.003851091</td><td>10.504640</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0051879</td><td>Hsp90 protein binding                                                                  </td><td> 38</td><td>0.003851091</td><td>13.361981</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC6/HDAC8                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0070840</td><td>dynein complex binding                                                                 </td><td> 22</td><td>0.003325942</td><td> 9.703984</td><td>0.002</td><td>0.007770898</td><td>0.001525175</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0031420</td><td>alkali metal ion binding                                                               </td><td> 15</td><td>0.003252033</td><td> 7.345294</td><td>0.004</td><td>0.011784038</td><td>0.002312824</td><td>HDAC4                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0051787</td><td>misfolded protein binding                                                              </td><td> 23</td><td>0.003181336</td><td> 9.411763</td><td>0.001</td><td>0.004700375</td><td>0.000922531</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0005080</td><td>protein kinase C binding                                                               </td><td> 49</td><td>0.002986560</td><td>11.730107</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC9/HDAC5/HDAC7                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0031492</td><td>nucleosomal DNA binding                                                                </td><td> 55</td><td>0.002660754</td><td>11.638539</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0005200</td><td>structural constituent of cytoskeleton                                                 </td><td>102</td><td>0.002630320</td><td>14.148821</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0001046</td><td>core promoter sequence-specific DNA binding                                            </td><td> 38</td><td>0.002567394</td><td>10.537154</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0033613</td><td>activating transcription factor binding                                                </td><td> 76</td><td>0.002567394</td><td>14.571480</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC4/HDAC7                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0042288</td><td>MHC class I protein binding                                                            </td><td> 19</td><td>0.002567394</td><td> 7.189019</td><td>0.004</td><td>0.011784038</td><td>0.002312824</td><td>TUBB4B/TUBB                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0030332</td><td>cyclin binding                                                                         </td><td> 29</td><td>0.002523129</td><td> 8.963574</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC3                                                                  </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>MF</td><td>GO:0001965</td><td>G-protein alpha-subunit binding                     </td><td> 21</td><td>0.0011614402</td><td>3.619951</td><td>0.009</td><td>0.019609375</td><td>0.003848684</td><td>DRD1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0035326</td><td>enhancer binding                                    </td><td>133</td><td>0.0011003118</td><td>7.445978</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>HDAC1/HDAC2                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0043130</td><td>ubiquitin binding                                   </td><td> 73</td><td>0.0010023388</td><td>5.618923</td><td>0.006</td><td>0.015304878</td><td>0.003003851</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0047485</td><td>protein N-terminus binding                          </td><td>107</td><td>0.0009117848</td><td>5.590891</td><td>0.001</td><td>0.004700375</td><td>0.000922531</td><td>HDAC1                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0051019</td><td>mitogen-activated protein kinase binding            </td><td> 27</td><td>0.0009033424</td><td>2.769569</td><td>0.018</td><td>0.029606815</td><td>0.005810857</td><td>ACE                                                                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0003924</td><td>GTPase activity                                     </td><td>300</td><td>0.0008943089</td><td>9.233977</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0008013</td><td>beta-catenin binding                                </td><td> 82</td><td>0.0008923260</td><td>4.804455</td><td>0.007</td><td>0.016638258</td><td>0.003265550</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0008227</td><td>G protein-coupled amine receptor activity           </td><td> 59</td><td>0.0008267879</td><td>3.661295</td><td>0.019</td><td>0.030728093</td><td>0.006030928</td><td>ADRA1A/HRH1                                                            </td></tr>\n","\t<tr><td>MF</td><td>GO:0032182</td><td>ubiquitin-like protein binding                      </td><td> 91</td><td>0.0008040740</td><td>5.119257</td><td>0.007</td><td>0.016638258</td><td>0.003265550</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0004993</td><td>G protein-coupled serotonin receptor activity       </td><td> 34</td><td>0.0007173601</td><td>2.356498</td><td>0.021</td><td>0.032657993</td><td>0.006409705</td><td>HRH1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0005525</td><td>GTP binding                                         </td><td>374</td><td>0.0007173601</td><td>8.413829</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0099589</td><td>serotonin receptor activity                         </td><td> 34</td><td>0.0007173601</td><td>2.356498</td><td>0.021</td><td>0.032657993</td><td>0.006409705</td><td>HRH1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0032550</td><td>purine ribonucleoside binding                       </td><td>379</td><td>0.0007078963</td><td>8.403598</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0001883</td><td>purine nucleoside binding                           </td><td>382</td><td>0.0007023369</td><td>8.345043</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0032549</td><td>ribonucleoside binding                              </td><td>383</td><td>0.0007005031</td><td>8.330657</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0001882</td><td>nucleoside binding                                  </td><td>390</td><td>0.0006879300</td><td>8.206680</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0019001</td><td>guanyl nucleotide binding                           </td><td>395</td><td>0.0006792220</td><td>8.295904</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0032561</td><td>guanyl ribonucleotide binding                       </td><td>395</td><td>0.0006792220</td><td>8.295904</td><td>0.000</td><td>0.000000000</td><td>0.000000000</td><td>TUBA4A/TUBA3C/TUBA1A/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBB1/TUBA1C/TUBB</td></tr>\n","\t<tr><td>MF</td><td>GO:0003725</td><td>double-stranded RNA binding                         </td><td> 75</td><td>0.0006504065</td><td>3.520588</td><td>0.016</td><td>0.027811634</td><td>0.005458522</td><td>TUBA1B/TUBB4B                                                          </td></tr>\n","\t<tr><td>MF</td><td>GO:0099528</td><td>G protein-coupled neurotransmitter receptor activity</td><td> 41</td><td>0.0005948840</td><td>2.183189</td><td>0.024</td><td>0.035602837</td><td>0.006987682</td><td>HRH1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0004180</td><td>carboxypeptidase activity                           </td><td> 45</td><td>0.0005420054</td><td>2.273947</td><td>0.022</td><td>0.033711844</td><td>0.006616541</td><td>ACE                                                                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0004177</td><td>aminopeptidase activity                             </td><td> 46</td><td>0.0005302227</td><td>2.007145</td><td>0.032</td><td>0.043604777</td><td>0.008558203</td><td>ACE                                                                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0140030</td><td>modification-dependent protein binding              </td><td>142</td><td>0.0005152868</td><td>3.889880</td><td>0.020</td><td>0.031772152</td><td>0.006235843</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0031625</td><td>ubiquitin protein ligase binding                    </td><td>285</td><td>0.0004278990</td><td>5.303349</td><td>0.002</td><td>0.007770898</td><td>0.001525175</td><td>HDAC6/TUBA1B/TUBB                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0030594</td><td>neurotransmitter receptor activity                  </td><td>117</td><td>0.0004169272</td><td>2.784576</td><td>0.031</td><td>0.042658991</td><td>0.008372576</td><td>DRD1/HRH1                                                              </td></tr>\n","\t<tr><td>MF</td><td>GO:0044389</td><td>ubiquitin-like protein ligase binding               </td><td>300</td><td>0.0004065041</td><td>5.262555</td><td>0.002</td><td>0.007770898</td><td>0.001525175</td><td>HDAC6/TUBA1B/TUBB                                                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0008235</td><td>metalloexopeptidase activity                        </td><td> 63</td><td>0.0003871467</td><td>1.967474</td><td>0.031</td><td>0.042658991</td><td>0.008372576</td><td>ACE                                                                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0070405</td><td>ammonium ion binding                                </td><td> 74</td><td>0.0003295979</td><td>1.691824</td><td>0.039</td><td>0.049994893</td><td>0.009812376</td><td>DRD1                                                                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0008017</td><td>microtubule binding                                 </td><td>238</td><td>0.0003074400</td><td>3.151055</td><td>0.026</td><td>0.037505747</td><td>0.007361162</td><td>HDAC6                                                                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0019787</td><td>ubiquitin-like protein transferase activity         </td><td>417</td><td>0.0002339592</td><td>3.112221</td><td>0.019</td><td>0.030728093</td><td>0.006030928</td><td>HDAC4/HDAC7                                                            </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}},{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["   ID       Description                                       setSize\n","1  hsa05034 Alcoholism                                        187    \n","2  hsa04613 Neutrophil extracellular trap formation           190    \n","3  hsa04540 Gap junction                                       88    \n","4  hsa05203 Viral carcinogenesis                              204    \n","5  hsa04330 Notch signaling pathway                            59    \n","6  hsa05031 Amphetamine addiction                              69    \n","7  hsa04213 Longevity regulating pathway - multiple species    62    \n","8  hsa05220 Chronic myeloid leukemia                           76    \n","9  hsa04919 Thyroid hormone signaling pathway                 121    \n","10 hsa04145 Phagosome                                         152    \n","11 hsa05130 Pathogenic Escherichia coli infection             197    \n","12 hsa05016 Huntington disease                                306    \n","13 hsa04110 Cell cycle                                        126    \n","14 hsa05012 Parkinson disease                                 266    \n","15 hsa05132 Salmonella infection                              249    \n","16 hsa04210 Apoptosis                                         136    \n","17 hsa04614 Renin-angiotensin system                           23    \n","18 hsa05020 Prion disease                                     273    \n","19 hsa05014 Amyotrophic lateral sclerosis                     364    \n","20 hsa04530 Tight junction                                    169    \n","21 hsa05206 MicroRNAs in cancer                               310    \n","22 hsa05202 Transcriptional misregulation in cancer           192    \n","23 hsa05169 Epstein-Barr virus infection                      202    \n","24 hsa04371 Apelin signaling pathway                          139    \n","25 hsa05010 Alzheimer disease                                 384    \n","26 hsa05022 Pathways of neurodegeneration - multiple diseases 476    \n","27 hsa05030 Cocaine addiction                                  49    \n","28 hsa05165 Human papillomavirus infection                    331    \n","29 hsa04924 Renin secretion                                    69    \n","30 hsa04020 Calcium signaling pathway                         240    \n","31 hsa05410 Hypertrophic cardiomyopathy                        90    \n","32 hsa05032 Morphine addiction                                 91    \n","33 hsa04970 Salivary secretion                                 93    \n","34 hsa04750 Inflammatory mediator regulation of TRP channels   98    \n","35 hsa05142 Chagas disease                                    102    \n","36 hsa04080 Neuroactive ligand-receptor interaction           350    \n","37 hsa04152 AMPK signaling pathway                            120    \n","   mabs         Nmabs      pvalue p.adjust    qvalues     \n","1  0.0035215860 16.7826082 0.000  0.000000000 0.0000000000\n","2  0.0033376123 15.7749929 0.000  0.000000000 0.0000000000\n","3  0.0033259424 11.5414923 0.000  0.000000000 0.0000000000\n","4  0.0031085605 15.7662546 0.000  0.000000000 0.0000000000\n","5  0.0024803638  7.0329402 0.001  0.002200000 0.0008947368\n","6  0.0024743726  7.7912403 0.000  0.000000000 0.0000000000\n","7  0.0023603462  7.8075934 0.000  0.000000000 0.0000000000\n","8  0.0019255456  6.3827669 0.000  0.000000000 0.0000000000\n","9  0.0018141504  8.2960906 0.000  0.000000000 0.0000000000\n","10 0.0017650834  8.7996660 0.000  0.000000000 0.0000000000\n","11 0.0013618918  7.7422994 0.000  0.000000000 0.0000000000\n","12 0.0013550136  8.9069536 0.000  0.000000000 0.0000000000\n","13 0.0011614402  5.2573227 0.002  0.004000000 0.0016267943\n","14 0.0011003118  6.9501351 0.000  0.000000000 0.0000000000\n","15 0.0010774807  6.2761115 0.000  0.000000000 0.0000000000\n","16 0.0010760402  5.1207797 0.001  0.002200000 0.0008947368\n","17 0.0010604454  2.1730774 0.030  0.048888889 0.0198830409\n","18 0.0009827571  6.2111464 0.000  0.000000000 0.0000000000\n","19 0.0009380863  6.9842671 0.000  0.000000000 0.0000000000\n","20 0.0008659258  4.7030226 0.002  0.004000000 0.0016267943\n","21 0.0007867821  5.1987551 0.000  0.000000000 0.0000000000\n","22 0.0007621951  4.1504518 0.005  0.009565217 0.0038901602\n","23 0.0007244627  4.2448040 0.006  0.011000000 0.0044736842\n","24 0.0007018775  3.3999791 0.013  0.022880000 0.0093052632\n","25 0.0006986789  4.5994939 0.000  0.000000000 0.0000000000\n","26 0.0005636401  4.1546232 0.001  0.002200000 0.0008947368\n","27 0.0004977601  1.4186225 0.068  0.106857143 0.0434586466\n","28 0.0004421192  2.7013593 0.023  0.038923077 0.0158299595\n","29 0.0003534818  1.1754723 0.107  0.151870968 0.0617657046\n","30 0.0003048780  1.3056225 0.092  0.139586207 0.0567695100\n","31 0.0002710027  1.1306162 0.106  0.151870968 0.0617657046\n","32 0.0002680247  1.0617152 0.125  0.163428571 0.0664661654\n","33 0.0002622607  1.0517556 0.124  0.163428571 0.0664661654\n","34 0.0002488800  1.0343531 0.128  0.163428571 0.0664661654\n","35 0.0002391200  0.9269916 0.130  0.163428571 0.0664661654\n","36 0.0002090592  1.1420106 0.152  0.180756757 0.0735135135\n","37 0.0002032520  0.9736707 0.144  0.176000000 0.0715789474\n","   itemID                                                                   \n","1  10013/10014/1812/3065/3066/51564/55869/79885/83933/8841/9734/9759        \n","2  10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             \n","3  10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \n","4  10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             \n","5  3065/3066                                                                \n","6  1812/3065/3066                                                           \n","7  3065/3066                                                                \n","8  3065/3066                                                                \n","9  3065/3066/8841                                                           \n","10 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","11 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","12 10376/10381/10382/10383/203068/3065/3066/51807/7277/7278/7846/81027/84790\n","13 3065/3066                                                                \n","14 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \n","15 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","16 10376/51807/7277/7278/7846/84790                                         \n","17 1636                                                                     \n","18 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","19 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790    \n","20 10376/51807/7277/7278/7846/84790                                         \n","21 10014/3065/3066/9759                                                     \n","22 3065/3066                                                                \n","23 3065/3066                                                                \n","24 10014/9759                                                               \n","25 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","26 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \n","27 1812                                                                     \n","28 3065/3066                                                                \n","29 1636                                                                     \n","30 148/1812/3269                                                            \n","31 1636                                                                     \n","32 1812                                                                     \n","33 148                                                                      \n","34 3269                                                                     \n","35 1636                                                                     \n","36 148/1812/3269                                                            \n","37 148                                                                      "],"text/latex":"A tibble: 37 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & setSize & mabs & Nmabs & pvalue & p.adjust & qvalues & itemID\\\\\n <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr>\\\\\n\\hline\n\t hsa05034 & Alcoholism                                        & 187 & 0.0035215860 & 16.7826082 & 0.000 & 0.000000000 & 0.0000000000 & 10013/10014/1812/3065/3066/51564/55869/79885/83933/8841/9734/9759        \\\\\n\t hsa04613 & Neutrophil extracellular trap formation           & 190 & 0.0033376123 & 15.7749929 & 0.000 & 0.000000000 & 0.0000000000 & 10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             \\\\\n\t hsa04540 & Gap junction                                      &  88 & 0.0033259424 & 11.5414923 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \\\\\n\t hsa05203 & Viral carcinogenesis                              & 204 & 0.0031085605 & 15.7662546 & 0.000 & 0.000000000 & 0.0000000000 & 10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             \\\\\n\t hsa04330 & Notch signaling pathway                           &  59 & 0.0024803638 &  7.0329402 & 0.001 & 0.002200000 & 0.0008947368 & 3065/3066                                                                \\\\\n\t hsa05031 & Amphetamine addiction                             &  69 & 0.0024743726 &  7.7912403 & 0.000 & 0.000000000 & 0.0000000000 & 1812/3065/3066                                                           \\\\\n\t hsa04213 & Longevity regulating pathway - multiple species   &  62 & 0.0023603462 &  7.8075934 & 0.000 & 0.000000000 & 0.0000000000 & 3065/3066                                                                \\\\\n\t hsa05220 & Chronic myeloid leukemia                          &  76 & 0.0019255456 &  6.3827669 & 0.000 & 0.000000000 & 0.0000000000 & 3065/3066                                                                \\\\\n\t hsa04919 & Thyroid hormone signaling pathway                 & 121 & 0.0018141504 &  8.2960906 & 0.000 & 0.000000000 & 0.0000000000 & 3065/3066/8841                                                           \\\\\n\t hsa04145 & Phagosome                                         & 152 & 0.0017650834 &  8.7996660 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa05130 & Pathogenic Escherichia coli infection             & 197 & 0.0013618918 &  7.7422994 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa05016 & Huntington disease                                & 306 & 0.0013550136 &  8.9069536 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/3065/3066/51807/7277/7278/7846/81027/84790\\\\\n\t hsa04110 & Cell cycle                                        & 126 & 0.0011614402 &  5.2573227 & 0.002 & 0.004000000 & 0.0016267943 & 3065/3066                                                                \\\\\n\t hsa05012 & Parkinson disease                                 & 266 & 0.0011003118 &  6.9501351 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     \\\\\n\t hsa05132 & Salmonella infection                              & 249 & 0.0010774807 &  6.2761115 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa04210 & Apoptosis                                         & 136 & 0.0010760402 &  5.1207797 & 0.001 & 0.002200000 & 0.0008947368 & 10376/51807/7277/7278/7846/84790                                         \\\\\n\t hsa04614 & Renin-angiotensin system                          &  23 & 0.0010604454 &  2.1730774 & 0.030 & 0.048888889 & 0.0198830409 & 1636                                                                     \\\\\n\t hsa05020 & Prion disease                                     & 273 & 0.0009827571 &  6.2111464 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                     & 364 & 0.0009380863 &  6.9842671 & 0.000 & 0.000000000 & 0.0000000000 & 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790    \\\\\n\t hsa04530 & Tight junction                                    & 169 & 0.0008659258 &  4.7030226 & 0.002 & 0.004000000 & 0.0016267943 & 10376/51807/7277/7278/7846/84790                                         \\\\\n\t hsa05206 & MicroRNAs in cancer                               & 310 & 0.0007867821 &  5.1987551 & 0.000 & 0.000000000 & 0.0000000000 & 10014/3065/3066/9759                                                     \\\\\n\t hsa05202 & Transcriptional misregulation in cancer           & 192 & 0.0007621951 &  4.1504518 & 0.005 & 0.009565217 & 0.0038901602 & 3065/3066                                                                \\\\\n\t hsa05169 & Epstein-Barr virus infection                      & 202 & 0.0007244627 &  4.2448040 & 0.006 & 0.011000000 & 0.0044736842 & 3065/3066                                                                \\\\\n\t hsa04371 & Apelin signaling pathway                          & 139 & 0.0007018775 &  3.3999791 & 0.013 & 0.022880000 & 0.0093052632 & 10014/9759                                                               \\\\\n\t hsa05010 & Alzheimer disease                                 & 384 & 0.0006986789 &  4.5994939 & 0.000 & 0.000000000 & 0.0000000000 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa05022 & Pathways of neurodegeneration - multiple diseases & 476 & 0.0005636401 &  4.1546232 & 0.001 & 0.002200000 & 0.0008947368 & 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          \\\\\n\t hsa05030 & Cocaine addiction                                 &  49 & 0.0004977601 &  1.4186225 & 0.068 & 0.106857143 & 0.0434586466 & 1812                                                                     \\\\\n\t hsa05165 & Human papillomavirus infection                    & 331 & 0.0004421192 &  2.7013593 & 0.023 & 0.038923077 & 0.0158299595 & 3065/3066                                                                \\\\\n\t hsa04924 & Renin secretion                                   &  69 & 0.0003534818 &  1.1754723 & 0.107 & 0.151870968 & 0.0617657046 & 1636                                                                     \\\\\n\t hsa04020 & Calcium signaling pathway                         & 240 & 0.0003048780 &  1.3056225 & 0.092 & 0.139586207 & 0.0567695100 & 148/1812/3269                                                            \\\\\n\t hsa05410 & Hypertrophic cardiomyopathy                       &  90 & 0.0002710027 &  1.1306162 & 0.106 & 0.151870968 & 0.0617657046 & 1636                                                                     \\\\\n\t hsa05032 & Morphine addiction                                &  91 & 0.0002680247 &  1.0617152 & 0.125 & 0.163428571 & 0.0664661654 & 1812                                                                     \\\\\n\t hsa04970 & Salivary secretion                                &  93 & 0.0002622607 &  1.0517556 & 0.124 & 0.163428571 & 0.0664661654 & 148                                                                      \\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels  &  98 & 0.0002488800 &  1.0343531 & 0.128 & 0.163428571 & 0.0664661654 & 3269                                                                     \\\\\n\t hsa05142 & Chagas disease                                    & 102 & 0.0002391200 &  0.9269916 & 0.130 & 0.163428571 & 0.0664661654 & 1636                                                                     \\\\\n\t hsa04080 & Neuroactive ligand-receptor interaction           & 350 & 0.0002090592 &  1.1420106 & 0.152 & 0.180756757 & 0.0735135135 & 148/1812/3269                                                            \\\\\n\t hsa04152 & AMPK signaling pathway                            & 120 & 0.0002032520 &  0.9736707 & 0.144 & 0.176000000 & 0.0715789474 & 148                                                                      \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 37 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | mabs &lt;dbl&gt; | Nmabs &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | itemID &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|\n| hsa05034 | Alcoholism                                        | 187 | 0.0035215860 | 16.7826082 | 0.000 | 0.000000000 | 0.0000000000 | 10013/10014/1812/3065/3066/51564/55869/79885/83933/8841/9734/9759         |\n| hsa04613 | Neutrophil extracellular trap formation           | 190 | 0.0033376123 | 15.7749929 | 0.000 | 0.000000000 | 0.0000000000 | 10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759              |\n| hsa04540 | Gap junction                                      |  88 | 0.0033259424 | 11.5414923 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      |\n| hsa05203 | Viral carcinogenesis                              | 204 | 0.0031085605 | 15.7662546 | 0.000 | 0.000000000 | 0.0000000000 | 10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759              |\n| hsa04330 | Notch signaling pathway                           |  59 | 0.0024803638 |  7.0329402 | 0.001 | 0.002200000 | 0.0008947368 | 3065/3066                                                                 |\n| hsa05031 | Amphetamine addiction                             |  69 | 0.0024743726 |  7.7912403 | 0.000 | 0.000000000 | 0.0000000000 | 1812/3065/3066                                                            |\n| hsa04213 | Longevity regulating pathway - multiple species   |  62 | 0.0023603462 |  7.8075934 | 0.000 | 0.000000000 | 0.0000000000 | 3065/3066                                                                 |\n| hsa05220 | Chronic myeloid leukemia                          |  76 | 0.0019255456 |  6.3827669 | 0.000 | 0.000000000 | 0.0000000000 | 3065/3066                                                                 |\n| hsa04919 | Thyroid hormone signaling pathway                 | 121 | 0.0018141504 |  8.2960906 | 0.000 | 0.000000000 | 0.0000000000 | 3065/3066/8841                                                            |\n| hsa04145 | Phagosome                                         | 152 | 0.0017650834 |  8.7996660 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa05130 | Pathogenic Escherichia coli infection             | 197 | 0.0013618918 |  7.7422994 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa05016 | Huntington disease                                | 306 | 0.0013550136 |  8.9069536 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/3065/3066/51807/7277/7278/7846/81027/84790 |\n| hsa04110 | Cell cycle                                        | 126 | 0.0011614402 |  5.2573227 | 0.002 | 0.004000000 | 0.0016267943 | 3065/3066                                                                 |\n| hsa05012 | Parkinson disease                                 | 266 | 0.0011003118 |  6.9501351 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790      |\n| hsa05132 | Salmonella infection                              | 249 | 0.0010774807 |  6.2761115 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa04210 | Apoptosis                                         | 136 | 0.0010760402 |  5.1207797 | 0.001 | 0.002200000 | 0.0008947368 | 10376/51807/7277/7278/7846/84790                                          |\n| hsa04614 | Renin-angiotensin system                          |  23 | 0.0010604454 |  2.1730774 | 0.030 | 0.048888889 | 0.0198830409 | 1636                                                                      |\n| hsa05020 | Prion disease                                     | 273 | 0.0009827571 |  6.2111464 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa05014 | Amyotrophic lateral sclerosis                     | 364 | 0.0009380863 |  6.9842671 | 0.000 | 0.000000000 | 0.0000000000 | 10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790     |\n| hsa04530 | Tight junction                                    | 169 | 0.0008659258 |  4.7030226 | 0.002 | 0.004000000 | 0.0016267943 | 10376/51807/7277/7278/7846/84790                                          |\n| hsa05206 | MicroRNAs in cancer                               | 310 | 0.0007867821 |  5.1987551 | 0.000 | 0.000000000 | 0.0000000000 | 10014/3065/3066/9759                                                      |\n| hsa05202 | Transcriptional misregulation in cancer           | 192 | 0.0007621951 |  4.1504518 | 0.005 | 0.009565217 | 0.0038901602 | 3065/3066                                                                 |\n| hsa05169 | Epstein-Barr virus infection                      | 202 | 0.0007244627 |  4.2448040 | 0.006 | 0.011000000 | 0.0044736842 | 3065/3066                                                                 |\n| hsa04371 | Apelin signaling pathway                          | 139 | 0.0007018775 |  3.3999791 | 0.013 | 0.022880000 | 0.0093052632 | 10014/9759                                                                |\n| hsa05010 | Alzheimer disease                                 | 384 | 0.0006986789 |  4.5994939 | 0.000 | 0.000000000 | 0.0000000000 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa05022 | Pathways of neurodegeneration - multiple diseases | 476 | 0.0005636401 |  4.1546232 | 0.001 | 0.002200000 | 0.0008947368 | 10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790           |\n| hsa05030 | Cocaine addiction                                 |  49 | 0.0004977601 |  1.4186225 | 0.068 | 0.106857143 | 0.0434586466 | 1812                                                                      |\n| hsa05165 | Human papillomavirus infection                    | 331 | 0.0004421192 |  2.7013593 | 0.023 | 0.038923077 | 0.0158299595 | 3065/3066                                                                 |\n| hsa04924 | Renin secretion                                   |  69 | 0.0003534818 |  1.1754723 | 0.107 | 0.151870968 | 0.0617657046 | 1636                                                                      |\n| hsa04020 | Calcium signaling pathway                         | 240 | 0.0003048780 |  1.3056225 | 0.092 | 0.139586207 | 0.0567695100 | 148/1812/3269                                                             |\n| hsa05410 | Hypertrophic cardiomyopathy                       |  90 | 0.0002710027 |  1.1306162 | 0.106 | 0.151870968 | 0.0617657046 | 1636                                                                      |\n| hsa05032 | Morphine addiction                                |  91 | 0.0002680247 |  1.0617152 | 0.125 | 0.163428571 | 0.0664661654 | 1812                                                                      |\n| hsa04970 | Salivary secretion                                |  93 | 0.0002622607 |  1.0517556 | 0.124 | 0.163428571 | 0.0664661654 | 148                                                                       |\n| hsa04750 | Inflammatory mediator regulation of TRP channels  |  98 | 0.0002488800 |  1.0343531 | 0.128 | 0.163428571 | 0.0664661654 | 3269                                                                      |\n| hsa05142 | Chagas disease                                    | 102 | 0.0002391200 |  0.9269916 | 0.130 | 0.163428571 | 0.0664661654 | 1636                                                                      |\n| hsa04080 | Neuroactive ligand-receptor interaction           | 350 | 0.0002090592 |  1.1420106 | 0.152 | 0.180756757 | 0.0735135135 | 148/1812/3269                                                             |\n| hsa04152 | AMPK signaling pathway                            | 120 | 0.0002032520 |  0.9736707 | 0.144 | 0.176000000 | 0.0715789474 | 148                                                                       |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 37 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>mabs</th><th scope=col>Nmabs</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>itemID</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                       </td><td>187</td><td>0.0035215860</td><td>16.7826082</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10013/10014/1812/3065/3066/51564/55869/79885/83933/8841/9734/9759        </td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation          </td><td>190</td><td>0.0033376123</td><td>15.7749929</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             </td></tr>\n","\t<tr><td>hsa04540</td><td>Gap junction                                     </td><td> 88</td><td>0.0033259424</td><td>11.5414923</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     </td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                             </td><td>204</td><td>0.0031085605</td><td>15.7662546</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10013/10014/3065/3066/51564/55869/79885/83933/8841/9734/9759             </td></tr>\n","\t<tr><td>hsa04330</td><td>Notch signaling pathway                          </td><td> 59</td><td>0.0024803638</td><td> 7.0329402</td><td>0.001</td><td>0.002200000</td><td>0.0008947368</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                            </td><td> 69</td><td>0.0024743726</td><td> 7.7912403</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>1812/3065/3066                                                           </td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species  </td><td> 62</td><td>0.0023603462</td><td> 7.8075934</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                         </td><td> 76</td><td>0.0019255456</td><td> 6.3827669</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway                </td><td>121</td><td>0.0018141504</td><td> 8.2960906</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>3065/3066/8841                                                           </td></tr>\n","\t<tr><td>hsa04145</td><td>Phagosome                                        </td><td>152</td><td>0.0017650834</td><td> 8.7996660</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa05130</td><td>Pathogenic Escherichia coli infection            </td><td>197</td><td>0.0013618918</td><td> 7.7422994</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                               </td><td>306</td><td>0.0013550136</td><td> 8.9069536</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/3065/3066/51807/7277/7278/7846/81027/84790</td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                       </td><td>126</td><td>0.0011614402</td><td> 5.2573227</td><td>0.002</td><td>0.004000000</td><td>0.0016267943</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                                </td><td>266</td><td>0.0011003118</td><td> 6.9501351</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/1812/203068/51807/7277/7278/7846/81027/84790     </td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                             </td><td>249</td><td>0.0010774807</td><td> 6.2761115</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa04210</td><td>Apoptosis                                        </td><td>136</td><td>0.0010760402</td><td> 5.1207797</td><td>0.001</td><td>0.002200000</td><td>0.0008947368</td><td>10376/51807/7277/7278/7846/84790                                         </td></tr>\n","\t<tr><td>hsa04614</td><td>Renin-angiotensin system                         </td><td> 23</td><td>0.0010604454</td><td> 2.1730774</td><td>0.030</td><td>0.048888889</td><td>0.0198830409</td><td>1636                                                                     </td></tr>\n","\t<tr><td>hsa05020</td><td>Prion disease                                    </td><td>273</td><td>0.0009827571</td><td> 6.2111464</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                    </td><td>364</td><td>0.0009380863</td><td> 6.9842671</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10013/10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790    </td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                   </td><td>169</td><td>0.0008659258</td><td> 4.7030226</td><td>0.002</td><td>0.004000000</td><td>0.0016267943</td><td>10376/51807/7277/7278/7846/84790                                         </td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                              </td><td>310</td><td>0.0007867821</td><td> 5.1987551</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10014/3065/3066/9759                                                     </td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer          </td><td>192</td><td>0.0007621951</td><td> 4.1504518</td><td>0.005</td><td>0.009565217</td><td>0.0038901602</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                     </td><td>202</td><td>0.0007244627</td><td> 4.2448040</td><td>0.006</td><td>0.011000000</td><td>0.0044736842</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                         </td><td>139</td><td>0.0007018775</td><td> 3.3999791</td><td>0.013</td><td>0.022880000</td><td>0.0093052632</td><td>10014/9759                                                               </td></tr>\n","\t<tr><td>hsa05010</td><td>Alzheimer disease                                </td><td>384</td><td>0.0006986789</td><td> 4.5994939</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa05022</td><td>Pathways of neurodegeneration - multiple diseases</td><td>476</td><td>0.0005636401</td><td> 4.1546232</td><td>0.001</td><td>0.002200000</td><td>0.0008947368</td><td>10376/10381/10382/10383/203068/51807/7277/7278/7846/81027/84790          </td></tr>\n","\t<tr><td>hsa05030</td><td>Cocaine addiction                                </td><td> 49</td><td>0.0004977601</td><td> 1.4186225</td><td>0.068</td><td>0.106857143</td><td>0.0434586466</td><td>1812                                                                     </td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                   </td><td>331</td><td>0.0004421192</td><td> 2.7013593</td><td>0.023</td><td>0.038923077</td><td>0.0158299595</td><td>3065/3066                                                                </td></tr>\n","\t<tr><td>hsa04924</td><td>Renin secretion                                  </td><td> 69</td><td>0.0003534818</td><td> 1.1754723</td><td>0.107</td><td>0.151870968</td><td>0.0617657046</td><td>1636                                                                     </td></tr>\n","\t<tr><td>hsa04020</td><td>Calcium signaling pathway                        </td><td>240</td><td>0.0003048780</td><td> 1.3056225</td><td>0.092</td><td>0.139586207</td><td>0.0567695100</td><td>148/1812/3269                                                            </td></tr>\n","\t<tr><td>hsa05410</td><td>Hypertrophic cardiomyopathy                      </td><td> 90</td><td>0.0002710027</td><td> 1.1306162</td><td>0.106</td><td>0.151870968</td><td>0.0617657046</td><td>1636                                                                     </td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                               </td><td> 91</td><td>0.0002680247</td><td> 1.0617152</td><td>0.125</td><td>0.163428571</td><td>0.0664661654</td><td>1812                                                                     </td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                               </td><td> 93</td><td>0.0002622607</td><td> 1.0517556</td><td>0.124</td><td>0.163428571</td><td>0.0664661654</td><td>148                                                                      </td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels </td><td> 98</td><td>0.0002488800</td><td> 1.0343531</td><td>0.128</td><td>0.163428571</td><td>0.0664661654</td><td>3269                                                                     </td></tr>\n","\t<tr><td>hsa05142</td><td>Chagas disease                                   </td><td>102</td><td>0.0002391200</td><td> 0.9269916</td><td>0.130</td><td>0.163428571</td><td>0.0664661654</td><td>1636                                                                     </td></tr>\n","\t<tr><td>hsa04080</td><td>Neuroactive ligand-receptor interaction          </td><td>350</td><td>0.0002090592</td><td> 1.1420106</td><td>0.152</td><td>0.180756757</td><td>0.0735135135</td><td>148/1812/3269                                                            </td></tr>\n","\t<tr><td>hsa04152</td><td>AMPK signaling pathway                           </td><td>120</td><td>0.0002032520</td><td> 0.9736707</td><td>0.144</td><td>0.176000000</td><td>0.0715789474</td><td>148                                                                      </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}},{"output_type":"stream","name":"stderr","text":["No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]},{"output_type":"display_data","data":{"text/plain":["    ID           \n","1   R-HSA-193670 \n","2   R-HSA-350054 \n","3   R-HSA-9701898\n","4   R-HSA-190840 \n","5   R-HSA-2122947\n","6   R-HSA-190872 \n","7   R-HSA-9022702\n","8   R-HSA-9005891\n","9   R-HSA-9005895\n","10  R-HSA-9675151\n","11  R-HSA-9697154\n","12  R-HSA-389977 \n","13  R-HSA-2644602\n","14  R-HSA-2644603\n","15  R-HSA-2644606\n","16  R-HSA-2894858\n","17  R-HSA-2894862\n","18  R-HSA-9022537\n","19  R-HSA-389960 \n","20  R-HSA-8941284\n","21  R-HSA-9022699\n","22  R-HSA-1980143\n","23  R-HSA-9619483\n","24  R-HSA-201556 \n","25  R-HSA-4641265\n","26  R-HSA-9668328\n","27  R-HSA-389958 \n","28  R-HSA-5626467\n","29  R-HSA-9646399\n","30  R-HSA-389957 \n","⋮   ⋮            \n","157 R-HSA-3108214\n","158 R-HSA-1989781\n","159 R-HSA-400206 \n","160 R-HSA-5617472\n","161 R-HSA-5619507\n","162 R-HSA-112316 \n","163 R-HSA-9707564\n","164 R-HSA-9006931\n","165 R-HSA-8878159\n","166 R-HSA-9711123\n","167 R-HSA-8939211\n","168 R-HSA-201681 \n","169 R-HSA-8878171\n","170 R-HSA-3700989\n","171 R-HSA-416482 \n","172 R-HSA-195721 \n","173 R-HSA-2980736\n","174 R-HSA-416476 \n","175 R-HSA-373076 \n","176 R-HSA-114608 \n","177 R-HSA-76005  \n","178 R-HSA-9660821\n","179 R-HSA-418555 \n","180 R-HSA-500792 \n","181 R-HSA-9662851\n","182 R-HSA-9664433\n","183 R-HSA-6798695\n","184 R-HSA-9658195\n","185 R-HSA-76002  \n","186 R-HSA-9012999\n","    Description                                                                         \n","1   p75NTR negatively regulates cell cycle via SC1                                      \n","2   Notch-HLH transcription pathway                                                     \n","3   STAT3 nuclear events downstream of ALK signaling                                    \n","4   Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane    \n","5   NOTCH1 Intracellular Domain Regulates Transcription                                 \n","6   Transport of connexons to the plasma membrane                                       \n","7   MECP2 regulates transcription of neuronal ligands                                   \n","8   Loss of function of MECP2 in Rett syndrome                                          \n","9   Pervasive developmental disorders                                                   \n","10  Disorders of Developmental Biology                                                  \n","11  Disorders of Nervous System Development                                             \n","12  Post-chaperonin tubulin folding pathway                                             \n","13  Signaling by NOTCH1 PEST Domain Mutants in Cancer                                   \n","14  Signaling by NOTCH1 in Cancer                                                       \n","15  Constitutive Signaling by NOTCH1 PEST Domain Mutants                                \n","16  Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                                \n","17  Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                             \n","18  Loss of MECP2 binding ability to the NCoR/SMRT complex                              \n","19  Formation of tubulin folding intermediates by CCT/TriC                              \n","20  RUNX2 regulates chondrocyte maturation                                              \n","21  MECP2 regulates neuronal receptors and channels                                     \n","22  Signaling by NOTCH1                                                                 \n","23  Activation of AMPK downstream of NMDARs                                             \n","24  Signaling by ALK                                                                    \n","25  Repression of WNT target genes                                                      \n","26  Sealing of the nuclear envelope (NE) by ESCRT-III                                   \n","27  Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding                 \n","28  RHO GTPases activate IQGAPs                                                         \n","29  Aggrephagy                                                                          \n","30  Prefoldin mediated transfer of substrate  to CCT/TriC                               \n","⋮   ⋮                                                                                   \n","157 SUMOylation of DNA damage response and repair proteins                              \n","158 PPARA activates gene expression                                                     \n","159 Regulation of lipid metabolism by PPARalpha                                         \n","160 Activation of anterior HOX genes in hindbrain development during early embryogenesis\n","161 Activation of HOX genes during differentiation                                      \n","162 Neuronal System                                                                     \n","163 Cytoprotection by HMOX1                                                             \n","164 Signaling by Nuclear Receptors                                                      \n","165 Transcriptional regulation by RUNX3                                                 \n","166 Cellular response to chemical stress                                                \n","167 ESR-mediated signaling                                                              \n","168 TCF dependent signaling in response to WNT                                          \n","169 Transcriptional regulation by RUNX1                                                 \n","170 Transcriptional Regulation by TP53                                                  \n","171 G alpha (12/13) signalling events                                                   \n","172 Signaling by WNT                                                                    \n","173 Peptide hormone metabolism                                                          \n","174 G alpha (q) signalling events                                                       \n","175 Class A/1 (Rhodopsin-like receptors)                                                \n","176 Platelet degranulation                                                              \n","177 Response to elevated platelet cytosolic Ca2+                                        \n","178 ADORA2B mediated anti-inflammatory cytokines production                             \n","179 G alpha (s) signalling events                                                       \n","180 GPCR ligand binding                                                                 \n","181 Anti-inflammatory response favouring Leishmania parasite infection                  \n","182 Leishmania parasite growth and survival                                             \n","183 Neutrophil degranulation                                                            \n","184 Leishmania infection                                                                \n","185 Platelet activation, signaling and aggregation                                      \n","186 RHO GTPase cycle                                                                    \n","    setSize mabs         Nmabs     pvalue p.adjust    qvalues     \n","1    6      0.036585366  26.52905  0.000  0.000000000 0.0000000000\n","2   28      0.022648084  28.08201  0.000  0.000000000 0.0000000000\n","3   10      0.021951220  24.35668  0.000  0.000000000 0.0000000000\n","4   18      0.013550136  19.91941  0.000  0.000000000 0.0000000000\n","5   48      0.013211382  25.57905  0.000  0.000000000 0.0000000000\n","6   19      0.012836970  19.57476  0.000  0.000000000 0.0000000000\n","7    8      0.012195122  18.93978  0.000  0.000000000 0.0000000000\n","8   14      0.012195122  17.72823  0.000  0.000000000 0.0000000000\n","9   14      0.012195122  17.72823  0.000  0.000000000 0.0000000000\n","10  14      0.012195122  17.72823  0.000  0.000000000 0.0000000000\n","11  14      0.012195122  17.72823  0.000  0.000000000 0.0000000000\n","12  22      0.011086475  19.23895  0.000  0.000000000 0.0000000000\n","13  58      0.010933558  24.90274  0.000  0.000000000 0.0000000000\n","14  58      0.010933558  24.90274  0.000  0.000000000 0.0000000000\n","15  58      0.010933558  24.90274  0.000  0.000000000 0.0000000000\n","16  58      0.010933558  24.90274  0.000  0.000000000 0.0000000000\n","17  58      0.010933558  24.90274  0.000  0.000000000 0.0000000000\n","18   7      0.010452962  10.35129  0.003  0.004164179 0.0003770621\n","19  25      0.009756098  18.46124  0.000  0.000000000 0.0000000000\n","20   5      0.009756098  10.88214  0.001  0.001476190 0.0001336675\n","21  17      0.008608321  13.85203  0.000  0.000000000 0.0000000000\n","22  74      0.008569545  24.06719  0.000  0.000000000 0.0000000000\n","23  29      0.008410429  15.76461  0.000  0.000000000 0.0000000000\n","24  27      0.008130081  17.44480  0.000  0.000000000 0.0000000000\n","25  12      0.008130081  14.55223  0.000  0.000000000 0.0000000000\n","26  31      0.007867821  18.00299  0.000  0.000000000 0.0000000000\n","27  32      0.007621951  17.27967  0.000  0.000000000 0.0000000000\n","28  32      0.007621951  17.70097  0.000  0.000000000 0.0000000000\n","29  43      0.007373795  17.37006  0.000  0.000000000 0.0000000000\n","30  28      0.006968641  15.58254  0.000  0.000000000 0.0000000000\n","⋮   ⋮       ⋮            ⋮         ⋮      ⋮           ⋮           \n","157  77     6.335128e-04 2.4817536 0.039  0.043178571 0.0039097744\n","158 117     6.253909e-04 3.1535718 0.018  0.020925000 0.0018947368\n","159 119     6.148801e-04 3.1495611 0.024  0.027555556 0.0024951267\n","160 121     6.047168e-04 3.0289668 0.025  0.028181818 0.0025518341\n","161 121     6.047168e-04 3.0289668 0.025  0.028181818 0.0025518341\n","162 410     5.948840e-04 4.9326747 0.001  0.001476190 0.0001336675\n","163 124     5.900865e-04 3.0580636 0.025  0.028181818 0.0025518341\n","164 299     5.710091e-04 4.0376968 0.004  0.005352518 0.0004846649\n","165  96     5.081301e-04 2.1337080 0.052  0.056561404 0.0051215759\n","166 160     4.573171e-04 2.6928407 0.045  0.049526627 0.0044845842\n","167 223     4.374932e-04 3.0774253 0.024  0.027555556 0.0024951267\n","168 233     4.187166e-04 3.0699621 0.017  0.019886792 0.0018007282\n","169 239     4.082049e-04 2.9462189 0.028  0.031373494 0.0028408370\n","170 365     4.009355e-04 3.0232712 0.014  0.016692308 0.0015114710\n","171  80     3.048780e-04 1.3762517 0.065  0.070290698 0.0063647491\n","172 332     2.938584e-04 1.9222115 0.046  0.050329412 0.0045572755\n","173  91     2.680247e-04 1.2432552 0.079  0.084936416 0.0076909036\n","174 216     2.258356e-04 1.6280362 0.105  0.111600000 0.0101052632\n","175 335     2.184201e-04 1.2541263 0.088  0.094068966 0.0085178463\n","176 129     1.890717e-04 1.0637125 0.120  0.126818182 0.0114832536\n","177 134     1.820167e-04 1.0180255 0.124  0.130305085 0.0117989890\n","178 134     1.820167e-04 0.9701944 0.132  0.137932584 0.0124896511\n","179 145     1.682086e-04 0.9524702 0.139  0.144435754 0.0130785063\n","180 467     1.566825e-04 1.0559158 0.158  0.163266667 0.0147836257\n","181 169     1.443210e-04 0.8848947 0.166  0.169648352 0.0153614806\n","182 169     1.443210e-04 0.8848947 0.166  0.169648352 0.0153614806\n","183 480     1.016260e-04 0.5292602 0.289  0.290562162 0.0263100996\n","184 254     9.602458e-05 0.7079975 0.243  0.246983607 0.0223641070\n","185 263     9.273857e-05 0.7340001 0.251  0.253728261 0.0229748284\n","186 449     5.432126e-05 0.0000000 0.437  0.437000000 0.0395698925\n","    itemID                                                                  \n","1   HDAC1/HDAC2/HDAC3                                                       \n","2   HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","3   HDAC1/HDAC2/HDAC3                                                       \n","4   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","5   HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","6   TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","7   HDAC1                                                                   \n","8   HDAC1/HDAC3                                                             \n","9   HDAC1/HDAC3                                                             \n","10  HDAC1/HDAC3                                                             \n","11  HDAC1/HDAC3                                                             \n","12  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","13  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","14  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","15  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","16  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","17  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","18  HDAC3                                                                   \n","19  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","20  HDAC4                                                                   \n","21  HDAC1/HDAC2                                                             \n","22  HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \n","23  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","24  HDAC1/HDAC2/HDAC3                                                       \n","25  HDAC1                                                                   \n","26  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","27  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","28  TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","29  HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C\n","30  TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                   \n","⋮   ⋮                                                                       \n","157 HDAC7                                                                   \n","158 HDAC3                                                                   \n","159 HDAC3                                                                   \n","160 HDAC3                                                                   \n","161 HDAC3                                                                   \n","162 TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \n","163 HDAC3                                                                   \n","164 HDAC1/HDAC3                                                             \n","165 HDAC4                                                                   \n","166 HDAC3                                                                   \n","167 HDAC1                                                                   \n","168 HDAC1                                                                   \n","169 HDAC1                                                                   \n","170 HDAC1/HDAC2                                                             \n","171 ADRA1A                                                                  \n","172 HDAC1                                                                   \n","173 ACE                                                                     \n","174 ADRA1A/HRH1                                                             \n","175 ADRA1A/DRD1/HRH1                                                        \n","176 TUBA4A                                                                  \n","177 TUBA4A                                                                  \n","178 DRD1                                                                    \n","179 DRD1                                                                    \n","180 ADRA1A/DRD1/HRH1                                                        \n","181 DRD1                                                                    \n","182 DRD1                                                                    \n","183 TUBB4B/TUBB                                                             \n","184 DRD1                                                                    \n","185 TUBA4A                                                                  \n","186 TUBA1B                                                                  "],"text/latex":"A tibble: 186 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & setSize & mabs & Nmabs & pvalue & p.adjust & qvalues & itemID\\\\\n <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr>\\\\\n\\hline\n\t R-HSA-193670  & p75NTR negatively regulates cell cycle via SC1                                   &  6 & 0.036585366 & 26.52905 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC2/HDAC3                                                       \\\\\n\t R-HSA-350054  & Notch-HLH transcription pathway                                                  & 28 & 0.022648084 & 28.08201 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-9701898 & STAT3 nuclear events downstream of ALK signaling                                 & 10 & 0.021951220 & 24.35668 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC2/HDAC3                                                       \\\\\n\t R-HSA-190840  & Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane & 18 & 0.013550136 & 19.91941 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-2122947 & NOTCH1 Intracellular Domain Regulates Transcription                              & 48 & 0.013211382 & 25.57905 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-190872  & Transport of connexons to the plasma membrane                                    & 19 & 0.012836970 & 19.57476 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-9022702 & MECP2 regulates transcription of neuronal ligands                                &  8 & 0.012195122 & 18.93978 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1                                                                   \\\\\n\t R-HSA-9005891 & Loss of function of MECP2 in Rett syndrome                                       & 14 & 0.012195122 & 17.72823 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC3                                                             \\\\\n\t R-HSA-9005895 & Pervasive developmental disorders                                                & 14 & 0.012195122 & 17.72823 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC3                                                             \\\\\n\t R-HSA-9675151 & Disorders of Developmental Biology                                               & 14 & 0.012195122 & 17.72823 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC3                                                             \\\\\n\t R-HSA-9697154 & Disorders of Nervous System Development                                          & 14 & 0.012195122 & 17.72823 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC3                                                             \\\\\n\t R-HSA-389977  & Post-chaperonin tubulin folding pathway                                          & 22 & 0.011086475 & 19.23895 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-2644602 & Signaling by NOTCH1 PEST Domain Mutants in Cancer                                & 58 & 0.010933558 & 24.90274 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-2644603 & Signaling by NOTCH1 in Cancer                                                    & 58 & 0.010933558 & 24.90274 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-2644606 & Constitutive Signaling by NOTCH1 PEST Domain Mutants                             & 58 & 0.010933558 & 24.90274 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-2894858 & Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             & 58 & 0.010933558 & 24.90274 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-2894862 & Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          & 58 & 0.010933558 & 24.90274 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-9022537 & Loss of MECP2 binding ability to the NCoR/SMRT complex                           &  7 & 0.010452962 & 10.35129 & 0.003 & 0.004164179 & 0.0003770621 & HDAC3                                                                   \\\\\n\t R-HSA-389960  & Formation of tubulin folding intermediates by CCT/TriC                           & 25 & 0.009756098 & 18.46124 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-8941284 & RUNX2 regulates chondrocyte maturation                                           &  5 & 0.009756098 & 10.88214 & 0.001 & 0.001476190 & 0.0001336675 & HDAC4                                                                   \\\\\n\t R-HSA-9022699 & MECP2 regulates neuronal receptors and channels                                  & 17 & 0.008608321 & 13.85203 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC2                                                             \\\\\n\t R-HSA-1980143 & Signaling by NOTCH1                                                              & 74 & 0.008569545 & 24.06719 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     \\\\\n\t R-HSA-9619483 & Activation of AMPK downstream of NMDARs                                          & 29 & 0.008410429 & 15.76461 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-201556  & Signaling by ALK                                                                 & 27 & 0.008130081 & 17.44480 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1/HDAC2/HDAC3                                                       \\\\\n\t R-HSA-4641265 & Repression of WNT target genes                                                   & 12 & 0.008130081 & 14.55223 & 0.000 & 0.000000000 & 0.0000000000 & HDAC1                                                                   \\\\\n\t R-HSA-9668328 & Sealing of the nuclear envelope (NE) by ESCRT-III                                & 31 & 0.007867821 & 18.00299 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-389958  & Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              & 32 & 0.007621951 & 17.27967 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-5626467 & RHO GTPases activate IQGAPs                                                      & 32 & 0.007621951 & 17.70097 & 0.000 & 0.000000000 & 0.0000000000 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      \\\\\n\t R-HSA-9646399 & Aggrephagy                                                                       & 43 & 0.007373795 & 17.37006 & 0.000 & 0.000000000 & 0.0000000000 & HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C\\\\\n\t R-HSA-389957  & Prefoldin mediated transfer of substrate  to CCT/TriC                            & 28 & 0.006968641 & 15.58254 & 0.000 & 0.000000000 & 0.0000000000 & TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                   \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t R-HSA-3108214 & SUMOylation of DNA damage response and repair proteins                               &  77 & 6.335128e-04 & 2.4817536 & 0.039 & 0.043178571 & 0.0039097744 & HDAC7                                                             \\\\\n\t R-HSA-1989781 & PPARA activates gene expression                                                      & 117 & 6.253909e-04 & 3.1535718 & 0.018 & 0.020925000 & 0.0018947368 & HDAC3                                                             \\\\\n\t R-HSA-400206  & Regulation of lipid metabolism by PPARalpha                                          & 119 & 6.148801e-04 & 3.1495611 & 0.024 & 0.027555556 & 0.0024951267 & HDAC3                                                             \\\\\n\t R-HSA-5617472 & Activation of anterior HOX genes in hindbrain development during early embryogenesis & 121 & 6.047168e-04 & 3.0289668 & 0.025 & 0.028181818 & 0.0025518341 & HDAC3                                                             \\\\\n\t R-HSA-5619507 & Activation of HOX genes during differentiation                                       & 121 & 6.047168e-04 & 3.0289668 & 0.025 & 0.028181818 & 0.0025518341 & HDAC3                                                             \\\\\n\t R-HSA-112316  & Neuronal System                                                                      & 410 & 5.948840e-04 & 4.9326747 & 0.001 & 0.001476190 & 0.0001336675 & TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C\\\\\n\t R-HSA-9707564 & Cytoprotection by HMOX1                                                              & 124 & 5.900865e-04 & 3.0580636 & 0.025 & 0.028181818 & 0.0025518341 & HDAC3                                                             \\\\\n\t R-HSA-9006931 & Signaling by Nuclear Receptors                                                       & 299 & 5.710091e-04 & 4.0376968 & 0.004 & 0.005352518 & 0.0004846649 & HDAC1/HDAC3                                                       \\\\\n\t R-HSA-8878159 & Transcriptional regulation by RUNX3                                                  &  96 & 5.081301e-04 & 2.1337080 & 0.052 & 0.056561404 & 0.0051215759 & HDAC4                                                             \\\\\n\t R-HSA-9711123 & Cellular response to chemical stress                                                 & 160 & 4.573171e-04 & 2.6928407 & 0.045 & 0.049526627 & 0.0044845842 & HDAC3                                                             \\\\\n\t R-HSA-8939211 & ESR-mediated signaling                                                               & 223 & 4.374932e-04 & 3.0774253 & 0.024 & 0.027555556 & 0.0024951267 & HDAC1                                                             \\\\\n\t R-HSA-201681  & TCF dependent signaling in response to WNT                                           & 233 & 4.187166e-04 & 3.0699621 & 0.017 & 0.019886792 & 0.0018007282 & HDAC1                                                             \\\\\n\t R-HSA-8878171 & Transcriptional regulation by RUNX1                                                  & 239 & 4.082049e-04 & 2.9462189 & 0.028 & 0.031373494 & 0.0028408370 & HDAC1                                                             \\\\\n\t R-HSA-3700989 & Transcriptional Regulation by TP53                                                   & 365 & 4.009355e-04 & 3.0232712 & 0.014 & 0.016692308 & 0.0015114710 & HDAC1/HDAC2                                                       \\\\\n\t R-HSA-416482  & G alpha (12/13) signalling events                                                    &  80 & 3.048780e-04 & 1.3762517 & 0.065 & 0.070290698 & 0.0063647491 & ADRA1A                                                            \\\\\n\t R-HSA-195721  & Signaling by WNT                                                                     & 332 & 2.938584e-04 & 1.9222115 & 0.046 & 0.050329412 & 0.0045572755 & HDAC1                                                             \\\\\n\t R-HSA-2980736 & Peptide hormone metabolism                                                           &  91 & 2.680247e-04 & 1.2432552 & 0.079 & 0.084936416 & 0.0076909036 & ACE                                                               \\\\\n\t R-HSA-416476  & G alpha (q) signalling events                                                        & 216 & 2.258356e-04 & 1.6280362 & 0.105 & 0.111600000 & 0.0101052632 & ADRA1A/HRH1                                                       \\\\\n\t R-HSA-373076  & Class A/1 (Rhodopsin-like receptors)                                                 & 335 & 2.184201e-04 & 1.2541263 & 0.088 & 0.094068966 & 0.0085178463 & ADRA1A/DRD1/HRH1                                                  \\\\\n\t R-HSA-114608  & Platelet degranulation                                                               & 129 & 1.890717e-04 & 1.0637125 & 0.120 & 0.126818182 & 0.0114832536 & TUBA4A                                                            \\\\\n\t R-HSA-76005   & Response to elevated platelet cytosolic Ca2+                                         & 134 & 1.820167e-04 & 1.0180255 & 0.124 & 0.130305085 & 0.0117989890 & TUBA4A                                                            \\\\\n\t R-HSA-9660821 & ADORA2B mediated anti-inflammatory cytokines production                              & 134 & 1.820167e-04 & 0.9701944 & 0.132 & 0.137932584 & 0.0124896511 & DRD1                                                              \\\\\n\t R-HSA-418555  & G alpha (s) signalling events                                                        & 145 & 1.682086e-04 & 0.9524702 & 0.139 & 0.144435754 & 0.0130785063 & DRD1                                                              \\\\\n\t R-HSA-500792  & GPCR ligand binding                                                                  & 467 & 1.566825e-04 & 1.0559158 & 0.158 & 0.163266667 & 0.0147836257 & ADRA1A/DRD1/HRH1                                                  \\\\\n\t R-HSA-9662851 & Anti-inflammatory response favouring Leishmania parasite infection                   & 169 & 1.443210e-04 & 0.8848947 & 0.166 & 0.169648352 & 0.0153614806 & DRD1                                                              \\\\\n\t R-HSA-9664433 & Leishmania parasite growth and survival                                              & 169 & 1.443210e-04 & 0.8848947 & 0.166 & 0.169648352 & 0.0153614806 & DRD1                                                              \\\\\n\t R-HSA-6798695 & Neutrophil degranulation                                                             & 480 & 1.016260e-04 & 0.5292602 & 0.289 & 0.290562162 & 0.0263100996 & TUBB4B/TUBB                                                       \\\\\n\t R-HSA-9658195 & Leishmania infection                                                                 & 254 & 9.602458e-05 & 0.7079975 & 0.243 & 0.246983607 & 0.0223641070 & DRD1                                                              \\\\\n\t R-HSA-76002   & Platelet activation, signaling and aggregation                                       & 263 & 9.273857e-05 & 0.7340001 & 0.251 & 0.253728261 & 0.0229748284 & TUBA4A                                                            \\\\\n\t R-HSA-9012999 & RHO GTPase cycle                                                                     & 449 & 5.432126e-05 & 0.0000000 & 0.437 & 0.437000000 & 0.0395698925 & TUBA1B                                                            \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 186 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | mabs &lt;dbl&gt; | Nmabs &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | itemID &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|\n| R-HSA-193670  | p75NTR negatively regulates cell cycle via SC1                                   |  6 | 0.036585366 | 26.52905 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC2/HDAC3                                                        |\n| R-HSA-350054  | Notch-HLH transcription pathway                                                  | 28 | 0.022648084 | 28.08201 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling                                 | 10 | 0.021951220 | 24.35668 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC2/HDAC3                                                        |\n| R-HSA-190840  | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 18 | 0.013550136 | 19.91941 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription                              | 48 | 0.013211382 | 25.57905 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-190872  | Transport of connexons to the plasma membrane                                    | 19 | 0.012836970 | 19.57476 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-9022702 | MECP2 regulates transcription of neuronal ligands                                |  8 | 0.012195122 | 18.93978 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1                                                                    |\n| R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome                                       | 14 | 0.012195122 | 17.72823 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC3                                                              |\n| R-HSA-9005895 | Pervasive developmental disorders                                                | 14 | 0.012195122 | 17.72823 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC3                                                              |\n| R-HSA-9675151 | Disorders of Developmental Biology                                               | 14 | 0.012195122 | 17.72823 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC3                                                              |\n| R-HSA-9697154 | Disorders of Nervous System Development                                          | 14 | 0.012195122 | 17.72823 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC3                                                              |\n| R-HSA-389977  | Post-chaperonin tubulin folding pathway                                          | 22 | 0.011086475 | 19.23895 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer                                | 58 | 0.010933558 | 24.90274 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-2644603 | Signaling by NOTCH1 in Cancer                                                    | 58 | 0.010933558 | 24.90274 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants                             | 58 | 0.010933558 | 24.90274 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                             | 58 | 0.010933558 | 24.90274 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                          | 58 | 0.010933558 | 24.90274 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex                           |  7 | 0.010452962 | 10.35129 | 0.003 | 0.004164179 | 0.0003770621 | HDAC3                                                                    |\n| R-HSA-389960  | Formation of tubulin folding intermediates by CCT/TriC                           | 25 | 0.009756098 | 18.46124 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-8941284 | RUNX2 regulates chondrocyte maturation                                           |  5 | 0.009756098 | 10.88214 | 0.001 | 0.001476190 | 0.0001336675 | HDAC4                                                                    |\n| R-HSA-9022699 | MECP2 regulates neuronal receptors and channels                                  | 17 | 0.008608321 | 13.85203 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC2                                                              |\n| R-HSA-1980143 | Signaling by NOTCH1                                                              | 74 | 0.008569545 | 24.06719 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4      |\n| R-HSA-9619483 | Activation of AMPK downstream of NMDARs                                          | 29 | 0.008410429 | 15.76461 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-201556  | Signaling by ALK                                                                 | 27 | 0.008130081 | 17.44480 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1/HDAC2/HDAC3                                                        |\n| R-HSA-4641265 | Repression of WNT target genes                                                   | 12 | 0.008130081 | 14.55223 | 0.000 | 0.000000000 | 0.0000000000 | HDAC1                                                                    |\n| R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III                                | 31 | 0.007867821 | 18.00299 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-389958  | Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding              | 32 | 0.007621951 | 17.27967 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-5626467 | RHO GTPases activate IQGAPs                                                      | 32 | 0.007621951 | 17.70097 | 0.000 | 0.000000000 | 0.0000000000 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C       |\n| R-HSA-9646399 | Aggrephagy                                                                       | 43 | 0.007373795 | 17.37006 | 0.000 | 0.000000000 | 0.0000000000 | HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C |\n| R-HSA-389957  | Prefoldin mediated transfer of substrate  to CCT/TriC                            | 28 | 0.006968641 | 15.58254 | 0.000 | 0.000000000 | 0.0000000000 | TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                    |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins                               |  77 | 6.335128e-04 | 2.4817536 | 0.039 | 0.043178571 | 0.0039097744 | HDAC7                                                              |\n| R-HSA-1989781 | PPARA activates gene expression                                                      | 117 | 6.253909e-04 | 3.1535718 | 0.018 | 0.020925000 | 0.0018947368 | HDAC3                                                              |\n| R-HSA-400206  | Regulation of lipid metabolism by PPARalpha                                          | 119 | 6.148801e-04 | 3.1495611 | 0.024 | 0.027555556 | 0.0024951267 | HDAC3                                                              |\n| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis | 121 | 6.047168e-04 | 3.0289668 | 0.025 | 0.028181818 | 0.0025518341 | HDAC3                                                              |\n| R-HSA-5619507 | Activation of HOX genes during differentiation                                       | 121 | 6.047168e-04 | 3.0289668 | 0.025 | 0.028181818 | 0.0025518341 | HDAC3                                                              |\n| R-HSA-112316  | Neuronal System                                                                      | 410 | 5.948840e-04 | 4.9326747 | 0.001 | 0.001476190 | 0.0001336675 | TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C |\n| R-HSA-9707564 | Cytoprotection by HMOX1                                                              | 124 | 5.900865e-04 | 3.0580636 | 0.025 | 0.028181818 | 0.0025518341 | HDAC3                                                              |\n| R-HSA-9006931 | Signaling by Nuclear Receptors                                                       | 299 | 5.710091e-04 | 4.0376968 | 0.004 | 0.005352518 | 0.0004846649 | HDAC1/HDAC3                                                        |\n| R-HSA-8878159 | Transcriptional regulation by RUNX3                                                  |  96 | 5.081301e-04 | 2.1337080 | 0.052 | 0.056561404 | 0.0051215759 | HDAC4                                                              |\n| R-HSA-9711123 | Cellular response to chemical stress                                                 | 160 | 4.573171e-04 | 2.6928407 | 0.045 | 0.049526627 | 0.0044845842 | HDAC3                                                              |\n| R-HSA-8939211 | ESR-mediated signaling                                                               | 223 | 4.374932e-04 | 3.0774253 | 0.024 | 0.027555556 | 0.0024951267 | HDAC1                                                              |\n| R-HSA-201681  | TCF dependent signaling in response to WNT                                           | 233 | 4.187166e-04 | 3.0699621 | 0.017 | 0.019886792 | 0.0018007282 | HDAC1                                                              |\n| R-HSA-8878171 | Transcriptional regulation by RUNX1                                                  | 239 | 4.082049e-04 | 2.9462189 | 0.028 | 0.031373494 | 0.0028408370 | HDAC1                                                              |\n| R-HSA-3700989 | Transcriptional Regulation by TP53                                                   | 365 | 4.009355e-04 | 3.0232712 | 0.014 | 0.016692308 | 0.0015114710 | HDAC1/HDAC2                                                        |\n| R-HSA-416482  | G alpha (12/13) signalling events                                                    |  80 | 3.048780e-04 | 1.3762517 | 0.065 | 0.070290698 | 0.0063647491 | ADRA1A                                                             |\n| R-HSA-195721  | Signaling by WNT                                                                     | 332 | 2.938584e-04 | 1.9222115 | 0.046 | 0.050329412 | 0.0045572755 | HDAC1                                                              |\n| R-HSA-2980736 | Peptide hormone metabolism                                                           |  91 | 2.680247e-04 | 1.2432552 | 0.079 | 0.084936416 | 0.0076909036 | ACE                                                                |\n| R-HSA-416476  | G alpha (q) signalling events                                                        | 216 | 2.258356e-04 | 1.6280362 | 0.105 | 0.111600000 | 0.0101052632 | ADRA1A/HRH1                                                        |\n| R-HSA-373076  | Class A/1 (Rhodopsin-like receptors)                                                 | 335 | 2.184201e-04 | 1.2541263 | 0.088 | 0.094068966 | 0.0085178463 | ADRA1A/DRD1/HRH1                                                   |\n| R-HSA-114608  | Platelet degranulation                                                               | 129 | 1.890717e-04 | 1.0637125 | 0.120 | 0.126818182 | 0.0114832536 | TUBA4A                                                             |\n| R-HSA-76005   | Response to elevated platelet cytosolic Ca2+                                         | 134 | 1.820167e-04 | 1.0180255 | 0.124 | 0.130305085 | 0.0117989890 | TUBA4A                                                             |\n| R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production                              | 134 | 1.820167e-04 | 0.9701944 | 0.132 | 0.137932584 | 0.0124896511 | DRD1                                                               |\n| R-HSA-418555  | G alpha (s) signalling events                                                        | 145 | 1.682086e-04 | 0.9524702 | 0.139 | 0.144435754 | 0.0130785063 | DRD1                                                               |\n| R-HSA-500792  | GPCR ligand binding                                                                  | 467 | 1.566825e-04 | 1.0559158 | 0.158 | 0.163266667 | 0.0147836257 | ADRA1A/DRD1/HRH1                                                   |\n| R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection                   | 169 | 1.443210e-04 | 0.8848947 | 0.166 | 0.169648352 | 0.0153614806 | DRD1                                                               |\n| R-HSA-9664433 | Leishmania parasite growth and survival                                              | 169 | 1.443210e-04 | 0.8848947 | 0.166 | 0.169648352 | 0.0153614806 | DRD1                                                               |\n| R-HSA-6798695 | Neutrophil degranulation                                                             | 480 | 1.016260e-04 | 0.5292602 | 0.289 | 0.290562162 | 0.0263100996 | TUBB4B/TUBB                                                        |\n| R-HSA-9658195 | Leishmania infection                                                                 | 254 | 9.602458e-05 | 0.7079975 | 0.243 | 0.246983607 | 0.0223641070 | DRD1                                                               |\n| R-HSA-76002   | Platelet activation, signaling and aggregation                                       | 263 | 9.273857e-05 | 0.7340001 | 0.251 | 0.253728261 | 0.0229748284 | TUBA4A                                                             |\n| R-HSA-9012999 | RHO GTPase cycle                                                                     | 449 | 5.432126e-05 | 0.0000000 | 0.437 | 0.437000000 | 0.0395698925 | TUBA1B                                                             |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 186 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>mabs</th><th scope=col>Nmabs</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>itemID</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>R-HSA-193670 </td><td>p75NTR negatively regulates cell cycle via SC1                                  </td><td> 6</td><td>0.036585366</td><td>26.52905</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC2/HDAC3                                                       </td></tr>\n","\t<tr><td>R-HSA-350054 </td><td>Notch-HLH transcription pathway                                                 </td><td>28</td><td>0.022648084</td><td>28.08201</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-9701898</td><td>STAT3 nuclear events downstream of ALK signaling                                </td><td>10</td><td>0.021951220</td><td>24.35668</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC2/HDAC3                                                       </td></tr>\n","\t<tr><td>R-HSA-190840 </td><td>Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane</td><td>18</td><td>0.013550136</td><td>19.91941</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-2122947</td><td>NOTCH1 Intracellular Domain Regulates Transcription                             </td><td>48</td><td>0.013211382</td><td>25.57905</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-190872 </td><td>Transport of connexons to the plasma membrane                                   </td><td>19</td><td>0.012836970</td><td>19.57476</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-9022702</td><td>MECP2 regulates transcription of neuronal ligands                               </td><td> 8</td><td>0.012195122</td><td>18.93978</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1                                                                   </td></tr>\n","\t<tr><td>R-HSA-9005891</td><td>Loss of function of MECP2 in Rett syndrome                                      </td><td>14</td><td>0.012195122</td><td>17.72823</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-9005895</td><td>Pervasive developmental disorders                                               </td><td>14</td><td>0.012195122</td><td>17.72823</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-9675151</td><td>Disorders of Developmental Biology                                              </td><td>14</td><td>0.012195122</td><td>17.72823</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-9697154</td><td>Disorders of Nervous System Development                                         </td><td>14</td><td>0.012195122</td><td>17.72823</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-389977 </td><td>Post-chaperonin tubulin folding pathway                                         </td><td>22</td><td>0.011086475</td><td>19.23895</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-2644602</td><td>Signaling by NOTCH1 PEST Domain Mutants in Cancer                               </td><td>58</td><td>0.010933558</td><td>24.90274</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-2644603</td><td>Signaling by NOTCH1 in Cancer                                                   </td><td>58</td><td>0.010933558</td><td>24.90274</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-2644606</td><td>Constitutive Signaling by NOTCH1 PEST Domain Mutants                            </td><td>58</td><td>0.010933558</td><td>24.90274</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-2894858</td><td>Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer                            </td><td>58</td><td>0.010933558</td><td>24.90274</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-2894862</td><td>Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants                         </td><td>58</td><td>0.010933558</td><td>24.90274</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-9022537</td><td>Loss of MECP2 binding ability to the NCoR/SMRT complex                          </td><td> 7</td><td>0.010452962</td><td>10.35129</td><td>0.003</td><td>0.004164179</td><td>0.0003770621</td><td>HDAC3                                                                   </td></tr>\n","\t<tr><td>R-HSA-389960 </td><td>Formation of tubulin folding intermediates by CCT/TriC                          </td><td>25</td><td>0.009756098</td><td>18.46124</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-8941284</td><td>RUNX2 regulates chondrocyte maturation                                          </td><td> 5</td><td>0.009756098</td><td>10.88214</td><td>0.001</td><td>0.001476190</td><td>0.0001336675</td><td>HDAC4                                                                   </td></tr>\n","\t<tr><td>R-HSA-9022699</td><td>MECP2 regulates neuronal receptors and channels                                 </td><td>17</td><td>0.008608321</td><td>13.85203</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC2                                                             </td></tr>\n","\t<tr><td>R-HSA-1980143</td><td>Signaling by NOTCH1                                                             </td><td>74</td><td>0.008569545</td><td>24.06719</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/HDAC5/HDAC1/HDAC2/HDAC7/HDAC8/HDAC11/HDAC10/HDAC3/HDAC9/HDAC4     </td></tr>\n","\t<tr><td>R-HSA-9619483</td><td>Activation of AMPK downstream of NMDARs                                         </td><td>29</td><td>0.008410429</td><td>15.76461</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-201556 </td><td>Signaling by ALK                                                                </td><td>27</td><td>0.008130081</td><td>17.44480</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1/HDAC2/HDAC3                                                       </td></tr>\n","\t<tr><td>R-HSA-4641265</td><td>Repression of WNT target genes                                                  </td><td>12</td><td>0.008130081</td><td>14.55223</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC1                                                                   </td></tr>\n","\t<tr><td>R-HSA-9668328</td><td>Sealing of the nuclear envelope (NE) by ESCRT-III                               </td><td>31</td><td>0.007867821</td><td>18.00299</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-389958 </td><td>Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding             </td><td>32</td><td>0.007621951</td><td>17.27967</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-5626467</td><td>RHO GTPases activate IQGAPs                                                     </td><td>32</td><td>0.007621951</td><td>17.70097</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C      </td></tr>\n","\t<tr><td>R-HSA-9646399</td><td>Aggrephagy                                                                      </td><td>43</td><td>0.007373795</td><td>17.37006</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>HDAC6/TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C</td></tr>\n","\t<tr><td>R-HSA-389957 </td><td>Prefoldin mediated transfer of substrate  to CCT/TriC                           </td><td>28</td><td>0.006968641</td><td>15.58254</td><td>0.000</td><td>0.000000000</td><td>0.0000000000</td><td>TUBB3/TUBB4A/TUBB4B/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C                   </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>R-HSA-3108214</td><td>SUMOylation of DNA damage response and repair proteins                              </td><td> 77</td><td>6.335128e-04</td><td>2.4817536</td><td>0.039</td><td>0.043178571</td><td>0.0039097744</td><td>HDAC7                                                             </td></tr>\n","\t<tr><td>R-HSA-1989781</td><td>PPARA activates gene expression                                                     </td><td>117</td><td>6.253909e-04</td><td>3.1535718</td><td>0.018</td><td>0.020925000</td><td>0.0018947368</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-400206 </td><td>Regulation of lipid metabolism by PPARalpha                                         </td><td>119</td><td>6.148801e-04</td><td>3.1495611</td><td>0.024</td><td>0.027555556</td><td>0.0024951267</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-5617472</td><td>Activation of anterior HOX genes in hindbrain development during early embryogenesis</td><td>121</td><td>6.047168e-04</td><td>3.0289668</td><td>0.025</td><td>0.028181818</td><td>0.0025518341</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-5619507</td><td>Activation of HOX genes during differentiation                                      </td><td>121</td><td>6.047168e-04</td><td>3.0289668</td><td>0.025</td><td>0.028181818</td><td>0.0025518341</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-112316 </td><td>Neuronal System                                                                     </td><td>410</td><td>5.948840e-04</td><td>4.9326747</td><td>0.001</td><td>0.001476190</td><td>0.0001336675</td><td>TUBA1B/TUBB3/TUBB4A/TUBB4B/TUBA8/TUBA4A/TUBA3C/TUBA1A/TUBB1/TUBA1C</td></tr>\n","\t<tr><td>R-HSA-9707564</td><td>Cytoprotection by HMOX1                                                             </td><td>124</td><td>5.900865e-04</td><td>3.0580636</td><td>0.025</td><td>0.028181818</td><td>0.0025518341</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-9006931</td><td>Signaling by Nuclear Receptors                                                      </td><td>299</td><td>5.710091e-04</td><td>4.0376968</td><td>0.004</td><td>0.005352518</td><td>0.0004846649</td><td>HDAC1/HDAC3                                                       </td></tr>\n","\t<tr><td>R-HSA-8878159</td><td>Transcriptional regulation by RUNX3                                                 </td><td> 96</td><td>5.081301e-04</td><td>2.1337080</td><td>0.052</td><td>0.056561404</td><td>0.0051215759</td><td>HDAC4                                                             </td></tr>\n","\t<tr><td>R-HSA-9711123</td><td>Cellular response to chemical stress                                                </td><td>160</td><td>4.573171e-04</td><td>2.6928407</td><td>0.045</td><td>0.049526627</td><td>0.0044845842</td><td>HDAC3                                                             </td></tr>\n","\t<tr><td>R-HSA-8939211</td><td>ESR-mediated signaling                                                              </td><td>223</td><td>4.374932e-04</td><td>3.0774253</td><td>0.024</td><td>0.027555556</td><td>0.0024951267</td><td>HDAC1                                                             </td></tr>\n","\t<tr><td>R-HSA-201681 </td><td>TCF dependent signaling in response to WNT                                          </td><td>233</td><td>4.187166e-04</td><td>3.0699621</td><td>0.017</td><td>0.019886792</td><td>0.0018007282</td><td>HDAC1                                                             </td></tr>\n","\t<tr><td>R-HSA-8878171</td><td>Transcriptional regulation by RUNX1                                                 </td><td>239</td><td>4.082049e-04</td><td>2.9462189</td><td>0.028</td><td>0.031373494</td><td>0.0028408370</td><td>HDAC1                                                             </td></tr>\n","\t<tr><td>R-HSA-3700989</td><td>Transcriptional Regulation by TP53                                                  </td><td>365</td><td>4.009355e-04</td><td>3.0232712</td><td>0.014</td><td>0.016692308</td><td>0.0015114710</td><td>HDAC1/HDAC2                                                       </td></tr>\n","\t<tr><td>R-HSA-416482 </td><td>G alpha (12/13) signalling events                                                   </td><td> 80</td><td>3.048780e-04</td><td>1.3762517</td><td>0.065</td><td>0.070290698</td><td>0.0063647491</td><td>ADRA1A                                                            </td></tr>\n","\t<tr><td>R-HSA-195721 </td><td>Signaling by WNT                                                                    </td><td>332</td><td>2.938584e-04</td><td>1.9222115</td><td>0.046</td><td>0.050329412</td><td>0.0045572755</td><td>HDAC1                                                             </td></tr>\n","\t<tr><td>R-HSA-2980736</td><td>Peptide hormone metabolism                                                          </td><td> 91</td><td>2.680247e-04</td><td>1.2432552</td><td>0.079</td><td>0.084936416</td><td>0.0076909036</td><td>ACE                                                               </td></tr>\n","\t<tr><td>R-HSA-416476 </td><td>G alpha (q) signalling events                                                       </td><td>216</td><td>2.258356e-04</td><td>1.6280362</td><td>0.105</td><td>0.111600000</td><td>0.0101052632</td><td>ADRA1A/HRH1                                                       </td></tr>\n","\t<tr><td>R-HSA-373076 </td><td>Class A/1 (Rhodopsin-like receptors)                                                </td><td>335</td><td>2.184201e-04</td><td>1.2541263</td><td>0.088</td><td>0.094068966</td><td>0.0085178463</td><td>ADRA1A/DRD1/HRH1                                                  </td></tr>\n","\t<tr><td>R-HSA-114608 </td><td>Platelet degranulation                                                              </td><td>129</td><td>1.890717e-04</td><td>1.0637125</td><td>0.120</td><td>0.126818182</td><td>0.0114832536</td><td>TUBA4A                                                            </td></tr>\n","\t<tr><td>R-HSA-76005  </td><td>Response to elevated platelet cytosolic Ca2+                                        </td><td>134</td><td>1.820167e-04</td><td>1.0180255</td><td>0.124</td><td>0.130305085</td><td>0.0117989890</td><td>TUBA4A                                                            </td></tr>\n","\t<tr><td>R-HSA-9660821</td><td>ADORA2B mediated anti-inflammatory cytokines production                             </td><td>134</td><td>1.820167e-04</td><td>0.9701944</td><td>0.132</td><td>0.137932584</td><td>0.0124896511</td><td>DRD1                                                              </td></tr>\n","\t<tr><td>R-HSA-418555 </td><td>G alpha (s) signalling events                                                       </td><td>145</td><td>1.682086e-04</td><td>0.9524702</td><td>0.139</td><td>0.144435754</td><td>0.0130785063</td><td>DRD1                                                              </td></tr>\n","\t<tr><td>R-HSA-500792 </td><td>GPCR ligand binding                                                                 </td><td>467</td><td>1.566825e-04</td><td>1.0559158</td><td>0.158</td><td>0.163266667</td><td>0.0147836257</td><td>ADRA1A/DRD1/HRH1                                                  </td></tr>\n","\t<tr><td>R-HSA-9662851</td><td>Anti-inflammatory response favouring Leishmania parasite infection                  </td><td>169</td><td>1.443210e-04</td><td>0.8848947</td><td>0.166</td><td>0.169648352</td><td>0.0153614806</td><td>DRD1                                                              </td></tr>\n","\t<tr><td>R-HSA-9664433</td><td>Leishmania parasite growth and survival                                             </td><td>169</td><td>1.443210e-04</td><td>0.8848947</td><td>0.166</td><td>0.169648352</td><td>0.0153614806</td><td>DRD1                                                              </td></tr>\n","\t<tr><td>R-HSA-6798695</td><td>Neutrophil degranulation                                                            </td><td>480</td><td>1.016260e-04</td><td>0.5292602</td><td>0.289</td><td>0.290562162</td><td>0.0263100996</td><td>TUBB4B/TUBB                                                       </td></tr>\n","\t<tr><td>R-HSA-9658195</td><td>Leishmania infection                                                                </td><td>254</td><td>9.602458e-05</td><td>0.7079975</td><td>0.243</td><td>0.246983607</td><td>0.0223641070</td><td>DRD1                                                              </td></tr>\n","\t<tr><td>R-HSA-76002  </td><td>Platelet activation, signaling and aggregation                                      </td><td>263</td><td>9.273857e-05</td><td>0.7340001</td><td>0.251</td><td>0.253728261</td><td>0.0229748284</td><td>TUBA4A                                                            </td></tr>\n","\t<tr><td>R-HSA-9012999</td><td>RHO GTPase cycle                                                                    </td><td>449</td><td>5.432126e-05</td><td>0.0000000</td><td>0.437</td><td>0.437000000</td><td>0.0395698925</td><td>TUBA1B                                                            </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"aOSnHulYKsHy"},"source":["## DSEA\n","\n","### 1. Hypergeometric"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"HSI2vZ9fLKNV","executionInfo":{"status":"ok","timestamp":1636338412930,"user_tz":-480,"elapsed":19815,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"b131a0e8-f11a-463d-c936-4e02135c78c3"},"source":["drugs <- unique(result(lincs)$pert[1:10])\n","hyperG_res <- dsea_hyperG(drugs=drugs, type='GO', ont='MF')\n","result(hyperG_res)"],"execution_count":35,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ont ID        \n","1  MF  GO:0035851\n","2  MF  GO:0031078\n","3  MF  GO:0032041\n","4  MF  GO:0017136\n","5  MF  GO:0034979\n","6  MF  GO:0031492\n","7  MF  GO:0001046\n","8  MF  GO:0004407\n","9  MF  GO:0033558\n","10 MF  GO:0031491\n","11 MF  GO:0019213\n","12 MF  GO:0070888\n","13 MF  GO:0001047\n","14 MF  GO:1990841\n","15 MF  GO:0001103\n","16 MF  GO:0031490\n","17 MF  GO:0033613\n","18 MF  GO:0051059\n","19 MF  GO:0000980\n","20 MF  GO:0001158\n","21 MF  GO:0003714\n","22 MF  GO:0070491\n","23 MF  GO:0070840\n","24 MF  GO:0042903\n","25 MF  GO:0035326\n","26 MF  GO:0051787\n","27 MF  GO:0051879\n","28 MF  GO:0031593\n","29 MF  GO:0002039\n","30 MF  GO:0030332\n","31 MF  GO:0030544\n","32 MF  GO:0048487\n","33 MF  GO:0043130\n","34 MF  GO:0043014\n","35 MF  GO:0048156\n","36 MF  GO:0140030\n","37 MF  GO:0019789\n","38 MF  GO:0032182\n","39 MF  GO:0008013\n","40 MF  GO:0030955\n","41 MF  GO:0071889\n","42 MF  GO:0019787\n","43 MF  GO:0031420\n","44 MF  GO:0008241\n","45 MF  GO:0070573\n","46 MF  GO:0005080\n","47 MF  GO:0008240\n","48 MF  GO:0031711\n","49 MF  GO:0042288\n","50 MF  GO:0042287\n","51 MF  GO:0001588\n","   Description                                                     GeneRatio\n","1  Krueppel-associated box domain binding                          4/8      \n","2  histone deacetylase activity (H3-K14 specific)                  5/8      \n","3  NAD-dependent histone deacetylase activity (H3-K14 specific)    5/8      \n","4  NAD-dependent histone deacetylase activity                      5/8      \n","5  NAD-dependent protein deacetylase activity                      5/8      \n","6  nucleosomal DNA binding                                         4/8      \n","7  core promoter sequence-specific DNA binding                     4/8      \n","8  histone deacetylase activity                                    5/8      \n","9  protein deacetylase activity                                    5/8      \n","10 nucleosome binding                                              4/8      \n","11 deacetylase activity                                            5/8      \n","12 E-box binding                                                   4/8      \n","13 core promoter binding                                           4/8      \n","14 promoter-specific chromatin binding                             4/8      \n","15 RNA polymerase II repressing transcription factor binding       4/8      \n","16 chromatin DNA binding                                           4/8      \n","17 activating transcription factor binding                         4/8      \n","18 NF-kappaB binding                                               4/8      \n","19 RNA polymerase II distal enhancer sequence-specific DNA binding 4/8      \n","20 enhancer sequence-specific DNA binding                          4/8      \n","21 transcription corepressor activity                              4/8      \n","22 repressing transcription factor binding                         4/8      \n","23 dynein complex binding                                          3/8      \n","24 tubulin deacetylase activity                                    3/8      \n","25 enhancer binding                                                4/8      \n","26 misfolded protein binding                                       3/8      \n","27 Hsp90 protein binding                                           4/8      \n","28 polyubiquitin modification-dependent protein binding            3/8      \n","29 p53 binding                                                     4/8      \n","30 cyclin binding                                                  3/8      \n","31 Hsp70 protein binding                                           3/8      \n","32 beta-tubulin binding                                            3/8      \n","33 ubiquitin binding                                               3/8      \n","34 alpha-tubulin binding                                           3/8      \n","35 tau protein binding                                             3/8      \n","36 modification-dependent protein binding                          3/8      \n","37 SUMO transferase activity                                       2/8      \n","38 ubiquitin-like protein binding                                  3/8      \n","39 beta-catenin binding                                            3/8      \n","40 potassium ion binding                                           2/8      \n","41 14-3-3 protein binding                                          2/8      \n","42 ubiquitin-like protein transferase activity                     2/8      \n","43 alkali metal ion binding                                        2/8      \n","44 peptidyl-dipeptidase activity                                   1/8      \n","45 metallodipeptidase activity                                     1/8      \n","46 protein kinase C binding                                        2/8      \n","47 tripeptidyl-peptidase activity                                  1/8      \n","48 bradykinin receptor binding                                     1/8      \n","49 MHC class I protein binding                                     1/8      \n","50 MHC protein binding                                             1/8      \n","51 dopamine neurotransmitter receptor activity, coupled via Gs     1/8      \n","   BgRatio   pvalue       p.adjust     qvalue      \n","1  27/22568  1.133215e-10 5.892719e-08 1.729644e-08\n","2  199/22568 2.778580e-09 3.042474e-07 8.930338e-08\n","3  199/22568 2.778580e-09 3.042474e-07 8.930338e-08\n","4  261/22568 1.083945e-08 3.382311e-07 9.927836e-08\n","5  266/22568 1.192028e-08 3.382311e-07 9.927836e-08\n","6  88/22568  1.492725e-08 3.881085e-07 1.139185e-07\n","7  94/22568  1.950428e-08 4.610103e-07 1.353168e-07\n","8  318/22568 2.911950e-08 6.108402e-07 1.792952e-07\n","9  323/22568 3.147974e-08 6.108772e-07 1.793061e-07\n","10 106/22568 3.171862e-08 6.108772e-07 1.793061e-07\n","11 432/22568 1.341354e-07 1.788472e-06 5.249563e-07\n","12 195/22568 3.682448e-07 3.908974e-06 1.147371e-06\n","13 196/22568 3.758629e-07 3.908974e-06 1.147371e-06\n","14 197/22568 3.835981e-07 3.911196e-06 1.148023e-06\n","15 218/22568 5.752075e-07 5.538712e-06 1.625735e-06\n","16 276/22568 1.474251e-06 1.179401e-05 3.461804e-06\n","17 292/22568 1.844990e-06 1.409470e-05 4.137109e-06\n","18 299/22568 2.027323e-06 1.410150e-05 4.139105e-06\n","19 322/22568 2.721815e-06 1.645749e-05 4.830639e-06\n","20 322/22568 2.721815e-06 1.645749e-05 4.830639e-06\n","21 325/22568 2.823951e-06 1.664300e-05 4.885091e-06\n","22 331/22568 3.036748e-06 1.725257e-05 5.064014e-06\n","23 88/22568  3.163190e-06 1.725257e-05 5.064014e-06\n","24 95/22568  3.985227e-06 2.031684e-05 5.963446e-06\n","25 364/22568 4.427580e-06 2.235283e-05 6.561054e-06\n","26 119/22568 7.852298e-06 3.711995e-05 1.089553e-05\n","27 447/22568 9.980478e-06 4.512912e-05 1.324640e-05\n","28 139/22568 1.251839e-05 5.335706e-05 1.566148e-05\n","29 500/22568 1.552779e-05 6.340012e-05 1.860935e-05\n","30 179/22568 2.668591e-05 9.983219e-05 2.930297e-05\n","31 195/22568 3.445636e-05 1.252958e-04 3.677712e-05\n","32 210/22568 4.297508e-05 1.530619e-04 4.492708e-05\n","33 303/22568 1.276585e-04 4.148900e-04 1.217795e-04\n","34 316/22568 1.445491e-04 4.528046e-04 1.329082e-04\n","35 363/22568 2.176659e-04 6.358779e-04 1.866443e-04\n","36 376/22568 2.414415e-04 6.936441e-04 2.036000e-04\n","37 69/22568  2.549112e-04 7.283178e-04 2.137775e-04\n","38 400/22568 2.896601e-04 8.054718e-04 2.364239e-04\n","39 412/22568 3.159518e-04 8.529347e-04 2.503553e-04\n","40 183/22568 1.773229e-03 3.907115e-03 1.146825e-03\n","41 197/22568 2.050617e-03 4.370168e-03 1.282742e-03\n","42 286/22568 4.260921e-03 8.206218e-03 2.408708e-03\n","43 312/22568 5.048931e-03 9.444044e-03 2.772037e-03\n","44 23/22568  8.125370e-03 1.413108e-02 4.147786e-03\n","45 25/22568  8.829186e-03 1.520257e-02 4.462293e-03\n","46 490/22568 1.207889e-02 1.944590e-02 5.707804e-03\n","47 35/22568  1.234171e-02 1.968617e-02 5.778329e-03\n","48 41/22568  1.444400e-02 2.282942e-02 6.700944e-03\n","49 58/22568  2.037923e-02 3.211272e-02 9.425798e-03\n","50 77/22568  2.697568e-02 4.212419e-02 1.236439e-02\n","51 82/22568  2.870512e-02 4.416172e-02 1.296245e-02\n","   itemID                                                        Count\n","1  vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","2  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","3  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","4  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","5  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","6  vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","7  vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","8  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","9  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","10 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","11 vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 5    \n","12 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","13 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","14 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","15 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","16 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","17 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","18 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","19 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","20 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","21 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","22 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","23 vorinostat/trichostatin-a/pyroxamide                          3    \n","24 vorinostat/trichostatin-a/pyroxamide                          3    \n","25 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","26 vorinostat/trichostatin-a/pyroxamide                          3    \n","27 vorinostat/trichostatin-a/pyroxamide/apha-compound-8          4    \n","28 vorinostat/trichostatin-a/pyroxamide                          3    \n","29 vorinostat/trichostatin-a/hc-toxin/pyroxamide                 4    \n","30 vorinostat/trichostatin-a/pyroxamide                          3    \n","31 vorinostat/trichostatin-a/apha-compound-8                     3    \n","32 vorinostat/trichostatin-a/pyroxamide                          3    \n","33 vorinostat/trichostatin-a/pyroxamide                          3    \n","34 vorinostat/trichostatin-a/pyroxamide                          3    \n","35 vorinostat/trichostatin-a/pyroxamide                          3    \n","36 vorinostat/trichostatin-a/pyroxamide                          3    \n","37 vorinostat/trichostatin-a                                     2    \n","38 vorinostat/trichostatin-a/pyroxamide                          3    \n","39 vorinostat/trichostatin-a/pyroxamide                          3    \n","40 vorinostat/trichostatin-a                                     2    \n","41 vorinostat/trichostatin-a                                     2    \n","42 vorinostat/trichostatin-a                                     2    \n","43 vorinostat/trichostatin-a                                     2    \n","44 rescinnamine                                                  1    \n","45 rescinnamine                                                  1    \n","46 vorinostat/trichostatin-a                                     2    \n","47 rescinnamine                                                  1    \n","48 rescinnamine                                                  1    \n","49 epothilone                                                    1    \n","50 epothilone                                                    1    \n","51 zuclopenthixol                                                1    "],"text/latex":"A tibble: 51 × 10\n\\begin{tabular}{llllllllll}\n ont & ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <int>\\\\\n\\hline\n\t MF & GO:0035851 & Krueppel-associated box domain binding                          & 4/8 & 27/22568  & 1.133215e-10 & 5.892719e-08 & 1.729644e-08 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0031078 & histone deacetylase activity (H3-K14 specific)                  & 5/8 & 199/22568 & 2.778580e-09 & 3.042474e-07 & 8.930338e-08 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0032041 & NAD-dependent histone deacetylase activity (H3-K14 specific)    & 5/8 & 199/22568 & 2.778580e-09 & 3.042474e-07 & 8.930338e-08 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0017136 & NAD-dependent histone deacetylase activity                      & 5/8 & 261/22568 & 1.083945e-08 & 3.382311e-07 & 9.927836e-08 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0034979 & NAD-dependent protein deacetylase activity                      & 5/8 & 266/22568 & 1.192028e-08 & 3.382311e-07 & 9.927836e-08 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0031492 & nucleosomal DNA binding                                         & 4/8 & 88/22568  & 1.492725e-08 & 3.881085e-07 & 1.139185e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0001046 & core promoter sequence-specific DNA binding                     & 4/8 & 94/22568  & 1.950428e-08 & 4.610103e-07 & 1.353168e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0004407 & histone deacetylase activity                                    & 5/8 & 318/22568 & 2.911950e-08 & 6.108402e-07 & 1.792952e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0033558 & protein deacetylase activity                                    & 5/8 & 323/22568 & 3.147974e-08 & 6.108772e-07 & 1.793061e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0031491 & nucleosome binding                                              & 4/8 & 106/22568 & 3.171862e-08 & 6.108772e-07 & 1.793061e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0019213 & deacetylase activity                                            & 5/8 & 432/22568 & 1.341354e-07 & 1.788472e-06 & 5.249563e-07 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 & 5\\\\\n\t MF & GO:0070888 & E-box binding                                                   & 4/8 & 195/22568 & 3.682448e-07 & 3.908974e-06 & 1.147371e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0001047 & core promoter binding                                           & 4/8 & 196/22568 & 3.758629e-07 & 3.908974e-06 & 1.147371e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:1990841 & promoter-specific chromatin binding                             & 4/8 & 197/22568 & 3.835981e-07 & 3.911196e-06 & 1.148023e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0001103 & RNA polymerase II repressing transcription factor binding       & 4/8 & 218/22568 & 5.752075e-07 & 5.538712e-06 & 1.625735e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0031490 & chromatin DNA binding                                           & 4/8 & 276/22568 & 1.474251e-06 & 1.179401e-05 & 3.461804e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0033613 & activating transcription factor binding                         & 4/8 & 292/22568 & 1.844990e-06 & 1.409470e-05 & 4.137109e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0051059 & NF-kappaB binding                                               & 4/8 & 299/22568 & 2.027323e-06 & 1.410150e-05 & 4.139105e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0000980 & RNA polymerase II distal enhancer sequence-specific DNA binding & 4/8 & 322/22568 & 2.721815e-06 & 1.645749e-05 & 4.830639e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0001158 & enhancer sequence-specific DNA binding                          & 4/8 & 322/22568 & 2.721815e-06 & 1.645749e-05 & 4.830639e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0003714 & transcription corepressor activity                              & 4/8 & 325/22568 & 2.823951e-06 & 1.664300e-05 & 4.885091e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0070491 & repressing transcription factor binding                         & 4/8 & 331/22568 & 3.036748e-06 & 1.725257e-05 & 5.064014e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0070840 & dynein complex binding                                          & 3/8 & 88/22568  & 3.163190e-06 & 1.725257e-05 & 5.064014e-06 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0042903 & tubulin deacetylase activity                                    & 3/8 & 95/22568  & 3.985227e-06 & 2.031684e-05 & 5.963446e-06 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0035326 & enhancer binding                                                & 4/8 & 364/22568 & 4.427580e-06 & 2.235283e-05 & 6.561054e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0051787 & misfolded protein binding                                       & 3/8 & 119/22568 & 7.852298e-06 & 3.711995e-05 & 1.089553e-05 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0051879 & Hsp90 protein binding                                           & 4/8 & 447/22568 & 9.980478e-06 & 4.512912e-05 & 1.324640e-05 & vorinostat/trichostatin-a/pyroxamide/apha-compound-8          & 4\\\\\n\t MF & GO:0031593 & polyubiquitin modification-dependent protein binding            & 3/8 & 139/22568 & 1.251839e-05 & 5.335706e-05 & 1.566148e-05 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0002039 & p53 binding                                                     & 4/8 & 500/22568 & 1.552779e-05 & 6.340012e-05 & 1.860935e-05 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                 & 4\\\\\n\t MF & GO:0030332 & cyclin binding                                                  & 3/8 & 179/22568 & 2.668591e-05 & 9.983219e-05 & 2.930297e-05 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0030544 & Hsp70 protein binding                                           & 3/8 & 195/22568 & 3.445636e-05 & 1.252958e-04 & 3.677712e-05 & vorinostat/trichostatin-a/apha-compound-8                     & 3\\\\\n\t MF & GO:0048487 & beta-tubulin binding                                            & 3/8 & 210/22568 & 4.297508e-05 & 1.530619e-04 & 4.492708e-05 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0043130 & ubiquitin binding                                               & 3/8 & 303/22568 & 1.276585e-04 & 4.148900e-04 & 1.217795e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0043014 & alpha-tubulin binding                                           & 3/8 & 316/22568 & 1.445491e-04 & 4.528046e-04 & 1.329082e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0048156 & tau protein binding                                             & 3/8 & 363/22568 & 2.176659e-04 & 6.358779e-04 & 1.866443e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0140030 & modification-dependent protein binding                          & 3/8 & 376/22568 & 2.414415e-04 & 6.936441e-04 & 2.036000e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0019789 & SUMO transferase activity                                       & 2/8 & 69/22568  & 2.549112e-04 & 7.283178e-04 & 2.137775e-04 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0032182 & ubiquitin-like protein binding                                  & 3/8 & 400/22568 & 2.896601e-04 & 8.054718e-04 & 2.364239e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0008013 & beta-catenin binding                                            & 3/8 & 412/22568 & 3.159518e-04 & 8.529347e-04 & 2.503553e-04 & vorinostat/trichostatin-a/pyroxamide                          & 3\\\\\n\t MF & GO:0030955 & potassium ion binding                                           & 2/8 & 183/22568 & 1.773229e-03 & 3.907115e-03 & 1.146825e-03 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0071889 & 14-3-3 protein binding                                          & 2/8 & 197/22568 & 2.050617e-03 & 4.370168e-03 & 1.282742e-03 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0019787 & ubiquitin-like protein transferase activity                     & 2/8 & 286/22568 & 4.260921e-03 & 8.206218e-03 & 2.408708e-03 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0031420 & alkali metal ion binding                                        & 2/8 & 312/22568 & 5.048931e-03 & 9.444044e-03 & 2.772037e-03 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0008241 & peptidyl-dipeptidase activity                                   & 1/8 & 23/22568  & 8.125370e-03 & 1.413108e-02 & 4.147786e-03 & rescinnamine                                                  & 1\\\\\n\t MF & GO:0070573 & metallodipeptidase activity                                     & 1/8 & 25/22568  & 8.829186e-03 & 1.520257e-02 & 4.462293e-03 & rescinnamine                                                  & 1\\\\\n\t MF & GO:0005080 & protein kinase C binding                                        & 2/8 & 490/22568 & 1.207889e-02 & 1.944590e-02 & 5.707804e-03 & vorinostat/trichostatin-a                                     & 2\\\\\n\t MF & GO:0008240 & tripeptidyl-peptidase activity                                  & 1/8 & 35/22568  & 1.234171e-02 & 1.968617e-02 & 5.778329e-03 & rescinnamine                                                  & 1\\\\\n\t MF & GO:0031711 & bradykinin receptor binding                                     & 1/8 & 41/22568  & 1.444400e-02 & 2.282942e-02 & 6.700944e-03 & rescinnamine                                                  & 1\\\\\n\t MF & GO:0042288 & MHC class I protein binding                                     & 1/8 & 58/22568  & 2.037923e-02 & 3.211272e-02 & 9.425798e-03 & epothilone                                                    & 1\\\\\n\t MF & GO:0042287 & MHC protein binding                                             & 1/8 & 77/22568  & 2.697568e-02 & 4.212419e-02 & 1.236439e-02 & epothilone                                                    & 1\\\\\n\t MF & GO:0001588 & dopamine neurotransmitter receptor activity, coupled via Gs     & 1/8 & 82/22568  & 2.870512e-02 & 4.416172e-02 & 1.296245e-02 & zuclopenthixol                                                & 1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 51 × 10\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| MF | GO:0035851 | Krueppel-associated box domain binding                          | 4/8 | 27/22568  | 1.133215e-10 | 5.892719e-08 | 1.729644e-08 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0031078 | histone deacetylase activity (H3-K14 specific)                  | 5/8 | 199/22568 | 2.778580e-09 | 3.042474e-07 | 8.930338e-08 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific)    | 5/8 | 199/22568 | 2.778580e-09 | 3.042474e-07 | 8.930338e-08 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0017136 | NAD-dependent histone deacetylase activity                      | 5/8 | 261/22568 | 1.083945e-08 | 3.382311e-07 | 9.927836e-08 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0034979 | NAD-dependent protein deacetylase activity                      | 5/8 | 266/22568 | 1.192028e-08 | 3.382311e-07 | 9.927836e-08 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0031492 | nucleosomal DNA binding                                         | 4/8 | 88/22568  | 1.492725e-08 | 3.881085e-07 | 1.139185e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0001046 | core promoter sequence-specific DNA binding                     | 4/8 | 94/22568  | 1.950428e-08 | 4.610103e-07 | 1.353168e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0004407 | histone deacetylase activity                                    | 5/8 | 318/22568 | 2.911950e-08 | 6.108402e-07 | 1.792952e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0033558 | protein deacetylase activity                                    | 5/8 | 323/22568 | 3.147974e-08 | 6.108772e-07 | 1.793061e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0031491 | nucleosome binding                                              | 4/8 | 106/22568 | 3.171862e-08 | 6.108772e-07 | 1.793061e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0019213 | deacetylase activity                                            | 5/8 | 432/22568 | 1.341354e-07 | 1.788472e-06 | 5.249563e-07 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8 | 5 |\n| MF | GO:0070888 | E-box binding                                                   | 4/8 | 195/22568 | 3.682448e-07 | 3.908974e-06 | 1.147371e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0001047 | core promoter binding                                           | 4/8 | 196/22568 | 3.758629e-07 | 3.908974e-06 | 1.147371e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:1990841 | promoter-specific chromatin binding                             | 4/8 | 197/22568 | 3.835981e-07 | 3.911196e-06 | 1.148023e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0001103 | RNA polymerase II repressing transcription factor binding       | 4/8 | 218/22568 | 5.752075e-07 | 5.538712e-06 | 1.625735e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0031490 | chromatin DNA binding                                           | 4/8 | 276/22568 | 1.474251e-06 | 1.179401e-05 | 3.461804e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0033613 | activating transcription factor binding                         | 4/8 | 292/22568 | 1.844990e-06 | 1.409470e-05 | 4.137109e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0051059 | NF-kappaB binding                                               | 4/8 | 299/22568 | 2.027323e-06 | 1.410150e-05 | 4.139105e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4/8 | 322/22568 | 2.721815e-06 | 1.645749e-05 | 4.830639e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0001158 | enhancer sequence-specific DNA binding                          | 4/8 | 322/22568 | 2.721815e-06 | 1.645749e-05 | 4.830639e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0003714 | transcription corepressor activity                              | 4/8 | 325/22568 | 2.823951e-06 | 1.664300e-05 | 4.885091e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0070491 | repressing transcription factor binding                         | 4/8 | 331/22568 | 3.036748e-06 | 1.725257e-05 | 5.064014e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0070840 | dynein complex binding                                          | 3/8 | 88/22568  | 3.163190e-06 | 1.725257e-05 | 5.064014e-06 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0042903 | tubulin deacetylase activity                                    | 3/8 | 95/22568  | 3.985227e-06 | 2.031684e-05 | 5.963446e-06 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0035326 | enhancer binding                                                | 4/8 | 364/22568 | 4.427580e-06 | 2.235283e-05 | 6.561054e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0051787 | misfolded protein binding                                       | 3/8 | 119/22568 | 7.852298e-06 | 3.711995e-05 | 1.089553e-05 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0051879 | Hsp90 protein binding                                           | 4/8 | 447/22568 | 9.980478e-06 | 4.512912e-05 | 1.324640e-05 | vorinostat/trichostatin-a/pyroxamide/apha-compound-8          | 4 |\n| MF | GO:0031593 | polyubiquitin modification-dependent protein binding            | 3/8 | 139/22568 | 1.251839e-05 | 5.335706e-05 | 1.566148e-05 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0002039 | p53 binding                                                     | 4/8 | 500/22568 | 1.552779e-05 | 6.340012e-05 | 1.860935e-05 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                 | 4 |\n| MF | GO:0030332 | cyclin binding                                                  | 3/8 | 179/22568 | 2.668591e-05 | 9.983219e-05 | 2.930297e-05 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0030544 | Hsp70 protein binding                                           | 3/8 | 195/22568 | 3.445636e-05 | 1.252958e-04 | 3.677712e-05 | vorinostat/trichostatin-a/apha-compound-8                     | 3 |\n| MF | GO:0048487 | beta-tubulin binding                                            | 3/8 | 210/22568 | 4.297508e-05 | 1.530619e-04 | 4.492708e-05 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0043130 | ubiquitin binding                                               | 3/8 | 303/22568 | 1.276585e-04 | 4.148900e-04 | 1.217795e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0043014 | alpha-tubulin binding                                           | 3/8 | 316/22568 | 1.445491e-04 | 4.528046e-04 | 1.329082e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0048156 | tau protein binding                                             | 3/8 | 363/22568 | 2.176659e-04 | 6.358779e-04 | 1.866443e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0140030 | modification-dependent protein binding                          | 3/8 | 376/22568 | 2.414415e-04 | 6.936441e-04 | 2.036000e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0019789 | SUMO transferase activity                                       | 2/8 | 69/22568  | 2.549112e-04 | 7.283178e-04 | 2.137775e-04 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0032182 | ubiquitin-like protein binding                                  | 3/8 | 400/22568 | 2.896601e-04 | 8.054718e-04 | 2.364239e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0008013 | beta-catenin binding                                            | 3/8 | 412/22568 | 3.159518e-04 | 8.529347e-04 | 2.503553e-04 | vorinostat/trichostatin-a/pyroxamide                          | 3 |\n| MF | GO:0030955 | potassium ion binding                                           | 2/8 | 183/22568 | 1.773229e-03 | 3.907115e-03 | 1.146825e-03 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0071889 | 14-3-3 protein binding                                          | 2/8 | 197/22568 | 2.050617e-03 | 4.370168e-03 | 1.282742e-03 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0019787 | ubiquitin-like protein transferase activity                     | 2/8 | 286/22568 | 4.260921e-03 | 8.206218e-03 | 2.408708e-03 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0031420 | alkali metal ion binding                                        | 2/8 | 312/22568 | 5.048931e-03 | 9.444044e-03 | 2.772037e-03 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0008241 | peptidyl-dipeptidase activity                                   | 1/8 | 23/22568  | 8.125370e-03 | 1.413108e-02 | 4.147786e-03 | rescinnamine                                                  | 1 |\n| MF | GO:0070573 | metallodipeptidase activity                                     | 1/8 | 25/22568  | 8.829186e-03 | 1.520257e-02 | 4.462293e-03 | rescinnamine                                                  | 1 |\n| MF | GO:0005080 | protein kinase C binding                                        | 2/8 | 490/22568 | 1.207889e-02 | 1.944590e-02 | 5.707804e-03 | vorinostat/trichostatin-a                                     | 2 |\n| MF | GO:0008240 | tripeptidyl-peptidase activity                                  | 1/8 | 35/22568  | 1.234171e-02 | 1.968617e-02 | 5.778329e-03 | rescinnamine                                                  | 1 |\n| MF | GO:0031711 | bradykinin receptor binding                                     | 1/8 | 41/22568  | 1.444400e-02 | 2.282942e-02 | 6.700944e-03 | rescinnamine                                                  | 1 |\n| MF | GO:0042288 | MHC class I protein binding                                     | 1/8 | 58/22568  | 2.037923e-02 | 3.211272e-02 | 9.425798e-03 | epothilone                                                    | 1 |\n| MF | GO:0042287 | MHC protein binding                                             | 1/8 | 77/22568  | 2.697568e-02 | 4.212419e-02 | 1.236439e-02 | epothilone                                                    | 1 |\n| MF | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs     | 1/8 | 82/22568  | 2.870512e-02 | 4.416172e-02 | 1.296245e-02 | zuclopenthixol                                                | 1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 51 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>MF</td><td>GO:0035851</td><td>Krueppel-associated box domain binding                         </td><td>4/8</td><td>27/22568 </td><td>1.133215e-10</td><td>5.892719e-08</td><td>1.729644e-08</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0031078</td><td>histone deacetylase activity (H3-K14 specific)                 </td><td>5/8</td><td>199/22568</td><td>2.778580e-09</td><td>3.042474e-07</td><td>8.930338e-08</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0032041</td><td>NAD-dependent histone deacetylase activity (H3-K14 specific)   </td><td>5/8</td><td>199/22568</td><td>2.778580e-09</td><td>3.042474e-07</td><td>8.930338e-08</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0017136</td><td>NAD-dependent histone deacetylase activity                     </td><td>5/8</td><td>261/22568</td><td>1.083945e-08</td><td>3.382311e-07</td><td>9.927836e-08</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0034979</td><td>NAD-dependent protein deacetylase activity                     </td><td>5/8</td><td>266/22568</td><td>1.192028e-08</td><td>3.382311e-07</td><td>9.927836e-08</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0031492</td><td>nucleosomal DNA binding                                        </td><td>4/8</td><td>88/22568 </td><td>1.492725e-08</td><td>3.881085e-07</td><td>1.139185e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0001046</td><td>core promoter sequence-specific DNA binding                    </td><td>4/8</td><td>94/22568 </td><td>1.950428e-08</td><td>4.610103e-07</td><td>1.353168e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0004407</td><td>histone deacetylase activity                                   </td><td>5/8</td><td>318/22568</td><td>2.911950e-08</td><td>6.108402e-07</td><td>1.792952e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0033558</td><td>protein deacetylase activity                                   </td><td>5/8</td><td>323/22568</td><td>3.147974e-08</td><td>6.108772e-07</td><td>1.793061e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0031491</td><td>nucleosome binding                                             </td><td>4/8</td><td>106/22568</td><td>3.171862e-08</td><td>6.108772e-07</td><td>1.793061e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0019213</td><td>deacetylase activity                                           </td><td>5/8</td><td>432/22568</td><td>1.341354e-07</td><td>1.788472e-06</td><td>5.249563e-07</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8</td><td>5</td></tr>\n","\t<tr><td>MF</td><td>GO:0070888</td><td>E-box binding                                                  </td><td>4/8</td><td>195/22568</td><td>3.682448e-07</td><td>3.908974e-06</td><td>1.147371e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0001047</td><td>core promoter binding                                          </td><td>4/8</td><td>196/22568</td><td>3.758629e-07</td><td>3.908974e-06</td><td>1.147371e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:1990841</td><td>promoter-specific chromatin binding                            </td><td>4/8</td><td>197/22568</td><td>3.835981e-07</td><td>3.911196e-06</td><td>1.148023e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0001103</td><td>RNA polymerase II repressing transcription factor binding      </td><td>4/8</td><td>218/22568</td><td>5.752075e-07</td><td>5.538712e-06</td><td>1.625735e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0031490</td><td>chromatin DNA binding                                          </td><td>4/8</td><td>276/22568</td><td>1.474251e-06</td><td>1.179401e-05</td><td>3.461804e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0033613</td><td>activating transcription factor binding                        </td><td>4/8</td><td>292/22568</td><td>1.844990e-06</td><td>1.409470e-05</td><td>4.137109e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0051059</td><td>NF-kappaB binding                                              </td><td>4/8</td><td>299/22568</td><td>2.027323e-06</td><td>1.410150e-05</td><td>4.139105e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0000980</td><td>RNA polymerase II distal enhancer sequence-specific DNA binding</td><td>4/8</td><td>322/22568</td><td>2.721815e-06</td><td>1.645749e-05</td><td>4.830639e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0001158</td><td>enhancer sequence-specific DNA binding                         </td><td>4/8</td><td>322/22568</td><td>2.721815e-06</td><td>1.645749e-05</td><td>4.830639e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0003714</td><td>transcription corepressor activity                             </td><td>4/8</td><td>325/22568</td><td>2.823951e-06</td><td>1.664300e-05</td><td>4.885091e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0070491</td><td>repressing transcription factor binding                        </td><td>4/8</td><td>331/22568</td><td>3.036748e-06</td><td>1.725257e-05</td><td>5.064014e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0070840</td><td>dynein complex binding                                         </td><td>3/8</td><td>88/22568 </td><td>3.163190e-06</td><td>1.725257e-05</td><td>5.064014e-06</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0042903</td><td>tubulin deacetylase activity                                   </td><td>3/8</td><td>95/22568 </td><td>3.985227e-06</td><td>2.031684e-05</td><td>5.963446e-06</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0035326</td><td>enhancer binding                                               </td><td>4/8</td><td>364/22568</td><td>4.427580e-06</td><td>2.235283e-05</td><td>6.561054e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0051787</td><td>misfolded protein binding                                      </td><td>3/8</td><td>119/22568</td><td>7.852298e-06</td><td>3.711995e-05</td><td>1.089553e-05</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0051879</td><td>Hsp90 protein binding                                          </td><td>4/8</td><td>447/22568</td><td>9.980478e-06</td><td>4.512912e-05</td><td>1.324640e-05</td><td>vorinostat/trichostatin-a/pyroxamide/apha-compound-8         </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0031593</td><td>polyubiquitin modification-dependent protein binding           </td><td>3/8</td><td>139/22568</td><td>1.251839e-05</td><td>5.335706e-05</td><td>1.566148e-05</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0002039</td><td>p53 binding                                                    </td><td>4/8</td><td>500/22568</td><td>1.552779e-05</td><td>6.340012e-05</td><td>1.860935e-05</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                </td><td>4</td></tr>\n","\t<tr><td>MF</td><td>GO:0030332</td><td>cyclin binding                                                 </td><td>3/8</td><td>179/22568</td><td>2.668591e-05</td><td>9.983219e-05</td><td>2.930297e-05</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0030544</td><td>Hsp70 protein binding                                          </td><td>3/8</td><td>195/22568</td><td>3.445636e-05</td><td>1.252958e-04</td><td>3.677712e-05</td><td>vorinostat/trichostatin-a/apha-compound-8                    </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0048487</td><td>beta-tubulin binding                                           </td><td>3/8</td><td>210/22568</td><td>4.297508e-05</td><td>1.530619e-04</td><td>4.492708e-05</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0043130</td><td>ubiquitin binding                                              </td><td>3/8</td><td>303/22568</td><td>1.276585e-04</td><td>4.148900e-04</td><td>1.217795e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0043014</td><td>alpha-tubulin binding                                          </td><td>3/8</td><td>316/22568</td><td>1.445491e-04</td><td>4.528046e-04</td><td>1.329082e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0048156</td><td>tau protein binding                                            </td><td>3/8</td><td>363/22568</td><td>2.176659e-04</td><td>6.358779e-04</td><td>1.866443e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0140030</td><td>modification-dependent protein binding                         </td><td>3/8</td><td>376/22568</td><td>2.414415e-04</td><td>6.936441e-04</td><td>2.036000e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0019789</td><td>SUMO transferase activity                                      </td><td>2/8</td><td>69/22568 </td><td>2.549112e-04</td><td>7.283178e-04</td><td>2.137775e-04</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0032182</td><td>ubiquitin-like protein binding                                 </td><td>3/8</td><td>400/22568</td><td>2.896601e-04</td><td>8.054718e-04</td><td>2.364239e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0008013</td><td>beta-catenin binding                                           </td><td>3/8</td><td>412/22568</td><td>3.159518e-04</td><td>8.529347e-04</td><td>2.503553e-04</td><td>vorinostat/trichostatin-a/pyroxamide                         </td><td>3</td></tr>\n","\t<tr><td>MF</td><td>GO:0030955</td><td>potassium ion binding                                          </td><td>2/8</td><td>183/22568</td><td>1.773229e-03</td><td>3.907115e-03</td><td>1.146825e-03</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0071889</td><td>14-3-3 protein binding                                         </td><td>2/8</td><td>197/22568</td><td>2.050617e-03</td><td>4.370168e-03</td><td>1.282742e-03</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0019787</td><td>ubiquitin-like protein transferase activity                    </td><td>2/8</td><td>286/22568</td><td>4.260921e-03</td><td>8.206218e-03</td><td>2.408708e-03</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0031420</td><td>alkali metal ion binding                                       </td><td>2/8</td><td>312/22568</td><td>5.048931e-03</td><td>9.444044e-03</td><td>2.772037e-03</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0008241</td><td>peptidyl-dipeptidase activity                                  </td><td>1/8</td><td>23/22568 </td><td>8.125370e-03</td><td>1.413108e-02</td><td>4.147786e-03</td><td>rescinnamine                                                 </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0070573</td><td>metallodipeptidase activity                                    </td><td>1/8</td><td>25/22568 </td><td>8.829186e-03</td><td>1.520257e-02</td><td>4.462293e-03</td><td>rescinnamine                                                 </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0005080</td><td>protein kinase C binding                                       </td><td>2/8</td><td>490/22568</td><td>1.207889e-02</td><td>1.944590e-02</td><td>5.707804e-03</td><td>vorinostat/trichostatin-a                                    </td><td>2</td></tr>\n","\t<tr><td>MF</td><td>GO:0008240</td><td>tripeptidyl-peptidase activity                                 </td><td>1/8</td><td>35/22568 </td><td>1.234171e-02</td><td>1.968617e-02</td><td>5.778329e-03</td><td>rescinnamine                                                 </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0031711</td><td>bradykinin receptor binding                                    </td><td>1/8</td><td>41/22568 </td><td>1.444400e-02</td><td>2.282942e-02</td><td>6.700944e-03</td><td>rescinnamine                                                 </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0042288</td><td>MHC class I protein binding                                    </td><td>1/8</td><td>58/22568 </td><td>2.037923e-02</td><td>3.211272e-02</td><td>9.425798e-03</td><td>epothilone                                                   </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0042287</td><td>MHC protein binding                                            </td><td>1/8</td><td>77/22568 </td><td>2.697568e-02</td><td>4.212419e-02</td><td>1.236439e-02</td><td>epothilone                                                   </td><td>1</td></tr>\n","\t<tr><td>MF</td><td>GO:0001588</td><td>dopamine neurotransmitter receptor activity, coupled via Gs    </td><td>1/8</td><td>82/22568 </td><td>2.870512e-02</td><td>4.416172e-02</td><td>1.296245e-02</td><td>zuclopenthixol                                               </td><td>1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"SeUTMnwRLUPs","executionInfo":{"status":"ok","timestamp":1636338416518,"user_tz":-480,"elapsed":3594,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"f04fa45c-5dcd-42a9-c4c6-81e8f261dad2"},"source":["# KEGG\n","hyperG_k_res <- dsea_hyperG(drugs=drugs, type='KEGG',\n","                            pvalueCutoff = 1, qvalueCutoff = 1,\n","                            minGSSize = 10, maxGSSize = 2000)\n","result(hyperG_k_res)                            "],"execution_count":36,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ID       Description                                      GeneRatio\n","1  hsa04330 Notch signaling pathway                          4/8      \n","2  hsa05034 Alcoholism                                       6/8      \n","3  hsa05031 Amphetamine addiction                            5/8      \n","4  hsa05203 Viral carcinogenesis                             5/8      \n","5  hsa05016 Huntington disease                               5/8      \n","6  hsa04613 Neutrophil extracellular trap formation          5/8      \n","7  hsa04213 Longevity regulating pathway - multiple species  4/8      \n","8  hsa04110 Cell cycle                                       4/8      \n","9  hsa05220 Chronic myeloid leukemia                         4/8      \n","10 hsa05202 Transcriptional misregulation in cancer          4/8      \n","11 hsa05014 Amyotrophic lateral sclerosis                    4/8      \n","12 hsa04919 Thyroid hormone signaling pathway                4/8      \n","13 hsa05169 Epstein-Barr virus infection                     4/8      \n","14 hsa05165 Human papillomavirus infection                   4/8      \n","15 hsa05206 MicroRNAs in cancer                              4/8      \n","16 hsa04540 Gap junction                                     2/8      \n","17 hsa04371 Apelin signaling pathway                         2/8      \n","18 hsa05012 Parkinson disease                                2/8      \n","19 hsa04614 Renin-angiotensin system                         1/8      \n","20 hsa05410 Hypertrophic cardiomyopathy                      1/8      \n","21 hsa04145 Phagosome                                        1/8      \n","22 hsa05030 Cocaine addiction                                1/8      \n","23 hsa04924 Renin secretion                                  1/8      \n","24 hsa05032 Morphine addiction                               1/8      \n","25 hsa04530 Tight junction                                   1/8      \n","26 hsa04970 Salivary secretion                               1/8      \n","27 hsa04152 AMPK signaling pathway                           1/8      \n","28 hsa04261 Adrenergic signaling in cardiomyocytes           1/8      \n","29 hsa05142 Chagas disease                                   1/8      \n","30 hsa05130 Pathogenic Escherichia coli infection            1/8      \n","31 hsa04750 Inflammatory mediator regulation of TRP channels 1/8      \n","32 hsa04270 Vascular smooth muscle contraction               1/8      \n","33 hsa04728 Dopaminergic synapse                             1/8      \n","34 hsa05171 Coronavirus disease - COVID-19                   1/8      \n","35 hsa05020 Prion disease                                    1/8      \n","36 hsa04210 Apoptosis                                        1/8      \n","37 hsa04022 cGMP-PKG signaling pathway                       1/8      \n","38 hsa05415 Diabetic cardiomyopathy                          1/8      \n","39 hsa05132 Salmonella infection                             1/8      \n","   BgRatio    pvalue       p.adjust     qvalue      \n","1  146/20464  1.702210e-07 6.638621e-06 4.300321e-06\n","2  1131/20464 7.155232e-07 1.395270e-05 9.038187e-06\n","3  916/20464  8.891270e-06 1.155865e-04 7.487385e-05\n","4  1175/20464 2.995078e-05 2.244118e-04 1.453680e-04\n","5  1185/20464 3.120945e-05 2.244118e-04 1.453680e-04\n","6  1237/20464 3.844183e-05 2.244118e-04 1.453680e-04\n","7  578/20464  4.027905e-05 2.244118e-04 1.453680e-04\n","8  730/20464  1.002403e-04 4.886717e-04 3.165484e-04\n","9  822/20464  1.589356e-04 6.887208e-04 4.461349e-04\n","10 1001/20464 3.400106e-04 1.326041e-03 8.589740e-04\n","11 1174/20464 6.260554e-04 2.041298e-03 1.322298e-03\n","12 1175/20464 6.280916e-04 2.041298e-03 1.322298e-03\n","13 1405/20464 1.237672e-03 3.713015e-03 2.405192e-03\n","14 1478/20464 1.497881e-03 4.116902e-03 2.666819e-03\n","15 1500/20464 1.583424e-03 4.116902e-03 2.666819e-03\n","16 994/20464  5.430407e-02 1.323662e-01 8.574327e-02\n","17 1167/20464 7.234465e-02 1.659671e-01 1.075091e-01\n","18 1257/20464 8.245601e-02 1.786547e-01 1.157277e-01\n","19 353/20464  1.299691e-01 2.667787e-01 1.728121e-01\n","20 419/20464  1.525544e-01 2.974810e-01 1.927003e-01\n","21 480/20464  1.729707e-01 3.212314e-01 2.080851e-01\n","22 617/20464  2.172623e-01 3.851468e-01 2.494878e-01\n","23 740/20464  2.552450e-01 4.328067e-01 2.803606e-01\n","24 825/20464  2.805415e-01 4.464826e-01 2.892195e-01\n","25 869/20464  2.933383e-01 4.464826e-01 2.892195e-01\n","26 884/20464  2.976551e-01 4.464826e-01 2.892195e-01\n","27 1016/20464 3.346590e-01 4.673059e-01 3.027083e-01\n","28 1089/20464 3.543814e-01 4.673059e-01 3.027083e-01\n","29 1129/20464 3.649696e-01 4.673059e-01 3.027083e-01\n","30 1155/20464 3.717703e-01 4.673059e-01 3.027083e-01\n","31 1195/20464 3.821083e-01 4.673059e-01 3.027083e-01\n","32 1253/20464 3.968341e-01 4.673059e-01 3.027083e-01\n","33 1323/20464 4.141969e-01 4.673059e-01 3.027083e-01\n","34 1356/20464 4.222294e-01 4.673059e-01 3.027083e-01\n","35 1382/20464 4.284900e-01 4.673059e-01 3.027083e-01\n","36 1454/20464 4.455183e-01 4.673059e-01 3.027083e-01\n","37 1509/20464 4.582252e-01 4.673059e-01 3.027083e-01\n","38 1542/20464 4.657265e-01 4.673059e-01 3.027083e-01\n","39 1549/20464 4.673059e-01 4.673059e-01 3.027083e-01\n","   itemID                                                                      \n","1  vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","2  vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8\n","3  vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                \n","4  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8               \n","5  vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                    \n","6  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8               \n","7  vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","8  vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","9  vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","10 vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","11 vorinostat/trichostatin-a/pyroxamide/epothilone                             \n","12 vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","13 vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","14 vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","15 vorinostat/trichostatin-a/hc-toxin/pyroxamide                               \n","16 zuclopenthixol/epothilone                                                   \n","17 vorinostat/trichostatin-a                                                   \n","18 zuclopenthixol/epothilone                                                   \n","19 rescinnamine                                                                \n","20 rescinnamine                                                                \n","21 epothilone                                                                  \n","22 zuclopenthixol                                                              \n","23 rescinnamine                                                                \n","24 zuclopenthixol                                                              \n","25 epothilone                                                                  \n","26 zuclopenthixol                                                              \n","27 zuclopenthixol                                                              \n","28 zuclopenthixol                                                              \n","29 rescinnamine                                                                \n","30 epothilone                                                                  \n","31 zuclopenthixol                                                              \n","32 zuclopenthixol                                                              \n","33 zuclopenthixol                                                              \n","34 rescinnamine                                                                \n","35 epothilone                                                                  \n","36 epothilone                                                                  \n","37 zuclopenthixol                                                              \n","38 rescinnamine                                                                \n","39 epothilone                                                                  \n","   Count\n","1  4    \n","2  6    \n","3  5    \n","4  5    \n","5  5    \n","6  5    \n","7  4    \n","8  4    \n","9  4    \n","10 4    \n","11 4    \n","12 4    \n","13 4    \n","14 4    \n","15 4    \n","16 2    \n","17 2    \n","18 2    \n","19 1    \n","20 1    \n","21 1    \n","22 1    \n","23 1    \n","24 1    \n","25 1    \n","26 1    \n","27 1    \n","28 1    \n","29 1    \n","30 1    \n","31 1    \n","32 1    \n","33 1    \n","34 1    \n","35 1    \n","36 1    \n","37 1    \n","38 1    \n","39 1    "],"text/latex":"A tibble: 39 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <int>\\\\\n\\hline\n\t hsa04330 & Notch signaling pathway                          & 4/8 & 146/20464  & 1.702210e-07 & 6.638621e-06 & 4.300321e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05034 & Alcoholism                                       & 6/8 & 1131/20464 & 7.155232e-07 & 1.395270e-05 & 9.038187e-06 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8 & 6\\\\\n\t hsa05031 & Amphetamine addiction                            & 5/8 & 916/20464  & 8.891270e-06 & 1.155865e-04 & 7.487385e-05 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                 & 5\\\\\n\t hsa05203 & Viral carcinogenesis                             & 5/8 & 1175/20464 & 2.995078e-05 & 2.244118e-04 & 1.453680e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                & 5\\\\\n\t hsa05016 & Huntington disease                               & 5/8 & 1185/20464 & 3.120945e-05 & 2.244118e-04 & 1.453680e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                     & 5\\\\\n\t hsa04613 & Neutrophil extracellular trap formation          & 5/8 & 1237/20464 & 3.844183e-05 & 2.244118e-04 & 1.453680e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                & 5\\\\\n\t hsa04213 & Longevity regulating pathway - multiple species  & 4/8 & 578/20464  & 4.027905e-05 & 2.244118e-04 & 1.453680e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa04110 & Cell cycle                                       & 4/8 & 730/20464  & 1.002403e-04 & 4.886717e-04 & 3.165484e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05220 & Chronic myeloid leukemia                         & 4/8 & 822/20464  & 1.589356e-04 & 6.887208e-04 & 4.461349e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05202 & Transcriptional misregulation in cancer          & 4/8 & 1001/20464 & 3.400106e-04 & 1.326041e-03 & 8.589740e-04 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                    & 4/8 & 1174/20464 & 6.260554e-04 & 2.041298e-03 & 1.322298e-03 & vorinostat/trichostatin-a/pyroxamide/epothilone                              & 4\\\\\n\t hsa04919 & Thyroid hormone signaling pathway                & 4/8 & 1175/20464 & 6.280916e-04 & 2.041298e-03 & 1.322298e-03 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05169 & Epstein-Barr virus infection                     & 4/8 & 1405/20464 & 1.237672e-03 & 3.713015e-03 & 2.405192e-03 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05165 & Human papillomavirus infection                   & 4/8 & 1478/20464 & 1.497881e-03 & 4.116902e-03 & 2.666819e-03 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa05206 & MicroRNAs in cancer                              & 4/8 & 1500/20464 & 1.583424e-03 & 4.116902e-03 & 2.666819e-03 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                & 4\\\\\n\t hsa04540 & Gap junction                                     & 2/8 & 994/20464  & 5.430407e-02 & 1.323662e-01 & 8.574327e-02 & zuclopenthixol/epothilone                                                    & 2\\\\\n\t hsa04371 & Apelin signaling pathway                         & 2/8 & 1167/20464 & 7.234465e-02 & 1.659671e-01 & 1.075091e-01 & vorinostat/trichostatin-a                                                    & 2\\\\\n\t hsa05012 & Parkinson disease                                & 2/8 & 1257/20464 & 8.245601e-02 & 1.786547e-01 & 1.157277e-01 & zuclopenthixol/epothilone                                                    & 2\\\\\n\t hsa04614 & Renin-angiotensin system                         & 1/8 & 353/20464  & 1.299691e-01 & 2.667787e-01 & 1.728121e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa05410 & Hypertrophic cardiomyopathy                      & 1/8 & 419/20464  & 1.525544e-01 & 2.974810e-01 & 1.927003e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa04145 & Phagosome                                        & 1/8 & 480/20464  & 1.729707e-01 & 3.212314e-01 & 2.080851e-01 & epothilone                                                                   & 1\\\\\n\t hsa05030 & Cocaine addiction                                & 1/8 & 617/20464  & 2.172623e-01 & 3.851468e-01 & 2.494878e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04924 & Renin secretion                                  & 1/8 & 740/20464  & 2.552450e-01 & 4.328067e-01 & 2.803606e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa05032 & Morphine addiction                               & 1/8 & 825/20464  & 2.805415e-01 & 4.464826e-01 & 2.892195e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04530 & Tight junction                                   & 1/8 & 869/20464  & 2.933383e-01 & 4.464826e-01 & 2.892195e-01 & epothilone                                                                   & 1\\\\\n\t hsa04970 & Salivary secretion                               & 1/8 & 884/20464  & 2.976551e-01 & 4.464826e-01 & 2.892195e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04152 & AMPK signaling pathway                           & 1/8 & 1016/20464 & 3.346590e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04261 & Adrenergic signaling in cardiomyocytes           & 1/8 & 1089/20464 & 3.543814e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa05142 & Chagas disease                                   & 1/8 & 1129/20464 & 3.649696e-01 & 4.673059e-01 & 3.027083e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa05130 & Pathogenic Escherichia coli infection            & 1/8 & 1155/20464 & 3.717703e-01 & 4.673059e-01 & 3.027083e-01 & epothilone                                                                   & 1\\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels & 1/8 & 1195/20464 & 3.821083e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04270 & Vascular smooth muscle contraction               & 1/8 & 1253/20464 & 3.968341e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa04728 & Dopaminergic synapse                             & 1/8 & 1323/20464 & 4.141969e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa05171 & Coronavirus disease - COVID-19                   & 1/8 & 1356/20464 & 4.222294e-01 & 4.673059e-01 & 3.027083e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa05020 & Prion disease                                    & 1/8 & 1382/20464 & 4.284900e-01 & 4.673059e-01 & 3.027083e-01 & epothilone                                                                   & 1\\\\\n\t hsa04210 & Apoptosis                                        & 1/8 & 1454/20464 & 4.455183e-01 & 4.673059e-01 & 3.027083e-01 & epothilone                                                                   & 1\\\\\n\t hsa04022 & cGMP-PKG signaling pathway                       & 1/8 & 1509/20464 & 4.582252e-01 & 4.673059e-01 & 3.027083e-01 & zuclopenthixol                                                               & 1\\\\\n\t hsa05415 & Diabetic cardiomyopathy                          & 1/8 & 1542/20464 & 4.657265e-01 & 4.673059e-01 & 3.027083e-01 & rescinnamine                                                                 & 1\\\\\n\t hsa05132 & Salmonella infection                             & 1/8 & 1549/20464 & 4.673059e-01 & 4.673059e-01 & 3.027083e-01 & epothilone                                                                   & 1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 39 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;int&gt; |\n|---|---|---|---|---|---|---|---|---|\n| hsa04330 | Notch signaling pathway                          | 4/8 | 146/20464  | 1.702210e-07 | 6.638621e-06 | 4.300321e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05034 | Alcoholism                                       | 6/8 | 1131/20464 | 7.155232e-07 | 1.395270e-05 | 9.038187e-06 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8 | 6 |\n| hsa05031 | Amphetamine addiction                            | 5/8 | 916/20464  | 8.891270e-06 | 1.155865e-04 | 7.487385e-05 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                 | 5 |\n| hsa05203 | Viral carcinogenesis                             | 5/8 | 1175/20464 | 2.995078e-05 | 2.244118e-04 | 1.453680e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                | 5 |\n| hsa05016 | Huntington disease                               | 5/8 | 1185/20464 | 3.120945e-05 | 2.244118e-04 | 1.453680e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                     | 5 |\n| hsa04613 | Neutrophil extracellular trap formation          | 5/8 | 1237/20464 | 3.844183e-05 | 2.244118e-04 | 1.453680e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                | 5 |\n| hsa04213 | Longevity regulating pathway - multiple species  | 4/8 | 578/20464  | 4.027905e-05 | 2.244118e-04 | 1.453680e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa04110 | Cell cycle                                       | 4/8 | 730/20464  | 1.002403e-04 | 4.886717e-04 | 3.165484e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05220 | Chronic myeloid leukemia                         | 4/8 | 822/20464  | 1.589356e-04 | 6.887208e-04 | 4.461349e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05202 | Transcriptional misregulation in cancer          | 4/8 | 1001/20464 | 3.400106e-04 | 1.326041e-03 | 8.589740e-04 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05014 | Amyotrophic lateral sclerosis                    | 4/8 | 1174/20464 | 6.260554e-04 | 2.041298e-03 | 1.322298e-03 | vorinostat/trichostatin-a/pyroxamide/epothilone                              | 4 |\n| hsa04919 | Thyroid hormone signaling pathway                | 4/8 | 1175/20464 | 6.280916e-04 | 2.041298e-03 | 1.322298e-03 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05169 | Epstein-Barr virus infection                     | 4/8 | 1405/20464 | 1.237672e-03 | 3.713015e-03 | 2.405192e-03 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05165 | Human papillomavirus infection                   | 4/8 | 1478/20464 | 1.497881e-03 | 4.116902e-03 | 2.666819e-03 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa05206 | MicroRNAs in cancer                              | 4/8 | 1500/20464 | 1.583424e-03 | 4.116902e-03 | 2.666819e-03 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                | 4 |\n| hsa04540 | Gap junction                                     | 2/8 | 994/20464  | 5.430407e-02 | 1.323662e-01 | 8.574327e-02 | zuclopenthixol/epothilone                                                    | 2 |\n| hsa04371 | Apelin signaling pathway                         | 2/8 | 1167/20464 | 7.234465e-02 | 1.659671e-01 | 1.075091e-01 | vorinostat/trichostatin-a                                                    | 2 |\n| hsa05012 | Parkinson disease                                | 2/8 | 1257/20464 | 8.245601e-02 | 1.786547e-01 | 1.157277e-01 | zuclopenthixol/epothilone                                                    | 2 |\n| hsa04614 | Renin-angiotensin system                         | 1/8 | 353/20464  | 1.299691e-01 | 2.667787e-01 | 1.728121e-01 | rescinnamine                                                                 | 1 |\n| hsa05410 | Hypertrophic cardiomyopathy                      | 1/8 | 419/20464  | 1.525544e-01 | 2.974810e-01 | 1.927003e-01 | rescinnamine                                                                 | 1 |\n| hsa04145 | Phagosome                                        | 1/8 | 480/20464  | 1.729707e-01 | 3.212314e-01 | 2.080851e-01 | epothilone                                                                   | 1 |\n| hsa05030 | Cocaine addiction                                | 1/8 | 617/20464  | 2.172623e-01 | 3.851468e-01 | 2.494878e-01 | zuclopenthixol                                                               | 1 |\n| hsa04924 | Renin secretion                                  | 1/8 | 740/20464  | 2.552450e-01 | 4.328067e-01 | 2.803606e-01 | rescinnamine                                                                 | 1 |\n| hsa05032 | Morphine addiction                               | 1/8 | 825/20464  | 2.805415e-01 | 4.464826e-01 | 2.892195e-01 | zuclopenthixol                                                               | 1 |\n| hsa04530 | Tight junction                                   | 1/8 | 869/20464  | 2.933383e-01 | 4.464826e-01 | 2.892195e-01 | epothilone                                                                   | 1 |\n| hsa04970 | Salivary secretion                               | 1/8 | 884/20464  | 2.976551e-01 | 4.464826e-01 | 2.892195e-01 | zuclopenthixol                                                               | 1 |\n| hsa04152 | AMPK signaling pathway                           | 1/8 | 1016/20464 | 3.346590e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa04261 | Adrenergic signaling in cardiomyocytes           | 1/8 | 1089/20464 | 3.543814e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa05142 | Chagas disease                                   | 1/8 | 1129/20464 | 3.649696e-01 | 4.673059e-01 | 3.027083e-01 | rescinnamine                                                                 | 1 |\n| hsa05130 | Pathogenic Escherichia coli infection            | 1/8 | 1155/20464 | 3.717703e-01 | 4.673059e-01 | 3.027083e-01 | epothilone                                                                   | 1 |\n| hsa04750 | Inflammatory mediator regulation of TRP channels | 1/8 | 1195/20464 | 3.821083e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa04270 | Vascular smooth muscle contraction               | 1/8 | 1253/20464 | 3.968341e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa04728 | Dopaminergic synapse                             | 1/8 | 1323/20464 | 4.141969e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa05171 | Coronavirus disease - COVID-19                   | 1/8 | 1356/20464 | 4.222294e-01 | 4.673059e-01 | 3.027083e-01 | rescinnamine                                                                 | 1 |\n| hsa05020 | Prion disease                                    | 1/8 | 1382/20464 | 4.284900e-01 | 4.673059e-01 | 3.027083e-01 | epothilone                                                                   | 1 |\n| hsa04210 | Apoptosis                                        | 1/8 | 1454/20464 | 4.455183e-01 | 4.673059e-01 | 3.027083e-01 | epothilone                                                                   | 1 |\n| hsa04022 | cGMP-PKG signaling pathway                       | 1/8 | 1509/20464 | 4.582252e-01 | 4.673059e-01 | 3.027083e-01 | zuclopenthixol                                                               | 1 |\n| hsa05415 | Diabetic cardiomyopathy                          | 1/8 | 1542/20464 | 4.657265e-01 | 4.673059e-01 | 3.027083e-01 | rescinnamine                                                                 | 1 |\n| hsa05132 | Salmonella infection                             | 1/8 | 1549/20464 | 4.673059e-01 | 4.673059e-01 | 3.027083e-01 | epothilone                                                                   | 1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 39 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa04330</td><td>Notch signaling pathway                         </td><td>4/8</td><td>146/20464 </td><td>1.702210e-07</td><td>6.638621e-06</td><td>4.300321e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                      </td><td>6/8</td><td>1131/20464</td><td>7.155232e-07</td><td>1.395270e-05</td><td>9.038187e-06</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8</td><td>6</td></tr>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                           </td><td>5/8</td><td>916/20464 </td><td>8.891270e-06</td><td>1.155865e-04</td><td>7.487385e-05</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                </td><td>5</td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                            </td><td>5/8</td><td>1175/20464</td><td>2.995078e-05</td><td>2.244118e-04</td><td>1.453680e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8               </td><td>5</td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                              </td><td>5/8</td><td>1185/20464</td><td>3.120945e-05</td><td>2.244118e-04</td><td>1.453680e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                    </td><td>5</td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation         </td><td>5/8</td><td>1237/20464</td><td>3.844183e-05</td><td>2.244118e-04</td><td>1.453680e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8               </td><td>5</td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species </td><td>4/8</td><td>578/20464 </td><td>4.027905e-05</td><td>2.244118e-04</td><td>1.453680e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                      </td><td>4/8</td><td>730/20464 </td><td>1.002403e-04</td><td>4.886717e-04</td><td>3.165484e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                        </td><td>4/8</td><td>822/20464 </td><td>1.589356e-04</td><td>6.887208e-04</td><td>4.461349e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer         </td><td>4/8</td><td>1001/20464</td><td>3.400106e-04</td><td>1.326041e-03</td><td>8.589740e-04</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                   </td><td>4/8</td><td>1174/20464</td><td>6.260554e-04</td><td>2.041298e-03</td><td>1.322298e-03</td><td>vorinostat/trichostatin-a/pyroxamide/epothilone                             </td><td>4</td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway               </td><td>4/8</td><td>1175/20464</td><td>6.280916e-04</td><td>2.041298e-03</td><td>1.322298e-03</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                    </td><td>4/8</td><td>1405/20464</td><td>1.237672e-03</td><td>3.713015e-03</td><td>2.405192e-03</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                  </td><td>4/8</td><td>1478/20464</td><td>1.497881e-03</td><td>4.116902e-03</td><td>2.666819e-03</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                             </td><td>4/8</td><td>1500/20464</td><td>1.583424e-03</td><td>4.116902e-03</td><td>2.666819e-03</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                               </td><td>4</td></tr>\n","\t<tr><td>hsa04540</td><td>Gap junction                                    </td><td>2/8</td><td>994/20464 </td><td>5.430407e-02</td><td>1.323662e-01</td><td>8.574327e-02</td><td>zuclopenthixol/epothilone                                                   </td><td>2</td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                        </td><td>2/8</td><td>1167/20464</td><td>7.234465e-02</td><td>1.659671e-01</td><td>1.075091e-01</td><td>vorinostat/trichostatin-a                                                   </td><td>2</td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                               </td><td>2/8</td><td>1257/20464</td><td>8.245601e-02</td><td>1.786547e-01</td><td>1.157277e-01</td><td>zuclopenthixol/epothilone                                                   </td><td>2</td></tr>\n","\t<tr><td>hsa04614</td><td>Renin-angiotensin system                        </td><td>1/8</td><td>353/20464 </td><td>1.299691e-01</td><td>2.667787e-01</td><td>1.728121e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa05410</td><td>Hypertrophic cardiomyopathy                     </td><td>1/8</td><td>419/20464 </td><td>1.525544e-01</td><td>2.974810e-01</td><td>1.927003e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa04145</td><td>Phagosome                                       </td><td>1/8</td><td>480/20464 </td><td>1.729707e-01</td><td>3.212314e-01</td><td>2.080851e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","\t<tr><td>hsa05030</td><td>Cocaine addiction                               </td><td>1/8</td><td>617/20464 </td><td>2.172623e-01</td><td>3.851468e-01</td><td>2.494878e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04924</td><td>Renin secretion                                 </td><td>1/8</td><td>740/20464 </td><td>2.552450e-01</td><td>4.328067e-01</td><td>2.803606e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                              </td><td>1/8</td><td>825/20464 </td><td>2.805415e-01</td><td>4.464826e-01</td><td>2.892195e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                  </td><td>1/8</td><td>869/20464 </td><td>2.933383e-01</td><td>4.464826e-01</td><td>2.892195e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                              </td><td>1/8</td><td>884/20464 </td><td>2.976551e-01</td><td>4.464826e-01</td><td>2.892195e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04152</td><td>AMPK signaling pathway                          </td><td>1/8</td><td>1016/20464</td><td>3.346590e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04261</td><td>Adrenergic signaling in cardiomyocytes          </td><td>1/8</td><td>1089/20464</td><td>3.543814e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa05142</td><td>Chagas disease                                  </td><td>1/8</td><td>1129/20464</td><td>3.649696e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa05130</td><td>Pathogenic Escherichia coli infection           </td><td>1/8</td><td>1155/20464</td><td>3.717703e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels</td><td>1/8</td><td>1195/20464</td><td>3.821083e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04270</td><td>Vascular smooth muscle contraction              </td><td>1/8</td><td>1253/20464</td><td>3.968341e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa04728</td><td>Dopaminergic synapse                            </td><td>1/8</td><td>1323/20464</td><td>4.141969e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa05171</td><td>Coronavirus disease - COVID-19                  </td><td>1/8</td><td>1356/20464</td><td>4.222294e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa05020</td><td>Prion disease                                   </td><td>1/8</td><td>1382/20464</td><td>4.284900e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","\t<tr><td>hsa04210</td><td>Apoptosis                                       </td><td>1/8</td><td>1454/20464</td><td>4.455183e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","\t<tr><td>hsa04022</td><td>cGMP-PKG signaling pathway                      </td><td>1/8</td><td>1509/20464</td><td>4.582252e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>zuclopenthixol                                                              </td><td>1</td></tr>\n","\t<tr><td>hsa05415</td><td>Diabetic cardiomyopathy                         </td><td>1/8</td><td>1542/20464</td><td>4.657265e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>rescinnamine                                                                </td><td>1</td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                            </td><td>1/8</td><td>1549/20464</td><td>4.673059e-01</td><td>4.673059e-01</td><td>3.027083e-01</td><td>epothilone                                                                  </td><td>1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"_hG_nSSxLiDj"},"source":["### 2. GSEA method\n"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"ouqYezgyLl46","executionInfo":{"status":"ok","timestamp":1636338419506,"user_tz":-480,"elapsed":2994,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"6b746c85-60c6-4dc2-fa0d-e2979ddff7d8"},"source":["# GO\n","dl <- abs(result(lincs)$NCS); names(dl) <- result(lincs)$pert\n","dl <- dl[dl > 0]\n","dl <- dl[!duplicated(names(dl))]\n","gsea_res <- dsea_GSEA(drugList = dl, type='GO', ont='MF', exponent = 1, nPerm=1000,\n","                      pvalueCutoff = 0.2, minGSSize = 5)\n","result(gsea_res)                      "],"execution_count":37,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ont ID        \n","1  MF  GO:0004407\n","2  MF  GO:0016811\n","3  MF  GO:0017136\n","4  MF  GO:0019213\n","5  MF  GO:0031078\n","6  MF  GO:0032041\n","7  MF  GO:0033558\n","8  MF  GO:0034979\n","9  MF  GO:0003714\n","10 MF  GO:0002039\n","11 MF  GO:0047485\n","12 MF  GO:0001103\n","13 MF  GO:0070491\n","14 MF  GO:0001047\n","15 MF  GO:0016810\n","16 MF  GO:0000980\n","17 MF  GO:0001158\n","18 MF  GO:0035326\n","19 MF  GO:0051059\n","20 MF  GO:0042826\n","21 MF  GO:0001085\n","22 MF  GO:0000978\n","23 MF  GO:0000987\n","24 MF  GO:0016787\n","25 MF  GO:0003682\n","26 MF  GO:0030332\n","27 MF  GO:0140096\n","28 MF  GO:0031072\n","29 MF  GO:0051879\n","30 MF  GO:0008013\n","31 MF  GO:0003712\n","32 MF  GO:0003779\n","33 MF  GO:0000976\n","34 MF  GO:0000977\n","35 MF  GO:0001012\n","36 MF  GO:0003700\n","37 MF  GO:0043565\n","38 MF  GO:0140110\n","39 MF  GO:1990837\n","40 MF  GO:0019904\n","41 MF  GO:0044877\n","42 MF  GO:0031625\n","43 MF  GO:0044389\n","44 MF  GO:0042562\n","45 MF  GO:0001067\n","46 MF  GO:0003677\n","47 MF  GO:0003690\n","48 MF  GO:0044212\n","49 MF  GO:0008134\n","50 MF  GO:0003824\n","51 MF  GO:0019899\n","52 MF  GO:0003676\n","53 MF  GO:0008092\n","   Description                                                                            \n","1  histone deacetylase activity                                                           \n","2  hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides\n","3  NAD-dependent histone deacetylase activity                                             \n","4  deacetylase activity                                                                   \n","5  histone deacetylase activity (H3-K14 specific)                                         \n","6  NAD-dependent histone deacetylase activity (H3-K14 specific)                           \n","7  protein deacetylase activity                                                           \n","8  NAD-dependent protein deacetylase activity                                             \n","9  transcription corepressor activity                                                     \n","10 p53 binding                                                                            \n","11 protein N-terminus binding                                                             \n","12 RNA polymerase II repressing transcription factor binding                              \n","13 repressing transcription factor binding                                                \n","14 core promoter binding                                                                  \n","15 hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  \n","16 RNA polymerase II distal enhancer sequence-specific DNA binding                        \n","17 enhancer sequence-specific DNA binding                                                 \n","18 enhancer binding                                                                       \n","19 NF-kappaB binding                                                                      \n","20 histone deacetylase binding                                                            \n","21 RNA polymerase II transcription factor binding                                         \n","22 RNA polymerase II proximal promoter sequence-specific DNA binding                      \n","23 proximal promoter sequence-specific DNA binding                                        \n","24 hydrolase activity                                                                     \n","25 chromatin binding                                                                      \n","26 cyclin binding                                                                         \n","27 catalytic activity, acting on a protein                                                \n","28 heat shock protein binding                                                             \n","29 Hsp90 protein binding                                                                  \n","30 beta-catenin binding                                                                   \n","31 transcription coregulator activity                                                     \n","32 actin binding                                                                          \n","33 transcription regulatory region sequence-specific DNA binding                          \n","34 RNA polymerase II regulatory region sequence-specific DNA binding                      \n","35 RNA polymerase II regulatory region DNA binding                                        \n","36 DNA-binding transcription factor activity                                              \n","37 sequence-specific DNA binding                                                          \n","38 transcription regulator activity                                                       \n","39 sequence-specific double-stranded DNA binding                                          \n","40 protein domain specific binding                                                        \n","41 protein-containing complex binding                                                     \n","42 ubiquitin protein ligase binding                                                       \n","43 ubiquitin-like protein ligase binding                                                  \n","44 hormone binding                                                                        \n","45 regulatory region nucleic acid binding                                                 \n","46 DNA binding                                                                            \n","47 double-stranded DNA binding                                                            \n","48 transcription regulatory region DNA binding                                            \n","49 transcription factor binding                                                           \n","50 catalytic activity                                                                     \n","51 enzyme binding                                                                         \n","52 nucleic acid binding                                                                   \n","53 cytoskeletal protein binding                                                           \n","   setSize enrichmentScore NES      pvalue      p.adjust   qvalues   \n","1   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","2   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","3   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","4   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","5   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","6   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","7   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","8   5      0.9512195       2.831582 0.000999001 0.01562805 0.01031032\n","9   5      0.9306673       2.770403 0.000999001 0.01562805 0.01031032\n","10  5      0.9131440       2.718239 0.000999001 0.01562805 0.01031032\n","11  5      0.9131440       2.718239 0.000999001 0.01562805 0.01031032\n","12  5      0.9110264       2.711936 0.000999001 0.01562805 0.01031032\n","13  5      0.9110264       2.711936 0.000999001 0.01562805 0.01031032\n","14  5      0.9007076       2.681219 0.000999001 0.01562805 0.01031032\n","15  6      0.8631918       2.656485 0.000999001 0.01562805 0.01031032\n","16  6      0.8542390       2.628933 0.000999001 0.01562805 0.01031032\n","17  6      0.8542390       2.628933 0.000999001 0.01562805 0.01031032\n","18  6      0.8542390       2.628933 0.000999001 0.01562805 0.01031032\n","19  6      0.8383772       2.580118 0.000999001 0.01562805 0.01031032\n","20  6      0.8313787       2.558580 0.000999001 0.01562805 0.01031032\n","21  8      0.7223961       2.385120 0.001998002 0.02385334 0.01573680\n","22  8      0.7056713       2.329900 0.002997003 0.03343378 0.02205732\n","23  8      0.7056713       2.329900 0.002997003 0.03343378 0.02205732\n","24 14      0.6306224       2.313491 0.003996004 0.03725042 0.02457528\n","25  9      0.6721323       2.285414 0.003996004 0.03725042 0.02457528\n","26  5      0.7582839       2.257253 0.004995005 0.04222486 0.02785707\n","27 13      0.6084314       2.187241 0.005994006 0.04884935 0.03222746\n","28  7      0.6697225       2.150186 0.009990010 0.06180183 0.04077262\n","29  7      0.6697225       2.150186 0.009990010 0.06180183 0.04077262\n","30  6      0.6968757       2.144645 0.007992008 0.05755091 0.03796816\n","31 10      0.6137614       2.119832 0.008991009 0.06180183 0.04077262\n","32  7      0.6167022       1.979961 0.024975025 0.09548036 0.06299141\n","33 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","34 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","35 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","36 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","37 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","38 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","39 12      0.5534966       1.971107 0.019980020 0.08945002 0.05901301\n","40 12      0.5433266       1.934890 0.021978022 0.09232126 0.06090725\n","41 12      0.5399063       1.922709 0.022977023 0.09334844 0.06158492\n","42  8      0.5776569       1.907238 0.035964036 0.11766118 0.07762480\n","43  8      0.5776569       1.907238 0.035964036 0.11766118 0.07762480\n","44  5      0.6341463       1.887721 0.044955045 0.12799962 0.08444539\n","45 13      0.5220101       1.876566 0.026973027 0.09948588 0.06563398\n","46 13      0.5220101       1.876566 0.026973027 0.09948588 0.06563398\n","47 13      0.5220101       1.876566 0.026973027 0.09948588 0.06563398\n","48 13      0.5220101       1.876566 0.026973027 0.09948588 0.06563398\n","49 14      0.4953860       1.817365 0.044955045 0.12799962 0.08444539\n","50 21      0.4605594       1.776701 0.039960040 0.12415424 0.08190848\n","51 18      0.4658542       1.762831 0.041958042 0.12605937 0.08316535\n","52 16      0.4674425       1.756431 0.045954046 0.12948956 0.08542836\n","53 10      0.4862094       1.679289 0.081918082 0.18040536 0.11901912\n","   leadingEdge                                                                                                                        \n","1  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","2  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","3  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","4  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","5  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","6  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","7  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","8  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","9  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","10 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","11 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","12 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","13 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","14 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","15 vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","16 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","17 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","18 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","19 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","20 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","21 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","22 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","23 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","24 vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                              \n","25 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","26 vorinostat/trichostatin-a/pyroxamide                                                                                               \n","27 vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8                                                         \n","28 vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                               \n","29 vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                               \n","30 vorinostat/trichostatin-a/pyroxamide                                                                                               \n","31 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","32 vorinostat/trichostatin-a/pyroxamide/progesterone/afatinib/calcitriol                                                              \n","33 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","34 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","35 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","36 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","37 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","38 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","39 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      \n","40 vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                           \n","41 vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                           \n","42 vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                        \n","43 vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                        \n","44 calcifediol/progesterone/afatinib/huperzine-a/calcitriol                                                                           \n","45 vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                \n","46 vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                \n","47 vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                \n","48 vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                \n","49 vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      \n","50 vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                              \n","51 vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/epothilone/warfarin/benzonatate/progesterone/afatinib/calcitriol/fasudil\n","52 vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone/warfarin/calcifediol/progesterone/afatinib/calcitriol/fasudil             \n","53 vorinostat/trichostatin-a/pyroxamide/benzonatate/progesterone/afatinib/calcitriol                                                  \n","   ledge_rank                   \n","1  1/2/3/4/7                    \n","2  1/2/3/4/7                    \n","3  1/2/3/4/7                    \n","4  1/2/3/4/7                    \n","5  1/2/3/4/7                    \n","6  1/2/3/4/7                    \n","7  1/2/3/4/7                    \n","8  1/2/3/4/7                    \n","9  1/2/3/4                      \n","10 1/2/3/4                      \n","11 1/2/3/4                      \n","12 1/2/3/4                      \n","13 1/2/3/4                      \n","14 1/2/3/4                      \n","15 1/2/3/4/7                    \n","16 1/2/3/4                      \n","17 1/2/3/4                      \n","18 1/2/3/4                      \n","19 1/2/3/4                      \n","20 1/2/3/4                      \n","21 1/2/3/4                      \n","22 1/2/3/4                      \n","23 1/2/3/4                      \n","24 1/2/3/4/6/7/8                \n","25 1/2/3/4                      \n","26 1/2/4                        \n","27 1/2/3/4/6/7                  \n","28 1/2/4/7                      \n","29 1/2/4/7                      \n","30 1/2/4                        \n","31 1/2/3/4                      \n","32 1/2/4/17/18/20               \n","33 1/2/3/4                      \n","34 1/2/3/4                      \n","35 1/2/3/4                      \n","36 1/2/3/4                      \n","37 1/2/3/4                      \n","38 1/2/3/4                      \n","39 1/2/3/4                      \n","40 1/2/3/4/8                    \n","41 1/2/3/4/8                    \n","42 1/2/4/8/12                   \n","43 1/2/4/8/12                   \n","44 15/17/18/19/20               \n","45 1/2/3/4/11/15/17/18/20       \n","46 1/2/3/4/11/15/17/18/20       \n","47 1/2/3/4/11/15/17/18/20       \n","48 1/2/3/4/11/15/17/18/20       \n","49 1/2/3/4/7                    \n","50 1/2/3/4/6/7/8                \n","51 1/2/3/4/6/8/11/12/17/18/20/21\n","52 1/2/3/4/8/11/15/17/18/20/21  \n","53 1/2/4/12/17/18/20            "],"text/latex":"A tibble: 53 × 11\n\\begin{tabular}{lllllllllll}\n ont & ID & Description & setSize & enrichmentScore & NES & pvalue & p.adjust & qvalues & leadingEdge & ledge\\_rank\\\\\n <chr> & <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <chr>\\\\\n\\hline\n\t MF & GO:0004407 & histone deacetylase activity                                                            &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0016811 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0017136 & NAD-dependent histone deacetylase activity                                              &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0019213 & deacetylase activity                                                                    &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0031078 & histone deacetylase activity (H3-K14 specific)                                          &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0032041 & NAD-dependent histone deacetylase activity (H3-K14 specific)                            &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0033558 & protein deacetylase activity                                                            &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0034979 & NAD-dependent protein deacetylase activity                                              &  5 & 0.9512195 & 2.831582 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0003714 & transcription corepressor activity                                                      &  5 & 0.9306673 & 2.770403 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0002039 & p53 binding                                                                             &  5 & 0.9131440 & 2.718239 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0047485 & protein N-terminus binding                                                              &  5 & 0.9131440 & 2.718239 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0001103 & RNA polymerase II repressing transcription factor binding                               &  5 & 0.9110264 & 2.711936 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0070491 & repressing transcription factor binding                                                 &  5 & 0.9110264 & 2.711936 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0001047 & core promoter binding                                                                   &  5 & 0.9007076 & 2.681219 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0016810 & hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   &  6 & 0.8631918 & 2.656485 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0000980 & RNA polymerase II distal enhancer sequence-specific DNA binding                         &  6 & 0.8542390 & 2.628933 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0001158 & enhancer sequence-specific DNA binding                                                  &  6 & 0.8542390 & 2.628933 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0035326 & enhancer binding                                                                        &  6 & 0.8542390 & 2.628933 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0051059 & NF-kappaB binding                                                                       &  6 & 0.8383772 & 2.580118 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0042826 & histone deacetylase binding                                                             &  6 & 0.8313787 & 2.558580 & 0.000999001 & 0.01562805 & 0.01031032 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0001085 & RNA polymerase II transcription factor binding                                          &  8 & 0.7223961 & 2.385120 & 0.001998002 & 0.02385334 & 0.01573680 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0000978 & RNA polymerase II proximal promoter sequence-specific DNA binding                       &  8 & 0.7056713 & 2.329900 & 0.002997003 & 0.03343378 & 0.02205732 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0000987 & proximal promoter sequence-specific DNA binding                                         &  8 & 0.7056713 & 2.329900 & 0.002997003 & 0.03343378 & 0.02205732 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0016787 & hydrolase activity                                                                      & 14 & 0.6306224 & 2.313491 & 0.003996004 & 0.03725042 & 0.02457528 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                               & 1/2/3/4/6/7/8                \\\\\n\t MF & GO:0003682 & chromatin binding                                                                       &  9 & 0.6721323 & 2.285414 & 0.003996004 & 0.03725042 & 0.02457528 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0030332 & cyclin binding                                                                          &  5 & 0.7582839 & 2.257253 & 0.004995005 & 0.04222486 & 0.02785707 & vorinostat/trichostatin-a/pyroxamide                                                                                                & 1/2/4                        \\\\\n\t MF & GO:0140096 & catalytic activity, acting on a protein                                                 & 13 & 0.6084314 & 2.187241 & 0.005994006 & 0.04884935 & 0.03222746 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8                                                          & 1/2/3/4/6/7                  \\\\\n\t MF & GO:0031072 & heat shock protein binding                                                              &  7 & 0.6697225 & 2.150186 & 0.009990010 & 0.06180183 & 0.04077262 & vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                                & 1/2/4/7                      \\\\\n\t MF & GO:0051879 & Hsp90 protein binding                                                                   &  7 & 0.6697225 & 2.150186 & 0.009990010 & 0.06180183 & 0.04077262 & vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                                & 1/2/4/7                      \\\\\n\t MF & GO:0008013 & beta-catenin binding                                                                    &  6 & 0.6968757 & 2.144645 & 0.007992008 & 0.05755091 & 0.03796816 & vorinostat/trichostatin-a/pyroxamide                                                                                                & 1/2/4                        \\\\\n\t MF & GO:0003712 & transcription coregulator activity                                                      & 10 & 0.6137614 & 2.119832 & 0.008991009 & 0.06180183 & 0.04077262 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0003779 & actin binding                                                                           &  7 & 0.6167022 & 1.979961 & 0.024975025 & 0.09548036 & 0.06299141 & vorinostat/trichostatin-a/pyroxamide/progesterone/afatinib/calcitriol                                                               & 1/2/4/17/18/20               \\\\\n\t MF & GO:0000976 & transcription regulatory region sequence-specific DNA binding                           & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0000977 & RNA polymerase II regulatory region sequence-specific DNA binding                       & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0001012 & RNA polymerase II regulatory region DNA binding                                         & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0003700 & DNA-binding transcription factor activity                                               & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0043565 & sequence-specific DNA binding                                                           & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0140110 & transcription regulator activity                                                        & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:1990837 & sequence-specific double-stranded DNA binding                                           & 12 & 0.5534966 & 1.971107 & 0.019980020 & 0.08945002 & 0.05901301 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       & 1/2/3/4                      \\\\\n\t MF & GO:0019904 & protein domain specific binding                                                         & 12 & 0.5433266 & 1.934890 & 0.021978022 & 0.09232126 & 0.06090725 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                            & 1/2/3/4/8                    \\\\\n\t MF & GO:0044877 & protein-containing complex binding                                                      & 12 & 0.5399063 & 1.922709 & 0.022977023 & 0.09334844 & 0.06158492 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                            & 1/2/3/4/8                    \\\\\n\t MF & GO:0031625 & ubiquitin protein ligase binding                                                        &  8 & 0.5776569 & 1.907238 & 0.035964036 & 0.11766118 & 0.07762480 & vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                         & 1/2/4/8/12                   \\\\\n\t MF & GO:0044389 & ubiquitin-like protein ligase binding                                                   &  8 & 0.5776569 & 1.907238 & 0.035964036 & 0.11766118 & 0.07762480 & vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                         & 1/2/4/8/12                   \\\\\n\t MF & GO:0042562 & hormone binding                                                                         &  5 & 0.6341463 & 1.887721 & 0.044955045 & 0.12799962 & 0.08444539 & calcifediol/progesterone/afatinib/huperzine-a/calcitriol                                                                            & 15/17/18/19/20               \\\\\n\t MF & GO:0001067 & regulatory region nucleic acid binding                                                  & 13 & 0.5220101 & 1.876566 & 0.026973027 & 0.09948588 & 0.06563398 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 & 1/2/3/4/11/15/17/18/20       \\\\\n\t MF & GO:0003677 & DNA binding                                                                             & 13 & 0.5220101 & 1.876566 & 0.026973027 & 0.09948588 & 0.06563398 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 & 1/2/3/4/11/15/17/18/20       \\\\\n\t MF & GO:0003690 & double-stranded DNA binding                                                             & 13 & 0.5220101 & 1.876566 & 0.026973027 & 0.09948588 & 0.06563398 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 & 1/2/3/4/11/15/17/18/20       \\\\\n\t MF & GO:0044212 & transcription regulatory region DNA binding                                             & 13 & 0.5220101 & 1.876566 & 0.026973027 & 0.09948588 & 0.06563398 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 & 1/2/3/4/11/15/17/18/20       \\\\\n\t MF & GO:0008134 & transcription factor binding                                                            & 14 & 0.4953860 & 1.817365 & 0.044955045 & 0.12799962 & 0.08444539 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       & 1/2/3/4/7                    \\\\\n\t MF & GO:0003824 & catalytic activity                                                                      & 21 & 0.4605594 & 1.776701 & 0.039960040 & 0.12415424 & 0.08190848 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                               & 1/2/3/4/6/7/8                \\\\\n\t MF & GO:0019899 & enzyme binding                                                                          & 18 & 0.4658542 & 1.762831 & 0.041958042 & 0.12605937 & 0.08316535 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/epothilone/warfarin/benzonatate/progesterone/afatinib/calcitriol/fasudil & 1/2/3/4/6/8/11/12/17/18/20/21\\\\\n\t MF & GO:0003676 & nucleic acid binding                                                                    & 16 & 0.4674425 & 1.756431 & 0.045954046 & 0.12948956 & 0.08542836 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone/warfarin/calcifediol/progesterone/afatinib/calcitriol/fasudil              & 1/2/3/4/8/11/15/17/18/20/21  \\\\\n\t MF & GO:0008092 & cytoskeletal protein binding                                                            & 10 & 0.4862094 & 1.679289 & 0.081918082 & 0.18040536 & 0.11901912 & vorinostat/trichostatin-a/pyroxamide/benzonatate/progesterone/afatinib/calcitriol                                                   & 1/2/4/12/17/18/20            \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 53 × 11\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | enrichmentScore &lt;dbl&gt; | NES &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | leadingEdge &lt;chr&gt; | ledge_rank &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|\n| MF | GO:0004407 | histone deacetylase activity                                                            |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0017136 | NAD-dependent histone deacetylase activity                                              |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0019213 | deacetylase activity                                                                    |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0031078 | histone deacetylase activity (H3-K14 specific)                                          |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0032041 | NAD-dependent histone deacetylase activity (H3-K14 specific)                            |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0033558 | protein deacetylase activity                                                            |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0034979 | NAD-dependent protein deacetylase activity                                              |  5 | 0.9512195 | 2.831582 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0003714 | transcription corepressor activity                                                      |  5 | 0.9306673 | 2.770403 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0002039 | p53 binding                                                                             |  5 | 0.9131440 | 2.718239 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0047485 | protein N-terminus binding                                                              |  5 | 0.9131440 | 2.718239 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0001103 | RNA polymerase II repressing transcription factor binding                               |  5 | 0.9110264 | 2.711936 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0070491 | repressing transcription factor binding                                                 |  5 | 0.9110264 | 2.711936 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0001047 | core promoter binding                                                                   |  5 | 0.9007076 | 2.681219 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                   |  6 | 0.8631918 | 2.656485 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding                         |  6 | 0.8542390 | 2.628933 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0001158 | enhancer sequence-specific DNA binding                                                  |  6 | 0.8542390 | 2.628933 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0035326 | enhancer binding                                                                        |  6 | 0.8542390 | 2.628933 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0051059 | NF-kappaB binding                                                                       |  6 | 0.8383772 | 2.580118 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0042826 | histone deacetylase binding                                                             |  6 | 0.8313787 | 2.558580 | 0.000999001 | 0.01562805 | 0.01031032 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0001085 | RNA polymerase II transcription factor binding                                          |  8 | 0.7223961 | 2.385120 | 0.001998002 | 0.02385334 | 0.01573680 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding                       |  8 | 0.7056713 | 2.329900 | 0.002997003 | 0.03343378 | 0.02205732 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0000987 | proximal promoter sequence-specific DNA binding                                         |  8 | 0.7056713 | 2.329900 | 0.002997003 | 0.03343378 | 0.02205732 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0016787 | hydrolase activity                                                                      | 14 | 0.6306224 | 2.313491 | 0.003996004 | 0.03725042 | 0.02457528 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                               | 1/2/3/4/6/7/8                 |\n| MF | GO:0003682 | chromatin binding                                                                       |  9 | 0.6721323 | 2.285414 | 0.003996004 | 0.03725042 | 0.02457528 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0030332 | cyclin binding                                                                          |  5 | 0.7582839 | 2.257253 | 0.004995005 | 0.04222486 | 0.02785707 | vorinostat/trichostatin-a/pyroxamide                                                                                                | 1/2/4                         |\n| MF | GO:0140096 | catalytic activity, acting on a protein                                                 | 13 | 0.6084314 | 2.187241 | 0.005994006 | 0.04884935 | 0.03222746 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8                                                          | 1/2/3/4/6/7                   |\n| MF | GO:0031072 | heat shock protein binding                                                              |  7 | 0.6697225 | 2.150186 | 0.009990010 | 0.06180183 | 0.04077262 | vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                                | 1/2/4/7                       |\n| MF | GO:0051879 | Hsp90 protein binding                                                                   |  7 | 0.6697225 | 2.150186 | 0.009990010 | 0.06180183 | 0.04077262 | vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                                | 1/2/4/7                       |\n| MF | GO:0008013 | beta-catenin binding                                                                    |  6 | 0.6968757 | 2.144645 | 0.007992008 | 0.05755091 | 0.03796816 | vorinostat/trichostatin-a/pyroxamide                                                                                                | 1/2/4                         |\n| MF | GO:0003712 | transcription coregulator activity                                                      | 10 | 0.6137614 | 2.119832 | 0.008991009 | 0.06180183 | 0.04077262 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0003779 | actin binding                                                                           |  7 | 0.6167022 | 1.979961 | 0.024975025 | 0.09548036 | 0.06299141 | vorinostat/trichostatin-a/pyroxamide/progesterone/afatinib/calcitriol                                                               | 1/2/4/17/18/20                |\n| MF | GO:0000976 | transcription regulatory region sequence-specific DNA binding                           | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding                       | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0001012 | RNA polymerase II regulatory region DNA binding                                         | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0003700 | DNA-binding transcription factor activity                                               | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0043565 | sequence-specific DNA binding                                                           | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0140110 | transcription regulator activity                                                        | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:1990837 | sequence-specific double-stranded DNA binding                                           | 12 | 0.5534966 | 1.971107 | 0.019980020 | 0.08945002 | 0.05901301 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                       | 1/2/3/4                       |\n| MF | GO:0019904 | protein domain specific binding                                                         | 12 | 0.5433266 | 1.934890 | 0.021978022 | 0.09232126 | 0.06090725 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                            | 1/2/3/4/8                     |\n| MF | GO:0044877 | protein-containing complex binding                                                      | 12 | 0.5399063 | 1.922709 | 0.022977023 | 0.09334844 | 0.06158492 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                            | 1/2/3/4/8                     |\n| MF | GO:0031625 | ubiquitin protein ligase binding                                                        |  8 | 0.5776569 | 1.907238 | 0.035964036 | 0.11766118 | 0.07762480 | vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                         | 1/2/4/8/12                    |\n| MF | GO:0044389 | ubiquitin-like protein ligase binding                                                   |  8 | 0.5776569 | 1.907238 | 0.035964036 | 0.11766118 | 0.07762480 | vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                         | 1/2/4/8/12                    |\n| MF | GO:0042562 | hormone binding                                                                         |  5 | 0.6341463 | 1.887721 | 0.044955045 | 0.12799962 | 0.08444539 | calcifediol/progesterone/afatinib/huperzine-a/calcitriol                                                                            | 15/17/18/19/20                |\n| MF | GO:0001067 | regulatory region nucleic acid binding                                                  | 13 | 0.5220101 | 1.876566 | 0.026973027 | 0.09948588 | 0.06563398 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 | 1/2/3/4/11/15/17/18/20        |\n| MF | GO:0003677 | DNA binding                                                                             | 13 | 0.5220101 | 1.876566 | 0.026973027 | 0.09948588 | 0.06563398 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 | 1/2/3/4/11/15/17/18/20        |\n| MF | GO:0003690 | double-stranded DNA binding                                                             | 13 | 0.5220101 | 1.876566 | 0.026973027 | 0.09948588 | 0.06563398 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 | 1/2/3/4/11/15/17/18/20        |\n| MF | GO:0044212 | transcription regulatory region DNA binding                                             | 13 | 0.5220101 | 1.876566 | 0.026973027 | 0.09948588 | 0.06563398 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                 | 1/2/3/4/11/15/17/18/20        |\n| MF | GO:0008134 | transcription factor binding                                                            | 14 | 0.4953860 | 1.817365 | 0.044955045 | 0.12799962 | 0.08444539 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                       | 1/2/3/4/7                     |\n| MF | GO:0003824 | catalytic activity                                                                      | 21 | 0.4605594 | 1.776701 | 0.039960040 | 0.12415424 | 0.08190848 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                               | 1/2/3/4/6/7/8                 |\n| MF | GO:0019899 | enzyme binding                                                                          | 18 | 0.4658542 | 1.762831 | 0.041958042 | 0.12605937 | 0.08316535 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/epothilone/warfarin/benzonatate/progesterone/afatinib/calcitriol/fasudil | 1/2/3/4/6/8/11/12/17/18/20/21 |\n| MF | GO:0003676 | nucleic acid binding                                                                    | 16 | 0.4674425 | 1.756431 | 0.045954046 | 0.12948956 | 0.08542836 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone/warfarin/calcifediol/progesterone/afatinib/calcitriol/fasudil              | 1/2/3/4/8/11/15/17/18/20/21   |\n| MF | GO:0008092 | cytoskeletal protein binding                                                            | 10 | 0.4862094 | 1.679289 | 0.081918082 | 0.18040536 | 0.11901912 | vorinostat/trichostatin-a/pyroxamide/benzonatate/progesterone/afatinib/calcitriol                                                   | 1/2/4/12/17/18/20             |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 53 × 11</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>enrichmentScore</th><th scope=col>NES</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>leadingEdge</th><th scope=col>ledge_rank</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>MF</td><td>GO:0004407</td><td>histone deacetylase activity                                                           </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0016811</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides</td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0017136</td><td>NAD-dependent histone deacetylase activity                                             </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0019213</td><td>deacetylase activity                                                                   </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0031078</td><td>histone deacetylase activity (H3-K14 specific)                                         </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0032041</td><td>NAD-dependent histone deacetylase activity (H3-K14 specific)                           </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0033558</td><td>protein deacetylase activity                                                           </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0034979</td><td>NAD-dependent protein deacetylase activity                                             </td><td> 5</td><td>0.9512195</td><td>2.831582</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0003714</td><td>transcription corepressor activity                                                     </td><td> 5</td><td>0.9306673</td><td>2.770403</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0002039</td><td>p53 binding                                                                            </td><td> 5</td><td>0.9131440</td><td>2.718239</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0047485</td><td>protein N-terminus binding                                                             </td><td> 5</td><td>0.9131440</td><td>2.718239</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0001103</td><td>RNA polymerase II repressing transcription factor binding                              </td><td> 5</td><td>0.9110264</td><td>2.711936</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0070491</td><td>repressing transcription factor binding                                                </td><td> 5</td><td>0.9110264</td><td>2.711936</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0001047</td><td>core promoter binding                                                                  </td><td> 5</td><td>0.9007076</td><td>2.681219</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0016810</td><td>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                  </td><td> 6</td><td>0.8631918</td><td>2.656485</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0000980</td><td>RNA polymerase II distal enhancer sequence-specific DNA binding                        </td><td> 6</td><td>0.8542390</td><td>2.628933</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0001158</td><td>enhancer sequence-specific DNA binding                                                 </td><td> 6</td><td>0.8542390</td><td>2.628933</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0035326</td><td>enhancer binding                                                                       </td><td> 6</td><td>0.8542390</td><td>2.628933</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0051059</td><td>NF-kappaB binding                                                                      </td><td> 6</td><td>0.8383772</td><td>2.580118</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0042826</td><td>histone deacetylase binding                                                            </td><td> 6</td><td>0.8313787</td><td>2.558580</td><td>0.000999001</td><td>0.01562805</td><td>0.01031032</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0001085</td><td>RNA polymerase II transcription factor binding                                         </td><td> 8</td><td>0.7223961</td><td>2.385120</td><td>0.001998002</td><td>0.02385334</td><td>0.01573680</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0000978</td><td>RNA polymerase II proximal promoter sequence-specific DNA binding                      </td><td> 8</td><td>0.7056713</td><td>2.329900</td><td>0.002997003</td><td>0.03343378</td><td>0.02205732</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0000987</td><td>proximal promoter sequence-specific DNA binding                                        </td><td> 8</td><td>0.7056713</td><td>2.329900</td><td>0.002997003</td><td>0.03343378</td><td>0.02205732</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0016787</td><td>hydrolase activity                                                                     </td><td>14</td><td>0.6306224</td><td>2.313491</td><td>0.003996004</td><td>0.03725042</td><td>0.02457528</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                              </td><td>1/2/3/4/6/7/8                </td></tr>\n","\t<tr><td>MF</td><td>GO:0003682</td><td>chromatin binding                                                                      </td><td> 9</td><td>0.6721323</td><td>2.285414</td><td>0.003996004</td><td>0.03725042</td><td>0.02457528</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0030332</td><td>cyclin binding                                                                         </td><td> 5</td><td>0.7582839</td><td>2.257253</td><td>0.004995005</td><td>0.04222486</td><td>0.02785707</td><td>vorinostat/trichostatin-a/pyroxamide                                                                                               </td><td>1/2/4                        </td></tr>\n","\t<tr><td>MF</td><td>GO:0140096</td><td>catalytic activity, acting on a protein                                                </td><td>13</td><td>0.6084314</td><td>2.187241</td><td>0.005994006</td><td>0.04884935</td><td>0.03222746</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8                                                         </td><td>1/2/3/4/6/7                  </td></tr>\n","\t<tr><td>MF</td><td>GO:0031072</td><td>heat shock protein binding                                                             </td><td> 7</td><td>0.6697225</td><td>2.150186</td><td>0.009990010</td><td>0.06180183</td><td>0.04077262</td><td>vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                               </td><td>1/2/4/7                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0051879</td><td>Hsp90 protein binding                                                                  </td><td> 7</td><td>0.6697225</td><td>2.150186</td><td>0.009990010</td><td>0.06180183</td><td>0.04077262</td><td>vorinostat/trichostatin-a/pyroxamide/apha-compound-8                                                                               </td><td>1/2/4/7                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0008013</td><td>beta-catenin binding                                                                   </td><td> 6</td><td>0.6968757</td><td>2.144645</td><td>0.007992008</td><td>0.05755091</td><td>0.03796816</td><td>vorinostat/trichostatin-a/pyroxamide                                                                                               </td><td>1/2/4                        </td></tr>\n","\t<tr><td>MF</td><td>GO:0003712</td><td>transcription coregulator activity                                                     </td><td>10</td><td>0.6137614</td><td>2.119832</td><td>0.008991009</td><td>0.06180183</td><td>0.04077262</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0003779</td><td>actin binding                                                                          </td><td> 7</td><td>0.6167022</td><td>1.979961</td><td>0.024975025</td><td>0.09548036</td><td>0.06299141</td><td>vorinostat/trichostatin-a/pyroxamide/progesterone/afatinib/calcitriol                                                              </td><td>1/2/4/17/18/20               </td></tr>\n","\t<tr><td>MF</td><td>GO:0000976</td><td>transcription regulatory region sequence-specific DNA binding                          </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0000977</td><td>RNA polymerase II regulatory region sequence-specific DNA binding                      </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0001012</td><td>RNA polymerase II regulatory region DNA binding                                        </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0003700</td><td>DNA-binding transcription factor activity                                              </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0043565</td><td>sequence-specific DNA binding                                                          </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0140110</td><td>transcription regulator activity                                                       </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:1990837</td><td>sequence-specific double-stranded DNA binding                                          </td><td>12</td><td>0.5534966</td><td>1.971107</td><td>0.019980020</td><td>0.08945002</td><td>0.05901301</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                                      </td><td>1/2/3/4                      </td></tr>\n","\t<tr><td>MF</td><td>GO:0019904</td><td>protein domain specific binding                                                        </td><td>12</td><td>0.5433266</td><td>1.934890</td><td>0.021978022</td><td>0.09232126</td><td>0.06090725</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                           </td><td>1/2/3/4/8                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0044877</td><td>protein-containing complex binding                                                     </td><td>12</td><td>0.5399063</td><td>1.922709</td><td>0.022977023</td><td>0.09334844</td><td>0.06158492</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                           </td><td>1/2/3/4/8                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0031625</td><td>ubiquitin protein ligase binding                                                       </td><td> 8</td><td>0.5776569</td><td>1.907238</td><td>0.035964036</td><td>0.11766118</td><td>0.07762480</td><td>vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                        </td><td>1/2/4/8/12                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0044389</td><td>ubiquitin-like protein ligase binding                                                  </td><td> 8</td><td>0.5776569</td><td>1.907238</td><td>0.035964036</td><td>0.11766118</td><td>0.07762480</td><td>vorinostat/trichostatin-a/pyroxamide/epothilone/benzonatate                                                                        </td><td>1/2/4/8/12                   </td></tr>\n","\t<tr><td>MF</td><td>GO:0042562</td><td>hormone binding                                                                        </td><td> 5</td><td>0.6341463</td><td>1.887721</td><td>0.044955045</td><td>0.12799962</td><td>0.08444539</td><td>calcifediol/progesterone/afatinib/huperzine-a/calcitriol                                                                           </td><td>15/17/18/19/20               </td></tr>\n","\t<tr><td>MF</td><td>GO:0001067</td><td>regulatory region nucleic acid binding                                                 </td><td>13</td><td>0.5220101</td><td>1.876566</td><td>0.026973027</td><td>0.09948588</td><td>0.06563398</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                </td><td>1/2/3/4/11/15/17/18/20       </td></tr>\n","\t<tr><td>MF</td><td>GO:0003677</td><td>DNA binding                                                                            </td><td>13</td><td>0.5220101</td><td>1.876566</td><td>0.026973027</td><td>0.09948588</td><td>0.06563398</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                </td><td>1/2/3/4/11/15/17/18/20       </td></tr>\n","\t<tr><td>MF</td><td>GO:0003690</td><td>double-stranded DNA binding                                                            </td><td>13</td><td>0.5220101</td><td>1.876566</td><td>0.026973027</td><td>0.09948588</td><td>0.06563398</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                </td><td>1/2/3/4/11/15/17/18/20       </td></tr>\n","\t<tr><td>MF</td><td>GO:0044212</td><td>transcription regulatory region DNA binding                                            </td><td>13</td><td>0.5220101</td><td>1.876566</td><td>0.026973027</td><td>0.09948588</td><td>0.06563398</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/warfarin/calcifediol/progesterone/afatinib/calcitriol                                </td><td>1/2/3/4/11/15/17/18/20       </td></tr>\n","\t<tr><td>MF</td><td>GO:0008134</td><td>transcription factor binding                                                           </td><td>14</td><td>0.4953860</td><td>1.817365</td><td>0.044955045</td><td>0.12799962</td><td>0.08444539</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                                      </td><td>1/2/3/4/7                    </td></tr>\n","\t<tr><td>MF</td><td>GO:0003824</td><td>catalytic activity                                                                     </td><td>21</td><td>0.4605594</td><td>1.776701</td><td>0.039960040</td><td>0.12415424</td><td>0.08190848</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/apha-compound-8/epothilone                                              </td><td>1/2/3/4/6/7/8                </td></tr>\n","\t<tr><td>MF</td><td>GO:0019899</td><td>enzyme binding                                                                         </td><td>18</td><td>0.4658542</td><td>1.762831</td><td>0.041958042</td><td>0.12605937</td><td>0.08316535</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/rescinnamine/epothilone/warfarin/benzonatate/progesterone/afatinib/calcitriol/fasudil</td><td>1/2/3/4/6/8/11/12/17/18/20/21</td></tr>\n","\t<tr><td>MF</td><td>GO:0003676</td><td>nucleic acid binding                                                                   </td><td>16</td><td>0.4674425</td><td>1.756431</td><td>0.045954046</td><td>0.12948956</td><td>0.08542836</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone/warfarin/calcifediol/progesterone/afatinib/calcitriol/fasudil             </td><td>1/2/3/4/8/11/15/17/18/20/21  </td></tr>\n","\t<tr><td>MF</td><td>GO:0008092</td><td>cytoskeletal protein binding                                                           </td><td>10</td><td>0.4862094</td><td>1.679289</td><td>0.081918082</td><td>0.18040536</td><td>0.11901912</td><td>vorinostat/trichostatin-a/pyroxamide/benzonatate/progesterone/afatinib/calcitriol                                                  </td><td>1/2/4/12/17/18/20            </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"Qf5XkoTCL7ul","executionInfo":{"status":"ok","timestamp":1636338422560,"user_tz":-480,"elapsed":3058,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"88128c86-1db4-4e88-da92-1a393203710f"},"source":["# KEGG\n","gsea_k_res <- dsea_GSEA(drugList=dl, type=\"KEGG\", exponent=1, nPerm=1000, \n","                        pvalueCutoff=1, minGSSize=5)\n","result(gsea_k_res)"],"execution_count":38,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ID       Description                                               setSize\n","1  hsa05031 Amphetamine addiction                                      8     \n","2  hsa04613 Neutrophil extracellular trap formation                    7     \n","3  hsa04110 Cell cycle                                                 6     \n","4  hsa05169 Epstein-Barr virus infection                               6     \n","5  hsa05034 Alcoholism                                                10     \n","6  hsa05202 Transcriptional misregulation in cancer                    7     \n","7  hsa04213 Longevity regulating pathway - multiple species            7     \n","8  hsa05016 Huntington disease                                         8     \n","9  hsa05220 Chronic myeloid leukemia                                   8     \n","10 hsa04919 Thyroid hormone signaling pathway                          9     \n","11 hsa05203 Viral carcinogenesis                                      10     \n","12 hsa05165 Human papillomavirus infection                            10     \n","13 hsa05206 MicroRNAs in cancer                                       10     \n","14 hsa05014 Amyotrophic lateral sclerosis                              7     \n","15 hsa05200 Pathways in cancer                                        12     \n","16 hsa04371 Apelin signaling pathway                                   6     \n","17 hsa05012 Parkinson disease                                          5     \n","18 hsa04928 Parathyroid hormone synthesis, secretion and action        7     \n","19 hsa04540 Gap junction                                               9     \n","20 hsa05207 Chemical carcinogenesis - receptor activation              8     \n","21 hsa04934 Cushing syndrome                                           7     \n","22 hsa05022 Pathways of neurodegeneration - multiple diseases          7     \n","23 hsa04530 Tight junction                                             5     \n","24 hsa04724 Glutamatergic synapse                                      5     \n","25 hsa04072 Phospholipase D signaling pathway                          6     \n","26 hsa04270 Vascular smooth muscle contraction                         6     \n","27 hsa04720 Long-term potentiation                                     6     \n","28 hsa05010 Alzheimer disease                                          6     \n","29 hsa04010 MAPK signaling pathway                                     5     \n","30 hsa04014 Ras signaling pathway                                      5     \n","⋮  ⋮        ⋮                                                         ⋮      \n","40 hsa05132 Salmonella infection                                       5     \n","41 hsa05160 Hepatitis C                                                5     \n","42 hsa05214 Glioma                                                     5     \n","43 hsa05215 Prostate cancer                                            5     \n","44 hsa05218 Melanoma                                                   5     \n","45 hsa05219 Bladder cancer                                             5     \n","46 hsa05223 Non-small cell lung cancer                                 5     \n","47 hsa05225 Hepatocellular carcinoma                                   5     \n","48 hsa05226 Gastric cancer                                             5     \n","49 hsa05417 Lipid and atherosclerosis                                  5     \n","50 hsa04080 Neuroactive ligand-receptor interaction                    7     \n","51 hsa05032 Morphine addiction                                         5     \n","52 hsa04750 Inflammatory mediator regulation of TRP channels           5     \n","53 hsa04725 Cholinergic synapse                                        5     \n","54 hsa04961 Endocrine and other factor-regulated calcium reabsorption  7     \n","55 hsa04723 Retrograde endocannabinoid signaling                       6     \n","56 hsa04970 Salivary secretion                                         6     \n","57 hsa04020 Calcium signaling pathway                                 10     \n","58 hsa04015 Rap1 signaling pathway                                     5     \n","59 hsa04261 Adrenergic signaling in cardiomyocytes                     8     \n","60 hsa05163 Human cytomegalovirus infection                            7     \n","61 hsa04062 Chemokine signaling pathway                                5     \n","62 hsa05167 Kaposi sarcoma-associated herpesvirus infection            5     \n","63 hsa01100 Metabolic pathways                                         7     \n","64 hsa04022 cGMP-PKG signaling pathway                                 7     \n","65 hsa04024 cAMP signaling pathway                                     7     \n","66 hsa01522 Endocrine resistance                                       7     \n","67 hsa04915 Estrogen signaling pathway                                 6     \n","68 hsa05205 Proteoglycans in cancer                                    6     \n","69 hsa05224 Breast cancer                                              6     \n","   enrichmentScore NES       pvalue      p.adjust   qvalues   \n","1  0.7846215       2.6130321 0.000999001 0.01148851 0.00946422\n","2  0.8068409       2.5893643 0.000999001 0.01148851 0.00946422\n","3  0.8384286       2.5605182 0.000999001 0.01148851 0.00946422\n","4  0.8384286       2.5605182 0.000999001 0.01148851 0.00946422\n","5  0.7307706       2.5252132 0.001998002 0.01969459 0.01622438\n","6  0.7715778       2.4761959 0.000999001 0.01148851 0.00946422\n","7  0.7619107       2.4451716 0.000999001 0.01148851 0.00946422\n","8  0.7179226       2.3909043 0.002997003 0.02297702 0.01892844\n","9  0.7167674       2.3870571 0.002997003 0.02297702 0.01892844\n","10 0.6729656       2.2859907 0.003996004 0.02506584 0.02064921\n","11 0.6393762       2.2093954 0.003996004 0.02506584 0.02064921\n","12 0.6206312       2.1446211 0.005994006 0.03181434 0.02620861\n","13 0.6167598       2.1312433 0.005994006 0.03181434 0.02620861\n","14 0.6333261       2.0325098 0.017982018 0.08271728 0.06814238\n","15 0.5586002       1.9987811 0.015984016 0.07877836 0.06489751\n","16 0.5791798       1.7687856 0.068931069 0.29726523 0.24488669\n","17 0.4222980       1.2408925 0.345654346 0.90654800 0.74681300\n","18 0.3363495       1.0794337 0.433566434 0.90654800 0.74681300\n","19 0.2702703       0.9180786 0.573426573 0.90654800 0.74681300\n","20 0.2516108       0.8379417 0.617382617 0.90654800 0.74681300\n","21 0.2564103       0.8228879 0.655344655 0.90654800 0.74681300\n","22 0.2564103       0.8228879 0.655344655 0.90654800 0.74681300\n","23 0.2682927       0.7883589 0.638361638 0.90654800 0.74681300\n","24 0.2682927       0.7883589 0.638361638 0.90654800 0.74681300\n","25 0.2500000       0.7634873 0.666333666 0.90654800 0.74681300\n","26 0.2500000       0.7634873 0.666333666 0.90654800 0.74681300\n","27 0.2500000       0.7634873 0.666333666 0.90654800 0.74681300\n","28 0.2500000       0.7634873 0.666333666 0.90654800 0.74681300\n","29 0.2439024       0.7166899 0.696303696 0.90654800 0.74681300\n","30 0.2439024       0.7166899 0.696303696 0.90654800 0.74681300\n","⋮  ⋮               ⋮         ⋮           ⋮          ⋮         \n","40 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","41 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","42 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","43 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","44 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","45 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","46 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","47 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","48 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","49 0.24390244      0.7166899 0.6963037   0.9065480  0.7468130 \n","50 0.20512821      0.6583103 0.7292707   0.9065480  0.7468130 \n","51 0.22310045      0.6555647 0.7222777   0.9065480  0.7468130 \n","52 0.21847059      0.6419602 0.7442557   0.9065480  0.7468130 \n","53 0.21836420      0.6416476 0.7442557   0.9065480  0.7468130 \n","54 0.19173131      0.6153161 0.7512488   0.9065480  0.7468130 \n","55 0.20000000      0.6107898 0.7752248   0.9065480  0.7468130 \n","56 0.19145159      0.5846834 0.7842158   0.9065480  0.7468130 \n","57 0.16649450      0.5753298 0.8131868   0.9065480  0.7468130 \n","58 0.19512195      0.5733519 0.7802198   0.9065480  0.7468130 \n","59 0.16655073      0.5546654 0.7802198   0.9065480  0.7468130 \n","60 0.15384615      0.4937327 0.8331668   0.9065480  0.7468130 \n","61 0.14634146      0.4300139 0.8351648   0.9065480  0.7468130 \n","62 0.14634146      0.4300139 0.8351648   0.9065480  0.7468130 \n","63 0.12820513      0.4114439 0.8561439   0.9065480  0.7468130 \n","64 0.12820513      0.4114439 0.8561439   0.9065480  0.7468130 \n","65 0.12820513      0.4114439 0.8561439   0.9065480  0.7468130 \n","66 0.11342597      0.3640137 0.8671329   0.9065480  0.7468130 \n","67 0.09854338      0.3009465 0.9100899   0.9190809  0.7571376 \n","68 0.09854338      0.3009465 0.9100899   0.9190809  0.7571376 \n","69 0.08618149      0.2631939 0.9190809   0.9190809  0.7571376 \n","   leadingEdge                                                                                                               \n","1  vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                                                              \n","2  vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                             \n","3  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","4  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","5  vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8                                              \n","6  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","7  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","8  vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                  \n","9  vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","10 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","11 vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                             \n","12 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","13 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","14 vorinostat/trichostatin-a/pyroxamide/epothilone                                                                           \n","15 vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             \n","16 vorinostat/trichostatin-a                                                                                                 \n","17 zuclopenthixol/epothilone/progesterone/fasudil                                                                            \n","18 sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol                            \n","19 zuclopenthixol/epothilone/progesterone/afatinib/fasudil/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib\n","20 propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol             \n","21 sorafenib/4,5,6,7-tetrabromobenzotriazole/hydroquinidine/ryuvidine/fasudil/afatinib/progesterone                          \n","22 epothilone/rimcazole/progesterone/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib                      \n","23 epothilone/afatinib/fasudil/ryuvidine/4,5,6,7-tetrabromobenzotriazole                                                     \n","24 4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                             \n","25 sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/afatinib/progesterone                                  \n","26 zuclopenthixol/progesterone/fasudil/scoulerine/4,5,6,7-tetrabromobenzotriazole/sorafenib                                  \n","27 sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                   \n","28 sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam                                                        \n","29 sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                   \n","30 sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                   \n","⋮  ⋮                                                                                                                         \n","40 epothilone/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/sorafenib                                                 \n","41 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","42 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","43 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","44 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","45 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","46 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","47 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","48 sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 \n","49                                                                                                                           \n","50 olvanil/decafluorobutane/fenobam/jwh-015/scoulerine                                                                       \n","51 zuclopenthixol/progesterone/fasudil                                                                                       \n","52 zuclopenthixol/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/olvanil                                               \n","53 xe-991/4,5,6,7-tetrabromobenzotriazole/fasudil/huperzine-a/progesterone                                                   \n","54 propylpyrazole/calmidazolium/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/progesterone/calcifediol                  \n","55 olvanil/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                     \n","56 zuclopenthixol/progesterone/fasudil/scoulerine                                                                            \n","57 calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/scoulerine/fasudil/afatinib/progesterone \n","58 olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole/afatinib/progesterone                                                   \n","59 zuclopenthixol/benzonatate/progesterone/fasudil/scoulerine                                                                \n","60 vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                              \n","61 vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/progesterone                                                 \n","62 vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine                                                            \n","63 calmidazolium/sorafenib/hydroquinidine/raltitrexed/calcitriol/progesterone/warfarin                                       \n","64 calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/scoulerine/fasudil/progesterone                                   \n","65 calmidazolium/olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole                                                           \n","66 propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                          \n","67 propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    \n","68 propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    \n","69 propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                  \n","   ledge_rank                \n","1  1/2/3/4/5                 \n","2  1/2/3/4/7                 \n","3  1/2/3/4                   \n","4  1/2/3/4                   \n","5  1/2/3/4/5/7               \n","6  1/2/3/4                   \n","7  1/2/3/4                   \n","8  1/2/3/4/8                 \n","9  1/2/3/4                   \n","10 1/2/3/4                   \n","11 1/2/3/4/7                 \n","12 1/2/3/4                   \n","13 1/2/3/4                   \n","14 1/2/4/8                   \n","15 1/2/3/4                   \n","16 1/2                       \n","17 5/8/17/21                 \n","18 36/35/21/20/18/17/15      \n","19 5/8/17/18/21/32/33/35/36  \n","20 43/36/35/21/20/18/17/15   \n","21 36/35/34/30/21/18/17      \n","22 8/16/17/32/33/35/36       \n","23 8/18/21/30/35             \n","24 35/33/32/21/17            \n","25 36/35/33/32/18/17         \n","26 5/17/21/25/35/36          \n","27 36/35/33/32/21/17         \n","28 36/35/33/32               \n","29 36/35/21/18/17            \n","30 36/35/21/18/17            \n","⋮  ⋮                         \n","40 8/17/21/35/36             \n","41 36/35/30/18/17            \n","42 36/35/30/18/17            \n","43 36/35/30/18/17            \n","44 36/35/30/18/17            \n","45 36/35/30/18/17            \n","46 36/35/30/18/17            \n","47 36/35/30/18/17            \n","48 36/35/30/18/17            \n","49                           \n","50 38/33/32/28/25            \n","51 5/17/21                   \n","52 5/17/21/35/38             \n","53 44/35/21/19/17            \n","54 43/41/35/21/20/17/15      \n","55 38/35/33/32/21/17         \n","56 5/17/21/25                \n","57 41/36/35/33/32/25/21/18/17\n","58 38/36/35/18/17            \n","59 5/12/17/21/25             \n","60 40/36/35/30/21/18/17      \n","61 40/36/35/21/17            \n","62 40/36/35/30               \n","63 41/36/34/27/20/17/11      \n","64 41/36/35/25/21/17         \n","65 41/38/36/35               \n","66 43/36/35/30/21/18/17      \n","67 43/36/35/21/18/17         \n","68 43/36/35/21/18/17         \n","69 43/36/35/30/18/17         "],"text/latex":"A tibble: 69 × 10\n\\begin{tabular}{llllllllll}\n ID & Description & setSize & enrichmentScore & NES & pvalue & p.adjust & qvalues & leadingEdge & ledge\\_rank\\\\\n <chr> & <chr> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <chr>\\\\\n\\hline\n\t hsa05031 & Amphetamine addiction                               &  8 & 0.7846215 & 2.6130321 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                                                               & 1/2/3/4/5               \\\\\n\t hsa04613 & Neutrophil extracellular trap formation             &  7 & 0.8068409 & 2.5893643 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                              & 1/2/3/4/7               \\\\\n\t hsa04110 & Cell cycle                                          &  6 & 0.8384286 & 2.5605182 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05169 & Epstein-Barr virus infection                        &  6 & 0.8384286 & 2.5605182 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05034 & Alcoholism                                          & 10 & 0.7307706 & 2.5252132 & 0.001998002 & 0.01969459 & 0.01622438 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8                                               & 1/2/3/4/5/7             \\\\\n\t hsa05202 & Transcriptional misregulation in cancer             &  7 & 0.7715778 & 2.4761959 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa04213 & Longevity regulating pathway - multiple species     &  7 & 0.7619107 & 2.4451716 & 0.000999001 & 0.01148851 & 0.00946422 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05016 & Huntington disease                                  &  8 & 0.7179226 & 2.3909043 & 0.002997003 & 0.02297702 & 0.01892844 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                   & 1/2/3/4/8               \\\\\n\t hsa05220 & Chronic myeloid leukemia                            &  8 & 0.7167674 & 2.3870571 & 0.002997003 & 0.02297702 & 0.01892844 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa04919 & Thyroid hormone signaling pathway                   &  9 & 0.6729656 & 2.2859907 & 0.003996004 & 0.02506584 & 0.02064921 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05203 & Viral carcinogenesis                                & 10 & 0.6393762 & 2.2093954 & 0.003996004 & 0.02506584 & 0.02064921 & vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                              & 1/2/3/4/7               \\\\\n\t hsa05165 & Human papillomavirus infection                      & 10 & 0.6206312 & 2.1446211 & 0.005994006 & 0.03181434 & 0.02620861 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05206 & MicroRNAs in cancer                                 & 10 & 0.6167598 & 2.1312433 & 0.005994006 & 0.03181434 & 0.02620861 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                       &  7 & 0.6333261 & 2.0325098 & 0.017982018 & 0.08271728 & 0.06814238 & vorinostat/trichostatin-a/pyroxamide/epothilone                                                                            & 1/2/4/8                 \\\\\n\t hsa05200 & Pathways in cancer                                  & 12 & 0.5586002 & 1.9987811 & 0.015984016 & 0.07877836 & 0.06489751 & vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              & 1/2/3/4                 \\\\\n\t hsa04371 & Apelin signaling pathway                            &  6 & 0.5791798 & 1.7687856 & 0.068931069 & 0.29726523 & 0.24488669 & vorinostat/trichostatin-a                                                                                                  & 1/2                     \\\\\n\t hsa05012 & Parkinson disease                                   &  5 & 0.4222980 & 1.2408925 & 0.345654346 & 0.90654800 & 0.74681300 & zuclopenthixol/epothilone/progesterone/fasudil                                                                             & 5/8/17/21               \\\\\n\t hsa04928 & Parathyroid hormone synthesis, secretion and action &  7 & 0.3363495 & 1.0794337 & 0.433566434 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol                             & 36/35/21/20/18/17/15    \\\\\n\t hsa04540 & Gap junction                                        &  9 & 0.2702703 & 0.9180786 & 0.573426573 & 0.90654800 & 0.74681300 & zuclopenthixol/epothilone/progesterone/afatinib/fasudil/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib & 5/8/17/18/21/32/33/35/36\\\\\n\t hsa05207 & Chemical carcinogenesis - receptor activation       &  8 & 0.2516108 & 0.8379417 & 0.617382617 & 0.90654800 & 0.74681300 & propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol              & 43/36/35/21/20/18/17/15 \\\\\n\t hsa04934 & Cushing syndrome                                    &  7 & 0.2564103 & 0.8228879 & 0.655344655 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/hydroquinidine/ryuvidine/fasudil/afatinib/progesterone                           & 36/35/34/30/21/18/17    \\\\\n\t hsa05022 & Pathways of neurodegeneration - multiple diseases   &  7 & 0.2564103 & 0.8228879 & 0.655344655 & 0.90654800 & 0.74681300 & epothilone/rimcazole/progesterone/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib                       & 8/16/17/32/33/35/36     \\\\\n\t hsa04530 & Tight junction                                      &  5 & 0.2682927 & 0.7883589 & 0.638361638 & 0.90654800 & 0.74681300 & epothilone/afatinib/fasudil/ryuvidine/4,5,6,7-tetrabromobenzotriazole                                                      & 8/18/21/30/35           \\\\\n\t hsa04724 & Glutamatergic synapse                               &  5 & 0.2682927 & 0.7883589 & 0.638361638 & 0.90654800 & 0.74681300 & 4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                              & 35/33/32/21/17          \\\\\n\t hsa04072 & Phospholipase D signaling pathway                   &  6 & 0.2500000 & 0.7634873 & 0.666333666 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/afatinib/progesterone                                   & 36/35/33/32/18/17       \\\\\n\t hsa04270 & Vascular smooth muscle contraction                  &  6 & 0.2500000 & 0.7634873 & 0.666333666 & 0.90654800 & 0.74681300 & zuclopenthixol/progesterone/fasudil/scoulerine/4,5,6,7-tetrabromobenzotriazole/sorafenib                                   & 5/17/21/25/35/36        \\\\\n\t hsa04720 & Long-term potentiation                              &  6 & 0.2500000 & 0.7634873 & 0.666333666 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                    & 36/35/33/32/21/17       \\\\\n\t hsa05010 & Alzheimer disease                                   &  6 & 0.2500000 & 0.7634873 & 0.666333666 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam                                                         & 36/35/33/32             \\\\\n\t hsa04010 & MAPK signaling pathway                              &  5 & 0.2439024 & 0.7166899 & 0.696303696 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                    & 36/35/21/18/17          \\\\\n\t hsa04014 & Ras signaling pathway                               &  5 & 0.2439024 & 0.7166899 & 0.696303696 & 0.90654800 & 0.74681300 & sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                    & 36/35/21/18/17          \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t hsa05132 & Salmonella infection                                      &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & epothilone/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/sorafenib                                                 & 8/17/21/35/36             \\\\\n\t hsa05160 & Hepatitis C                                               &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05214 & Glioma                                                    &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05215 & Prostate cancer                                           &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05218 & Melanoma                                                  &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05219 & Bladder cancer                                            &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05223 & Non-small cell lung cancer                                &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05225 & Hepatocellular carcinoma                                  &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05226 & Gastric cancer                                            &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 & sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 & 36/35/30/18/17            \\\\\n\t hsa05417 & Lipid and atherosclerosis                                 &  5 & 0.24390244 & 0.7166899 & 0.6963037 & 0.9065480 & 0.7468130 &                                                                                                                           &                           \\\\\n\t hsa04080 & Neuroactive ligand-receptor interaction                   &  7 & 0.20512821 & 0.6583103 & 0.7292707 & 0.9065480 & 0.7468130 & olvanil/decafluorobutane/fenobam/jwh-015/scoulerine                                                                       & 38/33/32/28/25            \\\\\n\t hsa05032 & Morphine addiction                                        &  5 & 0.22310045 & 0.6555647 & 0.7222777 & 0.9065480 & 0.7468130 & zuclopenthixol/progesterone/fasudil                                                                                       & 5/17/21                   \\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels          &  5 & 0.21847059 & 0.6419602 & 0.7442557 & 0.9065480 & 0.7468130 & zuclopenthixol/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/olvanil                                               & 5/17/21/35/38             \\\\\n\t hsa04725 & Cholinergic synapse                                       &  5 & 0.21836420 & 0.6416476 & 0.7442557 & 0.9065480 & 0.7468130 & xe-991/4,5,6,7-tetrabromobenzotriazole/fasudil/huperzine-a/progesterone                                                   & 44/35/21/19/17            \\\\\n\t hsa04961 & Endocrine and other factor-regulated calcium reabsorption &  7 & 0.19173131 & 0.6153161 & 0.7512488 & 0.9065480 & 0.7468130 & propylpyrazole/calmidazolium/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/progesterone/calcifediol                  & 43/41/35/21/20/17/15      \\\\\n\t hsa04723 & Retrograde endocannabinoid signaling                      &  6 & 0.20000000 & 0.6107898 & 0.7752248 & 0.9065480 & 0.7468130 & olvanil/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                     & 38/35/33/32/21/17         \\\\\n\t hsa04970 & Salivary secretion                                        &  6 & 0.19145159 & 0.5846834 & 0.7842158 & 0.9065480 & 0.7468130 & zuclopenthixol/progesterone/fasudil/scoulerine                                                                            & 5/17/21/25                \\\\\n\t hsa04020 & Calcium signaling pathway                                 & 10 & 0.16649450 & 0.5753298 & 0.8131868 & 0.9065480 & 0.7468130 & calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/scoulerine/fasudil/afatinib/progesterone & 41/36/35/33/32/25/21/18/17\\\\\n\t hsa04015 & Rap1 signaling pathway                                    &  5 & 0.19512195 & 0.5733519 & 0.7802198 & 0.9065480 & 0.7468130 & olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole/afatinib/progesterone                                                   & 38/36/35/18/17            \\\\\n\t hsa04261 & Adrenergic signaling in cardiomyocytes                    &  8 & 0.16655073 & 0.5546654 & 0.7802198 & 0.9065480 & 0.7468130 & zuclopenthixol/benzonatate/progesterone/fasudil/scoulerine                                                                & 5/12/17/21/25             \\\\\n\t hsa05163 & Human cytomegalovirus infection                           &  7 & 0.15384615 & 0.4937327 & 0.8331668 & 0.9065480 & 0.7468130 & vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                              & 40/36/35/30/21/18/17      \\\\\n\t hsa04062 & Chemokine signaling pathway                               &  5 & 0.14634146 & 0.4300139 & 0.8351648 & 0.9065480 & 0.7468130 & vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/progesterone                                                 & 40/36/35/21/17            \\\\\n\t hsa05167 & Kaposi sarcoma-associated herpesvirus infection           &  5 & 0.14634146 & 0.4300139 & 0.8351648 & 0.9065480 & 0.7468130 & vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine                                                            & 40/36/35/30               \\\\\n\t hsa01100 & Metabolic pathways                                        &  7 & 0.12820513 & 0.4114439 & 0.8561439 & 0.9065480 & 0.7468130 & calmidazolium/sorafenib/hydroquinidine/raltitrexed/calcitriol/progesterone/warfarin                                       & 41/36/34/27/20/17/11      \\\\\n\t hsa04022 & cGMP-PKG signaling pathway                                &  7 & 0.12820513 & 0.4114439 & 0.8561439 & 0.9065480 & 0.7468130 & calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/scoulerine/fasudil/progesterone                                   & 41/36/35/25/21/17         \\\\\n\t hsa04024 & cAMP signaling pathway                                    &  7 & 0.12820513 & 0.4114439 & 0.8561439 & 0.9065480 & 0.7468130 & calmidazolium/olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole                                                           & 41/38/36/35               \\\\\n\t hsa01522 & Endocrine resistance                                      &  7 & 0.11342597 & 0.3640137 & 0.8671329 & 0.9065480 & 0.7468130 & propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                          & 43/36/35/30/21/18/17      \\\\\n\t hsa04915 & Estrogen signaling pathway                                &  6 & 0.09854338 & 0.3009465 & 0.9100899 & 0.9190809 & 0.7571376 & propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    & 43/36/35/21/18/17         \\\\\n\t hsa05205 & Proteoglycans in cancer                                   &  6 & 0.09854338 & 0.3009465 & 0.9100899 & 0.9190809 & 0.7571376 & propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    & 43/36/35/21/18/17         \\\\\n\t hsa05224 & Breast cancer                                             &  6 & 0.08618149 & 0.2631939 & 0.9190809 & 0.9190809 & 0.7571376 & propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                  & 43/36/35/30/18/17         \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 69 × 10\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | setSize &lt;int&gt; | enrichmentScore &lt;dbl&gt; | NES &lt;dbl&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalues &lt;dbl&gt; | leadingEdge &lt;chr&gt; | ledge_rank &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| hsa05031 | Amphetamine addiction                               |  8 | 0.7846215 | 2.6130321 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                                                               | 1/2/3/4/5                |\n| hsa04613 | Neutrophil extracellular trap formation             |  7 | 0.8068409 | 2.5893643 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                              | 1/2/3/4/7                |\n| hsa04110 | Cell cycle                                          |  6 | 0.8384286 | 2.5605182 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05169 | Epstein-Barr virus infection                        |  6 | 0.8384286 | 2.5605182 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05034 | Alcoholism                                          | 10 | 0.7307706 | 2.5252132 | 0.001998002 | 0.01969459 | 0.01622438 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8                                               | 1/2/3/4/5/7              |\n| hsa05202 | Transcriptional misregulation in cancer             |  7 | 0.7715778 | 2.4761959 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa04213 | Longevity regulating pathway - multiple species     |  7 | 0.7619107 | 2.4451716 | 0.000999001 | 0.01148851 | 0.00946422 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05016 | Huntington disease                                  |  8 | 0.7179226 | 2.3909043 | 0.002997003 | 0.02297702 | 0.01892844 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                   | 1/2/3/4/8                |\n| hsa05220 | Chronic myeloid leukemia                            |  8 | 0.7167674 | 2.3870571 | 0.002997003 | 0.02297702 | 0.01892844 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa04919 | Thyroid hormone signaling pathway                   |  9 | 0.6729656 | 2.2859907 | 0.003996004 | 0.02506584 | 0.02064921 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05203 | Viral carcinogenesis                                | 10 | 0.6393762 | 2.2093954 | 0.003996004 | 0.02506584 | 0.02064921 | vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                              | 1/2/3/4/7                |\n| hsa05165 | Human papillomavirus infection                      | 10 | 0.6206312 | 2.1446211 | 0.005994006 | 0.03181434 | 0.02620861 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05206 | MicroRNAs in cancer                                 | 10 | 0.6167598 | 2.1312433 | 0.005994006 | 0.03181434 | 0.02620861 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa05014 | Amyotrophic lateral sclerosis                       |  7 | 0.6333261 | 2.0325098 | 0.017982018 | 0.08271728 | 0.06814238 | vorinostat/trichostatin-a/pyroxamide/epothilone                                                                            | 1/2/4/8                  |\n| hsa05200 | Pathways in cancer                                  | 12 | 0.5586002 | 1.9987811 | 0.015984016 | 0.07877836 | 0.06489751 | vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                              | 1/2/3/4                  |\n| hsa04371 | Apelin signaling pathway                            |  6 | 0.5791798 | 1.7687856 | 0.068931069 | 0.29726523 | 0.24488669 | vorinostat/trichostatin-a                                                                                                  | 1/2                      |\n| hsa05012 | Parkinson disease                                   |  5 | 0.4222980 | 1.2408925 | 0.345654346 | 0.90654800 | 0.74681300 | zuclopenthixol/epothilone/progesterone/fasudil                                                                             | 5/8/17/21                |\n| hsa04928 | Parathyroid hormone synthesis, secretion and action |  7 | 0.3363495 | 1.0794337 | 0.433566434 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol                             | 36/35/21/20/18/17/15     |\n| hsa04540 | Gap junction                                        |  9 | 0.2702703 | 0.9180786 | 0.573426573 | 0.90654800 | 0.74681300 | zuclopenthixol/epothilone/progesterone/afatinib/fasudil/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib | 5/8/17/18/21/32/33/35/36 |\n| hsa05207 | Chemical carcinogenesis - receptor activation       |  8 | 0.2516108 | 0.8379417 | 0.617382617 | 0.90654800 | 0.74681300 | propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol              | 43/36/35/21/20/18/17/15  |\n| hsa04934 | Cushing syndrome                                    |  7 | 0.2564103 | 0.8228879 | 0.655344655 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/hydroquinidine/ryuvidine/fasudil/afatinib/progesterone                           | 36/35/34/30/21/18/17     |\n| hsa05022 | Pathways of neurodegeneration - multiple diseases   |  7 | 0.2564103 | 0.8228879 | 0.655344655 | 0.90654800 | 0.74681300 | epothilone/rimcazole/progesterone/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib                       | 8/16/17/32/33/35/36      |\n| hsa04530 | Tight junction                                      |  5 | 0.2682927 | 0.7883589 | 0.638361638 | 0.90654800 | 0.74681300 | epothilone/afatinib/fasudil/ryuvidine/4,5,6,7-tetrabromobenzotriazole                                                      | 8/18/21/30/35            |\n| hsa04724 | Glutamatergic synapse                               |  5 | 0.2682927 | 0.7883589 | 0.638361638 | 0.90654800 | 0.74681300 | 4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                              | 35/33/32/21/17           |\n| hsa04072 | Phospholipase D signaling pathway                   |  6 | 0.2500000 | 0.7634873 | 0.666333666 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/afatinib/progesterone                                   | 36/35/33/32/18/17        |\n| hsa04270 | Vascular smooth muscle contraction                  |  6 | 0.2500000 | 0.7634873 | 0.666333666 | 0.90654800 | 0.74681300 | zuclopenthixol/progesterone/fasudil/scoulerine/4,5,6,7-tetrabromobenzotriazole/sorafenib                                   | 5/17/21/25/35/36         |\n| hsa04720 | Long-term potentiation                              |  6 | 0.2500000 | 0.7634873 | 0.666333666 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                    | 36/35/33/32/21/17        |\n| hsa05010 | Alzheimer disease                                   |  6 | 0.2500000 | 0.7634873 | 0.666333666 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam                                                         | 36/35/33/32              |\n| hsa04010 | MAPK signaling pathway                              |  5 | 0.2439024 | 0.7166899 | 0.696303696 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                    | 36/35/21/18/17           |\n| hsa04014 | Ras signaling pathway                               |  5 | 0.2439024 | 0.7166899 | 0.696303696 | 0.90654800 | 0.74681300 | sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                    | 36/35/21/18/17           |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| hsa05132 | Salmonella infection                                      |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | epothilone/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/sorafenib                                                 | 8/17/21/35/36              |\n| hsa05160 | Hepatitis C                                               |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05214 | Glioma                                                    |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05215 | Prostate cancer                                           |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05218 | Melanoma                                                  |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05219 | Bladder cancer                                            |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05223 | Non-small cell lung cancer                                |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05225 | Hepatocellular carcinoma                                  |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05226 | Gastric cancer                                            |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                 | 36/35/30/18/17             |\n| hsa05417 | Lipid and atherosclerosis                                 |  5 | 0.24390244 | 0.7166899 | 0.6963037 | 0.9065480 | 0.7468130 | <!----> | <!----> |\n| hsa04080 | Neuroactive ligand-receptor interaction                   |  7 | 0.20512821 | 0.6583103 | 0.7292707 | 0.9065480 | 0.7468130 | olvanil/decafluorobutane/fenobam/jwh-015/scoulerine                                                                       | 38/33/32/28/25             |\n| hsa05032 | Morphine addiction                                        |  5 | 0.22310045 | 0.6555647 | 0.7222777 | 0.9065480 | 0.7468130 | zuclopenthixol/progesterone/fasudil                                                                                       | 5/17/21                    |\n| hsa04750 | Inflammatory mediator regulation of TRP channels          |  5 | 0.21847059 | 0.6419602 | 0.7442557 | 0.9065480 | 0.7468130 | zuclopenthixol/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/olvanil                                               | 5/17/21/35/38              |\n| hsa04725 | Cholinergic synapse                                       |  5 | 0.21836420 | 0.6416476 | 0.7442557 | 0.9065480 | 0.7468130 | xe-991/4,5,6,7-tetrabromobenzotriazole/fasudil/huperzine-a/progesterone                                                   | 44/35/21/19/17             |\n| hsa04961 | Endocrine and other factor-regulated calcium reabsorption |  7 | 0.19173131 | 0.6153161 | 0.7512488 | 0.9065480 | 0.7468130 | propylpyrazole/calmidazolium/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/progesterone/calcifediol                  | 43/41/35/21/20/17/15       |\n| hsa04723 | Retrograde endocannabinoid signaling                      |  6 | 0.20000000 | 0.6107898 | 0.7752248 | 0.9065480 | 0.7468130 | olvanil/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                     | 38/35/33/32/21/17          |\n| hsa04970 | Salivary secretion                                        |  6 | 0.19145159 | 0.5846834 | 0.7842158 | 0.9065480 | 0.7468130 | zuclopenthixol/progesterone/fasudil/scoulerine                                                                            | 5/17/21/25                 |\n| hsa04020 | Calcium signaling pathway                                 | 10 | 0.16649450 | 0.5753298 | 0.8131868 | 0.9065480 | 0.7468130 | calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/scoulerine/fasudil/afatinib/progesterone | 41/36/35/33/32/25/21/18/17 |\n| hsa04015 | Rap1 signaling pathway                                    |  5 | 0.19512195 | 0.5733519 | 0.7802198 | 0.9065480 | 0.7468130 | olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole/afatinib/progesterone                                                   | 38/36/35/18/17             |\n| hsa04261 | Adrenergic signaling in cardiomyocytes                    |  8 | 0.16655073 | 0.5546654 | 0.7802198 | 0.9065480 | 0.7468130 | zuclopenthixol/benzonatate/progesterone/fasudil/scoulerine                                                                | 5/12/17/21/25              |\n| hsa05163 | Human cytomegalovirus infection                           |  7 | 0.15384615 | 0.4937327 | 0.8331668 | 0.9065480 | 0.7468130 | vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                              | 40/36/35/30/21/18/17       |\n| hsa04062 | Chemokine signaling pathway                               |  5 | 0.14634146 | 0.4300139 | 0.8351648 | 0.9065480 | 0.7468130 | vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/progesterone                                                 | 40/36/35/21/17             |\n| hsa05167 | Kaposi sarcoma-associated herpesvirus infection           |  5 | 0.14634146 | 0.4300139 | 0.8351648 | 0.9065480 | 0.7468130 | vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine                                                            | 40/36/35/30                |\n| hsa01100 | Metabolic pathways                                        |  7 | 0.12820513 | 0.4114439 | 0.8561439 | 0.9065480 | 0.7468130 | calmidazolium/sorafenib/hydroquinidine/raltitrexed/calcitriol/progesterone/warfarin                                       | 41/36/34/27/20/17/11       |\n| hsa04022 | cGMP-PKG signaling pathway                                |  7 | 0.12820513 | 0.4114439 | 0.8561439 | 0.9065480 | 0.7468130 | calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/scoulerine/fasudil/progesterone                                   | 41/36/35/25/21/17          |\n| hsa04024 | cAMP signaling pathway                                    |  7 | 0.12820513 | 0.4114439 | 0.8561439 | 0.9065480 | 0.7468130 | calmidazolium/olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole                                                           | 41/38/36/35                |\n| hsa01522 | Endocrine resistance                                      |  7 | 0.11342597 | 0.3640137 | 0.8671329 | 0.9065480 | 0.7468130 | propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                          | 43/36/35/30/21/18/17       |\n| hsa04915 | Estrogen signaling pathway                                |  6 | 0.09854338 | 0.3009465 | 0.9100899 | 0.9190809 | 0.7571376 | propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    | 43/36/35/21/18/17          |\n| hsa05205 | Proteoglycans in cancer                                   |  6 | 0.09854338 | 0.3009465 | 0.9100899 | 0.9190809 | 0.7571376 | propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                    | 43/36/35/21/18/17          |\n| hsa05224 | Breast cancer                                             |  6 | 0.08618149 | 0.2631939 | 0.9190809 | 0.9190809 | 0.7571376 | propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                  | 43/36/35/30/18/17          |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 69 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>setSize</th><th scope=col>enrichmentScore</th><th scope=col>NES</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalues</th><th scope=col>leadingEdge</th><th scope=col>ledge_rank</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                              </td><td> 8</td><td>0.7846215</td><td>2.6130321</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol                                                              </td><td>1/2/3/4/5               </td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation            </td><td> 7</td><td>0.8068409</td><td>2.5893643</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                             </td><td>1/2/3/4/7               </td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                         </td><td> 6</td><td>0.8384286</td><td>2.5605182</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                       </td><td> 6</td><td>0.8384286</td><td>2.5605182</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                         </td><td>10</td><td>0.7307706</td><td>2.5252132</td><td>0.001998002</td><td>0.01969459</td><td>0.01622438</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/zuclopenthixol/apha-compound-8                                              </td><td>1/2/3/4/5/7             </td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer            </td><td> 7</td><td>0.7715778</td><td>2.4761959</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species    </td><td> 7</td><td>0.7619107</td><td>2.4451716</td><td>0.000999001</td><td>0.01148851</td><td>0.00946422</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                                 </td><td> 8</td><td>0.7179226</td><td>2.3909043</td><td>0.002997003</td><td>0.02297702</td><td>0.01892844</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/epothilone                                                                  </td><td>1/2/3/4/8               </td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                           </td><td> 8</td><td>0.7167674</td><td>2.3870571</td><td>0.002997003</td><td>0.02297702</td><td>0.01892844</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway                  </td><td> 9</td><td>0.6729656</td><td>2.2859907</td><td>0.003996004</td><td>0.02506584</td><td>0.02064921</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                               </td><td>10</td><td>0.6393762</td><td>2.2093954</td><td>0.003996004</td><td>0.02506584</td><td>0.02064921</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide/apha-compound-8                                                             </td><td>1/2/3/4/7               </td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                     </td><td>10</td><td>0.6206312</td><td>2.1446211</td><td>0.005994006</td><td>0.03181434</td><td>0.02620861</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                                </td><td>10</td><td>0.6167598</td><td>2.1312433</td><td>0.005994006</td><td>0.03181434</td><td>0.02620861</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                      </td><td> 7</td><td>0.6333261</td><td>2.0325098</td><td>0.017982018</td><td>0.08271728</td><td>0.06814238</td><td>vorinostat/trichostatin-a/pyroxamide/epothilone                                                                           </td><td>1/2/4/8                 </td></tr>\n","\t<tr><td>hsa05200</td><td>Pathways in cancer                                 </td><td>12</td><td>0.5586002</td><td>1.9987811</td><td>0.015984016</td><td>0.07877836</td><td>0.06489751</td><td>vorinostat/trichostatin-a/hc-toxin/pyroxamide                                                                             </td><td>1/2/3/4                 </td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                           </td><td> 6</td><td>0.5791798</td><td>1.7687856</td><td>0.068931069</td><td>0.29726523</td><td>0.24488669</td><td>vorinostat/trichostatin-a                                                                                                 </td><td>1/2                     </td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                                  </td><td> 5</td><td>0.4222980</td><td>1.2408925</td><td>0.345654346</td><td>0.90654800</td><td>0.74681300</td><td>zuclopenthixol/epothilone/progesterone/fasudil                                                                            </td><td>5/8/17/21               </td></tr>\n","\t<tr><td>hsa04928</td><td>Parathyroid hormone synthesis, secretion and action</td><td> 7</td><td>0.3363495</td><td>1.0794337</td><td>0.433566434</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol                            </td><td>36/35/21/20/18/17/15    </td></tr>\n","\t<tr><td>hsa04540</td><td>Gap junction                                       </td><td> 9</td><td>0.2702703</td><td>0.9180786</td><td>0.573426573</td><td>0.90654800</td><td>0.74681300</td><td>zuclopenthixol/epothilone/progesterone/afatinib/fasudil/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib</td><td>5/8/17/18/21/32/33/35/36</td></tr>\n","\t<tr><td>hsa05207</td><td>Chemical carcinogenesis - receptor activation      </td><td> 8</td><td>0.2516108</td><td>0.8379417</td><td>0.617382617</td><td>0.90654800</td><td>0.74681300</td><td>propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/afatinib/progesterone/calcifediol             </td><td>43/36/35/21/20/18/17/15 </td></tr>\n","\t<tr><td>hsa04934</td><td>Cushing syndrome                                   </td><td> 7</td><td>0.2564103</td><td>0.8228879</td><td>0.655344655</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/hydroquinidine/ryuvidine/fasudil/afatinib/progesterone                          </td><td>36/35/34/30/21/18/17    </td></tr>\n","\t<tr><td>hsa05022</td><td>Pathways of neurodegeneration - multiple diseases  </td><td> 7</td><td>0.2564103</td><td>0.8228879</td><td>0.655344655</td><td>0.90654800</td><td>0.74681300</td><td>epothilone/rimcazole/progesterone/fenobam/decafluorobutane/4,5,6,7-tetrabromobenzotriazole/sorafenib                      </td><td>8/16/17/32/33/35/36     </td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                     </td><td> 5</td><td>0.2682927</td><td>0.7883589</td><td>0.638361638</td><td>0.90654800</td><td>0.74681300</td><td>epothilone/afatinib/fasudil/ryuvidine/4,5,6,7-tetrabromobenzotriazole                                                     </td><td>8/18/21/30/35           </td></tr>\n","\t<tr><td>hsa04724</td><td>Glutamatergic synapse                              </td><td> 5</td><td>0.2682927</td><td>0.7883589</td><td>0.638361638</td><td>0.90654800</td><td>0.74681300</td><td>4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                             </td><td>35/33/32/21/17          </td></tr>\n","\t<tr><td>hsa04072</td><td>Phospholipase D signaling pathway                  </td><td> 6</td><td>0.2500000</td><td>0.7634873</td><td>0.666333666</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/afatinib/progesterone                                  </td><td>36/35/33/32/18/17       </td></tr>\n","\t<tr><td>hsa04270</td><td>Vascular smooth muscle contraction                 </td><td> 6</td><td>0.2500000</td><td>0.7634873</td><td>0.666333666</td><td>0.90654800</td><td>0.74681300</td><td>zuclopenthixol/progesterone/fasudil/scoulerine/4,5,6,7-tetrabromobenzotriazole/sorafenib                                  </td><td>5/17/21/25/35/36        </td></tr>\n","\t<tr><td>hsa04720</td><td>Long-term potentiation                             </td><td> 6</td><td>0.2500000</td><td>0.7634873</td><td>0.666333666</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                   </td><td>36/35/33/32/21/17       </td></tr>\n","\t<tr><td>hsa05010</td><td>Alzheimer disease                                  </td><td> 6</td><td>0.2500000</td><td>0.7634873</td><td>0.666333666</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam                                                        </td><td>36/35/33/32             </td></tr>\n","\t<tr><td>hsa04010</td><td>MAPK signaling pathway                             </td><td> 5</td><td>0.2439024</td><td>0.7166899</td><td>0.696303696</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                   </td><td>36/35/21/18/17          </td></tr>\n","\t<tr><td>hsa04014</td><td>Ras signaling pathway                              </td><td> 5</td><td>0.2439024</td><td>0.7166899</td><td>0.696303696</td><td>0.90654800</td><td>0.74681300</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                                   </td><td>36/35/21/18/17          </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                                     </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>epothilone/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/sorafenib                                                </td><td>8/17/21/35/36             </td></tr>\n","\t<tr><td>hsa05160</td><td>Hepatitis C                                              </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05214</td><td>Glioma                                                   </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05215</td><td>Prostate cancer                                          </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05218</td><td>Melanoma                                                 </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05219</td><td>Bladder cancer                                           </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05223</td><td>Non-small cell lung cancer                               </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05225</td><td>Hepatocellular carcinoma                                 </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05226</td><td>Gastric cancer                                           </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                                </td><td>36/35/30/18/17            </td></tr>\n","\t<tr><td>hsa05417</td><td>Lipid and atherosclerosis                                </td><td> 5</td><td>0.24390244</td><td>0.7166899</td><td>0.6963037</td><td>0.9065480</td><td>0.7468130</td><td>                                                                                                                         </td><td>                          </td></tr>\n","\t<tr><td>hsa04080</td><td>Neuroactive ligand-receptor interaction                  </td><td> 7</td><td>0.20512821</td><td>0.6583103</td><td>0.7292707</td><td>0.9065480</td><td>0.7468130</td><td>olvanil/decafluorobutane/fenobam/jwh-015/scoulerine                                                                      </td><td>38/33/32/28/25            </td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                                       </td><td> 5</td><td>0.22310045</td><td>0.6555647</td><td>0.7222777</td><td>0.9065480</td><td>0.7468130</td><td>zuclopenthixol/progesterone/fasudil                                                                                      </td><td>5/17/21                   </td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels         </td><td> 5</td><td>0.21847059</td><td>0.6419602</td><td>0.7442557</td><td>0.9065480</td><td>0.7468130</td><td>zuclopenthixol/progesterone/fasudil/4,5,6,7-tetrabromobenzotriazole/olvanil                                              </td><td>5/17/21/35/38             </td></tr>\n","\t<tr><td>hsa04725</td><td>Cholinergic synapse                                      </td><td> 5</td><td>0.21836420</td><td>0.6416476</td><td>0.7442557</td><td>0.9065480</td><td>0.7468130</td><td>xe-991/4,5,6,7-tetrabromobenzotriazole/fasudil/huperzine-a/progesterone                                                  </td><td>44/35/21/19/17            </td></tr>\n","\t<tr><td>hsa04961</td><td>Endocrine and other factor-regulated calcium reabsorption</td><td> 7</td><td>0.19173131</td><td>0.6153161</td><td>0.7512488</td><td>0.9065480</td><td>0.7468130</td><td>propylpyrazole/calmidazolium/4,5,6,7-tetrabromobenzotriazole/fasudil/calcitriol/progesterone/calcifediol                 </td><td>43/41/35/21/20/17/15      </td></tr>\n","\t<tr><td>hsa04723</td><td>Retrograde endocannabinoid signaling                     </td><td> 6</td><td>0.20000000</td><td>0.6107898</td><td>0.7752248</td><td>0.9065480</td><td>0.7468130</td><td>olvanil/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/fasudil/progesterone                                    </td><td>38/35/33/32/21/17         </td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                                       </td><td> 6</td><td>0.19145159</td><td>0.5846834</td><td>0.7842158</td><td>0.9065480</td><td>0.7468130</td><td>zuclopenthixol/progesterone/fasudil/scoulerine                                                                           </td><td>5/17/21/25                </td></tr>\n","\t<tr><td>hsa04020</td><td>Calcium signaling pathway                                </td><td>10</td><td>0.16649450</td><td>0.5753298</td><td>0.8131868</td><td>0.9065480</td><td>0.7468130</td><td>calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/decafluorobutane/fenobam/scoulerine/fasudil/afatinib/progesterone</td><td>41/36/35/33/32/25/21/18/17</td></tr>\n","\t<tr><td>hsa04015</td><td>Rap1 signaling pathway                                   </td><td> 5</td><td>0.19512195</td><td>0.5733519</td><td>0.7802198</td><td>0.9065480</td><td>0.7468130</td><td>olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole/afatinib/progesterone                                                  </td><td>38/36/35/18/17            </td></tr>\n","\t<tr><td>hsa04261</td><td>Adrenergic signaling in cardiomyocytes                   </td><td> 8</td><td>0.16655073</td><td>0.5546654</td><td>0.7802198</td><td>0.9065480</td><td>0.7468130</td><td>zuclopenthixol/benzonatate/progesterone/fasudil/scoulerine                                                               </td><td>5/12/17/21/25             </td></tr>\n","\t<tr><td>hsa05163</td><td>Human cytomegalovirus infection                          </td><td> 7</td><td>0.15384615</td><td>0.4937327</td><td>0.8331668</td><td>0.9065480</td><td>0.7468130</td><td>vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                             </td><td>40/36/35/30/21/18/17      </td></tr>\n","\t<tr><td>hsa04062</td><td>Chemokine signaling pathway                              </td><td> 5</td><td>0.14634146</td><td>0.4300139</td><td>0.8351648</td><td>0.9065480</td><td>0.7468130</td><td>vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/progesterone                                                </td><td>40/36/35/21/17            </td></tr>\n","\t<tr><td>hsa05167</td><td>Kaposi sarcoma-associated herpesvirus infection          </td><td> 5</td><td>0.14634146</td><td>0.4300139</td><td>0.8351648</td><td>0.9065480</td><td>0.7468130</td><td>vicriviroc/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine                                                           </td><td>40/36/35/30               </td></tr>\n","\t<tr><td>hsa01100</td><td>Metabolic pathways                                       </td><td> 7</td><td>0.12820513</td><td>0.4114439</td><td>0.8561439</td><td>0.9065480</td><td>0.7468130</td><td>calmidazolium/sorafenib/hydroquinidine/raltitrexed/calcitriol/progesterone/warfarin                                      </td><td>41/36/34/27/20/17/11      </td></tr>\n","\t<tr><td>hsa04022</td><td>cGMP-PKG signaling pathway                               </td><td> 7</td><td>0.12820513</td><td>0.4114439</td><td>0.8561439</td><td>0.9065480</td><td>0.7468130</td><td>calmidazolium/sorafenib/4,5,6,7-tetrabromobenzotriazole/scoulerine/fasudil/progesterone                                  </td><td>41/36/35/25/21/17         </td></tr>\n","\t<tr><td>hsa04024</td><td>cAMP signaling pathway                                   </td><td> 7</td><td>0.12820513</td><td>0.4114439</td><td>0.8561439</td><td>0.9065480</td><td>0.7468130</td><td>calmidazolium/olvanil/sorafenib/4,5,6,7-tetrabromobenzotriazole                                                          </td><td>41/38/36/35               </td></tr>\n","\t<tr><td>hsa01522</td><td>Endocrine resistance                                     </td><td> 7</td><td>0.11342597</td><td>0.3640137</td><td>0.8671329</td><td>0.9065480</td><td>0.7468130</td><td>propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/fasudil/afatinib/progesterone                         </td><td>43/36/35/30/21/18/17      </td></tr>\n","\t<tr><td>hsa04915</td><td>Estrogen signaling pathway                               </td><td> 6</td><td>0.09854338</td><td>0.3009465</td><td>0.9100899</td><td>0.9190809</td><td>0.7571376</td><td>propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                   </td><td>43/36/35/21/18/17         </td></tr>\n","\t<tr><td>hsa05205</td><td>Proteoglycans in cancer                                  </td><td> 6</td><td>0.09854338</td><td>0.3009465</td><td>0.9100899</td><td>0.9190809</td><td>0.7571376</td><td>propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/fasudil/afatinib/progesterone                                   </td><td>43/36/35/21/18/17         </td></tr>\n","\t<tr><td>hsa05224</td><td>Breast cancer                                            </td><td> 6</td><td>0.08618149</td><td>0.2631939</td><td>0.9190809</td><td>0.9190809</td><td>0.7571376</td><td>propylpyrazole/sorafenib/4,5,6,7-tetrabromobenzotriazole/ryuvidine/afatinib/progesterone                                 </td><td>43/36/35/30/18/17         </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"markdown","metadata":{"id":"lpqPDXK9L_bF"},"source":["## Comparing FEA Results\n","The comp_fea_res function re-ranks the functional categories across the different FEA methods by using the mean rank of each functional category across the 5 FEA methods. Here the functional categories are re-ranked by their mean rank values in increasing order. Since the functional categories are not always present in all enrichment results, the mean rank of a functional category is corrected by an adjustment factor that is the number of enrichment result methods used divided by the number of occurrences of a functional category. For instance, if a functional category is only present in the result of one method, its mean rank will be increased accordingly. The following plots use the pvalue column in the result tables for this ranking approach. Alternative columns can be chosen under the rank_stat argument. After re-ranking only the top ranking functional categories are shown, here 20. Their number can be changed under the Nshow argument."]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":436},"id":"6aAoNhdyMHhU","executionInfo":{"status":"ok","timestamp":1636338423460,"user_tz":-480,"elapsed":908,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"9ffc6813-49cc-4995-c31b-f9e1613be131"},"source":["table_list = list(\"dup_hyperG\" = result(dup_hyperG_res), \n","                  \"mGSEA\" = result(mgsea_res), \n","                  \"mabs\" = result(mabs_res), \n","                  \"hyperG\" = result(hyperG_res), \n","                  \"GSEA\" = result(gsea_res))\n","comp_fea_res(table_list, rank_stat=\"pvalue\", Nshow=20)"],"execution_count":39,"outputs":[{"output_type":"display_data","data":{"image/png":"iVBORw0KGgoAAAANSUhEUgAAA0gAAANICAIAAAByhViMAAAACXBIWXMAABJ0AAASdAHeZh94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","text/plain":["plot without title"]},"metadata":{"image/png":{"width":420,"height":420}}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":436},"id":"vj_ftBW2MJ2j","executionInfo":{"status":"ok","timestamp":1636338424326,"user_tz":-480,"elapsed":872,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"5606bd57-74ee-43b3-e599-16e7218fa7be"},"source":["table_list = list(\"dup_hyperG\" = result(dup_hyperG_k_res), \n","                  \"mGSEA\" = result(mgsea_k_res), \n","                  \"mabs\" = result(mabs_k_res), \n","                  \"hyperG\" = result(hyperG_k_res), \n","                  \"GSEA\" = result(gsea_k_res))\n","comp_fea_res(table_list, rank_stat=\"pvalue\", Nshow=20)"],"execution_count":40,"outputs":[{"output_type":"display_data","data":{"image/png":"iVBORw0KGgoAAAANSUhEUgAAA0gAAANICAIAAAByhViMAAAACXBIWXMAABJ0AAASdAHeZh94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\nAFASCHYAAAAASgLBDgAAAEBJ/H+dy3FnOhkD1gAAAABJRU5ErkJggg==","text/plain":["plot without title"]},"metadata":{"image/png":{"width":420,"height":420}}}]},{"cell_type":"markdown","metadata":{"id":"gWQ05DJCM123"},"source":["# Drug-Target Network Visualization"]},{"cell_type":"code","metadata":{"id":"5qNlf--ANX15"},"source":["dtnetplot(drugs = drugs(dup_hyperG_res), set = 'GO:0032041', ont = 'MF',\n","                    desc=\"NAD-dependent histone deacetylase activity (H3-K14 specific)\")"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"lWFQLnWuNfzB"},"source":["dtnetplot(drugs = drugs(dup_hyperG_res), set = \"GO:0051059\", ont = \"MF\", \n","          desc=\"NF-kappaB binding\")"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"5wN2lA31OYs5"},"source":["dtnetplot(drugs = drugs(dup_hyperG_k_res), set = \"hsa05034\", \n","          desc=\"Alcoholism\")"],"execution_count":null,"outputs":[]},{"cell_type":"code","metadata":{"id":"wpdQ0PPNOca4"},"source":["dtnetplot(drugs = drugs, set = \"hsa04213\", \n","          desc=\"Longevity regulating pathway - multiple species\")"],"execution_count":null,"outputs":[]},{"cell_type":"markdown","metadata":{"id":"RZBvdR-cOeon"},"source":["# Run Workflow"]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"uXAnuLEUOtJq","executionInfo":{"status":"ok","timestamp":1636338465920,"user_tz":-480,"elapsed":19246,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"0058e36b-f899-4aac-aab2-272cd4884ac2"},"source":["drug <- \"vorinostat\"; cell <- \"SKB\"\n","refdb <- system.file(\"extdata\", \"sample_db.h5\", package=\"signatureSearch\")\n","env_dir <- tempdir()\n","wf_list <- runWF(drug, cell, refdb, gess_method=\"LINCS\", \n","    fea_method=\"dup_hyperG\", N_gess_drugs=10, env_dir=env_dir, tau=FALSE)"],"execution_count":45,"outputs":[{"output_type":"stream","name":"stderr","text":["150 / 150 genes in up set share identifiers with reference database\n","\n","150 / 150 genes in down set share identifiers with reference database\n","\n","No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n","No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n","No targets found in all databases for 2 drugs: \n","scopolamine-n-oxide / i-070759\n","\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":32},"id":"eW_Fu8YWOvTg","executionInfo":{"status":"ok","timestamp":1636338465922,"user_tz":-480,"elapsed":17,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"1af28c5a-a6f6-44f4-9750-0e2f03d3c7cf"},"source":["names(wf_list)"],"execution_count":46,"outputs":[{"output_type":"display_data","data":{"text/plain":["[1] \"gess_tb\" \"mf_tb\"   \"bp_tb\"   \"kegg_tb\""],"text/latex":"\\begin{enumerate*}\n\\item 'gess\\_tb'\n\\item 'mf\\_tb'\n\\item 'bp\\_tb'\n\\item 'kegg\\_tb'\n\\end{enumerate*}\n","text/markdown":"1. 'gess_tb'\n2. 'mf_tb'\n3. 'bp_tb'\n4. 'kegg_tb'\n\n\n","text/html":["<style>\n",".list-inline {list-style: none; margin:0; padding: 0}\n",".list-inline>li {display: inline-block}\n",".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n","</style>\n","<ol class=list-inline><li>'gess_tb'</li><li>'mf_tb'</li><li>'bp_tb'</li><li>'kegg_tb'</li></ol>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"id":"GwbgqdmqPdcz","colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"status":"ok","timestamp":1636338465923,"user_tz":-480,"elapsed":14,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"cb749f9c-757b-4615-a396-7e53d8aa26a6"},"source":["wf_list$gess_tb"],"execution_count":47,"outputs":[{"output_type":"display_data","data":{"text/plain":["    pert                PCID     cell type   trend WTCS       WTCS_Pval   \n","1   vorinostat          5311     SKB  trt_cp up     1.0000000 0.000000e+00\n","2   trichostatin-a      444732   SKB  trt_cp up     0.8632721 5.962030e-06\n","3   HC-toxin            3571     SKB  trt_cp up     0.8566409 6.223141e-06\n","4   pyroxamide          4996     SKB  trt_cp up     0.6253459 1.631943e-05\n","5   zuclopenthixol      5311507  SKB  trt_cp down  -0.3214791 8.285917e-05\n","6   rescinnamine        5280954  SKB  trt_cp down  -0.3188884 9.604526e-05\n","7   APHA-compound-8     10379137 SKB  trt_cp up     0.4449388 2.415275e-05\n","8   epothilone          448013   SKB  trt_cp down  -0.3075832 2.402220e-04\n","9   scopolamine-n-oxide 3000667  SKB  trt_cp up     0.4156802 2.541479e-05\n","10  I-070759            24086306 SKB  trt_cp up     0.4075031 2.576293e-05\n","11  warfarin            54678486 SKB  trt_cp down  -0.2817883 2.448393e-03\n","12  benzonatate         7699     SKB  trt_cp up     0.3993739 2.615460e-05\n","13  MD-040              73707398 SKB  trt_cp up     0.3977545 2.619812e-05\n","14  ganglioside         4673190  SKB  trt_cp down  -0.2742264 4.681304e-03\n","15  calcifediol         46705323 SKB  trt_cp up     0.3943566 2.637219e-05\n","16  rimcazole           5072     SKB  trt_cp up     0.3693924 2.746015e-05\n","17  progesterone        5994     SKB  trt_cp down  -0.2560705 1.725925e-02\n","18  afatinib            22225683 SKB  trt_cp up     0.3645535 2.763423e-05\n","19  huperzine-a         1253     SKB  trt_cp up     0.3629478 2.776478e-05\n","20  calcitriol          21158442 SKB  trt_cp up     0.3602968 2.789534e-05\n","21  fasudil             3547     SKB  trt_cp up     0.3583908 2.798238e-05\n","22  BAY-11-7082         5353431  SKB  trt_cp down  -0.2478859 2.867713e-02\n","23  endecaphyllin-x     6710740  SKB  trt_cp down  -0.2471567 3.045638e-02\n","24  TUL-XIX029          67243342 SKB  trt_cp up     0.3510614 2.887450e-05\n","25  scoulerine          439654   SKB  trt_cp down  -0.2391343 4.793888e-02\n","26  sinensetin          145659   SKB  trt_cp up     0.3373698 3.622913e-05\n","27  raltitrexed         104758   SKB  trt_cp up     0.3334212 4.203884e-05\n","28  JWH-015             4273754  SKB  trt_cp up     0.3322586 4.377958e-05\n","29  GSK-0660            46233311 SKB  trt_cp up     0.3267081 5.600827e-05\n","30  ryuvidine           481747   SKB  trt_cp up     0.3264634 5.940271e-05\n","⋮   ⋮                   ⋮        ⋮    ⋮      ⋮     ⋮          ⋮           \n","71  ST-4029655          691928   SKB  trt_cp down  0          0.3144514   \n","72  tyrphostin-AG-556   2059     SKB  trt_cp down  0          0.3144514   \n","73  alvespimycin        73707383 SKB  trt_cp down  0          0.3144514   \n","74  AS-703026           44187362 SKB  trt_cp down  0          0.3144514   \n","75  procarbazine        9703     SKB  trt_cp down  0          0.3144514   \n","76  TUL-XX023           54596143 SKB  trt_cp down  0          0.3144514   \n","77  CGP-12177           2687     SKB  trt_cp down  0          0.3144514   \n","78  formoterol          23581795 SKB  trt_cp down  0          0.3144514   \n","79  midostaurin         9829523  SKB  trt_cp down  0          0.3144514   \n","80  NSC-693868          438981   SKB  trt_cp down  0          0.3144514   \n","81  CGP-13501           3519541  SKB  trt_cp down  0          0.3144514   \n","82  SPB02303            2744062  SKB  trt_cp down  0          0.3144514   \n","83  aprepitant          151165   SKB  trt_cp down  0          0.3144514   \n","84  evoxine             673465   SKB  trt_cp down  0          0.3144514   \n","85  carbetocin          73707428 SKB  trt_cp down  0          0.3144514   \n","86  ketorolac           3826     SKB  trt_cp down  0          0.3144514   \n","87  SKF-77434           11957703 SKB  trt_cp down  0          0.3144514   \n","88  oxalomalic-acid     439620   SKB  trt_cp down  0          0.3144514   \n","89  dibenzepin          9419     SKB  trt_cp down  0          0.3144514   \n","90  NNC-63-0532         3906780  SKB  trt_cp down  0          0.3144514   \n","91  pantoprazole        4679     SKB  trt_cp down  0          0.3144514   \n","92  trazodone           5533     SKB  trt_cp down  0          0.3144514   \n","93  quinpirol-(-)       NotFound SKB  trt_cp down  0          0.3144514   \n","94  vinorelbine         73707409 SKB  trt_cp down  0          0.3144514   \n","95  ST-001903           674282   SKB  trt_cp down  0          0.3144514   \n","96  L-erythro-MAPP      6610217  SKB  trt_cp down  0          0.3144514   \n","97  loreclezole         50988829 SKB  trt_cp down  0          0.3144514   \n","98  RAN-05              44229302 SKB  trt_cp down  0          0.3144514   \n","99  terguride           11957722 SKB  trt_cp down  0          0.3144514   \n","100 K784-3131           4381125  SKB  trt_cp down  0          0.3144514   \n","    WTCS_FDR     NCS        NCSct      N_upset N_downset\n","1   0.0000000000  2.5663193  2.5663193 150     150      \n","2   0.0001804657  2.2154320  2.2154320 150     150      \n","3   0.0001804657  2.1984140  2.1984140 150     150      \n","4   0.0001804657  1.6048373  1.6048373 150     150      \n","5   0.0003186891 -1.1881347 -1.1881347 150     150      \n","6   0.0003557232 -1.1785601 -1.1785601 150     150      \n","7   0.0001804657  1.1418551  1.1418551 150     150      \n","8   0.0008007398 -1.1367780 -1.1367780 150     150      \n","9   0.0001804657  1.0667682  1.0667682 150     150      \n","10  0.0001804657  1.0457832  1.0457832 150     150      \n","11  0.0069954076 -1.0414442 -1.0414442 150     150      \n","12  0.0001804657  1.0249210  1.0249210 150     150      \n","13  0.0001804657  1.0207651  1.0207651 150     150      \n","14  0.0126521718 -1.0134963 -1.0134963 150     150      \n","15  0.0001804657  1.0120451  1.0120451 150     150      \n","16  0.0001804657  0.9479788  0.9479788 150     150      \n","17  0.0442544901 -0.9463954 -0.9463954 150     150      \n","18  0.0001804657  0.9355606  0.9355606 150     150      \n","19  0.0001804657  0.9314399  0.9314399 150     150      \n","20  0.0001804657  0.9246366  0.9246366 150     150      \n","21  0.0001804657  0.9197452  0.9197452 150     150      \n","22  0.0682788735 -0.9161463 -0.9161463 150     150      \n","23  0.0708287895 -0.9134511 -0.9134511 150     150      \n","24  0.0001804657  0.9009355  0.9009355 150     150      \n","25  0.1065308453 -0.8838018 -0.8838018 150     150      \n","26  0.0002131125  0.8657986  0.8657986 150     150      \n","27  0.0002304188  0.8556654  0.8556654 150     150      \n","28  0.0002304188  0.8526817  0.8526817 150     150      \n","29  0.0002800414  0.8384372  0.8384372 150     150      \n","30  0.0002828701  0.8378093  0.8378093 150     150      \n","⋮   ⋮            ⋮          ⋮          ⋮       ⋮        \n","71  0.3144514    0          0          150     150      \n","72  0.3144514    0          0          150     150      \n","73  0.3144514    0          0          150     150      \n","74  0.3144514    0          0          150     150      \n","75  0.3144514    0          0          150     150      \n","76  0.3144514    0          0          150     150      \n","77  0.3144514    0          0          150     150      \n","78  0.3144514    0          0          150     150      \n","79  0.3144514    0          0          150     150      \n","80  0.3144514    0          0          150     150      \n","81  0.3144514    0          0          150     150      \n","82  0.3144514    0          0          150     150      \n","83  0.3144514    0          0          150     150      \n","84  0.3144514    0          0          150     150      \n","85  0.3144514    0          0          150     150      \n","86  0.3144514    0          0          150     150      \n","87  0.3144514    0          0          150     150      \n","88  0.3144514    0          0          150     150      \n","89  0.3144514    0          0          150     150      \n","90  0.3144514    0          0          150     150      \n","91  0.3144514    0          0          150     150      \n","92  0.3144514    0          0          150     150      \n","93  0.3144514    0          0          150     150      \n","94  0.3144514    0          0          150     150      \n","95  0.3144514    0          0          150     150      \n","96  0.3144514    0          0          150     150      \n","97  0.3144514    0          0          150     150      \n","98  0.3144514    0          0          150     150      \n","99  0.3144514    0          0          150     150      \n","100 0.3144514    0          0          150     150      \n","    t_gn_sym                                   \n","1   HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...   \n","2   HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...    \n","3   HDAC1                                      \n","4   HDAC1; HDAC3; HDAC6                        \n","5   ADRA1A; DRD1; HRH1                         \n","6   ACE                                        \n","7   HDAC8                                      \n","8   TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ...\n","9   NA                                         \n","10  NA                                         \n","11  ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...      \n","12  SCN5A                                      \n","13  NA                                         \n","14  NA                                         \n","15  VDR                                        \n","16  SIGMAR1                                    \n","17  AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...      \n","18  EGF; EGFR; ERBB2; ERBB4; GAK               \n","19  ACHE                                       \n","20  CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...     \n","21  CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...  \n","22  NA                                         \n","23  NA                                         \n","24  NA                                         \n","25  ADRA1D                                     \n","26  NA                                         \n","27  FPGS; TYMS                                 \n","28  CNR2; GPR55                                \n","29  PPARD                                      \n","30  CDK2; CDK4                                 \n","⋮   ⋮                                          \n","71  NA                                         \n","72  EGFR                                       \n","73  HSP90AA1                                   \n","74  MAP2K1; MAP2K2                             \n","75  MAOA; MAOB                                 \n","76  NA                                         \n","77  ADRB1; ADRB2; ADRB3                        \n","78  ADRB1; ADRB2; ADRB3                        \n","79  AAK1; AURKC; BCR; BRSK1; BRSK2; ...        \n","80  NA                                         \n","81  GABBR1                                     \n","82  NA                                         \n","83  CYP2C9; TACR1                              \n","84  NA                                         \n","85  OXTR                                       \n","86  LTF; TF                                    \n","87  DRD1                                       \n","88  ACO1; IDH1                                 \n","89  NA                                         \n","90  OPRL1                                      \n","91  ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4      \n","92  ADRA1A; HRH1; HTR2B; SLC6A4                \n","93  NA                                         \n","94  TUBB                                       \n","95  NA                                         \n","96  NA                                         \n","97  GABRB2; GABRB3                             \n","98  NA                                         \n","99  ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...    \n","100 NA                                         "],"text/latex":"A spec\\_tbl\\_df: 100 × 13\n\\begin{tabular}{lllllllllllll}\n pert & PCID & cell & type & trend & WTCS & WTCS\\_Pval & WTCS\\_FDR & NCS & NCSct & N\\_upset & N\\_downset & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr>\\\\\n\\hline\n\t vorinostat          & 5311     & SKB & trt\\_cp & up   &  1.0000000 & 0.000000e+00 & 0.0000000000 &  2.5663193 &  2.5663193 & 150 & 150 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...   \\\\\n\t trichostatin-a      & 444732   & SKB & trt\\_cp & up   &  0.8632721 & 5.962030e-06 & 0.0001804657 &  2.2154320 &  2.2154320 & 150 & 150 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...    \\\\\n\t HC-toxin            & 3571     & SKB & trt\\_cp & up   &  0.8566409 & 6.223141e-06 & 0.0001804657 &  2.1984140 &  2.1984140 & 150 & 150 & HDAC1                                      \\\\\n\t pyroxamide          & 4996     & SKB & trt\\_cp & up   &  0.6253459 & 1.631943e-05 & 0.0001804657 &  1.6048373 &  1.6048373 & 150 & 150 & HDAC1; HDAC3; HDAC6                        \\\\\n\t zuclopenthixol      & 5311507  & SKB & trt\\_cp & down & -0.3214791 & 8.285917e-05 & 0.0003186891 & -1.1881347 & -1.1881347 & 150 & 150 & ADRA1A; DRD1; HRH1                         \\\\\n\t rescinnamine        & 5280954  & SKB & trt\\_cp & down & -0.3188884 & 9.604526e-05 & 0.0003557232 & -1.1785601 & -1.1785601 & 150 & 150 & ACE                                        \\\\\n\t APHA-compound-8     & 10379137 & SKB & trt\\_cp & up   &  0.4449388 & 2.415275e-05 & 0.0001804657 &  1.1418551 &  1.1418551 & 150 & 150 & HDAC8                                      \\\\\n\t epothilone          & 448013   & SKB & trt\\_cp & down & -0.3075832 & 2.402220e-04 & 0.0008007398 & -1.1367780 & -1.1367780 & 150 & 150 & TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ...\\\\\n\t scopolamine-n-oxide & 3000667  & SKB & trt\\_cp & up   &  0.4156802 & 2.541479e-05 & 0.0001804657 &  1.0667682 &  1.0667682 & 150 & 150 & NA                                         \\\\\n\t I-070759            & 24086306 & SKB & trt\\_cp & up   &  0.4075031 & 2.576293e-05 & 0.0001804657 &  1.0457832 &  1.0457832 & 150 & 150 & NA                                         \\\\\n\t warfarin            & 54678486 & SKB & trt\\_cp & down & -0.2817883 & 2.448393e-03 & 0.0069954076 & -1.0414442 & -1.0414442 & 150 & 150 & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...      \\\\\n\t benzonatate         & 7699     & SKB & trt\\_cp & up   &  0.3993739 & 2.615460e-05 & 0.0001804657 &  1.0249210 &  1.0249210 & 150 & 150 & SCN5A                                      \\\\\n\t MD-040              & 73707398 & SKB & trt\\_cp & up   &  0.3977545 & 2.619812e-05 & 0.0001804657 &  1.0207651 &  1.0207651 & 150 & 150 & NA                                         \\\\\n\t ganglioside         & 4673190  & SKB & trt\\_cp & down & -0.2742264 & 4.681304e-03 & 0.0126521718 & -1.0134963 & -1.0134963 & 150 & 150 & NA                                         \\\\\n\t calcifediol         & 46705323 & SKB & trt\\_cp & up   &  0.3943566 & 2.637219e-05 & 0.0001804657 &  1.0120451 &  1.0120451 & 150 & 150 & VDR                                        \\\\\n\t rimcazole           & 5072     & SKB & trt\\_cp & up   &  0.3693924 & 2.746015e-05 & 0.0001804657 &  0.9479788 &  0.9479788 & 150 & 150 & SIGMAR1                                    \\\\\n\t progesterone        & 5994     & SKB & trt\\_cp & down & -0.2560705 & 1.725925e-02 & 0.0442544901 & -0.9463954 & -0.9463954 & 150 & 150 & AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...      \\\\\n\t afatinib            & 22225683 & SKB & trt\\_cp & up   &  0.3645535 & 2.763423e-05 & 0.0001804657 &  0.9355606 &  0.9355606 & 150 & 150 & EGF; EGFR; ERBB2; ERBB4; GAK               \\\\\n\t huperzine-a         & 1253     & SKB & trt\\_cp & up   &  0.3629478 & 2.776478e-05 & 0.0001804657 &  0.9314399 &  0.9314399 & 150 & 150 & ACHE                                       \\\\\n\t calcitriol          & 21158442 & SKB & trt\\_cp & up   &  0.3602968 & 2.789534e-05 & 0.0001804657 &  0.9246366 &  0.9246366 & 150 & 150 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...     \\\\\n\t fasudil             & 3547     & SKB & trt\\_cp & up   &  0.3583908 & 2.798238e-05 & 0.0001804657 &  0.9197452 &  0.9197452 & 150 & 150 & CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...  \\\\\n\t BAY-11-7082         & 5353431  & SKB & trt\\_cp & down & -0.2478859 & 2.867713e-02 & 0.0682788735 & -0.9161463 & -0.9161463 & 150 & 150 & NA                                         \\\\\n\t endecaphyllin-x     & 6710740  & SKB & trt\\_cp & down & -0.2471567 & 3.045638e-02 & 0.0708287895 & -0.9134511 & -0.9134511 & 150 & 150 & NA                                         \\\\\n\t TUL-XIX029          & 67243342 & SKB & trt\\_cp & up   &  0.3510614 & 2.887450e-05 & 0.0001804657 &  0.9009355 &  0.9009355 & 150 & 150 & NA                                         \\\\\n\t scoulerine          & 439654   & SKB & trt\\_cp & down & -0.2391343 & 4.793888e-02 & 0.1065308453 & -0.8838018 & -0.8838018 & 150 & 150 & ADRA1D                                     \\\\\n\t sinensetin          & 145659   & SKB & trt\\_cp & up   &  0.3373698 & 3.622913e-05 & 0.0002131125 &  0.8657986 &  0.8657986 & 150 & 150 & NA                                         \\\\\n\t raltitrexed         & 104758   & SKB & trt\\_cp & up   &  0.3334212 & 4.203884e-05 & 0.0002304188 &  0.8556654 &  0.8556654 & 150 & 150 & FPGS; TYMS                                 \\\\\n\t JWH-015             & 4273754  & SKB & trt\\_cp & up   &  0.3322586 & 4.377958e-05 & 0.0002304188 &  0.8526817 &  0.8526817 & 150 & 150 & CNR2; GPR55                                \\\\\n\t GSK-0660            & 46233311 & SKB & trt\\_cp & up   &  0.3267081 & 5.600827e-05 & 0.0002800414 &  0.8384372 &  0.8384372 & 150 & 150 & PPARD                                      \\\\\n\t ryuvidine           & 481747   & SKB & trt\\_cp & up   &  0.3264634 & 5.940271e-05 & 0.0002828701 &  0.8378093 &  0.8378093 & 150 & 150 & CDK2; CDK4                                 \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t ST-4029655        & 691928   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t tyrphostin-AG-556 & 2059     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & EGFR                                   \\\\\n\t alvespimycin      & 73707383 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & HSP90AA1                               \\\\\n\t AS-703026         & 44187362 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAP2K1; MAP2K2                         \\\\\n\t procarbazine      & 9703     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAOA; MAOB                             \\\\\n\t TUL-XX023         & 54596143 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t CGP-12177         & 2687     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                    \\\\\n\t formoterol        & 23581795 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                    \\\\\n\t midostaurin       & 9829523  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & AAK1; AURKC; BCR; BRSK1; BRSK2; ...    \\\\\n\t NSC-693868        & 438981   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t CGP-13501         & 3519541  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABBR1                                 \\\\\n\t SPB02303          & 2744062  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t aprepitant        & 151165   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CYP2C9; TACR1                          \\\\\n\t evoxine           & 673465   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t carbetocin        & 73707428 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OXTR                                   \\\\\n\t ketorolac         & 3826     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & LTF; TF                                \\\\\n\t SKF-77434         & 11957703 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & DRD1                                   \\\\\n\t oxalomalic-acid   & 439620   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ACO1; IDH1                             \\\\\n\t dibenzepin        & 9419     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t NNC-63-0532       & 3906780  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OPRL1                                  \\\\\n\t pantoprazole      & 4679     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4  \\\\\n\t trazodone         & 5533     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; HRH1; HTR2B; SLC6A4            \\\\\n\t quinpirol-(-)     & NotFound & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t vinorelbine       & 73707409 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & TUBB                                   \\\\\n\t ST-001903         & 674282   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t L-erythro-MAPP    & 6610217  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t loreclezole       & 50988829 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABRB2; GABRB3                         \\\\\n\t RAN-05            & 44229302 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\t terguride         & 11957722 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...\\\\\n\t K784-3131         & 4381125  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & NA                                     \\\\\n\\end{tabular}\n","text/markdown":"\nA spec_tbl_df: 100 × 13\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | WTCS &lt;dbl&gt; | WTCS_Pval &lt;dbl&gt; | WTCS_FDR &lt;dbl&gt; | NCS &lt;dbl&gt; | NCSct &lt;dbl&gt; | N_upset &lt;dbl&gt; | N_downset &lt;dbl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| vorinostat          | 5311     | SKB | trt_cp | up   |  1.0000000 | 0.000000e+00 | 0.0000000000 |  2.5663193 |  2.5663193 | 150 | 150 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...    |\n| trichostatin-a      | 444732   | SKB | trt_cp | up   |  0.8632721 | 5.962030e-06 | 0.0001804657 |  2.2154320 |  2.2154320 | 150 | 150 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...     |\n| HC-toxin            | 3571     | SKB | trt_cp | up   |  0.8566409 | 6.223141e-06 | 0.0001804657 |  2.1984140 |  2.1984140 | 150 | 150 | HDAC1                                       |\n| pyroxamide          | 4996     | SKB | trt_cp | up   |  0.6253459 | 1.631943e-05 | 0.0001804657 |  1.6048373 |  1.6048373 | 150 | 150 | HDAC1; HDAC3; HDAC6                         |\n| zuclopenthixol      | 5311507  | SKB | trt_cp | down | -0.3214791 | 8.285917e-05 | 0.0003186891 | -1.1881347 | -1.1881347 | 150 | 150 | ADRA1A; DRD1; HRH1                          |\n| rescinnamine        | 5280954  | SKB | trt_cp | down | -0.3188884 | 9.604526e-05 | 0.0003557232 | -1.1785601 | -1.1785601 | 150 | 150 | ACE                                         |\n| APHA-compound-8     | 10379137 | SKB | trt_cp | up   |  0.4449388 | 2.415275e-05 | 0.0001804657 |  1.1418551 |  1.1418551 | 150 | 150 | HDAC8                                       |\n| epothilone          | 448013   | SKB | trt_cp | down | -0.3075832 | 2.402220e-04 | 0.0008007398 | -1.1367780 | -1.1367780 | 150 | 150 | TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ... |\n| scopolamine-n-oxide | 3000667  | SKB | trt_cp | up   |  0.4156802 | 2.541479e-05 | 0.0001804657 |  1.0667682 |  1.0667682 | 150 | 150 | NA                                          |\n| I-070759            | 24086306 | SKB | trt_cp | up   |  0.4075031 | 2.576293e-05 | 0.0001804657 |  1.0457832 |  1.0457832 | 150 | 150 | NA                                          |\n| warfarin            | 54678486 | SKB | trt_cp | down | -0.2817883 | 2.448393e-03 | 0.0069954076 | -1.0414442 | -1.0414442 | 150 | 150 | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...       |\n| benzonatate         | 7699     | SKB | trt_cp | up   |  0.3993739 | 2.615460e-05 | 0.0001804657 |  1.0249210 |  1.0249210 | 150 | 150 | SCN5A                                       |\n| MD-040              | 73707398 | SKB | trt_cp | up   |  0.3977545 | 2.619812e-05 | 0.0001804657 |  1.0207651 |  1.0207651 | 150 | 150 | NA                                          |\n| ganglioside         | 4673190  | SKB | trt_cp | down | -0.2742264 | 4.681304e-03 | 0.0126521718 | -1.0134963 | -1.0134963 | 150 | 150 | NA                                          |\n| calcifediol         | 46705323 | SKB | trt_cp | up   |  0.3943566 | 2.637219e-05 | 0.0001804657 |  1.0120451 |  1.0120451 | 150 | 150 | VDR                                         |\n| rimcazole           | 5072     | SKB | trt_cp | up   |  0.3693924 | 2.746015e-05 | 0.0001804657 |  0.9479788 |  0.9479788 | 150 | 150 | SIGMAR1                                     |\n| progesterone        | 5994     | SKB | trt_cp | down | -0.2560705 | 1.725925e-02 | 0.0442544901 | -0.9463954 | -0.9463954 | 150 | 150 | AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...       |\n| afatinib            | 22225683 | SKB | trt_cp | up   |  0.3645535 | 2.763423e-05 | 0.0001804657 |  0.9355606 |  0.9355606 | 150 | 150 | EGF; EGFR; ERBB2; ERBB4; GAK                |\n| huperzine-a         | 1253     | SKB | trt_cp | up   |  0.3629478 | 2.776478e-05 | 0.0001804657 |  0.9314399 |  0.9314399 | 150 | 150 | ACHE                                        |\n| calcitriol          | 21158442 | SKB | trt_cp | up   |  0.3602968 | 2.789534e-05 | 0.0001804657 |  0.9246366 |  0.9246366 | 150 | 150 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...      |\n| fasudil             | 3547     | SKB | trt_cp | up   |  0.3583908 | 2.798238e-05 | 0.0001804657 |  0.9197452 |  0.9197452 | 150 | 150 | CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...   |\n| BAY-11-7082         | 5353431  | SKB | trt_cp | down | -0.2478859 | 2.867713e-02 | 0.0682788735 | -0.9161463 | -0.9161463 | 150 | 150 | NA                                          |\n| endecaphyllin-x     | 6710740  | SKB | trt_cp | down | -0.2471567 | 3.045638e-02 | 0.0708287895 | -0.9134511 | -0.9134511 | 150 | 150 | NA                                          |\n| TUL-XIX029          | 67243342 | SKB | trt_cp | up   |  0.3510614 | 2.887450e-05 | 0.0001804657 |  0.9009355 |  0.9009355 | 150 | 150 | NA                                          |\n| scoulerine          | 439654   | SKB | trt_cp | down | -0.2391343 | 4.793888e-02 | 0.1065308453 | -0.8838018 | -0.8838018 | 150 | 150 | ADRA1D                                      |\n| sinensetin          | 145659   | SKB | trt_cp | up   |  0.3373698 | 3.622913e-05 | 0.0002131125 |  0.8657986 |  0.8657986 | 150 | 150 | NA                                          |\n| raltitrexed         | 104758   | SKB | trt_cp | up   |  0.3334212 | 4.203884e-05 | 0.0002304188 |  0.8556654 |  0.8556654 | 150 | 150 | FPGS; TYMS                                  |\n| JWH-015             | 4273754  | SKB | trt_cp | up   |  0.3322586 | 4.377958e-05 | 0.0002304188 |  0.8526817 |  0.8526817 | 150 | 150 | CNR2; GPR55                                 |\n| GSK-0660            | 46233311 | SKB | trt_cp | up   |  0.3267081 | 5.600827e-05 | 0.0002800414 |  0.8384372 |  0.8384372 | 150 | 150 | PPARD                                       |\n| ryuvidine           | 481747   | SKB | trt_cp | up   |  0.3264634 | 5.940271e-05 | 0.0002828701 |  0.8378093 |  0.8378093 | 150 | 150 | CDK2; CDK4                                  |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| ST-4029655        | 691928   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| tyrphostin-AG-556 | 2059     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | EGFR                                    |\n| alvespimycin      | 73707383 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | HSP90AA1                                |\n| AS-703026         | 44187362 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAP2K1; MAP2K2                          |\n| procarbazine      | 9703     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAOA; MAOB                              |\n| TUL-XX023         | 54596143 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| CGP-12177         | 2687     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                     |\n| formoterol        | 23581795 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                     |\n| midostaurin       | 9829523  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | AAK1; AURKC; BCR; BRSK1; BRSK2; ...     |\n| NSC-693868        | 438981   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| CGP-13501         | 3519541  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABBR1                                  |\n| SPB02303          | 2744062  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| aprepitant        | 151165   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CYP2C9; TACR1                           |\n| evoxine           | 673465   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| carbetocin        | 73707428 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OXTR                                    |\n| ketorolac         | 3826     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | LTF; TF                                 |\n| SKF-77434         | 11957703 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | DRD1                                    |\n| oxalomalic-acid   | 439620   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ACO1; IDH1                              |\n| dibenzepin        | 9419     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| NNC-63-0532       | 3906780  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OPRL1                                   |\n| pantoprazole      | 4679     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4   |\n| trazodone         | 5533     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; HRH1; HTR2B; SLC6A4             |\n| quinpirol-(-)     | NotFound | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| vinorelbine       | 73707409 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | TUBB                                    |\n| ST-001903         | 674282   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| L-erythro-MAPP    | 6610217  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| loreclezole       | 50988829 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABRB2; GABRB3                          |\n| RAN-05            | 44229302 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n| terguride         | 11957722 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ... |\n| K784-3131         | 4381125  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | NA                                      |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A spec_tbl_df: 100 × 13</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>WTCS</th><th scope=col>WTCS_Pval</th><th scope=col>WTCS_FDR</th><th scope=col>NCS</th><th scope=col>NCSct</th><th scope=col>N_upset</th><th scope=col>N_downset</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat         </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.0000000</td><td>0.000000e+00</td><td>0.0000000000</td><td> 2.5663193</td><td> 2.5663193</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...   </td></tr>\n","\t<tr><td>trichostatin-a     </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8632721</td><td>5.962030e-06</td><td>0.0001804657</td><td> 2.2154320</td><td> 2.2154320</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...    </td></tr>\n","\t<tr><td>HC-toxin           </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8566409</td><td>6.223141e-06</td><td>0.0001804657</td><td> 2.1984140</td><td> 2.1984140</td><td>150</td><td>150</td><td>HDAC1                                      </td></tr>\n","\t<tr><td>pyroxamide         </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.6253459</td><td>1.631943e-05</td><td>0.0001804657</td><td> 1.6048373</td><td> 1.6048373</td><td>150</td><td>150</td><td>HDAC1; HDAC3; HDAC6                        </td></tr>\n","\t<tr><td>zuclopenthixol     </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3214791</td><td>8.285917e-05</td><td>0.0003186891</td><td>-1.1881347</td><td>-1.1881347</td><td>150</td><td>150</td><td>ADRA1A; DRD1; HRH1                         </td></tr>\n","\t<tr><td>rescinnamine       </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3188884</td><td>9.604526e-05</td><td>0.0003557232</td><td>-1.1785601</td><td>-1.1785601</td><td>150</td><td>150</td><td>ACE                                        </td></tr>\n","\t<tr><td>APHA-compound-8    </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4449388</td><td>2.415275e-05</td><td>0.0001804657</td><td> 1.1418551</td><td> 1.1418551</td><td>150</td><td>150</td><td>HDAC8                                      </td></tr>\n","\t<tr><td>epothilone         </td><td>448013  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3075832</td><td>2.402220e-04</td><td>0.0008007398</td><td>-1.1367780</td><td>-1.1367780</td><td>150</td><td>150</td><td>TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ...</td></tr>\n","\t<tr><td>scopolamine-n-oxide</td><td>3000667 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4156802</td><td>2.541479e-05</td><td>0.0001804657</td><td> 1.0667682</td><td> 1.0667682</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>I-070759           </td><td>24086306</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4075031</td><td>2.576293e-05</td><td>0.0001804657</td><td> 1.0457832</td><td> 1.0457832</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>warfarin           </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2817883</td><td>2.448393e-03</td><td>0.0069954076</td><td>-1.0414442</td><td>-1.0414442</td><td>150</td><td>150</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...      </td></tr>\n","\t<tr><td>benzonatate        </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3993739</td><td>2.615460e-05</td><td>0.0001804657</td><td> 1.0249210</td><td> 1.0249210</td><td>150</td><td>150</td><td>SCN5A                                      </td></tr>\n","\t<tr><td>MD-040             </td><td>73707398</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3977545</td><td>2.619812e-05</td><td>0.0001804657</td><td> 1.0207651</td><td> 1.0207651</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>ganglioside        </td><td>4673190 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2742264</td><td>4.681304e-03</td><td>0.0126521718</td><td>-1.0134963</td><td>-1.0134963</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>calcifediol        </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3943566</td><td>2.637219e-05</td><td>0.0001804657</td><td> 1.0120451</td><td> 1.0120451</td><td>150</td><td>150</td><td>VDR                                        </td></tr>\n","\t<tr><td>rimcazole          </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3693924</td><td>2.746015e-05</td><td>0.0001804657</td><td> 0.9479788</td><td> 0.9479788</td><td>150</td><td>150</td><td>SIGMAR1                                    </td></tr>\n","\t<tr><td>progesterone       </td><td>5994    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2560705</td><td>1.725925e-02</td><td>0.0442544901</td><td>-0.9463954</td><td>-0.9463954</td><td>150</td><td>150</td><td>AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...      </td></tr>\n","\t<tr><td>afatinib           </td><td>22225683</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3645535</td><td>2.763423e-05</td><td>0.0001804657</td><td> 0.9355606</td><td> 0.9355606</td><td>150</td><td>150</td><td>EGF; EGFR; ERBB2; ERBB4; GAK               </td></tr>\n","\t<tr><td>huperzine-a        </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3629478</td><td>2.776478e-05</td><td>0.0001804657</td><td> 0.9314399</td><td> 0.9314399</td><td>150</td><td>150</td><td>ACHE                                       </td></tr>\n","\t<tr><td>calcitriol         </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3602968</td><td>2.789534e-05</td><td>0.0001804657</td><td> 0.9246366</td><td> 0.9246366</td><td>150</td><td>150</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...     </td></tr>\n","\t<tr><td>fasudil            </td><td>3547    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3583908</td><td>2.798238e-05</td><td>0.0001804657</td><td> 0.9197452</td><td> 0.9197452</td><td>150</td><td>150</td><td>CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...  </td></tr>\n","\t<tr><td>BAY-11-7082        </td><td>5353431 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2478859</td><td>2.867713e-02</td><td>0.0682788735</td><td>-0.9161463</td><td>-0.9161463</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>endecaphyllin-x    </td><td>6710740 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2471567</td><td>3.045638e-02</td><td>0.0708287895</td><td>-0.9134511</td><td>-0.9134511</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>TUL-XIX029         </td><td>67243342</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3510614</td><td>2.887450e-05</td><td>0.0001804657</td><td> 0.9009355</td><td> 0.9009355</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>scoulerine         </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2391343</td><td>4.793888e-02</td><td>0.1065308453</td><td>-0.8838018</td><td>-0.8838018</td><td>150</td><td>150</td><td>ADRA1D                                     </td></tr>\n","\t<tr><td>sinensetin         </td><td>145659  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3373698</td><td>3.622913e-05</td><td>0.0002131125</td><td> 0.8657986</td><td> 0.8657986</td><td>150</td><td>150</td><td>NA                                         </td></tr>\n","\t<tr><td>raltitrexed        </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3334212</td><td>4.203884e-05</td><td>0.0002304188</td><td> 0.8556654</td><td> 0.8556654</td><td>150</td><td>150</td><td>FPGS; TYMS                                 </td></tr>\n","\t<tr><td>JWH-015            </td><td>4273754 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3322586</td><td>4.377958e-05</td><td>0.0002304188</td><td> 0.8526817</td><td> 0.8526817</td><td>150</td><td>150</td><td>CNR2; GPR55                                </td></tr>\n","\t<tr><td>GSK-0660           </td><td>46233311</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3267081</td><td>5.600827e-05</td><td>0.0002800414</td><td> 0.8384372</td><td> 0.8384372</td><td>150</td><td>150</td><td>PPARD                                      </td></tr>\n","\t<tr><td>ryuvidine          </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3264634</td><td>5.940271e-05</td><td>0.0002828701</td><td> 0.8378093</td><td> 0.8378093</td><td>150</td><td>150</td><td>CDK2; CDK4                                 </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>ST-4029655       </td><td>691928  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>tyrphostin-AG-556</td><td>2059    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>EGFR                                   </td></tr>\n","\t<tr><td>alvespimycin     </td><td>73707383</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>HSP90AA1                               </td></tr>\n","\t<tr><td>AS-703026        </td><td>44187362</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAP2K1; MAP2K2                         </td></tr>\n","\t<tr><td>procarbazine     </td><td>9703    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAOA; MAOB                             </td></tr>\n","\t<tr><td>TUL-XX023        </td><td>54596143</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>CGP-12177        </td><td>2687    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                    </td></tr>\n","\t<tr><td>formoterol       </td><td>23581795</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                    </td></tr>\n","\t<tr><td>midostaurin      </td><td>9829523 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; ...    </td></tr>\n","\t<tr><td>NSC-693868       </td><td>438981  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>CGP-13501        </td><td>3519541 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABBR1                                 </td></tr>\n","\t<tr><td>SPB02303         </td><td>2744062 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>aprepitant       </td><td>151165  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CYP2C9; TACR1                          </td></tr>\n","\t<tr><td>evoxine          </td><td>673465  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>carbetocin       </td><td>73707428</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OXTR                                   </td></tr>\n","\t<tr><td>ketorolac        </td><td>3826    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>LTF; TF                                </td></tr>\n","\t<tr><td>SKF-77434        </td><td>11957703</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>DRD1                                   </td></tr>\n","\t<tr><td>oxalomalic-acid  </td><td>439620  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ACO1; IDH1                             </td></tr>\n","\t<tr><td>dibenzepin       </td><td>9419    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>NNC-63-0532      </td><td>3906780 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OPRL1                                  </td></tr>\n","\t<tr><td>pantoprazole     </td><td>4679    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4  </td></tr>\n","\t<tr><td>trazodone        </td><td>5533    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; HRH1; HTR2B; SLC6A4            </td></tr>\n","\t<tr><td>quinpirol-(-)    </td><td>NotFound</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>vinorelbine      </td><td>73707409</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>TUBB                                   </td></tr>\n","\t<tr><td>ST-001903        </td><td>674282  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>L-erythro-MAPP   </td><td>6610217 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>loreclezole      </td><td>50988829</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABRB2; GABRB3                         </td></tr>\n","\t<tr><td>RAN-05           </td><td>44229302</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","\t<tr><td>terguride        </td><td>11957722</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...</td></tr>\n","\t<tr><td>K784-3131        </td><td>4381125 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>NA                                     </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"id":"OcBfY6HBdI8x","colab":{"base_uri":"https://localhost:8080/"},"executionInfo":{"status":"ok","timestamp":1636338467310,"user_tz":-480,"elapsed":1398,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"e8c14ed0-afb1-49ef-ce4b-b952056a6e91"},"source":["library(tidyverse)"],"execution_count":48,"outputs":[{"output_type":"stream","name":"stderr","text":["Warning message in system(\"timedatectl\", intern = TRUE):\n","“running command 'timedatectl' had status 1”\n","── \u001b[1mAttaching packages\u001b[22m ─────────────────────────────────────── tidyverse 1.3.1 ──\n","\n","\u001b[32m✔\u001b[39m \u001b[34mggplot2\u001b[39m 3.3.5     \u001b[32m✔\u001b[39m \u001b[34mpurrr  \u001b[39m 0.3.4\n","\u001b[32m✔\u001b[39m \u001b[34mtibble \u001b[39m 3.1.6     \u001b[32m✔\u001b[39m \u001b[34mstringr\u001b[39m 1.4.0\n","\u001b[32m✔\u001b[39m \u001b[34mtidyr  \u001b[39m 1.1.4     \u001b[32m✔\u001b[39m \u001b[34mforcats\u001b[39m 0.5.1\n","\n","── \u001b[1mConflicts\u001b[22m ────────────────────────────────────────── tidyverse_conflicts() ──\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mcollapse()\u001b[39m   masks \u001b[34mIRanges\u001b[39m::collapse()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mcombine()\u001b[39m    masks \u001b[34mBiobase\u001b[39m::combine(), \u001b[34mBiocGenerics\u001b[39m::combine()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mcount()\u001b[39m      masks \u001b[34mmatrixStats\u001b[39m::count()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mdesc()\u001b[39m       masks \u001b[34mIRanges\u001b[39m::desc()\n","\u001b[31m✖\u001b[39m \u001b[34mtidyr\u001b[39m::\u001b[32mexpand()\u001b[39m     masks \u001b[34mMatrix\u001b[39m::expand(), \u001b[34mS4Vectors\u001b[39m::expand()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mfilter()\u001b[39m     masks \u001b[34mstats\u001b[39m::filter()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mfirst()\u001b[39m      masks \u001b[34mS4Vectors\u001b[39m::first()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mident()\u001b[39m      masks \u001b[34mdbplyr\u001b[39m::ident()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mlag()\u001b[39m        masks \u001b[34mstats\u001b[39m::lag()\n","\u001b[31m✖\u001b[39m \u001b[34mtidyr\u001b[39m::\u001b[32mpack()\u001b[39m       masks \u001b[34mMatrix\u001b[39m::pack()\n","\u001b[31m✖\u001b[39m \u001b[34mggplot2\u001b[39m::\u001b[32mPosition()\u001b[39m masks \u001b[34mBiocGenerics\u001b[39m::Position(), \u001b[34mbase\u001b[39m::Position()\n","\u001b[31m✖\u001b[39m \u001b[34mpurrr\u001b[39m::\u001b[32mreduce()\u001b[39m     masks \u001b[34mGenomicRanges\u001b[39m::reduce(), \u001b[34mIRanges\u001b[39m::reduce()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mrename()\u001b[39m     masks \u001b[34mS4Vectors\u001b[39m::rename()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mselect()\u001b[39m     masks \u001b[34mAnnotationDbi\u001b[39m::select()\n","\u001b[31m✖\u001b[39m \u001b[34mpurrr\u001b[39m::\u001b[32msimplify()\u001b[39m   masks \u001b[34mDelayedArray\u001b[39m::simplify()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mslice()\u001b[39m      masks \u001b[34mIRanges\u001b[39m::slice()\n","\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32msql()\u001b[39m        masks \u001b[34mdbplyr\u001b[39m::sql()\n","\u001b[31m✖\u001b[39m \u001b[34mtidyr\u001b[39m::\u001b[32munpack()\u001b[39m     masks \u001b[34mMatrix\u001b[39m::unpack()\n","\n"]}]},{"cell_type":"code","metadata":{"id":"IC_T_iJNeJbM","colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"status":"ok","timestamp":1636338467639,"user_tz":-480,"elapsed":332,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"957b5255-9cdc-4f7e-bdfb-5cafad355c28"},"source":["drop_na(wf_list$gess_tb)"],"execution_count":49,"outputs":[{"output_type":"display_data","data":{"text/plain":["   pert                            PCID      cell type   trend WTCS      \n","1  vorinostat                      5311      SKB  trt_cp up     1.0000000\n","2  trichostatin-a                  444732    SKB  trt_cp up     0.8632721\n","3  HC-toxin                        3571      SKB  trt_cp up     0.8566409\n","4  pyroxamide                      4996      SKB  trt_cp up     0.6253459\n","5  zuclopenthixol                  5311507   SKB  trt_cp down  -0.3214791\n","6  rescinnamine                    5280954   SKB  trt_cp down  -0.3188884\n","7  APHA-compound-8                 10379137  SKB  trt_cp up     0.4449388\n","8  epothilone                      448013    SKB  trt_cp down  -0.3075832\n","9  warfarin                        54678486  SKB  trt_cp down  -0.2817883\n","10 benzonatate                     7699      SKB  trt_cp up     0.3993739\n","11 calcifediol                     46705323  SKB  trt_cp up     0.3943566\n","12 rimcazole                       5072      SKB  trt_cp up     0.3693924\n","13 progesterone                    5994      SKB  trt_cp down  -0.2560705\n","14 afatinib                        22225683  SKB  trt_cp up     0.3645535\n","15 huperzine-a                     1253      SKB  trt_cp up     0.3629478\n","16 calcitriol                      21158442  SKB  trt_cp up     0.3602968\n","17 fasudil                         3547      SKB  trt_cp up     0.3583908\n","18 scoulerine                      439654    SKB  trt_cp down  -0.2391343\n","19 raltitrexed                     104758    SKB  trt_cp up     0.3334212\n","20 JWH-015                         4273754   SKB  trt_cp up     0.3322586\n","21 GSK-0660                        46233311  SKB  trt_cp up     0.3267081\n","22 ryuvidine                       481747    SKB  trt_cp up     0.3264634\n","23 fenobam                         162834    SKB  trt_cp up     0.3242132\n","24 decafluorobutane                9638      SKB  trt_cp up     0.3232482\n","25 hydroquinidine                  45479756  SKB  trt_cp up     0.3215956\n","26 4,5,6,7-tetrabromobenzotriazole 1694      SKB  trt_cp up     0.3181929\n","27 sorafenib                       406563    SKB  trt_cp up     0.3084565\n","28 olvanil                         5808649   SKB  trt_cp up     0.3017790\n","29 vicriviroc                      73707391  SKB  trt_cp up     0.2920371\n","30 calmidazolium                   2531      SKB  trt_cp up     0.2891219\n","⋮  ⋮                               ⋮         ⋮    ⋮      ⋮     ⋮         \n","41 IRL-2500                        4574540   SKB  trt_cp down  0         \n","42 LY-456236                       9926999   SKB  trt_cp down  0         \n","43 amiodarone                      2157      SKB  trt_cp down  0         \n","44 clozapine                       135398737 SKB  trt_cp down  0         \n","45 catechin                        73160     SKB  trt_cp down  0         \n","46 SB-525334                       9967941   SKB  trt_cp down  0         \n","47 sphingosine                     5280335   SKB  trt_cp down  0         \n","48 chlorprothixene                 667467    SKB  trt_cp down  0         \n","49 treprostinil                    73707411  SKB  trt_cp down  0         \n","50 MDL-28170                       72430     SKB  trt_cp down  0         \n","51 clofibric-acid                  2797      SKB  trt_cp down  0         \n","52 tyrphostin-AG-556               2059      SKB  trt_cp down  0         \n","53 alvespimycin                    73707383  SKB  trt_cp down  0         \n","54 AS-703026                       44187362  SKB  trt_cp down  0         \n","55 procarbazine                    9703      SKB  trt_cp down  0         \n","56 CGP-12177                       2687      SKB  trt_cp down  0         \n","57 formoterol                      23581795  SKB  trt_cp down  0         \n","58 midostaurin                     9829523   SKB  trt_cp down  0         \n","59 CGP-13501                       3519541   SKB  trt_cp down  0         \n","60 aprepitant                      151165    SKB  trt_cp down  0         \n","61 carbetocin                      73707428  SKB  trt_cp down  0         \n","62 ketorolac                       3826      SKB  trt_cp down  0         \n","63 SKF-77434                       11957703  SKB  trt_cp down  0         \n","64 oxalomalic-acid                 439620    SKB  trt_cp down  0         \n","65 NNC-63-0532                     3906780   SKB  trt_cp down  0         \n","66 pantoprazole                    4679      SKB  trt_cp down  0         \n","67 trazodone                       5533      SKB  trt_cp down  0         \n","68 vinorelbine                     73707409  SKB  trt_cp down  0         \n","69 loreclezole                     50988829  SKB  trt_cp down  0         \n","70 terguride                       11957722  SKB  trt_cp down  0         \n","   WTCS_Pval    WTCS_FDR     NCS        NCSct      N_upset N_downset\n","1  0.000000e+00 0.0000000000  2.5663193  2.5663193 150     150      \n","2  5.962030e-06 0.0001804657  2.2154320  2.2154320 150     150      \n","3  6.223141e-06 0.0001804657  2.1984140  2.1984140 150     150      \n","4  1.631943e-05 0.0001804657  1.6048373  1.6048373 150     150      \n","5  8.285917e-05 0.0003186891 -1.1881347 -1.1881347 150     150      \n","6  9.604526e-05 0.0003557232 -1.1785601 -1.1785601 150     150      \n","7  2.415275e-05 0.0001804657  1.1418551  1.1418551 150     150      \n","8  2.402220e-04 0.0008007398 -1.1367780 -1.1367780 150     150      \n","9  2.448393e-03 0.0069954076 -1.0414442 -1.0414442 150     150      \n","10 2.615460e-05 0.0001804657  1.0249210  1.0249210 150     150      \n","11 2.637219e-05 0.0001804657  1.0120451  1.0120451 150     150      \n","12 2.746015e-05 0.0001804657  0.9479788  0.9479788 150     150      \n","13 1.725925e-02 0.0442544901 -0.9463954 -0.9463954 150     150      \n","14 2.763423e-05 0.0001804657  0.9355606  0.9355606 150     150      \n","15 2.776478e-05 0.0001804657  0.9314399  0.9314399 150     150      \n","16 2.789534e-05 0.0001804657  0.9246366  0.9246366 150     150      \n","17 2.798238e-05 0.0001804657  0.9197452  0.9197452 150     150      \n","18 4.793888e-02 0.1065308453 -0.8838018 -0.8838018 150     150      \n","19 4.203884e-05 0.0002304188  0.8556654  0.8556654 150     150      \n","20 4.377958e-05 0.0002304188  0.8526817  0.8526817 150     150      \n","21 5.600827e-05 0.0002800414  0.8384372  0.8384372 150     150      \n","22 5.940271e-05 0.0002828701  0.8378093  0.8378093 150     150      \n","23 6.710548e-05 0.0002917630  0.8320346  0.8320346 150     150      \n","24 7.195779e-05 0.0002998241  0.8295582  0.8295582 150     150      \n","25 7.741936e-05 0.0003096774  0.8253171  0.8253171 150     150      \n","26 1.032693e-04 0.0003688190  0.8165846  0.8165846 150     150      \n","27 2.402220e-04 0.0008007398  0.7915978  0.7915978 150     150      \n","28 4.167111e-04 0.0013442294  0.7744612  0.7744612 150     150      \n","29 1.031671e-03 0.0031262746  0.7494604  0.7494604 150     150      \n","30 1.342088e-03 0.0039473172  0.7419791  0.7419791 150     150      \n","⋮  ⋮            ⋮            ⋮          ⋮          ⋮       ⋮        \n","41 0.3144514    0.3144514    0          0          150     150      \n","42 0.3144514    0.3144514    0          0          150     150      \n","43 0.3144514    0.3144514    0          0          150     150      \n","44 0.3144514    0.3144514    0          0          150     150      \n","45 0.3144514    0.3144514    0          0          150     150      \n","46 0.3144514    0.3144514    0          0          150     150      \n","47 0.3144514    0.3144514    0          0          150     150      \n","48 0.3144514    0.3144514    0          0          150     150      \n","49 0.3144514    0.3144514    0          0          150     150      \n","50 0.3144514    0.3144514    0          0          150     150      \n","51 0.3144514    0.3144514    0          0          150     150      \n","52 0.3144514    0.3144514    0          0          150     150      \n","53 0.3144514    0.3144514    0          0          150     150      \n","54 0.3144514    0.3144514    0          0          150     150      \n","55 0.3144514    0.3144514    0          0          150     150      \n","56 0.3144514    0.3144514    0          0          150     150      \n","57 0.3144514    0.3144514    0          0          150     150      \n","58 0.3144514    0.3144514    0          0          150     150      \n","59 0.3144514    0.3144514    0          0          150     150      \n","60 0.3144514    0.3144514    0          0          150     150      \n","61 0.3144514    0.3144514    0          0          150     150      \n","62 0.3144514    0.3144514    0          0          150     150      \n","63 0.3144514    0.3144514    0          0          150     150      \n","64 0.3144514    0.3144514    0          0          150     150      \n","65 0.3144514    0.3144514    0          0          150     150      \n","66 0.3144514    0.3144514    0          0          150     150      \n","67 0.3144514    0.3144514    0          0          150     150      \n","68 0.3144514    0.3144514    0          0          150     150      \n","69 0.3144514    0.3144514    0          0          150     150      \n","70 0.3144514    0.3144514    0          0          150     150      \n","   t_gn_sym                                    \n","1  HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...    \n","2  HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...     \n","3  HDAC1                                       \n","4  HDAC1; HDAC3; HDAC6                         \n","5  ADRA1A; DRD1; HRH1                          \n","6  ACE                                         \n","7  HDAC8                                       \n","8  TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ... \n","9  ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...       \n","10 SCN5A                                       \n","11 VDR                                         \n","12 SIGMAR1                                     \n","13 AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...       \n","14 EGF; EGFR; ERBB2; ERBB4; GAK                \n","15 ACHE                                        \n","16 CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...      \n","17 CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...   \n","18 ADRA1D                                      \n","19 FPGS; TYMS                                  \n","20 CNR2; GPR55                                 \n","21 PPARD                                       \n","22 CDK2; CDK4                                  \n","23 GRM5                                        \n","24 GRM5                                        \n","25 KMT2A; PSIP1                                \n","26 AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; ...  \n","27 ARAF; BRAF; CCNC; CDK8; CYP2B6; ...         \n","28 CNR1; GPR119; TRPV1                         \n","29 CCR5                                        \n","30 ATP2B1; PDE1A                               \n","⋮  ⋮                                           \n","41 EDNRB; HBA2; HBB                            \n","42 GRM1                                        \n","43 ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; ...\n","44 ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ... \n","45 BACE1; CA1; CA12; CA14; CA4; ...            \n","46 TGFBR1                                      \n","47 ACER1; ACER2; ASAH1; ASAH2; ASAH2C; ...     \n","48 CHRM1; CHRM4; CHRM5; DRD1; DRD3; ...        \n","49 CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; ...   \n","50 CAPN1; CTSB; CTSL                           \n","51 PPARA                                       \n","52 EGFR                                        \n","53 HSP90AA1                                    \n","54 MAP2K1; MAP2K2                              \n","55 MAOA; MAOB                                  \n","56 ADRB1; ADRB2; ADRB3                         \n","57 ADRB1; ADRB2; ADRB3                         \n","58 AAK1; AURKC; BCR; BRSK1; BRSK2; ...         \n","59 GABBR1                                      \n","60 CYP2C9; TACR1                               \n","61 OXTR                                        \n","62 LTF; TF                                     \n","63 DRD1                                        \n","64 ACO1; IDH1                                  \n","65 OPRL1                                       \n","66 ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4       \n","67 ADRA1A; HRH1; HTR2B; SLC6A4                 \n","68 TUBB                                        \n","69 GABRB2; GABRB3                              \n","70 ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...     "],"text/latex":"A tibble: 70 × 13\n\\begin{tabular}{lllllllllllll}\n pert & PCID & cell & type & trend & WTCS & WTCS\\_Pval & WTCS\\_FDR & NCS & NCSct & N\\_upset & N\\_downset & t\\_gn\\_sym\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <dbl> & <chr>\\\\\n\\hline\n\t vorinostat                      & 5311     & SKB & trt\\_cp & up   &  1.0000000 & 0.000000e+00 & 0.0000000000 &  2.5663193 &  2.5663193 & 150 & 150 & HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...   \\\\\n\t trichostatin-a                  & 444732   & SKB & trt\\_cp & up   &  0.8632721 & 5.962030e-06 & 0.0001804657 &  2.2154320 &  2.2154320 & 150 & 150 & HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...    \\\\\n\t HC-toxin                        & 3571     & SKB & trt\\_cp & up   &  0.8566409 & 6.223141e-06 & 0.0001804657 &  2.1984140 &  2.1984140 & 150 & 150 & HDAC1                                      \\\\\n\t pyroxamide                      & 4996     & SKB & trt\\_cp & up   &  0.6253459 & 1.631943e-05 & 0.0001804657 &  1.6048373 &  1.6048373 & 150 & 150 & HDAC1; HDAC3; HDAC6                        \\\\\n\t zuclopenthixol                  & 5311507  & SKB & trt\\_cp & down & -0.3214791 & 8.285917e-05 & 0.0003186891 & -1.1881347 & -1.1881347 & 150 & 150 & ADRA1A; DRD1; HRH1                         \\\\\n\t rescinnamine                    & 5280954  & SKB & trt\\_cp & down & -0.3188884 & 9.604526e-05 & 0.0003557232 & -1.1785601 & -1.1785601 & 150 & 150 & ACE                                        \\\\\n\t APHA-compound-8                 & 10379137 & SKB & trt\\_cp & up   &  0.4449388 & 2.415275e-05 & 0.0001804657 &  1.1418551 &  1.1418551 & 150 & 150 & HDAC8                                      \\\\\n\t epothilone                      & 448013   & SKB & trt\\_cp & down & -0.3075832 & 2.402220e-04 & 0.0008007398 & -1.1367780 & -1.1367780 & 150 & 150 & TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ...\\\\\n\t warfarin                        & 54678486 & SKB & trt\\_cp & down & -0.2817883 & 2.448393e-03 & 0.0069954076 & -1.0414442 & -1.0414442 & 150 & 150 & ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...      \\\\\n\t benzonatate                     & 7699     & SKB & trt\\_cp & up   &  0.3993739 & 2.615460e-05 & 0.0001804657 &  1.0249210 &  1.0249210 & 150 & 150 & SCN5A                                      \\\\\n\t calcifediol                     & 46705323 & SKB & trt\\_cp & up   &  0.3943566 & 2.637219e-05 & 0.0001804657 &  1.0120451 &  1.0120451 & 150 & 150 & VDR                                        \\\\\n\t rimcazole                       & 5072     & SKB & trt\\_cp & up   &  0.3693924 & 2.746015e-05 & 0.0001804657 &  0.9479788 &  0.9479788 & 150 & 150 & SIGMAR1                                    \\\\\n\t progesterone                    & 5994     & SKB & trt\\_cp & down & -0.2560705 & 1.725925e-02 & 0.0442544901 & -0.9463954 & -0.9463954 & 150 & 150 & AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...      \\\\\n\t afatinib                        & 22225683 & SKB & trt\\_cp & up   &  0.3645535 & 2.763423e-05 & 0.0001804657 &  0.9355606 &  0.9355606 & 150 & 150 & EGF; EGFR; ERBB2; ERBB4; GAK               \\\\\n\t huperzine-a                     & 1253     & SKB & trt\\_cp & up   &  0.3629478 & 2.776478e-05 & 0.0001804657 &  0.9314399 &  0.9314399 & 150 & 150 & ACHE                                       \\\\\n\t calcitriol                      & 21158442 & SKB & trt\\_cp & up   &  0.3602968 & 2.789534e-05 & 0.0001804657 &  0.9246366 &  0.9246366 & 150 & 150 & CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...     \\\\\n\t fasudil                         & 3547     & SKB & trt\\_cp & up   &  0.3583908 & 2.798238e-05 & 0.0001804657 &  0.9197452 &  0.9197452 & 150 & 150 & CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...  \\\\\n\t scoulerine                      & 439654   & SKB & trt\\_cp & down & -0.2391343 & 4.793888e-02 & 0.1065308453 & -0.8838018 & -0.8838018 & 150 & 150 & ADRA1D                                     \\\\\n\t raltitrexed                     & 104758   & SKB & trt\\_cp & up   &  0.3334212 & 4.203884e-05 & 0.0002304188 &  0.8556654 &  0.8556654 & 150 & 150 & FPGS; TYMS                                 \\\\\n\t JWH-015                         & 4273754  & SKB & trt\\_cp & up   &  0.3322586 & 4.377958e-05 & 0.0002304188 &  0.8526817 &  0.8526817 & 150 & 150 & CNR2; GPR55                                \\\\\n\t GSK-0660                        & 46233311 & SKB & trt\\_cp & up   &  0.3267081 & 5.600827e-05 & 0.0002800414 &  0.8384372 &  0.8384372 & 150 & 150 & PPARD                                      \\\\\n\t ryuvidine                       & 481747   & SKB & trt\\_cp & up   &  0.3264634 & 5.940271e-05 & 0.0002828701 &  0.8378093 &  0.8378093 & 150 & 150 & CDK2; CDK4                                 \\\\\n\t fenobam                         & 162834   & SKB & trt\\_cp & up   &  0.3242132 & 6.710548e-05 & 0.0002917630 &  0.8320346 &  0.8320346 & 150 & 150 & GRM5                                       \\\\\n\t decafluorobutane                & 9638     & SKB & trt\\_cp & up   &  0.3232482 & 7.195779e-05 & 0.0002998241 &  0.8295582 &  0.8295582 & 150 & 150 & GRM5                                       \\\\\n\t hydroquinidine                  & 45479756 & SKB & trt\\_cp & up   &  0.3215956 & 7.741936e-05 & 0.0003096774 &  0.8253171 &  0.8253171 & 150 & 150 & KMT2A; PSIP1                               \\\\\n\t 4,5,6,7-tetrabromobenzotriazole & 1694     & SKB & trt\\_cp & up   &  0.3181929 & 1.032693e-04 & 0.0003688190 &  0.8165846 &  0.8165846 & 150 & 150 & AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; ... \\\\\n\t sorafenib                       & 406563   & SKB & trt\\_cp & up   &  0.3084565 & 2.402220e-04 & 0.0008007398 &  0.7915978 &  0.7915978 & 150 & 150 & ARAF; BRAF; CCNC; CDK8; CYP2B6; ...        \\\\\n\t olvanil                         & 5808649  & SKB & trt\\_cp & up   &  0.3017790 & 4.167111e-04 & 0.0013442294 &  0.7744612 &  0.7744612 & 150 & 150 & CNR1; GPR119; TRPV1                        \\\\\n\t vicriviroc                      & 73707391 & SKB & trt\\_cp & up   &  0.2920371 & 1.031671e-03 & 0.0031262746 &  0.7494604 &  0.7494604 & 150 & 150 & CCR5                                       \\\\\n\t calmidazolium                   & 2531     & SKB & trt\\_cp & up   &  0.2891219 & 1.342088e-03 & 0.0039473172 &  0.7419791 &  0.7419791 & 150 & 150 & ATP2B1; PDE1A                              \\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t IRL-2500          & 4574540   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & EDNRB; HBA2; HBB                            \\\\\n\t LY-456236         & 9926999   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GRM1                                        \\\\\n\t amiodarone        & 2157      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; ...\\\\\n\t clozapine         & 135398737 & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ... \\\\\n\t catechin          & 73160     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & BACE1; CA1; CA12; CA14; CA4; ...            \\\\\n\t SB-525334         & 9967941   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & TGFBR1                                      \\\\\n\t sphingosine       & 5280335   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ACER1; ACER2; ASAH1; ASAH2; ASAH2C; ...     \\\\\n\t chlorprothixene   & 667467    & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CHRM1; CHRM4; CHRM5; DRD1; DRD3; ...        \\\\\n\t treprostinil      & 73707411  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; ...   \\\\\n\t MDL-28170         & 72430     & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CAPN1; CTSB; CTSL                           \\\\\n\t clofibric-acid    & 2797      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & PPARA                                       \\\\\n\t tyrphostin-AG-556 & 2059      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & EGFR                                        \\\\\n\t alvespimycin      & 73707383  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & HSP90AA1                                    \\\\\n\t AS-703026         & 44187362  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAP2K1; MAP2K2                              \\\\\n\t procarbazine      & 9703      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & MAOA; MAOB                                  \\\\\n\t CGP-12177         & 2687      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                         \\\\\n\t formoterol        & 23581795  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRB1; ADRB2; ADRB3                         \\\\\n\t midostaurin       & 9829523   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & AAK1; AURKC; BCR; BRSK1; BRSK2; ...         \\\\\n\t CGP-13501         & 3519541   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABBR1                                      \\\\\n\t aprepitant        & 151165    & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & CYP2C9; TACR1                               \\\\\n\t carbetocin        & 73707428  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OXTR                                        \\\\\n\t ketorolac         & 3826      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & LTF; TF                                     \\\\\n\t SKF-77434         & 11957703  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & DRD1                                        \\\\\n\t oxalomalic-acid   & 439620    & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ACO1; IDH1                                  \\\\\n\t NNC-63-0532       & 3906780   & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & OPRL1                                       \\\\\n\t pantoprazole      & 4679      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4       \\\\\n\t trazodone         & 5533      & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; HRH1; HTR2B; SLC6A4                 \\\\\n\t vinorelbine       & 73707409  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & TUBB                                        \\\\\n\t loreclezole       & 50988829  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & GABRB2; GABRB3                              \\\\\n\t terguride         & 11957722  & SKB & trt\\_cp & down & 0 & 0.3144514 & 0.3144514 & 0 & 0 & 150 & 150 & ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...     \\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 70 × 13\n\n| pert &lt;chr&gt; | PCID &lt;chr&gt; | cell &lt;chr&gt; | type &lt;chr&gt; | trend &lt;chr&gt; | WTCS &lt;dbl&gt; | WTCS_Pval &lt;dbl&gt; | WTCS_FDR &lt;dbl&gt; | NCS &lt;dbl&gt; | NCSct &lt;dbl&gt; | N_upset &lt;dbl&gt; | N_downset &lt;dbl&gt; | t_gn_sym &lt;chr&gt; |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| vorinostat                      | 5311     | SKB | trt_cp | up   |  1.0000000 | 0.000000e+00 | 0.0000000000 |  2.5663193 |  2.5663193 | 150 | 150 | HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...    |\n| trichostatin-a                  | 444732   | SKB | trt_cp | up   |  0.8632721 | 5.962030e-06 | 0.0001804657 |  2.2154320 |  2.2154320 | 150 | 150 | HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...     |\n| HC-toxin                        | 3571     | SKB | trt_cp | up   |  0.8566409 | 6.223141e-06 | 0.0001804657 |  2.1984140 |  2.1984140 | 150 | 150 | HDAC1                                       |\n| pyroxamide                      | 4996     | SKB | trt_cp | up   |  0.6253459 | 1.631943e-05 | 0.0001804657 |  1.6048373 |  1.6048373 | 150 | 150 | HDAC1; HDAC3; HDAC6                         |\n| zuclopenthixol                  | 5311507  | SKB | trt_cp | down | -0.3214791 | 8.285917e-05 | 0.0003186891 | -1.1881347 | -1.1881347 | 150 | 150 | ADRA1A; DRD1; HRH1                          |\n| rescinnamine                    | 5280954  | SKB | trt_cp | down | -0.3188884 | 9.604526e-05 | 0.0003557232 | -1.1785601 | -1.1785601 | 150 | 150 | ACE                                         |\n| APHA-compound-8                 | 10379137 | SKB | trt_cp | up   |  0.4449388 | 2.415275e-05 | 0.0001804657 |  1.1418551 |  1.1418551 | 150 | 150 | HDAC8                                       |\n| epothilone                      | 448013   | SKB | trt_cp | down | -0.3075832 | 2.402220e-04 | 0.0008007398 | -1.1367780 | -1.1367780 | 150 | 150 | TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ... |\n| warfarin                        | 54678486 | SKB | trt_cp | down | -0.2817883 | 2.448393e-03 | 0.0069954076 | -1.0414442 | -1.0414442 | 150 | 150 | ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...       |\n| benzonatate                     | 7699     | SKB | trt_cp | up   |  0.3993739 | 2.615460e-05 | 0.0001804657 |  1.0249210 |  1.0249210 | 150 | 150 | SCN5A                                       |\n| calcifediol                     | 46705323 | SKB | trt_cp | up   |  0.3943566 | 2.637219e-05 | 0.0001804657 |  1.0120451 |  1.0120451 | 150 | 150 | VDR                                         |\n| rimcazole                       | 5072     | SKB | trt_cp | up   |  0.3693924 | 2.746015e-05 | 0.0001804657 |  0.9479788 |  0.9479788 | 150 | 150 | SIGMAR1                                     |\n| progesterone                    | 5994     | SKB | trt_cp | down | -0.2560705 | 1.725925e-02 | 0.0442544901 | -0.9463954 | -0.9463954 | 150 | 150 | AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...       |\n| afatinib                        | 22225683 | SKB | trt_cp | up   |  0.3645535 | 2.763423e-05 | 0.0001804657 |  0.9355606 |  0.9355606 | 150 | 150 | EGF; EGFR; ERBB2; ERBB4; GAK                |\n| huperzine-a                     | 1253     | SKB | trt_cp | up   |  0.3629478 | 2.776478e-05 | 0.0001804657 |  0.9314399 |  0.9314399 | 150 | 150 | ACHE                                        |\n| calcitriol                      | 21158442 | SKB | trt_cp | up   |  0.3602968 | 2.789534e-05 | 0.0001804657 |  0.9246366 |  0.9246366 | 150 | 150 | CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...      |\n| fasudil                         | 3547     | SKB | trt_cp | up   |  0.3583908 | 2.798238e-05 | 0.0001804657 |  0.9197452 |  0.9197452 | 150 | 150 | CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...   |\n| scoulerine                      | 439654   | SKB | trt_cp | down | -0.2391343 | 4.793888e-02 | 0.1065308453 | -0.8838018 | -0.8838018 | 150 | 150 | ADRA1D                                      |\n| raltitrexed                     | 104758   | SKB | trt_cp | up   |  0.3334212 | 4.203884e-05 | 0.0002304188 |  0.8556654 |  0.8556654 | 150 | 150 | FPGS; TYMS                                  |\n| JWH-015                         | 4273754  | SKB | trt_cp | up   |  0.3322586 | 4.377958e-05 | 0.0002304188 |  0.8526817 |  0.8526817 | 150 | 150 | CNR2; GPR55                                 |\n| GSK-0660                        | 46233311 | SKB | trt_cp | up   |  0.3267081 | 5.600827e-05 | 0.0002800414 |  0.8384372 |  0.8384372 | 150 | 150 | PPARD                                       |\n| ryuvidine                       | 481747   | SKB | trt_cp | up   |  0.3264634 | 5.940271e-05 | 0.0002828701 |  0.8378093 |  0.8378093 | 150 | 150 | CDK2; CDK4                                  |\n| fenobam                         | 162834   | SKB | trt_cp | up   |  0.3242132 | 6.710548e-05 | 0.0002917630 |  0.8320346 |  0.8320346 | 150 | 150 | GRM5                                        |\n| decafluorobutane                | 9638     | SKB | trt_cp | up   |  0.3232482 | 7.195779e-05 | 0.0002998241 |  0.8295582 |  0.8295582 | 150 | 150 | GRM5                                        |\n| hydroquinidine                  | 45479756 | SKB | trt_cp | up   |  0.3215956 | 7.741936e-05 | 0.0003096774 |  0.8253171 |  0.8253171 | 150 | 150 | KMT2A; PSIP1                                |\n| 4,5,6,7-tetrabromobenzotriazole | 1694     | SKB | trt_cp | up   |  0.3181929 | 1.032693e-04 | 0.0003688190 |  0.8165846 |  0.8165846 | 150 | 150 | AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; ...  |\n| sorafenib                       | 406563   | SKB | trt_cp | up   |  0.3084565 | 2.402220e-04 | 0.0008007398 |  0.7915978 |  0.7915978 | 150 | 150 | ARAF; BRAF; CCNC; CDK8; CYP2B6; ...         |\n| olvanil                         | 5808649  | SKB | trt_cp | up   |  0.3017790 | 4.167111e-04 | 0.0013442294 |  0.7744612 |  0.7744612 | 150 | 150 | CNR1; GPR119; TRPV1                         |\n| vicriviroc                      | 73707391 | SKB | trt_cp | up   |  0.2920371 | 1.031671e-03 | 0.0031262746 |  0.7494604 |  0.7494604 | 150 | 150 | CCR5                                        |\n| calmidazolium                   | 2531     | SKB | trt_cp | up   |  0.2891219 | 1.342088e-03 | 0.0039473172 |  0.7419791 |  0.7419791 | 150 | 150 | ATP2B1; PDE1A                               |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| IRL-2500          | 4574540   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | EDNRB; HBA2; HBB                             |\n| LY-456236         | 9926999   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GRM1                                         |\n| amiodarone        | 2157      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; ... |\n| clozapine         | 135398737 | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ...  |\n| catechin          | 73160     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | BACE1; CA1; CA12; CA14; CA4; ...             |\n| SB-525334         | 9967941   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | TGFBR1                                       |\n| sphingosine       | 5280335   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ACER1; ACER2; ASAH1; ASAH2; ASAH2C; ...      |\n| chlorprothixene   | 667467    | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CHRM1; CHRM4; CHRM5; DRD1; DRD3; ...         |\n| treprostinil      | 73707411  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; ...    |\n| MDL-28170         | 72430     | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CAPN1; CTSB; CTSL                            |\n| clofibric-acid    | 2797      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | PPARA                                        |\n| tyrphostin-AG-556 | 2059      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | EGFR                                         |\n| alvespimycin      | 73707383  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | HSP90AA1                                     |\n| AS-703026         | 44187362  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAP2K1; MAP2K2                               |\n| procarbazine      | 9703      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | MAOA; MAOB                                   |\n| CGP-12177         | 2687      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                          |\n| formoterol        | 23581795  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRB1; ADRB2; ADRB3                          |\n| midostaurin       | 9829523   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | AAK1; AURKC; BCR; BRSK1; BRSK2; ...          |\n| CGP-13501         | 3519541   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABBR1                                       |\n| aprepitant        | 151165    | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | CYP2C9; TACR1                                |\n| carbetocin        | 73707428  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OXTR                                         |\n| ketorolac         | 3826      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | LTF; TF                                      |\n| SKF-77434         | 11957703  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | DRD1                                         |\n| oxalomalic-acid   | 439620    | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ACO1; IDH1                                   |\n| NNC-63-0532       | 3906780   | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | OPRL1                                        |\n| pantoprazole      | 4679      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4        |\n| trazodone         | 5533      | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; HRH1; HTR2B; SLC6A4                  |\n| vinorelbine       | 73707409  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | TUBB                                         |\n| loreclezole       | 50988829  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | GABRB2; GABRB3                               |\n| terguride         | 11957722  | SKB | trt_cp | down | 0 | 0.3144514 | 0.3144514 | 0 | 0 | 150 | 150 | ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...      |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 70 × 13</caption>\n","<thead>\n","\t<tr><th scope=col>pert</th><th scope=col>PCID</th><th scope=col>cell</th><th scope=col>type</th><th scope=col>trend</th><th scope=col>WTCS</th><th scope=col>WTCS_Pval</th><th scope=col>WTCS_FDR</th><th scope=col>NCS</th><th scope=col>NCSct</th><th scope=col>N_upset</th><th scope=col>N_downset</th><th scope=col>t_gn_sym</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>vorinostat                     </td><td>5311    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 1.0000000</td><td>0.000000e+00</td><td>0.0000000000</td><td> 2.5663193</td><td> 2.5663193</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; ...   </td></tr>\n","\t<tr><td>trichostatin-a                 </td><td>444732  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8632721</td><td>5.962030e-06</td><td>0.0001804657</td><td> 2.2154320</td><td> 2.2154320</td><td>150</td><td>150</td><td>HDAC1; HDAC10; HDAC2; HDAC3; HDAC4; ...    </td></tr>\n","\t<tr><td>HC-toxin                       </td><td>3571    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.8566409</td><td>6.223141e-06</td><td>0.0001804657</td><td> 2.1984140</td><td> 2.1984140</td><td>150</td><td>150</td><td>HDAC1                                      </td></tr>\n","\t<tr><td>pyroxamide                     </td><td>4996    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.6253459</td><td>1.631943e-05</td><td>0.0001804657</td><td> 1.6048373</td><td> 1.6048373</td><td>150</td><td>150</td><td>HDAC1; HDAC3; HDAC6                        </td></tr>\n","\t<tr><td>zuclopenthixol                 </td><td>5311507 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3214791</td><td>8.285917e-05</td><td>0.0003186891</td><td>-1.1881347</td><td>-1.1881347</td><td>150</td><td>150</td><td>ADRA1A; DRD1; HRH1                         </td></tr>\n","\t<tr><td>rescinnamine                   </td><td>5280954 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3188884</td><td>9.604526e-05</td><td>0.0003557232</td><td>-1.1785601</td><td>-1.1785601</td><td>150</td><td>150</td><td>ACE                                        </td></tr>\n","\t<tr><td>APHA-compound-8                </td><td>10379137</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.4449388</td><td>2.415275e-05</td><td>0.0001804657</td><td> 1.1418551</td><td> 1.1418551</td><td>150</td><td>150</td><td>HDAC8                                      </td></tr>\n","\t<tr><td>epothilone                     </td><td>448013  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.3075832</td><td>2.402220e-04</td><td>0.0008007398</td><td>-1.1367780</td><td>-1.1367780</td><td>150</td><td>150</td><td>TUBA1A; TUBA1B; TUBA1C; TUBA3C; TUBA4A; ...</td></tr>\n","\t<tr><td>warfarin                       </td><td>54678486</td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2817883</td><td>2.448393e-03</td><td>0.0069954076</td><td>-1.0414442</td><td>-1.0414442</td><td>150</td><td>150</td><td>ARSE; CYP2C8; CYP2C9; CYP4F2; F3; ...      </td></tr>\n","\t<tr><td>benzonatate                    </td><td>7699    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3993739</td><td>2.615460e-05</td><td>0.0001804657</td><td> 1.0249210</td><td> 1.0249210</td><td>150</td><td>150</td><td>SCN5A                                      </td></tr>\n","\t<tr><td>calcifediol                    </td><td>46705323</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3943566</td><td>2.637219e-05</td><td>0.0001804657</td><td> 1.0120451</td><td> 1.0120451</td><td>150</td><td>150</td><td>VDR                                        </td></tr>\n","\t<tr><td>rimcazole                      </td><td>5072    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3693924</td><td>2.746015e-05</td><td>0.0001804657</td><td> 0.9479788</td><td> 0.9479788</td><td>150</td><td>150</td><td>SIGMAR1                                    </td></tr>\n","\t<tr><td>progesterone                   </td><td>5994    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2560705</td><td>1.725925e-02</td><td>0.0442544901</td><td>-0.9463954</td><td>-0.9463954</td><td>150</td><td>150</td><td>AKR1C1; AKR1C2; AKR1D1; APOD; AR; ...      </td></tr>\n","\t<tr><td>afatinib                       </td><td>22225683</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3645535</td><td>2.763423e-05</td><td>0.0001804657</td><td> 0.9355606</td><td> 0.9355606</td><td>150</td><td>150</td><td>EGF; EGFR; ERBB2; ERBB4; GAK               </td></tr>\n","\t<tr><td>huperzine-a                    </td><td>1253    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3629478</td><td>2.776478e-05</td><td>0.0001804657</td><td> 0.9314399</td><td> 0.9314399</td><td>150</td><td>150</td><td>ACHE                                       </td></tr>\n","\t<tr><td>calcitriol                     </td><td>21158442</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3602968</td><td>2.789534e-05</td><td>0.0001804657</td><td> 0.9246366</td><td> 0.9246366</td><td>150</td><td>150</td><td>CDA; CYP24A1; CYP27B1; CYP3A5; GC; ...     </td></tr>\n","\t<tr><td>fasudil                        </td><td>3547    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3583908</td><td>2.798238e-05</td><td>0.0001804657</td><td> 0.9197452</td><td> 0.9197452</td><td>150</td><td>150</td><td>CDC42BPB; MYLK3; PKIA; PRKACA; PRKG1; ...  </td></tr>\n","\t<tr><td>scoulerine                     </td><td>439654  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>-0.2391343</td><td>4.793888e-02</td><td>0.1065308453</td><td>-0.8838018</td><td>-0.8838018</td><td>150</td><td>150</td><td>ADRA1D                                     </td></tr>\n","\t<tr><td>raltitrexed                    </td><td>104758  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3334212</td><td>4.203884e-05</td><td>0.0002304188</td><td> 0.8556654</td><td> 0.8556654</td><td>150</td><td>150</td><td>FPGS; TYMS                                 </td></tr>\n","\t<tr><td>JWH-015                        </td><td>4273754 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3322586</td><td>4.377958e-05</td><td>0.0002304188</td><td> 0.8526817</td><td> 0.8526817</td><td>150</td><td>150</td><td>CNR2; GPR55                                </td></tr>\n","\t<tr><td>GSK-0660                       </td><td>46233311</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3267081</td><td>5.600827e-05</td><td>0.0002800414</td><td> 0.8384372</td><td> 0.8384372</td><td>150</td><td>150</td><td>PPARD                                      </td></tr>\n","\t<tr><td>ryuvidine                      </td><td>481747  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3264634</td><td>5.940271e-05</td><td>0.0002828701</td><td> 0.8378093</td><td> 0.8378093</td><td>150</td><td>150</td><td>CDK2; CDK4                                 </td></tr>\n","\t<tr><td>fenobam                        </td><td>162834  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3242132</td><td>6.710548e-05</td><td>0.0002917630</td><td> 0.8320346</td><td> 0.8320346</td><td>150</td><td>150</td><td>GRM5                                       </td></tr>\n","\t<tr><td>decafluorobutane               </td><td>9638    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3232482</td><td>7.195779e-05</td><td>0.0002998241</td><td> 0.8295582</td><td> 0.8295582</td><td>150</td><td>150</td><td>GRM5                                       </td></tr>\n","\t<tr><td>hydroquinidine                 </td><td>45479756</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3215956</td><td>7.741936e-05</td><td>0.0003096774</td><td> 0.8253171</td><td> 0.8253171</td><td>150</td><td>150</td><td>KMT2A; PSIP1                               </td></tr>\n","\t<tr><td>4,5,6,7-tetrabromobenzotriazole</td><td>1694    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3181929</td><td>1.032693e-04</td><td>0.0003688190</td><td> 0.8165846</td><td> 0.8165846</td><td>150</td><td>150</td><td>AKT1; CHEK1; CSNK2A1; CSNK2A2; CSNK2B; ... </td></tr>\n","\t<tr><td>sorafenib                      </td><td>406563  </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3084565</td><td>2.402220e-04</td><td>0.0008007398</td><td> 0.7915978</td><td> 0.7915978</td><td>150</td><td>150</td><td>ARAF; BRAF; CCNC; CDK8; CYP2B6; ...        </td></tr>\n","\t<tr><td>olvanil                        </td><td>5808649 </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.3017790</td><td>4.167111e-04</td><td>0.0013442294</td><td> 0.7744612</td><td> 0.7744612</td><td>150</td><td>150</td><td>CNR1; GPR119; TRPV1                        </td></tr>\n","\t<tr><td>vicriviroc                     </td><td>73707391</td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2920371</td><td>1.031671e-03</td><td>0.0031262746</td><td> 0.7494604</td><td> 0.7494604</td><td>150</td><td>150</td><td>CCR5                                       </td></tr>\n","\t<tr><td>calmidazolium                  </td><td>2531    </td><td>SKB</td><td>trt_cp</td><td>up  </td><td> 0.2891219</td><td>1.342088e-03</td><td>0.0039473172</td><td> 0.7419791</td><td> 0.7419791</td><td>150</td><td>150</td><td>ATP2B1; PDE1A                              </td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>IRL-2500         </td><td>4574540  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>EDNRB; HBA2; HBB                            </td></tr>\n","\t<tr><td>LY-456236        </td><td>9926999  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GRM1                                        </td></tr>\n","\t<tr><td>amiodarone       </td><td>2157     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ABCG2; ADRB1; CACNA1H; CACNA2D2; CYP2C8; ...</td></tr>\n","\t<tr><td>clozapine        </td><td>135398737</td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ... </td></tr>\n","\t<tr><td>catechin         </td><td>73160    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>BACE1; CA1; CA12; CA14; CA4; ...            </td></tr>\n","\t<tr><td>SB-525334        </td><td>9967941  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>TGFBR1                                      </td></tr>\n","\t<tr><td>sphingosine      </td><td>5280335  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ACER1; ACER2; ASAH1; ASAH2; ASAH2C; ...     </td></tr>\n","\t<tr><td>chlorprothixene  </td><td>667467   </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CHRM1; CHRM4; CHRM5; DRD1; DRD3; ...        </td></tr>\n","\t<tr><td>treprostinil     </td><td>73707411 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CYP2C8; P2RY12; PPARD; PTGDR; PTGER1; ...   </td></tr>\n","\t<tr><td>MDL-28170        </td><td>72430    </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CAPN1; CTSB; CTSL                           </td></tr>\n","\t<tr><td>clofibric-acid   </td><td>2797     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>PPARA                                       </td></tr>\n","\t<tr><td>tyrphostin-AG-556</td><td>2059     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>EGFR                                        </td></tr>\n","\t<tr><td>alvespimycin     </td><td>73707383 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>HSP90AA1                                    </td></tr>\n","\t<tr><td>AS-703026        </td><td>44187362 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAP2K1; MAP2K2                              </td></tr>\n","\t<tr><td>procarbazine     </td><td>9703     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>MAOA; MAOB                                  </td></tr>\n","\t<tr><td>CGP-12177        </td><td>2687     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                         </td></tr>\n","\t<tr><td>formoterol       </td><td>23581795 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRB1; ADRB2; ADRB3                         </td></tr>\n","\t<tr><td>midostaurin      </td><td>9829523  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>AAK1; AURKC; BCR; BRSK1; BRSK2; ...         </td></tr>\n","\t<tr><td>CGP-13501        </td><td>3519541  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABBR1                                      </td></tr>\n","\t<tr><td>aprepitant       </td><td>151165   </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>CYP2C9; TACR1                               </td></tr>\n","\t<tr><td>carbetocin       </td><td>73707428 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OXTR                                        </td></tr>\n","\t<tr><td>ketorolac        </td><td>3826     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>LTF; TF                                     </td></tr>\n","\t<tr><td>SKF-77434        </td><td>11957703 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>DRD1                                        </td></tr>\n","\t<tr><td>oxalomalic-acid  </td><td>439620   </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ACO1; IDH1                                  </td></tr>\n","\t<tr><td>NNC-63-0532      </td><td>3906780  </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>OPRL1                                       </td></tr>\n","\t<tr><td>pantoprazole     </td><td>4679     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ATP12A; ATP1A1; ATP4A; CYP2C9; CYP3A4       </td></tr>\n","\t<tr><td>trazodone        </td><td>5533     </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; HRH1; HTR2B; SLC6A4                 </td></tr>\n","\t<tr><td>vinorelbine      </td><td>73707409 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>TUBB                                        </td></tr>\n","\t<tr><td>loreclezole      </td><td>50988829 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>GABRB2; GABRB3                              </td></tr>\n","\t<tr><td>terguride        </td><td>11957722 </td><td>SKB</td><td>trt_cp</td><td>down</td><td>0</td><td>0.3144514</td><td>0.3144514</td><td>0</td><td>0</td><td>150</td><td>150</td><td>ADRA1A; ADRA2B; ADRA2C; DRD3; DRD4; ...     </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"id":"mc3SAUkueRRv","colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"status":"ok","timestamp":1636338468032,"user_tz":-480,"elapsed":397,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"8cd948c3-66c9-4851-cc09-29e322d29ec9"},"source":["drop_na(wf_list$bp_tb)"],"execution_count":50,"outputs":[{"output_type":"display_data","data":{"text/plain":["     ont ID         Description                                            \n","1    BP  GO:0060789 hair follicle placode formation                        \n","2    BP  GO:0061197 fungiform papilla morphogenesis                        \n","3    BP  GO:0070932 histone H3 deacetylation                               \n","4    BP  GO:0070933 histone H4 deacetylation                               \n","5    BP  GO:0016575 histone deacetylation                                  \n","6    BP  GO:0006476 protein deacetylation                                  \n","7    BP  GO:0035601 protein deacylation                                    \n","8    BP  GO:0098732 macromolecule deacylation                              \n","9    BP  GO:0016570 histone modification                                   \n","10   BP  GO:0016569 covalent chromatin modification                        \n","11   BP  GO:0010870 positive regulation of receptor biosynthetic process   \n","12   BP  GO:0010869 regulation of receptor biosynthetic process            \n","13   BP  GO:0034983 peptidyl-lysine deacetylation                          \n","14   BP  GO:0032800 receptor biosynthetic process                          \n","15   BP  GO:0061196 fungiform papilla development                          \n","16   BP  GO:0043587 tongue morphogenesis                                   \n","17   BP  GO:0060788 ectodermal placode formation                           \n","18   BP  GO:0071697 ectodermal placode morphogenesis                       \n","19   BP  GO:0061029 eyelid development in camera-type eye                  \n","20   BP  GO:0071696 ectodermal placode development                         \n","21   BP  GO:0048709 oligodendrocyte differentiation                        \n","22   BP  GO:0060765 regulation of androgen receptor signaling pathway      \n","23   BP  GO:0048714 positive regulation of oligodendrocyte differentiation \n","24   BP  GO:0006338 chromatin remodeling                                   \n","25   BP  GO:0043586 tongue development                                     \n","26   BP  GO:0010001 glial cell differentiation                             \n","27   BP  GO:0006342 chromatin silencing                                    \n","28   BP  GO:0048713 regulation of oligodendrocyte differentiation          \n","29   BP  GO:0030521 androgen receptor signaling pathway                    \n","30   BP  GO:0043112 receptor metabolic process                             \n","⋮    ⋮   ⋮          ⋮                                                      \n","1047 BP  GO:0007411 axon guidance                                          \n","1048 BP  GO:0043270 positive regulation of ion transport                   \n","1049 BP  GO:0097485 neuron projection guidance                             \n","1050 BP  GO:0032943 mononuclear cell proliferation                         \n","1051 BP  GO:0001822 kidney development                                     \n","1052 BP  GO:0051258 protein polymerization                                 \n","1053 BP  GO:0070661 leukocyte proliferation                                \n","1054 BP  GO:0072001 renal system development                               \n","1055 BP  GO:0060326 cell chemotaxis                                        \n","1056 BP  GO:0070588 calcium ion transmembrane transport                    \n","1057 BP  GO:0016485 protein processing                                     \n","1058 BP  GO:0007568 aging                                                  \n","1059 BP  GO:1904062 regulation of cation transmembrane transport           \n","1060 BP  GO:0015849 organic acid transport                                 \n","1061 BP  GO:0046942 carboxylic acid transport                              \n","1062 BP  GO:0051235 maintenance of location                                \n","1063 BP  GO:0051056 regulation of small GTPase mediated signal transduction\n","1064 BP  GO:0001655 urogenital system development                          \n","1065 BP  GO:0070372 regulation of ERK1 and ERK2 cascade                    \n","1066 BP  GO:0032102 negative regulation of response to external stimulus   \n","1067 BP  GO:0070371 ERK1 and ERK2 cascade                                  \n","1068 BP  GO:0006066 alcohol metabolic process                              \n","1069 BP  GO:0006869 lipid transport                                        \n","1070 BP  GO:0051604 protein maturation                                     \n","1071 BP  GO:0010959 regulation of metal ion transport                      \n","1072 BP  GO:0010876 lipid localization                                     \n","1073 BP  GO:0007265 Ras protein signal transduction                        \n","1074 BP  GO:0034765 regulation of ion transmembrane transport              \n","1075 BP  GO:0015711 organic anion transport                                \n","1076 BP  GO:0050900 leukocyte migration                                    \n","     GeneRatio BgRatio   pvalue       p.adjust     qvalue      \n","1    6/41      5/19330   0.000000e+00 0.000000e+00 0.000000e+00\n","2    6/41      5/19330   0.000000e+00 0.000000e+00 0.000000e+00\n","3    26/41     21/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","4    16/41     11/19330  0.000000e+00 0.000000e+00 0.000000e+00\n","5    26/41     86/19330  6.489037e-53 6.264416e-51 2.007135e-51\n","6    26/41     101/19330 8.372876e-51 7.005307e-49 2.244518e-49\n","7    26/41     111/19330 1.368786e-49 1.073641e-47 3.439975e-48\n","8    26/41     112/19330 1.781265e-49 1.314993e-47 4.213272e-48\n","9    27/41     456/19330 1.399645e-34 8.782770e-33 2.814022e-33\n","10   27/41     469/19330 3.028543e-34 1.809915e-32 5.799014e-33\n","11   9/41      11/19330  1.853730e-23 1.011492e-21 3.240846e-22\n","12   9/41      20/19330  5.585446e-20 2.920723e-18 9.358072e-19\n","13   7/41      7/19330   1.124898e-19 5.646989e-18 1.809310e-18\n","14   9/41      24/19330  4.322178e-19 2.086282e-17 6.684501e-18\n","15   6/41      6/19330   6.210724e-17 2.687744e-15 8.611602e-16\n","16   6/41      8/19330   1.733607e-15 6.798991e-14 2.178414e-14\n","17   6/41      12/19330  5.685459e-14 2.038643e-12 6.531865e-13\n","18   6/41      12/19330  5.685459e-14 2.038643e-12 6.531865e-13\n","19   6/41      13/19330  1.054232e-13 3.392463e-12 1.086954e-12\n","20   6/41      13/19330  1.054232e-13 3.392463e-12 1.086954e-12\n","21   9/41      87/19330  1.543236e-13 4.841903e-12 1.551358e-12\n","22   7/41      29/19330  1.697188e-13 5.195052e-12 1.664508e-12\n","23   6/41      17/19330  7.556135e-13 2.061511e-11 6.605134e-12\n","24   10/41     165/19330 1.392710e-12 3.718833e-11 1.191524e-11\n","25   6/41      20/19330  2.355476e-12 6.158587e-11 1.973227e-11\n","26   10/41     194/19330 7.029186e-12 1.764326e-10 5.652946e-11\n","27   8/41      106/19330 5.142466e-11 1.217697e-09 3.901533e-10\n","28   6/41      32/19330  5.405253e-11 1.256221e-09 4.024964e-10\n","29   7/41      70/19330  1.223674e-10 2.742340e-09 8.786530e-10\n","30   9/41      184/19330 1.420954e-10 3.128591e-09 1.002409e-09\n","⋮    ⋮         ⋮         ⋮            ⋮            ⋮           \n","1047 1/41      259/19330 0.4251487    0.4380637    0.1403567   \n","1048 1/41      260/19330 0.4263845    0.4386169    0.1405340   \n","1049 1/41      260/19330 0.4263845    0.4386169    0.1405340   \n","1050 1/41      266/19330 0.4337454    0.4458235    0.1428430   \n","1051 1/41      271/19330 0.4398089    0.4516859    0.1447214   \n","1052 1/41      275/19330 0.4446142    0.4555027    0.1459442   \n","1053 1/41      283/19330 0.4541042    0.4644668    0.1488164   \n","1054 1/41      286/19330 0.4576221    0.4676838    0.1498471   \n","1055 1/41      295/19330 0.4680434    0.4779451    0.1531348   \n","1056 1/41      302/19330 0.4760136    0.4852941    0.1554895   \n","1057 1/41      310/19330 0.4849798    0.4940338    0.1582897   \n","1058 1/41      311/19330 0.4860899    0.4947631    0.1585234   \n","1059 1/41      314/19330 0.4894065    0.4977352    0.1594756   \n","1060 1/41      316/19330 0.4916060    0.4987595    0.1598038   \n","1061 1/41      316/19330 0.4916060    0.4987595    0.1598038   \n","1062 1/41      316/19330 0.4916060    0.4987595    0.1598038   \n","1063 1/41      321/19330 0.4970642    0.5038898    0.1614476   \n","1064 1/41      322/19330 0.4981490    0.5045819    0.1616694   \n","1065 1/41      324/19330 0.5003117    0.5063638    0.1622403   \n","1066 1/41      328/19330 0.5046098    0.5103024    0.1635022   \n","1067 1/41      341/19330 0.5183312    0.5233352    0.1676779   \n","1068 1/41      346/19330 0.5235093    0.5281384    0.1692169   \n","1069 1/41      354/19330 0.5316815    0.5359520    0.1717204   \n","1070 1/41      373/19330 0.5505463    0.5536343    0.1773859   \n","1071 1/41      376/19330 0.5534563    0.5561151    0.1781807   \n","1072 1/41      388/19330 0.5649139    0.5671736    0.1817239   \n","1073 1/41      429/19330 0.6019375    0.6038621    0.1934790   \n","1074 1/41      454/19330 0.6229847    0.6244775    0.2000842   \n","1075 1/41      460/19330 0.6278722    0.6288744    0.2014930   \n","1076 1/41      478/19330 0.6421666    0.6426787    0.2059159   \n","     itemID                                                                                                                                                             \n","1    HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","2    HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","3    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     \n","4    HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC8                                                                    \n","5    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     \n","6    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     \n","7    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     \n","8    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     \n","9    HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8\n","10   HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8\n","11   HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              \n","12   HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              \n","13   HDAC4/HDAC6/HDAC9/HDAC4/HDAC6/HDAC9/HDAC6                                                                                                                          \n","14   HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              \n","15   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","16   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","17   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","18   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","19   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","20   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","21   HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1                                                                                                           \n","22   HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                          \n","23   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","24   HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                        \n","25   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","26   HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1/DRD1                                                                                                      \n","27   HDAC1/HDAC2/HDAC5/HDAC1/HDAC2/HDAC5/HDAC1/HDAC1                                                                                                                    \n","28   HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                \n","29   HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                          \n","30   HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              \n","⋮    ⋮                                                                                                                                                                  \n","1047 TUBB3                                                                                                                                                              \n","1048 DRD1                                                                                                                                                               \n","1049 TUBB3                                                                                                                                                              \n","1050 ACE                                                                                                                                                                \n","1051 ACE                                                                                                                                                                \n","1052 TUBB4A                                                                                                                                                             \n","1053 ACE                                                                                                                                                                \n","1054 ACE                                                                                                                                                                \n","1055 HRH1                                                                                                                                                               \n","1056 DRD1                                                                                                                                                               \n","1057 ACE                                                                                                                                                                \n","1058 ADRA1A                                                                                                                                                             \n","1059 DRD1                                                                                                                                                               \n","1060 ACE                                                                                                                                                                \n","1061 ACE                                                                                                                                                                \n","1062 DRD1                                                                                                                                                               \n","1063 ADRA1A                                                                                                                                                             \n","1064 ACE                                                                                                                                                                \n","1065 ADRA1A                                                                                                                                                             \n","1066 DRD1                                                                                                                                                               \n","1067 ADRA1A                                                                                                                                                             \n","1068 HRH1                                                                                                                                                               \n","1069 ACE                                                                                                                                                                \n","1070 ACE                                                                                                                                                                \n","1071 DRD1                                                                                                                                                               \n","1072 ACE                                                                                                                                                                \n","1073 ADRA1A                                                                                                                                                             \n","1074 DRD1                                                                                                                                                               \n","1075 ACE                                                                                                                                                                \n","1076 HRH1                                                                                                                                                               \n","     Count\n","1     6   \n","2     6   \n","3    26   \n","4    16   \n","5    26   \n","6    26   \n","7    26   \n","8    26   \n","9    27   \n","10   27   \n","11    9   \n","12    9   \n","13    7   \n","14    9   \n","15    6   \n","16    6   \n","17    6   \n","18    6   \n","19    6   \n","20    6   \n","21    9   \n","22    7   \n","23    6   \n","24   10   \n","25    6   \n","26   10   \n","27    8   \n","28    6   \n","29    7   \n","30    9   \n","⋮    ⋮    \n","1047 1    \n","1048 1    \n","1049 1    \n","1050 1    \n","1051 1    \n","1052 1    \n","1053 1    \n","1054 1    \n","1055 1    \n","1056 1    \n","1057 1    \n","1058 1    \n","1059 1    \n","1060 1    \n","1061 1    \n","1062 1    \n","1063 1    \n","1064 1    \n","1065 1    \n","1066 1    \n","1067 1    \n","1068 1    \n","1069 1    \n","1070 1    \n","1071 1    \n","1072 1    \n","1073 1    \n","1074 1    \n","1075 1    \n","1076 1    "],"text/latex":"A tibble: 1076 × 10\n\\begin{tabular}{llllllllll}\n ont & ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <dbl>\\\\\n\\hline\n\t BP & GO:0060789 & hair follicle placode formation                        & 6/41  & 5/19330   & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0061197 & fungiform papilla morphogenesis                        & 6/41  & 5/19330   & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0070932 & histone H3 deacetylation                               & 26/41 & 21/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      & 26\\\\\n\t BP & GO:0070933 & histone H4 deacetylation                               & 16/41 & 11/19330  & 0.000000e+00 & 0.000000e+00 & 0.000000e+00 & HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC8                                                                     & 16\\\\\n\t BP & GO:0016575 & histone deacetylation                                  & 26/41 & 86/19330  & 6.489037e-53 & 6.264416e-51 & 2.007135e-51 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      & 26\\\\\n\t BP & GO:0006476 & protein deacetylation                                  & 26/41 & 101/19330 & 8.372876e-51 & 7.005307e-49 & 2.244518e-49 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      & 26\\\\\n\t BP & GO:0035601 & protein deacylation                                    & 26/41 & 111/19330 & 1.368786e-49 & 1.073641e-47 & 3.439975e-48 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      & 26\\\\\n\t BP & GO:0098732 & macromolecule deacylation                              & 26/41 & 112/19330 & 1.781265e-49 & 1.314993e-47 & 4.213272e-48 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      & 26\\\\\n\t BP & GO:0016570 & histone modification                                   & 27/41 & 456/19330 & 1.399645e-34 & 8.782770e-33 & 2.814022e-33 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8 & 27\\\\\n\t BP & GO:0016569 & covalent chromatin modification                        & 27/41 & 469/19330 & 3.028543e-34 & 1.809915e-32 & 5.799014e-33 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8 & 27\\\\\n\t BP & GO:0010870 & positive regulation of receptor biosynthetic process   & 9/41  & 11/19330  & 1.853730e-23 & 1.011492e-21 & 3.240846e-22 & HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               &  9\\\\\n\t BP & GO:0010869 & regulation of receptor biosynthetic process            & 9/41  & 20/19330  & 5.585446e-20 & 2.920723e-18 & 9.358072e-19 & HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               &  9\\\\\n\t BP & GO:0034983 & peptidyl-lysine deacetylation                          & 7/41  & 7/19330   & 1.124898e-19 & 5.646989e-18 & 1.809310e-18 & HDAC4/HDAC6/HDAC9/HDAC4/HDAC6/HDAC9/HDAC6                                                                                                                           &  7\\\\\n\t BP & GO:0032800 & receptor biosynthetic process                          & 9/41  & 24/19330  & 4.322178e-19 & 2.086282e-17 & 6.684501e-18 & HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               &  9\\\\\n\t BP & GO:0061196 & fungiform papilla development                          & 6/41  & 6/19330   & 6.210724e-17 & 2.687744e-15 & 8.611602e-16 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0043587 & tongue morphogenesis                                   & 6/41  & 8/19330   & 1.733607e-15 & 6.798991e-14 & 2.178414e-14 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0060788 & ectodermal placode formation                           & 6/41  & 12/19330  & 5.685459e-14 & 2.038643e-12 & 6.531865e-13 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0071697 & ectodermal placode morphogenesis                       & 6/41  & 12/19330  & 5.685459e-14 & 2.038643e-12 & 6.531865e-13 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0061029 & eyelid development in camera-type eye                  & 6/41  & 13/19330  & 1.054232e-13 & 3.392463e-12 & 1.086954e-12 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0071696 & ectodermal placode development                         & 6/41  & 13/19330  & 1.054232e-13 & 3.392463e-12 & 1.086954e-12 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0048709 & oligodendrocyte differentiation                        & 9/41  & 87/19330  & 1.543236e-13 & 4.841903e-12 & 1.551358e-12 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1                                                                                                            &  9\\\\\n\t BP & GO:0060765 & regulation of androgen receptor signaling pathway      & 7/41  & 29/19330  & 1.697188e-13 & 5.195052e-12 & 1.664508e-12 & HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                           &  7\\\\\n\t BP & GO:0048714 & positive regulation of oligodendrocyte differentiation & 6/41  & 17/19330  & 7.556135e-13 & 2.061511e-11 & 6.605134e-12 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0006338 & chromatin remodeling                                   & 10/41 & 165/19330 & 1.392710e-12 & 3.718833e-11 & 1.191524e-11 & HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                         & 10\\\\\n\t BP & GO:0043586 & tongue development                                     & 6/41  & 20/19330  & 2.355476e-12 & 6.158587e-11 & 1.973227e-11 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0010001 & glial cell differentiation                             & 10/41 & 194/19330 & 7.029186e-12 & 1.764326e-10 & 5.652946e-11 & HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1/DRD1                                                                                                       & 10\\\\\n\t BP & GO:0006342 & chromatin silencing                                    & 8/41  & 106/19330 & 5.142466e-11 & 1.217697e-09 & 3.901533e-10 & HDAC1/HDAC2/HDAC5/HDAC1/HDAC2/HDAC5/HDAC1/HDAC1                                                                                                                     &  8\\\\\n\t BP & GO:0048713 & regulation of oligodendrocyte differentiation          & 6/41  & 32/19330  & 5.405253e-11 & 1.256221e-09 & 4.024964e-10 & HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 &  6\\\\\n\t BP & GO:0030521 & androgen receptor signaling pathway                    & 7/41  & 70/19330  & 1.223674e-10 & 2.742340e-09 & 8.786530e-10 & HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                           &  7\\\\\n\t BP & GO:0043112 & receptor metabolic process                             & 9/41  & 184/19330 & 1.420954e-10 & 3.128591e-09 & 1.002409e-09 & HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               &  9\\\\\n\t ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮ & ⋮\\\\\n\t BP & GO:0007411 & axon guidance                                           & 1/41 & 259/19330 & 0.4251487 & 0.4380637 & 0.1403567 & TUBB3  & 1\\\\\n\t BP & GO:0043270 & positive regulation of ion transport                    & 1/41 & 260/19330 & 0.4263845 & 0.4386169 & 0.1405340 & DRD1   & 1\\\\\n\t BP & GO:0097485 & neuron projection guidance                              & 1/41 & 260/19330 & 0.4263845 & 0.4386169 & 0.1405340 & TUBB3  & 1\\\\\n\t BP & GO:0032943 & mononuclear cell proliferation                          & 1/41 & 266/19330 & 0.4337454 & 0.4458235 & 0.1428430 & ACE    & 1\\\\\n\t BP & GO:0001822 & kidney development                                      & 1/41 & 271/19330 & 0.4398089 & 0.4516859 & 0.1447214 & ACE    & 1\\\\\n\t BP & GO:0051258 & protein polymerization                                  & 1/41 & 275/19330 & 0.4446142 & 0.4555027 & 0.1459442 & TUBB4A & 1\\\\\n\t BP & GO:0070661 & leukocyte proliferation                                 & 1/41 & 283/19330 & 0.4541042 & 0.4644668 & 0.1488164 & ACE    & 1\\\\\n\t BP & GO:0072001 & renal system development                                & 1/41 & 286/19330 & 0.4576221 & 0.4676838 & 0.1498471 & ACE    & 1\\\\\n\t BP & GO:0060326 & cell chemotaxis                                         & 1/41 & 295/19330 & 0.4680434 & 0.4779451 & 0.1531348 & HRH1   & 1\\\\\n\t BP & GO:0070588 & calcium ion transmembrane transport                     & 1/41 & 302/19330 & 0.4760136 & 0.4852941 & 0.1554895 & DRD1   & 1\\\\\n\t BP & GO:0016485 & protein processing                                      & 1/41 & 310/19330 & 0.4849798 & 0.4940338 & 0.1582897 & ACE    & 1\\\\\n\t BP & GO:0007568 & aging                                                   & 1/41 & 311/19330 & 0.4860899 & 0.4947631 & 0.1585234 & ADRA1A & 1\\\\\n\t BP & GO:1904062 & regulation of cation transmembrane transport            & 1/41 & 314/19330 & 0.4894065 & 0.4977352 & 0.1594756 & DRD1   & 1\\\\\n\t BP & GO:0015849 & organic acid transport                                  & 1/41 & 316/19330 & 0.4916060 & 0.4987595 & 0.1598038 & ACE    & 1\\\\\n\t BP & GO:0046942 & carboxylic acid transport                               & 1/41 & 316/19330 & 0.4916060 & 0.4987595 & 0.1598038 & ACE    & 1\\\\\n\t BP & GO:0051235 & maintenance of location                                 & 1/41 & 316/19330 & 0.4916060 & 0.4987595 & 0.1598038 & DRD1   & 1\\\\\n\t BP & GO:0051056 & regulation of small GTPase mediated signal transduction & 1/41 & 321/19330 & 0.4970642 & 0.5038898 & 0.1614476 & ADRA1A & 1\\\\\n\t BP & GO:0001655 & urogenital system development                           & 1/41 & 322/19330 & 0.4981490 & 0.5045819 & 0.1616694 & ACE    & 1\\\\\n\t BP & GO:0070372 & regulation of ERK1 and ERK2 cascade                     & 1/41 & 324/19330 & 0.5003117 & 0.5063638 & 0.1622403 & ADRA1A & 1\\\\\n\t BP & GO:0032102 & negative regulation of response to external stimulus    & 1/41 & 328/19330 & 0.5046098 & 0.5103024 & 0.1635022 & DRD1   & 1\\\\\n\t BP & GO:0070371 & ERK1 and ERK2 cascade                                   & 1/41 & 341/19330 & 0.5183312 & 0.5233352 & 0.1676779 & ADRA1A & 1\\\\\n\t BP & GO:0006066 & alcohol metabolic process                               & 1/41 & 346/19330 & 0.5235093 & 0.5281384 & 0.1692169 & HRH1   & 1\\\\\n\t BP & GO:0006869 & lipid transport                                         & 1/41 & 354/19330 & 0.5316815 & 0.5359520 & 0.1717204 & ACE    & 1\\\\\n\t BP & GO:0051604 & protein maturation                                      & 1/41 & 373/19330 & 0.5505463 & 0.5536343 & 0.1773859 & ACE    & 1\\\\\n\t BP & GO:0010959 & regulation of metal ion transport                       & 1/41 & 376/19330 & 0.5534563 & 0.5561151 & 0.1781807 & DRD1   & 1\\\\\n\t BP & GO:0010876 & lipid localization                                      & 1/41 & 388/19330 & 0.5649139 & 0.5671736 & 0.1817239 & ACE    & 1\\\\\n\t BP & GO:0007265 & Ras protein signal transduction                         & 1/41 & 429/19330 & 0.6019375 & 0.6038621 & 0.1934790 & ADRA1A & 1\\\\\n\t BP & GO:0034765 & regulation of ion transmembrane transport               & 1/41 & 454/19330 & 0.6229847 & 0.6244775 & 0.2000842 & DRD1   & 1\\\\\n\t BP & GO:0015711 & organic anion transport                                 & 1/41 & 460/19330 & 0.6278722 & 0.6288744 & 0.2014930 & ACE    & 1\\\\\n\t BP & GO:0050900 & leukocyte migration                                     & 1/41 & 478/19330 & 0.6421666 & 0.6426787 & 0.2059159 & HRH1   & 1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 1076 × 10\n\n| ont &lt;chr&gt; | ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;dbl&gt; |\n|---|---|---|---|---|---|---|---|---|---|\n| BP | GO:0060789 | hair follicle placode formation                        | 6/41  | 5/19330   | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0061197 | fungiform papilla morphogenesis                        | 6/41  | 5/19330   | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0070932 | histone H3 deacetylation                               | 26/41 | 21/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      | 26 |\n| BP | GO:0070933 | histone H4 deacetylation                               | 16/41 | 11/19330  | 0.000000e+00 | 0.000000e+00 | 0.000000e+00 | HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC8                                                                     | 16 |\n| BP | GO:0016575 | histone deacetylation                                  | 26/41 | 86/19330  | 6.489037e-53 | 6.264416e-51 | 2.007135e-51 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      | 26 |\n| BP | GO:0006476 | protein deacetylation                                  | 26/41 | 101/19330 | 8.372876e-51 | 7.005307e-49 | 2.244518e-49 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      | 26 |\n| BP | GO:0035601 | protein deacylation                                    | 26/41 | 111/19330 | 1.368786e-49 | 1.073641e-47 | 3.439975e-48 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      | 26 |\n| BP | GO:0098732 | macromolecule deacylation                              | 26/41 | 112/19330 | 1.781265e-49 | 1.314993e-47 | 4.213272e-48 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8      | 26 |\n| BP | GO:0016570 | histone modification                                   | 27/41 | 456/19330 | 1.399645e-34 | 8.782770e-33 | 2.814022e-33 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8 | 27 |\n| BP | GO:0016569 | covalent chromatin modification                        | 27/41 | 469/19330 | 3.028543e-34 | 1.809915e-32 | 5.799014e-33 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8 | 27 |\n| BP | GO:0010870 | positive regulation of receptor biosynthetic process   | 9/41  | 11/19330  | 1.853730e-23 | 1.011492e-21 | 3.240846e-22 | HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               |  9 |\n| BP | GO:0010869 | regulation of receptor biosynthetic process            | 9/41  | 20/19330  | 5.585446e-20 | 2.920723e-18 | 9.358072e-19 | HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               |  9 |\n| BP | GO:0034983 | peptidyl-lysine deacetylation                          | 7/41  | 7/19330   | 1.124898e-19 | 5.646989e-18 | 1.809310e-18 | HDAC4/HDAC6/HDAC9/HDAC4/HDAC6/HDAC9/HDAC6                                                                                                                           |  7 |\n| BP | GO:0032800 | receptor biosynthetic process                          | 9/41  | 24/19330  | 4.322178e-19 | 2.086282e-17 | 6.684501e-18 | HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               |  9 |\n| BP | GO:0061196 | fungiform papilla development                          | 6/41  | 6/19330   | 6.210724e-17 | 2.687744e-15 | 8.611602e-16 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0043587 | tongue morphogenesis                                   | 6/41  | 8/19330   | 1.733607e-15 | 6.798991e-14 | 2.178414e-14 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0060788 | ectodermal placode formation                           | 6/41  | 12/19330  | 5.685459e-14 | 2.038643e-12 | 6.531865e-13 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0071697 | ectodermal placode morphogenesis                       | 6/41  | 12/19330  | 5.685459e-14 | 2.038643e-12 | 6.531865e-13 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0061029 | eyelid development in camera-type eye                  | 6/41  | 13/19330  | 1.054232e-13 | 3.392463e-12 | 1.086954e-12 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0071696 | ectodermal placode development                         | 6/41  | 13/19330  | 1.054232e-13 | 3.392463e-12 | 1.086954e-12 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0048709 | oligodendrocyte differentiation                        | 9/41  | 87/19330  | 1.543236e-13 | 4.841903e-12 | 1.551358e-12 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1                                                                                                            |  9 |\n| BP | GO:0060765 | regulation of androgen receptor signaling pathway      | 7/41  | 29/19330  | 1.697188e-13 | 5.195052e-12 | 1.664508e-12 | HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                           |  7 |\n| BP | GO:0048714 | positive regulation of oligodendrocyte differentiation | 6/41  | 17/19330  | 7.556135e-13 | 2.061511e-11 | 6.605134e-12 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0006338 | chromatin remodeling                                   | 10/41 | 165/19330 | 1.392710e-12 | 3.718833e-11 | 1.191524e-11 | HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                         | 10 |\n| BP | GO:0043586 | tongue development                                     | 6/41  | 20/19330  | 2.355476e-12 | 6.158587e-11 | 1.973227e-11 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0010001 | glial cell differentiation                             | 10/41 | 194/19330 | 7.029186e-12 | 1.764326e-10 | 5.652946e-11 | HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1/DRD1                                                                                                       | 10 |\n| BP | GO:0006342 | chromatin silencing                                    | 8/41  | 106/19330 | 5.142466e-11 | 1.217697e-09 | 3.901533e-10 | HDAC1/HDAC2/HDAC5/HDAC1/HDAC2/HDAC5/HDAC1/HDAC1                                                                                                                     |  8 |\n| BP | GO:0048713 | regulation of oligodendrocyte differentiation          | 6/41  | 32/19330  | 5.405253e-11 | 1.256221e-09 | 4.024964e-10 | HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                 |  6 |\n| BP | GO:0030521 | androgen receptor signaling pathway                    | 7/41  | 70/19330  | 1.223674e-10 | 2.742340e-09 | 8.786530e-10 | HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                           |  7 |\n| BP | GO:0043112 | receptor metabolic process                             | 9/41  | 184/19330 | 1.420954e-10 | 3.128591e-09 | 1.002409e-09 | HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                               |  9 |\n| ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ | ⋮ |\n| BP | GO:0007411 | axon guidance                                           | 1/41 | 259/19330 | 0.4251487 | 0.4380637 | 0.1403567 | TUBB3  | 1 |\n| BP | GO:0043270 | positive regulation of ion transport                    | 1/41 | 260/19330 | 0.4263845 | 0.4386169 | 0.1405340 | DRD1   | 1 |\n| BP | GO:0097485 | neuron projection guidance                              | 1/41 | 260/19330 | 0.4263845 | 0.4386169 | 0.1405340 | TUBB3  | 1 |\n| BP | GO:0032943 | mononuclear cell proliferation                          | 1/41 | 266/19330 | 0.4337454 | 0.4458235 | 0.1428430 | ACE    | 1 |\n| BP | GO:0001822 | kidney development                                      | 1/41 | 271/19330 | 0.4398089 | 0.4516859 | 0.1447214 | ACE    | 1 |\n| BP | GO:0051258 | protein polymerization                                  | 1/41 | 275/19330 | 0.4446142 | 0.4555027 | 0.1459442 | TUBB4A | 1 |\n| BP | GO:0070661 | leukocyte proliferation                                 | 1/41 | 283/19330 | 0.4541042 | 0.4644668 | 0.1488164 | ACE    | 1 |\n| BP | GO:0072001 | renal system development                                | 1/41 | 286/19330 | 0.4576221 | 0.4676838 | 0.1498471 | ACE    | 1 |\n| BP | GO:0060326 | cell chemotaxis                                         | 1/41 | 295/19330 | 0.4680434 | 0.4779451 | 0.1531348 | HRH1   | 1 |\n| BP | GO:0070588 | calcium ion transmembrane transport                     | 1/41 | 302/19330 | 0.4760136 | 0.4852941 | 0.1554895 | DRD1   | 1 |\n| BP | GO:0016485 | protein processing                                      | 1/41 | 310/19330 | 0.4849798 | 0.4940338 | 0.1582897 | ACE    | 1 |\n| BP | GO:0007568 | aging                                                   | 1/41 | 311/19330 | 0.4860899 | 0.4947631 | 0.1585234 | ADRA1A | 1 |\n| BP | GO:1904062 | regulation of cation transmembrane transport            | 1/41 | 314/19330 | 0.4894065 | 0.4977352 | 0.1594756 | DRD1   | 1 |\n| BP | GO:0015849 | organic acid transport                                  | 1/41 | 316/19330 | 0.4916060 | 0.4987595 | 0.1598038 | ACE    | 1 |\n| BP | GO:0046942 | carboxylic acid transport                               | 1/41 | 316/19330 | 0.4916060 | 0.4987595 | 0.1598038 | ACE    | 1 |\n| BP | GO:0051235 | maintenance of location                                 | 1/41 | 316/19330 | 0.4916060 | 0.4987595 | 0.1598038 | DRD1   | 1 |\n| BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 1/41 | 321/19330 | 0.4970642 | 0.5038898 | 0.1614476 | ADRA1A | 1 |\n| BP | GO:0001655 | urogenital system development                           | 1/41 | 322/19330 | 0.4981490 | 0.5045819 | 0.1616694 | ACE    | 1 |\n| BP | GO:0070372 | regulation of ERK1 and ERK2 cascade                     | 1/41 | 324/19330 | 0.5003117 | 0.5063638 | 0.1622403 | ADRA1A | 1 |\n| BP | GO:0032102 | negative regulation of response to external stimulus    | 1/41 | 328/19330 | 0.5046098 | 0.5103024 | 0.1635022 | DRD1   | 1 |\n| BP | GO:0070371 | ERK1 and ERK2 cascade                                   | 1/41 | 341/19330 | 0.5183312 | 0.5233352 | 0.1676779 | ADRA1A | 1 |\n| BP | GO:0006066 | alcohol metabolic process                               | 1/41 | 346/19330 | 0.5235093 | 0.5281384 | 0.1692169 | HRH1   | 1 |\n| BP | GO:0006869 | lipid transport                                         | 1/41 | 354/19330 | 0.5316815 | 0.5359520 | 0.1717204 | ACE    | 1 |\n| BP | GO:0051604 | protein maturation                                      | 1/41 | 373/19330 | 0.5505463 | 0.5536343 | 0.1773859 | ACE    | 1 |\n| BP | GO:0010959 | regulation of metal ion transport                       | 1/41 | 376/19330 | 0.5534563 | 0.5561151 | 0.1781807 | DRD1   | 1 |\n| BP | GO:0010876 | lipid localization                                      | 1/41 | 388/19330 | 0.5649139 | 0.5671736 | 0.1817239 | ACE    | 1 |\n| BP | GO:0007265 | Ras protein signal transduction                         | 1/41 | 429/19330 | 0.6019375 | 0.6038621 | 0.1934790 | ADRA1A | 1 |\n| BP | GO:0034765 | regulation of ion transmembrane transport               | 1/41 | 454/19330 | 0.6229847 | 0.6244775 | 0.2000842 | DRD1   | 1 |\n| BP | GO:0015711 | organic anion transport                                 | 1/41 | 460/19330 | 0.6278722 | 0.6288744 | 0.2014930 | ACE    | 1 |\n| BP | GO:0050900 | leukocyte migration                                     | 1/41 | 478/19330 | 0.6421666 | 0.6426787 | 0.2059159 | HRH1   | 1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 1076 × 10</caption>\n","<thead>\n","\t<tr><th scope=col>ont</th><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>BP</td><td>GO:0060789</td><td>hair follicle placode formation                       </td><td>6/41 </td><td>5/19330  </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0061197</td><td>fungiform papilla morphogenesis                       </td><td>6/41 </td><td>5/19330  </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0070932</td><td>histone H3 deacetylation                              </td><td>26/41</td><td>21/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     </td><td>26</td></tr>\n","\t<tr><td>BP</td><td>GO:0070933</td><td>histone H4 deacetylation                              </td><td>16/41</td><td>11/19330 </td><td>0.000000e+00</td><td>0.000000e+00</td><td>0.000000e+00</td><td>HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC2/HDAC3/HDAC4/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC8                                                                    </td><td>16</td></tr>\n","\t<tr><td>BP</td><td>GO:0016575</td><td>histone deacetylation                                 </td><td>26/41</td><td>86/19330 </td><td>6.489037e-53</td><td>6.264416e-51</td><td>2.007135e-51</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     </td><td>26</td></tr>\n","\t<tr><td>BP</td><td>GO:0006476</td><td>protein deacetylation                                 </td><td>26/41</td><td>101/19330</td><td>8.372876e-51</td><td>7.005307e-49</td><td>2.244518e-49</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     </td><td>26</td></tr>\n","\t<tr><td>BP</td><td>GO:0035601</td><td>protein deacylation                                   </td><td>26/41</td><td>111/19330</td><td>1.368786e-49</td><td>1.073641e-47</td><td>3.439975e-48</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     </td><td>26</td></tr>\n","\t<tr><td>BP</td><td>GO:0098732</td><td>macromolecule deacylation                             </td><td>26/41</td><td>112/19330</td><td>1.781265e-49</td><td>1.314993e-47</td><td>4.213272e-48</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/HDAC8     </td><td>26</td></tr>\n","\t<tr><td>BP</td><td>GO:0016570</td><td>histone modification                                  </td><td>27/41</td><td>456/19330</td><td>1.399645e-34</td><td>8.782770e-33</td><td>2.814022e-33</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8</td><td>27</td></tr>\n","\t<tr><td>BP</td><td>GO:0016569</td><td>covalent chromatin modification                       </td><td>27/41</td><td>469/19330</td><td>3.028543e-34</td><td>1.809915e-32</td><td>5.799014e-33</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC10/HDAC2/HDAC3/HDAC4/HDAC5/HDAC6/HDAC7/HDAC8/HDAC9/HDAC1/HDAC1/HDAC3/HDAC6/DRD1/HDAC8</td><td>27</td></tr>\n","\t<tr><td>BP</td><td>GO:0010870</td><td>positive regulation of receptor biosynthetic process  </td><td>9/41 </td><td>11/19330 </td><td>1.853730e-23</td><td>1.011492e-21</td><td>3.240846e-22</td><td>HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              </td><td> 9</td></tr>\n","\t<tr><td>BP</td><td>GO:0010869</td><td>regulation of receptor biosynthetic process           </td><td>9/41 </td><td>20/19330 </td><td>5.585446e-20</td><td>2.920723e-18</td><td>9.358072e-19</td><td>HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              </td><td> 9</td></tr>\n","\t<tr><td>BP</td><td>GO:0034983</td><td>peptidyl-lysine deacetylation                         </td><td>7/41 </td><td>7/19330  </td><td>1.124898e-19</td><td>5.646989e-18</td><td>1.809310e-18</td><td>HDAC4/HDAC6/HDAC9/HDAC4/HDAC6/HDAC9/HDAC6                                                                                                                          </td><td> 7</td></tr>\n","\t<tr><td>BP</td><td>GO:0032800</td><td>receptor biosynthetic process                         </td><td>9/41 </td><td>24/19330 </td><td>4.322178e-19</td><td>2.086282e-17</td><td>6.684501e-18</td><td>HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              </td><td> 9</td></tr>\n","\t<tr><td>BP</td><td>GO:0061196</td><td>fungiform papilla development                         </td><td>6/41 </td><td>6/19330  </td><td>6.210724e-17</td><td>2.687744e-15</td><td>8.611602e-16</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0043587</td><td>tongue morphogenesis                                  </td><td>6/41 </td><td>8/19330  </td><td>1.733607e-15</td><td>6.798991e-14</td><td>2.178414e-14</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0060788</td><td>ectodermal placode formation                          </td><td>6/41 </td><td>12/19330 </td><td>5.685459e-14</td><td>2.038643e-12</td><td>6.531865e-13</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0071697</td><td>ectodermal placode morphogenesis                      </td><td>6/41 </td><td>12/19330 </td><td>5.685459e-14</td><td>2.038643e-12</td><td>6.531865e-13</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0061029</td><td>eyelid development in camera-type eye                 </td><td>6/41 </td><td>13/19330 </td><td>1.054232e-13</td><td>3.392463e-12</td><td>1.086954e-12</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0071696</td><td>ectodermal placode development                        </td><td>6/41 </td><td>13/19330 </td><td>1.054232e-13</td><td>3.392463e-12</td><td>1.086954e-12</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0048709</td><td>oligodendrocyte differentiation                       </td><td>9/41 </td><td>87/19330 </td><td>1.543236e-13</td><td>4.841903e-12</td><td>1.551358e-12</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1                                                                                                           </td><td> 9</td></tr>\n","\t<tr><td>BP</td><td>GO:0060765</td><td>regulation of androgen receptor signaling pathway     </td><td>7/41 </td><td>29/19330 </td><td>1.697188e-13</td><td>5.195052e-12</td><td>1.664508e-12</td><td>HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                          </td><td> 7</td></tr>\n","\t<tr><td>BP</td><td>GO:0048714</td><td>positive regulation of oligodendrocyte differentiation</td><td>6/41 </td><td>17/19330 </td><td>7.556135e-13</td><td>2.061511e-11</td><td>6.605134e-12</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0006338</td><td>chromatin remodeling                                  </td><td>10/41</td><td>165/19330</td><td>1.392710e-12</td><td>3.718833e-11</td><td>1.191524e-11</td><td>HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC2/HDAC4/HDAC5/HDAC1/HDAC1                                                                                                        </td><td>10</td></tr>\n","\t<tr><td>BP</td><td>GO:0043586</td><td>tongue development                                    </td><td>6/41 </td><td>20/19330 </td><td>2.355476e-12</td><td>6.158587e-11</td><td>1.973227e-11</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0010001</td><td>glial cell differentiation                            </td><td>10/41</td><td>194/19330</td><td>7.029186e-12</td><td>1.764326e-10</td><td>5.652946e-11</td><td>HDAC1/HDAC10/HDAC11/HDAC2/HDAC1/HDAC10/HDAC2/HDAC1/HDAC1/DRD1                                                                                                      </td><td>10</td></tr>\n","\t<tr><td>BP</td><td>GO:0006342</td><td>chromatin silencing                                   </td><td>8/41 </td><td>106/19330</td><td>5.142466e-11</td><td>1.217697e-09</td><td>3.901533e-10</td><td>HDAC1/HDAC2/HDAC5/HDAC1/HDAC2/HDAC5/HDAC1/HDAC1                                                                                                                    </td><td> 8</td></tr>\n","\t<tr><td>BP</td><td>GO:0048713</td><td>regulation of oligodendrocyte differentiation         </td><td>6/41 </td><td>32/19330 </td><td>5.405253e-11</td><td>1.256221e-09</td><td>4.024964e-10</td><td>HDAC1/HDAC2/HDAC1/HDAC2/HDAC1/HDAC1                                                                                                                                </td><td> 6</td></tr>\n","\t<tr><td>BP</td><td>GO:0030521</td><td>androgen receptor signaling pathway                   </td><td>7/41 </td><td>70/19330 </td><td>1.223674e-10</td><td>2.742340e-09</td><td>8.786530e-10</td><td>HDAC1/HDAC6/HDAC1/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                                          </td><td> 7</td></tr>\n","\t<tr><td>BP</td><td>GO:0043112</td><td>receptor metabolic process                            </td><td>9/41 </td><td>184/19330</td><td>1.420954e-10</td><td>3.128591e-09</td><td>1.002409e-09</td><td>HDAC1/HDAC2/HDAC6/HDAC1/HDAC2/HDAC6/HDAC1/HDAC1/HDAC6                                                                                                              </td><td> 9</td></tr>\n","\t<tr><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td><td>⋮</td></tr>\n","\t<tr><td>BP</td><td>GO:0007411</td><td>axon guidance                                          </td><td>1/41</td><td>259/19330</td><td>0.4251487</td><td>0.4380637</td><td>0.1403567</td><td>TUBB3 </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0043270</td><td>positive regulation of ion transport                   </td><td>1/41</td><td>260/19330</td><td>0.4263845</td><td>0.4386169</td><td>0.1405340</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0097485</td><td>neuron projection guidance                             </td><td>1/41</td><td>260/19330</td><td>0.4263845</td><td>0.4386169</td><td>0.1405340</td><td>TUBB3 </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0032943</td><td>mononuclear cell proliferation                         </td><td>1/41</td><td>266/19330</td><td>0.4337454</td><td>0.4458235</td><td>0.1428430</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0001822</td><td>kidney development                                     </td><td>1/41</td><td>271/19330</td><td>0.4398089</td><td>0.4516859</td><td>0.1447214</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0051258</td><td>protein polymerization                                 </td><td>1/41</td><td>275/19330</td><td>0.4446142</td><td>0.4555027</td><td>0.1459442</td><td>TUBB4A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0070661</td><td>leukocyte proliferation                                </td><td>1/41</td><td>283/19330</td><td>0.4541042</td><td>0.4644668</td><td>0.1488164</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0072001</td><td>renal system development                               </td><td>1/41</td><td>286/19330</td><td>0.4576221</td><td>0.4676838</td><td>0.1498471</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0060326</td><td>cell chemotaxis                                        </td><td>1/41</td><td>295/19330</td><td>0.4680434</td><td>0.4779451</td><td>0.1531348</td><td>HRH1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0070588</td><td>calcium ion transmembrane transport                    </td><td>1/41</td><td>302/19330</td><td>0.4760136</td><td>0.4852941</td><td>0.1554895</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0016485</td><td>protein processing                                     </td><td>1/41</td><td>310/19330</td><td>0.4849798</td><td>0.4940338</td><td>0.1582897</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0007568</td><td>aging                                                  </td><td>1/41</td><td>311/19330</td><td>0.4860899</td><td>0.4947631</td><td>0.1585234</td><td>ADRA1A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:1904062</td><td>regulation of cation transmembrane transport           </td><td>1/41</td><td>314/19330</td><td>0.4894065</td><td>0.4977352</td><td>0.1594756</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0015849</td><td>organic acid transport                                 </td><td>1/41</td><td>316/19330</td><td>0.4916060</td><td>0.4987595</td><td>0.1598038</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0046942</td><td>carboxylic acid transport                              </td><td>1/41</td><td>316/19330</td><td>0.4916060</td><td>0.4987595</td><td>0.1598038</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0051235</td><td>maintenance of location                                </td><td>1/41</td><td>316/19330</td><td>0.4916060</td><td>0.4987595</td><td>0.1598038</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0051056</td><td>regulation of small GTPase mediated signal transduction</td><td>1/41</td><td>321/19330</td><td>0.4970642</td><td>0.5038898</td><td>0.1614476</td><td>ADRA1A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0001655</td><td>urogenital system development                          </td><td>1/41</td><td>322/19330</td><td>0.4981490</td><td>0.5045819</td><td>0.1616694</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0070372</td><td>regulation of ERK1 and ERK2 cascade                    </td><td>1/41</td><td>324/19330</td><td>0.5003117</td><td>0.5063638</td><td>0.1622403</td><td>ADRA1A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0032102</td><td>negative regulation of response to external stimulus   </td><td>1/41</td><td>328/19330</td><td>0.5046098</td><td>0.5103024</td><td>0.1635022</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0070371</td><td>ERK1 and ERK2 cascade                                  </td><td>1/41</td><td>341/19330</td><td>0.5183312</td><td>0.5233352</td><td>0.1676779</td><td>ADRA1A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0006066</td><td>alcohol metabolic process                              </td><td>1/41</td><td>346/19330</td><td>0.5235093</td><td>0.5281384</td><td>0.1692169</td><td>HRH1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0006869</td><td>lipid transport                                        </td><td>1/41</td><td>354/19330</td><td>0.5316815</td><td>0.5359520</td><td>0.1717204</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0051604</td><td>protein maturation                                     </td><td>1/41</td><td>373/19330</td><td>0.5505463</td><td>0.5536343</td><td>0.1773859</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0010959</td><td>regulation of metal ion transport                      </td><td>1/41</td><td>376/19330</td><td>0.5534563</td><td>0.5561151</td><td>0.1781807</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0010876</td><td>lipid localization                                     </td><td>1/41</td><td>388/19330</td><td>0.5649139</td><td>0.5671736</td><td>0.1817239</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0007265</td><td>Ras protein signal transduction                        </td><td>1/41</td><td>429/19330</td><td>0.6019375</td><td>0.6038621</td><td>0.1934790</td><td>ADRA1A</td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0034765</td><td>regulation of ion transmembrane transport              </td><td>1/41</td><td>454/19330</td><td>0.6229847</td><td>0.6244775</td><td>0.2000842</td><td>DRD1  </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0015711</td><td>organic anion transport                                </td><td>1/41</td><td>460/19330</td><td>0.6278722</td><td>0.6288744</td><td>0.2014930</td><td>ACE   </td><td>1</td></tr>\n","\t<tr><td>BP</td><td>GO:0050900</td><td>leukocyte migration                                    </td><td>1/41</td><td>478/19330</td><td>0.6421666</td><td>0.6426787</td><td>0.2059159</td><td>HRH1  </td><td>1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"id":"d3LXjzn-h9XB","colab":{"base_uri":"https://localhost:8080/","height":1000},"executionInfo":{"status":"ok","timestamp":1636338468033,"user_tz":-480,"elapsed":12,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"5d139ddc-baa7-48dc-a567-c67675cc40b0"},"source":["drop_na(wf_list$kegg_tb)"],"execution_count":51,"outputs":[{"output_type":"display_data","data":{"text/plain":["   ID       Description                                       GeneRatio\n","1  hsa05034 Alcoholism                                        27/41    \n","2  hsa04613 Neutrophil extracellular trap formation           26/41    \n","3  hsa05203 Viral carcinogenesis                              26/41    \n","4  hsa04540 Gap junction                                      12/41    \n","5  hsa05016 Huntington disease                                17/41    \n","6  hsa04145 Phagosome                                         11/41    \n","7  hsa05014 Amyotrophic lateral sclerosis                     14/41    \n","8  hsa05130 Pathogenic Escherichia coli infection             11/41    \n","9  hsa05012 Parkinson disease                                 12/41    \n","10 hsa04919 Thyroid hormone signaling pathway                 9/41     \n","11 hsa05132 Salmonella infection                              11/41    \n","12 hsa05031 Amphetamine addiction                             7/41     \n","13 hsa05020 Prion disease                                     11/41    \n","14 hsa04330 Notch signaling pathway                           6/41     \n","15 hsa04213 Longevity regulating pathway - multiple species   6/41     \n","16 hsa05220 Chronic myeloid leukemia                          6/41     \n","17 hsa05010 Alzheimer disease                                 11/41    \n","18 hsa05206 MicroRNAs in cancer                               10/41    \n","19 hsa05022 Pathways of neurodegeneration - multiple diseases 11/41    \n","20 hsa04110 Cell cycle                                        6/41     \n","21 hsa04210 Apoptosis                                         6/41     \n","22 hsa04530 Tight junction                                    6/41     \n","23 hsa05202 Transcriptional misregulation in cancer           6/41     \n","24 hsa05169 Epstein-Barr virus infection                      6/41     \n","25 hsa04371 Apelin signaling pathway                          4/41     \n","26 hsa05165 Human papillomavirus infection                    6/41     \n","27 hsa04614 Renin-angiotensin system                          1/41     \n","28 hsa04020 Calcium signaling pathway                         3/41     \n","29 hsa05030 Cocaine addiction                                 1/41     \n","30 hsa04080 Neuroactive ligand-receptor interaction           3/41     \n","31 hsa04924 Renin secretion                                   1/41     \n","32 hsa05410 Hypertrophic cardiomyopathy                       1/41     \n","33 hsa05032 Morphine addiction                                1/41     \n","34 hsa04970 Salivary secretion                                1/41     \n","35 hsa04750 Inflammatory mediator regulation of TRP channels  1/41     \n","36 hsa05142 Chagas disease                                    1/41     \n","37 hsa04152 AMPK signaling pathway                            1/41     \n","38 hsa04728 Dopaminergic synapse                              1/41     \n","39 hsa04270 Vascular smooth muscle contraction                1/41     \n","40 hsa04261 Adrenergic signaling in cardiomyocytes            1/41     \n","41 hsa04022 cGMP-PKG signaling pathway                        1/41     \n","42 hsa05415 Diabetic cardiomyopathy                           1/41     \n","43 hsa04024 cAMP signaling pathway                            1/41     \n","44 hsa05171 Coronavirus disease - COVID-19                    1/41     \n","   BgRatio  pvalue       p.adjust     qvalue      \n","1  187/8105 2.484687e-35 1.093262e-33 4.707828e-34\n","2  190/8105 3.408313e-33 7.498290e-32 3.228929e-32\n","3  204/8105 2.399346e-32 3.519041e-31 1.515377e-31\n","4  88/8105  7.571574e-15 8.328732e-14 3.586535e-14\n","5  306/8105 2.766830e-14 2.434810e-13 1.048483e-13\n","6  152/8105 1.367536e-10 1.002860e-09 4.318534e-10\n","7  364/8105 1.236296e-09 7.771005e-09 3.346366e-09\n","8  197/8105 2.211707e-09 1.216439e-08 5.238254e-09\n","9  266/8105 4.124709e-09 2.016524e-08 8.683598e-09\n","10 121/8105 6.401758e-09 2.816773e-08 1.212965e-08\n","11 249/8105 2.580020e-08 1.032008e-07 4.444054e-08\n","12 69/8105  4.244674e-08 1.556380e-07 6.702117e-08\n","13 273/8105 6.662155e-08 2.254883e-07 9.710024e-08\n","14 59/8105  4.234135e-07 1.330728e-06 5.730408e-07\n","15 62/8105  5.712819e-07 1.675760e-06 7.216192e-07\n","16 76/8105  1.928589e-06 5.291583e-06 2.278672e-06\n","17 384/8105 2.044475e-06 5.291583e-06 2.278672e-06\n","18 310/8105 2.261556e-06 5.528247e-06 2.380585e-06\n","19 476/8105 1.613424e-05 3.736351e-05 1.608955e-05\n","20 126/8105 3.607309e-05 7.936080e-05 3.417451e-05\n","21 136/8105 5.545450e-05 1.161904e-04 5.003413e-05\n","22 169/8105 1.846005e-04 3.692010e-04 1.589861e-04\n","23 192/8105 3.683098e-04 7.045927e-04 3.034131e-04\n","24 202/8105 4.831020e-04 8.856869e-04 3.813963e-04\n","25 139/8105 5.130563e-03 9.029791e-03 3.888427e-03\n","26 331/8105 5.952511e-03 1.007348e-02 4.337862e-03\n","27 23/8105  1.102388e-01 1.796485e-01 7.736059e-02\n","28 240/8105 1.204986e-01 1.893550e-01 8.154041e-02\n","29 49/8105  2.206082e-01 3.347159e-01 1.441360e-01\n","30 350/8105 2.598915e-01 3.811742e-01 1.641420e-01\n","31 69/8105  2.963046e-01 4.205613e-01 1.811030e-01\n","32 90/8105  3.680601e-01 4.888008e-01 2.104884e-01\n","33 91/8105  3.712927e-01 4.888008e-01 2.104884e-01\n","34 93/8105  3.777097e-01 4.888008e-01 2.104884e-01\n","35 98/8105  3.934738e-01 4.946527e-01 2.130083e-01\n","36 102/8105 4.058039e-01 4.959825e-01 2.135810e-01\n","37 120/8105 4.583292e-01 5.450401e-01 2.347063e-01\n","38 132/8105 4.907997e-01 5.596163e-01 2.409831e-01\n","39 134/8105 4.960235e-01 5.596163e-01 2.409831e-01\n","40 150/8105 5.359739e-01 5.895712e-01 2.538824e-01\n","41 167/8105 5.750346e-01 6.171103e-01 2.657413e-01\n","42 203/8105 6.474574e-01 6.782887e-01 2.920860e-01\n","43 219/8105 6.756383e-01 6.913508e-01 2.977109e-01\n","44 232/8105 6.969060e-01 6.969060e-01 3.001031e-01\n","   itemID                                                                                                                                             \n","1  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869\n","2  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     \n","3  3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     \n","4  1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               \n","5  3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                      \n","6  7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","7  10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                  \n","8  7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","9  1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               \n","10 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                       \n","11 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","12 3065/3066/3065/3066/3065/3065/1812                                                                                                                 \n","13 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","14 3065/3066/3065/3066/3065/3065                                                                                                                      \n","15 3065/3066/3065/3066/3065/3065                                                                                                                      \n","16 3065/3066/3065/3066/3065/3065                                                                                                                      \n","17 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","18 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                \n","19 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    \n","20 3065/3066/3065/3066/3065/3065                                                                                                                      \n","21 7846/10376/84790/7278/7277/51807                                                                                                                   \n","22 7846/10376/84790/7278/7277/51807                                                                                                                   \n","23 3065/3066/3065/3066/3065/3065                                                                                                                      \n","24 3065/3066/3065/3066/3065/3065                                                                                                                      \n","25 9759/10014/9759/10014                                                                                                                              \n","26 3065/3066/3065/3066/3065/3065                                                                                                                      \n","27 1636                                                                                                                                               \n","28 148/1812/3269                                                                                                                                      \n","29 1812                                                                                                                                               \n","30 148/1812/3269                                                                                                                                      \n","31 1636                                                                                                                                               \n","32 1636                                                                                                                                               \n","33 1812                                                                                                                                               \n","34 148                                                                                                                                                \n","35 3269                                                                                                                                               \n","36 1636                                                                                                                                               \n","37 148                                                                                                                                                \n","38 1812                                                                                                                                               \n","39 148                                                                                                                                                \n","40 148                                                                                                                                                \n","41 148                                                                                                                                                \n","42 1636                                                                                                                                               \n","43 1812                                                                                                                                               \n","44 1636                                                                                                                                               \n","   Count\n","1  27   \n","2  26   \n","3  26   \n","4  12   \n","5  17   \n","6  11   \n","7  14   \n","8  11   \n","9  12   \n","10  9   \n","11 11   \n","12  7   \n","13 11   \n","14  6   \n","15  6   \n","16  6   \n","17 11   \n","18 10   \n","19 11   \n","20  6   \n","21  6   \n","22  6   \n","23  6   \n","24  6   \n","25  4   \n","26  6   \n","27  1   \n","28  3   \n","29  1   \n","30  3   \n","31  1   \n","32  1   \n","33  1   \n","34  1   \n","35  1   \n","36  1   \n","37  1   \n","38  1   \n","39  1   \n","40  1   \n","41  1   \n","42  1   \n","43  1   \n","44  1   "],"text/latex":"A tibble: 44 × 9\n\\begin{tabular}{lllllllll}\n ID & Description & GeneRatio & BgRatio & pvalue & p.adjust & qvalue & itemID & Count\\\\\n <chr> & <chr> & <chr> & <chr> & <dbl> & <dbl> & <dbl> & <chr> & <dbl>\\\\\n\\hline\n\t hsa05034 & Alcoholism                                        & 27/41 & 187/8105 & 2.484687e-35 & 1.093262e-33 & 4.707828e-34 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869 & 27\\\\\n\t hsa04613 & Neutrophil extracellular trap formation           & 26/41 & 190/8105 & 3.408313e-33 & 7.498290e-32 & 3.228929e-32 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      & 26\\\\\n\t hsa05203 & Viral carcinogenesis                              & 26/41 & 204/8105 & 2.399346e-32 & 3.519041e-31 & 1.515377e-31 & 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      & 26\\\\\n\t hsa04540 & Gap junction                                      & 12/41 & 88/8105  & 7.571574e-15 & 8.328732e-14 & 3.586535e-14 & 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                & 12\\\\\n\t hsa05016 & Huntington disease                                & 17/41 & 306/8105 & 2.766830e-14 & 2.434810e-13 & 1.048483e-13 & 3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                       & 17\\\\\n\t hsa04145 & Phagosome                                         & 11/41 & 152/8105 & 1.367536e-10 & 1.002860e-09 & 4.318534e-10 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05014 & Amyotrophic lateral sclerosis                     & 14/41 & 364/8105 & 1.236296e-09 & 7.771005e-09 & 3.346366e-09 & 10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                   & 14\\\\\n\t hsa05130 & Pathogenic Escherichia coli infection             & 11/41 & 197/8105 & 2.211707e-09 & 1.216439e-08 & 5.238254e-09 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05012 & Parkinson disease                                 & 12/41 & 266/8105 & 4.124709e-09 & 2.016524e-08 & 8.683598e-09 & 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                & 12\\\\\n\t hsa04919 & Thyroid hormone signaling pathway                 & 9/41  & 121/8105 & 6.401758e-09 & 2.816773e-08 & 1.212965e-08 & 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                        &  9\\\\\n\t hsa05132 & Salmonella infection                              & 11/41 & 249/8105 & 2.580020e-08 & 1.032008e-07 & 4.444054e-08 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05031 & Amphetamine addiction                             & 7/41  & 69/8105  & 4.244674e-08 & 1.556380e-07 & 6.702117e-08 & 3065/3066/3065/3066/3065/3065/1812                                                                                                                  &  7\\\\\n\t hsa05020 & Prion disease                                     & 11/41 & 273/8105 & 6.662155e-08 & 2.254883e-07 & 9.710024e-08 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa04330 & Notch signaling pathway                           & 6/41  & 59/8105  & 4.234135e-07 & 1.330728e-06 & 5.730408e-07 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04213 & Longevity regulating pathway - multiple species   & 6/41  & 62/8105  & 5.712819e-07 & 1.675760e-06 & 7.216192e-07 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05220 & Chronic myeloid leukemia                          & 6/41  & 76/8105  & 1.928589e-06 & 5.291583e-06 & 2.278672e-06 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05010 & Alzheimer disease                                 & 11/41 & 384/8105 & 2.044475e-06 & 5.291583e-06 & 2.278672e-06 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa05206 & MicroRNAs in cancer                               & 10/41 & 310/8105 & 2.261556e-06 & 5.528247e-06 & 2.380585e-06 & 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                 & 10\\\\\n\t hsa05022 & Pathways of neurodegeneration - multiple diseases & 11/41 & 476/8105 & 1.613424e-05 & 3.736351e-05 & 1.608955e-05 & 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     & 11\\\\\n\t hsa04110 & Cell cycle                                        & 6/41  & 126/8105 & 3.607309e-05 & 7.936080e-05 & 3.417451e-05 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04210 & Apoptosis                                         & 6/41  & 136/8105 & 5.545450e-05 & 1.161904e-04 & 5.003413e-05 & 7846/10376/84790/7278/7277/51807                                                                                                                    &  6\\\\\n\t hsa04530 & Tight junction                                    & 6/41  & 169/8105 & 1.846005e-04 & 3.692010e-04 & 1.589861e-04 & 7846/10376/84790/7278/7277/51807                                                                                                                    &  6\\\\\n\t hsa05202 & Transcriptional misregulation in cancer           & 6/41  & 192/8105 & 3.683098e-04 & 7.045927e-04 & 3.034131e-04 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa05169 & Epstein-Barr virus infection                      & 6/41  & 202/8105 & 4.831020e-04 & 8.856869e-04 & 3.813963e-04 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04371 & Apelin signaling pathway                          & 4/41  & 139/8105 & 5.130563e-03 & 9.029791e-03 & 3.888427e-03 & 9759/10014/9759/10014                                                                                                                               &  4\\\\\n\t hsa05165 & Human papillomavirus infection                    & 6/41  & 331/8105 & 5.952511e-03 & 1.007348e-02 & 4.337862e-03 & 3065/3066/3065/3066/3065/3065                                                                                                                       &  6\\\\\n\t hsa04614 & Renin-angiotensin system                          & 1/41  & 23/8105  & 1.102388e-01 & 1.796485e-01 & 7.736059e-02 & 1636                                                                                                                                                &  1\\\\\n\t hsa04020 & Calcium signaling pathway                         & 3/41  & 240/8105 & 1.204986e-01 & 1.893550e-01 & 8.154041e-02 & 148/1812/3269                                                                                                                                       &  3\\\\\n\t hsa05030 & Cocaine addiction                                 & 1/41  & 49/8105  & 2.206082e-01 & 3.347159e-01 & 1.441360e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa04080 & Neuroactive ligand-receptor interaction           & 3/41  & 350/8105 & 2.598915e-01 & 3.811742e-01 & 1.641420e-01 & 148/1812/3269                                                                                                                                       &  3\\\\\n\t hsa04924 & Renin secretion                                   & 1/41  & 69/8105  & 2.963046e-01 & 4.205613e-01 & 1.811030e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa05410 & Hypertrophic cardiomyopathy                       & 1/41  & 90/8105  & 3.680601e-01 & 4.888008e-01 & 2.104884e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa05032 & Morphine addiction                                & 1/41  & 91/8105  & 3.712927e-01 & 4.888008e-01 & 2.104884e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa04970 & Salivary secretion                                & 1/41  & 93/8105  & 3.777097e-01 & 4.888008e-01 & 2.104884e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa04750 & Inflammatory mediator regulation of TRP channels  & 1/41  & 98/8105  & 3.934738e-01 & 4.946527e-01 & 2.130083e-01 & 3269                                                                                                                                                &  1\\\\\n\t hsa05142 & Chagas disease                                    & 1/41  & 102/8105 & 4.058039e-01 & 4.959825e-01 & 2.135810e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa04152 & AMPK signaling pathway                            & 1/41  & 120/8105 & 4.583292e-01 & 5.450401e-01 & 2.347063e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa04728 & Dopaminergic synapse                              & 1/41  & 132/8105 & 4.907997e-01 & 5.596163e-01 & 2.409831e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa04270 & Vascular smooth muscle contraction                & 1/41  & 134/8105 & 4.960235e-01 & 5.596163e-01 & 2.409831e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa04261 & Adrenergic signaling in cardiomyocytes            & 1/41  & 150/8105 & 5.359739e-01 & 5.895712e-01 & 2.538824e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa04022 & cGMP-PKG signaling pathway                        & 1/41  & 167/8105 & 5.750346e-01 & 6.171103e-01 & 2.657413e-01 & 148                                                                                                                                                 &  1\\\\\n\t hsa05415 & Diabetic cardiomyopathy                           & 1/41  & 203/8105 & 6.474574e-01 & 6.782887e-01 & 2.920860e-01 & 1636                                                                                                                                                &  1\\\\\n\t hsa04024 & cAMP signaling pathway                            & 1/41  & 219/8105 & 6.756383e-01 & 6.913508e-01 & 2.977109e-01 & 1812                                                                                                                                                &  1\\\\\n\t hsa05171 & Coronavirus disease - COVID-19                    & 1/41  & 232/8105 & 6.969060e-01 & 6.969060e-01 & 3.001031e-01 & 1636                                                                                                                                                &  1\\\\\n\\end{tabular}\n","text/markdown":"\nA tibble: 44 × 9\n\n| ID &lt;chr&gt; | Description &lt;chr&gt; | GeneRatio &lt;chr&gt; | BgRatio &lt;chr&gt; | pvalue &lt;dbl&gt; | p.adjust &lt;dbl&gt; | qvalue &lt;dbl&gt; | itemID &lt;chr&gt; | Count &lt;dbl&gt; |\n|---|---|---|---|---|---|---|---|---|\n| hsa05034 | Alcoholism                                        | 27/41 | 187/8105 | 2.484687e-35 | 1.093262e-33 | 4.707828e-34 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869 | 27 |\n| hsa04613 | Neutrophil extracellular trap formation           | 26/41 | 190/8105 | 3.408313e-33 | 7.498290e-32 | 3.228929e-32 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      | 26 |\n| hsa05203 | Viral carcinogenesis                              | 26/41 | 204/8105 | 2.399346e-32 | 3.519041e-31 | 1.515377e-31 | 3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869      | 26 |\n| hsa04540 | Gap junction                                      | 12/41 | 88/8105  | 7.571574e-15 | 8.328732e-14 | 3.586535e-14 | 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                | 12 |\n| hsa05016 | Huntington disease                                | 17/41 | 306/8105 | 2.766830e-14 | 2.434810e-13 | 1.048483e-13 | 3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                       | 17 |\n| hsa04145 | Phagosome                                         | 11/41 | 152/8105 | 1.367536e-10 | 1.002860e-09 | 4.318534e-10 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05014 | Amyotrophic lateral sclerosis                     | 14/41 | 364/8105 | 1.236296e-09 | 7.771005e-09 | 3.346366e-09 | 10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                   | 14 |\n| hsa05130 | Pathogenic Escherichia coli infection             | 11/41 | 197/8105 | 2.211707e-09 | 1.216439e-08 | 5.238254e-09 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05012 | Parkinson disease                                 | 12/41 | 266/8105 | 4.124709e-09 | 2.016524e-08 | 8.683598e-09 | 1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                | 12 |\n| hsa04919 | Thyroid hormone signaling pathway                 | 9/41  | 121/8105 | 6.401758e-09 | 2.816773e-08 | 1.212965e-08 | 3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                        |  9 |\n| hsa05132 | Salmonella infection                              | 11/41 | 249/8105 | 2.580020e-08 | 1.032008e-07 | 4.444054e-08 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05031 | Amphetamine addiction                             | 7/41  | 69/8105  | 4.244674e-08 | 1.556380e-07 | 6.702117e-08 | 3065/3066/3065/3066/3065/3065/1812                                                                                                                  |  7 |\n| hsa05020 | Prion disease                                     | 11/41 | 273/8105 | 6.662155e-08 | 2.254883e-07 | 9.710024e-08 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa04330 | Notch signaling pathway                           | 6/41  | 59/8105  | 4.234135e-07 | 1.330728e-06 | 5.730408e-07 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04213 | Longevity regulating pathway - multiple species   | 6/41  | 62/8105  | 5.712819e-07 | 1.675760e-06 | 7.216192e-07 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05220 | Chronic myeloid leukemia                          | 6/41  | 76/8105  | 1.928589e-06 | 5.291583e-06 | 2.278672e-06 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05010 | Alzheimer disease                                 | 11/41 | 384/8105 | 2.044475e-06 | 5.291583e-06 | 2.278672e-06 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa05206 | MicroRNAs in cancer                               | 10/41 | 310/8105 | 2.261556e-06 | 5.528247e-06 | 2.380585e-06 | 3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                 | 10 |\n| hsa05022 | Pathways of neurodegeneration - multiple diseases | 11/41 | 476/8105 | 1.613424e-05 | 3.736351e-05 | 1.608955e-05 | 7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                     | 11 |\n| hsa04110 | Cell cycle                                        | 6/41  | 126/8105 | 3.607309e-05 | 7.936080e-05 | 3.417451e-05 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04210 | Apoptosis                                         | 6/41  | 136/8105 | 5.545450e-05 | 1.161904e-04 | 5.003413e-05 | 7846/10376/84790/7278/7277/51807                                                                                                                    |  6 |\n| hsa04530 | Tight junction                                    | 6/41  | 169/8105 | 1.846005e-04 | 3.692010e-04 | 1.589861e-04 | 7846/10376/84790/7278/7277/51807                                                                                                                    |  6 |\n| hsa05202 | Transcriptional misregulation in cancer           | 6/41  | 192/8105 | 3.683098e-04 | 7.045927e-04 | 3.034131e-04 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa05169 | Epstein-Barr virus infection                      | 6/41  | 202/8105 | 4.831020e-04 | 8.856869e-04 | 3.813963e-04 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04371 | Apelin signaling pathway                          | 4/41  | 139/8105 | 5.130563e-03 | 9.029791e-03 | 3.888427e-03 | 9759/10014/9759/10014                                                                                                                               |  4 |\n| hsa05165 | Human papillomavirus infection                    | 6/41  | 331/8105 | 5.952511e-03 | 1.007348e-02 | 4.337862e-03 | 3065/3066/3065/3066/3065/3065                                                                                                                       |  6 |\n| hsa04614 | Renin-angiotensin system                          | 1/41  | 23/8105  | 1.102388e-01 | 1.796485e-01 | 7.736059e-02 | 1636                                                                                                                                                |  1 |\n| hsa04020 | Calcium signaling pathway                         | 3/41  | 240/8105 | 1.204986e-01 | 1.893550e-01 | 8.154041e-02 | 148/1812/3269                                                                                                                                       |  3 |\n| hsa05030 | Cocaine addiction                                 | 1/41  | 49/8105  | 2.206082e-01 | 3.347159e-01 | 1.441360e-01 | 1812                                                                                                                                                |  1 |\n| hsa04080 | Neuroactive ligand-receptor interaction           | 3/41  | 350/8105 | 2.598915e-01 | 3.811742e-01 | 1.641420e-01 | 148/1812/3269                                                                                                                                       |  3 |\n| hsa04924 | Renin secretion                                   | 1/41  | 69/8105  | 2.963046e-01 | 4.205613e-01 | 1.811030e-01 | 1636                                                                                                                                                |  1 |\n| hsa05410 | Hypertrophic cardiomyopathy                       | 1/41  | 90/8105  | 3.680601e-01 | 4.888008e-01 | 2.104884e-01 | 1636                                                                                                                                                |  1 |\n| hsa05032 | Morphine addiction                                | 1/41  | 91/8105  | 3.712927e-01 | 4.888008e-01 | 2.104884e-01 | 1812                                                                                                                                                |  1 |\n| hsa04970 | Salivary secretion                                | 1/41  | 93/8105  | 3.777097e-01 | 4.888008e-01 | 2.104884e-01 | 148                                                                                                                                                 |  1 |\n| hsa04750 | Inflammatory mediator regulation of TRP channels  | 1/41  | 98/8105  | 3.934738e-01 | 4.946527e-01 | 2.130083e-01 | 3269                                                                                                                                                |  1 |\n| hsa05142 | Chagas disease                                    | 1/41  | 102/8105 | 4.058039e-01 | 4.959825e-01 | 2.135810e-01 | 1636                                                                                                                                                |  1 |\n| hsa04152 | AMPK signaling pathway                            | 1/41  | 120/8105 | 4.583292e-01 | 5.450401e-01 | 2.347063e-01 | 148                                                                                                                                                 |  1 |\n| hsa04728 | Dopaminergic synapse                              | 1/41  | 132/8105 | 4.907997e-01 | 5.596163e-01 | 2.409831e-01 | 1812                                                                                                                                                |  1 |\n| hsa04270 | Vascular smooth muscle contraction                | 1/41  | 134/8105 | 4.960235e-01 | 5.596163e-01 | 2.409831e-01 | 148                                                                                                                                                 |  1 |\n| hsa04261 | Adrenergic signaling in cardiomyocytes            | 1/41  | 150/8105 | 5.359739e-01 | 5.895712e-01 | 2.538824e-01 | 148                                                                                                                                                 |  1 |\n| hsa04022 | cGMP-PKG signaling pathway                        | 1/41  | 167/8105 | 5.750346e-01 | 6.171103e-01 | 2.657413e-01 | 148                                                                                                                                                 |  1 |\n| hsa05415 | Diabetic cardiomyopathy                           | 1/41  | 203/8105 | 6.474574e-01 | 6.782887e-01 | 2.920860e-01 | 1636                                                                                                                                                |  1 |\n| hsa04024 | cAMP signaling pathway                            | 1/41  | 219/8105 | 6.756383e-01 | 6.913508e-01 | 2.977109e-01 | 1812                                                                                                                                                |  1 |\n| hsa05171 | Coronavirus disease - COVID-19                    | 1/41  | 232/8105 | 6.969060e-01 | 6.969060e-01 | 3.001031e-01 | 1636                                                                                                                                                |  1 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A tibble: 44 × 9</caption>\n","<thead>\n","\t<tr><th scope=col>ID</th><th scope=col>Description</th><th scope=col>GeneRatio</th><th scope=col>BgRatio</th><th scope=col>pvalue</th><th scope=col>p.adjust</th><th scope=col>qvalue</th><th scope=col>itemID</th><th scope=col>Count</th></tr>\n","\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><td>hsa05034</td><td>Alcoholism                                       </td><td>27/41</td><td>187/8105</td><td>2.484687e-35</td><td>1.093262e-33</td><td>4.707828e-34</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/1812/55869</td><td>27</td></tr>\n","\t<tr><td>hsa04613</td><td>Neutrophil extracellular trap formation          </td><td>26/41</td><td>190/8105</td><td>3.408313e-33</td><td>7.498290e-32</td><td>3.228929e-32</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     </td><td>26</td></tr>\n","\t<tr><td>hsa05203</td><td>Viral carcinogenesis                             </td><td>26/41</td><td>204/8105</td><td>2.399346e-32</td><td>3.519041e-31</td><td>1.515377e-31</td><td>3065/83933/79885/3066/8841/9759/10014/10013/51564/55869/9734/3065/83933/3066/8841/9759/10014/10013/51564/55869/9734/3065/3065/8841/10013/55869     </td><td>26</td></tr>\n","\t<tr><td>hsa04540</td><td>Gap junction                                     </td><td>12/41</td><td>88/8105 </td><td>7.571574e-15</td><td>8.328732e-14</td><td>3.586535e-14</td><td>1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               </td><td>12</td></tr>\n","\t<tr><td>hsa05016</td><td>Huntington disease                               </td><td>17/41</td><td>306/8105</td><td>2.766830e-14</td><td>2.434810e-13</td><td>1.048483e-13</td><td>3065/3066/3065/3066/3065/3065/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                      </td><td>17</td></tr>\n","\t<tr><td>hsa04145</td><td>Phagosome                                        </td><td>11/41</td><td>152/8105</td><td>1.367536e-10</td><td>1.002860e-09</td><td>4.318534e-10</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05014</td><td>Amyotrophic lateral sclerosis                    </td><td>14/41</td><td>364/8105</td><td>1.236296e-09</td><td>7.771005e-09</td><td>3.346366e-09</td><td>10013/10013/10013/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                  </td><td>14</td></tr>\n","\t<tr><td>hsa05130</td><td>Pathogenic Escherichia coli infection            </td><td>11/41</td><td>197/8105</td><td>2.211707e-09</td><td>1.216439e-08</td><td>5.238254e-09</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05012</td><td>Parkinson disease                                </td><td>12/41</td><td>266/8105</td><td>4.124709e-09</td><td>2.016524e-08</td><td>8.683598e-09</td><td>1812/7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                               </td><td>12</td></tr>\n","\t<tr><td>hsa04919</td><td>Thyroid hormone signaling pathway                </td><td>9/41 </td><td>121/8105</td><td>6.401758e-09</td><td>2.816773e-08</td><td>1.212965e-08</td><td>3065/3066/8841/3065/3066/8841/3065/3065/8841                                                                                                       </td><td> 9</td></tr>\n","\t<tr><td>hsa05132</td><td>Salmonella infection                             </td><td>11/41</td><td>249/8105</td><td>2.580020e-08</td><td>1.032008e-07</td><td>4.444054e-08</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05031</td><td>Amphetamine addiction                            </td><td>7/41 </td><td>69/8105 </td><td>4.244674e-08</td><td>1.556380e-07</td><td>6.702117e-08</td><td>3065/3066/3065/3066/3065/3065/1812                                                                                                                 </td><td> 7</td></tr>\n","\t<tr><td>hsa05020</td><td>Prion disease                                    </td><td>11/41</td><td>273/8105</td><td>6.662155e-08</td><td>2.254883e-07</td><td>9.710024e-08</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa04330</td><td>Notch signaling pathway                          </td><td>6/41 </td><td>59/8105 </td><td>4.234135e-07</td><td>1.330728e-06</td><td>5.730408e-07</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04213</td><td>Longevity regulating pathway - multiple species  </td><td>6/41 </td><td>62/8105 </td><td>5.712819e-07</td><td>1.675760e-06</td><td>7.216192e-07</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05220</td><td>Chronic myeloid leukemia                         </td><td>6/41 </td><td>76/8105 </td><td>1.928589e-06</td><td>5.291583e-06</td><td>2.278672e-06</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05010</td><td>Alzheimer disease                                </td><td>11/41</td><td>384/8105</td><td>2.044475e-06</td><td>5.291583e-06</td><td>2.278672e-06</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa05206</td><td>MicroRNAs in cancer                              </td><td>10/41</td><td>310/8105</td><td>2.261556e-06</td><td>5.528247e-06</td><td>2.380585e-06</td><td>3065/3066/9759/10014/3065/3066/9759/10014/3065/3065                                                                                                </td><td>10</td></tr>\n","\t<tr><td>hsa05022</td><td>Pathways of neurodegeneration - multiple diseases</td><td>11/41</td><td>476/8105</td><td>1.613424e-05</td><td>3.736351e-05</td><td>1.608955e-05</td><td>7846/10376/84790/7278/7277/51807/203068/81027/10381/10382/10383                                                                                    </td><td>11</td></tr>\n","\t<tr><td>hsa04110</td><td>Cell cycle                                       </td><td>6/41 </td><td>126/8105</td><td>3.607309e-05</td><td>7.936080e-05</td><td>3.417451e-05</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04210</td><td>Apoptosis                                        </td><td>6/41 </td><td>136/8105</td><td>5.545450e-05</td><td>1.161904e-04</td><td>5.003413e-05</td><td>7846/10376/84790/7278/7277/51807                                                                                                                   </td><td> 6</td></tr>\n","\t<tr><td>hsa04530</td><td>Tight junction                                   </td><td>6/41 </td><td>169/8105</td><td>1.846005e-04</td><td>3.692010e-04</td><td>1.589861e-04</td><td>7846/10376/84790/7278/7277/51807                                                                                                                   </td><td> 6</td></tr>\n","\t<tr><td>hsa05202</td><td>Transcriptional misregulation in cancer          </td><td>6/41 </td><td>192/8105</td><td>3.683098e-04</td><td>7.045927e-04</td><td>3.034131e-04</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa05169</td><td>Epstein-Barr virus infection                     </td><td>6/41 </td><td>202/8105</td><td>4.831020e-04</td><td>8.856869e-04</td><td>3.813963e-04</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04371</td><td>Apelin signaling pathway                         </td><td>4/41 </td><td>139/8105</td><td>5.130563e-03</td><td>9.029791e-03</td><td>3.888427e-03</td><td>9759/10014/9759/10014                                                                                                                              </td><td> 4</td></tr>\n","\t<tr><td>hsa05165</td><td>Human papillomavirus infection                   </td><td>6/41 </td><td>331/8105</td><td>5.952511e-03</td><td>1.007348e-02</td><td>4.337862e-03</td><td>3065/3066/3065/3066/3065/3065                                                                                                                      </td><td> 6</td></tr>\n","\t<tr><td>hsa04614</td><td>Renin-angiotensin system                         </td><td>1/41 </td><td>23/8105 </td><td>1.102388e-01</td><td>1.796485e-01</td><td>7.736059e-02</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04020</td><td>Calcium signaling pathway                        </td><td>3/41 </td><td>240/8105</td><td>1.204986e-01</td><td>1.893550e-01</td><td>8.154041e-02</td><td>148/1812/3269                                                                                                                                      </td><td> 3</td></tr>\n","\t<tr><td>hsa05030</td><td>Cocaine addiction                                </td><td>1/41 </td><td>49/8105 </td><td>2.206082e-01</td><td>3.347159e-01</td><td>1.441360e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04080</td><td>Neuroactive ligand-receptor interaction          </td><td>3/41 </td><td>350/8105</td><td>2.598915e-01</td><td>3.811742e-01</td><td>1.641420e-01</td><td>148/1812/3269                                                                                                                                      </td><td> 3</td></tr>\n","\t<tr><td>hsa04924</td><td>Renin secretion                                  </td><td>1/41 </td><td>69/8105 </td><td>2.963046e-01</td><td>4.205613e-01</td><td>1.811030e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05410</td><td>Hypertrophic cardiomyopathy                      </td><td>1/41 </td><td>90/8105 </td><td>3.680601e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05032</td><td>Morphine addiction                               </td><td>1/41 </td><td>91/8105 </td><td>3.712927e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04970</td><td>Salivary secretion                               </td><td>1/41 </td><td>93/8105 </td><td>3.777097e-01</td><td>4.888008e-01</td><td>2.104884e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa04750</td><td>Inflammatory mediator regulation of TRP channels </td><td>1/41 </td><td>98/8105 </td><td>3.934738e-01</td><td>4.946527e-01</td><td>2.130083e-01</td><td>3269                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05142</td><td>Chagas disease                                   </td><td>1/41 </td><td>102/8105</td><td>4.058039e-01</td><td>4.959825e-01</td><td>2.135810e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04152</td><td>AMPK signaling pathway                           </td><td>1/41 </td><td>120/8105</td><td>4.583292e-01</td><td>5.450401e-01</td><td>2.347063e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa04728</td><td>Dopaminergic synapse                             </td><td>1/41 </td><td>132/8105</td><td>4.907997e-01</td><td>5.596163e-01</td><td>2.409831e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04270</td><td>Vascular smooth muscle contraction               </td><td>1/41 </td><td>134/8105</td><td>4.960235e-01</td><td>5.596163e-01</td><td>2.409831e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa04261</td><td>Adrenergic signaling in cardiomyocytes           </td><td>1/41 </td><td>150/8105</td><td>5.359739e-01</td><td>5.895712e-01</td><td>2.538824e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa04022</td><td>cGMP-PKG signaling pathway                       </td><td>1/41 </td><td>167/8105</td><td>5.750346e-01</td><td>6.171103e-01</td><td>2.657413e-01</td><td>148                                                                                                                                                </td><td> 1</td></tr>\n","\t<tr><td>hsa05415</td><td>Diabetic cardiomyopathy                          </td><td>1/41 </td><td>203/8105</td><td>6.474574e-01</td><td>6.782887e-01</td><td>2.920860e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa04024</td><td>cAMP signaling pathway                           </td><td>1/41 </td><td>219/8105</td><td>6.756383e-01</td><td>6.913508e-01</td><td>2.977109e-01</td><td>1812                                                                                                                                               </td><td> 1</td></tr>\n","\t<tr><td>hsa05171</td><td>Coronavirus disease - COVID-19                   </td><td>1/41 </td><td>232/8105</td><td>6.969060e-01</td><td>6.969060e-01</td><td>3.001031e-01</td><td>1636                                                                                                                                               </td><td> 1</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":411},"id":"YmkBl4wml-Mh","executionInfo":{"status":"ok","timestamp":1636338468034,"user_tz":-480,"elapsed":11,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"8830a82f-d2e6-4286-ca5d-c4a55ea7f5ad"},"source":["cmap"],"execution_count":52,"outputs":[{"output_type":"display_data","data":{"text/plain":["#\n","# gessResult object \n","#\n","@result \n","\u001b[90m# A tibble: 100 × 10\u001b[39m\n","   pert       PCID    cell  type  trend raw_score scaled_score N_upset N_downset\n","   \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m      \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m   \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m \u001b[3m\u001b[90m<chr>\u001b[39m\u001b[23m     \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m        \u001b[3m\u001b[90m<dbl>\u001b[39m\u001b[23m   \u001b[3m\u001b[90m<int>\u001b[39m\u001b[23m     \u001b[3m\u001b[90m<int>\u001b[39m\u001b[23m\n","\u001b[90m 1\u001b[39m vorinostat 5311    SKB   trt_… up        1.94         1         150       150\n","\u001b[90m 2\u001b[39m rescinnam… 5280954 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m295\u001b[39m       -\u001b[31m1\u001b[39m         150       150\n","\u001b[90m 3\u001b[39m zuclopent… 5311507 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m287\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m972\u001b[39m     150       150\n","\u001b[90m 4\u001b[39m evoxine    673465  SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m244\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m828\u001b[39m     150       150\n","\u001b[90m 5\u001b[39m scoulerine 439654  SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m242\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m821\u001b[39m     150       150\n","\u001b[90m 6\u001b[39m gangliosi… 4673190 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m239\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m809\u001b[39m     150       150\n","\u001b[90m 7\u001b[39m warfarin   546784… SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m234\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m794\u001b[39m     150       150\n","\u001b[90m 8\u001b[39m trichosta… 444732  SKB   trt_… up        1.50         0.775     150       150\n","\u001b[90m 9\u001b[39m endecaphy… 6710740 SKB   trt_… down     -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m224\u001b[39m       -\u001b[31m0\u001b[39m\u001b[31m.\u001b[39m\u001b[31m760\u001b[39m     150       150\n","\u001b[90m10\u001b[39m HC-toxin   3571    SKB   trt_… up        1.44         0.745     150       150\n","\u001b[90m# … with 90 more rows, and 1 more variable: t_gn_sym <chr>\u001b[39m\n","@query \t up gene set (150): \t 230 5357 2015 2542 1759 6195 80347 5050 5883 6251 ... \n","      \t down gene set (150): \t 22864 9338 54793 10384 27000 10161 23363 114034 2997 23108 ... \n","\n","@gess_method \t CMAP \n","\n","@refdb \t /usr/local/lib/R/site-library/signatureSearch/extdata/sample_db.h5 "]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"RrZ7jITqlzkm","executionInfo":{"status":"ok","timestamp":1636338487746,"user_tz":-480,"elapsed":19721,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"7dbcfe58-c888-4e53-c9e1-d835293a3d09"},"source":["drug <- 'evoxine'\n","env_dir <- tempdir()\n","wf_list <- runWF(drug, cell, refdb, gess_method=\"LINCS\", \n","    fea_method=\"dup_hyperG\", N_gess_drugs=10, env_dir=env_dir, tau=FALSE)"],"execution_count":53,"outputs":[{"output_type":"stream","name":"stderr","text":["150 / 150 genes in up set share identifiers with reference database\n","\n","150 / 150 genes in down set share identifiers with reference database\n","\n","No targets found in all databases for 3 drugs: \n","evoxine / st-4066738 / fillalbin\n","\n","\n","No targets found in all databases for 3 drugs: \n","evoxine / st-4066738 / fillalbin\n","\n","\n","No targets found in all databases for 3 drugs: \n","evoxine / st-4066738 / fillalbin\n","\n","\n"]}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":450},"id":"bIbkxrsXmqUu","executionInfo":{"status":"ok","timestamp":1636338495470,"user_tz":-480,"elapsed":7731,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"6079a8c6-370e-42e7-dcf9-7f347cb361ba"},"source":["cmap <- eh[[\"EH3223\"]]; cmap_expr <- eh[[\"EH3224\"]]\n","lincs <- eh[[\"EH3226\"]]; lincs_expr <- eh[[\"EH3227\"]]\n","h5ls(lincs)"],"execution_count":54,"outputs":[{"output_type":"stream","name":"stderr","text":["see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n","see ?signatureSearchData and browseVignettes('signatureSearchData') for documentation\n","\n","loading from cache\n","\n"]},{"output_type":"display_data","data":{"text/plain":["  group name     otype       dclass dim          \n","0 /     assay    H5I_DATASET FLOAT  12328 x 45956\n","1 /     colnames H5I_DATASET STRING 45956 x 1    \n","2 /     rownames H5I_DATASET STRING 12328 x 1    "],"text/latex":"A data.frame: 3 × 5\n\\begin{tabular}{r|lllll}\n  & group & name & otype & dclass & dim\\\\\n  & <chr> & <chr> & <chr> & <chr> & <chr>\\\\\n\\hline\n\t0 & / & assay    & H5I\\_DATASET & FLOAT  & 12328 x 45956\\\\\n\t1 & / & colnames & H5I\\_DATASET & STRING & 45956 x 1    \\\\\n\t2 & / & rownames & H5I\\_DATASET & STRING & 12328 x 1    \\\\\n\\end{tabular}\n","text/markdown":"\nA data.frame: 3 × 5\n\n| <!--/--> | group &lt;chr&gt; | name &lt;chr&gt; | otype &lt;chr&gt; | dclass &lt;chr&gt; | dim &lt;chr&gt; |\n|---|---|---|---|---|---|\n| 0 | / | assay    | H5I_DATASET | FLOAT  | 12328 x 45956 |\n| 1 | / | colnames | H5I_DATASET | STRING | 45956 x 1     |\n| 2 | / | rownames | H5I_DATASET | STRING | 12328 x 1     |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A data.frame: 3 × 5</caption>\n","<thead>\n","\t<tr><th></th><th scope=col>group</th><th scope=col>name</th><th scope=col>otype</th><th scope=col>dclass</th><th scope=col>dim</th></tr>\n","\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><th scope=row>0</th><td>/</td><td>assay   </td><td>H5I_DATASET</td><td>FLOAT </td><td>12328 x 45956</td></tr>\n","\t<tr><th scope=row>1</th><td>/</td><td>colnames</td><td>H5I_DATASET</td><td>STRING</td><td>45956 x 1    </td></tr>\n","\t<tr><th scope=row>2</th><td>/</td><td>rownames</td><td>H5I_DATASET</td><td>STRING</td><td>12328 x 1    </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":217},"id":"tjfCUxOYqKaN","executionInfo":{"status":"ok","timestamp":1636338495736,"user_tz":-480,"elapsed":275,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"3b624d7c-dd39-4456-fde9-6e88a7345fe7"},"source":["h5ls(cmap)"],"execution_count":55,"outputs":[{"output_type":"display_data","data":{"text/plain":["  group name     otype       dclass dim         \n","0 /     assay    H5I_DATASET FLOAT  12403 x 3478\n","1 /     colnames H5I_DATASET STRING 3478 x 1    \n","2 /     padj     H5I_DATASET FLOAT  12403 x 3478\n","3 /     rownames H5I_DATASET STRING 12403 x 1   "],"text/latex":"A data.frame: 4 × 5\n\\begin{tabular}{r|lllll}\n  & group & name & otype & dclass & dim\\\\\n  & <chr> & <chr> & <chr> & <chr> & <chr>\\\\\n\\hline\n\t0 & / & assay    & H5I\\_DATASET & FLOAT  & 12403 x 3478\\\\\n\t1 & / & colnames & H5I\\_DATASET & STRING & 3478 x 1    \\\\\n\t2 & / & padj     & H5I\\_DATASET & FLOAT  & 12403 x 3478\\\\\n\t3 & / & rownames & H5I\\_DATASET & STRING & 12403 x 1   \\\\\n\\end{tabular}\n","text/markdown":"\nA data.frame: 4 × 5\n\n| <!--/--> | group &lt;chr&gt; | name &lt;chr&gt; | otype &lt;chr&gt; | dclass &lt;chr&gt; | dim &lt;chr&gt; |\n|---|---|---|---|---|---|\n| 0 | / | assay    | H5I_DATASET | FLOAT  | 12403 x 3478 |\n| 1 | / | colnames | H5I_DATASET | STRING | 3478 x 1     |\n| 2 | / | padj     | H5I_DATASET | FLOAT  | 12403 x 3478 |\n| 3 | / | rownames | H5I_DATASET | STRING | 12403 x 1    |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A data.frame: 4 × 5</caption>\n","<thead>\n","\t<tr><th></th><th scope=col>group</th><th scope=col>name</th><th scope=col>otype</th><th scope=col>dclass</th><th scope=col>dim</th></tr>\n","\t<tr><th></th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><th scope=row>0</th><td>/</td><td>assay   </td><td>H5I_DATASET</td><td>FLOAT </td><td>12403 x 3478</td></tr>\n","\t<tr><th scope=row>1</th><td>/</td><td>colnames</td><td>H5I_DATASET</td><td>STRING</td><td>3478 x 1    </td></tr>\n","\t<tr><th scope=row>2</th><td>/</td><td>padj    </td><td>H5I_DATASET</td><td>FLOAT </td><td>12403 x 3478</td></tr>\n","\t<tr><th scope=row>3</th><td>/</td><td>rownames</td><td>H5I_DATASET</td><td>STRING</td><td>12403 x 1   </td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"id":"zV4aJWMc3O-x","colab":{"base_uri":"https://localhost:8080/","height":284},"executionInfo":{"status":"ok","timestamp":1636338504741,"user_tz":-480,"elapsed":9009,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"c7b49a69-29ff-403e-ab16-9fa5a566c8a2"},"source":["cmap_db <- h5read(cmap_expr, name='assay')\n","rownames(cmap_db) <- h5read(cmap_expr, name='rownames')\n","colnames(cmap_db) <- h5read(cmap_expr, name='colnames')\n","head(cmap_db)"],"execution_count":56,"outputs":[{"output_type":"display_data","data":{"text/plain":["      (-)-atenolol__HL60__trt_cp (-)-atenolol__MCF7__trt_cp\n","10      3.944944                   2.775439                \n","100   113.797852                 566.188253                \n","1000    4.710985                   9.089360                \n","10000 294.690815                  26.646685                \n","10001 379.397558                 332.851746                \n","10002  15.936979                  29.818017                \n","      (-)-atenolol__PC3__trt_cp (-)-catechin__MCF7__trt_cp\n","10       2.567904                 2.285298                \n","100    221.892316               641.645919                \n","1000  1189.658447                18.093555                \n","10000  562.453553                37.374182                \n","10001 1346.898072               811.499503                \n","10002   15.522077                35.569466                \n","      (-)-isoprenaline__HL60__trt_cp (-)-isoprenaline__MCF7__trt_cp\n","10      2.236065                       6.192177                    \n","100    85.005499                     659.077556                    \n","1000   25.109200                      16.876221                    \n","10000 317.624590                      26.173294                    \n","10001 221.010439                     548.680375                    \n","10002   6.362289                      34.345412                    \n","      (-)-isoprenaline__PC3__trt_cp (-)-MK-801__HL60__trt_cp\n","10       1.427446                     2.415172              \n","100    266.334650                   102.096946              \n","1000   839.705642                    12.223669              \n","10000  424.678887                   368.643313              \n","10001 1083.407982                   364.028834              \n","10002   25.851880                    30.139198              \n","      (-)-MK-801__MCF7__trt_cp (-)-MK-801__PC3__trt_cp ⋯ zimeldine__PC3__trt_cp\n","10      3.695098                  3.636766             ⋯   36.20966            \n","100   501.552146                211.282256             ⋯  242.05819            \n","1000   33.155667               1332.028385             ⋯ 1904.64027            \n","10000  56.119237                464.549203             ⋯  726.33904            \n","10001 394.235845                736.698468             ⋯  426.91583            \n","10002  23.045184                  6.290986             ⋯   39.94316            \n","      zomepirac__HL60__trt_cp zomepirac__MCF7__trt_cp zomepirac__PC3__trt_cp\n","10      2.317943                3.60565                  2.366148           \n","100   299.551533              695.00658                184.123391           \n","1000    8.924897               17.02563                922.589647           \n","10000 204.383002               23.48133                464.380462           \n","10001 275.380103              660.96568               1019.593649           \n","10002  17.083898               27.64735                 35.106161           \n","      zoxazolamine__HL60__trt_cp zoxazolamine__MCF7__trt_cp\n","10      4.458931                  14.35209                 \n","100   152.224569                 513.47997                 \n","1000    5.859901                  14.72093                 \n","10000 357.654435                  25.66000                 \n","10001 145.209229                 471.03600                 \n","10002  43.436668                  53.42645                 \n","      zoxazolamine__PC3__trt_cp zuclopenthixol__HL60__trt_cp\n","10      24.70981                  6.632426                  \n","100    254.19571                114.170324                  \n","1000  2455.63906                  4.692525                  \n","10000  999.34626                321.465720                  \n","10001  463.22103                423.294786                  \n","10002   30.55594                 24.628253                  \n","      zuclopenthixol__MCF7__trt_cp zuclopenthixol__PC3__trt_cp\n","10      4.030373                      8.000441                \n","100   776.956241                    141.329154                \n","1000   18.261065                   1194.454511                \n","10000  30.644380                    572.252353                \n","10001 502.904136                    924.021392                \n","10002  35.130305                     43.064585                "],"text/latex":"A matrix: 6 × 3587 of type dbl\n\\begin{tabular}{r|lllllllllllllllllllll}\n  & (-)-atenolol\\_\\_HL60\\_\\_trt\\_cp & (-)-atenolol\\_\\_MCF7\\_\\_trt\\_cp & (-)-atenolol\\_\\_PC3\\_\\_trt\\_cp & (-)-catechin\\_\\_MCF7\\_\\_trt\\_cp & (-)-isoprenaline\\_\\_HL60\\_\\_trt\\_cp & (-)-isoprenaline\\_\\_MCF7\\_\\_trt\\_cp & (-)-isoprenaline\\_\\_PC3\\_\\_trt\\_cp & (-)-MK-801\\_\\_HL60\\_\\_trt\\_cp & (-)-MK-801\\_\\_MCF7\\_\\_trt\\_cp & (-)-MK-801\\_\\_PC3\\_\\_trt\\_cp & ⋯ & zimeldine\\_\\_PC3\\_\\_trt\\_cp & zomepirac\\_\\_HL60\\_\\_trt\\_cp & zomepirac\\_\\_MCF7\\_\\_trt\\_cp & zomepirac\\_\\_PC3\\_\\_trt\\_cp & zoxazolamine\\_\\_HL60\\_\\_trt\\_cp & zoxazolamine\\_\\_MCF7\\_\\_trt\\_cp & zoxazolamine\\_\\_PC3\\_\\_trt\\_cp & zuclopenthixol\\_\\_HL60\\_\\_trt\\_cp & zuclopenthixol\\_\\_MCF7\\_\\_trt\\_cp & zuclopenthixol\\_\\_PC3\\_\\_trt\\_cp\\\\\n\\hline\n\t10 &   3.944944 &   2.775439 &    2.567904 &   2.285298 &   2.236065 &   6.192177 &    1.427446 &   2.415172 &   3.695098 &    3.636766 & ⋯ &   36.20966 &   2.317943 &   3.60565 &    2.366148 &   4.458931 &  14.35209 &   24.70981 &   6.632426 &   4.030373 &    8.000441\\\\\n\t100 & 113.797852 & 566.188253 &  221.892316 & 641.645919 &  85.005499 & 659.077556 &  266.334650 & 102.096946 & 501.552146 &  211.282256 & ⋯ &  242.05819 & 299.551533 & 695.00658 &  184.123391 & 152.224569 & 513.47997 &  254.19571 & 114.170324 & 776.956241 &  141.329154\\\\\n\t1000 &   4.710985 &   9.089360 & 1189.658447 &  18.093555 &  25.109200 &  16.876221 &  839.705642 &  12.223669 &  33.155667 & 1332.028385 & ⋯ & 1904.64027 &   8.924897 &  17.02563 &  922.589647 &   5.859901 &  14.72093 & 2455.63906 &   4.692525 &  18.261065 & 1194.454511\\\\\n\t10000 & 294.690815 &  26.646685 &  562.453553 &  37.374182 & 317.624590 &  26.173294 &  424.678887 & 368.643313 &  56.119237 &  464.549203 & ⋯ &  726.33904 & 204.383002 &  23.48133 &  464.380462 & 357.654435 &  25.66000 &  999.34626 & 321.465720 &  30.644380 &  572.252353\\\\\n\t10001 & 379.397558 & 332.851746 & 1346.898072 & 811.499503 & 221.010439 & 548.680375 & 1083.407982 & 364.028834 & 394.235845 &  736.698468 & ⋯ &  426.91583 & 275.380103 & 660.96568 & 1019.593649 & 145.209229 & 471.03600 &  463.22103 & 423.294786 & 502.904136 &  924.021392\\\\\n\t10002 &  15.936979 &  29.818017 &   15.522077 &  35.569466 &   6.362289 &  34.345412 &   25.851880 &  30.139198 &  23.045184 &    6.290986 & ⋯ &   39.94316 &  17.083898 &  27.64735 &   35.106161 &  43.436668 &  53.42645 &   30.55594 &  24.628253 &  35.130305 &   43.064585\\\\\n\\end{tabular}\n","text/markdown":"\nA matrix: 6 × 3587 of type dbl\n\n| <!--/--> | (-)-atenolol__HL60__trt_cp | (-)-atenolol__MCF7__trt_cp | (-)-atenolol__PC3__trt_cp | (-)-catechin__MCF7__trt_cp | (-)-isoprenaline__HL60__trt_cp | (-)-isoprenaline__MCF7__trt_cp | (-)-isoprenaline__PC3__trt_cp | (-)-MK-801__HL60__trt_cp | (-)-MK-801__MCF7__trt_cp | (-)-MK-801__PC3__trt_cp | ⋯ | zimeldine__PC3__trt_cp | zomepirac__HL60__trt_cp | zomepirac__MCF7__trt_cp | zomepirac__PC3__trt_cp | zoxazolamine__HL60__trt_cp | zoxazolamine__MCF7__trt_cp | zoxazolamine__PC3__trt_cp | zuclopenthixol__HL60__trt_cp | zuclopenthixol__MCF7__trt_cp | zuclopenthixol__PC3__trt_cp |\n|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n| 10 |   3.944944 |   2.775439 |    2.567904 |   2.285298 |   2.236065 |   6.192177 |    1.427446 |   2.415172 |   3.695098 |    3.636766 | ⋯ |   36.20966 |   2.317943 |   3.60565 |    2.366148 |   4.458931 |  14.35209 |   24.70981 |   6.632426 |   4.030373 |    8.000441 |\n| 100 | 113.797852 | 566.188253 |  221.892316 | 641.645919 |  85.005499 | 659.077556 |  266.334650 | 102.096946 | 501.552146 |  211.282256 | ⋯ |  242.05819 | 299.551533 | 695.00658 |  184.123391 | 152.224569 | 513.47997 |  254.19571 | 114.170324 | 776.956241 |  141.329154 |\n| 1000 |   4.710985 |   9.089360 | 1189.658447 |  18.093555 |  25.109200 |  16.876221 |  839.705642 |  12.223669 |  33.155667 | 1332.028385 | ⋯ | 1904.64027 |   8.924897 |  17.02563 |  922.589647 |   5.859901 |  14.72093 | 2455.63906 |   4.692525 |  18.261065 | 1194.454511 |\n| 10000 | 294.690815 |  26.646685 |  562.453553 |  37.374182 | 317.624590 |  26.173294 |  424.678887 | 368.643313 |  56.119237 |  464.549203 | ⋯ |  726.33904 | 204.383002 |  23.48133 |  464.380462 | 357.654435 |  25.66000 |  999.34626 | 321.465720 |  30.644380 |  572.252353 |\n| 10001 | 379.397558 | 332.851746 | 1346.898072 | 811.499503 | 221.010439 | 548.680375 | 1083.407982 | 364.028834 | 394.235845 |  736.698468 | ⋯ |  426.91583 | 275.380103 | 660.96568 | 1019.593649 | 145.209229 | 471.03600 |  463.22103 | 423.294786 | 502.904136 |  924.021392 |\n| 10002 |  15.936979 |  29.818017 |   15.522077 |  35.569466 |   6.362289 |  34.345412 |   25.851880 |  30.139198 |  23.045184 |    6.290986 | ⋯ |   39.94316 |  17.083898 |  27.64735 |   35.106161 |  43.436668 |  53.42645 |   30.55594 |  24.628253 |  35.130305 |   43.064585 |\n\n","text/html":["<table class=\"dataframe\">\n","<caption>A matrix: 6 × 3587 of type dbl</caption>\n","<thead>\n","\t<tr><th></th><th scope=col>(-)-atenolol__HL60__trt_cp</th><th scope=col>(-)-atenolol__MCF7__trt_cp</th><th scope=col>(-)-atenolol__PC3__trt_cp</th><th scope=col>(-)-catechin__MCF7__trt_cp</th><th scope=col>(-)-isoprenaline__HL60__trt_cp</th><th scope=col>(-)-isoprenaline__MCF7__trt_cp</th><th scope=col>(-)-isoprenaline__PC3__trt_cp</th><th scope=col>(-)-MK-801__HL60__trt_cp</th><th scope=col>(-)-MK-801__MCF7__trt_cp</th><th scope=col>(-)-MK-801__PC3__trt_cp</th><th scope=col>⋯</th><th scope=col>zimeldine__PC3__trt_cp</th><th scope=col>zomepirac__HL60__trt_cp</th><th scope=col>zomepirac__MCF7__trt_cp</th><th scope=col>zomepirac__PC3__trt_cp</th><th scope=col>zoxazolamine__HL60__trt_cp</th><th scope=col>zoxazolamine__MCF7__trt_cp</th><th scope=col>zoxazolamine__PC3__trt_cp</th><th scope=col>zuclopenthixol__HL60__trt_cp</th><th scope=col>zuclopenthixol__MCF7__trt_cp</th><th scope=col>zuclopenthixol__PC3__trt_cp</th></tr>\n","</thead>\n","<tbody>\n","\t<tr><th scope=row>10</th><td>  3.944944</td><td>  2.775439</td><td>   2.567904</td><td>  2.285298</td><td>  2.236065</td><td>  6.192177</td><td>   1.427446</td><td>  2.415172</td><td>  3.695098</td><td>   3.636766</td><td>⋯</td><td>  36.20966</td><td>  2.317943</td><td>  3.60565</td><td>   2.366148</td><td>  4.458931</td><td> 14.35209</td><td>  24.70981</td><td>  6.632426</td><td>  4.030373</td><td>   8.000441</td></tr>\n","\t<tr><th scope=row>100</th><td>113.797852</td><td>566.188253</td><td> 221.892316</td><td>641.645919</td><td> 85.005499</td><td>659.077556</td><td> 266.334650</td><td>102.096946</td><td>501.552146</td><td> 211.282256</td><td>⋯</td><td> 242.05819</td><td>299.551533</td><td>695.00658</td><td> 184.123391</td><td>152.224569</td><td>513.47997</td><td> 254.19571</td><td>114.170324</td><td>776.956241</td><td> 141.329154</td></tr>\n","\t<tr><th scope=row>1000</th><td>  4.710985</td><td>  9.089360</td><td>1189.658447</td><td> 18.093555</td><td> 25.109200</td><td> 16.876221</td><td> 839.705642</td><td> 12.223669</td><td> 33.155667</td><td>1332.028385</td><td>⋯</td><td>1904.64027</td><td>  8.924897</td><td> 17.02563</td><td> 922.589647</td><td>  5.859901</td><td> 14.72093</td><td>2455.63906</td><td>  4.692525</td><td> 18.261065</td><td>1194.454511</td></tr>\n","\t<tr><th scope=row>10000</th><td>294.690815</td><td> 26.646685</td><td> 562.453553</td><td> 37.374182</td><td>317.624590</td><td> 26.173294</td><td> 424.678887</td><td>368.643313</td><td> 56.119237</td><td> 464.549203</td><td>⋯</td><td> 726.33904</td><td>204.383002</td><td> 23.48133</td><td> 464.380462</td><td>357.654435</td><td> 25.66000</td><td> 999.34626</td><td>321.465720</td><td> 30.644380</td><td> 572.252353</td></tr>\n","\t<tr><th scope=row>10001</th><td>379.397558</td><td>332.851746</td><td>1346.898072</td><td>811.499503</td><td>221.010439</td><td>548.680375</td><td>1083.407982</td><td>364.028834</td><td>394.235845</td><td> 736.698468</td><td>⋯</td><td> 426.91583</td><td>275.380103</td><td>660.96568</td><td>1019.593649</td><td>145.209229</td><td>471.03600</td><td> 463.22103</td><td>423.294786</td><td>502.904136</td><td> 924.021392</td></tr>\n","\t<tr><th scope=row>10002</th><td> 15.936979</td><td> 29.818017</td><td>  15.522077</td><td> 35.569466</td><td>  6.362289</td><td> 34.345412</td><td>  25.851880</td><td> 30.139198</td><td> 23.045184</td><td>   6.290986</td><td>⋯</td><td>  39.94316</td><td> 17.083898</td><td> 27.64735</td><td>  35.106161</td><td> 43.436668</td><td> 53.42645</td><td>  30.55594</td><td> 24.628253</td><td> 35.130305</td><td>  43.064585</td></tr>\n","</tbody>\n","</table>\n"]},"metadata":{}}]},{"cell_type":"code","metadata":{"colab":{"base_uri":"https://localhost:8080/","height":191},"id":"ZU4DuCVKxPTL","executionInfo":{"status":"error","timestamp":1636338505014,"user_tz":-480,"elapsed":293,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}},"outputId":"29a3a98d-bd4b-4e82-e803-a1b2a7e85654"},"source":["drug <- \"vorinostat\"; cell <- \"SKB\"\n","env_dir <- tempdir()\n","wf_list <- runWF(drug, cell, cmap_db, gess_method=\"CMAP\", \n","    fea_method=\"dup_hyperG\", N_gess_drugs=10, env_dir=env_dir, tau=FALSE)"],"execution_count":57,"outputs":[{"output_type":"error","ename":"ERROR","evalue":"ignored","traceback":["Error in apply(deprof, 2, sort, decreasing = TRUE): dim(X) must have a positive length\nTraceback:\n","1. runWF(drug, cell, cmap_db, gess_method = \"CMAP\", fea_method = \"dup_hyperG\", \n .     N_gess_drugs = 10, env_dir = env_dir, tau = FALSE)","2. getDEGSig(drug, cell, Nup = Nup, Ndown = Ndown, refdb = refdb)","3. apply(deprof, 2, sort, decreasing = TRUE)","4. stop(\"dim(X) must have a positive length\")"]}]},{"cell_type":"code","metadata":{"id":"JKJS3s79xY-D","executionInfo":{"status":"aborted","timestamp":1636338504743,"user_tz":-480,"elapsed":3122621,"user":{"displayName":"Indrik Wijaya","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"00208067985282844199"}}},"source":[""],"execution_count":null,"outputs":[]}]}